Clustering O 0 9.045814977071132e-07
of O 0 4.572048961648534e-09
missense O 0 0.00018652412109076977
mutations O 0 4.1362094634678215e-05
in O 0 2.781017416353393e-09
the O 0 2.93359363467971e-07
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999958276748657
telangiectasia I-Disease 1 0.9999997615814209
gene O 0 3.3806078135967255e-05
in O 0 1.0380214465754989e-09
a O 0 1.943333938214664e-09
sporadic B-Disease 0 5.430888995761052e-05
T I-Disease 1 0.9968532919883728
- I-Disease 0 0.04268968477845192
cell I-Disease 0 0.18918746709823608
leukaemia I-Disease 0 0.3809850215911865
. O 0 1.7531069929077603e-08

Ataxia B-Disease 1 0.9999977350234985
- I-Disease 1 0.999980092048645
telangiectasia I-Disease 1 0.9999994039535522
( O 0 3.873051809932804e-06
A B-Disease 1 0.9999954700469971
- I-Disease 1 0.9999974966049194
T I-Disease 1 0.9999998807907104
) O 0 6.923671358460837e-11
is O 0 5.2063206176788945e-12
a O 0 4.928899649536689e-11
recessive B-Disease 0 7.970998922246508e-06
multi I-Disease 0 0.011696835048496723
- I-Disease 1 0.9975234866142273
system I-Disease 0 0.0008375614415854216
disorder I-Disease 0 0.0009329603053629398
caused O 0 2.304384949525229e-08
by O 0 3.7387825474466396e-11
mutations O 0 1.9592492961351127e-08
in O 0 6.441540877089036e-12
the O 0 3.0956882023092103e-12
ATM O 0 2.88066530629294e-08
gene O 0 1.3249504826617908e-09
at O 0 8.555351566075231e-11
11q22 O 0 5.282891901714493e-09
- O 0 5.281182069438728e-08
q23 O 0 3.5358322492129446e-08
( O 0 3.4965336181969064e-11
ref O 0 1.5928560515021672e-07
. O 0 3.0919234186854716e-12
3 O 0 5.8857653993660275e-12
) O 0 7.653955594322248e-12
. O 0 3.16920018006428e-10

The O 0 7.715528660412474e-09
risk O 0 1.3530181774967787e-07
of O 0 8.691852099174113e-11
cancer B-Disease 0 4.3602753976301756e-06
, O 0 9.215195967415823e-11
especially O 0 3.0818347873662333e-10
lymphoid B-Disease 0 1.7197997692619538e-07
neoplasias I-Disease 0 5.665768640028546e-06
, O 0 1.3713688171157479e-11
is O 0 9.934641650999332e-12
substantially O 0 1.4505844303513982e-09
elevated O 0 9.086472374519872e-08
in O 0 1.7810599661771676e-09
A B-Disease 1 0.9999909400939941
- I-Disease 1 0.9999984502792358
T I-Disease 1 1.0
patients O 0 2.0749623672600137e-06
and O 0 4.955345467294592e-09
has O 0 2.6822588594654917e-09
long O 0 2.8777367155896627e-09
been O 0 2.6289646015698054e-09
associated O 0 4.45106884683355e-09
with O 0 5.336435293656905e-09
chromosomal O 1 0.9999980926513672
instability O 1 0.9999498128890991
. O 0 1.2864414600244345e-07

By O 0 6.7334551268061205e-09
analysing O 0 3.484021362964995e-06
tumour B-Disease 1 0.9998655319213867
DNA O 0 1.5606150327585055e-06
from O 0 5.246138523595789e-10
patients O 0 7.648126021386759e-10
with O 0 4.550243168366386e-11
sporadic B-Disease 0 1.4466789252765011e-05
T I-Disease 1 0.9513567090034485
- I-Disease 0 0.00015731321764178574
cell I-Disease 0 0.00040637102210894227
prolymphocytic I-Disease 0 0.007890602573752403
leukaemia I-Disease 0 0.034087520092725754
( O 0 6.016815934373199e-10
T B-Disease 0 6.438791024265811e-05
- I-Disease 0 2.3277059426618507e-06
PLL I-Disease 0 4.1625694393587764e-06
) O 0 8.617728058935015e-12
, O 0 1.838592348030535e-13
a O 0 4.921250906786412e-12
rare O 0 1.2009996330775152e-09
clonal B-Disease 0 2.900547428907885e-07
malignancy I-Disease 0 2.581023727543652e-05
with O 0 2.246848193609985e-11
similarities O 0 1.4522482105761014e-09
to O 0 1.772535070110326e-11
a O 0 4.4482422190128545e-09
mature B-Disease 0 6.988892096160271e-07
T I-Disease 0 5.7571549405111e-05
- I-Disease 0 5.908948992328078e-07
cell I-Disease 0 1.340532980975695e-05
leukaemia I-Disease 0 3.297830335213803e-05
seen O 0 1.0934693506214899e-07
in O 0 3.516767710376456e-10
A B-Disease 1 0.9998598098754883
- I-Disease 1 0.9999599456787109
T I-Disease 1 0.9999997615814209
, O 0 6.863661028422285e-11
we O 0 3.8563974930072575e-11
demonstrate O 0 4.521546331792692e-11
a O 0 3.069431861457694e-11
high O 0 3.136905457612471e-10
frequency O 0 1.1134709820836974e-09
of O 0 1.4874593527378077e-12
ATM O 0 5.160674163562362e-07
mutations O 0 2.0942147216373996e-07
in O 0 2.4204100945723894e-09
T B-Disease 0 0.0009770892793312669
- I-Disease 0 1.9687568055815063e-05
PLL I-Disease 0 7.066176476655528e-05
. O 0 2.0215697560388435e-08

In O 0 1.4344859744497285e-09
marked O 0 2.658873787808602e-09
contrast O 0 3.2223406165599044e-09
to O 0 1.925187223181246e-12
the O 0 2.937923558946065e-12
ATM O 0 3.565145618722454e-07
mutation O 0 3.149522598278054e-08
pattern O 0 7.989304151578835e-08
in O 0 5.433998251369587e-10
A B-Disease 1 0.999909520149231
- I-Disease 1 0.999982476234436
T I-Disease 1 0.9999998807907104
, O 0 3.1693678931299374e-11
the O 0 3.4463548009323886e-13
most O 0 4.891965196644754e-13
frequent O 0 5.62349680710561e-11
nucleotide O 0 3.1846641990185276e-10
changes O 0 9.827967432929352e-12
in O 0 4.009137639926497e-12
this O 0 5.268537342506541e-11
leukaemia B-Disease 0 7.961722985783126e-06
were O 0 2.46446529850175e-09
missense O 0 3.184188244631514e-05
mutations O 0 4.255254680174403e-06
. O 0 1.4449904384150614e-08

These O 0 1.1962580925839461e-09
clustered O 0 6.85207890427364e-09
in O 0 4.287034269245815e-11
the O 0 4.6587421420607456e-12
region O 0 3.3384656150659e-11
corresponding O 0 7.230455817408554e-11
to O 0 1.8127938386514053e-12
the O 0 7.43189038955594e-13
kinase O 0 1.5889370930111113e-09
domain O 0 4.682398913047336e-10
, O 0 1.0861624100133582e-12
which O 0 1.0969197555485422e-12
is O 0 1.9592266177481665e-12
highly O 0 1.9269110612674112e-11
conserved O 0 1.0686512785795799e-10
in O 0 4.758308764368779e-12
ATM O 0 3.6728916796846534e-08
- O 0 8.132576390096347e-09
related O 0 2.660170694834818e-10
proteins O 0 9.949033784317773e-12
in O 0 2.4135927631507847e-12
mouse O 0 4.646441009725777e-09
, O 0 6.600891708230527e-12
yeast O 0 1.526877291269102e-09
and O 0 2.2448404246588893e-10
Drosophila O 0 2.5838557959900754e-09
. O 0 4.3521058978868155e-10

The O 0 1.6182438722367465e-09
resulting O 0 2.6350188697676913e-09
amino O 0 5.307087547201661e-10
- O 0 6.9397021462691555e-09
acid O 0 1.777224478693995e-10
substitutions O 0 4.704815426137543e-10
are O 0 9.942432294129944e-12
predicted O 0 8.336852042045706e-11
to O 0 6.204296516647279e-13
interfere O 0 2.3804991311493495e-10
with O 0 6.070017752324297e-12
ATP O 0 2.8908464511090415e-09
binding O 0 2.1209267675459387e-09
or O 0 1.711932817727302e-10
substrate O 0 8.459723233045224e-08
recognition O 0 1.3394191533677713e-08
. O 0 1.1508807240545593e-08

Two O 0 1.3778848895196205e-10
of O 0 9.436099471238357e-12
seventeen O 0 1.7964812970561184e-09
mutated O 0 1.5877631653893332e-07
T B-Disease 0 1.7448730432079174e-05
- I-Disease 0 2.128159621861414e-07
PLL I-Disease 0 1.0174575209020986e-06
samples O 0 2.2251990472454963e-08
had O 0 5.033493621908747e-10
a O 0 1.332220167515885e-10
previously O 0 3.5225308891995155e-08
reported O 0 2.446641929054749e-06
A B-Disease 1 0.9999316930770874
- I-Disease 1 0.9999748468399048
T I-Disease 1 0.9999986886978149
allele O 0 2.6109815735253505e-05
. O 0 1.1682844025528993e-08

In O 0 1.4570564754734505e-09
contrast O 0 5.317073004107442e-08
, O 0 8.589098182687493e-11
no O 0 8.550543051377701e-10
mutations O 0 3.9113540850621575e-08
were O 0 1.2496975676512534e-09
detected O 0 3.284143588189181e-07
in O 0 6.666864109383663e-12
the O 0 2.5290086864970807e-12
p53 O 0 1.7045269362636617e-10
gene O 0 4.990989288522485e-10
, O 0 4.6904277337112e-13
suggesting O 0 5.093419574997426e-10
that O 0 1.2793636809671494e-11
this O 0 1.165314372775228e-10
tumour B-Disease 1 0.9999715089797974
suppressor O 0 1.6967695046332665e-05
is O 0 7.353924691422264e-10
not O 0 1.1454571319235995e-10
frequently O 0 1.1955418877107604e-09
altered O 0 6.203575431129593e-09
in O 0 8.807418683254298e-11
this O 0 1.4526387870361646e-09
leukaemia B-Disease 0 6.657074118265882e-05
. O 0 2.9142865898279524e-09

Occasional O 0 2.383501396252541e-06
missense O 0 9.096333087654784e-05
mutations O 0 7.254360752995126e-06
in O 0 3.2198446686670934e-10
ATM O 0 6.534961016768648e-07
were O 0 2.0952899415505044e-09
also O 0 9.102799763960334e-11
found O 0 5.497937105580775e-10
in O 0 2.181708147475092e-10
tumour B-Disease 1 0.9999791383743286
DNA O 0 8.612322943690742e-08
from O 0 3.907970475003353e-11
patients O 0 2.2854468317845544e-10
with O 0 1.297861540461298e-10
B B-Disease 0 5.850732804901781e-07
- I-Disease 0 1.0804101293615531e-06
cell I-Disease 0 2.2841564714326523e-05
non I-Disease 0 1.2852548252340057e-06
- I-Disease 0 0.35221928358078003
Hodgkins I-Disease 1 0.921935498714447
lymphomas I-Disease 0 0.004245570860803127
( O 0 9.756569163688056e-11
B B-Disease 0 1.7031215548968248e-08
- I-Disease 0 4.438769352077543e-08
NHL I-Disease 0 5.319697571337656e-09
) O 0 2.1152987673099533e-13
and O 0 1.659504239755194e-12
a O 0 2.15532841574273e-10
B B-Disease 0 1.1343854566803202e-07
- I-Disease 0 2.95593395094329e-07
NHL I-Disease 0 2.2140731914532807e-08
cell O 0 7.389758138742764e-08
line O 0 5.442385031528829e-08
. O 0 1.5035521716555422e-09

The O 0 3.0539407114282824e-10
evidence O 0 1.5543802356354774e-10
of O 0 5.163536156808923e-13
a O 0 1.2741321669604289e-12
significant O 0 3.678310694227305e-12
proportion O 0 3.627094180558288e-10
of O 0 1.422878091392188e-12
loss O 0 1.5606373970911136e-09
- O 0 1.527386883637405e-09
of O 0 5.55282816255831e-12
- O 0 2.9097790843479743e-07
function O 0 5.6291038497136014e-09
mutations O 0 1.4065446585220798e-09
and O 0 3.2054170515799507e-12
a O 0 3.3010801123861677e-12
complete O 0 1.6175016187558455e-11
absence O 0 7.067584711917263e-11
of O 0 2.2125815177416464e-13
the O 0 2.905368653993712e-12
normal O 0 3.387328265103129e-11
copy O 0 1.079937389514285e-10
of O 0 1.8170300062746864e-13
ATM O 0 4.206252679495037e-09
in O 0 5.798085969677125e-12
the O 0 9.948401694451214e-13
majority O 0 1.979273342445076e-11
of O 0 2.9251431138410666e-11
mutated O 0 4.072796582477167e-05
tumours B-Disease 1 0.9999722242355347
establishes O 0 2.2171834146433866e-08
somatic O 0 1.6691419801873053e-08
inactivation O 0 4.826249622169598e-08
of O 0 1.058749550704452e-12
this O 0 1.3424191229113869e-12
gene O 0 5.418657536560012e-11
in O 0 5.629900625553352e-12
the O 0 3.4629415220782667e-12
pathogenesis O 0 2.1211290501810254e-09
of O 0 2.3793846667258256e-12
sporadic B-Disease 0 8.540932299183623e-07
T I-Disease 0 0.0801292434334755
- I-Disease 0 1.3010040902372566e-06
PLL I-Disease 0 2.154641606466612e-06
and O 0 2.1648248471617393e-10
suggests O 0 1.7788930051221286e-10
that O 0 3.931106308530108e-12
ATM O 0 1.2877825916746133e-08
acts O 0 1.2964718187902236e-09
as O 0 1.4825148053621007e-11
a O 0 6.612948411088837e-09
tumour B-Disease 1 0.9999765157699585
suppressor O 0 0.00030640955083072186
. O 0 3.601521925133966e-08

As O 0 6.121599893660346e-10
constitutional O 0 5.0779858096206e-10
DNA O 0 5.355893506475695e-08
was O 0 1.2126312398663686e-08
not O 0 2.168088278353686e-11
available O 0 4.231917333924473e-12
, O 0 1.6115474026860005e-13
a O 0 1.892837102335232e-11
putative O 0 1.7711190025693213e-07
hereditary O 0 0.0004971966263838112
predisposition O 0 7.06221690052189e-05
to O 0 1.080354561366903e-08
T B-Disease 0 0.004231740720570087
- I-Disease 0 1.0123261517946958e-06
PLL I-Disease 0 3.040175442947657e-06
will O 0 7.77472947133262e-11
require O 0 2.1503422306667908e-11
further O 0 3.3361974207529732e-12
investigation O 0 1.1829663915108313e-09
. O 0 1.1028977731086798e-10
. O 0 5.826227833516384e-10

Myotonic B-Disease 1 0.9999774694442749
dystrophy I-Disease 1 0.9999924898147583
protein O 0 3.676828055176884e-05
kinase O 0 2.3366081222775392e-05
is O 0 5.139647041296769e-10
involved O 0 7.085968617426275e-11
in O 0 2.7068362742216356e-12
the O 0 1.1257438124051555e-12
modulation O 0 5.862243468435224e-10
of O 0 8.208501153100789e-13
the O 0 1.6809094047220974e-11
Ca2 O 0 8.382993854638698e-08
+ O 0 2.480722649522704e-08
homeostasis O 0 2.799545200105058e-06
in O 0 2.9690971903306718e-09
skeletal O 0 4.0096871089190245e-05
muscle O 0 7.981725502759218e-06
cells O 0 4.22324973214927e-07
. O 0 8.581802823925955e-09

Myotonic B-Disease 1 0.9999908208847046
dystrophy I-Disease 1 0.9999988079071045
( O 0 1.608913044037763e-05
DM B-Disease 1 0.9999978542327881
) O 0 1.132611671117445e-09
, O 0 5.4423015573290545e-12
the O 0 3.1206224670315974e-12
most O 0 8.80150813342695e-11
prevalent O 0 8.509833833159064e-07
muscular B-Disease 1 0.500067949295044
disorder I-Disease 0 0.009365099482238293
in O 0 6.506377658865858e-09
adults O 0 4.4389133790900814e-07
, O 0 7.351775438424468e-11
is O 0 3.030966588823958e-10
caused O 0 1.0078197831830948e-08
by O 0 1.1363589236257354e-10
( O 0 1.2770377637305597e-11
CTG O 0 1.5178244439084665e-08
) O 0 6.210252039180741e-13
n O 0 4.90855356360953e-10
- O 0 4.6322273794530133e-10
repeat O 0 1.8337490415021307e-09
expansion O 0 3.693582592556588e-11
in O 0 1.3093400062086369e-12
a O 0 1.9428306619745372e-12
gene O 0 2.35097444983845e-11
encoding O 0 1.9947019730404136e-11
a O 0 3.057302327968969e-11
protein O 0 3.4996860964753296e-09
kinase O 0 1.766899345057027e-06
( O 0 1.2407505023404042e-09
DM B-Disease 1 0.9999986886978149
protein O 0 3.566107693586673e-07
kinase O 0 4.93348761665402e-06
; O 0 2.0011124701735383e-10
DMPK O 0 1.0878065950237215e-06
) O 0 4.891983628081686e-13
and O 0 3.886164935858194e-13
involves O 0 1.5808453721413707e-12
changes O 0 1.0539788659891247e-11
in O 0 6.073144157708876e-12
cytoarchitecture O 0 3.643475210424185e-08
and O 0 5.099358157956146e-10
ion O 0 1.1447415090515278e-05
homeostasis O 0 0.0004267174517735839
. O 0 1.7150133757581898e-08

To O 0 1.1683501388581874e-10
obtain O 0 4.209589621329002e-10
clues O 0 1.2368125190675983e-08
to O 0 1.23709133215133e-11
the O 0 6.24255768605364e-12
normal O 0 3.9284270281214617e-10
biological O 0 3.344145238504126e-10
role O 0 8.536015644322603e-12
of O 0 3.490732822155479e-13
DMPK O 0 7.308291571916925e-08
in O 0 8.167384303592318e-12
cellular O 0 6.544388142515345e-09
ion O 0 3.0818063123660977e-07
homeostasis O 0 6.377600129781058e-06
, O 0 2.5837054717925412e-11
we O 0 4.874711051483516e-11
have O 0 4.220978167684963e-12
compared O 0 1.0350588441898623e-11
the O 0 1.7415521065197725e-12
resting O 0 1.1117674780791731e-08
[ O 0 2.5678171394760696e-11
Ca2 O 0 1.6355204690565728e-10
+ O 0 1.1108992892250313e-10
] O 0 2.1266130523223126e-10
i O 0 3.681079885353711e-10
, O 0 3.91893684387537e-14
the O 0 4.453783262331479e-14
amplitude O 0 2.6314014855977064e-10
and O 0 5.137691921203169e-12
shape O 0 1.5219575599800805e-09
of O 0 2.3995287094097373e-12
depolarization O 0 2.9296366221842618e-08
- O 0 6.393985358954524e-07
induced O 0 9.691239029052667e-07
Ca2 O 0 2.3603055510079685e-08
+ O 0 1.8140174917746776e-09
transients O 0 1.0936925320947921e-07
, O 0 5.447597668101212e-12
and O 0 4.979220161183129e-13
the O 0 1.3539514019493548e-13
content O 0 1.5262868009388586e-12
of O 0 2.6095708168145937e-13
ATP O 0 4.602451475488323e-10
- O 0 4.481274906709132e-09
driven O 0 1.65960898357298e-08
ion O 0 1.8485911823518109e-07
pumps O 0 3.906970036382518e-08
in O 0 1.1550203848909035e-10
cultured O 0 1.0068709599408976e-07
skeletal O 0 1.037301942119484e-07
muscle O 0 3.563236372627898e-09
cells O 0 8.790820849036152e-11
of O 0 3.9627071697807825e-13
wild O 0 6.219329495849024e-10
- O 0 3.0317650612232683e-07
type O 0 1.058305315382313e-06
and O 0 1.4245422619296733e-09
DMPK O 0 9.288012847719074e-07
[ O 0 2.71345168556536e-09
- O 0 5.2003368722353116e-08
/ O 0 3.227158273944042e-08
- O 0 1.9779336923875235e-07
] O 0 1.5292242139253176e-08
knockout O 0 8.882239512786327e-07
mice O 0 5.2452710406214464e-06
. O 0 2.4444146706770198e-09

In O 0 3.907362877697551e-09
vitro O 0 2.3145278760239307e-07
- O 0 1.3787113175567356e-06
differentiated O 0 2.4675526333339803e-07
DMPK O 0 1.4348981494549662e-05
[ O 0 1.1895694207453289e-08
- O 0 4.163591071915107e-08
/ O 0 3.383652114052893e-08
- O 0 8.99617802474495e-08
] O 0 1.0453111709551877e-09
myotubes O 0 1.0149296958417153e-09
exhibit O 0 1.6381992984371152e-10
a O 0 5.1720874111316206e-11
higher O 0 5.719251738867115e-10
resting O 0 5.865501417900987e-09
[ O 0 7.781152805419467e-11
Ca2 O 0 1.9874911438844123e-10
+ O 0 1.426270629378834e-10
] O 0 2.586902081436193e-10
i O 0 4.1127257155437746e-10
than O 0 2.1674378871544553e-12
do O 0 6.398816372599203e-12
wild O 0 1.818723990854032e-11
- O 0 1.5896099991863366e-09
type O 0 1.169345509310915e-08
myotubes O 0 5.6351012744926265e-08
because O 0 4.024669486568655e-11
of O 0 7.996918692564428e-14
an O 0 8.551471840758176e-14
altered O 0 8.428868020216029e-11
open O 0 2.2468181828938505e-11
probability O 0 2.241271231107067e-11
of O 0 6.430881218169593e-13
voltage O 0 3.369593741808785e-07
- O 0 2.590213341591152e-07
dependent O 0 1.75136580793378e-08
l O 0 9.151050051059428e-08
- O 0 4.751550264359139e-09
type O 0 3.777509860469763e-08
Ca2 O 0 3.878782628419231e-09
+ O 0 2.607231097684348e-10
and O 0 2.2696507867570048e-11
Na O 0 8.7426723638373e-09
+ O 0 1.1926357679215016e-09
channels O 0 2.369831664239541e-09
. O 0 1.0898579816398524e-09

The O 0 3.4658080849681028e-09
mutant O 0 4.579435142204602e-08
myotubes O 0 1.1658585208351724e-07
exhibit O 0 6.2868137362670495e-09
smaller O 0 6.107581662639916e-10
and O 0 4.108309525907572e-11
slower O 0 7.252627942655465e-10
Ca2 O 0 4.9642379096326295e-09
+ O 0 3.7064284974519524e-10
responses O 0 3.042968654831668e-10
upon O 0 1.4898764513771035e-11
triggering O 0 6.515887274183285e-10
by O 0 6.9269169393482155e-12
acetylcholine O 0 1.304760655074233e-08
or O 0 4.993886637549849e-09
high O 0 6.1276894669504145e-09
external O 0 1.4251919537855429e-06
K O 0 2.7945438887400087e-06
+ O 0 6.243281447382287e-09
. O 0 1.957529915941336e-09

In O 0 2.041629088012087e-09
addition O 0 2.0548250601049034e-10
, O 0 2.0354292903923543e-11
we O 0 4.837374945054762e-11
observed O 0 6.648379069496002e-11
that O 0 8.009653595757171e-13
these O 0 8.203664527209331e-13
Ca2 O 0 7.614909813824511e-10
+ O 0 4.814476040060356e-10
transients O 0 1.2146989547545672e-07
partially O 0 3.000867820901476e-08
result O 0 1.4136659898245085e-10
from O 0 5.73417398633258e-13
an O 0 8.451505689949582e-14
influx O 0 5.68242805240593e-12
of O 0 8.850232829579752e-13
extracellular O 0 7.646955291207291e-11
Ca2 O 0 5.346538767270204e-10
+ O 0 2.7792329201914434e-11
through O 0 1.772317752626873e-12
the O 0 1.3311120435066659e-11
l O 0 3.60563205958897e-08
- O 0 5.9027618348750366e-09
type O 0 3.26595284150244e-08
Ca2 O 0 1.7205209701387503e-08
+ O 0 4.424549615578144e-09
channel O 0 9.55226120424868e-09
. O 0 3.009291704714201e-09

Neither O 0 3.2586791576250107e-07
the O 0 8.151779251619473e-11
content O 0 1.79735420990923e-10
nor O 0 3.306371842981548e-09
the O 0 1.2826100858481793e-12
activity O 0 3.1236971342885056e-11
of O 0 7.892411767532193e-13
Na O 0 4.519679741576965e-09
+ O 0 1.393760662438126e-09
/ O 0 1.4602643538808024e-09
K O 0 1.3606520354869645e-08
+ O 0 2.3792418035739615e-10
ATPase O 0 7.137766377951493e-09
and O 0 3.6833185806939284e-11
sarcoplasmic O 0 8.773530169037258e-08
reticulum O 0 5.5229577355930815e-08
Ca2 O 0 4.371744921627396e-08
+ O 0 9.520575439125878e-09
- O 0 6.490118664714828e-08
ATPase O 0 4.492411562750931e-07
are O 0 1.8016756142547052e-10
affected O 0 3.100051604310039e-10
by O 0 9.487103463934332e-11
DMPK O 0 3.805234155151993e-05
absence O 0 4.635325367985388e-08
. O 0 2.2966653023814843e-09

In O 0 1.393051118903088e-09
conclusion O 0 1.026366547307589e-09
, O 0 4.990175373614791e-12
our O 0 1.1648627375182574e-11
data O 0 2.0585701546171897e-11
suggest O 0 7.687581821125278e-11
that O 0 3.281155945902836e-12
DMPK O 0 7.276911873077552e-08
is O 0 2.32115607116945e-12
involved O 0 3.6374408259737256e-12
in O 0 3.5710600058622144e-13
modulating O 0 5.922946022529629e-10
the O 0 9.678049377528919e-13
initial O 0 3.5957352546855947e-12
events O 0 2.927675680011732e-12
of O 0 1.181546180339943e-12
excitation O 0 8.007074256966007e-07
- O 0 1.1403351891203783e-05
contraction O 0 9.442379678148427e-07
coupling O 0 2.580680984465289e-07
in O 0 1.5683443432834565e-10
skeletal O 0 6.217275313247228e-06
muscle O 0 5.604337047770969e-07
. O 0 9.296197145403085e-10
. O 0 2.1818757911518105e-09

Constitutional O 0 5.3199100875644945e-06
RB1 O 0 0.0027940496802330017
- O 0 7.96916810941184e-06
gene O 0 3.5891994798475935e-07
mutations O 0 3.9774113247403875e-06
in O 0 1.0879596112900458e-09
patients O 0 3.741704279747182e-09
with O 0 4.756771088132439e-10
isolated O 0 1.2390743222567835e-06
unilateral B-Disease 0 5.5448988860007375e-05
retinoblastoma I-Disease 0 0.00503899110481143
. O 0 1.210424898090423e-07

In O 0 2.6525874829985696e-09
most O 0 1.6076784348229012e-10
patients O 0 5.69440161690693e-10
with O 0 2.7428540341767338e-11
isolated O 0 1.2990051345695974e-07
unilateral B-Disease 0 1.6067625665527885e-06
retinoblastoma I-Disease 0 0.00013545050751417875
, O 0 1.2789617975794698e-10
tumor B-Disease 0 1.3624387840138752e-08
development O 0 3.2543924152750314e-12
is O 0 2.0132695423974445e-12
initiated O 0 5.11351508011848e-12
by O 0 1.3414720723137208e-12
somatic O 0 1.7620298553566727e-09
inactivation O 0 2.947403743291943e-08
of O 0 4.762046876619075e-13
both O 0 4.637898572135146e-12
alleles O 0 1.3081358218869354e-10
of O 0 1.0421448426445323e-11
the O 0 7.015678593624841e-10
RB1 O 0 6.524339369207155e-06
gene O 0 4.063846148483208e-08
. O 0 2.586143521554618e-09

However O 0 3.1680794876365326e-08
, O 0 4.732982235300387e-12
some O 0 8.371464464565839e-14
of O 0 1.1821521138290908e-13
these O 0 1.6818938602947142e-11
patients O 0 3.919498059445914e-10
can O 0 2.499463080951614e-09
transmit O 0 3.5416251193964854e-05
retinoblastoma B-Disease 0 9.724069968797266e-06
predisposition O 0 4.692314632848138e-06
to O 0 2.054001968510022e-10
their O 0 1.4586302166108567e-09
offspring O 0 1.8537141954766412e-07
. O 0 1.5507918282864352e-09

To O 0 8.876873125451823e-10
determine O 0 3.5319818181278606e-09
the O 0 2.7513264236334045e-11
frequency O 0 9.063623451766034e-08
and O 0 1.3801145989922325e-11
nature O 0 9.551705260069099e-11
of O 0 6.886760042443263e-13
constitutional O 0 2.9956335190206573e-09
RB1 O 0 3.317097934996127e-06
- O 0 1.6248788980988138e-08
gene O 0 3.1404809863744276e-09
mutations O 0 1.7696629939223385e-08
in O 0 6.58291476884898e-11
patients O 0 1.9036529297355997e-10
with O 0 1.4448477136941307e-11
isolated O 0 2.9712062143971707e-08
unilateral B-Disease 0 1.2913631053379504e-07
retinoblastoma I-Disease 0 2.1951902908767806e-06
, O 0 2.3749106847770207e-11
we O 0 1.903343281595138e-11
analyzed O 0 1.263227439318726e-10
DNA O 0 2.287662281830194e-10
from O 0 4.056310842770472e-12
peripheral O 0 4.545528842214708e-09
blood O 0 3.4715991859002315e-08
and O 0 7.307085492236354e-10
from O 0 3.7762312721234537e-10
tumor B-Disease 0 1.1048179658246227e-05
tissue O 0 8.015592902665958e-05
. O 0 2.012164124209903e-08

The O 0 4.905258976783955e-10
analysis O 0 4.886172022544599e-10
of O 0 1.1541218675192866e-10
tumors B-Disease 1 0.9999864101409912
from O 0 1.9116942751029598e-10
54 O 0 4.805464706714169e-11
( O 0 4.182213115318939e-13
71 O 0 4.447531752604927e-12
% O 0 1.0410933183255255e-12
) O 0 2.512497046351647e-13
of O 0 6.919861818971418e-13
76 O 0 1.0501867431234047e-10
informative O 0 2.924690001293584e-08
patients O 0 1.3336374671268914e-08
showed O 0 5.703901706510806e-07
loss O 0 9.755686036783118e-09
of O 0 3.011568425193012e-11
constitutional O 0 2.2572945113097376e-07
heterozygosity O 0 0.0321313850581646
( O 0 7.26765989611522e-08
LOH O 1 0.9993314743041992
) O 0 2.6096788618978906e-10
at O 0 1.700618090794137e-09
intragenic O 0 9.569084795657545e-07
loci O 0 8.179342358971553e-08
. O 0 3.0397797612380373e-09

Three O 0 9.384865107264773e-10
of O 0 2.949738717172856e-11
13 O 0 4.187383773057718e-10
uninformative O 0 9.727018914418295e-05
patients O 0 3.0351210966728104e-07
had O 0 8.939455398149221e-09
constitutional O 0 7.908536936440669e-09
deletions O 0 7.910703970992472e-06
. O 0 3.7813450148860284e-08

For O 0 3.344426124929356e-10
39 O 0 5.838063921181913e-10
randomly O 0 3.731063902279175e-09
selected O 0 6.512787109613782e-08
tumors B-Disease 1 0.999998927116394
, O 0 5.035145078657877e-10
SSCP O 0 1.2950514246767852e-05
, O 0 4.55183148118099e-11
hetero O 0 2.8738443802467373e-07
- O 0 6.303587873901506e-09
duplex O 0 1.6445788730834465e-07
analysis O 0 2.718210934116172e-10
, O 0 1.5683866694520682e-13
sequencing O 0 1.869389408895583e-12
, O 0 7.551485072020483e-14
and O 0 6.776409403226602e-13
Southern O 0 1.6846027611067127e-12
blot O 0 1.5439072242884322e-08
analysis O 0 1.5913778628195985e-10
were O 0 2.1985876660912673e-11
used O 0 8.520518318677617e-11
to O 0 2.3857206141175702e-11
identify O 0 3.6979869832975965e-08
mutations O 0 2.6711106215770997e-07
. O 0 3.1702718228387994e-09

Mutations O 0 0.00028351982473395765
were O 0 9.7560954870346e-09
detected O 0 3.105180326201662e-07
in O 0 2.0026235877934617e-11
21 O 0 1.805059400561415e-11
( O 0 5.815982461257474e-13
91 O 0 1.0867970585970443e-11
% O 0 1.268320192794603e-12
) O 0 1.0944997078793373e-12
of O 0 3.217878394301543e-11
23 O 0 7.323151294258423e-07
tumors B-Disease 1 0.9999997615814209
with O 0 2.0024253899464384e-05
LOH O 1 0.9999886751174927
. O 0 2.796508908886608e-07

In O 0 6.221669845984934e-09
6 O 0 2.1444371278711571e-10
( O 0 2.1296306731977133e-12
38 O 0 9.279322969735215e-12
% O 0 8.841493075867346e-13
) O 0 4.2291151591995757e-13
of O 0 7.055149867096766e-12
16 O 0 1.530327864429637e-07
tumors B-Disease 1 0.9999998807907104
without O 0 6.576864961971296e-06
LOH O 1 0.9999107122421265
, O 0 2.2285511977471195e-11
one O 0 1.9374696291762916e-11
mutation O 0 9.543756895880051e-09
was O 0 2.4245918606169425e-09
detected O 0 1.4953525351302233e-07
, O 0 8.70255961477745e-13
and O 0 3.547883558122078e-12
in O 0 2.456567935182896e-12
9 O 0 1.9020913316625254e-11
( O 0 2.0290278517683807e-13
56 O 0 1.4802987394896272e-12
% O 0 1.3291544785371673e-13
) O 0 3.372656497070865e-14
of O 0 1.090850283366751e-12
the O 0 1.9059660871789674e-07
tumors B-Disease 1 1.0
without O 0 1.4149563867249526e-05
LOH O 1 0.9999380111694336
, O 0 4.3796417881214467e-11
both O 0 4.385635604675642e-11
mutations O 0 1.0906133773858073e-08
were O 0 5.604535724401671e-10
found O 0 6.08836980831029e-09
. O 0 2.6559134891357417e-09

Thus O 0 1.5887136939340962e-08
, O 0 6.362682949956344e-12
a O 0 2.3777332099766957e-12
total O 0 5.715818985653487e-13
of O 0 7.112365709403823e-13
45 O 0 1.3501798637460816e-11
mutations O 0 8.55012327605209e-09
were O 0 6.434572874525202e-10
identified O 0 1.9035428522329312e-07
in O 0 1.0874146028072573e-08
tumors B-Disease 1 0.9999983310699463
of O 0 1.0164402652890203e-10
36 O 0 2.9189484163083534e-09
patients O 0 4.683990972864649e-09
. O 0 3.167521578362198e-09

Thirty O 0 6.486776982228548e-08
- O 0 2.5710065187922737e-08
nine O 0 2.4281065005848923e-11
of O 0 5.060535866220628e-13
the O 0 4.222741947779163e-12
mutations O 0 1.7163802601416478e-09
- O 0 6.632651650129162e-10
including O 0 4.398701888841394e-12
34 O 0 5.5819454961025805e-12
small O 0 9.264713995982277e-12
mutations O 0 2.459273140686946e-08
, O 0 1.7928295566876917e-12
2 O 0 1.7390858718380198e-12
large O 0 6.765400739627836e-11
structural O 0 7.372740128630539e-06
alterations O 0 2.42252269799792e-07
, O 0 1.1565188043349828e-11
and O 0 2.1986967801979063e-11
hypermethylation O 0 3.2452476261823904e-07
in O 0 3.857931307749141e-09
3 O 0 1.9063587330947485e-07
tumors O 1 0.9999997615814209
- O 0 0.0006979652680456638
were O 0 3.4427048944962735e-07
not O 0 7.917441813276582e-09
detected O 0 3.4412016702844994e-07
in O 0 3.4359078082690786e-12
the O 0 3.5465575788651282e-12
corresponding O 0 5.972031202894357e-10
peripheral O 0 1.0596769683957064e-08
blood O 0 1.2214010247646456e-08
DNA O 0 1.2972013507805968e-07
. O 0 3.363209044593418e-09

In O 0 5.176602257961349e-09
6 O 0 4.793959673676795e-10
( O 0 3.672317224617805e-12
17 O 0 2.367189777530143e-12
% O 0 1.2119484289838806e-13
) O 0 1.7740678175635904e-14
of O 0 5.12272516073331e-14
the O 0 5.2805971401115315e-12
36 O 0 3.530590750311369e-11
patients O 0 3.58357718499569e-11
, O 0 2.9983941761749233e-13
a O 0 3.743699100722253e-11
mutation O 0 4.108519391365917e-08
was O 0 7.731025597479402e-09
detected O 0 2.046972191749319e-08
in O 0 2.2190320327769575e-12
constitutional O 0 1.4761464620094422e-11
DNA O 0 1.018350181958283e-09
, O 0 5.509192277722286e-13
and O 0 4.905625601916985e-13
1 O 0 2.5804819435773507e-13
of O 0 1.8884035773904934e-13
these O 0 3.71525275821849e-11
mutations O 0 7.659429535067375e-09
is O 0 1.0617915401078815e-11
known O 0 3.482729035719778e-11
to O 0 2.578182112245031e-11
be O 0 2.1986781284510926e-09
associated O 0 5.973500583067448e-10
with O 0 4.93022532521703e-11
reduced O 0 3.761864064699694e-08
expressivity O 0 0.00022081361385062337
. O 0 1.475504074477385e-08

The O 0 3.7469513602950144e-10
presence O 0 1.602602356376437e-10
of O 0 4.050232100660106e-13
a O 0 2.71165364468251e-11
constitutional O 0 1.834787988208575e-09
mutation O 0 1.2826612874050625e-06
was O 0 1.4149136973173881e-08
not O 0 6.390269563505413e-11
associated O 0 6.423753889928108e-11
with O 0 9.260363743185396e-13
an O 0 7.379190574557937e-13
early O 0 7.041834337861985e-10
age O 0 2.6467352753911655e-09
at O 0 1.5455910162831543e-10
treatment O 0 1.232565827180565e-09
. O 0 1.3299585877035724e-09

In O 0 3.2777083269763807e-09
1 O 0 1.1088971962891492e-09
patient O 0 6.450897416243606e-08
, O 0 2.414708537290533e-11
somatic O 0 3.544887761108839e-08
mosaicism O 0 4.2231058614561334e-05
was O 0 2.6484080706268287e-08
demonstrated O 0 5.566810901136421e-10
by O 0 1.3004795807944336e-12
molecular O 0 1.1125538268430546e-09
analysis O 0 7.880969314644215e-12
of O 0 5.800715810466706e-13
DNA O 0 1.017193707042452e-08
and O 0 9.555568142305404e-11
RNA O 0 1.3184967562196448e-09
from O 0 5.343325087947548e-11
peripheral O 0 8.216822777740163e-08
blood O 0 9.897246400214499e-07
. O 0 1.03013659824569e-08

In O 0 9.580927162744501e-09
2 O 0 1.882477063119836e-09
patients O 0 2.3863602205409506e-09
without O 0 1.475136679474076e-10
a O 0 4.739220127447652e-10
detectable O 0 9.369396866532043e-05
mutation O 0 1.345775615391176e-07
in O 0 4.191097122130394e-11
peripheral O 0 9.539501633071268e-08
blood O 0 2.0330429606474354e-07
, O 0 3.193396935774473e-11
mosaicism O 0 1.1646450559510413e-07
was O 0 3.0809195195047323e-09
suggested O 0 5.990295481872465e-10
because O 0 1.0391020509314952e-11
1 O 0 5.480517840765475e-13
of O 0 2.0427313540769682e-13
the O 0 1.773587526843201e-10
patients O 0 2.6821474818916613e-08
showed O 0 3.459850267972797e-05
multifocal O 1 0.999853253364563
tumors B-Disease 1 1.0
and O 0 4.646443230171826e-08
the O 0 3.485959090832047e-11
other O 0 2.7019309099124422e-12
later O 0 1.3403582410642656e-10
developed O 0 6.00783645055003e-10
bilateral B-Disease 0 4.1982641363347284e-08
retinoblastoma I-Disease 0 4.797285328095313e-06
. O 0 7.977956073546011e-09

In O 0 2.3557706896326636e-09
conclusion O 0 9.561571534533186e-10
, O 0 8.289991956789144e-12
our O 0 1.9409907708878293e-11
results O 0 8.311032417829267e-12
emphasize O 0 8.86663173438329e-11
that O 0 5.462382716286962e-12
the O 0 6.826445333486808e-13
manifestation O 0 5.586701101734093e-10
and O 0 1.1171309537150176e-11
transmissibility O 0 1.635792834520089e-09
of O 0 2.7199908449702936e-13
retinoblastoma B-Disease 0 1.413297257002455e-09
depend O 0 1.335349192332913e-10
on O 0 1.6442965045104785e-11
the O 0 1.0143552664487743e-12
nature O 0 5.601102567864835e-11
of O 0 6.842867472742903e-14
the O 0 5.447345591096109e-13
first O 0 7.472147033060761e-12
mutation O 0 4.5718115404547177e-10
, O 0 1.0080825063596421e-13
its O 0 1.1031443364036345e-13
time O 0 5.039867394945885e-12
in O 0 4.322557123435239e-13
development O 0 6.730074532607447e-14
, O 0 7.38872125375517e-14
and O 0 5.406067845985241e-13
the O 0 1.2536460313860437e-13
number O 0 3.997980765890752e-12
and O 0 3.106376050485138e-12
types O 0 2.4977067289433386e-11
of O 0 2.61760638121597e-13
cells O 0 9.294702507656183e-11
that O 0 3.2686273826465495e-11
are O 0 9.637381170879422e-12
affected O 0 3.652898122874504e-11
. O 0 1.105112442528755e-11
. O 0 3.340339671531467e-10

Hereditary B-Disease 1 0.9996250867843628
deficiency I-Disease 1 0.9994088411331177
of I-Disease 0 2.0636976849619515e-10
the I-Disease 0 1.0188917765052707e-10
fifth I-Disease 0 1.2798578863382204e-09
component I-Disease 0 1.0160318142382607e-09
of I-Disease 0 1.4600727311214756e-12
complement I-Disease 0 9.37475652662556e-10
in O 0 2.6647462014750545e-10
man O 0 2.589284804344061e-06
. O 0 7.846812088985189e-09

I O 0 0.0005283733480609953
. O 0 1.0131859085049655e-07

Clinical O 0 1.6769377907621674e-05
, O 0 2.7820465930972205e-09
immunochemical O 0 9.073853107111063e-06
, O 0 1.807706345724469e-10
and O 0 6.272003749696609e-11
family O 0 2.5752455723448975e-09
studies O 0 1.9001933360129897e-09
. O 0 1.9202759382608292e-09

The O 0 3.170737450375327e-09
first O 0 6.330791446629291e-10
recognized O 0 1.543950634008695e-09
human O 0 7.676478341878124e-10
kindred O 0 3.564254882348905e-07
with O 0 3.437125473126912e-09
hereditary B-Disease 1 0.9957452416419983
deficiency I-Disease 1 0.9432719349861145
of I-Disease 0 1.4244239468497177e-11
the I-Disease 0 1.426493038275689e-11
fifth I-Disease 0 6.18372575367232e-10
component I-Disease 0 3.311495244684437e-10
of I-Disease 0 6.3791849407024426e-12
complement I-Disease 0 2.4615022908847095e-08
( O 0 3.1878608086621796e-10
C5 O 0 1.4626283473262447e-06
) O 0 5.928274798144839e-12
is O 0 7.114652617046247e-11
described O 0 1.762410661854119e-08
. O 0 4.6138710629861635e-09

The O 0 1.0096721236863004e-09
proband O 0 1.2699693741069495e-07
, O 0 4.429981121517601e-12
a O 0 3.997691067070264e-12
20 O 0 9.648416614271849e-12
- O 0 3.2255507154133056e-09
year O 0 3.4100700041506116e-10
- O 0 1.6416736059454706e-07
old O 0 2.0553412127810589e-07
black O 0 3.5533602726900426e-07
female O 0 4.056644513639185e-07
with O 0 1.3486972250120743e-07
systemic B-Disease 1 0.9999986886978149
lupus I-Disease 1 0.9762504696846008
erythematosus I-Disease 1 0.9999438524246216
since O 0 1.695742321317084e-05
age O 0 2.2028180168831568e-08
11 O 0 8.330382911259093e-11
, O 0 1.1205430680560902e-11
lacked O 0 4.756113582971011e-07
serum O 0 1.655513551668264e-05
hemolytic O 0 4.2221081457682885e-06
complement O 0 6.804226626577758e-10
activity O 0 1.0994538612862925e-09
, O 0 1.4655776592320535e-12
even O 0 7.059972745304677e-11
during O 0 7.77473307955745e-10
remission O 0 2.7512047751088176e-08
. O 0 3.1128499777821617e-10

C5 O 0 0.010813601315021515
was O 0 1.6952209591636347e-07
undetectable O 0 7.371224910457386e-07
in O 0 9.576441722947138e-11
her O 0 1.6293377758103134e-09
serum O 0 6.858567758172285e-08
by O 0 1.4540400133933318e-11
both O 0 9.059238775810385e-11
immunodiffusion O 0 2.247067641292233e-06
and O 0 4.523750707363661e-09
hemolytic O 0 1.0416761142550968e-05
assays O 0 3.4438780858181417e-06
. O 0 1.4658320779403766e-08

Other O 0 7.668459200971256e-10
complement O 0 2.324442638368396e-09
components O 0 5.0637614101844974e-09
were O 0 1.253834536196763e-10
normal O 0 1.8986741345816682e-10
during O 0 7.166898324806326e-11
remission O 0 1.5599022074042068e-09
of O 0 2.254066941778654e-12
lupus O 0 3.9716987032534234e-08
, O 0 2.653343864067459e-11
but O 0 6.748482328511329e-10
C1 O 0 3.4001543554040836e-06
, O 0 3.6727162110172795e-12
C4 O 0 1.89441905718013e-07
, O 0 8.622500630162122e-11
C2 O 0 1.446216970180103e-06
, O 0 1.2842948926561348e-11
and O 0 4.070482562124056e-10
C3 O 0 4.962264938512817e-05
levels O 0 1.8087364139773854e-07
fell O 0 2.2581407677080279e-07
during O 0 4.515767759727396e-09
exacerbations O 0 7.479008490918204e-05
. O 0 9.189509597717915e-09

A O 0 4.9093074494521716e-08
younger O 0 1.2997779741397153e-08
half O 0 4.0845202220474164e-10
- O 0 6.656508588775978e-08
sister O 0 2.2628209705999325e-07
, O 0 3.399859213604195e-11
who O 0 9.184037974563353e-10
had O 0 8.69078320420158e-09
no O 0 1.9519049487826123e-08
underlying O 0 0.0002261760673718527
disease O 0 1.2170637546660146e-06
, O 0 1.044401370942083e-11
was O 0 1.5767763761331821e-09
also O 0 5.423248308766837e-11
found O 0 6.02384045422788e-11
to O 0 3.071552040490033e-11
lack O 0 1.4560792571671755e-08
immunochemically O 0 0.00013545852561946958
detectable O 0 0.002234595362097025
C5 O 0 1.6564437828492373e-05
. O 0 3.0683637852746415e-09

By O 0 1.410344019348031e-08
hemolytic O 0 8.098678517853841e-05
assay O 0 3.3265448564634426e-06
, O 0 1.322884163323934e-10
she O 0 9.830677383249053e-10
exhibited O 0 1.5106206285864232e-09
1 O 0 3.296348654105441e-12
- O 0 6.186297585308864e-10
2 O 0 8.03561037154843e-12
% O 0 5.561156461546257e-13
of O 0 2.1097464324593834e-13
the O 0 3.608282422851161e-11
normal O 0 7.825977199615863e-09
serum O 0 1.3052788006007177e-07
C5 O 0 6.118057171988767e-08
level O 0 3.537130310871106e-10
and O 0 1.5234227074278905e-11
normal O 0 6.040707517529498e-11
concentrations O 0 7.374840182983178e-10
of O 0 2.575859447614959e-13
other O 0 7.397439865525213e-13
complement O 0 3.0614349944002583e-10
components O 0 1.2142977290352519e-08
. O 0 6.305905242420806e-10

C5 O 0 0.001065857824869454
levels O 0 2.838852424247307e-07
of O 0 9.948407549142946e-12
other O 0 3.0768274213166524e-12
family O 0 5.198176611376226e-11
members O 0 1.0421859772749564e-12
were O 0 2.980356933468542e-11
either O 0 9.428242214726268e-11
normal O 0 2.0228675678968244e-10
or O 0 1.0898235439094073e-11
approximately O 0 1.323051911084061e-12
half O 0 7.318366052055936e-11
- O 0 3.065411817715358e-07
normal O 0 1.4554176752668013e-09
, O 0 1.133081042187234e-12
consistent O 0 1.8076408425660162e-10
with O 0 9.026514778687211e-12
autosomal O 0 2.0533603617423068e-07
codominant O 0 1.5766966043884167e-07
inheritance O 0 1.6275929937137334e-08
of O 0 4.1233644103300104e-12
the O 0 1.0083513884984185e-10
gene O 0 6.014182645230903e-07
determining O 0 0.0010918384650722146
C5 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999986886978149
. O 0 9.54474330683297e-08

Normal O 0 3.722924884641543e-05
hemolytic O 0 0.00433198781684041
titers O 0 0.0002780959475785494
were O 0 1.8805679236066908e-09
restored O 0 1.1286937606769243e-08
to O 0 8.566503756357591e-11
both O 0 1.1872844929428084e-08
homozygous O 1 0.9811104536056519
C5 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999958276748657
deficient I-Disease 1 0.9999995231628418
( O 0 6.358667548056474e-08
C5D B-Disease 1 0.9999994039535522
) O 0 2.6806702690951312e-11
sera O 0 3.686182470374888e-09
by O 0 1.862208087385908e-12
addition O 0 2.811934712854125e-11
of O 0 5.484944096134647e-12
highly O 0 7.620550412923421e-09
purified O 0 1.666180615700341e-08
human O 0 9.617160401376168e-09
C5 O 0 5.198489816393703e-06
. O 0 1.1720379111679335e-09

In O 0 5.825519622248976e-09
specific O 0 7.3824573121328285e-09
C5 O 0 1.039126163959736e-05
titrations O 0 1.6175206837942824e-05
, O 0 4.2502414782097375e-11
however O 0 6.725028867116123e-11
, O 0 2.4567880282239107e-12
it O 0 7.95219359112087e-12
was O 0 2.1568456742837583e-10
noted O 0 2.252744171760135e-11
that O 0 9.48662372615705e-13
when O 0 2.7954413957254065e-12
limited O 0 2.8554887404261264e-13
amounts O 0 6.323411412545443e-12
of O 0 1.498193713186935e-12
C5 O 0 6.468220448141437e-08
were O 0 3.618834398810833e-11
assayed O 0 8.867451661842551e-09
in O 0 9.987547898090976e-13
the O 0 3.230124501207854e-13
presence O 0 1.5284053536679387e-11
of O 0 6.562849764503442e-13
low O 0 1.6912212741360122e-09
dilutions O 0 7.95900323424803e-09
of O 0 9.610104378943163e-12
either O 0 4.590497937329019e-08
C5D B-Disease 1 0.9999977350234985
serum O 0 2.9644754704349907e-06
, O 0 9.955786195448013e-13
curving O 0 4.349348659005159e-11
rather O 0 9.993041116818091e-12
than O 0 1.0506825444400736e-12
linear O 0 5.883108583626395e-11
dose O 0 1.8732622564243684e-08
- O 0 1.7272844488047667e-08
response O 0 1.8270275570220207e-10
plots O 0 2.017875289084259e-08
were O 0 1.221402756712564e-09
consistently O 0 3.3150815426097324e-08
obtained O 0 1.0171985476148393e-10
, O 0 2.5062989335820907e-13
suggesting O 0 3.505909451639866e-11
some O 0 3.0499019108842784e-13
inhibitory O 0 1.040997510415309e-09
effect O 0 4.19875068047304e-09
. O 0 7.990210715291823e-10

Further O 0 7.468411666877728e-09
studies O 0 1.9717545374220435e-09
suggested O 0 1.3971650503208366e-09
that O 0 6.428337723241029e-11
low O 0 2.3350731126470237e-08
dilutions O 0 9.828733027461567e-07
of O 0 2.529697562536626e-09
C5D B-Disease 1 0.9999990463256836
serum O 0 5.6177625083364546e-05
contain O 0 1.910040570152205e-09
a O 0 9.351410618085865e-11
factor O 0 2.751653349619687e-10
( O 0 1.0505263109070184e-12
or O 0 4.4982351177225155e-11
factors O 0 6.967733334750648e-11
) O 0 2.3954850689872353e-13
interfering O 0 5.176873860146536e-11
at O 0 1.2187741267599694e-11
some O 0 1.3654009834666164e-13
step O 0 3.8943612223896196e-11
in O 0 6.263680112778003e-12
the O 0 4.284769761220275e-11
hemolytic O 0 1.6899876698062144e-07
assay O 0 2.6704476852046355e-08
of O 0 8.472145207605308e-11
C5 O 0 7.791449206706602e-06
, O 0 9.080078702816685e-12
rather O 0 3.153100003316922e-11
than O 0 1.1664879999429001e-11
a O 0 2.299838097741258e-10
true O 0 8.11558180657812e-08
C5 O 0 2.0770397668457008e-07
inhibitor O 0 2.363295559248968e-09
or O 0 4.0551700886126696e-10
inactivator O 0 1.3176625088817673e-06
. O 0 2.670028642626221e-09

Of O 0 1.02566011239702e-09
clinical O 0 5.6501470169223467e-08
interest O 0 3.132053905119392e-08
are O 0 1.7184562106642431e-10
( O 0 1.5351741145669395e-12
a O 0 2.625834966130114e-11
) O 0 5.152772739741573e-13
the O 0 7.593374171631362e-13
documentation O 0 2.4302495571504323e-09
of O 0 4.983589096951846e-10
membranous O 1 0.9828784465789795
glomerulonephritis B-Disease 1 0.9999994039535522
, O 0 5.777861247224791e-07
vasculitis B-Disease 1 0.999995231628418
, O 0 5.238292466458461e-09
and O 0 2.8652107175730634e-07
arthritis B-Disease 1 0.9999973773956299
in O 0 1.835046281595254e-10
an O 0 2.1956249318666465e-11
individual O 0 3.255280844882691e-08
lacking O 0 9.14362317416817e-06
C5 O 0 1.4175024261930957e-05
( O 0 4.394651743205857e-12
and O 0 2.2830179587096655e-12
its O 0 9.6995415171941e-13
biologic O 0 3.0086760860470463e-10
functions O 0 8.732393280697082e-12
) O 0 3.4028398046385966e-13
, O 0 4.740080940604519e-13
and O 0 4.857436067956522e-12
( O 0 1.5907146476770717e-12
b O 0 6.277916381192128e-11
) O 0 3.407228655032818e-14
a O 0 1.8532044388647195e-12
remarkable O 0 3.883259269699124e-10
propensity O 0 1.9864685896209267e-07
to O 0 1.4050653085462272e-08
bacterial B-Disease 1 0.9999995231628418
infections I-Disease 1 0.9999997615814209
in O 0 9.190972982686674e-11
the O 0 8.412160724946549e-12
proband O 0 6.962044807323764e-08
, O 0 8.708736856655186e-13
even O 0 4.29278401020694e-12
during O 0 9.58125939698462e-12
periods O 0 1.3406138699156855e-10
of O 0 6.851019317827278e-13
low O 0 5.869597696772644e-09
- O 0 3.2369771307827477e-09
dose O 0 3.1352860307976016e-09
or O 0 1.4289056049499038e-11
alternate O 0 1.467133532717657e-11
- O 0 6.975505950634897e-09
day O 0 4.889659233064947e-10
corticosteroid O 0 3.492316682240926e-05
therapy O 0 2.1393964289018186e-07
. O 0 1.4793244407229622e-09

Other O 0 3.2295502383483665e-10
observations O 0 1.4527614666803856e-08
indicate O 0 4.282388221810152e-09
that O 0 1.291386442225928e-11
the O 0 3.284664207292565e-11
C5D B-Disease 1 0.9999991655349731
state O 0 1.911708846780158e-10
is O 0 7.173418109518437e-12
compatible O 0 1.1649449634110187e-11
with O 0 3.086897057413829e-12
normal O 0 6.352839782008957e-11
coagulation O 0 1.661447507350644e-10
function O 0 1.850027769867424e-10
and O 0 5.850319360900524e-12
the O 0 2.0829581549169918e-12
capacity O 0 2.5486704760546708e-11
to O 0 1.7264739984867994e-12
mount O 0 3.128083747583332e-08
a O 0 2.6513850670539796e-08
neutrophilic O 0 0.006760411895811558
leukocytosis O 0 0.003217265708371997
during O 0 2.346955341181456e-07
pyogenic B-Disease 0 0.08204066008329391
infection I-Disease 0 0.0005755024030804634
. O 0 4.93786012079056e-10
. O 0 8.036169507619206e-10

Susceptibility O 1 0.753231406211853
to O 0 4.4291791709838435e-05
ankylosing B-Disease 1 0.9999995231628418
spondylitis I-Disease 1 1.0
in O 0 1.3477548236551229e-05
twins O 0 0.00010397014557383955
: O 0 1.760247676785287e-11
the O 0 2.7346395005227453e-13
role O 0 1.3432957003678414e-11
of O 0 9.579372885204496e-13
genes O 0 2.8218324898965363e-10
, O 0 2.458705331345734e-12
HLA O 0 3.1259650423720586e-09
, O 0 6.286432745888915e-12
and O 0 1.850104444645062e-11
the O 0 5.070144998287063e-11
environment O 0 3.645185131517792e-08
. O 0 9.208805384908203e-10

OBJECTIVE O 0 7.423550130170042e-08
To O 0 4.7107300699122945e-11
determine O 0 3.299396311717828e-10
the O 0 3.3640312757654556e-12
relative O 0 1.4456238428550705e-09
effects O 0 1.5395337227275263e-09
of O 0 6.093144109924065e-13
genetic O 0 3.444206475577971e-09
and O 0 2.3135373825033945e-11
environmental O 0 2.0002234590865697e-10
factors O 0 1.853431470799638e-11
in O 0 2.5391745997471737e-11
susceptibility O 0 0.0001358849258394912
to O 0 1.3922802281740587e-05
ankylosing B-Disease 1 0.9999998807907104
spondylitis I-Disease 1 1.0
( O 0 7.176447525125695e-06
AS B-Disease 1 0.999872088432312
) O 0 8.001786455658078e-10
. O 0 1.9919359495190747e-09

METHODS O 0 5.9803689509863034e-05
Twins O 0 0.00011548618203960359
with O 0 6.663019025410222e-10
AS B-Disease 1 0.9643551111221313
were O 0 2.234929796784968e-09
identified O 0 4.636843797811707e-09
from O 0 4.113733659272256e-12
the O 0 6.0124617957957316e-12
Royal O 0 4.891268190476694e-08
National O 0 1.4532179903881115e-09
Hospital O 0 1.2117411074541451e-08
for O 0 6.068611169141036e-10
Rheumatic B-Disease 0 0.01802966743707657
Diseases I-Disease 0 3.3093584761445527e-07
database O 0 1.4302166562174534e-08
. O 0 3.0091829028577877e-09

Clinical O 0 1.5201400174191804e-06
and O 0 7.845342153700585e-10
radiographic O 0 3.5517141441232525e-06
examinations O 0 1.0226074209640501e-06
were O 0 2.178947910991269e-09
performed O 0 3.097522238704187e-10
to O 0 4.219641996927592e-12
establish O 0 1.1944523148343933e-09
diagnoses O 0 1.379620789521141e-05
, O 0 6.55192566867413e-11
and O 0 2.959784639600116e-09
disease O 0 1.1422901025071042e-06
severity O 0 9.396759560331702e-05
was O 0 8.158148823156353e-09
assessed O 0 8.477241131288338e-10
using O 0 1.9325534228453733e-11
a O 0 6.038530786511842e-11
combination O 0 8.650954952393874e-10
of O 0 7.228948776388799e-12
validated O 0 2.4980725044088103e-08
scoring O 0 1.2024253814857389e-09
systems O 0 6.753674952619804e-09
. O 0 7.58967888536688e-10

HLA O 0 1.1396524314477574e-05
typing O 0 1.5735992064946913e-07
for O 0 1.0217700990855505e-10
HLA O 0 1.5742746484193049e-07
- O 0 2.0164364400443446e-08
B27 O 0 6.506700511721419e-09
, O 0 3.031767111666417e-12
HLA O 0 9.725268368399043e-10
- O 0 2.0802732869640295e-09
B60 O 0 1.9425632213909694e-09
, O 0 1.9319040724802283e-12
and O 0 3.722040384235292e-11
HLA O 0 1.1032801694454974e-07
- O 0 3.538859346008394e-06
DR1 O 1 0.9764886498451233
was O 0 1.94201952297135e-08
performed O 0 4.5718963337382235e-11
by O 0 5.769290752598299e-13
polymerase O 0 7.544154884131515e-11
chain O 0 1.0143393902595221e-09
reaction O 0 4.3972783747570077e-11
with O 0 3.518285109863767e-13
sequence O 0 1.597382989770857e-11
- O 0 3.079143606754542e-10
specific O 0 5.095212012723449e-12
primers O 0 1.54867620949517e-08
, O 0 2.7775832849019633e-12
and O 0 7.182974701147593e-12
zygosity O 0 1.8090705822260134e-08
was O 0 6.178444422744178e-10
assessed O 0 7.329475359973969e-10
using O 0 4.115338902987986e-10
microsatellite O 0 1.0280579090249375e-06
markers O 0 2.09522863769962e-06
. O 0 1.4734623299261784e-08

Genetic O 0 8.3653303590836e-06
and O 0 6.765326632240942e-10
environmental O 0 5.839377870131557e-10
variance O 0 4.840386425009058e-10
components O 0 4.983876422670619e-09
were O 0 2.716225855348142e-10
assessed O 0 6.3239640191170565e-09
with O 0 6.706682084689497e-12
the O 0 1.7989002648599595e-11
program O 0 1.9049169186491355e-10
Mx O 0 7.001899504643916e-09
, O 0 2.050514129965566e-14
using O 0 1.6260374936707261e-13
data O 0 7.162398712318163e-12
from O 0 1.1246959716630298e-13
this O 0 2.2238864937941527e-13
and O 0 2.861460200731525e-12
previous O 0 2.217467529042061e-11
studies O 0 6.100776134276842e-12
of O 0 1.8074285557806435e-12
twins O 0 1.1074943131461623e-06
with O 0 1.0936263700189741e-10
AS B-Disease 1 0.9856671690940857
. O 0 6.8359313765142815e-09

RESULTS O 0 4.4950556343792414e-07
Six O 0 2.523441455792863e-10
of O 0 2.5840652534414588e-11
8 O 0 1.3614568139530547e-08
monozygotic O 0 0.06051876023411751
( O 0 3.4791007852419398e-09
MZ O 1 0.98219233751297
) O 0 5.421399440486141e-10
twin O 0 0.0027143245097249746
pairs O 0 1.048703143169405e-05
were O 0 1.149192101479457e-07
disease O 0 9.089990982147356e-08
concordant O 0 3.6045733509126876e-08
, O 0 1.5382143475628496e-11
compared O 0 5.396811469937646e-11
with O 0 3.4746771432336843e-13
4 O 0 1.6431387500626116e-12
of O 0 1.208680182850086e-12
15 O 0 2.1394273505559447e-11
B27 O 0 6.9313021988648416e-09
- O 0 4.3906055680054124e-07
positive O 0 2.9494098274795988e-09
dizygotic O 0 7.324824764509685e-06
( O 0 4.237080478142197e-11
DZ O 0 2.2876638468005694e-05
) O 0 2.025256178039836e-11
twin O 0 1.1405447963852566e-07
pairs O 0 2.4881137150600807e-09
( O 0 5.649280956226965e-13
27 O 0 6.378187041022887e-12
% O 0 2.2326162186364629e-13
) O 0 5.836782744411337e-14
and O 0 1.3392836102285588e-12
4 O 0 3.0455323592887273e-12
of O 0 5.097233399253831e-12
32 O 0 1.5066554670539745e-09
DZ O 0 0.08071035891771317
twin O 0 2.8964312150492333e-05
pairs O 0 3.736378673124818e-08
overall O 0 9.047793625427403e-10
( O 0 5.646297231848285e-13
12 O 0 1.1835198619747356e-12
. O 0 3.7069175853887693e-13
5 O 0 3.527882846965369e-12
% O 0 3.2922017976361184e-12
) O 0 1.0692949997670453e-11
. O 0 1.9468573975167658e-10

Nonsignificant O 0 1.2274599612283055e-05
increases O 0 1.1145343137286545e-07
in O 0 7.741520098580867e-12
similarity O 0 7.202555912799724e-11
with O 0 2.5995219431890204e-12
regard O 0 1.906981655919182e-10
to O 0 6.39678171543423e-11
age O 0 4.9460253670474685e-09
at O 0 2.7393070034520406e-09
disease O 0 1.6338416841676917e-08
onset O 0 2.3829034301314778e-09
and O 0 8.593715149218806e-12
all O 0 1.543093588020697e-13
of O 0 2.339235305025972e-13
the O 0 1.4768061773473562e-10
disease O 0 1.2673078231273394e-07
severity O 0 4.248789480243431e-07
scores O 0 9.90045156967767e-10
assessed O 0 5.491715082683868e-09
were O 0 1.9027381059633086e-10
noted O 0 4.2844119918505896e-10
in O 0 5.90349102935761e-10
disease O 0 5.772623694610957e-07
- O 0 1.9128316125716083e-05
concordant O 0 0.036039579659700394
MZ O 1 0.9999393224716187
twins O 0 0.0002949447662103921
compared O 0 6.774472094406292e-09
with O 0 6.479178860097079e-10
concordant O 0 0.0018213236471638083
DZ O 1 0.9998425245285034
twins O 0 0.0009575712610967457
. O 0 2.9562527981141784e-09

HLA O 0 0.0001898877089843154
- O 0 1.6359033452317817e-06
B27 O 0 9.167717252012153e-08
and O 0 1.2097216284256973e-10
B60 O 0 3.3070848282079623e-09
were O 0 4.9365674742452015e-11
associated O 0 4.378063536703003e-11
with O 0 4.0998693155713806e-12
the O 0 2.33067898314232e-10
disease O 0 2.5797945113481546e-08
in O 0 7.971220905567122e-12
probands O 0 1.0621135970723117e-07
, O 0 1.0924203165327273e-12
and O 0 1.873351517314714e-12
the O 0 1.6099045924491961e-12
rate O 0 2.6829352961499353e-08
of O 0 3.1023378310734984e-12
disease O 0 1.9530248529520122e-09
concordance O 0 1.1524594611955763e-09
was O 0 1.6338431996221203e-10
significantly O 0 1.6059806262624932e-10
increased O 0 2.0535789735376397e-10
among O 0 1.8671678092552213e-10
DZ O 0 0.09564098715782166
twin O 0 6.154781294753775e-05
pairs O 0 6.953722930802542e-08
in O 0 1.6126038004937726e-11
which O 0 2.0296877026315663e-11
the O 0 6.381156020252021e-12
co O 0 2.3569209872675856e-07
- O 0 4.031389835290611e-06
twin O 0 0.00214212154969573
was O 0 1.674856031641525e-09
positive O 0 2.527735616306148e-12
for O 0 2.5031696550617544e-13
both O 0 7.805095111890203e-12
B27 O 0 8.811528395824553e-09
and O 0 5.4908246838181185e-09
DR1 O 0 0.1577182412147522
. O 0 9.240005205413127e-09

Additive O 0 3.420125267439289e-07
genetic O 0 6.689090810141352e-07
effects O 0 5.343995894691034e-07
were O 0 4.4545314659139024e-10
estimated O 0 4.0238253701252447e-11
to O 0 6.399655111399838e-13
contribute O 0 9.767494105195063e-12
97 O 0 4.6262802616547916e-12
% O 0 3.519533568665384e-13
of O 0 2.0242810791319676e-13
the O 0 1.00283080450847e-11
population O 0 1.1471028987797283e-11
variance O 0 9.965280822754607e-10
. O 0 2.894443573708827e-09

CONCLUSION O 0 1.3291457889863523e-07
Susceptibility O 0 5.7021232350962237e-05
to O 0 1.3704707368944469e-09
AS B-Disease 0 0.0932924672961235
is O 0 3.002529128104392e-11
largely O 0 1.6896395740872983e-11
genetically O 0 4.76062557430712e-11
determined O 0 8.329072542778704e-09
, O 0 1.7378258120731571e-12
and O 0 1.7516796390129596e-12
the O 0 6.750158158125297e-13
environmental O 0 1.132090601818625e-10
trigger O 0 9.513491106005745e-10
for O 0 2.160017824326399e-12
the O 0 2.2178790748395016e-10
disease O 0 6.732071256010386e-08
is O 0 9.680015816693199e-11
probably O 0 3.816943650036819e-09
ubiquitous O 0 8.414262708811293e-08
. O 0 1.3992504932502925e-09

HLA O 0 3.6621517210733145e-05
- O 0 2.481137642007525e-07
B27 O 0 2.6988665524640965e-08
accounts O 0 4.962342203818082e-10
for O 0 1.1214791031596838e-12
a O 0 1.01871636126738e-11
minority O 0 8.121035788288822e-11
of O 0 1.0098977860570346e-12
the O 0 7.962163914299047e-12
overall O 0 2.3905237789279e-09
genetic O 0 2.4643961538117765e-08
susceptibility O 0 1.4278325579653028e-05
to O 0 7.919616962226428e-09
AS B-Disease 1 0.9993650317192078
. O 0 6.994213919142567e-08

Cell O 0 2.0873028915957548e-05
cycle O 0 5.580008064498543e-07
- O 0 1.122700155065104e-06
dependent O 0 1.65024349740861e-08
colocalization O 0 7.200944907026496e-08
of O 0 3.324511152480447e-11
BARD1 O 0 1.3327495253179222e-05
and O 0 6.257954709987246e-10
BRCA1 O 0 1.1122853749157002e-07
proteins O 0 2.215540945149641e-10
in O 0 2.1533507615911773e-11
discrete O 0 4.7643027301091934e-08
nuclear O 0 7.696167813264765e-06
domains O 0 1.795879711607995e-07
. O 0 2.5821316196328326e-09

Germ O 0 0.002515423111617565
- O 0 4.363896732684225e-05
line O 0 1.4595639186154585e-07
mutations O 0 1.056349141492774e-08
of O 0 1.4331383302312872e-12
the O 0 9.591407529319085e-12
BRCA1 O 0 2.4979676993552857e-08
gene O 0 1.4445985518918292e-09
predispose O 0 6.030238086651707e-09
women O 0 7.919185446292332e-11
to O 0 1.1283929519934066e-11
early O 0 2.6271900210872445e-09
- O 0 0.028441190719604492
onset O 0 0.022018788382411003
breast B-Disease 1 0.9999815225601196
and I-Disease 1 0.999700665473938
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
by O 0 2.7496818155725578e-09
compromising O 0 3.2863786145753693e-06
the O 0 4.635256067864191e-11
genes O 0 1.766593094032487e-09
presumptive O 0 1.3950952961749863e-05
function O 0 3.777544055338922e-09
as O 0 1.3909364111885925e-11
a O 0 5.93199100951125e-10
tumor B-Disease 0 9.38111770665273e-06
suppressor O 0 3.3090200304286554e-05
. O 0 1.450275277647961e-08

Although O 0 6.0912856980621655e-09
the O 0 2.7326869933563813e-11
biochemical O 0 8.304279042192775e-09
properties O 0 1.3721918046272208e-09
of O 0 7.654613054519643e-12
BRCA1 O 0 1.1707893463608343e-06
polypeptides O 0 4.3006849637095e-08
are O 0 2.5822088911553465e-10
not O 0 2.481643224250263e-10
understood O 0 3.882469012950196e-09
, O 0 5.999617035817861e-13
their O 0 1.5780316506633363e-12
expression O 0 5.641289657631887e-10
pattern O 0 4.009288900874708e-09
and O 0 1.1587200816898235e-11
subcellular O 0 1.2586927056190689e-08
localization O 0 9.87246728811897e-10
suggest O 0 3.9365781467903815e-11
a O 0 2.847532973304645e-12
role O 0 7.052556455500181e-11
in O 0 2.8740038127139655e-11
cell O 0 1.242978271420725e-07
- O 0 1.5398055097648466e-07
cycle O 0 1.1871396310425553e-08
regulation O 0 7.766170817546936e-09
. O 0 8.24170953706016e-10

When O 0 1.1851694381448397e-07
resting O 0 6.639529601670802e-07
cells O 0 2.4993866976075196e-09
are O 0 1.1091627616366395e-11
induced O 0 7.685200031914974e-09
to O 0 7.950858721406107e-12
proliferate O 0 1.9860368905000314e-09
, O 0 1.0832674546875504e-13
the O 0 1.5941551735360743e-13
steady O 0 3.840925077991386e-10
- O 0 5.439359518355502e-10
state O 0 8.803098007492682e-12
levels O 0 3.287472030710781e-11
of O 0 7.125451894100451e-14
BRCA1 O 0 1.1893465101664447e-09
increase O 0 1.853088689440785e-11
in O 0 2.7561466563880144e-12
late O 0 1.013184536269307e-10
G1 O 0 5.528509205987575e-09
and O 0 8.404590391697386e-12
reach O 0 6.815051994957244e-12
a O 0 1.1179046403853032e-11
maximum O 0 7.739017759966771e-10
during O 0 1.872475507980198e-09
S O 0 2.30738351092441e-06
phase O 0 5.130325941848923e-09
. O 0 1.5657716234684926e-09

Moreover O 0 3.365094585205952e-07
, O 0 6.669959029537154e-11
in O 0 1.5219096816121436e-11
S O 0 8.157280717568938e-08
phase O 0 1.912187519437225e-09
cells O 0 7.970548665525712e-09
, O 0 2.6207412975876032e-11
BRCA1 O 0 3.0001352513409074e-08
polypeptides O 0 2.6886715076557266e-09
are O 0 1.7646649766445144e-11
hyperphosphorylated O 0 3.05022425095558e-08
and O 0 9.703213926792742e-11
accumulate O 0 1.3402464693612615e-09
into O 0 3.5855599739287314e-11
discrete O 0 2.649974462087812e-08
subnuclear O 0 5.322224296833156e-06
foci O 0 9.566534572513774e-06
termed O 0 8.94936817985581e-07
" O 0 6.018520082307077e-08
BRCA1 O 0 2.580726140877232e-05
nuclear O 0 1.0181691322941333e-05
dots O 0 0.00025104745873250067
. O 0 2.8720629430267763e-08

" O 0 3.7292983279257896e-07
BRCA1 O 0 3.6153793189441785e-05
associates O 0 9.714057114251773e-07
in O 0 1.0880301104521095e-09
vivo O 0 5.553474125008506e-07
with O 0 2.1528713534113564e-10
a O 0 2.0536672806770184e-08
structurally O 0 4.218260073685087e-05
related O 0 3.7501653338267715e-08
protein O 0 7.577492056043411e-08
termed O 0 1.6629635410936316e-06
BARD1 O 0 0.0003964383795391768
. O 0 1.1358227247626473e-08

Here O 0 1.5916890916400916e-08
we O 0 5.87178639044339e-11
show O 0 3.6470295533552743e-11
that O 0 3.5202049608606956e-13
the O 0 1.0353618461710068e-13
steady O 0 4.934226360830962e-10
- O 0 1.5264083330635003e-09
state O 0 2.456123845973046e-11
levels O 0 4.659748628621507e-11
of O 0 6.983556257150053e-14
BARD1 O 0 6.55565690621529e-09
, O 0 2.730423038273949e-13
unlike O 0 1.3666079986401902e-12
those O 0 2.6117167239644856e-13
of O 0 3.254204631458757e-13
BRCA1 O 0 1.002046801090728e-07
, O 0 1.331429324430422e-11
remain O 0 8.603674023222041e-11
relatively O 0 6.190685464257939e-11
constant O 0 1.5003873699015458e-08
during O 0 1.9631909431439e-09
cell O 0 7.172515097408905e-07
cycle O 0 2.892684669575374e-08
progression O 0 4.56266029402741e-08
. O 0 5.636213162851789e-10

However O 0 2.2136593003097005e-08
, O 0 5.996625418447366e-11
immunostaining O 0 6.707590927135243e-08
revealed O 0 5.304805839045912e-08
that O 0 5.73771412326618e-11
BARD1 O 0 1.0552199455560185e-05
resides O 0 1.2824488138107881e-08
within O 0 2.9481975888367984e-11
BRCA1 O 0 3.1804154332348844e-07
nuclear O 0 6.007544328667791e-08
dots O 0 1.5829462540750683e-07
during O 0 4.5489961797429146e-10
S O 0 3.3307490099332426e-08
phase O 0 2.5096641778632467e-11
of O 0 2.61438819811749e-13
the O 0 1.2436724827064038e-12
cell O 0 5.600360175606056e-09
cycle O 0 2.8853694433728094e-10
, O 0 5.535989418617437e-13
but O 0 3.8974058355623065e-12
not O 0 3.855013096937254e-12
during O 0 6.270230428623291e-12
the O 0 9.897174226003447e-12
G1 O 0 3.23069961893907e-08
phase O 0 4.117978846807091e-09
. O 0 1.5742431802578949e-09

Nevertheless O 0 3.051055500691291e-06
, O 0 3.86873227897766e-10
BARD1 O 0 1.6257321533430513e-07
polypeptides O 0 9.573547288255213e-09
are O 0 1.2758082784669611e-11
found O 0 1.3028612043386456e-11
exclusively O 0 1.776830418909192e-11
in O 0 7.668919319026024e-12
the O 0 2.2532544406705934e-12
nuclear O 0 6.360796334092811e-10
fractions O 0 5.700926709872878e-12
of O 0 1.0707837475856449e-13
both O 0 2.1865675502857895e-12
G1 O 0 1.2243936531319832e-08
- O 0 6.674711894305574e-09
and O 0 2.740496996000985e-10
S O 0 5.658537247654749e-07
- O 0 6.414736297699619e-09
phase O 0 1.2889590506048876e-09
cells O 0 8.24875900917732e-09
. O 0 3.6794439717269256e-10

Therefore O 0 6.79081395560388e-08
, O 0 1.6033415914384896e-11
progression O 0 1.2395034998391452e-10
to O 0 4.262937225441021e-12
S O 0 5.147217052581254e-07
phase O 0 7.001602075895619e-10
is O 0 1.7024109552621347e-11
accompanied O 0 4.93914839583276e-11
by O 0 5.747083581600365e-13
the O 0 5.42111223533065e-13
aggregation O 0 9.421280595944825e-12
of O 0 2.7674934826443787e-12
nuclear O 0 1.5974617184610906e-08
BARD1 O 0 3.824801808605116e-08
polypeptides O 0 9.278340873386526e-10
into O 0 1.8924085909421962e-10
BRCA1 O 0 2.4064145236479817e-06
nuclear O 0 3.856598596030381e-06
dots O 0 6.033636964275502e-05
. O 0 1.527970461268069e-08

This O 0 5.755670939855406e-10
cell O 0 1.3704223533750337e-07
cycle O 0 1.7483618108826704e-08
- O 0 1.8878235152897105e-07
dependent O 0 1.9789394567482077e-09
colocalization O 0 2.5037966366880937e-08
of O 0 1.0155617666263161e-11
BARD1 O 0 3.2952416404441465e-06
and O 0 5.62358493105819e-10
BRCA1 O 0 2.1282957618495857e-07
indicates O 0 1.3458770764529504e-09
a O 0 4.688614080317066e-12
role O 0 1.4678891782637926e-11
for O 0 3.1076322071221796e-12
BARD1 O 0 6.122248237261374e-07
in O 0 3.955366034702479e-10
BRCA1 O 0 1.2875518223154359e-05
- O 0 1.120317119784886e-05
mediated O 0 4.2606275201251265e-06
tumor B-Disease 0 8.274959691334516e-05
suppression O 0 1.3080218650429742e-06
. O 0 1.97131164725306e-08

Ethnic O 0 2.74376162678891e-07
differences O 0 4.3650629777403083e-07
in O 0 7.518273226203576e-10
the O 0 3.15843434739449e-10
HFE O 0 3.804998050327413e-05
codon O 0 1.1346278938617615e-07
282 O 0 2.0344661066928893e-08
( O 0 1.7218955150610782e-09
Cys O 0 0.0009535253630019724
/ O 0 7.445638402714394e-06
Tyr O 0 5.741198947362136e-06
) O 0 3.671053183662565e-10
polymorphism O 0 1.7823474536271533e-06
. O 0 7.074402841311667e-09

Recent O 0 4.344049386872939e-08
studies O 0 7.068481799876736e-09
have O 0 2.2111715236583507e-10
shown O 0 7.461903983596585e-09
that O 0 2.650053545494302e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.0284451491315849e-05
HH B-Disease 1 0.9999430179595947
) O 0 2.2585825570908824e-11
is O 0 1.2249382931595054e-11
likely O 0 1.132939575487768e-10
to O 0 5.978600860906402e-12
be O 0 8.884037949741241e-10
caused O 0 4.018833876795469e-10
by O 0 1.7038199193533665e-12
homozygosity O 0 1.5045426238202708e-08
for O 0 9.160581364645037e-13
a O 0 1.1045439562984427e-10
Cys282Tyr O 0 3.7593866863971925e-07
mutation O 0 1.734167298650391e-08
in O 0 8.042355843784765e-12
the O 0 2.7362648605255835e-11
HFE O 0 8.129677553370129e-07
gene O 0 4.600321013015218e-09
located O 0 2.8842703780895818e-09
4 O 0 1.979267860718892e-09
. O 0 3.1379960852007116e-09

5 O 0 1.1455811232963242e-07
Mb O 0 6.389745067281183e-06
telomeric O 0 7.767093484289944e-05
to O 0 1.692244921969177e-08
HLA O 0 2.979504097311292e-05
- O 0 8.754039299674332e-06
A O 0 1.3119755237767095e-07
. O 0 1.3820370625694522e-08

Population O 0 3.0814188978212087e-09
studies O 0 3.0547736562525074e-10
of O 0 1.5409650552106191e-12
this O 0 2.295728928139451e-12
polymorphism O 0 3.043784602141386e-08
are O 0 5.186992328709561e-12
facilitated O 0 1.0669907665739053e-11
by O 0 2.066586918952895e-12
the O 0 2.946936965286806e-12
fact O 0 9.145889601214208e-11
that O 0 2.068365227356206e-12
the O 0 2.951515767901647e-12
Cys282Tyr O 0 6.301150534682165e-08
mutation O 0 8.238963289386447e-09
creates O 0 1.770248531096641e-10
a O 0 8.687674885043961e-11
Rsal O 0 2.0508096554294752e-08
restriction O 0 5.432485572498535e-10
site O 0 2.163294654522474e-09
. O 0 8.18855983020228e-10

We O 0 1.206559403499341e-07
have O 0 1.9322965449930507e-10
studied O 0 3.592174335764753e-10
the O 0 1.3464405805574398e-11
codon O 0 2.297528389760828e-09
282 O 0 8.925837846618379e-10
( O 0 1.2995286791106508e-10
Cys O 0 0.00010167742584599182
/ O 0 2.3530826354090095e-07
Tyr O 0 8.587145572391819e-08
) O 0 3.9753439255718614e-12
polymorphism O 0 8.44838421443228e-09
in O 0 2.911450247555791e-11
different O 0 2.650703267992327e-11
ethnic O 0 1.4715903495776672e-10
groups O 0 9.18232101465577e-10
. O 0 9.884016938244145e-10

In O 0 2.634415796620715e-09
agreement O 0 2.1600034261215484e-10
with O 0 5.4601748469829126e-12
previous O 0 2.3686824723867517e-10
observations O 0 6.639591099144582e-09
the O 0 1.7999367621368556e-11
Tyr O 0 3.6890540400236205e-08
allele O 0 9.670096723368715e-09
appeared O 0 6.577258182538515e-10
to O 0 3.739971873861769e-12
be O 0 3.828065642252909e-11
rare O 0 1.4551672367080215e-10
or O 0 1.8965713721730282e-10
absent O 0 3.3040330471578727e-09
in O 0 1.8905533388791085e-11
Asiatic O 0 1.0979973597002868e-09
( O 0 2.2474942913686125e-12
Indian O 0 1.7910556935132882e-12
, O 0 1.7177106091670336e-12
Chinese O 0 2.458935182206301e-12
) O 0 1.9746571999074147e-12
populations O 0 3.0219268754017037e-10
. O 0 2.826745504336259e-10

The O 0 2.304322288537719e-09
highest O 0 9.357378871754918e-09
allele O 0 4.397486108587145e-08
frequency O 0 2.7517504719298813e-08
( O 0 9.391493659138828e-13
7 O 0 1.6248632214027614e-12
. O 0 2.81070902229813e-13
5 O 0 1.7083953609414726e-12
% O 0 3.9582050202595365e-13
) O 0 4.498788223460809e-13
was O 0 1.449306674672357e-09
found O 0 9.425099589677188e-10
in O 0 1.8684788438694255e-10
Swedes O 0 6.728080279572168e-06
. O 0 1.1775934005697763e-08

Saamis O 0 5.252374194242293e-06
( O 0 2.1022862617403604e-10
2 O 0 4.560495731054104e-11
% O 0 1.290514136526033e-12
) O 0 2.944985564006658e-13
and O 0 4.904122247184617e-12
Mordvinians O 0 7.760928788513866e-09
( O 0 2.9350713482909074e-13
1 O 0 4.046201579083891e-13
. O 0 1.2912324746754134e-13
8 O 0 8.362068633013808e-13
% O 0 2.6209237688132325e-13
) O 0 2.4816536629487795e-13
had O 0 3.176413854166782e-10
significantly O 0 2.9072635410187786e-09
lower O 0 1.9787056437792216e-09
frequencies O 0 1.78902026526373e-09
of O 0 2.9029537020747176e-12
the O 0 9.459241723241973e-11
Tyr O 0 3.322025463603495e-07
allele O 0 8.52784722837896e-08
. O 0 1.0718036458357005e-09

Comparisons O 0 4.7619135301602e-08
with O 0 6.6830402323248e-10
allele O 0 9.475072459963485e-08
frequencies O 0 3.498246314848075e-08
based O 0 7.676152768976152e-11
on O 0 2.751186223282076e-10
prevalence O 0 4.0363460129810846e-07
estimates O 0 9.063822470345428e-10
of O 0 3.6985383505827585e-11
HH B-Disease 1 0.9999147653579712
showed O 0 2.109286697304924e-06
some O 0 2.3021003506262794e-12
disagreements O 0 3.5197824654886745e-09
with O 0 1.0325093210972192e-11
the O 0 7.884848156336499e-12
RFLP O 0 9.472720385872435e-09
data O 0 2.0789523436093305e-09
, O 0 9.478105149687832e-13
particularly O 0 3.1817725537619523e-11
in O 0 1.1601228311342027e-10
Finns O 0 1.688716338321683e-06
. O 0 9.366003084210206e-09

The O 0 2.178533264896032e-08
newly O 0 7.170491045371818e-08
described O 0 7.367619758724686e-08
HFE O 0 4.042492946609855e-06
marker O 0 2.4699676970385553e-08
provides O 0 2.862302235506764e-11
a O 0 3.3404509627160683e-12
new O 0 6.682163503080041e-13
approach O 0 6.450909684901918e-12
to O 0 1.395420373218395e-13
the O 0 1.6558136155600534e-13
screening O 0 1.823628748010009e-11
of O 0 3.799751745886537e-12
HH B-Disease 0 0.49908682703971863
as O 0 1.80071270394766e-11
well O 0 1.2834770572733856e-11
as O 0 1.43554309064986e-12
studies O 0 3.562528690017469e-13
of O 0 2.53069981826946e-14
the O 0 1.5015093118506129e-12
relationship O 0 6.842150179764417e-10
between O 0 1.799710207250893e-11
the O 0 9.590077343357706e-11
HFE O 0 4.489021739573218e-05
Tyr O 0 2.960970277854358e-07
allele O 0 4.377886497763939e-08
and O 0 3.7193453872319537e-10
different O 0 7.111318756081175e-10
disorders O 0 5.5819737099227495e-06
including O 0 2.885460581580901e-08
cancer B-Disease 0 0.0007886637467890978

Autosomal B-Disease 1 0.9970090985298157
dominant I-Disease 0 0.49139976501464844
neurohypophyseal I-Disease 1 0.9988445043563843
diabetes I-Disease 1 0.999748170375824
insipidus I-Disease 1 0.9953076243400574
associated O 0 2.8030742669216124e-06
with O 0 3.075387444706479e-10
a O 0 2.1837740504793146e-09
missense O 0 1.8214943338534795e-05
mutation O 0 2.2064936899823806e-07
encoding O 0 6.198265456447416e-09
Gly23 O 0 4.326607722759945e-06
- O 0 4.027527666039532e-06
- O 0 1.8599081158754416e-05
> O 0 5.261355795482814e-07
Val O 0 8.070297553786077e-06
in O 0 5.4231499291290675e-09
neurophysin O 0 1.1534666555235162e-05
II O 0 0.00018330049351789057
. O 0 3.1510548836877206e-08

Autosomal B-Disease 1 0.9978213310241699
dominant I-Disease 0 0.32280710339546204
neurohypophyseal I-Disease 1 0.9985156655311584
diabetes I-Disease 1 0.9996814727783203
insipidus I-Disease 1 0.9925287961959839
( O 0 1.530470150612473e-08
ADNDI B-Disease 0 6.840956484666094e-05
) O 0 7.85899748056984e-11
is O 0 4.020451749298104e-10
an O 0 7.578822192044754e-08
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.00026808585971593857
by O 0 4.520697149956732e-09
progressive O 0 4.17863793700235e-06
degeneration O 0 5.260690613795305e-06
of O 0 2.6172845141170242e-11
the O 0 1.518987158277696e-10
magnocellular O 0 8.318088475789409e-07
neurons O 0 9.603430939364443e-09
of O 0 2.0077130062634563e-12
the O 0 1.7409818378610886e-11
hypothalamus O 0 1.6560704807488946e-08
leading O 0 1.83526319141869e-10
to O 0 1.850107914092014e-11
decreased O 0 7.083503117399914e-09
ability O 0 1.5912746120783083e-10
to O 0 3.831029243839268e-12
produce O 0 7.78565129033737e-11
the O 0 9.681676987893795e-11
hormone O 0 1.8988318473134314e-08
arginine O 0 8.578006749360156e-09
vasopressin O 0 1.4615217480695719e-08
( O 0 1.2343290452243583e-11
AVP O 0 2.603535165235371e-09
) O 0 4.1243418402725496e-11
. O 0 1.6964088467297245e-10

Affected O 0 3.6874013176202425e-07
individuals O 0 1.993688325541143e-09
are O 0 8.668045448079198e-11
not O 0 7.776983917961999e-11
symptomatic O 0 2.6444455514251786e-08
at O 0 1.3645166774267636e-08
birth O 0 2.474714619893348e-07
, O 0 1.2677404265248882e-11
but O 0 1.2939291305080758e-10
usually O 0 9.741349948910738e-09
develop O 0 3.233831691318301e-08
diabetes B-Disease 0 1.565878847031854e-05
insipidus I-Disease 0 1.2716222045128234e-05
at O 0 1.024968288021455e-08
1 O 0 1.0415098783411736e-09
- O 0 1.8838233017959283e-06
6 O 0 1.1227291096815861e-08
yr O 0 5.270754172670422e-06
of O 0 1.0201324507352894e-10
age O 0 1.685599215761613e-08
. O 0 2.8861304457450387e-09

The O 0 6.249700201799158e-10
genetic O 0 6.3686904638871056e-09
locus O 0 5.633274469118987e-08
of O 0 5.909537442727597e-11
the O 0 2.133296872486312e-09
disease O 0 1.949566694747773e-06
is O 0 2.8436702645406875e-11
the O 0 1.5256587659884246e-11
AVP O 0 4.35340545834606e-08
- O 0 1.7680150676824269e-06
neurophysin O 0 9.151378435490187e-06
II O 0 1.096250707632862e-05
( O 0 2.147604143132309e-11
NPII O 0 5.093686894497296e-08
) O 0 3.4377543671991473e-13
gene O 0 1.7780815014800666e-11
, O 0 4.4412815981310916e-13
and O 0 1.1260321668149498e-11
mutations O 0 1.706854102501154e-09
that O 0 2.0039341713795622e-11
cause O 0 3.8638376942401464e-09
ADNDI B-Disease 0 0.00012629342381842434
have O 0 1.1443729519555745e-08
been O 0 8.663355033355913e-10
found O 0 2.0294915747953723e-10
in O 0 4.3698855298202055e-12
both O 0 1.360057791215119e-12
the O 0 1.2200411037346925e-12
signal O 0 5.76859560119658e-10
peptide O 0 3.4983946295419344e-11
of O 0 7.806576159162873e-14
the O 0 1.470623536142801e-12
prepro O 0 4.668589781431365e-08
- O 0 2.6309022516102232e-08
AVP O 0 1.5106962791833212e-08
- O 0 4.7998383934100275e-08
NPII O 0 1.1790063325634037e-07
precursor O 0 3.0424174290999417e-10
and O 0 1.069809085069151e-11
within O 0 2.5313844770336047e-11
NPII O 0 4.5637486323357734e-07
itself O 0 1.1206795491602861e-08
. O 0 8.726757649846206e-10

An O 0 4.4247521202578355e-09
affected O 0 2.1987043297144737e-08
girl O 0 1.1774443009926472e-05
who O 0 8.794280303980884e-10
presented O 0 2.726383563356194e-10
at O 0 2.9273646007244025e-11
9 O 0 9.983458504336795e-12
months O 0 1.8123454126328653e-11
of O 0 1.0284009971731067e-12
age O 0 1.8516420619008045e-09
and O 0 3.135862750025531e-11
her O 0 1.052308684634795e-09
similarly O 0 9.878404760854664e-09
affected O 0 3.091596145754494e-10
younger O 0 3.913492030438448e-10
brother O 0 1.7810328767353667e-09
and O 0 1.8906048948608145e-10
father O 0 1.679206995675031e-08
were O 0 6.458632240136097e-11
all O 0 3.8112910180285176e-13
found O 0 1.6657111454043694e-11
to O 0 5.1432707919019105e-12
have O 0 3.396145517586824e-11
a O 0 2.0510412812591028e-11
novel O 0 3.011478011405444e-10
missense O 0 5.046014166509849e-07
mutation O 0 5.557618010243459e-08
( O 0 5.3312384888648534e-12
G1758 O 0 1.2907130919614929e-09
- O 0 1.354750764903656e-07
- O 0 7.095594583006459e-07
> O 0 3.350054100792477e-08
T O 0 8.19516117189778e-08
) O 0 1.7912188117301386e-13
encoding O 0 2.5718598258006597e-12
the O 0 1.1074708858305193e-12
amino O 0 5.609342417639551e-12
acid O 0 2.097406016227099e-12
substitution O 0 1.5211491788402753e-11
Gly23 O 0 1.0799178440379364e-08
- O 0 6.503378102706847e-08
- O 0 1.6105474287542165e-07
> O 0 1.0259697980075089e-08
Val O 0 4.1014033058672794e-07
within O 0 1.2315389819050893e-09
NPII O 0 6.590439625142608e-06
. O 0 2.8305990884547327e-09

The O 0 1.2659735482145607e-08
mutation O 0 1.7368770386383403e-06
was O 0 5.9755551617968194e-09
confirmed O 0 3.9914932470352937e-10
by O 0 4.716904818125034e-12
restriction O 0 5.258319890621976e-10
endonuclease O 0 2.085507304627754e-07
analysis O 0 7.729477502493864e-09
. O 0 1.9970338716035485e-09

A O 0 4.795364247911493e-07
T1 O 0 0.00016430696996394545
- O 0 2.687676499135705e-07
weighted O 0 2.5842812334531118e-08
magnetic O 0 3.6696505389954837e-07
resonance O 0 3.20085587190988e-06
imaging O 0 7.220189672807464e-06
of O 0 1.8319896988305828e-10
the O 0 6.0457621131604355e-09
fathers O 0 3.782304338528775e-05
pituitary O 0 1.0000122529163491e-05
gland O 0 5.93124980241555e-07
demonstrates O 0 1.7088028769762786e-08
an O 0 3.265094444815375e-11
attenuated O 0 1.2782499652530532e-05
posterior O 0 6.07311594649218e-05
pituitary O 0 0.0005565396277233958
bright O 0 2.60839588008821e-05
spot O 0 6.105064130679239e-06
. O 0 2.2380920228215473e-08

This O 0 9.430427994061574e-09
mutation O 0 1.945677240655641e-06
may O 0 4.048294144354259e-09
be O 0 1.6226054787987776e-12
valuable O 0 1.0333860503419778e-11
for O 0 3.412791425329298e-13
developing O 0 4.188891594703037e-11
models O 0 2.3348092348385308e-09
of O 0 3.453056590663195e-11
dominantly B-Disease 0 0.1083134114742279
inherited I-Disease 1 0.994120180606842
neurodegeneration I-Disease 1 0.9999996423721313
, O 0 1.3644033125537192e-10
as O 0 6.593162430942878e-13
the O 0 2.7553569777356846e-13
early O 0 3.096670142532787e-11
age O 0 2.8286747943973012e-11
of O 0 8.17112057269892e-13
onset O 0 7.637339094479501e-10
of O 0 3.287910915750203e-11
symptoms O 0 1.0900376423705893e-07
suggests O 0 1.1328422921952352e-10
that O 0 2.431511589295887e-12
this O 0 4.475434346035145e-12
mutation O 0 1.466553722906383e-08
may O 0 1.834543184031645e-09
be O 0 1.9832527980989667e-11
particularly O 0 5.323305685145385e-11
deleterious O 0 1.1867727245373771e-08
to O 0 4.4238952778830054e-11
the O 0 2.7890423304199885e-10
magnocellular O 0 2.634453267091885e-06
neuron O 0 1.6959468212007778e-06
. O 0 2.7559024506906837e-10
. O 0 9.59289980784206e-10

Frequent O 0 8.436505595454946e-06
inactivation O 0 1.4977908904256765e-05
of O 0 1.8968580040024108e-09
PTEN O 0 0.00017225492047145963
/ O 0 4.436892140802229e-06
MMAC1 O 0 7.255427044583485e-05
in O 0 1.9818752861056055e-08
primary O 1 0.563208281993866
prostate B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999986886978149
. O 0 1.928934807438054e-06

Sporadic B-Disease 0 0.0708494707942009
prostate I-Disease 1 0.9999723434448242
carcinoma I-Disease 1 1.0
is O 0 7.92369903024337e-08
the O 0 2.2525080758950544e-11
most O 0 1.1353010545556153e-11
common O 0 2.2560003865024214e-10
male B-Disease 0 1.0355815902585164e-06
cancer I-Disease 0 1.611425481939932e-08
in O 0 5.2782006196294695e-12
the O 0 2.183629362398354e-12
Western O 0 1.317293930186425e-11
world O 0 3.6634500988341756e-10
, O 0 1.895694105163992e-12
yet O 0 8.914684962446628e-12
many O 0 1.0200155404018786e-14
of O 0 7.247355351209985e-15
the O 0 7.283874837917675e-14
major O 0 7.468211162334204e-13
genetic O 0 8.504650976515205e-12
events O 0 5.288873072134548e-12
involved O 0 3.3698384360736355e-11
in O 0 7.515699868010373e-12
the O 0 8.277652001342783e-12
progression O 0 1.9821154439991773e-10
of O 0 3.067643795234831e-13
this O 0 7.147159253317881e-11
often O 0 1.6966539817531157e-07
fatal O 0 0.0034149526618421078
cancer B-Disease 0 5.681762195308693e-05
remain O 0 2.46884663823721e-08
to O 0 1.47260398319915e-10
be O 0 4.503141415312939e-09
elucidated O 0 1.2229020285303704e-06
. O 0 1.3956840128059866e-09

Numerous O 0 4.157409350113994e-08
cytogenetic O 0 0.00046858814312145114
and O 0 5.79988723714564e-09
allelotype O 0 8.79863273439696e-06
studies O 0 4.453565072282117e-09
have O 0 2.9380498034470293e-10
reported O 0 2.690307976394024e-09
frequent O 0 1.6251455292604078e-08
loss O 0 2.9947440083333277e-08
of O 0 3.7392460655594206e-11
heterozygosity O 0 1.085715393855935e-05
on O 0 2.983592040095573e-08
chromosomal O 0 0.023775290697813034
arm O 0 3.329103492433205e-05
10q O 0 4.2621331886039115e-07
in O 0 4.2246655063138405e-09
sporadic B-Disease 0 0.01964726485311985
prostate I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999990463256836
. O 0 1.140348331318819e-06

Deletion O 0 1.809975947253406e-05
mapping O 0 9.284574844059534e-06
studies O 0 4.169845624346635e-08
have O 0 1.0095353442096666e-09
unambiguously O 0 1.6107713918245281e-06
identified O 0 2.6076268255792456e-08
a O 0 1.842249408579022e-10
region O 0 2.008615218596077e-10
of O 0 4.96260194396414e-12
chromosome O 0 4.646425111332064e-08
10q23 O 0 3.0364883940592335e-09
to O 0 8.350327374007094e-12
be O 0 1.5839277806017904e-11
the O 0 1.2179207295459626e-12
minimal O 0 1.4289950556189979e-08
area O 0 2.369848484118364e-10
of O 0 7.462210016573323e-11
loss O 0 1.0268335159935305e-07
. O 0 2.1360209156995325e-09

A O 0 2.4098303796904474e-08
new O 0 7.105570021259666e-10
tumor B-Disease 0 4.3396440219112264e-07
suppressor O 0 2.71593398792902e-06
gene O 0 7.101037624579476e-08
, O 0 1.0080071499718457e-10
PTEN O 0 9.371736268803943e-06
/ O 0 6.203234761414933e-07
MMAC1 O 0 0.00011431211169110611
, O 0 3.687207206226617e-10
was O 0 4.45154402228809e-09
isolated O 0 1.749826417096756e-08
recently O 0 2.0334612216288406e-08
at O 0 2.0879879769619691e-10
this O 0 2.1202766105343773e-12
region O 0 3.781115351375597e-11
of O 0 1.7163122052049617e-12
chromosome O 0 5.8817711590108956e-08
10q23 O 0 1.7330883395061392e-09
and O 0 1.0199003100397341e-11
found O 0 1.902269140818813e-11
to O 0 5.120327339208641e-12
be O 0 9.192287903081464e-11
inactivated O 0 1.7907545446504969e-09
by O 0 5.413386319069735e-12
mutation O 0 4.973450096201759e-09
in O 0 2.269587018322028e-10
three O 0 9.209215363625844e-07
prostate B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999991655349731
cell O 0 0.02206127718091011
lines O 0 5.513704309123568e-05
. O 0 1.0685341500504819e-08

We O 0 7.902266929704638e-08
screened O 0 1.4384370388142997e-06
80 O 0 4.32359890112366e-08
prostate B-Disease 1 0.953937292098999
tumors I-Disease 1 0.9999983310699463
by O 0 3.113170554680522e-10
microsatellite O 0 7.629652827745304e-06
analysis O 0 3.843552676130457e-08
and O 0 1.1682788070288552e-10
found O 0 1.846037628316921e-10
chromosome O 0 7.370304899723124e-08
10q23 O 0 1.0656399318520471e-08
to O 0 2.7365573349036332e-11
be O 0 1.0322656618377835e-10
deleted O 0 3.6866607544538965e-09
in O 0 7.766192550162643e-11
23 O 0 1.6682237535814437e-10
cases O 0 5.220037735398364e-10
. O 0 2.426136846978011e-09

We O 0 3.1723480731216114e-08
then O 0 9.873837164553478e-11
proceeded O 0 8.80820416604422e-12
with O 0 7.50041169580648e-14
sequence O 0 3.5299155091983447e-12
analysis O 0 4.631548508431116e-13
of O 0 2.6079917441130043e-14
the O 0 2.0073799393560687e-12
entire O 0 3.4826511119412373e-10
PTEN O 0 1.6453238913527457e-06
/ O 0 7.493767384403327e-09
MMAC1 O 0 1.037163528394558e-07
coding O 0 2.1882282652541107e-08
region O 0 5.942749625731381e-10
and O 0 6.471172903088629e-11
tested O 0 2.5010462589847293e-09
for O 0 8.067964156997787e-13
homozygous O 0 3.5965501687940105e-09
deletion O 0 1.5795306174126722e-09
with O 0 8.601963759347075e-12
new O 0 3.676922048084785e-12
intragenic O 0 3.7911718209215906e-09
markers O 0 4.5405035287160445e-09
in O 0 1.1006359885989969e-11
these O 0 2.8586399740404556e-12
23 O 0 4.424196686086956e-12
cases O 0 3.2099260315748834e-12
with O 0 1.161561385271126e-11
10q23 O 0 4.801193398407122e-08
loss O 0 7.739213714330617e-09
of O 0 9.54245432671641e-11
heterozygosity O 0 2.169714935007505e-05
. O 0 1.3089057837589735e-08

The O 0 2.874361582083651e-10
identification O 0 7.068478025118452e-10
of O 0 2.902820778888371e-12
the O 0 5.627313719169802e-12
second O 0 5.832161836805128e-11
mutational O 0 6.682255815348981e-08
event O 0 7.16354398022645e-09
in O 0 2.804478697882029e-11
10 O 0 8.952461168221237e-12
( O 0 6.699161624740269e-13
43 O 0 2.8726392792277622e-11
% O 0 4.3893343820711195e-11
) O 0 1.5037902034720219e-09
tumors B-Disease 1 0.9999985694885254
establishes O 0 1.7987842511502095e-05
PTEN O 0 0.0005049776518717408
/ O 0 2.613462868339411e-07
MMAC1 O 0 8.200921115530946e-07
as O 0 8.63871127410043e-12
a O 0 1.052193228379128e-11
main O 0 1.7895961101910274e-10
inactivation O 0 7.678210955930354e-09
target O 0 3.049319130532524e-10
of O 0 1.9427120502568673e-12
10q O 0 9.987378035702932e-09
loss O 0 7.97967558696655e-09
in O 0 9.435100478683012e-10
sporadic B-Disease 0 0.11716588586568832
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 1.5616206994195636e-08
. O 0 3.950308968825311e-09

Risk O 0 8.888942829798907e-06
reversals O 0 4.334920049586799e-07
in O 0 3.7396047369853136e-10
predictive O 0 3.27080265094537e-08
testing O 0 2.044007096912992e-08
for O 0 4.877422021820621e-09
Huntington B-Disease 1 0.9999886751174927
disease I-Disease 1 0.9999914169311523
. O 0 1.5790321583608602e-07

The O 0 3.9557207509588466e-10
first O 0 5.232195926518912e-11
predictive O 0 3.853651175944606e-09
testing O 0 6.143288988624818e-09
for O 0 5.385413448522058e-09
Huntington B-Disease 1 0.9999966621398926
disease I-Disease 1 0.9999972581863403
( O 0 7.048566730283312e-10
HD B-Disease 0 2.5234945496777073e-05
) O 0 2.128206638696284e-11
was O 0 5.00611052611788e-10
based O 0 4.392062234737093e-12
on O 0 5.5951844719903665e-12
analysis O 0 1.0957054707994018e-11
of O 0 4.12403076098522e-13
linked O 0 1.0549356943556631e-08
polymorphic O 0 4.389439034468978e-09
DNA O 0 2.0932606759060945e-09
markers O 0 1.350768497054844e-09
to O 0 5.295070371752475e-12
estimate O 0 8.840929377473827e-11
the O 0 1.8151465573656989e-12
likelihood O 0 4.486626903332791e-10
of O 0 2.2616119046969807e-12
inheriting O 0 9.293364300333451e-09
the O 0 4.705037401353529e-11
mutation O 0 1.1944393918383867e-08
for O 0 6.597156848586749e-11
HD B-Disease 0 2.7097660222352715e-06
. O 0 6.037626842925192e-09

Limits O 0 2.1238061975736855e-08
to O 0 3.9678996199832284e-11
accuracy O 0 1.1749992090415162e-09
included O 0 2.8975216323501307e-12
recombination O 0 1.683053280077118e-10
between O 0 1.0331377246763918e-11
the O 0 1.040868888475821e-12
DNA O 0 9.339419237974766e-10
markers O 0 1.0793041127499237e-08
and O 0 1.3840767074113636e-11
the O 0 3.847336945556057e-12
mutation O 0 1.4035038020665525e-08
, O 0 3.666165461491122e-12
pedigree O 0 3.25519380339756e-08
structure O 0 3.763233280551503e-09
, O 0 4.577773164878007e-13
and O 0 2.3578922560101023e-13
whether O 0 2.7435694775063135e-12
DNA O 0 3.029533290899167e-10
samples O 0 3.9777370286486757e-10
were O 0 3.165561909823644e-11
available O 0 1.5324892396750833e-11
from O 0 5.400907152064427e-12
family O 0 1.8634534193484598e-10
members O 0 1.8362986478615007e-11
. O 0 4.689048038741817e-10

With O 0 2.5161073224921893e-10
direct O 0 2.5935817382638504e-10
tests O 0 1.016378758933456e-09
for O 0 9.400400379985796e-13
the O 0 1.3467154474922083e-11
HD B-Disease 0 8.777050766184402e-07
mutation O 0 5.3664365395889035e-08
, O 0 3.438536564856487e-12
we O 0 2.2226082085907706e-11
have O 0 9.225950082028533e-13
assessed O 0 1.5585772256132557e-11
the O 0 1.8461756646007133e-13
accuracy O 0 4.8568848942665e-10
of O 0 2.450076274675139e-13
results O 0 1.7062469492845622e-11
obtained O 0 7.214678507394545e-12
by O 0 9.93811898552209e-14
linkage O 0 1.999300447419472e-10
approaches O 0 9.697602963709695e-12
when O 0 1.6802449188946245e-12
requested O 0 7.952174075481766e-13
to O 0 1.2153124643796143e-12
do O 0 5.198275837559052e-11
so O 0 7.968481018257034e-13
by O 0 3.998238101276391e-13
the O 0 4.433480492449515e-12
test O 0 4.5514408214542e-11
individuals O 0 4.6889558208418336e-11
. O 0 2.9919317023896497e-10

For O 0 2.16097598149112e-10
six O 0 2.1872276559364856e-11
such O 0 4.833517700669754e-12
individuals O 0 5.821459286847741e-11
, O 0 5.375758432152322e-12
there O 0 1.4091265480853377e-11
was O 0 1.2712375596635184e-10
significant O 0 2.037091675899383e-11
disparity O 0 3.094464684494369e-09
between O 0 3.497327080714818e-11
the O 0 6.540288449707887e-11
tests O 0 3.615057586614512e-09
. O 0 5.901948374464894e-10

Three O 0 9.120322275180115e-10
went O 0 2.5627250321846873e-10
from O 0 1.7466785396519358e-12
a O 0 3.7083076193100695e-11
decreased O 0 1.005824827871038e-07
risk O 0 3.042401663932992e-09
to O 0 1.6622856520084883e-12
an O 0 1.7396597400479163e-12
increased O 0 7.281795610936115e-09
risk O 0 1.9465814204977505e-07
, O 0 1.18369582798733e-12
while O 0 6.3066448764692584e-12
in O 0 8.495339848257899e-13
another O 0 2.616260073168286e-12
three O 0 2.172371223879699e-12
the O 0 3.0835327347045194e-11
risk O 0 4.7408974523932557e-08
was O 0 4.996850044847179e-09
decreased O 0 5.78808716511503e-08
. O 0 6.695761167740955e-10

Knowledge O 0 1.0601500122220386e-08
of O 0 1.704562012372346e-11
the O 0 2.2048983732564365e-12
potential O 0 4.411306736562537e-11
reasons O 0 1.1411388327331462e-11
for O 0 5.472826917129678e-14
these O 0 1.9094137891900037e-13
changes O 0 2.595543571737302e-12
in O 0 1.916423617021046e-12
results O 0 3.960875030739608e-11
and O 0 9.81732663912771e-12
impact O 0 5.383774676070985e-11
of O 0 4.685053885643276e-13
these O 0 1.2983611581696142e-11
risk O 0 2.64075317168988e-10
reversals O 0 2.136345683689811e-10
on O 0 3.146023372369022e-11
both O 0 2.47075554460352e-11
patients O 0 5.7338741393797577e-11
and O 0 1.761207499284545e-12
the O 0 7.263969157081385e-13
counseling O 0 8.129683037871871e-11
team O 0 5.668021173937943e-12
can O 0 1.8476034504416594e-12
assist O 0 5.656127150845125e-13
in O 0 3.6475545348892136e-13
the O 0 5.121591830649884e-14
development O 0 2.098252059839871e-14
of O 0 8.641812986780531e-15
strategies O 0 1.8181888286616932e-12
for O 0 6.119602979741401e-14
the O 0 2.185450171526826e-12
prevention O 0 5.955105852883946e-10
and O 0 1.3665695311471104e-11
, O 0 2.6711898209845486e-13
where O 0 2.104418419038301e-12
necessary O 0 2.956396585873655e-11
, O 0 5.524471396838038e-13
management O 0 1.0028590371330415e-12
of O 0 9.738514824468667e-15
a O 0 2.2878619138078093e-11
risk O 0 6.947485919894802e-10
reversal O 0 1.3956195921149828e-10
in O 0 1.4334883106925655e-12
any O 0 6.373833318779054e-12
predictive O 0 1.0956396900851928e-09
testing O 0 3.152368088787938e-10
program O 0 5.659154742043704e-11
. O 0 5.6114934747497625e-12
. O 0 1.5633953853733118e-10

A O 0 5.994004226295147e-08
novel O 0 8.106713522693099e-09
common O 0 3.1282791912445873e-09
missense O 0 4.660458671423839e-06
mutation O 0 3.016672565081535e-07
G301C O 0 1.4515704194195678e-08
in O 0 1.306240185461327e-11
the O 0 7.869658050219108e-12
N O 0 1.0695117680370458e-06
- O 0 2.1267008776248986e-07
acetylgalactosamine O 0 5.2822679208475165e-06
- O 0 8.236654593929416e-07
6 O 0 1.1128127308523972e-09
- O 0 1.0153192988582305e-06
sulfate O 0 3.3318628993583843e-06
sulfatase O 0 4.82821974401304e-07
gene O 0 4.501483630292569e-09
in O 0 3.07944919564207e-10
mucopolysaccharidosis B-Disease 0 1.0420449143566657e-06
IVA I-Disease 0 4.3926393118454143e-05
. O 0 4.570796008351863e-08

Mucopolysaccharidosis B-Disease 0 0.0024252254515886307
IVA I-Disease 0 0.1336333006620407
( O 0 1.5749309341117623e-06
MPS B-Disease 1 0.9998941421508789
IVA I-Disease 1 0.9999932050704956
) O 0 9.770062092684384e-09
is O 0 7.03159308557133e-10
an O 0 4.4652243014198234e-10
autosomal B-Disease 1 0.993062436580658
recessive I-Disease 1 0.9998492002487183
lysosomal I-Disease 1 0.9999520778656006
storage I-Disease 1 0.9999657869338989
disorder I-Disease 1 0.9998921155929565
caused O 0 1.15236052806722e-05
by O 0 3.96336324870461e-10
a O 0 2.208300884376513e-06
genetic B-Disease 1 0.9999994039535522
defect I-Disease 1 0.9999996423721313
in O 0 4.365135364281514e-09
N O 0 7.215997356979642e-06
- O 0 2.363965222684783e-06
acetylgalactosamine O 0 8.514554792782292e-05
- O 0 6.0982325521763414e-05
6 O 0 9.730713657063461e-08
- O 0 0.00022549608547706157
sulfate O 0 0.000595899298787117
sulfatase O 0 2.3317441446124576e-05
( O 0 4.149040000456239e-10
GALNS O 0 5.706475576516823e-07
) O 0 1.3333971426998659e-10
. O 0 3.192619224545723e-10

In O 0 1.2648119218638953e-09
previous O 0 8.623129987839206e-10
studies O 0 1.6740535346837504e-10
, O 0 6.247751014459846e-12
we O 0 4.48912400308199e-11
have O 0 4.860114047322561e-12
found O 0 1.0310432195514974e-11
two O 0 8.636878105067192e-13
common O 0 8.838400150645853e-11
mutations O 0 1.331486587652364e-09
in O 0 7.974718108094692e-12
Caucasians O 0 2.0628605490458085e-09
and O 0 1.3954092048518163e-10
Japanese O 0 1.4131227743519048e-08
, O 0 9.620704406743119e-12
respectively O 0 6.025820398214421e-10
. O 0 3.296025119503554e-10

To O 0 1.3457280845230457e-09
characterize O 0 1.1092451757122035e-07
the O 0 2.0072861428577227e-10
mutational O 0 1.5152376136029488e-06
spectrum O 0 7.032861049083294e-08
in O 0 4.694376831704261e-12
various O 0 1.456036761429344e-13
ethnic O 0 2.059877008547817e-12
groups O 0 6.849298472139109e-12
, O 0 9.346995833575678e-13
mutations O 0 1.0079571899357376e-10
in O 0 5.721796192230399e-13
the O 0 8.619351434847877e-13
GALNS O 0 2.6369912475843194e-08
gene O 0 2.4314586455354004e-10
in O 0 3.6739864622825635e-11
Colombian O 0 7.006577362744792e-08
MPS B-Disease 1 0.9959618449211121
IVA I-Disease 1 0.9999798536300659
patients O 0 3.406938276384608e-06
were O 0 3.6776006684391405e-09
investigated O 0 4.824482857657131e-07
, O 0 7.811946402258574e-12
and O 0 1.7699899705625466e-12
genetic O 0 3.132612502732002e-10
backgrounds O 0 1.3841309209894348e-09
were O 0 2.1189675014632314e-11
extensively O 0 1.641107805205877e-10
analyzed O 0 1.8781340926921075e-09
to O 0 3.181789033634974e-12
identify O 0 1.3925589847918474e-10
racial O 0 1.8939395884931542e-10
origin O 0 4.0239425680432817e-10
, O 0 9.20970439667601e-13
based O 0 1.1998942421251324e-12
on O 0 3.1324557531187125e-11
mitochondrial O 0 1.9133048922981288e-08
DNA O 0 3.649790869530989e-08
( O 0 1.732478396854198e-11
mtDNA O 0 2.0368411401960884e-09
) O 0 2.836346435497461e-11
lineages O 0 1.3822339939295603e-09
. O 0 1.0658629534532338e-09

Three O 0 5.0182351607475084e-09
novel O 0 9.478051232747475e-09
missense O 0 5.929041071794927e-05
mutations O 0 8.133544906741008e-05
never O 0 1.2663330153372954e-06
identified O 0 1.850439090844702e-08
previously O 0 5.565260474682532e-10
in O 0 3.5692707470169616e-12
other O 0 1.043548494145119e-12
populations O 0 1.7249838710209353e-11
and O 0 6.836377384328296e-12
found O 0 2.6436044325839347e-11
in O 0 2.6613912896406022e-12
16 O 0 4.884096599377941e-13
out O 0 8.437770339202177e-13
of O 0 6.41800306476481e-13
19 O 0 1.0931301003269667e-10
Colombian O 0 4.913785289772932e-08
MPS B-Disease 1 0.984550416469574
IVA I-Disease 1 0.9990800619125366
unrelated O 0 3.279060933891742e-07
alleles O 0 4.1494851998891136e-09
account O 0 5.667777913664906e-10
for O 0 7.19697652168394e-12
84 O 0 2.683152589000315e-10
. O 0 6.684595654782299e-10

2 O 0 2.775940588506387e-09
% O 0 3.386371738578475e-11
of O 0 1.1015847522360955e-12
the O 0 1.862954929210403e-11
alleles O 0 9.586460514299233e-10
in O 0 4.311264886758259e-11
this O 0 1.8334323642621442e-11
study O 0 1.3212400618023423e-10
. O 0 2.7662666601813157e-10

The O 0 1.4314004426196902e-09
G301C O 0 3.9470119617135424e-08
and O 0 4.238964040892412e-11
S162F O 0 5.887222709333173e-09
mutations O 0 5.289657600826558e-09
account O 0 3.491164024538307e-10
for O 0 3.862227204720625e-11
68 O 0 2.1752686318876613e-09
. O 0 1.5688147447789902e-09

4 O 0 1.740937882743765e-08
% O 0 3.554566085917088e-10
and O 0 1.669032134721249e-10
10 O 0 4.5249909375044695e-10
. O 0 2.051399494717998e-09

5 O 0 1.6334950059260223e-09
% O 0 2.093330543628813e-11
of O 0 7.464996502892784e-12
mutations O 0 2.2103942853846092e-07
, O 0 3.12048130390874e-11
respectively O 0 1.110476155474771e-09
, O 0 2.390976305832737e-12
whereas O 0 5.6394684061489286e-11
the O 0 3.1394043181059983e-12
remaining O 0 4.0198594453144665e-11
F69V O 0 8.33404783406877e-07
is O 0 9.830423801371335e-12
limited O 0 2.3242219780728046e-12
to O 0 9.045364283977175e-13
a O 0 4.75857409032443e-11
single O 0 1.1805574295919996e-08
allele O 0 5.562146299098458e-08
. O 0 1.3983726399047214e-09

The O 0 7.1526486955519886e-09
skewed O 0 4.778481752509833e-07
prevalence O 0 8.928142278818996e-07
of O 0 8.869671490330244e-12
G301C O 0 5.0222186409598635e-09
in O 0 1.0797781072047208e-11
only O 0 2.1508662906288833e-12
Colombian O 0 2.8736504287252274e-09
patients O 0 1.2362665058329725e-10
and O 0 4.256080297221354e-12
haplotype O 0 1.902898949524001e-09
analysis O 0 5.589914815751218e-12
by O 0 5.922281979056643e-13
restriction O 0 6.141396419190315e-11
fragment O 0 2.8167148613533755e-09
length O 0 2.2125774545855847e-09
polymorphisms O 0 7.078590158471343e-08
in O 0 1.0265339793480432e-11
the O 0 2.5013619647795693e-12
GALNS O 0 3.2565543506279937e-07
gene O 0 6.313704004057286e-10
suggest O 0 8.052448707829285e-10
that O 0 4.695567719370519e-12
G301C O 0 4.016006693863261e-10
originated O 0 9.933414507612426e-11
from O 0 1.7046326373018617e-12
a O 0 3.9100656740176376e-11
common O 0 5.388873236533698e-10
ancestor O 0 3.2453922216291176e-08
. O 0 5.041787876081116e-09

Investigation O 0 1.1212717865305422e-08
of O 0 2.4485184713096686e-11
the O 0 9.549623244953231e-12
genetic O 0 2.4192008396539677e-09
background O 0 9.36359167980072e-09
by O 0 4.886968867773289e-12
means O 0 1.4452363784889233e-11
of O 0 1.438398282860992e-13
mtDNA O 0 9.645293591598048e-11
lineages O 0 3.734242776110008e-11
indicate O 0 5.185870066704013e-10
that O 0 4.323904082004226e-12
all O 0 1.8179184286398753e-12
our O 0 3.326638131628812e-10
patients O 0 2.3796581025137264e-11
are O 0 3.494918113591816e-12
probably O 0 1.1370981933822577e-10
of O 0 6.897250240563146e-13
native O 0 2.2878804406545328e-10
American O 0 1.3408761212474474e-08
descent O 0 2.596728336357046e-06

Low O 0 1.0191833098360803e-05
frequency O 0 1.7035492874128977e-06
of O 0 8.804316165011983e-10
BRCA1 O 0 8.050242286117282e-06
germline O 0 6.151491106720641e-06
mutations O 0 1.2402447282511275e-06
in O 0 3.465052966777904e-10
45 O 0 1.0538471206800182e-09
German O 1 0.9966290593147278
breast B-Disease 1 0.9999991655349731
/ I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 2.065511216642335e-05
. O 0 8.074511015365715e-08

In O 0 1.7116561501495653e-09
this O 0 1.3217410672894392e-11
study O 0 6.472749419783597e-12
we O 0 1.3149141497859063e-11
investigated O 0 4.575442691390208e-09
45 O 0 1.9959019159632163e-10
German O 1 0.8207184076309204
breast B-Disease 1 0.9999967813491821
/ I-Disease 1 0.9999974966049194
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 1.0893389301713796e-08
for O 0 4.485067178761071e-11
germline O 0 1.0745325198513456e-06
mutations O 0 2.0040640436036483e-07
in O 0 6.405206226522964e-11
the O 0 1.1191724630377209e-10
BRCA1 O 0 5.300454176904168e-06
gene O 0 4.733994103389705e-07
. O 0 8.798411776922421e-09

We O 0 4.493002592198536e-08
identified O 0 3.2676956696064963e-09
four O 0 1.9732649542136826e-11
germline O 0 1.1140625844063834e-07
mutations O 0 1.0358053259551525e-07
in O 0 2.696665460377723e-11
three O 0 2.3591240072562414e-10
breast B-Disease 0 0.3577822148799896
cancer I-Disease 0 0.0002739138435572386
families O 0 1.0241177905712107e-09
and O 0 5.335035538345245e-11
in O 0 3.458534153510939e-11
one O 0 1.0331697239962523e-06
breast B-Disease 1 0.9999985694885254
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
family O 0 1.3598665304925817e-07
. O 0 5.516787113940547e-12
among O 0 1.325913527193065e-13
these O 0 4.742387038625395e-13
were O 0 1.579565298004404e-11
one O 0 4.99085391070242e-11
frameshift O 0 4.114443072467111e-06
mutation O 0 3.9748972113784475e-08
, O 0 1.3795533725796671e-12
one O 0 8.801822118376101e-12
nonsense O 0 1.842692824993719e-07
mutation O 0 2.8039375266075695e-08
, O 0 1.133208435942501e-12
one O 0 2.210979446401473e-12
novel O 0 1.9100167628072207e-11
splice O 0 1.5597334979133848e-08
site O 0 2.3494360235076783e-08
mutation O 0 5.410248036241683e-07
, O 0 1.1744714575878668e-11
and O 0 2.5327174385525453e-11
one O 0 2.4017107747020816e-10
missense O 0 7.832562550902367e-05
mutation O 0 2.0061163013451733e-05
. O 0 1.8179845184818078e-08

The O 0 6.30037844118192e-09
missense O 0 0.00011003782856278121
mutation O 0 0.00033830790198408067
was O 0 2.8319613321059478e-08
also O 0 6.885716302695855e-11
found O 0 5.302888128611016e-10
in O 0 8.695666409153091e-11
2 O 0 1.2948703220772018e-09
. O 0 1.2248747793819348e-08

8 O 0 1.9999804035109037e-09
% O 0 1.8169347970609095e-11
of O 0 4.672471177330495e-13
the O 0 6.246139131090012e-13
general O 0 5.401731579396385e-12
population O 0 7.689744023833822e-13
, O 0 5.270391870322577e-13
suggesting O 0 8.565200770860315e-10
that O 0 9.382049304118567e-11
it O 0 6.498086096984323e-11
is O 0 1.4459373975928003e-10
not O 0 4.254390173485945e-09
disease O 0 4.529848496304112e-08
associated O 0 1.0583195653168787e-08
. O 0 3.5709515344706233e-09

The O 0 8.472714752016941e-10
average O 0 1.6775201672203366e-08
age O 0 2.833693002468607e-10
of O 0 1.6928299040319672e-11
disease O 0 1.834282272739074e-07
onset O 0 8.644760640663662e-08
in O 0 1.284300582549136e-10
those O 0 1.1187754195285393e-10
families O 0 1.9815861451721872e-10
harbouring O 0 1.0336616469430737e-06
causative O 0 2.1882633518544026e-06
mutations O 0 3.545743822996883e-07
was O 0 3.308483487174385e-10
between O 0 1.1798044485811232e-10
32 O 0 6.575465172353745e-10
. O 0 9.366678543898388e-10

3 O 0 1.8506048249378182e-08
and O 0 1.0636249658801944e-09
37 O 0 4.3380028458273046e-09
. O 0 4.950999166197789e-09

4 O 0 2.4313218105476153e-08
years O 0 8.620367752953939e-10
, O 0 6.0789619865664335e-12
whereas O 0 1.0861220256508375e-10
the O 0 4.2251506113255566e-12
family O 0 2.7563229476612605e-10
harbouring O 0 6.313950962066883e-08
the O 0 2.6602253386243113e-11
missense O 0 3.9162219422905764e-07
mutation O 0 2.447028748520097e-07
had O 0 4.739093562022845e-10
an O 0 2.3115246695903924e-12
average O 0 1.4478099608083994e-08
age O 0 1.052814016522241e-10
of O 0 2.6393609520170003e-12
onset O 0 5.838556749182544e-09
of O 0 7.474274671404046e-11
51 O 0 3.5166218825821716e-09
. O 0 1.5095722449842697e-09

2 O 0 1.8299648729680484e-07
years O 0 4.527162289491571e-08
. O 0 1.4568932726888306e-08

These O 0 5.934480684643972e-10
findings O 0 7.899487175500042e-10
show O 0 6.673999575212974e-09
that O 0 2.090402989596285e-10
BRCA1 O 0 3.3594542969694885e-07
is O 0 1.6896532784027585e-10
implicated O 0 2.216587269288084e-08
in O 0 4.772160097643585e-12
a O 0 3.607633506166885e-12
small O 0 1.4367765657774534e-11
fraction O 0 2.336822735315991e-09
of O 0 1.174235819689784e-08
breast B-Disease 1 0.999993085861206
/ I-Disease 1 0.9999961853027344
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 1.6052839058033896e-08
suggesting O 0 1.7074475167078162e-08
the O 0 3.332209942003006e-12
involvement O 0 2.539820298519402e-10
of O 0 2.059303465598572e-12
another O 0 2.6531174479593744e-10
susceptibility O 0 1.2673474884650204e-05
gene O 0 3.288841696758027e-07
( O 0 1.98570004883436e-09
s O 0 3.591445420170203e-05
) O 0 7.806804092069797e-09

Paternal O 0 0.0841367170214653
transmission O 0 0.00279291276820004
of O 0 2.280082071592915e-06
congenital B-Disease 1 0.999991774559021
myotonic I-Disease 1 0.9999994039535522
dystrophy I-Disease 1 0.9999995231628418
. O 0 0.00010813541302923113

We O 0 1.861643994516271e-07
report O 0 1.1205678607240088e-09
a O 0 3.824737748736595e-11
rare O 0 1.1697911528329996e-09
case O 0 4.818851540022706e-09
of O 0 1.305309971222357e-09
paternally O 1 0.9911062121391296
transmitted O 1 0.9999439716339111
congenital B-Disease 1 0.9999990463256836
myotonic I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 0 0.00017771105922292918
DM B-Disease 1 0.9999996423721313
) O 0 1.470901445088657e-08
. O 0 6.147742759310404e-09

The O 0 2.264071152779934e-09
proband O 0 6.093670776863291e-07
is O 0 9.380814874893062e-11
a O 0 2.6214612078301336e-11
23 O 0 2.2370260158166566e-11
year O 0 3.936029974171973e-11
old O 0 2.4832281724229688e-06
, O 0 2.680664401566446e-08
mentally B-Disease 1 0.9999994039535522
retarded I-Disease 1 0.9999991655349731
male O 0 0.08487389981746674
who O 0 7.588131211377913e-06
suffers O 0 0.07061135023832321
severe O 0 0.004989181645214558
muscular B-Disease 1 0.9333085417747498
weakness I-Disease 1 0.7177314162254333
. O 0 2.7526542112354946e-07

He O 0 2.1078095358006976e-07
presented O 0 5.080432785575795e-08
with O 0 7.001394664030158e-08
respiratory O 0 0.08405805379152298
and O 0 1.2867316989684241e-08
feeding O 0 9.692404319139314e-07
difficulties O 0 6.543011750181904e-07
at O 0 2.4154216404781437e-08
birth O 0 3.2871642474674445e-07
. O 0 9.727921801427897e-10

His O 0 2.389545841197105e-07
two O 0 2.0540669609658835e-08
sibs O 0 0.29736489057540894
suffer O 0 0.0002236147556686774
from O 0 5.6207277054909355e-08
childhood O 0 0.004275501240044832
onset O 1 0.6688157320022583
DM B-Disease 1 0.9999947547912598
. O 0 3.663580173451919e-06

Their O 0 5.100625699583361e-09
late O 0 5.145878834156292e-09
father O 0 2.0858804461454383e-08
had O 0 1.6749575337815514e-10
the O 0 1.1309909172391164e-12
adult O 0 2.0872553685435946e-10
type O 0 4.61514950700348e-08
of O 0 4.1331796318822e-10
DM B-Disease 1 0.9999997615814209
, O 0 2.5315437246486994e-11
with O 0 9.69301722220095e-12
onset O 0 4.436862433010447e-09
around O 0 3.46231793235674e-10
30 O 0 3.154495761825693e-11
years O 0 1.198056792661717e-10
. O 0 2.9298796722088127e-10

Only O 0 5.615888865051488e-10
six O 0 1.2361455609122274e-11
other O 0 6.03991791477132e-13
cases O 0 5.507325064740831e-12
of O 0 3.203449007796455e-12
paternal O 0 5.742285065934993e-05
transmission O 0 4.595225982484408e-05
of O 0 1.2751461220261717e-08
congenital B-Disease 1 0.9999974966049194
DM I-Disease 1 1.0
have O 0 0.00010787063365569338
been O 0 1.7029078946961818e-07
reported O 0 1.3941156851160486e-07
recently O 0 3.6510300560621545e-08
. O 0 2.0289467883571888e-09

We O 0 5.320428542177069e-09
review O 0 1.2512066382974751e-10
the O 0 5.431548006501474e-12
sex O 0 2.0432615599474957e-09
related O 0 2.564838785801271e-09
effects O 0 8.070337997878596e-08
on O 0 3.286392313839315e-08
transmission O 0 4.154634734732099e-05
of O 0 8.710402710221388e-08
congenital B-Disease 1 0.9999918937683105
DM I-Disease 1 0.9999995231628418
. O 0 1.9067056200583465e-06

Decreased O 0 6.641842901444761e-06
fertility O 0 2.996452508341463e-07
of O 0 5.764127369856098e-11
males O 0 6.0992144668148285e-09
with O 0 1.4531341407941767e-10
adult O 0 1.2979862731299363e-06
onset O 0 0.00018687144620344043
DM B-Disease 1 0.9999997615814209
and O 0 2.43422189072362e-08
contraction O 0 3.931549130697931e-08
of O 0 8.634176815354444e-13
the O 0 2.952996788069262e-12
repeat O 0 2.7037290184495077e-09
upon O 0 1.0819825591035226e-10
male O 0 1.1677519395902891e-08
transmission O 0 8.364510861724739e-09
contribute O 0 6.954532436043159e-12
to O 0 2.2313529062650828e-12
the O 0 5.816517840290247e-12
almost O 0 8.503860809971897e-11
absent O 0 7.245936073374537e-10
occurrence O 0 3.070524057235957e-09
of O 0 8.130873578593434e-12
paternal O 0 1.0540353287069593e-05
transmission O 0 1.884112316474784e-05
of O 0 1.484271194840403e-08
congenital B-Disease 1 0.9999881982803345
DM I-Disease 1 0.9999994039535522
. O 0 1.543623739053146e-06

Also O 0 5.1024939828892e-09
the O 0 3.4877746524220044e-11
fathers O 0 8.245388261052256e-10
of O 0 1.4339832489843052e-12
the O 0 3.708349946562883e-11
reported O 0 1.7925943041063874e-07
congenitally O 0 0.0004190390172880143
affected O 0 1.5753101934024016e-08
children O 0 7.8190492969199e-10
showed O 0 2.0076527107448783e-07
, O 0 2.1760789784691648e-12
on O 0 3.746249144231939e-11
average O 0 1.6577542671925016e-09
, O 0 7.223101782492802e-13
shorter O 0 5.397339242207977e-10
CTG O 0 5.5710192015112625e-09
repeat O 0 3.2473228550600197e-09
lengths O 0 2.8063192303307005e-07
and O 0 6.985245021295938e-11
hence O 0 1.2281164973870773e-09
less O 0 2.338543803048765e-09
severe O 0 1.2632427797143464e-06
clinical O 0 5.194249865780876e-07
symptoms O 0 5.984255153634876e-07
than O 0 1.682937678104679e-10
the O 0 2.4385551911088044e-10
mothers O 0 1.9288702191033735e-08
of O 0 7.672957755278098e-12
children O 0 6.400205254664115e-09
with O 0 9.417378805665066e-07
congenital B-Disease 1 0.9999849796295166
DM I-Disease 1 0.9999995231628418
. O 0 2.442781124045723e-06

We O 0 3.762689715358647e-08
conclude O 0 6.722458145702603e-09
that O 0 9.913918297410618e-11
paternal O 0 1.9611281913967105e-06
transmission O 0 6.118318651715526e-06
of O 0 1.4493710231988643e-08
congenital B-Disease 1 0.9999970197677612
DM I-Disease 1 1.0
is O 0 2.6839336086936783e-08
rare O 0 6.877349356670948e-09
and O 0 1.4358457478547137e-10
preferentially O 0 1.7523181128353826e-08
occurs O 0 2.7393579071777197e-10
with O 0 2.3684452836458814e-12
onset O 0 2.6192548130410387e-09
of O 0 1.1222848345093794e-10
DM B-Disease 1 0.9999982118606567
past O 0 5.297990313124501e-08
30 O 0 2.242502711302663e-11
years O 0 1.2912632768591337e-11
in O 0 2.6546078703282294e-12
the O 0 6.78449614197052e-12
father O 0 6.351767112278139e-09
. O 0 2.7506025235268794e-11
. O 0 1.6478765574312604e-10

The O 0 4.5514653379541414e-08
RB1 O 0 7.995629130164161e-05
gene O 0 2.9259464895403653e-07
mutation O 0 8.016135666366608e-07
in O 0 3.1271799039167547e-10
a O 0 3.1336300221340707e-09
child O 0 1.4834081412118394e-05
with O 0 2.923575550539681e-07
ectopic B-Disease 1 0.999842643737793
intracranial I-Disease 1 0.9999804496765137
retinoblastoma I-Disease 1 0.9991344809532166
. O 0 6.475264854088891e-06

The O 0 1.3980507418409616e-08
RB1 O 0 2.4668830519658513e-05
gene O 0 8.091670622434322e-08
mutation O 0 8.685846637490613e-07
was O 0 1.066753796408193e-09
investigated O 0 4.284866150783273e-08
in O 0 4.769250619429677e-11
a O 0 2.8239768301574486e-09
child O 0 9.598499673302285e-06
with O 0 1.6608533215389798e-08
ectopic B-Disease 1 0.9840171933174133
intracranial I-Disease 1 0.995740532875061
retinoblastoma I-Disease 0 3.31856390403118e-05
using O 0 4.38262137691936e-09
DNA O 0 7.499718890358054e-08
obtained O 0 8.067252976751149e-10
from O 0 4.1713806887833105e-12
both O 0 8.70653202311722e-12
the O 0 3.9733143858411424e-11
pineal B-Disease 0 4.4953688416171644e-07
and I-Disease 0 5.3305244662738005e-09
retinal I-Disease 0 2.9939335945528e-05
tumours I-Disease 1 0.9999949932098389
of O 0 2.754830252804652e-10
the O 0 2.2712336456010007e-09
patient O 0 1.4885515611240407e-06
. O 0 9.723028604469164e-09

A O 0 1.474707147508525e-07
nonsense O 0 5.194277036935091e-06
mutation O 0 4.987236366105208e-07
in O 0 1.8525171674443897e-10
exon O 0 4.0546257196183433e-07
17 O 0 1.9997972167118405e-09
( O 0 2.9416861741654587e-12
codon O 0 7.903522281083042e-11
556 O 0 2.2316733530591826e-11
) O 0 1.1935389471456198e-13
of O 0 1.003229617435597e-13
the O 0 1.9474654527895652e-11
RB1 O 0 2.0655473065289698e-07
gene O 0 5.982588313635517e-10
was O 0 6.081797843116021e-10
found O 0 6.862718726630135e-11
to O 0 3.9813787683362634e-11
be O 0 3.463916375956444e-10
present O 0 8.871774148655476e-11
homozygously O 0 2.809436239203933e-07
in O 0 1.4532859290983247e-11
both O 0 5.680997772899987e-12
the O 0 1.395821045552248e-11
retinal B-Disease 0 4.9989210992862354e-08
and I-Disease 0 1.2893056622331756e-09
the I-Disease 0 3.3097287133188047e-09
pineal I-Disease 0 0.0005009601009078324
tumours I-Disease 1 0.9999780654907227
. O 0 4.319329249824477e-08

The O 0 4.676418696725193e-10
same O 0 1.7390046347376398e-10
mutation O 0 1.359889267860126e-08
was O 0 7.117462175187939e-11
present O 0 4.7941286357433555e-12
heterozygously O 0 3.984330199102715e-09
in O 0 2.5594543845430806e-12
the O 0 2.9127579254800695e-13
DNA O 0 3.693948619210019e-11
from O 0 1.932676973103939e-13
the O 0 2.1038312964568456e-13
constitutional O 0 1.3391769464188297e-11
cells O 0 6.5376536649564e-12
of O 0 5.922686115416437e-14
the O 0 3.3879010707948964e-12
patient O 0 2.310210467371121e-09
, O 0 2.2047470186331575e-12
proving O 0 1.3042498192561425e-09
it O 0 3.0631901095506953e-12
to O 0 1.9091052523567686e-12
be O 0 2.770743183500013e-11
of O 0 4.038570259462526e-12
germline O 0 6.283747211455193e-08
origin O 0 4.009747645028483e-09
. O 0 2.5452724372598823e-09

The O 0 4.065881242798497e-10
initial O 0 2.4239767970613e-09
mutation O 0 8.082061242475902e-08
was O 0 1.2140840555119325e-09
shown O 0 6.84789502880534e-10
to O 0 1.8249962305261214e-11
have O 0 8.296738851498731e-10
occurred O 0 3.192543118757385e-08
in O 0 1.370181745841137e-11
the O 0 8.146152502552795e-11
paternally O 0 7.80819107149e-07
derived O 0 2.0661770960828107e-08
RB1 O 0 2.6167999749304727e-06
allele O 0 8.381954330616281e-08
. O 0 2.0694179703184545e-09

The O 0 4.022916222368167e-09
mutation O 0 3.944250579479558e-07
is O 0 3.896500483380194e-11
in O 0 1.750961355073688e-12
an O 0 3.4420781654630195e-13
area O 0 9.258672821477187e-12
of O 0 3.4360106990552475e-13
the O 0 1.5808936191380463e-12
gene O 0 6.032233046404656e-11
that O 0 6.713718123108059e-13
encodes O 0 9.162591475472825e-13
the O 0 4.300362420762288e-13
protein O 0 1.9518546501284817e-10
- O 0 2.0107409071101756e-08
binding O 0 1.1211305661618098e-08
region O 0 1.0920193221908292e-10
known O 0 2.4246587376763884e-11
as O 0 2.8989809684742962e-12
the O 0 4.402747697668241e-12
pocket O 0 2.3352760763373226e-05
region O 0 5.352480236808788e-09
and O 0 9.12752706749842e-10
has O 0 5.406581293776469e-10
been O 0 2.898414286356399e-10
detected O 0 5.581105000374009e-08
in O 0 1.0157879311994966e-12
other O 0 2.2368955646112632e-13
cases O 0 4.804802389291041e-12
of O 0 7.687313459403544e-12
retinoblastoma B-Disease 0 4.7014785309329454e-07
. O 0 3.5058309033608737e-10
. O 0 1.6724107654297882e-09

Low O 0 0.00010265007585985586
levels O 0 4.101582362636691e-08
of O 0 6.190564554031663e-12
beta O 0 5.3932094901121275e-11
hexosaminidase O 0 1.3080471816806494e-08
A O 0 4.263421282679758e-10
in O 0 3.874519802216092e-11
healthy O 0 7.371127597188831e-10
individuals O 0 1.4127648703676776e-11
with O 0 1.9157860020602158e-10
apparent O 0 0.0007956544286571443
deficiency O 0 0.0008271170081570745
of O 0 5.3392372988125825e-12
this O 0 5.3924691101325806e-11
enzyme O 0 4.300158007453092e-09
. O 0 6.900089943862042e-10

Appreciable O 0 2.606781890790444e-05
beta O 0 1.1477464312292796e-07
hexosaminidase O 0 8.142418437273591e-07
A O 0 1.421682060964713e-08
( O 0 1.511570209278279e-11
hex O 0 4.743436754495178e-09
A O 0 1.0037695119535783e-09
) O 0 2.1273167689211947e-12
activity O 0 4.932814712255151e-10
has O 0 4.341408482710918e-11
been O 0 1.36957639673696e-10
detected O 0 6.06699686045431e-08
in O 0 4.976746792451081e-11
cultured O 0 1.3599875501313363e-06
skin O 0 3.4592332667671144e-05
fibroblasts O 0 7.336863561135942e-09
and O 0 1.4014921667637736e-08
melanoma B-Disease 0 0.002517661079764366
tissue O 0 1.1949016425205627e-06
from O 0 1.065854349224793e-10
healthy O 0 7.230435805638535e-09
individuals O 0 6.696127680116959e-11
previously O 0 6.865069401840174e-09
reported O 0 2.1620376600139934e-08
as O 0 2.941184240601302e-10
having O 0 9.495205972598342e-07
deficiency B-Disease 0 1.6150173905771226e-05
of I-Disease 0 6.638463108214754e-13
hex I-Disease 0 1.4535367354184814e-09
A I-Disease 0 1.723346881865595e-10
activity O 0 2.428696133094377e-10
indistinguishable O 0 3.5881136950521864e-10
from O 0 3.4124984196921837e-13
that O 0 1.0095531181864015e-12
of O 0 1.202967196342608e-12
patients O 0 6.5559819795169005e-09
with O 0 6.50638230581535e-06
Tay B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
Sachs I-Disease 1 0.9999997615814209
disease I-Disease 0 0.010150955058634281
( O 0 4.719609147940673e-10
TSD B-Disease 0 1.7720124105835566e-06
) O 0 2.28197960527865e-10
. O 0 1.3896012118763679e-09

Identification O 0 1.6615099696082325e-07
and O 0 2.7789531786837074e-10
quantitation O 0 1.1033071132260375e-06
of O 0 5.863113466952896e-11
hex O 0 2.4405025556006876e-08
A O 0 1.3785453889525456e-09
, O 0 3.27111428222171e-12
amounting O 0 6.034995420067801e-11
to O 0 1.3080527112852014e-11
3 O 0 4.5415746163790516e-10
. O 0 1.5334380432108219e-09

5 O 0 8.871714918257112e-09
% O 0 8.317891930786914e-10
- O 0 4.5921487412670103e-07
6 O 0 1.189337961449155e-08
. O 0 6.447045119983841e-09

9 O 0 9.773919451561142e-09
% O 0 3.0560717151351113e-11
of O 0 8.175969124814275e-13
total O 0 2.264906838467251e-11
beta O 0 2.7558341719746693e-10
hexosaminidase O 0 1.8023929726496135e-07
activity O 0 1.4974713025139863e-08
, O 0 2.3509284796663366e-12
has O 0 3.1177194072945502e-12
been O 0 2.0828668650940685e-12
obtained O 0 1.7602879223699297e-11
by O 0 8.92843438071722e-12
cellulose O 0 2.6972617206411087e-07
acetate O 0 3.204207033036255e-08
gel O 0 1.9733307965452695e-07
electrophoresis O 0 7.492967135647177e-09
, O 0 7.158096598097741e-12
DEAE O 0 1.1300470248443162e-07
- O 0 2.2910095154315968e-08
cellulose O 0 4.3776529423666943e-07
ion O 0 1.4297974075816455e-06
- O 0 1.0305020623491146e-06
exchange O 0 9.080992846577374e-09
chromatography O 0 2.607631799378396e-08
, O 0 4.859474368040795e-12
radial O 0 1.48620249440512e-09
immunodiffusion O 0 1.5354882521023683e-07
, O 0 1.87566923798288e-11
and O 0 1.2930705117764063e-10
radioimmunoassay O 0 8.680654559611867e-07
. O 0 4.673318176884322e-09

Previous O 0 4.565742273143769e-08
family O 0 2.9896742859136793e-09
studies O 0 1.9011202334606736e-10
suggested O 0 3.8333428098447087e-10
that O 0 1.2962702092278455e-11
these O 0 1.981557713054416e-12
individuals O 0 3.507461335261475e-11
may O 0 5.280794135309463e-10
be O 0 2.105993504586401e-11
compound O 0 1.8410094282383938e-10
heterozygotes O 0 1.4011172222438972e-09
for O 0 5.803062023967964e-13
the O 0 6.788608846071409e-13
common O 0 9.83459147452237e-11
mutant O 0 3.141217730373569e-09
TSD B-Disease 0 4.317896085126449e-08
gene O 0 2.103972107647678e-09
and O 0 1.6428011728741865e-11
a O 0 1.2563385054509268e-10
rare O 0 1.7075745262218334e-08
( O 0 1.1738225669244429e-10
allelic O 0 3.381994702067459e-07
) O 0 1.3879687676965347e-10
mutant O 0 2.9378510291167004e-08
gene O 0 1.1713975567317902e-07
. O 0 4.4513401853407686e-09

Thus O 0 3.018312355607122e-08
, O 0 1.2625234191432355e-11
the O 0 3.4409838260002212e-12
postulated O 0 2.944335975030299e-08
rate O 0 1.0785962345494227e-08
mutant O 0 5.864423946455588e-10
gene O 0 4.2822309587187135e-10
appears O 0 5.482575504700549e-10
to O 0 1.0917058273010594e-12
code O 0 3.827494311076096e-12
for O 0 2.9241694243960226e-13
the O 0 1.1038521442394145e-12
expression O 0 2.0686119484025767e-10
of O 0 1.4483594445308112e-12
low O 0 3.0923996696685663e-09
amounts O 0 2.1304211172967769e-10
of O 0 1.1445851211266955e-11
hex O 0 2.3269056015351453e-08
A O 0 6.37729646868479e-09
. O 0 4.661353525392542e-09

Heterozygotes O 0 3.812456952800858e-06
for O 0 7.765763032629991e-11
the O 0 1.783682750111648e-11
rare O 0 1.0733092192793947e-09
mutant O 0 7.166389082158275e-08
may O 0 2.0177635562390606e-08
be O 0 5.0781288896128984e-11
indistinguishable O 0 2.8752402680964906e-09
from O 0 7.549649273796977e-12
heterozygotes O 0 8.431513265350077e-09
for O 0 3.9325613078455834e-12
the O 0 1.0628066135498493e-11
common O 0 2.2363113583168115e-09
TSD B-Disease 0 2.1435639609990176e-06
mutant O 0 1.4458568386999104e-07
. O 0 3.080854682480094e-09

However O 0 8.159751985203911e-09
, O 0 9.572967418769451e-12
direct O 0 1.240498502530496e-11
visualization O 0 4.687995325269867e-09
and O 0 4.703314473997189e-11
quantitation O 0 4.94619314395095e-07
of O 0 8.590060086854923e-12
hex O 0 4.8792272444586615e-09
A O 0 5.592295723721996e-11
by O 0 1.4997491096235827e-12
the O 0 1.2568884735081332e-12
methods O 0 5.85842097056144e-10
described O 0 3.986808216893678e-09
may O 0 3.870621878565572e-10
prevent O 0 1.9238713400149265e-10
false O 0 2.2170057789594466e-08
- O 0 6.197605983970789e-08
positive O 0 2.73860545352278e-10
prenatal O 0 9.711908433018834e-07
diagnosis O 0 1.4337514642193128e-07
of O 0 4.983108543854531e-12
TSD B-Disease 0 1.8867251583287725e-06
in O 0 1.0505458725162953e-09
fetuses O 0 4.621500977464166e-07
having O 0 6.737588820193707e-10
the O 0 3.801638517875183e-11
incomplete O 0 2.0959534108300204e-09
hex B-Disease 0 4.0911046994551725e-08
A I-Disease 0 5.0586574928956907e-08
deficiency I-Disease 0 4.585528131428873e-06
of O 0 1.3871470161755384e-12
the O 0 6.335656305145321e-11
type O 0 9.99560234049568e-06
described O 0 5.970601932858699e-07
in O 0 7.632092874354512e-11
the O 0 3.254245137251921e-11
four O 0 8.976784870995402e-10
healthy O 0 9.169902881467351e-08
individuals O 0 1.4750594523604832e-08

The O 0 9.432155501087891e-09
tumor B-Disease 0 4.082580289832549e-06
suppressor O 0 3.667054670586367e-06
gene O 0 3.730995103978785e-07
Smad4 O 0 2.669773493835237e-06
/ O 0 1.166003045227626e-07
Dpc4 O 0 4.6857627467034035e-07
is O 0 3.6497575794935955e-11
required O 0 4.323524611243856e-12
for O 0 7.450085470414591e-13
gastrulation O 0 4.657869645541268e-09
and O 0 5.0446209709509304e-11
later O 0 2.2652869163808376e-11
for O 0 1.7210457234698162e-12
anterior O 0 4.611530712850254e-09
development O 0 1.9112365769874406e-12
of O 0 3.7704247276421077e-13
the O 0 1.8846632587887768e-11
mouse O 0 5.644459477593955e-08
embryo O 0 9.259061783950528e-08
. O 0 9.150610935648729e-09

Mutations O 0 2.2389376681530848e-05
in O 0 7.791834955028776e-10
the O 0 4.86340190342105e-10
SMAD4 O 0 0.0005514908698387444
/ O 0 1.9161452655680478e-05
DPC4 O 0 8.124397572828457e-05
tumor B-Disease 0 3.326126034153276e-06
suppressor O 0 1.2603486538864672e-06
gene O 0 1.6597354601799452e-08
, O 0 4.106959997779436e-12
a O 0 9.907202662418069e-12
key O 0 4.6355858041025044e-10
signal O 0 1.9908698689619087e-08
transducer O 0 1.8289196646037453e-07
in O 0 8.019888919630347e-11
most O 0 4.5718005770023495e-11
TGFbeta O 0 1.8450226946242765e-07
- O 0 4.2729993765533436e-08
related O 0 8.200282120007785e-10
pathways O 0 1.4629426836609838e-10
, O 0 5.403686938014463e-13
are O 0 1.1023829554280065e-13
involved O 0 1.053395543536284e-12
in O 0 1.0917537490370832e-12
50 O 0 4.554651794608233e-12
% O 0 5.953316832563171e-12
of O 0 3.9001757379253377e-10
pancreatic B-Disease 0 0.02214878611266613
cancers I-Disease 1 0.8923739790916443
. O 0 1.2206864141717233e-07

Homozygous O 0 0.00022268350585363805
Smad4 O 0 0.0001886957761598751
mutant O 0 4.746329796034843e-05
mice O 0 0.0018017565598711371
die O 0 6.4246472902596e-05
before O 0 5.96372173866655e-10
day O 0 5.763349797405226e-10
7 O 0 5.828806881602588e-10
. O 0 7.839657811814504e-10

5 O 0 1.3233902862452851e-08
of O 0 5.041728146082392e-10
embryogenesis O 0 2.0419749944267096e-06
. O 0 5.364542943198103e-08

Mutant O 0 4.313484112117294e-07
embryos O 0 3.5089719574443734e-08
have O 0 6.161239296531562e-10
reduced O 0 9.555901625546426e-10
size O 0 1.503628084265074e-07
, O 0 3.461268216486957e-10
fail O 0 6.164018628851409e-08
to O 0 1.7556373022031835e-11
gastrulate O 0 7.168815159275255e-07
or O 0 6.879746772270323e-10
express O 0 8.804530021722101e-11
a O 0 1.420303024496361e-11
mesodermal O 0 3.422943706254955e-08
marker O 0 2.9912735044490546e-07
, O 0 2.306549395925117e-11
and O 0 1.1394184207258462e-11
show O 0 2.2646121422553733e-08
abnormal O 0 6.319734069393235e-08
visceral O 0 8.130390938276832e-07
endoderm O 0 1.2179892109998036e-05
development O 0 1.8892358788491492e-09
. O 0 2.0919754817327885e-09

Growth B-Disease 1 0.9990429282188416
retardation I-Disease 1 0.9999024868011475
of O 0 5.079323073253761e-10
the O 0 3.430620232336423e-10
Smad4 O 0 1.2681539374170825e-05
- O 0 6.158135420264443e-06
deficient O 0 1.7703591481676995e-07
embryos O 0 4.05976696704613e-10
results O 0 1.0251745979905635e-10
from O 0 2.2790153011292835e-12
reduced O 0 1.9231632952809719e-10
cell O 0 6.929941065436651e-09
proliferation O 0 2.088016870516185e-09
rather O 0 1.754592825198298e-11
than O 0 3.097944210189718e-12
increased O 0 1.5130564856580264e-10
apoptosis O 0 6.522879125725467e-09
. O 0 1.8011715452459498e-09

Aggregation O 0 2.442452000650519e-07
of O 0 6.449316636292224e-10
mutant O 0 2.2137464839033782e-07
Smad4 O 0 3.3038948004104896e-06
ES O 0 6.336124869221749e-08
cells O 0 2.975462376486604e-10
with O 0 4.2668173681759125e-12
wild O 0 2.6928388408009596e-09
- O 0 1.6400882714151521e-06
type O 0 3.7503843941522064e-06
tetraploid O 0 3.7912641346338205e-06
morulae O 0 4.7847111090959515e-06
rescues O 0 4.3585569642345945e-07
the O 0 3.3059288639947226e-10
gastrulation B-Disease 0 1.1616815527304425e-06
defect I-Disease 0 1.0660531188477762e-05
. O 0 6.798366758431484e-09

These O 0 4.2359293850324775e-09
results O 0 7.010559244235992e-09
indicate O 0 5.516122225657227e-09
that O 0 4.872433359559558e-11
Smad4 O 0 1.2792904158231977e-07
is O 0 2.9219869579488744e-11
initially O 0 2.8953464625836034e-11
required O 0 2.1519084257570764e-12
for O 0 4.7954038472335786e-14
the O 0 6.565939876220298e-14
differentiation O 0 3.2164207278487233e-13
of O 0 7.446259863048976e-14
the O 0 1.0942136953462356e-12
visceral O 0 1.1699211377447227e-08
endoderm O 0 4.02792096565463e-07
and O 0 7.671966534283925e-11
that O 0 5.594468898556526e-12
the O 0 2.635965013972341e-12
gastrulation B-Disease 0 3.904755629946521e-09
defect I-Disease 0 3.246810109658327e-08
in O 0 3.1357774449985998e-12
the O 0 1.0969935897164884e-11
epiblast O 0 2.1275934614095604e-07
is O 0 1.794891180129099e-10
secondary O 0 3.177358931516494e-10
and O 0 2.2837648439022473e-10
non O 0 1.3522944986021912e-09
- O 0 2.5310509954579175e-07
cell O 0 8.66202299221186e-07
autonomous O 0 1.8982778016152224e-08
. O 0 6.340885594369183e-09

Rescued O 0 4.601188993547112e-05
embryos O 0 1.617694351807586e-06
show O 0 3.1785523333383026e-06
severe O 0 0.00017457912326790392
anterior O 0 0.00011424477270338684
truncations O 0 3.243200990254991e-05
, O 0 2.2248585196393833e-09
indicating O 0 1.2859515230445595e-08
a O 0 4.151856289325018e-11
second O 0 2.8267763130251922e-11
important O 0 1.0734903417575214e-11
role O 0 4.946586543153053e-11
for O 0 6.997710137041091e-12
Smad4 O 0 1.3924547204169357e-07
in O 0 1.2197026721949555e-10
anterior O 0 2.6323561996832723e-07
patterning O 0 9.102687727136072e-06
during O 0 1.1079865913643516e-08
embryogenesis O 0 5.805993623653194e-07
. O 0 1.0655179849550223e-08

Prevalence O 0 0.00033128398354165256
of O 0 1.6931448465484777e-09
p16 O 0 5.299152689985931e-07
and O 0 1.5841317146936262e-09
CDK4 O 0 3.1990828119887738e-06
germline O 0 2.4986238713609055e-06
mutations O 0 5.218022351982654e-07
in O 0 3.239279122713157e-10
48 O 0 7.673905955130067e-09
melanoma B-Disease 1 0.8876374363899231
- O 1 0.6318752765655518
prone O 1 0.9987467527389526
families O 0 4.411364074030644e-08
in O 0 5.587311946442242e-09
France O 0 5.177719685889315e-06
. O 0 1.2435373619723578e-08

The O 0 2.2464531568289203e-08
French O 0 2.414211621726281e-06
Familial B-Disease 0 0.20464324951171875
Melanoma I-Disease 1 0.9990505576133728
Study O 0 3.0964329766902665e-07
Group O 0 6.769178639842721e-08
. O 0 3.1564126867777986e-09

Germline O 0 0.00042901377310045063
mutations O 0 3.2343676139134914e-05
in O 0 2.963432277347522e-10
the O 0 1.6416642351080313e-11
p16 O 0 6.6762146921917065e-09
and O 0 9.349269969316509e-11
CDK4 O 0 2.639779950186494e-06
genes O 0 5.048360396386897e-09
have O 0 4.1985959153834074e-10
been O 0 2.2818881506569966e-10
reported O 0 1.14953091490122e-09
in O 0 1.3857138093237298e-12
a O 0 1.8751675559536274e-12
subset O 0 2.3526489090208713e-10
of O 0 7.622985576105634e-11
melanoma B-Disease 0 0.008600800298154354
pedigrees O 0 4.04704087486607e-06
, O 0 2.4323803388126564e-11
but O 0 4.9248306821514376e-11
their O 0 9.540398332452682e-11
prevalence O 0 2.2443509806180373e-07
is O 0 2.8013886349542716e-11
not O 0 2.5480968030011653e-11
well O 0 4.6637943507121804e-11
known O 0 9.087400276719393e-10
. O 0 6.539656038917485e-10

We O 0 1.62690394489573e-08
searched O 0 1.9856583044486342e-09
for O 0 5.867995976280294e-13
such O 0 3.7914120627757786e-12
germline O 0 2.3468293974815424e-08
mutations O 0 8.425146802437666e-09
in O 0 2.5905990894137254e-11
48 O 0 1.3580528368528633e-10
French O 0 1.4657757674285676e-06
melanoma B-Disease 1 0.9867112040519714
- O 0 0.10475420206785202
prone O 0 0.033388614654541016
families O 0 1.7026488552396302e-10
selected O 0 1.2013879474581657e-11
according O 0 2.876327648282384e-12
to O 0 1.1859643041928214e-13
two O 0 2.241362884137718e-13
major O 0 5.880570336236346e-12
criteria O 0 1.1798584331756956e-10
families O 0 7.76040906882991e-13
with O 0 5.182499937007867e-13
at O 0 1.4161480148267014e-11
least O 0 3.5326769721316653e-12
three O 0 2.640277319693185e-12
affected O 0 1.1328850184344486e-11
members O 0 2.4493195015587443e-13
( O 0 3.0830175109901325e-13
n O 0 6.579391476080332e-10
= O 0 3.02151192954625e-10
20 O 0 3.5383398684987744e-13
) O 0 3.701673231717821e-14
or O 0 5.443786046943622e-12
families O 0 1.4177310584187475e-12
with O 0 9.199381707791776e-13
two O 0 1.2001556866370056e-11
affected O 0 3.687205402114202e-11
members O 0 3.354930536939721e-13
, O 0 1.9040567462557528e-13
one O 0 1.1530991547888114e-13
of O 0 3.269296115836033e-14
them O 0 8.732288980448089e-13
affected O 0 1.8408178627249416e-12
before O 0 9.216101189493675e-13
the O 0 4.651884888580426e-13
age O 0 5.85833681912562e-12
of O 0 8.855227342412578e-14
50 O 0 1.3492575112739047e-12
( O 0 2.4850117081275103e-13
n O 0 2.0915924547892928e-09
= O 0 4.255689134424756e-09
28 O 0 4.1275424918219006e-12
) O 0 6.221179848402494e-14
, O 0 1.482128628811294e-13
and O 0 1.7202186940526443e-12
one O 0 1.8826071344207884e-12
additional O 0 5.87046166886096e-12
minor O 0 1.0683602891248256e-09
criterion O 0 8.486175318012101e-09
. O 0 1.3365066831028116e-09

Sixteen O 0 1.0042855080882873e-07
different O 0 1.5906654882158477e-09
p16 O 0 6.995681900434647e-08
germline O 0 8.445357480013627e-07
mutations O 0 1.1400895800761646e-06
were O 0 2.0928403454689715e-10
found O 0 1.3681350496952405e-10
in O 0 1.602421320634484e-11
21 O 0 3.5079827931383534e-11
families O 0 9.758165629702997e-12
, O 0 7.134158173070781e-13
while O 0 1.6820640366677075e-11
one O 0 4.490734173412392e-11
germline O 0 1.880967026579583e-08
mutation O 0 2.965968626256199e-08
, O 0 2.6505807097787493e-12
Arg24His O 0 8.634392756334819e-09
, O 0 1.0037014622210627e-11
was O 0 1.3289443989705774e-09
detected O 0 1.501581721186085e-07
in O 0 9.36918771732298e-12
the O 0 3.068378190418386e-11
CDK4 O 0 3.453481440374162e-06
gene O 0 1.473549371411309e-08
. O 0 1.989198805674164e-09

The O 0 1.3804003495820893e-09
frequency O 0 2.448466140947403e-08
of O 0 5.0363116455010015e-12
p16 O 0 2.3320407827043255e-09
gene O 0 3.336431797507089e-09
mutation O 0 1.9823897190462958e-08
in O 0 5.535506948650681e-12
our O 0 9.409195644849433e-12
sample O 0 4.495044614305499e-11
( O 0 3.072873173363272e-13
44 O 0 5.18048386306813e-13
% O 0 9.026832151768152e-14
) O 0 4.486806027626314e-14
is O 0 4.421537192367958e-13
among O 0 1.4854229771123911e-13
the O 0 5.026830080662181e-12
highest O 0 8.571485210495666e-08
rates O 0 1.1833014212925264e-07
yet O 0 5.041141393213877e-10
reported O 0 7.89123072442166e-11
and O 0 2.5746620547356658e-12
the O 0 1.815863323421929e-12
CDK4 O 0 2.2628100282418018e-07
mutation O 0 3.728083619591871e-09
is O 0 3.0656974354947852e-12
the O 0 4.693058550282736e-13
second O 0 3.203317611166767e-10
mutation O 0 1.407572511880062e-07
detected O 0 4.40924907252338e-07
in O 0 9.875262066416646e-12
this O 0 3.90775259373477e-12
gene O 0 2.7858380047263154e-09
worldwide O 0 1.2569048024602125e-09
. O 0 9.172378412358739e-10

In O 0 2.787427177963764e-09
summary O 0 7.130051216108768e-09
, O 0 1.5936824776519032e-11
our O 0 1.0218129814498766e-10
results O 0 3.379654889279493e-11
show O 0 4.695107080898708e-10
frequent O 0 8.727407130315612e-10
involvement O 0 1.037902652711864e-09
of O 0 5.945426984933777e-13
the O 0 1.7591828601476456e-12
p16 O 0 2.8110241911960543e-10
gene O 0 2.1705097441593324e-10
in O 0 1.2618637905414953e-11
familial B-Disease 0 1.797792901925277e-05
melanoma I-Disease 1 0.7540959119796753
and O 0 8.760750347391877e-09
confirm O 0 4.2919822362819104e-08
the O 0 5.06863344698627e-12
role O 0 1.854075226681573e-11
of O 0 5.254031801640857e-13
the O 0 4.562747315389748e-12
CDK4 O 0 3.66992267686328e-08
gene O 0 8.676232648996418e-11
as O 0 4.211513082719165e-12
a O 0 7.918162236997262e-10
melanoma B-Disease 0 0.01060519553720951
- O 0 1.957587301149033e-06
predisposing O 0 1.797243527335013e-07
gene O 0 4.131087294467761e-08
. O 0 1.2205102206674923e-10
. O 0 3.1787772414304527e-10

Progression O 0 4.312893906899262e-06
of O 0 3.0973390519051236e-10
somatic O 0 2.39226153553318e-07
CTG O 0 2.6981128939951304e-06
repeat O 0 1.6536975522285502e-07
length O 0 1.332859422831234e-08
heterogeneity O 0 9.45272589092383e-08
in O 0 9.34483115888618e-11
the O 0 5.897601851323486e-11
blood O 0 2.0207531292726344e-07
cells O 0 7.555613734666622e-08
of O 0 2.0957545032729286e-08
myotonic B-Disease 1 0.9999994039535522
dystrophy I-Disease 1 0.9999998807907104
patients O 0 0.00012474313552957028
. O 0 1.4783069879342747e-08

The O 0 1.689338335886248e-09
genetic O 0 1.6070700326054066e-08
basis O 0 3.2008886652334922e-09
of O 0 6.690252263297225e-08
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 0 1.4230476153898053e-05
DM B-Disease 1 1.0
) O 0 5.093672150735529e-10
is O 0 2.029668447200983e-11
the O 0 2.921209281414594e-13
expansion O 0 2.783084006308112e-11
of O 0 2.559078600070097e-12
an O 0 4.993386606977346e-11
unstable O 0 3.9485930756200105e-06
CTG O 0 1.6654379919600615e-07
repeat O 0 2.330036785735956e-08
in O 0 1.1126503364489171e-11
the O 0 2.45568235884841e-12
34 O 0 8.151448266380257e-12
UTR O 0 7.846868155247932e-10
of O 0 8.973380849139345e-13
the O 0 3.8247541245262084e-10
DM B-Disease 1 0.9999974966049194
protein O 0 1.286471551509294e-08
kinase O 0 8.764681780348837e-08
gene O 0 1.952913164515735e-09
on O 0 2.7944007108260394e-09
chromosome O 0 3.819877292698948e-06
19 O 0 4.514923546139471e-09
. O 0 8.320002464756726e-10

One O 0 3.0018909580320496e-09
of O 0 8.352206946893315e-12
the O 0 6.3110493393747635e-12
principal O 0 1.2904367852062393e-10
features O 0 5.49250575576643e-11
of O 0 4.918050775654104e-12
the O 0 8.795760564339616e-09
DM B-Disease 1 0.9999998807907104
mutation O 0 1.9369059373275377e-05
is O 0 9.867397871010652e-11
an O 0 1.5989734493057628e-12
extraordinarily O 0 4.3577921360338223e-07
high O 0 2.9898512554638046e-09
level O 0 3.1579225345801376e-10
of O 0 7.267059675374055e-13
somatic O 0 3.900245015842074e-09
mosaicism O 0 4.895795200354769e-07
, O 0 1.8429443734979678e-11
due O 0 3.7833951249677256e-11
to O 0 4.5398901651894086e-12
an O 0 5.218121074124227e-12
extremely O 0 2.391332465379037e-08
high O 0 2.89542656517483e-09
degree O 0 8.424387853978033e-10
of O 0 1.3951497292510884e-12
somatic O 0 2.680356381290494e-09
instability O 0 9.023398206409183e-08
both O 0 2.2691269002672598e-11
within O 0 6.883218387626622e-12
and O 0 1.595717308289224e-11
between O 0 1.2166954076187064e-11
different O 0 1.205508748380879e-10
tissues O 0 1.8515270028274244e-07
. O 0 8.601053758106048e-10

This O 0 3.6584171247966424e-09
instability O 0 1.214596920817712e-07
appears O 0 2.092003237308404e-09
to O 0 4.877572738065661e-12
be O 0 4.655357696559115e-12
biased O 0 4.701421890684898e-11
towards O 0 5.804877520505791e-13
further O 0 2.9684230334198203e-13
expansion O 0 5.5149352966299414e-12
and O 0 3.3016135398550306e-13
continuous O 0 5.332367360166845e-12
throughout O 0 1.038808253826795e-12
the O 0 5.076158135323972e-13
life O 0 5.7724532619152225e-12
of O 0 2.1218844484748554e-14
an O 0 5.432080566608599e-14
individual O 0 2.433590438541411e-12
, O 0 1.2780210646278628e-13
features O 0 7.44746486702752e-11
that O 0 3.641803802967303e-10
could O 0 1.5211051973551548e-08
be O 0 2.655912156868112e-10
associated O 0 8.453420602405615e-11
with O 0 4.380307748463874e-12
the O 0 3.515887234128989e-11
progressive O 0 3.3940443788793573e-09
nature O 0 4.543206255647192e-09
of O 0 3.717781724837943e-12
the O 0 4.368040096291992e-10
disease O 0 2.7012259806724614e-07
. O 0 1.2702104923434376e-09

Although O 0 8.892145686445474e-09
increasing O 0 3.851138075106064e-09
measured O 0 1.9200795975393703e-07
allele O 0 5.960792748282984e-08
size O 0 2.5902325617721544e-08
between O 0 3.521324898336786e-10
patients O 0 1.1951678535737642e-09
clearly O 0 9.376437404284843e-10
correlates O 0 7.077260999466262e-10
with O 0 5.941867549201507e-13
an O 0 7.394562392959436e-13
increased O 0 1.8885009112068474e-09
severity O 0 3.248580924264388e-06
of O 0 1.194340043531028e-10
symptoms O 0 2.883508045670169e-07
and O 0 8.602291622084035e-12
an O 0 9.13493347805272e-13
earlier O 0 8.656979577637003e-10
age O 0 5.756282950297731e-11
of O 0 5.210013193437946e-13
onset O 0 1.999099330518561e-09
, O 0 6.425352329191003e-13
this O 0 7.481081048697422e-14
correlation O 0 2.584490399470951e-10
is O 0 3.984977712395699e-12
not O 0 6.351115813818531e-12
precise O 0 1.7270307850481004e-08
and O 0 8.69870217523605e-11
measured O 0 1.2760760625951661e-07
allele O 0 5.107011258331795e-09
length O 0 1.7299385035585146e-08
cannot O 0 4.08339460022944e-08
be O 0 1.1429664506512616e-11
used O 0 5.941541529608241e-12
as O 0 6.060227189866318e-13
an O 0 3.4173575427787206e-13
accurate O 0 1.9485906221916593e-08
predictor O 0 2.24452648467377e-07
of O 0 7.563775127061856e-12
age O 0 9.271335366101141e-10
of O 0 2.4603954290602914e-11
onset O 0 7.306591243150251e-08
. O 0 3.2075255784747014e-09

In O 0 1.4144433402307754e-09
order O 0 3.3352955813859e-11
to O 0 3.878444006927273e-12
further O 0 4.926406071276146e-12
characterize O 0 7.266034884878536e-09
the O 0 6.138070607342172e-11
dynamics O 0 1.7931888862676715e-08
of O 0 3.428461681220796e-10
DM B-Disease 1 0.9999939203262329
CTG O 0 1.7038645410138997e-06
repeat O 0 2.8270287444343012e-08
somatic O 0 2.1396020954966843e-08
instability O 0 2.0972086645087984e-07
, O 0 1.3002892165769886e-11
we O 0 2.4928616462749353e-11
have O 0 3.759755094062678e-12
studied O 0 5.598646199422852e-11
repeat O 0 5.290997084905769e-10
length O 0 1.4598403041965469e-10
changes O 0 3.0175293687373372e-12
over O 0 1.1832082622703632e-12
time O 0 3.188211847304778e-11
in O 0 1.4032668083086008e-10
111 O 0 2.2653335207678538e-08
myotonic B-Disease 1 0.9999980926513672
dystrophy I-Disease 1 0.9999997615814209
patients O 0 1.678404117910759e-07
with O 0 5.05022378083364e-11
varying O 0 1.5017215915236193e-08
clinical O 0 5.2354085511296944e-08
severity O 0 1.0242149073746987e-05
and O 0 1.5026711819299265e-10
CTG O 0 1.8521586042652416e-08
repeat O 0 3.1598523797526923e-09
size O 0 4.040942247485191e-09
over O 0 3.747756965877258e-11
time O 0 4.2386892606938176e-11
intervals O 0 4.0719111416009923e-10
of O 0 6.388276951700689e-13
1 O 0 1.3751117432236892e-11
- O 0 3.028259598636396e-08
7 O 0 2.356281836313201e-10
years O 0 1.8252650779704283e-10
. O 0 3.6289141136514047e-10

We O 0 2.0475897599681048e-07
have O 0 3.9262917916893514e-10
found O 0 2.1887217732663444e-11
a O 0 1.1625338278836717e-12
direct O 0 1.1694241061621646e-11
progression O 0 3.3652283737417577e-10
of O 0 5.162834203664875e-14
the O 0 1.0930747409640396e-12
size O 0 2.003095467273397e-09
heterogeneity O 0 7.439787674812237e-10
over O 0 4.9831583304182914e-11
time O 0 3.9053326544857825e-11
related O 0 3.2903450797316935e-11
to O 0 7.058026580721022e-13
initial O 0 2.9892834735312235e-11
CTG O 0 3.034734019635721e-09
repeat O 0 1.039983321682314e-09
size O 0 4.6781694074127245e-09
and O 0 7.929519887928116e-12
the O 0 8.670748038834553e-13
time O 0 5.296931643306024e-11
interval O 0 7.191796602690204e-10
and O 0 1.811274047414102e-11
always O 0 1.3528458908673713e-10
biased O 0 3.947412535731942e-11
towards O 0 3.7212650495777044e-12
further O 0 3.821082773108886e-12
expansion O 0 5.002245284657647e-10
. O 0 4.001875775205832e-10

Attempts O 0 3.774290746605402e-08
to O 0 4.3595166365761884e-10
mathematically O 0 3.175459895032873e-08
model O 0 2.9557511993516528e-09
the O 0 4.037671239021101e-11
dynamics O 0 1.1991215842499514e-07
have O 0 6.923806528114085e-10
proved O 0 5.435058625380407e-09
only O 0 5.6370676355943505e-12
partially O 0 3.732053333038721e-09
successful O 0 5.5298217394028626e-11
suggesting O 0 1.7345433978022129e-09
that O 0 1.1705191937244619e-12
individual O 0 5.188711873355123e-13
specific O 0 1.02148454625417e-12
genetic O 0 6.244264133536959e-11
and O 0 1.997972794154368e-11
/ O 0 1.4308926266082267e-09
or O 0 2.2835340562910034e-10
environmental O 0 2.7739450736419258e-09
factors O 0 2.8251609385243626e-10
also O 0 6.99292013184305e-12
play O 0 6.223191666848704e-12
a O 0 8.340586034327746e-12
role O 0 1.0999440941406036e-10
in O 0 4.064832151429165e-11
somatic O 0 9.860032790243167e-09
mosaicism O 0 1.3349261962503078e-06
. O 0 3.164066231242657e-10
. O 0 1.0728281596428246e-09

Aspartylglucosaminuria B-Disease 1 0.9996404647827148
among O 0 2.8020982867360544e-08
Palestinian O 0 4.7012591153361427e-07
Arabs O 0 1.416449322277913e-07
. O 0 6.335844293658965e-09

Aspartylglucosaminuria B-Disease 1 0.9999843835830688
( O 0 1.5535451893811114e-06
AGU B-Disease 1 0.9999656677246094
) O 0 4.709276857361999e-10
is O 0 2.9295260661754696e-11
a O 0 1.846499064761531e-10
rare O 0 3.027555237622437e-07
disorder B-Disease 0 0.0001394298451486975
of I-Disease 0 4.678221143805672e-10
glycoprotein I-Disease 1 0.8533060550689697
metabolism I-Disease 0 0.001792768482118845
caused O 0 6.585410972093086e-08
by O 0 1.4867290731856997e-10
the O 0 1.723006981535491e-08
deficiency B-Disease 0 0.00010541539813857526
of I-Disease 0 7.068686348060682e-12
the I-Disease 0 1.8005041901858476e-10
lysosomal I-Disease 0 7.342252956732409e-06
enzyme I-Disease 0 4.820748245037976e-08
aspartylglucosaminidase I-Disease 0 1.3633105027111014e-06
( O 0 7.324174600142896e-11
AGA O 0 3.879169341303168e-08
) O 0 9.928755040355952e-11
. O 0 1.081747913467268e-09

AGU B-Disease 1 0.9999535083770752
is O 0 6.984801075304858e-07
inherited O 0 7.512181036872789e-05
as O 0 1.753613643185048e-10
an O 0 8.576443721874938e-11
autosomal O 0 0.12396039068698883
recessive O 1 0.8760886192321777
trait O 0 0.18574729561805725
and O 0 1.34207098767547e-08
occurs O 0 1.9171615406321507e-09
with O 0 3.982105877681219e-12
a O 0 2.1522637838611303e-10
high O 0 1.2451560671422612e-08
frequency O 0 3.3089652333728736e-06
in O 0 8.891226088714177e-10
Finland O 0 4.7511266529909335e-06
because O 0 9.12822317733486e-10
of O 0 6.060967699950126e-13
a O 0 2.473005689118679e-10
founder O 0 1.0891270108004392e-08
effect O 0 9.582919346939889e-09
. O 0 1.877253019699765e-09

While O 0 6.650262562857279e-09
very O 0 4.879345816277691e-10
few O 0 1.698279988859852e-10
patients O 0 2.7167026961372187e-10
with O 0 1.7222239190317623e-09
AGU B-Disease 1 0.9999978542327881
have O 0 1.4639629952739597e-08
been O 0 6.035044686214519e-10
reported O 0 1.9246970683894915e-10
from O 0 1.0155012681450915e-12
non O 0 6.070252633882944e-11
- O 0 2.6821320275871585e-08
Finnish O 0 2.0109311549276754e-07
origin O 0 9.51612344479713e-10
, O 0 1.1897444834874094e-11
we O 0 3.4818823380078356e-09
diagnosed O 0 1.959937492301833e-07
the O 0 6.22489212953603e-11
disorder O 0 3.2883428957575234e-07
in O 0 5.6553782490365023e-11
8 O 0 9.730607292146587e-11
patients O 0 7.455964318170416e-11
originating O 0 3.4678544758026675e-11
from O 0 2.4176658938723783e-12
3 O 0 9.300035568038378e-12
unrelated O 0 9.425819014197145e-10
families O 0 3.066587955791178e-11
, O 0 2.7784404551395303e-13
all O 0 1.9230061607759114e-13
Palestinian O 0 7.48447484544279e-11
Arabs O 0 2.7900680030223945e-11
from O 0 1.7742590166167083e-12
the O 0 5.7055827076823995e-12
region O 0 7.953789710191117e-11
of O 0 1.1096536016441672e-11
Jerusalem O 0 4.317286794730535e-08
. O 0 8.16565215444598e-09

The O 0 2.1166199459798918e-08
clinical O 0 5.577587103289261e-07
diagnosis O 0 0.00017566917813383043
of O 0 7.963406822852903e-09
AGU B-Disease 1 0.9999991655349731
is O 0 4.119898022736379e-08
often O 0 1.2070699995092582e-08
difficult O 0 2.004277455114334e-08
, O 0 5.379838284927385e-13
in O 0 2.204640685505091e-13
particular O 0 5.482590510058616e-12
early O 0 7.241990861162062e-12
in O 0 7.266075761902524e-13
the O 0 8.376467379965502e-13
course O 0 5.234841379819777e-11
of O 0 2.2786490034253093e-13
the O 0 1.0616057338763696e-10
disease O 0 2.5692418859080135e-08
, O 0 2.982310036946101e-13
and O 0 1.3750061202480457e-12
most O 0 2.967470494048656e-14
of O 0 4.0640352818059264e-14
the O 0 2.7787504935927743e-11
patients O 0 6.689263587489336e-10
are O 0 4.904135986194547e-10
diagnosed O 0 2.0699526714906824e-07
after O 0 2.3443516225518657e-11
the O 0 1.1584152040389206e-11
age O 0 6.3787745918642e-11
of O 0 1.9604667010880011e-13
5 O 0 1.826030299190151e-11
years O 0 2.135278343029512e-10
. O 0 3.3057584447604427e-10

However O 0 2.1793438165218504e-08
, O 0 3.8742242053357856e-11
since O 0 8.021984465589327e-11
these O 0 8.699925328758962e-12
patients O 0 6.61328283801943e-11
excrete O 0 4.6220338667524175e-10
early O 0 2.9780594223288714e-12
large O 0 5.531865764074606e-12
amounts O 0 3.3859390985435667e-11
of O 0 1.312377832275724e-12
aspartylglucosamine O 0 1.9593688449504043e-08
in O 0 1.632409485363695e-11
urine O 0 6.969251842292579e-10
, O 0 2.8935103553624775e-13
biochemical O 0 9.00231070244395e-11
screening O 0 1.913933421471281e-11
is O 0 6.518715255088292e-12
easy O 0 9.576258536148075e-11
by O 0 3.722324531940657e-11
urine O 0 2.152241229680385e-08
chromatography O 0 2.9178571026022837e-07
. O 0 8.735962647721252e-11
. O 0 2.8057053902408313e-10

Detection O 0 1.0856984999918495e-06
of O 0 1.526433840437491e-10
heterozygous O 0 3.894530209436198e-08
carriers O 0 6.384842876627772e-09
of O 0 1.0813038658907814e-10
the O 0 3.9420470443474187e-07
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999959468841553
telangiectasia I-Disease 1 0.9999997615814209
( O 0 4.347296300721837e-09
ATM O 0 1.1116804898847477e-06
) O 0 6.221945268031215e-12
gene O 0 1.9421175778688848e-10
by O 0 3.1007894168988415e-11
G2 O 0 7.134829616006755e-08
phase O 0 6.021204423944937e-09
chromosomal O 0 1.4740415281266905e-05
radiosensitivity O 0 3.5254561225883663e-06
of O 0 3.285524352580893e-10
peripheral O 0 1.898606751637999e-05
blood O 0 9.81153134489432e-05
lymphocytes O 0 6.678953650407493e-05
. O 0 3.491753375328699e-08

In O 0 1.557036375743337e-05
ataxia B-Disease 1 0.9999979734420776
- I-Disease 1 0.999976396560669
telangiectasia I-Disease 1 0.9999995231628418
( O 0 8.661446372570936e-06
A B-Disease 1 0.9999964237213135
- I-Disease 1 0.9999974966049194
T I-Disease 1 1.0
) O 0 2.2801318610987664e-09
patients O 0 5.129227598210662e-10
, O 0 3.4826742184579373e-12
mutations O 0 2.1299750851966337e-09
in O 0 3.2599715028142073e-12
a O 0 1.0424827667776526e-11
single O 0 4.985223900355606e-10
gene O 0 2.5893109878438736e-10
, O 0 6.172545656026041e-13
ATM O 0 5.6527094116631815e-09
, O 0 1.0086234148234952e-12
result O 0 1.0077187695411993e-10
in O 0 4.906924311320893e-10
an O 0 8.03071179689141e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.1859178528084158e-07
embraces O 0 1.7036349220234115e-08
a O 0 1.8286382130749956e-10
variety O 0 1.2157728990214167e-10
of O 0 4.3752731472557205e-12
clinical O 0 2.751896266417475e-09
features O 0 6.431314858446058e-08
and O 0 2.1031947738947565e-08
manifests O 0 7.391365386411053e-08
extreme O 0 7.992230877107431e-08
radiosensitivity O 0 1.1582091019590735e-06
and O 0 5.49296649832165e-11
a O 0 2.73488228591523e-11
strong O 0 2.5627788780013816e-10
pre O 0 2.1716968490181898e-07
- O 0 2.417307996438467e-06
disposition O 0 3.8300660776258155e-07
to O 0 7.334565732541876e-10
malignancy B-Disease 0 3.679984365589917e-05
. O 0 3.0912321591358705e-09

Heterozygotes O 0 3.5098505577479955e-06
for O 0 6.745223130044664e-11
the O 0 9.645730394969299e-12
ATM O 0 2.919278507818035e-08
gene O 0 7.517073186136258e-09
have O 0 1.1980065550698527e-10
no O 0 5.021906848701185e-11
clinical O 0 1.7559162457381206e-10
expression O 0 2.035571267100522e-09
of O 0 2.529372024329124e-11
A B-Disease 1 0.9999855756759644
- I-Disease 1 0.9999934434890747
T I-Disease 1 1.0
but O 0 2.529917082938482e-06
may O 0 3.601502100991638e-07
be O 0 2.929737163981372e-08
cancer B-Disease 0 2.2946078388486058e-06
prone O 0 4.010525117337238e-06
with O 0 5.49962029042228e-12
a O 0 3.255985203676204e-10
moderate O 0 1.6348733922200154e-08
increase O 0 2.2451582815108395e-09
in O 0 4.726561850243449e-11
in O 0 4.639334055811517e-11
vitro O 0 1.0368272285177227e-07
radiosensitivity O 0 4.562366029858822e-06
. O 0 4.183298596416307e-09

We O 0 1.5499740868563094e-07
performed O 0 3.750578514427616e-09
a O 0 4.450608215300633e-10
blind O 0 1.6598621144225945e-08
chromosomal O 0 4.771423505189887e-07
analysis O 0 8.210689350640621e-10
on O 0 1.0271435091357972e-10
G2 O 0 7.383587785625423e-08
- O 0 2.5470315634379403e-08
phase O 0 4.0256336042432395e-09
lymphocytes O 0 9.461560424028903e-09
from O 0 1.6846968264871975e-11
7 O 0 4.5659184766400074e-11
unrelated O 0 3.734234255148294e-08
A B-Disease 1 0.9999759197235107
- I-Disease 1 0.9999947547912598
T I-Disease 1 1.0
patients O 0 1.318724258680959e-07
, O 0 3.4308849164443878e-12
13 O 0 7.135808870878391e-12
obligate O 0 2.112626873440604e-08
A B-Disease 1 0.999954342842102
- I-Disease 1 0.9999747276306152
T I-Disease 1 0.9999991655349731
heterozygotes O 0 9.787345334189013e-06
( O 0 2.195582951558528e-11
parents O 0 3.748257607072425e-11
of O 0 1.593580546384657e-13
the O 0 1.2407967014960164e-11
patients O 0 8.800416645415865e-11
) O 0 1.849449819636348e-13
, O 0 3.1962941408197887e-13
and O 0 2.342062307980619e-12
14 O 0 7.998310672628628e-13
normal O 0 9.216211127593965e-12
controls O 0 9.942892342795773e-11
following O 0 5.7799225475219096e-12
X O 0 2.2282830514086527e-07
- O 0 1.5198602376642611e-09
irradiation O 0 1.1113343578728063e-09
with O 0 1.3630916707862983e-11
1 O 0 3.8834126886433395e-11
Gy O 0 1.7308468613919104e-07
in O 0 4.203119189499782e-12
order O 0 1.1479646443504632e-12
to O 0 7.626933481476306e-13
evaluate O 0 5.0299306386669684e-11
this O 0 2.006135925783359e-12
cytogenetic O 0 1.1235110619622901e-08
method O 0 2.862476922160795e-11
as O 0 4.302856356809548e-13
a O 0 1.0965118786912531e-12
tool O 0 2.0153194391081541e-10
for O 0 5.785898019375346e-13
detection O 0 1.4667432823856075e-09
of O 0 6.437634713502005e-12
ATM O 0 2.1569483124039834e-06
carriers O 0 5.8073286623994136e-08
. O 0 1.4010049786961076e-09

Both O 0 1.7597845669570233e-07
A B-Disease 1 0.9959914088249207
- I-Disease 1 0.9998058676719666
T I-Disease 1 0.9999990463256836
homozygotes O 0 0.0002105300809489563
and O 0 1.9635044978816296e-10
heterozygotes O 0 7.343292907080468e-08
showed O 0 4.581007573278839e-08
significantly O 0 8.621288682952866e-10
increased O 0 2.0418969293167777e-10
levels O 0 1.2986745012710799e-09
of O 0 3.044058755063972e-11
radiation O 1 0.9999579191207886
- O 0 0.0001499201316619292
induced O 0 3.452974124229513e-05
chromatid O 0 0.00016283124568872154
damage O 0 9.041675184562337e-06
relative O 0 9.86184218731978e-08
to O 0 1.1933854078549633e-11
that O 0 7.77468107254764e-12
of O 0 3.2366509646053476e-12
normal O 0 3.3644216301809138e-09
controls O 0 1.1671746591446208e-07
. O 0 6.645089811740945e-09

These O 0 2.207376059715216e-09
results O 0 1.2292624695930954e-09
show O 0 1.569152918712291e-09
that O 0 3.686162920041314e-12
the O 0 5.938108945530152e-12
G2 O 0 3.4631668199835985e-08
- O 0 8.403272744317292e-09
phase O 0 8.120730199401294e-10
chromosomal O 0 3.444461640356167e-07
radiosensitivity O 0 1.3174597768284002e-07
assay O 0 4.466420833182383e-08
can O 0 1.693644530176286e-10
be O 0 1.4435275891289123e-12
used O 0 3.691369258873589e-12
for O 0 3.426076696649849e-13
the O 0 1.773474162664046e-12
detection O 0 5.00346182263911e-08
of O 0 2.6762578264616366e-10
A B-Disease 1 0.999991774559021
- I-Disease 1 0.9999784231185913
T I-Disease 1 0.9999977350234985
heterozygotes O 0 0.0002476544468663633
. O 0 2.3586673947306735e-08

In O 0 1.3218230954237242e-09
combination O 0 4.845570611422545e-09
with O 0 3.557290573219518e-11
molecular O 0 6.04837140372183e-08
genetic O 0 1.552615813693592e-08
analyses O 0 2.386133779452848e-08
, O 0 1.212459928463805e-12
this O 0 2.2658042976575477e-12
test O 0 7.683242236877774e-11
may O 0 1.342543298754606e-10
be O 0 1.680684020774481e-12
of O 0 3.693175458377787e-14
value O 0 1.6472637143216673e-10
in O 0 2.538519524794558e-12
studies O 0 2.6941346289305335e-12
of O 0 1.5587242596908774e-13
familial B-Disease 0 6.025273791010477e-08
and I-Disease 0 3.139049686851081e-09
sporadic I-Disease 0 3.104249572061235e-06
cancers I-Disease 0 0.00940463412553072
aimed O 0 1.0052280785544099e-08
at O 0 3.006805915362065e-10
determination O 0 1.585833797612679e-09
of O 0 2.720224219487921e-13
the O 0 7.397806867960599e-13
potential O 0 3.3283053396671036e-11
involvement O 0 7.19464696152805e-11
of O 0 3.500602368741723e-12
ATM O 0 2.9735474527115002e-06
mutations O 0 4.2682222556322813e-07
in O 0 6.948254749339355e-10
tumor B-Disease 0 2.1499336071428843e-05
risk O 0 1.5501915413551615e-06
or O 0 9.916495402606529e-10
development O 0 6.738305052822469e-11
. O 0 1.0157696905821467e-10
. O 0 1.4635461731415944e-09

Ataxia B-Disease 1 0.9999970197677612
- I-Disease 1 0.999829888343811
telangiectasia I-Disease 1 0.999995231628418
: O 0 6.490042281370734e-09
identification O 0 7.364104881446565e-09
and O 0 2.76870922022443e-11
detection O 0 4.9319419659354935e-09
of O 0 3.349702026173018e-12
founder O 0 1.1360935303628139e-08
- O 0 3.359556899340532e-07
effect O 0 7.751298269909057e-09
mutations O 0 6.348109593545814e-09
in O 0 2.090149667927088e-12
the O 0 7.573225900558977e-13
ATM O 0 5.118147683447205e-09
gene O 0 2.0147927770608476e-10
in O 0 2.487674649609417e-11
ethnic O 0 2.8825530851150916e-10
populations O 0 2.092335549264135e-08
. O 0 5.129875635390135e-09

To O 0 4.047234214432649e-10
facilitate O 0 2.7194710372491215e-10
the O 0 1.5616183693389907e-11
evaluation O 0 9.635395779861167e-12
of O 0 3.50514349533107e-13
ATM O 0 5.9491291892754816e-08
heterozygotes O 0 2.7413362246875295e-08
for O 0 6.606383409074601e-12
susceptibility O 0 9.262378739549604e-07
to O 0 4.548611834409577e-11
other O 0 8.60695681392798e-11
diseases O 0 2.0188808491639065e-07
, O 0 2.342195176956857e-13
such O 0 1.0681957705524492e-12
as O 0 5.901812927255889e-10
breast B-Disease 0 0.0643581748008728
cancer I-Disease 0 1.5684492609580047e-05
, O 0 3.8553531894747195e-11
we O 0 1.6677242919982405e-10
have O 0 2.339932284392554e-12
attempted O 0 9.551486684911126e-11
to O 0 1.6299259034471825e-12
define O 0 9.760887237364457e-11
the O 0 6.888704016938529e-13
most O 0 6.48493086487234e-13
common O 0 7.596507624330062e-12
mutations O 0 8.551602759254706e-10
and O 0 1.0970940302057475e-11
their O 0 1.1451835139897337e-11
frequencies O 0 1.6577240558035555e-07
in O 0 1.6983271677872835e-08
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.999991774559021
telangiectasia I-Disease 1 0.9999998807907104
( O 0 1.466740627620311e-06
A B-Disease 1 0.9999983310699463
- I-Disease 1 0.9999966621398926
T I-Disease 1 0.9999997615814209
) O 0 1.6513312939281377e-10
homozygotes O 0 5.040935135980362e-08
from O 0 7.390561253262096e-12
10 O 0 1.5162857081030268e-11
ethnic O 0 4.473465348153738e-11
populations O 0 4.5577088769732654e-09
. O 0 1.1589136317269322e-09

Both O 0 2.7440549832391525e-09
genomic O 0 1.0552159324106469e-07
mutations O 0 2.327901484022732e-06
and O 0 7.949543801011316e-11
their O 0 7.502679900961429e-12
effects O 0 3.348021193616546e-09
on O 0 1.2260305271016847e-10
cDNA O 0 1.3611055615925238e-09
were O 0 2.233259577266722e-09
characterized O 0 7.466734075478598e-08
. O 0 5.092362975744891e-09

Protein O 0 3.208782572983182e-07
- O 0 3.220855404606482e-08
truncation O 0 2.55175329755275e-08
testing O 0 4.174586454297469e-09
of O 0 2.1178675133071145e-12
the O 0 2.169406798299689e-12
entire O 0 1.954543298043898e-11
ATM O 0 1.444570907338516e-09
cDNA O 0 1.8258013156913222e-10
detected O 0 1.1184181580858876e-08
92 O 0 1.629081244902686e-11
( O 0 3.920007764571243e-13
66 O 0 8.095297869548101e-12
% O 0 9.528441403949817e-13
) O 0 3.56880622059616e-13
truncating O 0 2.22615725853359e-09
mutations O 0 5.934686964081948e-09
in O 0 2.3420411443542122e-11
140 O 0 8.245887306301825e-11
mutant O 0 1.5890561755327326e-08
alleles O 0 4.607172598980469e-08
screened O 0 1.8351935295868316e-06
. O 0 3.008553051131457e-08

The O 0 2.3751849376196787e-09
haplotyping O 0 1.4642651535723417e-07
of O 0 5.5746386673494186e-11
patients O 0 1.2669512106100456e-09
with O 0 1.1479177330908641e-10
identical O 0 1.5201184396573808e-05
mutations O 0 3.063365284106112e-06
indicates O 0 3.078947230505946e-08
that O 0 1.1568828360564165e-11
almost O 0 5.556610727097677e-12
all O 0 2.409084487887264e-13
of O 0 1.3696291008887668e-13
these O 0 1.648767819321939e-12
represent O 0 1.0021099401680278e-11
common O 0 4.6981141199609056e-11
ancestry O 0 8.567591081032333e-09
and O 0 1.8527927803102529e-10
that O 0 6.48950337911458e-11
very O 0 1.1645723274611441e-10
few O 0 3.056463970807499e-10
spontaneously O 0 3.3368390273125215e-09
recurring O 0 1.2695183571054258e-08
ATM O 0 3.2034790820034686e-06
mutations O 0 6.272090331549407e-07
exist O 0 6.57624852351546e-08
. O 0 2.6623345750209637e-09

Assays O 0 2.6148468350584153e-06
requiring O 0 3.186921659903419e-08
minimal O 0 1.9378717297513504e-08
amounts O 0 4.089392435790984e-10
of O 0 3.4462647579419636e-12
genomic O 0 1.3412796429079776e-09
DNA O 0 3.3569108381925616e-08
were O 0 2.1414370277028638e-10
designed O 0 2.7718929374032086e-09
to O 0 3.1939312306050738e-12
allow O 0 1.1207333672214048e-11
rapid O 0 6.331984242491373e-11
screening O 0 7.393892442753014e-11
for O 0 2.6738825997102422e-12
common O 0 4.100277756213799e-11
ethnic O 0 1.1540734340398373e-10
mutations O 0 2.7565474169932713e-07
. O 0 3.0612847812250266e-09

These O 0 1.0183540677388692e-09
rapid O 0 3.3997133996876983e-09
assays O 0 2.9868834872104344e-07
detected O 0 4.592652373958117e-07
mutations O 0 2.27904592975392e-08
in O 0 1.1937769349434912e-11
76 O 0 5.680870704405372e-11
% O 0 2.5392363992710054e-12
of O 0 4.760650641061348e-12
Costa O 0 5.6810421256159316e-08
Rican O 0 7.734391971325749e-08
patients O 0 6.263423668606549e-10
( O 0 1.6800165317069904e-13
3 O 0 3.4683670865898186e-13
) O 0 2.7061159370745e-14
, O 0 2.62729867429954e-14
50 O 0 2.2255160496593984e-13
% O 0 8.320524580744323e-14
of O 0 1.0225098762486895e-12
Norwegian O 0 6.466592458309606e-05
patients O 0 1.4475911580547063e-09
( O 0 4.3059105543294396e-13
1 O 0 2.0890776088189345e-12
) O 0 8.462716340413082e-14
, O 0 8.473893109558692e-14
25 O 0 1.6242394798929305e-13
% O 0 7.559930329317788e-14
of O 0 1.544080835413908e-12
Polish O 0 5.152784433448687e-05
patients O 0 1.068468957754476e-08
( O 0 1.1077667646033906e-12
4 O 0 1.4236871230532966e-12
) O 0 1.5825761653844722e-13
, O 0 1.010635328137395e-13
and O 0 1.587741114798813e-12
14 O 0 6.29743436217356e-13
% O 0 6.825348120888253e-14
of O 0 1.4677868024736557e-13
Italian O 0 2.1603351996191122e-08
patients O 0 1.5876586711982554e-09
( O 0 5.760428484040403e-13
1 O 0 8.436937780353926e-12
) O 0 3.3168251673855453e-13
, O 0 2.0333978641498551e-13
as O 0 2.977444408646529e-13
well O 0 1.1751167747209301e-11
as O 0 5.104715261605719e-12
in O 0 1.9189923955442723e-11
patients O 0 1.754014121446712e-11
of O 0 1.1323593972212276e-12
Amish O 0 2.2909095775958122e-07
/ O 0 5.24846583971339e-08
Mennonite O 0 3.540522541811697e-08
and O 0 2.6814097608962584e-09
Irish O 0 4.227795358247022e-08
English O 0 3.5412903720555278e-09
backgrounds O 0 3.573958196056992e-08
. O 0 1.8612412722163185e-09

Additional O 0 2.1757335932903743e-09
mutations O 0 2.426025389468123e-07
were O 0 3.3959723921839213e-10
observed O 0 3.6647724854788066e-09
in O 0 1.2748280729668604e-11
Japanese O 0 1.0539878969595406e-09
, O 0 1.131213178684476e-12
Utah O 0 7.822905517818057e-12
Mormon O 0 3.080421117837573e-12
, O 0 4.766435727013296e-13
and O 0 1.8600637523291663e-12
African O 0 3.32593024301997e-12
American O 0 2.890177819292461e-10
patients O 0 6.526011953056354e-10
. O 0 3.029995421233167e-10

These O 0 7.081432662481291e-10
assays O 0 2.571536228401783e-08
should O 0 7.839414534194233e-11
facilitate O 0 1.5342147691166375e-11
screening O 0 3.9452768829661977e-10
for O 0 2.2842179536741725e-10
A B-Disease 1 0.9996432065963745
- I-Disease 1 0.9997207522392273
T I-Disease 1 0.9999957084655762
heterozygotes O 0 1.388464966112224e-06
in O 0 5.2564324420911746e-11
the O 0 1.164607212750246e-11
populations O 0 3.945893889412133e-10
studied O 0 2.061440573797313e-09
. O 0 2.8916761346531317e-11
. O 0 3.90692145302296e-10

The O 0 4.794302981281362e-07
von B-Disease 1 0.9577409625053406
Hippel I-Disease 1 0.9991832375526428
- I-Disease 1 0.9662631750106812
Lindau I-Disease 1 0.9915943741798401
tumor I-Disease 0 0.0005467489827424288
suppressor O 0 7.582756552437786e-06
gene O 0 1.9335968204359233e-07
is O 0 8.982140725644072e-11
required O 0 1.2776273095038704e-11
for O 0 5.159066533352852e-13
cell O 0 1.07490771839025e-08
cycle O 0 1.0710596853868992e-09
exit O 0 1.1708223279782715e-09
upon O 0 3.430083439504017e-10
serum O 0 1.3139313637111627e-07
withdrawal O 0 2.5114205826071156e-08
. O 0 2.3380533065164855e-09

The O 0 3.881091448221241e-09
inactivation O 0 1.6570507455071493e-07
of O 0 7.466438578518364e-11
the O 0 1.256784898373553e-09
von B-Disease 1 0.9978437423706055
Hippel I-Disease 1 0.999900221824646
- I-Disease 1 0.9995738863945007
Lindau I-Disease 1 0.9986240863800049
( I-Disease 0 3.9151309749740903e-08
VHL I-Disease 0 5.768547271145508e-05
) I-Disease 0 7.47685524604691e-11
tumor I-Disease 0 4.9721339934194475e-08
suppressor O 0 4.434090214999742e-07
gene O 0 1.8369256338246487e-07
predisposes O 0 4.392772552819224e-06
affected O 0 1.2504682622704877e-08
individuals O 0 7.339291674401949e-11
to O 0 2.915562583027942e-11
the O 0 5.943455061441227e-09
human O 0 0.000892569194547832
VHL B-Disease 1 0.9999867677688599
cancer I-Disease 1 0.9999765157699585
syndrome I-Disease 1 0.9999839067459106
and O 0 2.4525310671208445e-09
is O 0 4.2450504222912855e-10
associated O 0 3.075177668065976e-09
with O 0 4.3437964336590085e-10
sporadic B-Disease 0 0.005390217062085867
renal I-Disease 1 0.9997830986976624
cell I-Disease 1 0.9999668598175049
carcinomas I-Disease 1 1.0
( O 0 3.6950650610378943e-06
RCC B-Disease 1 0.8756847381591797
) O 0 1.3717416091907353e-09
and O 0 1.369645641347006e-08
brain B-Disease 0 9.577288437867537e-05
hemangioblastomas I-Disease 0 0.00011020983220078051
. O 0 2.0143874124300964e-08

VHL O 0 0.010392814874649048
- O 0 4.095983967999928e-06
negative O 0 4.2210552919641486e-07
786 O 0 6.330772635010362e-07
- O 0 6.705199666612316e-06
0 O 0 9.815206425400902e-09
RCC B-Disease 0 7.93958952272078e-06
cells O 0 2.3145634298060713e-09
are O 0 1.0609291223317996e-11
tumorigenic O 0 7.349612474172318e-08
in O 0 2.6374863404399207e-10
nude O 0 0.1405181884765625
mice O 0 7.354356785072014e-05
which O 0 5.057301799560321e-10
is O 0 1.4220459879088487e-11
suppressed O 0 8.344344659683145e-11
by O 0 1.0685645077113115e-12
the O 0 2.5821669021736104e-12
reintroduction O 0 1.6039303218917667e-09
of O 0 1.7323868728436054e-10
VHL B-Disease 0 8.913381861930247e-06
. O 0 2.4954425192902363e-09

Remarkably O 0 1.4903135706845205e-05
, O 0 1.1476243566566069e-10
this O 0 4.169248713631335e-12
occurs O 0 5.14708102528072e-11
without O 0 3.4838900427741626e-12
affecting O 0 9.052997934633211e-12
the O 0 2.666482703042594e-12
growth O 0 6.014417852640008e-10
rate O 0 5.7030131728197375e-09
and O 0 4.42974433176313e-12
cell O 0 1.4354247790393515e-09
cycle O 0 1.08929837372429e-10
profile O 0 7.359621245761616e-10
of O 0 6.540257159633189e-13
these O 0 9.54620063553513e-12
cells O 0 1.762829049400949e-10
in O 0 1.2710380491165463e-11
culture O 0 1.880105404694632e-09
. O 0 5.734708263815946e-10

The O 0 2.755225825268326e-09
786 O 0 8.987757382783457e-08
- O 0 1.4604940190565685e-07
0 O 0 9.494747210680998e-10
cell O 0 3.141231630365837e-08
line O 0 3.481166999108609e-08
, O 0 1.1872412775115748e-12
like O 0 1.9447781926529295e-11
many O 0 3.947245308388858e-12
cancer B-Disease 0 1.1598119797895379e-08
cells O 0 2.488833861225004e-10
, O 0 1.7390359985380854e-12
fails O 0 1.7814329178467148e-10
to O 0 7.216216556596433e-13
exit O 0 1.1912051900431209e-10
the O 0 2.348939619201129e-11
cell O 0 2.1539579009299814e-08
cycle O 0 6.658179563245881e-10
upon O 0 7.25925361488855e-11
serum O 0 3.453826025179296e-08
withdrawal O 0 9.085289853771883e-09
. O 0 2.310915681036363e-09

Here O 0 2.040062128116915e-07
, O 0 3.18162683698997e-11
it O 0 2.876267366641594e-12
is O 0 3.1649563612262677e-12
shown O 0 2.918333283363772e-11
that O 0 9.298540670082955e-13
reintroduction O 0 4.887036608725026e-11
of O 0 2.7762416931337297e-13
the O 0 4.0562644389174896e-12
wild O 0 1.3377946528336793e-09
- O 0 2.7198088901059236e-06
type O 0 2.0101597328903154e-06
VHL B-Disease 0 1.059882038134674e-06
gene O 0 1.4897614253328584e-09
restores O 0 2.559780609701079e-09
the O 0 7.41657256442263e-12
ability O 0 1.9168862330776193e-10
of O 0 3.5177787766071944e-11
VHL O 0 9.688951831776649e-05
- O 0 5.88773673371179e-06
negative O 0 6.257881068449933e-06
RCC B-Disease 0 0.030958473682403564
cancer I-Disease 0 3.509749149088748e-07
cells O 0 1.6726971197034146e-10
to O 0 7.134730089716768e-13
exit O 0 1.248560421718281e-10
the O 0 1.463338304696915e-11
cell O 0 2.503887586158271e-08
cycle O 0 4.3446415909365044e-10
and O 0 1.1396314447686962e-11
enter O 0 1.164658924857065e-10
G0 O 0 7.835136273115495e-08
/ O 0 4.18142365177232e-09
quiescence O 0 1.2973907814739505e-07
in O 0 1.0587933862993282e-09
low O 0 1.1791036058639293e-06
serum O 0 8.646294190839399e-06
. O 0 5.367559730018456e-09

Both O 0 9.049993821008684e-08
VHL O 0 0.0010158984223380685
- O 0 4.098113095096778e-06
positive O 0 6.510685324201404e-09
and O 0 3.617885768747442e-09
VHL O 0 7.055632886476815e-05
- O 0 3.5149614063811896e-07
negative O 0 1.0134333194855571e-07
RCC B-Disease 0 4.600244665198261e-06
cells O 0 4.956496324481918e-10
exit O 0 2.0501664255156982e-10
the O 0 1.705755502123818e-11
cell O 0 1.865186938232455e-08
cycle O 0 6.177737210677492e-10
by O 0 1.7224260212556075e-11
contact O 0 4.197007186235169e-08
inhibition O 0 5.0238686100101404e-08
. O 0 2.9575051296859556e-09

The O 0 1.8693574688199988e-08
cyclin O 0 0.0001549659646116197
- O 0 1.0130581813427852e-06
dependent O 0 3.131641790332651e-08
kinase O 0 1.0466946065434968e-07
inhibitor O 0 7.930742285111592e-09
, O 0 3.3968886731239323e-12
p27 O 0 1.2070094923544161e-09
, O 0 1.2797779329332126e-12
accumulates O 0 6.048365697175484e-10
upon O 0 1.3681240168539333e-11
serum O 0 7.734683116211727e-09
withdrawal O 0 1.010036165816075e-09
, O 0 6.260416447398387e-13
only O 0 2.1436651553245062e-13
in O 0 1.4389855138626645e-13
the O 0 6.016783750915911e-13
presence O 0 2.557445401285552e-11
of O 0 6.6649064739410235e-12
VHL B-Disease 0 6.593806460841733e-07
, O 0 7.399923230601291e-13
as O 0 9.051883998216145e-14
a O 0 3.911495693315059e-12
result O 0 8.93526988510196e-11
of O 0 2.1910710821648055e-13
the O 0 2.4540532366640333e-12
stabilization O 0 1.1009200495681881e-10
of O 0 5.150610840609637e-13
the O 0 6.952145456540215e-12
protein O 0 7.472952812115352e-10
. O 0 2.8596081058651635e-10

We O 0 5.4849422781444446e-09
propose O 0 1.6219767751124436e-09
that O 0 8.766453708786148e-12
the O 0 1.4027381686765317e-12
loss O 0 4.3015972728266405e-11
of O 0 6.653522676390577e-13
wild O 0 2.2808712696331668e-09
- O 0 5.242960924078943e-06
type O 0 8.928755050874315e-06
VHL B-Disease 0 9.802765816857573e-07
gene O 0 3.757428812534158e-10
results O 0 1.3165661616465485e-10
in O 0 9.589025537146134e-13
a O 0 5.007127091422037e-12
specific O 0 2.504085550025792e-10
cellular O 0 6.759301527381467e-07
defect O 0 5.790737418465142e-07
in O 0 6.418682946263132e-11
serum O 0 1.129249312725733e-06
- O 0 1.0422197647130815e-06
dependent O 0 3.5451716229317753e-08
growth O 0 3.7459031432263146e-09
control O 0 4.886016480298849e-09
, O 0 7.48598405486689e-12
which O 0 1.893577482314779e-11
may O 0 2.63592231375398e-10
initiate O 0 2.7220878884293143e-09
tumor B-Disease 0 1.363834599032998e-06
formation O 0 2.3758701672704774e-08
. O 0 1.4549458304813356e-09

This O 0 1.886934608563706e-09
is O 0 1.2249483372084313e-10
corrected O 0 2.178968561139527e-09
by O 0 5.756430488529363e-13
the O 0 5.218586522116875e-13
reintroduction O 0 8.532731465837884e-11
of O 0 1.3528084902292292e-12
wild O 0 4.87558970974078e-09
- O 0 5.420912566478364e-05
type O 0 0.0002435398637317121
VHL B-Disease 0 0.00023877769126556814
, O 0 4.556895832896757e-11
implicating O 0 8.197238230422954e-07
VHL B-Disease 0 1.60259401127405e-06
as O 0 2.538655266906553e-12
the O 0 4.906206192180351e-13
first O 0 9.219271179805588e-12
tumor B-Disease 0 4.642002782162535e-09
suppressor O 0 8.317245558941977e-09
involved O 0 1.5270336384265448e-10
in O 0 3.092713585228779e-12
the O 0 9.948401694451214e-13
regulation O 0 7.042501998233419e-11
of O 0 6.597967614971334e-13
cell O 0 4.415932952639423e-09
cycle O 0 2.687937095124937e-10
exit O 0 5.696106919472754e-10
, O 0 4.157433078355588e-12
which O 0 1.8025511638875003e-11
is O 0 1.2127613149837124e-11
consistent O 0 1.1511919195683618e-09
with O 0 6.115382180683915e-13
its O 0 1.9039234164935914e-12
gatekeeper O 0 5.279565118421203e-10
function O 0 7.500680632155365e-11
in O 0 6.2613863746618925e-12
the O 0 2.0540246586930877e-11
kidney O 0 2.4842883306064323e-08
. O 0 3.8902572829790927e-10
. O 0 1.6508723277297577e-09

Piebaldism B-Disease 1 0.9999735355377197
with O 0 1.5191969396255445e-05
deafness B-Disease 1 0.9999995231628418
: O 0 4.121468055728883e-09
molecular O 0 4.850724266702855e-08
evidence O 0 1.974596042231269e-09
for O 0 1.955251759111487e-11
an O 0 8.249525507153521e-10
expanded O 0 2.492602652637288e-05
syndrome O 1 0.9990894794464111
. O 0 7.038510574375323e-08

In O 0 1.4664298664257558e-09
a O 0 2.7560970172757493e-10
South O 0 1.6419499093700551e-10
African O 0 7.819194597358248e-11
girl O 0 7.575021498951173e-08
of O 0 1.476503988517841e-11
Xhosa O 0 4.567388600662525e-08
stock O 0 5.034677119652997e-09
with O 0 3.459347253098599e-10
severe O 0 4.970767804479692e-06
piebaldism B-Disease 0 0.00024714539176784456
and O 0 1.449717217383295e-07
profound O 0 0.0005565878236666322
congenital O 1 0.999995231628418
sensorineural B-Disease 1 0.9999897480010986
deafness I-Disease 1 1.0
we O 0 2.2925736629986204e-05
identified O 0 5.716552919921014e-08
a O 0 5.4194326110090785e-11
novel O 0 6.104084598890225e-11
missense O 0 9.738247541690725e-09
substitution O 0 3.4268204940346436e-10
at O 0 7.9751941162165e-11
a O 0 2.585687219891497e-11
highly O 0 6.844904643088512e-10
conserved O 0 5.328491869960317e-09
residue O 0 4.763248995232061e-08
in O 0 5.630835207826035e-12
the O 0 4.321290287406798e-12
intracellular O 0 1.3767743611836636e-09
kinase O 0 2.0201620376525398e-09
domain O 0 5.420600426853106e-11
of O 0 6.048195256257161e-13
the O 0 1.147644063115294e-10
KIT O 0 4.0512280975235626e-05
proto O 0 8.539127884432673e-05
- O 0 7.559269761259202e-06
oncogene O 0 9.998797168009332e-07
, O 0 6.721002226983686e-11
R796G O 0 3.445121521394867e-08
. O 0 2.598980586299149e-09

Though O 0 2.7173065575425426e-08
auditory B-Disease 0 6.269632422117866e-07
anomalies I-Disease 0 0.0012340270914137363
have O 0 1.4642142609488928e-08
been O 0 8.517094252091795e-10
observed O 0 1.5469934666612062e-08
in O 0 3.6494092470196193e-11
mice O 0 3.603060960699622e-08
with O 0 9.539106310407774e-11
dominant O 0 2.1953022155685176e-07
white O 0 1.469627477490576e-07
spotting O 0 2.266547926410567e-05
( O 0 1.0957707657910376e-10
W O 0 0.0001897103647934273
) O 0 2.0494292027328775e-12
due O 0 8.36678434867899e-11
to O 0 1.9693556507771603e-10
KIT O 0 0.18517859280109406
mutations O 0 0.0030172448605298996
, O 0 3.941783432992452e-08
deafness B-Disease 1 0.9999995231628418
is O 0 8.799921680235911e-09
not O 0 1.399441951210889e-10
typical O 0 8.051270761200158e-09
in O 0 2.817223676565561e-10
human O 0 2.058348602673732e-09
piebaldism B-Disease 0 2.0723834950331366e-06
. O 0 4.6853401158841734e-09

Thus O 0 4.3740218558241395e-08
, O 0 2.178945739117477e-11
the O 0 5.252180634851555e-12
occurrence O 0 3.5654068142321194e-08
of O 0 3.462364006612262e-10
sensorineural B-Disease 1 0.9998921155929565
deafness I-Disease 1 1.0
in O 0 1.925429771176823e-08
this O 0 2.758274164627039e-10
patient O 0 1.5510648765371116e-08
extends O 0 2.9216318253588724e-10
considerably O 0 3.595539976863904e-10
the O 0 2.050371591261202e-12
phenotypic O 0 1.5598576874609194e-09
range O 0 1.140258887311063e-09
of O 0 6.0029624500412826e-12
piebaldism B-Disease 0 1.9062896683408326e-07
due O 0 2.1035295727500625e-10
to O 0 4.575549574642457e-12
KIT O 0 1.165453866747157e-07
gene O 0 1.80334058796916e-09
mutation O 0 5.393914648266218e-09
in O 0 1.1041516659315853e-11
humans O 0 1.2090412004894802e-10
and O 0 4.3164877054635564e-12
tightens O 0 4.397486108587145e-08
the O 0 3.819793006204497e-12
clinical O 0 8.825782465970988e-11
similarity O 0 6.610624825320599e-10
between O 0 5.797569369025979e-11
piebaldism B-Disease 0 1.9855157518122724e-07
and O 0 5.329248847774082e-11
the O 0 9.017526851097524e-13
various O 0 1.6496579493055497e-12
forms O 0 4.962030231148162e-10
of O 0 3.5318219460123146e-08
Waardenburg B-Disease 1 0.9999492168426514
syndrome I-Disease 1 0.9992978572845459
. O 0 3.6279104720371436e-10
. O 0 1.7078309877405218e-09

Cycloheximide O 0 3.388168579476769e-06
facilitates O 0 6.44609876587765e-09
the O 0 1.8392782089038384e-11
identification O 0 2.879717297954443e-10
of O 0 4.561372113354167e-12
aberrant O 0 1.583987518927188e-08
transcripts O 0 7.600939433416443e-09
resulting O 0 6.855268797067993e-09
from O 0 1.9790696859089962e-11
a O 0 5.5573448620727106e-11
novel O 0 2.1237106517801863e-10
splice O 0 1.3805187393245433e-07
- O 0 8.314915476148599e-07
site O 0 6.992530998672919e-09
mutation O 0 1.4874659370889276e-07
in O 0 3.3967415685731694e-11
COL17A1 O 0 1.8867432345359703e-06
in O 0 4.693215260864747e-11
a O 0 1.8318367933645163e-09
patient O 0 3.1537308586848667e-07
with O 0 4.4033172663660025e-09
generalized O 0 3.732480763574131e-05
atrophic B-Disease 1 0.9934167861938477
benign I-Disease 1 0.994330883026123
epidermolysis I-Disease 1 0.9935417175292969
bullosa I-Disease 1 0.9751410484313965
. O 0 1.5210245010166545e-06

Patients O 0 1.7003379980451427e-05
with O 0 1.8007291657795577e-08
generalized O 0 3.98720549128484e-05
atrophic B-Disease 1 0.9961236119270325
benign I-Disease 1 0.9896774291992188
epidermolysis I-Disease 1 0.9936591982841492
bullosa I-Disease 1 0.9556929469108582
often O 0 4.391468166886625e-07
show O 0 5.001706071539047e-08
decreased O 0 2.3804334503552127e-08
expression O 0 1.4390652003370974e-09
of O 0 1.3137685384023712e-11
type O 0 3.1228491934598424e-06
XVII O 0 4.506453024077928e-06
collagen O 0 3.001268567004445e-07
, O 0 2.5034155304304306e-11
a O 0 1.2460600606889471e-10
transmembrane O 0 4.571066654079914e-07
hemidesmosomal O 0 9.077966467430088e-08
protein O 0 3.472131748782914e-10
encoded O 0 5.656977664081353e-10
by O 0 1.4915463308895482e-10
COL17A1 O 0 3.5874192690243945e-05
. O 0 3.4390403857997853e-09

This O 0 3.065655285183766e-09
report O 0 2.74078981732373e-10
documents O 0 1.3948077415282256e-10
a O 0 3.1135136135951313e-11
novel O 0 7.771926852084832e-11
splice O 0 6.274310493381563e-08
- O 0 5.575698764914705e-07
site O 0 2.264935972107196e-08
mutation O 0 1.698561220564443e-07
in O 0 6.670251156970508e-11
COL17A1 O 0 9.611237601347966e-07
in O 0 4.0663597489221104e-11
a O 0 8.402804008156295e-10
patient O 0 1.1442097758163072e-07
with O 0 6.532749341481292e-10
generalized O 0 7.0235159910225775e-06
atrophic B-Disease 1 0.9526413083076477
benign I-Disease 0 0.2535927891731262
epidermolysis I-Disease 0 0.398063600063324
bullosa I-Disease 0 0.09643155336380005
, O 0 7.103022614529664e-10
and O 0 9.131035337561766e-12
applies O 0 4.862555150197956e-11
a O 0 2.5339819218622717e-12
new O 0 3.7704889666208274e-13
methodology O 0 7.44602643432124e-12
to O 0 8.248931052112773e-13
define O 0 5.874499775515574e-10
and O 0 6.948860931110801e-11
characterize O 0 1.3932271336614122e-08
the O 0 3.108653612304835e-11
resulting O 0 7.768714560540957e-10
mRNA O 0 1.02948782831902e-09
splice O 0 2.7536302127373347e-08
variants O 0 4.4649475228197844e-08
. O 0 6.718099854197135e-09

Mutational O 0 0.00043114068103022873
analysis O 0 1.4307273943359178e-07
of O 0 3.909888524056271e-10
COL17A1 O 0 2.5920720872818492e-05
identified O 0 4.469207937063402e-08
a O 0 1.3125450726292343e-09
maternally O 0 3.7078170862514526e-05
inherited O 0 5.400191730586812e-05
G O 0 1.1490728866192512e-05
- O 0 2.644925416461774e-07
to O 0 8.625038461218537e-10
- O 0 1.765083652571775e-06
T O 0 1.973190364878974e-06
transversion O 0 1.0484865420323786e-08
at O 0 1.6478159114985402e-11
the O 0 8.848494311396171e-13
- O 0 8.135644380402596e-10
1 O 0 4.5811032918507966e-12
position O 0 1.4749904075905818e-10
of O 0 2.1078852639050405e-12
exon O 0 1.3034347823293047e-08
32 O 0 1.5697606547959708e-09
. O 0 2.104301177752177e-09

This O 0 7.154500880623971e-10
acceptor O 0 2.3272728189027703e-09
splice O 0 2.0585662241501268e-07
- O 0 5.668631501976051e-07
site O 0 6.5749912181445325e-09
mutation O 0 4.954516086286276e-08
led O 0 2.9565037917844705e-11
to O 0 2.7144881394741693e-12
the O 0 6.196872875952053e-12
formation O 0 5.747857051430216e-11
of O 0 9.720709480409706e-13
aberrant O 0 1.21976373446131e-09
transcripts O 0 8.826662178940126e-10
present O 0 1.3984972901948112e-10
at O 0 8.695952291581932e-10
extremely O 0 7.809845925521586e-08
low O 0 3.754531689992291e-06
levels O 0 1.645708493924758e-07
. O 0 2.3627051426444723e-09

Based O 0 1.5218017068718837e-08
on O 0 2.8065991197756546e-10
our O 0 6.882341918590384e-11
recent O 0 2.5608815415467667e-11
finding O 0 2.2909929162096e-11
that O 0 1.3885294823656746e-11
cycloheximide O 0 1.464631083081258e-07
stabilized O 0 1.6078417957032798e-06
mutant O 0 3.828398043026482e-09
COL17A1 O 0 5.480510623101509e-08
transcripts O 0 1.1632276253337182e-09
in O 0 9.242034221257356e-12
keratinocytes O 0 1.484901979154074e-09
homozygous O 0 1.338039679055214e-09
for O 0 1.1742155641911167e-12
a O 0 4.5936901504894934e-10
frameshift O 0 0.003232811577618122
mutation O 0 2.652452849360998e-06
, O 0 3.0341679689571688e-12
the O 0 1.2457687876069046e-12
effects O 0 3.06779024406012e-09
of O 0 2.362661065055671e-12
the O 0 1.8361305531566785e-11
splice O 0 1.2383107161895168e-07
- O 0 6.019863576511852e-07
site O 0 1.9432671027885817e-09
mutation O 0 3.0681355234207786e-09
on O 0 4.699608757707807e-12
splicing O 0 5.6965602374114965e-11
of O 0 1.1418067012713973e-12
COL17A1 O 0 1.959275408580652e-08
transcripts O 0 1.75678815939051e-09
were O 0 3.983581520206059e-11
determined O 0 4.2205055422739335e-11
using O 0 1.4941395343193165e-11
reverse O 0 1.5421670607196347e-09
transcriptase O 0 4.4794956632898675e-10
polymerase O 0 4.489109362015853e-10
chain O 0 6.540503694196786e-10
reaction O 0 1.5299541147872908e-11
of O 0 1.5549055641141118e-13
total O 0 1.6192016260782593e-12
RNA O 0 7.889304487473936e-11
from O 0 5.69927438576201e-12
keratinocytes O 0 3.0261333439085547e-09
incubated O 0 2.085390082839922e-09
for O 0 3.3664126174171027e-12
2 O 0 1.5056721147654883e-10
. O 0 2.8318236644508943e-10

5 O 0 1.0345492462704442e-08
h O 0 4.7249011458916357e-07
in O 0 2.195595441567555e-11
the O 0 3.768945225357534e-12
presence O 0 2.1434802544018083e-10
or O 0 1.2390000136974777e-10
absence O 0 8.76771225066797e-11
of O 0 1.6020352362408619e-12
10 O 0 1.3109974911218458e-11
microg O 0 1.6422365689550134e-08
cycloheximide O 0 7.029226622989881e-08
per O 0 8.77155148515385e-09
ml O 0 8.93089293185767e-07
. O 0 8.485107727551622e-09

Using O 0 4.4797712206445794e-09
this O 0 1.3152987032860608e-10
approach O 0 2.452914760198155e-09
, O 0 1.2899094986584814e-11
an O 0 5.6484331101280816e-12
abnormally O 0 6.1114789673411e-08
spliced O 0 2.427703407192894e-07
transcript O 0 1.2196548595966306e-05
was O 0 6.51047642463709e-08
identified O 0 2.570019974612592e-09
that O 0 9.725458285925193e-13
contains O 0 2.4764616897952896e-13
an O 0 2.8111688595445355e-14
extra O 0 5.113486023500258e-12
264 O 0 9.676428928961922e-12
bases O 0 1.786825722105423e-11
upstream O 0 9.645619372666836e-12
from O 0 2.313014146534953e-13
exon O 0 4.89688289917467e-10
32 O 0 3.527696190719354e-11
, O 0 5.410008378781139e-13
resulting O 0 5.6896539563089377e-11
in O 0 2.522251504877282e-11
a O 0 2.081563144074039e-09
premature O 0 3.340595355894038e-07
termination O 0 1.6870659536039057e-08
codon O 0 6.513529715590494e-09
27 O 0 1.2916531733075942e-10
bp O 0 8.390587780127134e-09
downstream O 0 2.5820809379517584e-10
from O 0 1.1197248857286457e-11
the O 0 4.7983023804265557e-11
cryptic O 0 1.4475897103238822e-07
splice O 0 2.014891435919708e-07
site O 0 8.780612148484579e-08
. O 0 4.666352637627824e-09

Three O 0 9.066312700589663e-10
other O 0 1.1110005276870893e-11
splice O 0 4.197853620269143e-09
variants O 0 4.180929380481757e-09
, O 0 7.208351537196789e-12
including O 0 1.3399147243131626e-12
one O 0 1.0991633818402402e-11
derived O 0 1.4243180419815094e-11
from O 0 7.597575455049743e-13
the O 0 3.074291851905969e-13
skipping O 0 1.998422434479341e-11
of O 0 4.4166569273390577e-13
exon O 0 2.0389090416017552e-09
32 O 0 1.2988224384891112e-10
, O 0 2.8803736739496655e-12
were O 0 6.838454108537562e-11
also O 0 5.681339287910703e-10
identified O 0 5.395398972041221e-08
. O 0 1.507696190117258e-09

These O 0 2.04878736198566e-09
results O 0 2.290431622142819e-09
indicate O 0 6.694829135511782e-10
the O 0 2.625498126199166e-12
usefulness O 0 3.69155622736983e-10
of O 0 2.434156608915883e-12
cycloheximide O 0 8.984311961057756e-08
treatment O 0 6.948838171538796e-10
in O 0 4.9579281652389895e-12
evaluating O 0 7.626504983093696e-11
the O 0 2.1241541511840545e-12
abnormal O 0 8.27175342110742e-11
processing O 0 5.3986207865230895e-12
of O 0 1.203168559791093e-13
mRNA O 0 2.1374613884406202e-11
due O 0 7.710720950626637e-12
to O 0 1.973934037058367e-12
splice O 0 1.2678754046646645e-08
- O 0 1.9217576152641414e-07
site O 0 3.0222988556261043e-08
mutations O 0 2.6460961066732125e-07
, O 0 1.5955499074737922e-11
because O 0 9.871935213734417e-11
( O 0 3.189755100677094e-12
i O 0 4.951606769054706e-08
) O 0 4.433207544552592e-13
aberrant O 0 8.864399492214403e-11
splicing O 0 9.098147235597764e-11
often O 0 9.748199469861163e-11
generates O 0 8.274309709621619e-11
a O 0 9.197987510534134e-11
premature O 0 1.2695644535654083e-08
termination O 0 2.1099921809764055e-09
codon O 0 5.792388235725809e-10
, O 0 2.8553702371286738e-12
( O 0 7.011640617074488e-13
ii O 0 2.027589829367571e-08
) O 0 1.6782431564235645e-12
transcripts O 0 2.315569264110806e-10
with O 0 7.783542560479972e-11
premature O 0 1.272648386674291e-08
termination O 0 5.253458223997143e-10
codons O 0 7.478866137500262e-11
can O 0 8.470577711472416e-11
occur O 0 1.7771023541612863e-10
at O 0 7.655492212377268e-11
low O 0 1.5418582677284576e-07
or O 0 1.8452579908512234e-08
undetectable O 0 1.6508123508174322e-06
levels O 0 3.5248615137817296e-09
due O 0 1.4728362626725833e-11
to O 0 7.938584685451833e-12
nonsense O 0 4.0247833510420605e-08
- O 0 4.315563906232001e-09
mediated O 0 9.028590097770461e-10
mRNA O 0 1.0612697526335424e-10
decay O 0 1.5091432548075545e-09
, O 0 3.1591344666105636e-13
and O 0 6.061268023951905e-13
( O 0 1.5398183487828898e-13
iii O 0 3.8286079862004385e-10
) O 0 2.1889324933795778e-13
the O 0 4.234695059890381e-12
levels O 0 1.443377639631649e-10
of O 0 2.904213734734526e-14
these O 0 3.4361288770920484e-13
transcripts O 0 3.747978663537488e-11
can O 0 1.1395626109411694e-10
be O 0 1.1546497265257916e-11
increased O 0 1.0169283817806907e-11
by O 0 1.1057576729256446e-11
cycloheximide O 0 5.91853677178733e-07
. O 0 2.4309265711508488e-09

A O 0 9.749550855531197e-08
deletion O 0 1.3180696214476484e-06
mutation O 0 3.1473418857785873e-06
in O 0 2.4169535817186727e-10
COL17A1 O 0 2.0540765035548247e-06
in O 0 1.2909487367984696e-10
five O 0 1.5812087750255444e-10
Austrian O 0 8.112165960483253e-05
families O 0 3.1663258681646766e-09
with O 0 2.238897955919583e-09
generalized O 0 3.120756446151063e-05
atrophic B-Disease 1 0.9957818984985352
benign I-Disease 1 0.9919162392616272
epidermolysis I-Disease 1 0.9885991811752319
bullosa I-Disease 1 0.6197261214256287
represents O 0 2.945331232240278e-07
propagation O 0 6.496410520639984e-08
of O 0 1.8955722408398046e-11
an O 0 2.7060683555069076e-11
ancestral O 0 6.845406232969253e-07
allele O 0 3.843857484753244e-06
. O 0 4.931904662441866e-09

Patients O 0 7.201080734375864e-06
with O 0 1.3198989456952859e-08
generalized O 0 2.6385305318399332e-05
atrophic B-Disease 1 0.9981768131256104
benign I-Disease 1 0.9967339038848877
epidermolysis I-Disease 1 0.9975430965423584
bullosa I-Disease 1 0.9844719767570496
, O 0 2.7821951409379153e-09
a O 0 1.3783921226639961e-10
usually O 0 8.932940498418418e-10
nonlethal O 0 4.318890578502987e-09
form O 0 7.300816617927808e-10
of O 0 6.080591585799766e-10
junctional B-Disease 0 0.010613192804157734
epidermolysis I-Disease 0 0.30682000517845154
bullosa I-Disease 0 0.1834632009267807
, O 0 5.454829365980629e-10
have O 0 5.5680821064996167e-11
generalized O 0 3.2655149695415275e-09
blistering B-Disease 0 3.8091968690423528e-06
, O 0 5.637054378837547e-09
nail B-Disease 1 0.9999806880950928
dystrophy I-Disease 1 0.9998397827148438
, O 0 3.2859663434692266e-08
patchy B-Disease 0 0.038282014429569244
alopecia I-Disease 1 0.9990315437316895
, O 0 1.3344671145887332e-08
and O 0 2.3510234825607768e-07
dental B-Disease 1 0.9802517294883728
abnormalities I-Disease 1 0.9687064290046692
. O 0 1.8405553703360056e-07

Skin B-Disease 1 0.7580602169036865
fragility I-Disease 0 0.00034011402749456465
in O 0 1.2862445830652547e-10
most O 0 1.985993314246315e-11
cases O 0 7.450078748361122e-11
is O 0 3.383892471786609e-11
due O 0 8.876970686300112e-11
to O 0 1.8207994140206907e-11
mutations O 0 1.1528910270897086e-08
in O 0 4.397502327557756e-12
the O 0 1.9378086375115844e-12
gene O 0 1.0376449005589095e-10
encoding O 0 6.117467643562691e-10
type O 0 5.8127084230363835e-06
XVII O 0 6.1126147556933574e-06
collagen O 0 1.3588698948296951e-06
( O 0 7.637222521061915e-10
COL17A1 O 0 8.297580279759131e-06
) O 0 1.5957943300115573e-10
. O 0 6.157362952841083e-10

Recently O 0 7.529100116698828e-07
, O 0 1.9729537448220924e-10
we O 0 4.759402871812313e-10
reported O 0 5.247529633045644e-10
five O 0 1.8484148239794607e-11
Austrian O 0 1.0492874025658239e-05
families O 0 3.337473630793397e-10
with O 0 4.503490913521091e-10
generalized O 0 3.6674289276561467e-06
atrophic B-Disease 1 0.9204772114753723
benign I-Disease 0 0.4902173578739166
epidermolysis I-Disease 1 0.7671730518341064
bullosa I-Disease 0 0.19668583571910858
who O 0 3.8590155071460686e-08
share O 0 9.981641069245484e-10
the O 0 4.081317575566068e-11
same O 0 6.388761741860094e-10
COL17A1 O 0 3.393586302991025e-05
mutation O 0 2.0905458768538665e-06
. O 0 3.745688648137957e-09

Affected O 0 7.09122446096444e-07
individuals O 0 9.324876426575202e-10
in O 0 1.9560948347208118e-11
three O 0 1.2498320954568154e-11
families O 0 2.903453692748581e-11
are O 0 1.982529158200963e-12
homozygous O 0 6.927386997368501e-10
for O 0 1.4807534538807676e-12
4003delTC O 0 5.297513094859596e-09
, O 0 6.9713684694786e-13
whereas O 0 2.8152563613659254e-11
those O 0 2.160841817977488e-12
in O 0 2.939728538722819e-12
two O 0 4.240142525285817e-12
others O 0 5.6880267856884714e-11
are O 0 2.200446248823429e-11
compound O 0 7.202783258719592e-09
heterozygotes O 0 4.940059739055869e-07
. O 0 2.155543077364541e-09

To O 0 1.033365393254826e-09
determine O 0 1.697378237963676e-08
if O 0 2.415769251307154e-10
the O 0 1.5725242288877617e-12
occurrence O 0 3.151119143396386e-09
of O 0 2.2568331752015336e-12
4003delTC O 0 2.651632868833076e-08
in O 0 1.7535089699705075e-11
these O 0 3.999170786195272e-12
unrelated O 0 4.1054759591929724e-10
families O 0 1.2704006249752986e-11
signifies O 0 1.551406364486141e-10
propagation O 0 1.1337263766675321e-10
of O 0 1.5680875651777337e-13
an O 0 1.736274291659276e-13
ancestral O 0 3.3528264609117286e-09
allele O 0 5.070110553617724e-09
or O 0 3.320955663244085e-11
a O 0 7.416349478983619e-11
mutational O 0 1.5539970945610548e-06
hot O 0 4.921946015201684e-07
spot O 0 5.442540214062319e-07
, O 0 1.5648446080596123e-11
haplotypes O 0 3.3922840092515116e-09
were O 0 4.559350397226325e-10
determined O 0 1.2973456975373665e-08
for O 0 3.0794225676367137e-12
polymorphisms O 0 8.397044126695619e-08
both O 0 4.642272677379822e-11
within O 0 3.7835248822837286e-11
and O 0 6.767907900773196e-10
flanking O 0 1.4522798664984293e-05
COL17A1 O 0 0.0008075202349573374
. O 0 2.4279112054159668e-08

Five O 0 1.4838636097636027e-08
intragenic O 0 1.2957267472302192e-06
polymorphisms O 0 3.308390887468704e-06
were O 0 1.7547086006430845e-09
chosen O 0 3.086575994792895e-10
based O 0 3.8761757692462595e-11
on O 0 3.439045159758791e-10
their O 0 4.709412304571003e-10
informativeness O 0 1.7238868394997553e-06
. O 0 3.146098714879031e-09

One O 0 1.419053430318229e-09
of O 0 4.080070049178319e-12
these O 0 8.768477263720875e-12
, O 0 2.947701544658843e-12
not O 0 3.1132759564789225e-11
previously O 0 1.135326055390351e-09
reported O 0 1.740609079092792e-08
, O 0 5.995890416110594e-12
was O 0 1.6688571358169924e-10
2988 O 0 1.9238612924965537e-09
A O 0 8.351848657106586e-10
or O 0 6.7661298785992585e-09
C O 0 7.413981428783245e-09
that O 0 3.665802036922905e-12
introduces O 0 6.967464365875697e-12
a O 0 4.1546900468592e-12
new O 0 7.106561975174508e-13
restriction O 0 5.837133727759625e-12
site O 0 1.1438388430873303e-11
for O 0 3.2773031250626916e-12
Eco0109 O 0 1.669753402211427e-08
I O 0 1.0678229500626912e-06
. O 0 9.167743786342442e-10

All O 0 5.911591771656788e-10
the O 0 5.598048066768335e-11
4003delTC O 0 1.602059995775562e-08
alleles O 0 3.009756666116914e-09
showed O 0 4.994544333669637e-09
the O 0 3.1001728961754793e-12
same O 0 2.971513313188012e-11
haplotype O 0 3.979780505147801e-09
for O 0 2.085561974854433e-12
these O 0 4.644945452575433e-12
five O 0 2.3941720134201816e-11
polymorphic O 0 2.917669839064274e-08
markers O 0 1.5527068626397522e-06
. O 0 1.3076730809302717e-08

Fourteen O 0 1.8203775198344374e-07
microsatellite O 0 7.3521887316019274e-06
polymorphisms O 0 3.9516191463917494e-05
were O 0 1.0530474270353807e-09
selected O 0 2.226477856248632e-11
based O 0 9.711226614528279e-12
on O 0 5.912141609609733e-11
their O 0 1.1894547846669212e-10
high O 0 2.2900124019287205e-09
heterozygosity O 0 1.7995760970279662e-07
and O 0 7.295704318455165e-11
their O 0 3.5829332122733204e-12
location O 0 1.403510363484628e-10
within O 0 8.389791465723828e-12
10q23 O 0 7.73707409251756e-09
- O 0 4.792264007846825e-08
q25 O 0 2.6193260893592196e-08
near O 0 3.7641896710738365e-08
COL17A1 O 0 1.083995903172763e-05
. O 0 1.12906191063189e-08

Three O 0 4.11792377974507e-09
families O 0 1.1685981071707374e-09
shared O 0 1.0007452644344994e-09
microsatellite O 0 1.5898131096037105e-06
polymorphisms O 0 1.9258566680946387e-05
covering O 0 8.749415769671032e-08
at O 0 6.851265665908102e-10
most O 0 1.2477313453274075e-11
19 O 0 3.065804554669427e-11
cM O 0 3.2023926621604915e-08
, O 0 4.252518042563436e-12
whereas O 0 8.373809284867306e-11
the O 0 3.973236670229419e-12
others O 0 2.206439198015886e-11
shared O 0 3.8776249572380905e-11
smaller O 0 8.713629817691526e-11
regions O 0 1.0910116560181038e-10
consistent O 0 4.7289825388929785e-09
with O 0 2.6588390777265714e-12
cross O 0 5.420396909094904e-10
- O 0 6.391312812326078e-09
over O 0 1.0860593674388852e-11
events O 0 1.838218986749407e-11
during O 0 7.688486132473304e-12
passage O 0 1.5712499660744395e-12
of O 0 6.302093856535088e-14
this O 0 8.643403917943382e-13
mutation O 0 9.479488721764184e-11
through O 0 3.467421120194325e-13
several O 0 3.539313373629449e-12
generations O 0 3.4017568761868233e-09
. O 0 8.401841999905457e-10

These O 0 1.2690553052863152e-09
results O 0 4.296992983654491e-09
indicate O 0 4.157946431604387e-09
that O 0 6.306936917166439e-11
4003delTC O 0 6.313493372545054e-08
occurs O 0 4.1760420121939035e-10
on O 0 1.0792099852663384e-11
a O 0 4.910105308453261e-11
single O 0 1.2929749493295617e-09
ancestral O 0 1.510577973817817e-08
allele O 0 3.8164213123081936e-08
. O 0 6.711677047466225e-11
. O 0 2.3558457962202795e-10

The O 0 1.6307563299733374e-08
haptoglobin O 0 1.4841805750620551e-05
- O 0 3.132568053842988e-07
gene O 0 3.4655982972253696e-08
deletion O 0 1.197599317492859e-07
responsible O 0 3.10111971657534e-08
for O 0 3.442641449691308e-10
anhaptoglobinemia B-Disease 0 1.3699059309146833e-05
. O 0 1.297382734577468e-08

We O 0 6.034009061295365e-07
have O 0 3.921030999887165e-10
found O 0 1.2313426320242904e-11
an O 0 6.214707025907484e-13
allelic O 0 8.144498409023981e-09
deletion O 0 3.4921129099529935e-08
of O 0 2.5250385116137863e-11
the O 0 1.945012761961351e-10
haptoglobin O 0 1.3970451391287497e-06
( O 0 6.945253400170159e-12
Hp O 0 3.851692575995713e-11
) O 0 1.8576306671288373e-13
gene O 0 1.582348488349261e-11
from O 0 5.804478534106317e-13
an O 0 1.0474171443369817e-12
individual O 0 7.773127974619598e-11
with O 0 2.49013032416201e-10
anhaptoglobinemia B-Disease 0 1.0490893146197777e-05
. O 0 6.348170433767564e-09

The O 0 3.4053011521706367e-09
Hp O 0 9.54417522791573e-09
gene O 0 1.3482517324803212e-08
cluster O 0 1.7548265063282997e-08
consists O 0 7.323322503971497e-11
of O 0 9.42273602894117e-12
coding O 0 5.636670508124553e-08
regions O 0 4.2161224511616524e-10
of O 0 3.585052176999226e-12
the O 0 3.112456820053566e-11
alpha O 0 2.6082458415288556e-10
chain O 0 2.8297476362126872e-08
and O 0 5.808560576969768e-11
beta O 0 3.212390076168248e-11
chain O 0 5.840191108497095e-10
of O 0 8.982953812221306e-13
the O 0 4.80546245157365e-12
haptoglobin O 0 2.489259109950126e-08
gene O 0 5.623649323993618e-10
( O 0 8.974100217280789e-13
Hp O 0 1.2666141573081102e-11
) O 0 2.415047057734848e-13
and O 0 2.8870840180356128e-12
of O 0 7.276200041789194e-13
the O 0 2.1218714285620166e-11
alpha O 0 1.6405320157897307e-10
chain O 0 8.178667521008265e-09
and O 0 1.7103490498882046e-11
beta O 0 5.868827125665721e-12
chain O 0 2.572573543080381e-10
of O 0 5.939464957187279e-13
the O 0 2.122333038478974e-11
haptoglobin O 0 4.2399165067763533e-07
- O 0 6.558386189681187e-08
related O 0 2.828095091444993e-09
gene O 0 2.2725856752003892e-09
( O 0 6.395961017757745e-12
Hpr O 0 9.131780664972666e-09
) O 0 1.7651184333611347e-12
, O 0 6.232049381757476e-13
in O 0 3.0150094660480464e-12
tandem O 0 4.2125336108256306e-08
from O 0 1.904799755425568e-11
the O 0 2.747440816519564e-11
5 O 0 1.7208767744136821e-10
side O 0 1.1985498815647588e-07
. O 0 5.630328203665158e-09

Southern O 0 3.86250604833549e-08
blot O 0 1.5349802424680092e-06
and O 0 1.0640911068948711e-10
PCR O 0 3.5598208825149413e-08
analyses O 0 3.6020438187733816e-08
have O 0 1.9024686340185504e-11
indicated O 0 1.8016688141386794e-10
that O 0 4.768118408784994e-13
the O 0 1.2976913380674526e-13
individual O 0 4.437093054088237e-12
with O 0 4.6182836201114075e-12
anhaptoglobinemia B-Disease 0 3.320257846439745e-08
was O 0 1.383021891454561e-10
homozygous O 0 1.8222734432526977e-10
for O 0 1.523005625694157e-13
the O 0 2.4833534209046937e-13
gene O 0 3.993097866250572e-11
deletion O 0 1.4852672425291757e-09
and O 0 2.299591073118279e-11
that O 0 2.3117276322370817e-12
the O 0 5.91669291685748e-13
gene O 0 7.107599231392925e-11
deletion O 0 1.7934206342218317e-09
was O 0 1.759067336237763e-10
included O 0 2.7604186297880418e-12
at O 0 3.50944169558165e-11
least O 0 3.724936591814609e-12
from O 0 7.336540771597788e-13
the O 0 3.03020065636761e-12
promoter O 0 2.4865496328629888e-08
region O 0 2.707581207850307e-11
of O 0 2.9300650447594556e-13
Hp O 0 6.89925755414933e-11
to O 0 1.4326936338682206e-11
Hpr O 0 1.849352315730357e-08
alpha O 0 8.361265152467823e-11
but O 0 4.4489249090284844e-11
not O 0 8.116169195049316e-12
to O 0 1.2791294065617187e-11
Hpr O 0 8.355775804602672e-08
beta O 0 3.4489180955610266e-10
( O 0 2.14247786178845e-11
Hpdel O 0 2.4681217070110506e-08
) O 0 3.704150874916934e-11
. O 0 2.8228661075324624e-10

In O 0 9.34084365411536e-10
addition O 0 3.391130709573531e-10
, O 0 3.0164086506356824e-11
we O 0 3.514640314894457e-11
found O 0 5.4037100315207365e-12
seven O 0 3.486999371974525e-13
individuals O 0 2.5632344554174513e-13
with O 0 9.69946779144637e-13
hypohaptoglobinemia B-Disease 0 7.586227468436846e-08
in O 0 7.128911610337907e-12
three O 0 4.043503379347335e-12
families O 0 7.347509753397041e-12
, O 0 3.4262859476691387e-13
and O 0 2.182055534524774e-12
the O 0 9.102581969427925e-13
genotypes O 0 2.292935147307773e-10
of O 0 1.9534494735771318e-13
six O 0 7.592012955803806e-13
of O 0 9.675810500042736e-14
the O 0 2.2390013020706645e-12
seven O 0 4.041853223640812e-12
individuals O 0 3.634424141849002e-12
were O 0 3.1530882071972854e-11
found O 0 3.674582166324214e-11
to O 0 7.982145326657086e-12
be O 0 1.8392660727784005e-09
Hp2 O 0 4.1782215021157754e-07
/ O 0 7.698567827674196e-08
Hpdel O 0 2.8197112555972126e-07
. O 0 1.3854356550879743e-09

The O 0 9.285426649796591e-09
phenotypes O 0 9.761326964508044e-07
and O 0 2.3233555357382585e-10
genotypes O 0 1.799957232151428e-07
in O 0 3.766819842154767e-11
one O 0 1.3389854329470818e-11
of O 0 3.274995834419425e-13
these O 0 3.146165836534487e-12
three O 0 1.8700527237847098e-12
families O 0 8.786709207453391e-12
showed O 0 4.78107775592207e-09
the O 0 7.774917862302111e-12
father O 0 2.556306499812422e-09
to O 0 5.656756313365818e-12
be O 0 9.024419406200579e-11
hypohaptoglobinemic B-Disease 0 5.804360370120776e-08
( O 0 4.677769890187866e-12
Hp2 O 0 2.5232211875447774e-09
) O 0 2.504535478748543e-13
and O 0 6.393582711872181e-12
Hp2 O 0 1.0583396381491639e-08
/ O 0 6.253873530148724e-10
Hpdel O 0 5.092227084446677e-09
, O 0 8.651981041329915e-13
the O 0 7.549458562634837e-13
mother O 0 1.0636127534269235e-09
to O 0 1.3908587823130425e-12
be O 0 2.987339889348739e-11
Hp2 O 0 1.8247579003372039e-09
- O 0 4.775333461992659e-10
1 O 0 2.8394196716075015e-12
and O 0 2.2588497045061828e-11
Hp1 O 0 1.344694844362948e-08
/ O 0 4.612628057287793e-10
Hp2 O 0 5.6753854948965454e-09
, O 0 5.241949452630679e-13
one O 0 2.4336541354190444e-13
of O 0 1.9913043246668274e-14
the O 0 2.972060260657966e-13
two O 0 1.8166220481022344e-12
children O 0 1.0211773267265745e-11
to O 0 1.8912664403319956e-12
be O 0 1.322985054841297e-10
hypohaptoglobinemic B-Disease 0 2.5034339046214882e-08
( O 0 1.3455156043160055e-12
Hp2 O 0 1.6565436800064504e-09
) O 0 3.5761378667370503e-13
and O 0 5.675571991548001e-12
Hp2 O 0 7.772039012365894e-09
/ O 0 7.297113469029171e-10
Hpdel O 0 7.603882856699329e-09
, O 0 4.848676798605012e-13
and O 0 3.350901912717308e-13
the O 0 1.3053422817481397e-13
other O 0 6.770840940868716e-13
child O 0 5.149145554383949e-10
to O 0 1.9945640191559866e-12
be O 0 2.915228822231164e-11
Hp1 O 0 4.385690033359424e-09
and O 0 1.5351690405007723e-11
Hp1 O 0 1.137405192253027e-08
/ O 0 8.092188030772718e-10
Hpdel O 0 9.590837457551515e-09
, O 0 6.134740610473643e-13
showing O 0 1.652654679773491e-10
an O 0 5.491797880168015e-13
anomalous O 0 2.227563244971975e-09
inheritance O 0 8.078313129544767e-09
of O 0 8.077067660539061e-12
Hp O 0 2.2712942637781453e-09
phenotypes O 0 1.0116642812363352e-07
in O 0 7.275235275328029e-11
the O 0 1.2481841948908112e-10
child O 0 2.717779068461823e-07
with O 0 5.810657510707529e-10
Hp1 O 0 5.37478763362742e-06
. O 0 5.331632912941586e-09

The O 0 3.3898328588577442e-09
Hp2 O 0 8.51153004077787e-07
/ O 0 4.308057199864379e-08
Hpdel O 0 1.7878961955375416e-07
individuals O 0 5.020386328880022e-10
had O 0 6.664226948061014e-10
an O 0 4.907471998216728e-12
extremely O 0 4.6207603077164094e-08
low O 0 2.10749206530636e-07
level O 0 9.165435632674246e-10
of O 0 7.578500544128119e-13
Hp O 0 1.576913877254782e-10
( O 0 2.2832443401232805e-12
mean O 0 2.948424282500639e-10
+ O 0 2.0753055524069808e-11
/ O 0 2.1936587268900354e-10
- O 0 1.4564395245386663e-09
SD O 0 6.160869929772161e-07
= O 0 6.061048996031104e-09
0 O 0 1.2137470715989362e-11
. O 0 7.215266795493336e-13
049 O 0 1.7891634840339066e-09
+ O 0 1.585427761296998e-10
/ O 0 7.217521580393793e-10
- O 0 1.2446188524251056e-09
0 O 0 2.4890702346458404e-11
. O 0 8.432654531251305e-13
043 O 0 7.131775170421406e-10
mg O 0 3.003735038475952e-09
/ O 0 5.277843717621522e-10
ml O 0 2.625286654733827e-09
; O 0 1.9961129103795994e-12
n O 0 1.164750629278899e-09
= O 0 2.2248585196393833e-09
6 O 0 5.039069422146936e-12
) O 0 6.67976416367233e-14
, O 0 6.705051146466481e-14
compared O 0 6.902675913494916e-12
with O 0 6.073928794821104e-13
the O 0 1.3775636013846349e-11
level O 0 7.664701651144412e-10
( O 0 3.00709232362896e-14
1 O 0 1.5487432300162474e-13
. O 0 5.207605993564485e-14
64 O 0 1.0349235574427795e-13
+ O 0 9.050058337282951e-13
/ O 0 9.895455982400492e-12
- O 0 4.3794499277050036e-11
1 O 0 2.009954485834853e-12
. O 0 1.1099282300544577e-12
07 O 0 2.2484859460436546e-11
mg O 0 1.3815987243148697e-09
/ O 0 1.0303339431638747e-10
ml O 0 3.3501912355404784e-10
) O 0 8.077182857019888e-14
obtained O 0 3.604758418845888e-12
from O 0 9.355112171038904e-13
52 O 0 1.9620098948291975e-11
healthy O 0 2.854240732652613e-10
volunteers O 0 4.7934361341317455e-11
having O 0 7.380848709992449e-10
phenotype O 0 2.6387521501192168e-08
Hp2 O 0 5.879065234637437e-09
, O 0 1.1155355068501183e-12
whereas O 0 1.6738548047623425e-11
the O 0 2.2277000123055446e-12
serum O 0 1.9017813990274135e-09
Hp O 0 2.9968649090106325e-11
level O 0 5.2805294858959684e-11
of O 0 1.8140241912767419e-13
an O 0 3.957601119649462e-13
individual O 0 1.146072906715867e-11
with O 0 2.7818263317880287e-11
Hp1 O 0 5.635696993522288e-07
/ O 0 1.934348681231768e-08
Hpdel O 0 1.3495025541487848e-07
was O 0 4.840499556735267e-09
0 O 0 8.582961008585244e-10
. O 0 5.285560322754179e-10

50 O 0 2.0805241973675948e-08
mg O 0 2.1301841002241417e-07
/ O 0 2.5009329718272966e-08
ml O 0 1.745758595461666e-07
, O 0 1.243134761796938e-11
which O 0 5.680629144161342e-12
was O 0 7.702875143289489e-11
approximately O 0 1.4405406121437148e-12
half O 0 5.292657371397391e-12
the O 0 1.4375323847959365e-12
level O 0 7.226802489768147e-11
of O 0 1.6626209144252752e-13
Hp O 0 7.276651503573817e-11
in O 0 1.808871108455179e-11
control O 0 5.3193525140216025e-09
sera O 0 1.2436133012272421e-08
from O 0 1.648802296951024e-12
the O 0 4.468891836445499e-12
Hp1 O 0 1.972109053838267e-08
phenotype O 0 2.583688374357962e-09
( O 0 2.3534486534061705e-13
1 O 0 5.38863875396145e-13
. O 0 5.636591454000195e-13
26 O 0 1.2065173079361946e-12
+ O 0 2.769753610493142e-12
/ O 0 1.582903946806269e-11
- O 0 1.7610882196983368e-10
0 O 0 1.4861271935284748e-11
. O 0 1.6532386354004003e-13
33 O 0 3.368950084181588e-12
mg O 0 1.2051485365205394e-09
/ O 0 4.2754896845131896e-10
ml O 0 9.047039561949077e-09
; O 0 6.01963314264542e-12
n O 0 9.524426580753698e-09
= O 0 6.034829524992347e-09
9 O 0 1.1105767347419082e-11
) O 0 1.4573758866376352e-13
, O 0 9.95488888262501e-14
showing O 0 6.939698815600082e-10
a O 0 1.4272802384418526e-10
gene O 0 2.8940146279410328e-08
- O 0 4.034832272736821e-06
dosage O 0 7.22374261385994e-06
effect O 0 4.846645751399592e-08
. O 0 2.640069718395921e-09

The O 0 1.191753473683832e-09
other O 0 5.889508325473969e-11
allele O 0 1.5146373044672146e-08
( O 0 6.310616092186638e-12
Hp2 O 0 3.188372899032288e-09
) O 0 2.291690058206508e-13
of O 0 1.303113297606781e-13
individuals O 0 3.762825554615157e-12
with O 0 2.536420552756713e-11
Hp2 O 0 4.895225629297784e-07
/ O 0 8.629041481356126e-09
Hpdel O 0 6.029285515296579e-08
was O 0 1.6748049613823923e-09
found O 0 7.350260677885245e-11
to O 0 2.428463159731553e-11
have O 0 3.9784200933645764e-10
, O 0 1.007675496864091e-12
in O 0 1.5424236323932639e-12
all O 0 1.190556550914601e-12
exons O 0 1.6942293401545072e-10
, O 0 1.7495492901642429e-12
no O 0 9.968394165671413e-11
mutation O 0 9.905872788706915e-10
, O 0 1.6669871320991458e-13
by O 0 7.177506744331097e-13
DNA O 0 7.385101419288276e-10
sequencing O 0 6.819662612400634e-10
. O 0 4.143156373537238e-10

On O 0 2.842057034158074e-09
the O 0 3.87007179775134e-12
basis O 0 3.3886636986030227e-12
of O 0 2.403237656621593e-13
the O 0 1.2999538511609954e-12
present O 0 6.887236440877853e-12
study O 0 5.2166383192331356e-12
, O 0 7.352675597278174e-14
the O 0 8.444109398254157e-14
mechanism O 0 6.007784981304498e-12
of O 0 1.9155529484664313e-13
anhaptoglobinemia B-Disease 0 8.711179333431573e-09
and O 0 7.172228089213917e-12
the O 0 2.397898774073731e-13
mechanism O 0 8.065337460394506e-12
of O 0 2.8338022575215283e-13
anomalous O 0 7.740006968681712e-10
inheritance O 0 2.4082165150929313e-09
of O 0 1.9876112908323584e-11
Hp O 0 3.762659073203167e-09
phenotypes O 0 3.544604396665818e-07
were O 0 5.503742350754237e-09
well O 0 4.398339470412793e-09
explained O 0 2.259719877883981e-07
. O 0 1.27284671691541e-09

However O 0 6.838294552835578e-08
, O 0 2.4358530817392143e-11
the O 0 1.7608412557906794e-12
mechanism O 0 1.097199206490096e-10
of O 0 2.942938948091722e-11
hypohaptoglobinemia B-Disease 0 3.35312397510279e-05
remains O 0 2.9628031938955246e-07
unknown O 0 9.23456127566169e-07

ATM O 0 0.00024780139210633934
mutations O 0 0.00025490846019238234
and O 0 2.3886975952791545e-08
phenotypes O 0 9.927561768563464e-05
in O 0 4.57308971135717e-07
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.999996542930603
telangiectasia I-Disease 1 0.9999998807907104
families O 0 1.3705207493330818e-06
in O 0 2.1372423275600738e-10
the O 0 3.216368837932748e-11
British O 0 3.5833298994703e-08
Isles O 0 1.421749828978136e-08
: O 0 6.340911736651966e-12
expression O 0 5.6886097395125734e-12
of O 0 5.932725827533653e-14
mutant O 0 2.225857866078318e-11
ATM O 0 4.332768366310802e-09
and O 0 1.983419158080313e-11
the O 0 1.2925003081698527e-11
risk O 0 1.695977047688757e-08
of O 0 4.0381584187620945e-10
leukemia B-Disease 1 0.9130581021308899
, O 0 1.07837195173488e-06
lymphoma B-Disease 1 1.0
, O 0 3.5218910010570426e-09
and O 0 1.498066097838091e-07
breast B-Disease 1 0.9972391128540039
cancer I-Disease 0 0.06536643952131271
. O 0 1.274175360777008e-07

We O 0 4.137506337542618e-08
report O 0 1.198120769263511e-10
the O 0 2.32213055208208e-12
spectrum O 0 1.4927131752884293e-10
of O 0 1.656269305733149e-12
59 O 0 7.055987738535663e-11
ATM O 0 1.3145346429155325e-06
mutations O 0 2.768946387732285e-06
observed O 0 1.996979335672222e-06
in O 0 1.1388123510869264e-07
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999971389770508
telangiectasia I-Disease 1 1.0
( O 0 4.173472916590981e-06
A B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999980926513672
T I-Disease 1 0.9999998807907104
) O 0 1.899164159269162e-09
patients O 0 3.1942026801345946e-10
in O 0 3.547249299851174e-11
the O 0 9.503257902832019e-11
British O 0 3.7699564359172655e-07
Isles O 0 5.944625627307687e-07
. O 0 7.018988057438946e-09

Of O 0 1.8131423029643656e-09
51 O 0 2.254418651759238e-09
ATM O 0 2.061711029455182e-06
mutations O 0 5.399586370913312e-06
identified O 0 1.2270849936157902e-07
in O 0 6.479126957170678e-11
families O 0 2.2935464291662377e-11
native O 0 7.438616562993605e-12
to O 0 7.696527443146195e-12
the O 0 2.661900214140367e-11
British O 0 5.140260483926795e-08
Isles O 0 7.107281430052126e-09
, O 0 7.510125334120321e-12
11 O 0 4.297232274880214e-12
were O 0 7.897234949316712e-12
founder O 0 2.6649343842777284e-10
mutations O 0 3.9719623146083904e-09
, O 0 6.381152659225287e-13
and O 0 5.961608160257037e-13
2 O 0 9.451458712894656e-13
of O 0 1.8999718790456421e-13
these O 0 6.354447783935013e-12
11 O 0 4.868510542627158e-12
conferred O 0 7.706166954557503e-11
a O 0 4.560234828643317e-11
milder O 0 4.567745648387245e-08
clinical O 0 3.5628555661304517e-09
phenotype O 0 1.87614777047429e-08
with O 0 7.104762958509703e-12
respect O 0 4.959976873664118e-10
to O 0 2.8501211807308025e-11
both O 0 2.127441778299044e-09
cerebellar B-Disease 0 0.0077720447443425655
degeneration I-Disease 0 6.039220534148626e-05
and O 0 3.225747446933269e-09
cellular O 0 1.2655914360948373e-07
features O 0 4.427464261880232e-08
. O 0 1.572788299597505e-08

We O 0 1.0145066653421964e-07
report O 0 1.0101169900522677e-09
, O 0 2.1573456996520912e-12
in O 0 1.2124576516392427e-12
two O 0 5.242535225380429e-11
A B-Disease 1 0.9999792575836182
- I-Disease 1 0.9999920129776001
T I-Disease 1 0.9999997615814209
families O 0 4.2824105372929466e-10
, O 0 2.5904679876870285e-13
an O 0 2.906836284264497e-13
ATM O 0 4.810295806123577e-08
mutation O 0 4.746051995851985e-09
( O 0 4.434882094807996e-13
7271T O 0 2.242341312630458e-10
- O 0 8.180024657633567e-09
- O 0 2.42781847958895e-08
> O 0 2.828872025517626e-09
G O 0 4.331266723056615e-08
) O 0 2.302762201842473e-13
that O 0 1.0415148778142314e-11
may O 0 1.914059355456743e-09
be O 0 1.241113808947425e-11
associated O 0 1.6041275946454547e-11
with O 0 4.0416354616344685e-13
an O 0 1.4694290706093738e-12
increased O 0 5.068118813511546e-09
risk O 0 1.5688515375700263e-08
of O 0 1.1399516053334224e-10
breast B-Disease 1 0.8007202744483948
cancer I-Disease 0 2.8572492738021538e-05
in O 0 1.2495419976499278e-10
both O 0 1.7906648386301072e-10
homozygotes O 0 1.2169175533927046e-06
and O 0 1.9648981053332903e-10
heterozygotes O 0 1.7028909837790707e-08
( O 0 5.898453600550191e-12
relative O 0 4.905317041448143e-09
risk O 0 3.9127105999625655e-09
12 O 0 3.5662291262422707e-12
. O 0 7.971490763487854e-13
7 O 0 9.933296372943712e-12
; O 0 8.243052941614426e-12
P O 0 5.714825420000125e-06
= O 0 1.2853187847383651e-08
. O 0 2.137395078635751e-12
0025 O 0 1.950828387720094e-09
) O 0 3.5544928545655496e-13
, O 0 1.1857698254281318e-13
although O 0 1.1524511813604255e-12
there O 0 9.068443153521788e-13
is O 0 9.655812390971241e-13
a O 0 1.834380217169418e-11
less O 0 1.2514131064733647e-08
severe O 0 9.071550448425114e-05
A B-Disease 1 0.9999978542327881
- I-Disease 1 0.9999983310699463
T I-Disease 1 0.9999998807907104
phenotype O 0 4.443932630238123e-05
in O 0 7.56297038884135e-11
terms O 0 1.8388160438753687e-10
of O 0 5.094577646032328e-13
the O 0 6.579823925295658e-12
degree O 0 5.954507109606766e-09
of O 0 4.284649302022103e-10
cerebellar B-Disease 0 0.03997420519590378
degeneration I-Disease 0 0.002390320412814617
. O 0 1.4339073572955385e-07

This O 0 3.385961955260086e-09
mutation O 0 6.59144347991969e-08
( O 0 1.257037703095154e-11
7271T O 0 3.744417220730156e-09
- O 0 1.1217277773312162e-07
- O 0 6.574799158443057e-07
> O 0 3.1314566939499855e-08
G O 0 1.5431189126502431e-07
) O 0 1.856093539498796e-13
also O 0 1.4117399198439184e-13
allows O 0 2.7841802214406686e-13
expression O 0 9.073465069564524e-12
of O 0 1.1026752156761271e-13
full O 0 1.4549444114775323e-11
- O 0 1.6005137215557852e-09
length O 0 1.7165364962767882e-10
ATM O 0 1.3960913536337216e-09
protein O 0 1.089301912560181e-11
at O 0 4.2985276796358995e-12
a O 0 1.899557074136471e-11
level O 0 4.001626141558745e-09
comparable O 0 2.5191061681084648e-08
with O 0 6.158084459029212e-12
that O 0 1.3849435487323092e-10
in O 0 9.470958045598721e-11
unaffected O 0 3.339017951020651e-08
individuals O 0 4.879634474264094e-10
. O 0 6.500370242079612e-10

In O 0 1.2956510309081182e-09
addition O 0 1.2934035786837939e-10
, O 0 5.58618429291613e-12
we O 0 1.731992847753272e-11
have O 0 5.974451836032735e-12
studied O 0 1.1618749296005149e-09
18 O 0 1.7404015728583744e-10
A B-Disease 1 0.9992218017578125
- I-Disease 1 0.9999649524688721
T I-Disease 1 0.9999998807907104
patients O 0 2.801782983397061e-08
, O 0 9.205349156549136e-13
in O 0 5.06179083023528e-13
15 O 0 3.155834155197518e-13
families O 0 1.0638343504731917e-12
, O 0 1.4964688559507278e-12
who O 0 1.4912853174564589e-09
developed O 0 5.614758720184909e-07
leukemia B-Disease 1 0.7678864598274231
, O 0 1.3100576268243458e-07
lymphoma B-Disease 1 1.0
, O 0 3.6936337322046597e-10
preleukemic O 0 5.809782123833429e-06
T O 0 9.849111665971577e-05
- O 0 6.020098908265936e-07
cell O 0 1.690598537607002e-06
proliferation O 0 3.127547358872107e-07
, O 0 1.7023470133548102e-10
or O 0 8.619587788416538e-06
Hodgkin B-Disease 1 0.9999996423721313
lymphoma I-Disease 1 1.0
, O 0 1.585703679474193e-09
mostly O 0 1.572372787528309e-10
in O 0 8.870763013035798e-10
childhood O 0 9.071231033885852e-06
. O 0 1.5553931476119942e-08

A O 0 2.6576429945635027e-08
wide O 0 3.385006053235884e-09
variety O 0 3.6024527805267326e-10
of O 0 1.8887511346599162e-11
ATM O 0 1.0009491234086454e-05
mutation O 0 1.852333525675931e-06
types O 0 1.3170446955257376e-08
, O 0 3.3801880565398346e-12
including O 0 1.6499702645833558e-11
missense O 0 9.068549843505025e-06
mutations O 0 3.2873128930077655e-06
and O 0 6.388249929045742e-10
in O 0 1.2766973589428687e-10
- O 0 1.3420510924788687e-07
frame O 0 4.565536437439732e-05
deletions O 0 2.6386774152342696e-06
, O 0 4.4646791819147325e-10
were O 0 1.7653120631955233e-10
seen O 0 2.0390112709378627e-08
in O 0 1.713447786433342e-11
these O 0 6.338605335054481e-11
patients O 0 9.71212554823353e-10
. O 0 5.60510193814423e-10

We O 0 1.9075040214033834e-08
also O 0 1.1075053200915175e-11
show O 0 3.378681362464775e-11
that O 0 1.2766037142328268e-12
25 O 0 4.1104923284573935e-13
% O 0 4.075213067391073e-14
of O 0 1.4250829249301544e-13
all O 0 5.231171051889305e-10
A B-Disease 1 0.9999865293502808
- I-Disease 1 0.9999915361404419
T I-Disease 1 0.9999998807907104
patients O 0 4.06963245325187e-08
carried O 0 5.527623692103134e-09
in O 0 1.9116276270270127e-11
- O 0 5.962849325413799e-09
frame O 0 7.567807074337907e-07
deletions O 0 9.499085251718498e-08
or O 0 3.141151783125906e-09
missense O 0 1.0111065193996183e-06
mutations O 0 5.986280626757434e-08
, O 0 1.2694650018685305e-12
many O 0 1.111588577261402e-13
of O 0 2.440631518500075e-13
which O 0 3.4641145507663396e-10
were O 0 2.4110797802734396e-09
also O 0 3.7469871649875586e-10
associated O 0 2.9596025630240774e-10
with O 0 5.536267191214028e-12
expression O 0 2.529050024957513e-10
of O 0 8.008187212318885e-13
mutant O 0 7.900376464142767e-10
ATM O 0 1.0378383308307093e-07
protein O 0 6.203812130678443e-09
. O 0 1.3121546071914736e-09

The O 0 4.008378962083725e-09
DMPK O 0 2.0523455077636754e-06
gene O 0 1.5159183419655164e-07
of O 0 3.746695842465897e-09
severely O 0 0.09050571918487549
affected O 0 0.0013892686692997813
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
patients O 0 0.0006032187957316637
is O 0 4.4033590107517284e-09
hypermethylated O 0 3.6179361018184863e-07
proximal O 0 4.812167730960937e-08
to O 0 1.7112930517093616e-10
the O 0 3.146947633037023e-11
largely O 0 3.778154733513617e-10
expanded O 0 1.1274216005219273e-09
CTG O 0 5.968831260361185e-07
repeat O 0 3.0664818950754125e-07
. O 0 4.493017513595987e-09

Using O 0 3.4249205693726026e-09
methylation O 0 2.1389679716321552e-07
- O 0 2.96851624170813e-07
sensitive O 0 4.3374342340030125e-07
restriction O 0 7.47072959050854e-10
enzymes O 0 1.9473328505270615e-10
, O 0 8.719872697168785e-13
we O 0 8.122704765745059e-12
characterized O 0 2.6269320052563216e-11
the O 0 9.128383812728735e-13
methylation O 0 5.928778579189498e-10
pattern O 0 3.8305967287044496e-09
on O 0 3.759140221326618e-11
the O 0 3.2846936975916563e-12
5 O 0 3.5501853193342647e-12
side O 0 1.559485041102704e-10
of O 0 2.841374054443624e-13
the O 0 5.031328652316258e-12
CTG O 0 8.131165962765863e-09
repeat O 0 1.0541326700419518e-09
in O 0 9.073357299868579e-13
the O 0 7.330987488070317e-13
DMPK O 0 2.7463589180598547e-09
gene O 0 2.8395293061311833e-11
of O 0 5.042287659455524e-13
normal O 0 5.463552527062987e-11
individuals O 0 2.3416067262277407e-12
and O 0 5.22223323612403e-12
of O 0 7.42468326403456e-12
patients O 0 4.087943761277302e-09
affected O 0 2.280675426291623e-09
with O 0 5.001601266485523e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.692073148262807e-09
showing O 0 2.5753439381048793e-09
expansions O 0 1.3398426812472053e-09
of O 0 4.590050561859016e-12
the O 0 5.7099294042961546e-11
repetitive O 0 5.001177214580821e-07
sequence O 0 1.4721026175834595e-08
. O 0 2.495390116763474e-09

The O 0 9.68164548531547e-10
gene O 0 5.396178615058034e-09
segment O 0 4.7022963300946685e-09
analyzed O 0 1.0383130799596074e-08
corresponds O 0 2.7793893853100826e-09
to O 0 4.706947071692058e-12
the O 0 2.405467535229744e-12
genomic O 0 1.8262131806778825e-09
SacI O 0 4.119827963222633e-07
- O 0 1.0303865849436988e-07
HindIII O 0 2.7605191021962128e-08
fragment O 0 9.827063607303899e-09
carrying O 0 3.539600557100897e-10
exons O 0 3.634131440222177e-09
11 O 0 2.1636814562242535e-10
- O 0 2.345607796883087e-08
15 O 0 2.62369348469349e-10
. O 0 6.606011848653282e-10

There O 0 6.114741601948026e-09
is O 0 4.6992167102022364e-11
constitutive O 0 4.103761497287195e-10
methylation O 0 7.185092520956005e-10
in O 0 7.376816171800193e-12
intron O 0 7.233860088717847e-08
12 O 0 3.210184895685586e-11
at O 0 8.580857378814866e-12
restriction O 0 2.228431198250669e-12
sites O 0 2.1555892921326647e-12
of O 0 2.422345093608391e-13
SacII O 0 6.064960444973622e-08
and O 0 5.6376511098354953e-11
HhaI O 0 6.294397003614449e-09
, O 0 3.7994889352799266e-13
localized O 0 6.623482318168783e-11
1 O 0 1.3113901457806332e-11
, O 0 7.953660516660244e-13
159 O 0 1.0602008854165845e-11
- O 0 1.6451420226104574e-09
1 O 0 1.899654912540516e-11
, O 0 4.3044159816346683e-13
232 O 0 3.2057960886594516e-12
bp O 0 5.695944271799647e-10
upstream O 0 2.8347823220753465e-12
of O 0 1.3218935765880319e-13
the O 0 2.733180869129992e-12
CTG O 0 5.8858984353094e-09
repeat O 0 3.2757330181709676e-09
, O 0 8.107779855479058e-13
whereas O 0 6.086015372219755e-12
most O 0 7.344830039307526e-13
, O 0 6.533449454192153e-13
if O 0 2.9978824978016405e-11
not O 0 4.995765520016127e-12
all O 0 6.877935314385589e-14
, O 0 1.416100004999251e-14
of O 0 2.9798390385510527e-15
the O 0 3.2367097419156235e-14
other O 0 1.2407096359958077e-14
sites O 0 2.0518179169592976e-13
of O 0 9.896484944472289e-14
SacII O 0 2.2290378431932822e-09
, O 0 6.961191063685479e-13
HhaI O 0 5.048569895471644e-10
, O 0 2.3953937249542034e-13
and O 0 9.538877934062162e-13
HpaII O 0 5.313691708863644e-10
in O 0 1.7784027288997306e-12
this O 0 1.3406177210018022e-12
region O 0 9.03621275027966e-12
are O 0 3.2752969173627244e-12
unmethylated O 0 3.864397690733767e-09
, O 0 1.6612683451100452e-12
in O 0 1.5582613324682804e-12
normal O 0 4.799602382199453e-11
individuals O 0 1.0503659574057078e-12
and O 0 2.353836093052508e-12
most O 0 5.272291934629858e-13
of O 0 2.82525332339148e-13
the O 0 1.5658932484008403e-10
patients O 0 2.5339761400289262e-09
. O 0 1.44400347235063e-09

In O 0 8.941735685219498e-10
a O 0 4.49010030545427e-11
number O 0 5.294242474973565e-12
of O 0 3.476992782233679e-12
young O 0 2.808689281152965e-09
and O 0 3.288805006107509e-09
severely O 0 1.4173970157571603e-05
affected O 0 2.8574451693685887e-09
patients O 0 5.121895685356037e-10
, O 0 6.5054498246674974e-12
however O 0 5.15963010164211e-12
, O 0 6.753323215317325e-14
complete O 0 1.91675898785805e-13
methylation O 0 7.33956818932402e-12
of O 0 4.3584273424482e-14
these O 0 2.699518668498879e-13
restriction O 0 3.3578515402227227e-12
sites O 0 1.8927144573854804e-11
was O 0 4.676632969768946e-10
found O 0 4.6473137838010103e-11
in O 0 7.154465821862521e-12
the O 0 2.1509698536203992e-11
mutated O 0 1.1036590308322047e-07
allele O 0 1.229514481337901e-07
. O 0 2.662090992089361e-09

In O 0 1.784834724460893e-09
most O 0 1.1905003892420662e-11
of O 0 1.2066830824483676e-12
these O 0 2.932886225548437e-11
patients O 0 2.190765208132106e-10
, O 0 6.47996034001258e-13
the O 0 1.793684666941131e-12
onset O 0 2.903799867226553e-09
of O 0 1.6086377022106468e-11
the O 0 2.6211651515950507e-08
disease O 0 0.0001561067474540323
was O 0 2.481701631040778e-05
congenital O 1 0.9994651675224304
. O 0 6.340984981534348e-08

Preliminary O 0 1.3545935644287965e-06
in O 0 1.0288917273726383e-08
vivo O 0 1.11871349872672e-06
footprinting O 0 1.5444335076608695e-05
data O 0 1.6457729623553519e-09
gave O 0 1.6526160648289157e-11
evidence O 0 1.4046800181355401e-11
for O 0 2.8343695663082813e-13
protein O 0 5.110689996201678e-11
- O 0 4.1667589378846515e-09
DNA O 0 1.640436408933965e-08
contact O 0 1.0537677752608943e-07
in O 0 1.0284099266621993e-10
normal O 0 5.400057623283772e-10
genes O 0 5.475194950199658e-11
at O 0 9.132776999931647e-12
an O 0 3.594951755985648e-13
Sp1 O 0 7.663414902658872e-10
consensus O 0 1.5300125749684312e-11
binding O 0 1.1367014274288323e-10
site O 0 2.9338823037683426e-11
upstream O 0 8.882386146047416e-12
of O 0 2.6780257156820697e-13
the O 0 2.537473920219413e-12
CTG O 0 1.0612201783999353e-08
repeat O 0 3.955352934070788e-09
and O 0 3.940595245943701e-12
for O 0 5.170570324978738e-14
a O 0 7.65739793621989e-13
significant O 0 2.3277844495711575e-12
reduction O 0 4.504339262689783e-11
of O 0 8.73313398051627e-14
this O 0 2.4208624471375173e-13
interaction O 0 8.196958736772508e-12
in O 0 8.762642521309427e-12
cells O 0 2.5603102971061276e-11
with O 0 1.3209464988853115e-12
a O 0 2.6635776917416365e-10
hypermethylated O 0 1.2191245559733943e-06
DMPK O 0 7.221926807687851e-07
gene O 0 5.39453193226791e-09
. O 0 4.123508132169995e-11
. O 0 4.745859816246423e-10

The O 0 1.1257616705506734e-07
hemochromatosis B-Disease 1 0.9999473094940186
gene O 0 7.214306947389559e-07
product O 0 5.485998766374678e-09
complexes O 0 1.3033279344654147e-08
with O 0 1.189435876181033e-11
the O 0 2.850653914310275e-11
transferrin O 0 2.520882844692096e-07
receptor O 0 6.825078724403966e-09
and O 0 1.426004037075046e-10
lowers O 0 4.878662096530206e-08
its O 0 2.0989666168341747e-12
affinity O 0 5.203305147860604e-11
for O 0 2.999596664804427e-12
ligand O 0 8.705249854301655e-09
binding O 0 4.0047968496992326e-08
. O 0 1.4301314577025437e-09

We O 0 1.9397248252062127e-07
recently O 0 5.974449379664293e-09
reported O 0 3.954943317285853e-10
the O 0 8.180897907890394e-13
positional O 0 4.125815245004105e-10
cloning O 0 2.2327302506841562e-10
of O 0 2.843493669690833e-13
a O 0 1.4731396658085316e-11
candidate O 0 7.47960182678753e-09
gene O 0 4.588493141000072e-08
for O 0 7.240581822998138e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 0.007704183459281921
HFE O 1 0.9360881447792053
. O 0 1.1965923363277398e-07

The O 0 1.0427820829050916e-09
gene O 0 1.5402012110143914e-08
product O 0 1.3526969544486178e-09
, O 0 5.208982550852781e-12
a O 0 4.618568028025294e-11
member O 0 2.404211899009745e-11
of O 0 5.998346892972795e-13
the O 0 6.1168782712617276e-12
major O 0 1.1573491470739938e-10
histocompatibility O 0 2.475628093634441e-07
complex O 0 3.292126393716899e-08
class O 0 5.467498898070744e-09
I O 0 5.860270562152436e-07
- O 0 1.384622083655529e-09
like O 0 3.273888937727065e-10
family O 0 1.4208374754520747e-10
, O 0 2.502645660151792e-12
was O 0 6.795222717848048e-11
found O 0 2.1981349032640374e-11
to O 0 2.560543357205125e-12
have O 0 3.014418575864042e-11
a O 0 5.070763600678596e-11
mutation O 0 9.400329403774776e-09
, O 0 3.848812327872375e-12
Cys O 0 4.6318255897404015e-08
- O 0 1.5758233606888439e-09
282 O 0 2.966955847671926e-10
- O 0 1.2351037526059372e-07
- O 0 3.219311111024581e-07
> O 0 7.250805733605148e-09
Tyr O 0 3.4460332365426893e-09
( O 0 3.5930186235121064e-13
C282Y O 0 2.949626307091613e-11
) O 0 8.011131905419355e-14
, O 0 1.3943793697262195e-14
in O 0 9.139598664475654e-14
85 O 0 1.9161094152314595e-12
% O 0 4.1757648228980815e-13
of O 0 4.056480845671118e-12
patient O 0 3.2466189736624074e-07
chromosomes O 0 5.043455075792735e-07
. O 0 6.256024143169725e-09

This O 0 1.797591853147651e-09
mutation O 0 1.2944025229444378e-07
eliminates O 0 1.7988995182349754e-08
the O 0 4.209989301617867e-11
ability O 0 3.7070715941389665e-10
of O 0 2.75406585557858e-12
HFE O 0 1.1827796697616577e-06
to O 0 1.8934112958057803e-11
associate O 0 9.366779574193629e-11
with O 0 6.49151739307019e-12
beta2 O 0 2.4910484626161633e-06
- O 0 2.8641582048294367e-06
microglobulin O 0 1.171390181298193e-06
( O 0 4.572094872840049e-12
beta2m O 0 4.1973251541094214e-09
) O 0 4.311244015866439e-13
and O 0 1.1042564432295343e-12
prevents O 0 9.157218733291117e-11
cell O 0 2.0692421287549223e-07
- O 0 8.018835615075659e-06
surface O 0 0.0006804066943004727
expression O 0 1.248175749424263e-06
. O 0 5.92170668056724e-09

A O 0 2.5140900916653663e-08
second O 0 3.202311305017247e-09
mutation O 0 4.897738108411431e-07
that O 0 4.2333261895954877e-10
has O 0 1.0724920951332706e-10
no O 0 3.223099565019538e-11
effect O 0 2.110957242340561e-10
on O 0 2.600427095877933e-10
beta2m O 0 6.038735023139452e-07
association O 0 1.6350426221278802e-11
, O 0 2.845186380332626e-13
H63D O 0 2.4141456833604025e-08
, O 0 1.6383788856849657e-12
was O 0 9.872556244738817e-11
found O 0 1.8573562826640355e-11
in O 0 2.7357731965244048e-12
eight O 0 1.2817419651686701e-12
out O 0 4.488051423556794e-12
of O 0 6.080002495391368e-13
nine O 0 5.139145012322821e-11
patients O 0 1.026624479871785e-10
heterozygous O 0 1.4014532589978757e-10
for O 0 3.3286084392264437e-12
the O 0 2.315364913685336e-11
C282Y O 0 1.5331318437006303e-08
mutant O 0 6.608941305330518e-08
. O 0 2.358414352698901e-09

In O 0 3.608712662028779e-09
this O 0 3.979602064552168e-11
report O 0 2.1467860822355078e-10
, O 0 7.198414499025307e-13
we O 0 4.1765393227199965e-12
demonstrate O 0 1.556278023118196e-11
in O 0 2.112251996574943e-12
cultured O 0 2.8197144619213077e-09
293 O 0 2.1784854475903614e-10
cells O 0 5.064387242903479e-10
overexpressing O 0 6.818991948875919e-08
wild O 0 2.490953443512467e-09
- O 0 2.7712633254850516e-07
type O 0 2.90856377205273e-07
or O 0 7.197999973840297e-10
mutant O 0 8.519161376341344e-09
HFE O 0 1.4905387502039957e-07
proteins O 0 5.109247400159056e-11
that O 0 1.9019670820935586e-12
both O 0 5.422187763885755e-13
the O 0 6.695750724705629e-13
wild O 0 1.5961534871600236e-10
- O 0 2.9356507980082824e-07
type O 0 1.3319187246452202e-06
and O 0 3.700186157473695e-09
H63D O 0 5.297528787195915e-06
HFE O 0 8.672437843415537e-07
proteins O 0 1.7953225017741659e-10
form O 0 4.2771697295052036e-10
stable O 0 4.005301335041622e-08
complexes O 0 1.621877743218647e-09
with O 0 1.6123576432325315e-11
the O 0 1.6043762152140317e-10
transferrin O 0 5.586029487858468e-07
receptor O 0 4.3936967841773367e-08
( O 0 4.2672937405896505e-10
TfR O 0 1.7680049495538697e-06
) O 0 1.1300346769438363e-10
. O 0 2.8967619969400005e-10

The O 0 2.657550401963249e-09
C282Y O 0 1.368911028976072e-07
mutation O 0 4.031806213333766e-07
nearly O 0 1.4575345375078541e-09
completely O 0 3.1246536469353714e-09
prevents O 0 4.362344929731421e-10
the O 0 1.2180561247132626e-11
association O 0 6.924882976072633e-12
of O 0 8.72978650630872e-14
the O 0 3.669397685007736e-12
mutant O 0 4.469487002722872e-09
HFE O 0 3.48486139500892e-07
protein O 0 2.7604107888379303e-10
with O 0 3.0663013794729466e-11
the O 0 1.6533554525466343e-09
TfR O 0 7.769457442918792e-05
. O 0 2.6749884529664314e-09

Studies O 0 1.370315061421934e-07
on O 0 3.195368192265846e-09
cell O 0 4.119820289361087e-07
- O 0 2.8346968861114874e-07
associated O 0 2.2909514285629484e-09
transferrin O 0 1.299453167291631e-08
at O 0 2.91767776605667e-10
37 O 0 3.167156120698067e-11
degrees O 0 2.7458562090743044e-09
C O 0 1.5986229229270066e-08
suggest O 0 4.4422118761211493e-10
that O 0 1.0960523287584234e-11
the O 0 6.9379844751249475e-12
overexpressed O 0 1.7492766346549615e-07
wild O 0 2.6651543194589067e-09
- O 0 5.317793352332956e-07
type O 0 2.009232048294507e-06
HFE O 0 3.1266217774827965e-06
protein O 0 2.0470023454066677e-09
decreases O 0 1.276551975237794e-09
the O 0 1.3744423351183532e-12
affinity O 0 1.5049544943579463e-10
of O 0 3.63162451499921e-12
the O 0 1.1765459440038484e-10
TfR O 0 7.804602546457318e-07
for O 0 1.8070435772732374e-11
transferrin O 0 2.546327948493854e-07
. O 0 1.9470329792881103e-09

The O 0 3.5149720911675786e-09
overexpressed O 0 1.7358486275043106e-06
H63D O 0 8.197777674467943e-07
protein O 0 4.218577931425216e-09
does O 0 6.332687152443839e-10
not O 0 6.705390149380763e-12
have O 0 9.586373578632235e-13
this O 0 3.969068726027841e-13
effect O 0 1.2751205646921449e-10
, O 0 1.5032594581024933e-13
providing O 0 8.792249426344684e-14
the O 0 6.215462714821707e-14
first O 0 1.675801695761453e-13
direct O 0 6.455620543341367e-13
evidence O 0 3.640392501336187e-11
for O 0 9.746274967636914e-13
a O 0 1.852657437184657e-11
functional O 0 9.683898127832435e-10
consequence O 0 4.024433564175922e-10
of O 0 7.806877431841552e-13
the O 0 5.613230366630084e-11
H63D O 0 1.216436066897586e-05
mutation O 0 2.2628898932453012e-07
. O 0 1.4036717344012573e-09

Addition O 0 2.1997350607705357e-09
of O 0 1.7534564078491854e-10
soluble O 0 2.9075488328089705e-07
wild O 0 2.6954250387234424e-08
- O 0 2.5187342544086277e-05
type O 0 7.426324009429663e-05
HFE O 0 0.0010770264780148864
/ O 0 4.36083553267963e-07
beta2m O 0 2.902982600971882e-07
heterodimers O 0 2.082593653085496e-07
to O 0 7.460075612808481e-11
cultured O 0 3.486090349724691e-08
cells O 0 4.051182944664333e-09
also O 0 3.3125294174318753e-11
decreased O 0 3.0447686039103417e-10
the O 0 2.2123535642348813e-13
apparent O 0 2.1056291432675067e-10
affinity O 0 9.130343009422504e-11
of O 0 7.905353888865152e-13
the O 0 6.200514494208997e-12
TfR O 0 8.359742231789369e-09
for O 0 3.264896626707994e-14
its O 0 6.019122510527233e-14
ligand O 0 3.5460318709157335e-11
under O 0 2.572837255743199e-11
steady O 0 8.507080373476583e-09
- O 0 7.141773039620603e-08
state O 0 4.990256541326232e-10
conditions O 0 4.1130649997001e-09
, O 0 9.634669770981416e-14
both O 0 3.4309745799640523e-13
in O 0 1.7550038028738002e-12
293 O 0 3.4480546889925634e-11
cells O 0 1.1289445767115325e-10
and O 0 5.563527763485787e-11
in O 0 1.0545564421704512e-10
HeLa O 0 1.7592192591564526e-07
cells O 0 1.836809460087352e-08
. O 0 7.92068466370921e-10

Furthermore O 0 9.817456003702318e-08
, O 0 2.792937756068703e-11
at O 0 2.3038057572755122e-11
4 O 0 3.132646919645765e-11
degrees O 0 9.160689984355486e-08
C O 0 1.2554926343000261e-06
, O 0 9.31969258710641e-12
the O 0 2.9180713401188996e-11
added O 0 2.4199486858833552e-09
soluble O 0 1.0964575913874341e-08
complex O 0 4.076200765812388e-10
of O 0 1.9892802682885957e-11
HFE O 0 2.393491922703106e-05
/ O 0 2.1116679960186957e-08
beta2m O 0 2.539619181618491e-08
inhibited O 0 2.514784380736046e-09
binding O 0 2.606097559976206e-10
of O 0 5.502274851021394e-12
transferrin O 0 1.1940452182557237e-08
to O 0 1.0775341729996057e-10
HeLa O 0 1.4083472876791348e-07
cell O 0 5.979029538139002e-07
TfR O 0 2.3880018034105888e-06
in O 0 1.1767046538546655e-11
a O 0 1.4044154728054536e-10
concentration O 0 9.287365173804574e-06
- O 0 1.1607556871240376e-06
dependent O 0 3.116274882586367e-08
manner O 0 5.060327339379e-07
. O 0 3.6814606918511572e-09

Scatchard O 0 5.294170023262268e-06
plots O 0 9.239726495025025e-08
of O 0 4.890281235514493e-11
these O 0 4.925936394895025e-12
data O 0 3.025041050985777e-10
indicate O 0 2.960643064042756e-09
that O 0 1.0005457400097395e-11
the O 0 3.773520124844554e-12
added O 0 7.459619727478994e-11
heterodimer O 0 7.958548486897143e-09
substantially O 0 4.641046658093728e-09
reduced O 0 3.28521550241323e-11
the O 0 8.322544584916935e-13
affinity O 0 8.953524727184359e-11
of O 0 1.8637688614653314e-11
TfR O 0 2.044713482973748e-07
for O 0 4.615169010846465e-11
transferrin O 0 2.577648388069065e-07
. O 0 2.2885016104368106e-09

These O 0 1.073124922257307e-09
results O 0 4.768943573374429e-10
establish O 0 7.12103362388028e-11
a O 0 8.00211841234244e-11
molecular O 0 9.827630265135667e-08
link O 0 2.551705051700992e-07
between O 0 5.48797673971535e-09
HFE O 0 0.0005200225859880447
and O 0 1.9176982224422545e-10
a O 0 2.6318017209980837e-11
key O 0 7.69523889054824e-11
protein O 0 2.88619909222243e-11
involved O 0 2.68694615168652e-11
in O 0 1.3384313622688548e-11
iron O 0 1.766417426551925e-06
transport O 0 1.738793331540478e-09
, O 0 1.7059140558495223e-12
the O 0 6.093066155787863e-12
TfR O 0 2.659895130818768e-07
, O 0 2.6766826602409033e-13
and O 0 4.542191817981378e-13
raise O 0 1.2584219256928098e-11
the O 0 2.2734437487952064e-13
possibility O 0 8.279310396985817e-12
that O 0 7.31110376232802e-13
alterations O 0 1.6728941149013465e-11
in O 0 1.2374776767534734e-12
this O 0 3.763828441624706e-13
regulatory O 0 3.606149753809795e-11
mechanism O 0 7.216723330039088e-10
may O 0 3.936460046816137e-10
play O 0 1.6123014381919099e-12
a O 0 1.2760778761791713e-12
role O 0 1.5107689405047253e-11
in O 0 1.4517724045495783e-12
the O 0 7.309978143632545e-12
pathogenesis O 0 1.7046685840682585e-08
of O 0 1.206657329611005e-09
hereditary B-Disease 1 0.9999998807907104
hemochromatosis I-Disease 1 1.0
. O 0 7.934427230793517e-07
. O 0 8.06604205649819e-09

Genomic O 0 1.4124566405371297e-06
organization O 0 6.063107349518759e-09
of O 0 7.538458746125798e-11
the O 0 2.2889456996466606e-10
UBE3A O 0 4.918815830023959e-05
/ O 0 3.94419060967266e-07
E6 O 0 3.604368203014019e-06
- O 0 9.128343663178384e-05
AP O 0 2.163041972380597e-05
gene O 0 8.82462991569355e-09
and O 0 1.8614142172079795e-10
related O 0 4.430587896564475e-09
pseudogenes O 0 1.5525764638368855e-06
. O 0 1.7220934012129874e-08

The O 0 5.905171907016893e-09
UBE3A O 0 5.492604941537138e-06
gene O 0 1.023481654982561e-08
encodes O 0 2.9658200340065832e-09
the O 0 4.003309142519562e-11
E6 O 0 1.0293979357811622e-06
- O 0 7.940860086819157e-05
AP O 0 4.045211881020805e-06
ubiquitin O 0 3.759360822641611e-08
- O 0 8.552716757037615e-09
protein O 0 1.702177981899311e-10
ligase O 0 4.831052224929522e-10
and O 0 3.271733925447329e-11
has O 0 3.5082707572353655e-11
recently O 0 3.35201949530628e-10
been O 0 2.1789705456631836e-11
shown O 0 6.809728475554166e-11
to O 0 2.4632114924150184e-12
be O 0 4.220603866400552e-10
mutated O 0 2.104552777382196e-06
in O 0 1.456429799873149e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 3.470041292530368e-06
who O 0 5.667391889119244e-09
lack O 0 1.0754116486211274e-09
15q11 O 0 3.823999605856443e-08
- O 0 8.752520841426303e-08
q13 O 0 1.3656700659225862e-08
deletions O 0 3.0500788739118434e-07
or O 0 2.6311832712622163e-08
chromosome O 0 1.4037914297659881e-05
15 O 0 8.320783173587643e-09
paternal O 0 3.1079678592504933e-05
uniparental B-Disease 0 0.016615331172943115
disomy I-Disease 0 0.0007427955279126763
. O 0 6.228951576758845e-08

Previous O 0 1.673660108281183e-07
UBE3A O 0 5.861768386239419e-06
cDNA O 0 2.7753488396342618e-08
analysis O 0 1.6412409209465295e-08
has O 0 9.126095018574532e-11
shown O 0 1.1245389341940637e-10
a O 0 5.4131511773025665e-11
coding O 0 1.2090562329092336e-08
region O 0 3.6956632198936745e-10
of O 0 7.802594507999583e-12
approximately O 0 6.02149718975653e-11
2 O 0 5.11720832374607e-10
. O 0 1.6300030214466688e-09

6 O 0 1.888883716105738e-08
kb O 0 6.441970867854252e-07
and O 0 7.319109762704556e-10
a O 0 1.704423935322552e-09
3 O 0 5.640711453480662e-09
- O 0 4.151649045525119e-05
untranslated O 0 7.432246638927609e-05
region O 0 1.948768968418335e-08
( O 0 4.970426847883402e-12
UTR O 0 1.462318488520964e-09
) O 0 1.743133090127691e-13
of O 0 2.1148065395236448e-13
< O 0 2.0335146899697065e-09
50 O 0 9.626651906180506e-12
bp O 0 2.6075557268967486e-09
, O 0 4.869251161131183e-13
whereas O 0 4.938834497619782e-12
Northern O 0 2.0503989131559486e-12
analysis O 0 1.3403856150007165e-11
has O 0 5.368862472654445e-12
indicated O 0 3.075268512064966e-11
mRNA O 0 1.0371200426240179e-11
sizes O 0 1.7637573346274138e-10
of O 0 1.0755351687388726e-12
5 O 0 2.7168049060444233e-11
- O 0 1.5634507022355137e-08
8 O 0 2.3747170896371017e-10
kb O 0 6.213963956724911e-07
. O 0 5.558219218215754e-09

We O 0 4.129212527459458e-08
have O 0 4.848246804023404e-11
analyzed O 0 1.1517645170933122e-10
additional O 0 1.1128536243562581e-12
cDNA O 0 5.305526157295404e-11
clones O 0 2.5222576804928565e-10
and O 0 3.01626909213204e-12
provide O 0 8.802086121605102e-13
evidence O 0 1.8023414358192547e-11
for O 0 2.3551370272392735e-13
an O 0 3.453329744558531e-13
additional O 0 5.5965530820767384e-11
0 O 0 1.1663155996544106e-09
. O 0 9.625266139678956e-10

5 O 0 6.906953675667182e-09
kb O 0 8.155227249062591e-08
of O 0 7.109362404333908e-11
5 O 0 5.377835399222874e-10
- O 0 4.335585686021659e-07
UTR O 0 5.341061637409439e-07
and O 0 7.833421411529429e-11
> O 0 1.1905919305998935e-10
2 O 0 2.1781302889795073e-12
kb O 0 4.8484274373095104e-09
of O 0 3.6728300956134774e-11
3 O 0 2.9612077234730805e-09
- O 0 1.4673541954834945e-05
UTR O 0 5.147254341864027e-06
. O 0 2.584363389956934e-09

We O 0 8.368935056068949e-08
have O 0 1.096036178482862e-10
established O 0 5.2942828072943815e-12
the O 0 2.9217887874757875e-13
genomic O 0 4.326496105822031e-11
organization O 0 1.0880368871493684e-12
of O 0 4.0676823346262603e-13
UBE3A O 0 2.5524207103444496e-07
and O 0 1.474438279802648e-11
the O 0 3.2861398064493175e-13
sequence O 0 1.4804633213794105e-11
of O 0 1.523061624736366e-12
intron O 0 3.386300306829071e-07
- O 0 7.93413221344963e-07
exon O 0 7.733852385172213e-07
borders O 0 1.0459582711064286e-07
. O 0 3.800873837889185e-09

We O 0 4.288169463961822e-07
have O 0 3.995111186316791e-10
also O 0 1.3979632555727317e-11
mapped O 0 1.0758429702661942e-08
two O 0 4.520431771959377e-12
highly O 0 1.5478242298971878e-10
homologous O 0 8.479116853088442e-10
processed O 0 1.0254430637957057e-09
pseudogenes O 0 1.4335267195519918e-08
, O 0 6.039114520961508e-12
UBE3AP1 O 0 2.994663717004187e-08
and O 0 1.671736186981132e-11
UBE3AP2 O 0 4.6843865675327834e-08
, O 0 6.805877476173672e-13
to O 0 4.3155550747547844e-13
chromosomes O 0 6.462710921972814e-11
2 O 0 5.7799338232245034e-12
and O 0 1.7117753395301527e-11
21 O 0 1.5312006870771278e-11
, O 0 1.22856445069347e-12
respectively O 0 3.432557571514394e-10
, O 0 2.8069979066819295e-12
and O 0 4.725038069142151e-11
determined O 0 2.2014233991285437e-08
their O 0 5.043832018714056e-11
genomic O 0 1.9314205790266215e-09
organization O 0 3.3483388284238913e-10
. O 0 3.5040792489837713e-10

These O 0 9.059986094683836e-10
results O 0 1.22730869911436e-09
will O 0 2.0031316882995753e-11
form O 0 2.647528897503637e-12
the O 0 8.222791479835234e-13
basis O 0 6.790011261581519e-12
for O 0 6.352384438780556e-13
studies O 0 7.1480824731517956e-12
of O 0 7.767873258686386e-13
mutation O 0 1.2681994121521711e-08
and O 0 7.027420312333277e-11
imprinting O 0 5.0931813433408024e-08
of O 0 1.49022114093178e-10
UBE3A O 0 3.584970545489341e-05
. O 0 9.319422566989033e-09

Mutation O 0 0.00011002145038219169
spectrum O 0 6.586607014469337e-06
and O 0 7.136935931129074e-09
genotype O 0 0.00179003132507205
- O 0 3.366902456036769e-05
phenotype O 0 8.314317710755859e-06
analyses O 0 3.83910588652725e-07
in O 0 1.458786091923514e-09
Cowden B-Disease 0 0.0662166178226471
disease I-Disease 0 4.506754339672625e-05
and O 0 3.918066937558251e-08
Bannayan B-Disease 1 0.9806810021400452
- I-Disease 1 0.9999884366989136
Zonana I-Disease 1 0.9999881982803345
syndrome I-Disease 1 0.999976396560669
, O 0 1.3153889089068116e-10
two O 0 8.221299196975451e-10
hamartoma B-Disease 1 0.7902625799179077
syndromes I-Disease 0 0.004743493162095547
with O 0 8.295572229144454e-09
germline O 0 0.004243676550686359
PTEN O 0 0.22960472106933594
mutation O 0 0.0008079030085355043
. O 0 4.7076657239131237e-08

The O 0 3.4702458151514293e-07
tumour B-Disease 1 0.9999234676361084
suppressor O 0 0.0004469477862585336
gene O 0 3.6749913761013886e-06
PTEN O 0 0.00021960110461805016
, O 0 1.091534154729068e-10
which O 0 8.812488933029883e-12
maps O 0 7.762715470427395e-10
to O 0 1.2558210027435734e-10
10q23 O 0 2.6674041464502807e-07
. O 0 3.6259337754529497e-09

3 O 0 5.408399061934688e-09
and O 0 3.4272303744975474e-11
encodes O 0 7.649745281668174e-10
a O 0 1.192157483842493e-10
403 O 0 2.901079931838524e-10
amino O 0 4.394471453394999e-10
acid O 0 4.85525508686635e-10
dual O 0 1.7051334566531295e-08
specificity O 0 3.168478599491209e-07
phosphatase O 0 0.00018230678688269109
( O 0 1.726425426229472e-11
protein O 0 7.584324834830625e-10
tyrosine O 0 4.815785459300059e-08
phosphatase O 0 4.099332363693975e-05
; O 0 1.8516550792657682e-10
PTPase O 0 1.6144903725034965e-07
) O 0 2.97522076420087e-12
, O 0 1.3128936956693926e-12
was O 0 2.4991708702515325e-10
shown O 0 7.877298813241396e-09
recently O 0 2.7070521380068158e-09
to O 0 7.520890160650495e-12
play O 0 4.187597144045263e-11
a O 0 1.1031328628341441e-11
broad O 0 4.824493582411549e-11
role O 0 3.308660567746813e-10
in O 0 1.2571846341735693e-10
human O 0 3.5276457310828846e-09
malignancy B-Disease 0 8.787882507022005e-06
. O 0 4.452792357056978e-09

Somatic O 0 1.6037427485571243e-05
PTEN O 0 7.104528049239889e-05
deletions O 0 1.8811447262123693e-06
and O 0 6.4590945925147025e-09
mutations O 0 1.8757583575279568e-07
were O 0 4.213140114561753e-10
observed O 0 1.2523204695469303e-08
in O 0 4.8067574226484666e-11
sporadic B-Disease 0 4.8065080591186415e-06
breast I-Disease 1 0.9996403455734253
, I-Disease 0 1.4327235930977622e-07
brain I-Disease 0 0.02016090787947178
, I-Disease 0 3.6853249341106675e-09
prostate I-Disease 0 0.060994431376457214
and I-Disease 0 8.530089985470113e-07
kidney I-Disease 0 0.001928417943418026
cancer I-Disease 0 0.0002024455607170239
cell O 0 3.420155917410739e-05
lines O 0 5.419282842922257e-06
and O 0 1.8504618670700523e-10
in O 0 4.34675082386371e-12
several O 0 1.4525597738512808e-11
primary O 0 9.777108971320558e-07
tumours B-Disease 1 0.999991774559021
such O 0 2.2315138625828013e-09
as O 0 5.005972525395919e-07
endometrial B-Disease 1 0.9999645948410034
carcinomas I-Disease 1 1.0
, O 0 0.0928851068019867
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9972700476646423
thyroid B-Disease 1 0.999996542930603
tumours I-Disease 1 0.9999992847442627
. O 0 1.5356289395640488e-06

In O 0 4.15701872924501e-09
addition O 0 4.76645223290717e-10
, O 0 7.906929971879251e-11
PTEN O 0 3.0573003186873393e-06
was O 0 2.9402824619495505e-09
identified O 0 1.1702107061140055e-09
as O 0 4.679599589774153e-12
the O 0 4.0642411311409e-12
susceptibility O 0 3.49166100477305e-07
gene O 0 1.8138410773360647e-09
for O 0 5.105857056597607e-11
two O 0 1.7147025133112948e-08
hamartoma B-Disease 1 0.9990535378456116
syndromes I-Disease 1 0.9995855689048767
Cowden B-Disease 1 0.9991925358772278
disease I-Disease 1 0.653553307056427
( O 0 4.365990624588534e-10
CD B-Disease 0 5.202254214964341e-06
; O 0 1.986749209592631e-09
MIM O 0 2.8751462650689064e-06
158350 O 0 1.0940326689024005e-07
) O 0 1.389311062027776e-11
and O 0 2.7121777046446027e-10
Bannayan B-Disease 0 4.909579365630634e-05
- I-Disease 0 0.000699235824868083
Zonana I-Disease 0 0.0007645429577678442
( I-Disease 0 9.381889015669387e-11
BZS I-Disease 0 2.0113340326588514e-07
) I-Disease 0 4.522414994573287e-12
or I-Disease 0 1.3761855544025536e-10
Ruvalcaba I-Disease 0 7.145749805204105e-06
- I-Disease 0 2.3227401470649056e-05
Riley I-Disease 0 1.0401235158497002e-05
- I-Disease 1 0.9736494421958923
Smith I-Disease 0 0.008698809891939163
syndrome I-Disease 1 0.9962265491485596
( O 0 2.369514029432196e-10
MIM O 0 3.6952519621991087e-06
153480 O 0 2.867569719455787e-07
) O 0 1.4427142813744354e-10
. O 0 3.753582167309588e-10

Constitutive O 0 6.814518656028667e-07
DNA O 0 5.0456677058718924e-08
from O 0 1.3007611654458628e-10
37 O 0 8.106318394318635e-11
CD B-Disease 0 2.0642469067411184e-08
families O 0 2.549712108113056e-10
and O 0 4.366779507436469e-11
seven O 0 5.361803709358348e-11
BZS B-Disease 0 8.863750622367661e-07
families O 0 1.871267862885162e-10
was O 0 2.27878285685712e-10
screened O 0 8.354863467729956e-09
for O 0 1.4927016567245488e-10
germline O 0 2.996875628014095e-05
PTEN O 0 0.0003028134233318269
mutations O 0 3.982018824899569e-06
. O 0 9.546906376556308e-09

PTEN O 0 0.0022651152685284615
mutations O 0 6.518922600662336e-05
were O 0 9.413118062795434e-10
identified O 0 2.6373216943653688e-09
in O 0 4.91046786565974e-12
30 O 0 1.1544200925056591e-12
of O 0 3.881461395783409e-13
37 O 0 2.0191235836075627e-11
( O 0 8.416072201124225e-13
81 O 0 1.2056300402463194e-11
% O 0 1.2104427703218956e-12
) O 0 4.491577465862151e-13
CD B-Disease 0 6.513181993739181e-09
families O 0 9.451842954144585e-12
, O 0 1.7158891224122036e-13
including O 0 8.327562272571198e-13
missense O 0 3.761125810797239e-07
and O 0 7.819347946913524e-10
nonsense O 0 1.0946275352807788e-07
point O 0 1.5591258284430864e-09
mutations O 0 1.3111070451543583e-08
, O 0 2.942891156459959e-13
deletions O 0 3.939314152656692e-10
, O 0 1.7908882926978564e-12
insertions O 0 1.552953499128762e-08
, O 0 3.2574355539327637e-12
a O 0 7.232179438654285e-11
deletion O 0 2.506772034394089e-07
/ O 0 2.328099846238274e-08
insertion O 0 3.5296516820437773e-09
and O 0 1.7606861524299688e-09
splice O 0 1.2313525985518936e-06
site O 0 7.804208053130424e-07
mutations O 0 4.26632368544233e-06
. O 0 1.5910879724856386e-08

These O 0 4.583810664371413e-09
mutations O 0 1.9328703615428822e-07
were O 0 5.172491601701523e-11
scattered O 0 1.6409323899679862e-10
over O 0 1.559419537944251e-10
the O 0 3.686319305362673e-11
entire O 0 3.6878403109064095e-10
length O 0 3.630639566765126e-09
of O 0 5.11269585695695e-12
PTEN O 0 2.1645881531640043e-07
, O 0 7.352441138558374e-13
with O 0 1.8817301774935735e-13
the O 0 3.3451803068025587e-13
exception O 0 7.570096459408315e-12
of O 0 2.341734933134637e-13
the O 0 3.0425128562383552e-12
first O 0 1.895304746479809e-11
, O 0 1.4577965570805596e-12
fourth O 0 2.358294982907072e-11
and O 0 2.7897965187984042e-11
last O 0 3.771005729902299e-10
exons O 0 1.6409497760605518e-08
. O 0 2.0433355008009357e-09

A O 0 7.618156416810962e-08
hot O 0 3.3173148494825e-07
spot O 0 2.0830782432312844e-07
for O 0 3.278800564388007e-10
PTEN O 0 0.00012180583144072443
mutation O 0 4.403656930662692e-06
in O 0 2.689306277670056e-10
CD B-Disease 0 5.181140068089007e-07
was O 0 2.294074796793666e-08
identified O 0 6.375557415339017e-09
in O 0 5.488774365569604e-12
exon O 0 5.415480064385747e-09
5 O 0 6.135565666642862e-11
that O 0 4.478892950965374e-12
contains O 0 6.765371249328744e-12
the O 0 5.384316256740185e-12
PTPase O 0 4.214398074964265e-08
core O 0 3.0809135243003993e-09
motif O 0 3.4436482554411896e-09
, O 0 1.3883399909309785e-13
with O 0 7.746652305089599e-14
13 O 0 1.7499120642111565e-13
of O 0 7.824374693076938e-14
30 O 0 6.323375417033317e-12
( O 0 4.5134162791719834e-13
43 O 0 8.7898100256667e-12
% O 0 2.211624980374971e-12
) O 0 8.954659388125952e-13
CD B-Disease 0 4.4634660412157245e-08
mutations O 0 3.198925213609982e-08
identified O 0 6.046743106224994e-09
in O 0 2.0994681687591665e-11
this O 0 3.573005433188392e-11
exon O 0 2.711068987082399e-07
. O 0 1.528912108028635e-08

Seven O 0 1.110501579582035e-09
of O 0 1.180406987433269e-11
30 O 0 2.0608723061421585e-11
( O 0 8.507598922222193e-13
23 O 0 3.9442195169658856e-12
% O 0 6.825676634146516e-13
) O 0 5.806471839800431e-13
were O 0 1.5395617072866408e-11
within O 0 1.724838045828736e-12
the O 0 7.47149217494858e-12
core O 0 3.3433371626756525e-09
motif O 0 1.937656257666731e-09
, O 0 2.7258387604381373e-13
the O 0 2.2530728097016478e-13
majority O 0 2.3105725232425156e-12
( O 0 1.262187511626156e-13
five O 0 1.1020991655093584e-13
of O 0 8.196934342223627e-14
seven O 0 1.3218487719332539e-12
) O 0 9.622879072355636e-14
of O 0 1.7226869345084161e-13
which O 0 2.3512178315421295e-10
were O 0 6.979601896439647e-10
missense O 0 3.925078999600373e-06
mutations O 0 9.206299296238285e-07
, O 0 1.1451485593116928e-11
possibly O 0 2.4782753627050624e-10
pointing O 0 5.702893268733078e-09
to O 0 4.824334508268802e-12
the O 0 3.734853138565031e-12
functional O 0 1.954424955208367e-10
significance O 0 1.2705854424144292e-10
of O 0 1.1220931952701796e-12
this O 0 2.4320231592489527e-11
region O 0 8.758924696650183e-10
. O 0 1.986938835685237e-09

Germline O 0 0.002225064905360341
PTEN O 0 0.0024848233442753553
mutations O 0 0.0001800135796656832
were O 0 2.8731024226402724e-09
identified O 0 9.358610775223042e-09
in O 0 1.2799005778829642e-11
four O 0 8.48956148435942e-12
of O 0 3.594638258927474e-12
seven O 0 4.0155677394349e-11
( O 0 3.5432041415456306e-12
57 O 0 2.2015209100167965e-11
% O 0 1.0097981478773832e-11
) O 0 2.8224663925491278e-11
BZS B-Disease 0 9.033607284436584e-07
families O 0 7.945454294500109e-10
studied O 0 1.7150885156524964e-08
. O 0 3.239774892804803e-09

Interestingly O 0 5.425767540145898e-06
, O 0 3.1482100260049606e-10
none O 0 3.430005168780781e-10
of O 0 4.256962891999866e-13
these O 0 2.6776759629032476e-11
mutations O 0 2.4759154726439192e-08
was O 0 2.7843929384374633e-09
observed O 0 1.1251923837107825e-08
in O 0 1.2857532746823885e-11
the O 0 3.4747999616557834e-11
PTPase O 0 3.723502004504553e-07
core O 0 3.2343681510837996e-08
motif O 0 1.5084165738699085e-07
. O 0 1.3574448232134273e-09

It O 0 6.625839432672365e-09
is O 0 3.4960933453787035e-11
also O 0 2.581221477879203e-12
worthy O 0 2.570366697263182e-10
of O 0 2.2077515596935493e-12
note O 0 1.4497167022398116e-08
that O 0 7.299695570228693e-12
a O 0 1.0316745721605791e-11
single O 0 5.751643605833578e-10
nonsense O 0 2.691700373702588e-08
point O 0 1.0267948991060649e-10
mutation O 0 7.040262817170628e-10
, O 0 1.0726725632953862e-13
R233X O 0 7.762608611461275e-11
, O 0 1.230346770644819e-12
was O 0 1.544615407800265e-10
observed O 0 3.4760347378259837e-10
in O 0 8.921654105591148e-13
the O 0 5.165328885101128e-13
germline O 0 2.652965624960757e-10
DNA O 0 6.724326651053047e-10
from O 0 2.7668971714495116e-12
two O 0 3.2828271351315053e-12
unrelated O 0 2.3602142462664233e-09
CD B-Disease 0 3.576713822894817e-07
families O 0 2.1670433503206965e-10
and O 0 5.920932494296594e-11
one O 0 3.8821929004839717e-10
BZS B-Disease 0 4.43363524027518e-06
family O 0 8.204166235259436e-09
. O 0 1.5532991559652487e-09

Genotype O 0 0.16588741540908813
- O 0 0.00031844459590502083
phenotype O 0 8.370210707653314e-05
studies O 0 1.2467269883131848e-08
were O 0 1.4078276322493366e-09
not O 0 1.826529205661842e-10
performed O 0 1.4527931635477387e-10
on O 0 8.389651473539317e-11
this O 0 2.6393256070261772e-12
small O 0 3.7668774349741696e-11
group O 0 9.993046667933214e-11
of O 0 1.0941391022367686e-11
BZS B-Disease 0 3.1541328553430503e-06
families O 0 7.331404927590768e-10
. O 0 8.676981910760162e-10

However O 0 2.5854248519863177e-08
, O 0 4.973969014443469e-10
genotype O 0 1.057314239005791e-05
- O 0 2.0033216969750356e-06
phenotype O 0 5.34923287887068e-07
analysis O 0 6.810848551808135e-10
inthe O 0 6.110197148245788e-08
group O 0 3.0430619135657366e-10
of O 0 8.927390077184683e-13
CD B-Disease 0 1.530161455320922e-07
families O 0 1.597859206059482e-10
revealed O 0 1.9744266221977114e-09
two O 0 1.1688148279093147e-12
possible O 0 3.201935591667926e-11
associations O 0 1.1885310444159636e-11
worthy O 0 1.615677036603813e-10
of O 0 8.638739680197349e-13
follow O 0 2.920515912441246e-11
- O 0 8.573737275696658e-09
up O 0 1.8101767307321381e-10
in O 0 9.590804712911183e-12
independent O 0 7.853901556886811e-11
analyses O 0 1.8235409626754517e-08
. O 0 7.670126755954243e-10

The O 0 4.916614226857519e-09
first O 0 1.1973902980244588e-09
was O 0 5.541388681251647e-09
an O 0 9.589688418354392e-12
association O 0 1.8504820939457822e-11
noted O 0 2.0753937457484994e-10
in O 0 5.4856869914632345e-12
the O 0 2.3863792886213986e-12
group O 0 9.943513026855477e-12
of O 0 2.756534421295004e-13
CD B-Disease 0 1.827503979257017e-07
families O 0 1.4303189188602516e-10
with O 0 3.5854612612240544e-09
breast B-Disease 1 0.9795814156532288
disease I-Disease 0 0.00044485912076197565
. O 0 2.1931212401682387e-08

A O 0 3.280530691540662e-08
correlation O 0 5.421699142971192e-07
was O 0 1.961268303318775e-08
observed O 0 1.1266735322479349e-09
between O 0 8.112362344381285e-12
the O 0 5.0695519830668e-12
presence O 0 6.165541965863497e-10
/ O 0 1.1552153900140638e-08
absence O 0 1.1757518569854852e-10
of O 0 1.0152185082185072e-12
a O 0 1.425180251590774e-10
PTEN O 0 4.186591922916705e-06
mutation O 0 5.168623928852867e-08
and O 0 8.281378187369182e-12
the O 0 4.496988718905026e-12
type O 0 3.200658227342501e-08
of O 0 9.374787057758738e-11
breast O 0 0.0031680173706263304
involvement O 0 8.80202333064517e-06
( O 0 1.2490231071637936e-09
unaffected O 0 5.344995201994607e-07
versus O 0 3.4900738228316186e-06
benign O 0 0.00020116980886086822
versus O 0 6.572686834260821e-05
malignant O 0 0.00022617090144194663
) O 0 1.884992162359822e-09
. O 0 2.075529303979806e-09

Specifically O 0 3.8948719804920984e-08
and O 0 1.2606207744347842e-10
more O 0 2.45327629738723e-12
directly O 0 2.0886173346390535e-10
, O 0 5.058627995657705e-12
an O 0 3.5431093822757553e-12
association O 0 6.523245832390501e-11
was O 0 2.7429352122965156e-09
also O 0 2.341880335487989e-11
observed O 0 2.569959800524657e-10
between O 0 1.2623469977657287e-12
the O 0 4.231116325359441e-13
presence O 0 6.197345154418388e-12
of O 0 1.546818364584271e-13
a O 0 2.710233426572728e-10
PTEN O 0 0.0001329805381828919
mutation O 0 8.664436791150365e-06
and O 0 6.821281317570538e-08
malignant B-Disease 1 0.9984108209609985
breast I-Disease 1 0.9998886585235596
disease I-Disease 1 0.7185879945755005
. O 0 1.0543829631615154e-07

Secondly O 0 3.229337016819045e-05
, O 0 2.2055061943415666e-10
there O 0 7.108657412713271e-11
appeared O 0 2.4519886121510126e-09
to O 0 1.640424775184446e-11
be O 0 2.624354344948898e-10
an O 0 1.0966838548398528e-11
interdependent O 0 1.6115649486891925e-05
association O 0 6.928043555509689e-11
between O 0 5.5104594498534e-11
mutations O 0 5.760615984229389e-09
upstream O 0 5.10208021664571e-11
and O 0 4.241695536477685e-12
within O 0 4.1360125502439005e-13
the O 0 3.0857020497793153e-12
PTPase O 0 3.391871672420166e-08
core O 0 5.148657056253114e-09
motif O 0 1.8578123928136847e-08
, O 0 1.188410372714166e-12
the O 0 7.293540229234841e-13
core O 0 3.3964969725630567e-10
motif O 0 2.9874611118252403e-10
containing O 0 1.3714107106876927e-11
the O 0 6.155016817402381e-13
majority O 0 3.234688558673149e-12
of O 0 1.5757397556909192e-12
missense O 0 1.1226101150896284e-06
mutations O 0 6.34174682545563e-07
, O 0 5.479788931644913e-12
and O 0 2.792936455026096e-12
the O 0 6.314500788570654e-13
involvement O 0 3.501113010617729e-10
of O 0 1.8049653568649737e-12
all O 0 2.338023004366807e-12
major O 0 6.103782063116014e-11
organ O 0 1.6672653657678893e-07
systems O 0 1.3820977251555178e-08
( O 0 2.984103849440478e-12
central O 0 1.3752383953846703e-10
nervous O 0 2.629714117574622e-07
system O 0 1.474603728013335e-08
, O 0 6.218428549864541e-10
thyroid O 0 0.000538864464033395
, O 0 3.0202787493216476e-10
breast O 0 0.005307188723236322
, O 0 4.14109067037316e-08
skin O 1 0.9942295551300049
and O 0 1.0304931493010372e-05
gastrointestinal O 1 0.9665029644966125
tract O 0 0.020029084756970406
) O 0 2.9532378764685063e-09
. O 0 2.9438571580442385e-09

However O 0 1.4208010767902124e-08
, O 0 5.7239057243974045e-12
these O 0 5.126676535550934e-13
observations O 0 5.351130094588541e-10
would O 0 1.5150021862031515e-11
need O 0 2.2837592927871242e-11
to O 0 3.168109004303421e-12
be O 0 8.081725566544407e-11
confirmed O 0 2.3491455308777276e-11
by O 0 4.5173091070722926e-13
studying O 0 5.119155533500619e-12
a O 0 2.6360706152639413e-12
larger O 0 3.687564142929034e-11
number O 0 2.1288358229010207e-11
of O 0 2.582812219306674e-12
CD B-Disease 0 4.898859060631366e-07
families O 0 4.372983086753379e-10
. O 0 8.088083536250679e-10

Molecular O 0 0.4344753324985504
defects O 1 0.9927645325660706
leading O 0 1.935980087353073e-08
to O 0 1.3545861654584712e-10
human O 0 2.541289845225947e-09
complement B-Disease 0 1.4303116131486604e-06
component I-Disease 0 0.38008710741996765
C6 I-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
in O 0 5.772238798051887e-10
an O 0 7.468613401340196e-12
African O 0 7.905346516290379e-11
- O 0 2.9252905164867116e-07
American O 0 8.792070183005762e-09
family O 0 8.060135670007185e-09
. O 0 1.6811675385142166e-09

Complement B-Disease 0 0.00025810603983700275
component I-Disease 0 0.32506245374679565
C6 I-Disease 1 0.9999991655349731
deficiency I-Disease 1 0.9999991655349731
( O 0 1.1357095264230566e-09
C6D B-Disease 0 9.392217179993168e-06
) O 0 9.026278335877436e-11
was O 0 6.015467590714252e-08
diagnosed O 0 1.0922183719230816e-05
in O 0 1.7395711607304243e-11
a O 0 9.716363130740646e-11
16 O 0 1.5321618973551665e-11
- O 0 4.95019669699559e-09
year O 0 1.19630763628642e-10
- O 0 5.79508796505479e-09
old O 0 1.0843741016230979e-08
African O 0 1.0297617793197933e-11
- O 0 5.124536350820108e-09
American O 0 4.827819255481813e-10
male O 0 3.073678200848917e-08
with O 0 5.642252887128052e-08
meningococcal B-Disease 1 0.9999914169311523
meningitis I-Disease 1 0.9999686479568481
. O 0 3.335650688995884e-08

The O 0 2.0132890909962953e-08
patients O 0 6.90303210149068e-08
father O 0 1.3468128656768386e-07
and O 0 1.7393066154003378e-10
two O 0 4.4876685700856456e-11
brothers O 0 6.448843237194524e-08
also O 0 4.196632624742236e-11
had O 0 5.41547751087279e-10
C6D B-Disease 0 2.327372357058266e-07
, O 0 6.501923023420619e-13
but O 0 4.841986186998604e-13
gave O 0 2.9582170046893452e-12
no O 0 9.448867903383285e-12
history O 0 3.53116980100765e-11
of O 0 1.4307710398397955e-11
meningitis B-Disease 1 0.9996517896652222
or O 0 2.5113125468045894e-10
other O 0 6.34707356117481e-11
neisserial B-Disease 0 2.9875445761717856e-05
infection I-Disease 0 5.294788570608944e-05
. O 0 4.042191026343289e-09

By O 0 4.3226297541387737e-10
using O 0 3.031718209811629e-10
exon O 0 4.440691725449142e-08
- O 0 2.9058289996442e-08
specific O 0 2.0756392438148197e-10
polymerase O 0 3.7540570652083716e-09
chain O 0 1.2738115451327303e-08
reaction O 0 8.046937005623533e-10
( O 0 1.4458146051915532e-12
PCR O 0 9.418091861945754e-10
) O 0 6.984198375886708e-13
/ O 0 1.1475061179044843e-10
single O 0 2.8974969645823023e-10
- O 0 4.942790621242921e-09
strand O 0 4.9523882772462e-09
conformation O 0 4.060173708353432e-08
polymorphism O 0 1.2717699782172076e-08
as O 0 1.4513653950540273e-12
a O 0 8.472766216925665e-13
screening O 0 1.7357629222836124e-11
step O 0 1.2985939580600903e-11
and O 0 2.9213149911264114e-13
nucleotide O 0 1.9454227725285156e-12
sequencing O 0 1.521553878985199e-13
of O 0 2.4545466435202043e-14
target O 0 7.404787200071539e-11
exons O 0 1.9090488911910342e-10
, O 0 1.8542474413546506e-12
we O 0 2.6462327121223872e-11
determined O 0 3.7531883156916024e-10
that O 0 7.770722433575461e-12
the O 0 2.5316825458948644e-12
proband O 0 2.224160056130131e-07
was O 0 3.1944460965327437e-10
a O 0 1.2133049773210836e-11
compound O 0 6.822263864947331e-10
heterozygote O 0 4.214379512035293e-09
for O 0 3.2268684252434454e-12
two O 0 1.1129226012984716e-10
C6 O 0 2.4270362700917758e-05
gene O 0 1.239935585317653e-07
mutations O 0 7.614240189468546e-07
. O 0 4.3377959002555144e-09

The O 0 1.626279555466681e-09
first O 0 8.260338246746102e-11
, O 0 3.9192399325926885e-12
1195delC O 0 1.1056975335321795e-09
located O 0 9.212244161949101e-11
in O 0 1.8095440076915104e-11
exon O 0 2.925074937820682e-08
7 O 0 2.053106129551452e-09
, O 0 7.129727797733354e-12
is O 0 2.0667523682044164e-12
a O 0 1.1111086009596427e-11
novel O 0 3.457823471997301e-10
mutation O 0 2.7130393931429353e-08
, O 0 5.291513754945854e-13
while O 0 1.8952315845172096e-12
the O 0 5.91171805518903e-13
second O 0 2.3578182808958736e-11
, O 0 4.0558135734440615e-13
1936delG O 0 5.1930730549099025e-11
in O 0 1.230668236588961e-12
exon O 0 1.1703491509251762e-09
12 O 0 3.81077842892541e-11
, O 0 2.856879229712339e-12
has O 0 2.1899536004066356e-11
been O 0 4.6977199907871636e-11
described O 0 4.4132786314321493e-10
before O 0 1.477597037780054e-11
to O 0 1.06174903938272e-11
cause O 0 4.138577480716776e-09
C6D B-Disease 0 1.200697738568124e-06
in O 0 1.264236718784284e-11
an O 0 7.99176859671985e-13
unrelated O 0 1.4668103398562948e-09
African O 0 2.0752738069673704e-11
- O 0 2.05887555893014e-08
American O 0 5.637438849070975e-10
individual O 0 1.445502495478479e-09
. O 0 1.498593360516054e-09

Both O 0 1.2314337993757363e-08
mutations O 0 1.1619042652455391e-06
result O 0 8.846015475683089e-09
in O 0 6.362313453855961e-10
premature O 0 4.943481712871289e-07
termination O 0 1.2833204721118818e-07
codons O 0 6.09711179322403e-08
and O 0 6.667840946050774e-09
C6 O 0 0.000121254452096764
null O 0 2.0368984223750886e-06
alleles O 0 1.4886395547364373e-06
. O 0 3.141057547395576e-08

Allele O 0 8.876846550265327e-06
- O 0 4.256267516211665e-08
specific O 0 1.7727895540442518e-10
PCR O 0 3.365501299867901e-08
indicated O 0 7.883341091030616e-09
that O 0 5.1208252048462466e-12
the O 0 5.171206778759041e-12
probands O 0 3.265959662712703e-07
two O 0 1.0065200756192993e-10
brothers O 0 3.0973303921655315e-08
also O 0 2.059029682865976e-11
inherited O 0 3.8006855440642084e-09
the O 0 2.4937924988921445e-12
1195delC O 0 4.993334190572796e-09
mutation O 0 2.08552930480721e-09
from O 0 8.367062468220277e-13
their O 0 1.1145620017194435e-11
heterozygous O 0 1.7421868392375472e-08
mother O 0 3.591931374558044e-08
and O 0 7.1944650757715944e-12
the O 0 2.165103599877094e-12
1936delG O 0 6.8804326680549366e-09
mutation O 0 2.198099258166053e-09
from O 0 1.4986682684778319e-12
their O 0 1.3818609451154984e-11
homozygous O 0 6.246654749020308e-08
father O 0 4.0614750673739763e-08
. O 0 6.637646682294829e-11
. O 0 7.133244550594497e-10

PAX6 O 0 0.017940683290362358
mutations O 0 0.0002786668192129582
reviewed O 0 2.9510092645068653e-06
. O 0 5.906728972604469e-08

Mutations O 0 0.00013487438263837248
in O 0 2.3533008874920824e-09
PAX6 O 0 7.634441317350138e-06
are O 0 1.4394599401335029e-10
responsible O 0 3.4900587975172925e-10
for O 0 5.588592956462524e-12
human O 0 2.3435628992984903e-09
aniridia B-Disease 1 0.9999996423721313
and O 0 4.8596138668699496e-08
have O 0 1.6060426322184185e-09
also O 0 1.1404534434877878e-11
been O 0 2.3884205377355805e-11
found O 0 5.472459291278042e-11
in O 0 5.354506768528999e-11
patients O 0 3.8160899440420337e-10
with O 0 3.463686892857254e-09
Peters B-Disease 1 0.9999967813491821
anomaly I-Disease 1 0.9999996423721313
, O 0 6.039112321332141e-09
with O 0 2.0817665244976524e-06
congenital B-Disease 1 0.9999982118606567
cataracts I-Disease 1 0.9558911323547363
, O 0 7.784705102764633e-10
with O 0 2.08293737813392e-09
autosomal B-Disease 0 0.04320375248789787
dominant I-Disease 0 0.0029097143560647964
keratitis I-Disease 1 0.6663790345191956
, O 0 2.6743305348020385e-09
and O 0 1.8721388328479804e-10
with O 0 3.4598111042782875e-09
isolated B-Disease 0 0.001152202719822526
foveal I-Disease 1 0.9999980926513672
hypoplasia I-Disease 1 0.9999988079071045
. O 0 2.1560188088187715e-06

No O 0 1.0201508970908435e-08
locus O 0 4.050443180858565e-08
other O 0 3.6326167768274686e-11
than O 0 6.714109129779544e-11
chromosome O 0 3.268395971645077e-07
11p13 O 0 1.1255684029265467e-07
has O 0 1.5397217945078978e-09
been O 0 2.5157953498222696e-10
implicated O 0 1.8599048701162246e-07
in O 0 3.823180882989163e-09
aniridia B-Disease 1 0.9999994039535522
, O 0 1.3068987558817469e-10
and O 0 3.9099907339634754e-11
PAX6 O 0 2.228674134130415e-07
is O 0 5.2598422145555546e-11
clearly O 0 6.183840939311125e-11
the O 0 2.0212755351845663e-13
major O 0 2.8234450367981e-12
, O 0 2.58387668899962e-12
if O 0 3.3450624215003444e-11
not O 0 1.2997809425985274e-11
only O 0 1.6782879339732881e-12
, O 0 1.1414670207307576e-12
gene O 0 2.61908356113949e-10
responsible O 0 6.349938352911977e-09
. O 0 2.094298956478724e-09

Twenty O 0 8.981570687183194e-08
- O 0 6.057029366957067e-08
eight O 0 3.146433114054048e-10
percent O 0 3.1964456082000936e-10
of O 0 3.6965053414050875e-12
identified O 0 2.7393186385893387e-08
PAX6 O 0 8.900648936105426e-06
mutations O 0 2.418805991055706e-07
are O 0 2.169288915165879e-10
C O 0 4.1880670664795616e-07
- O 0 2.2939843802305404e-06
T O 0 6.4261184888891876e-06
changes O 0 4.946162229790829e-11
at O 0 7.518136287132382e-12
CpG O 0 1.1020739876244079e-09
dinucleotides O 0 4.37773373107575e-09
, O 0 8.038196302150025e-13
20 O 0 3.0271951937353714e-13
% O 0 1.0228447998522974e-13
are O 0 9.487433083078811e-14
splicing O 0 7.022609577189698e-11
errors O 0 1.1972236535484626e-09
, O 0 5.158811203741231e-13
and O 0 4.2062043409916983e-13
more O 0 1.29620706529332e-13
than O 0 3.111125506521928e-12
30 O 0 1.073688447178478e-12
% O 0 3.5596216729424923e-13
are O 0 1.1335435628340162e-12
deletion O 0 5.177785422638692e-10
or O 0 1.2996501097539692e-10
insertion O 0 9.283846469365642e-10
events O 0 7.696538517620866e-09
. O 0 5.1098174580488376e-09

There O 0 2.6376149264706328e-08
is O 0 1.922224324157895e-10
a O 0 3.737543885495853e-10
noticeably O 0 2.9844858318028855e-07
elevated O 0 2.14626481920277e-07
level O 0 1.8643822041752856e-09
of O 0 2.3906662240114063e-12
mutation O 0 4.64272886802064e-09
in O 0 3.4366418131398513e-12
the O 0 1.0790282512981864e-12
paired O 0 1.3458103520491704e-09
domain O 0 3.3567218449270797e-10
compared O 0 1.688728740179002e-10
with O 0 8.63091661942178e-13
the O 0 7.348785642513622e-12
rest O 0 1.9291210989758056e-11
of O 0 7.951324603079624e-13
the O 0 1.5396614538865094e-11
gene O 0 2.0986576920734024e-09
. O 0 8.199250167706396e-10

Increased O 0 2.9146784186195873e-07
mutation O 0 1.0082678727485472e-06
in O 0 1.0194282917819208e-10
the O 0 9.304152066846871e-12
homeodomain O 0 3.375021506712983e-08
is O 0 4.7562148663971016e-11
accounted O 0 3.4407560134397386e-11
for O 0 6.36997439930169e-14
by O 0 9.669026647049495e-13
the O 0 2.6891662507910752e-11
hypermutable O 0 4.6910116680010105e-07
CpG O 0 1.0636868097435581e-07
dinucleotide O 0 1.7529632856394528e-08
in O 0 1.0174178166622028e-10
codon O 0 2.2575297187188426e-09
240 O 0 7.167093585280782e-10
. O 0 1.1862200111067978e-09

Very O 0 2.0039676584815425e-08
nearly O 0 3.3036659519147804e-10
all O 0 8.168303707034585e-12
mutations O 0 3.006922266735046e-09
appear O 0 8.160619957564563e-10
to O 0 3.4116560271302276e-11
cause O 0 2.0887196683361253e-07
loss O 0 1.1901775565092976e-08
of O 0 2.0536003453308638e-12
function O 0 1.5082361748408601e-10
of O 0 1.825004719829132e-13
the O 0 1.8142293223277761e-12
mutant O 0 1.4026386718768435e-09
allele O 0 1.0017918716798135e-09
, O 0 4.926056849756388e-13
and O 0 1.799598610321279e-13
more O 0 4.820788747036432e-14
than O 0 1.3398226755487186e-12
80 O 0 6.977808088282078e-13
% O 0 1.153173964738713e-13
of O 0 3.638160736216256e-13
exonic O 0 4.6479144089062174e-08
substitutions O 0 4.270178433074534e-09
result O 0 1.7246334360621063e-09
in O 0 1.965527879344009e-10
nonsense O 0 2.1336201427857304e-07
codons O 0 2.2433873425597994e-08
. O 0 7.324416628762265e-10

In O 0 8.281070829063708e-10
a O 0 6.54548013012679e-11
gene O 0 4.5312956165055596e-10
with O 0 1.441926786305281e-11
such O 0 6.15120870905983e-11
extraordinarily O 0 6.585300070582889e-06
high O 0 4.408855058812833e-09
sequence O 0 7.926348466469335e-11
conservation O 0 6.993720706727213e-12
throughout O 0 9.95812265112972e-13
evolution O 0 8.48659944402419e-12
, O 0 3.8382610891701807e-13
there O 0 2.253787651299022e-12
are O 0 1.0900314505180031e-11
presumed O 0 1.3417312061392295e-07
undiscovered O 0 3.7745863323834783e-07
missense O 0 9.744510407472262e-07
mutations O 0 2.4288567601615796e-07
, O 0 2.452405899883159e-12
these O 0 5.725245581442162e-13
are O 0 1.6291612156549284e-12
hypothesized O 0 1.3986040103830533e-10
to O 0 1.408172623645898e-11
exist O 0 1.5682075638068227e-09
in O 0 2.505445850786714e-11
as O 0 2.094713291711514e-10
- O 0 9.519187074147339e-07
yet O 0 3.479135557427071e-08
unidentified O 0 5.474701652019576e-07
phenotypes O 0 7.358477205343661e-08
. O 0 5.780267237076586e-11
. O 0 3.489526445576985e-10

Genetic O 0 7.47768808651017e-06
heterogeneity O 0 8.154033821483608e-06
and O 0 4.5652437385967914e-09
penetrance O 0 1.262063960894011e-06
analysis O 0 6.70121624857245e-10
of O 0 4.379322425529519e-12
the O 0 1.241858005318619e-10
BRCA1 O 0 1.5725381672382355e-05
and O 0 1.0200380984315416e-08
BRCA2 O 0 8.133492883644067e-06
genes O 0 1.981018016294911e-07
in O 0 3.2928614501770426e-08
breast B-Disease 1 0.9981970191001892
cancer I-Disease 0 0.07588419318199158
families O 0 1.8305686921848974e-07
. O 0 1.7383298356321575e-08

The O 0 3.747585287783295e-05
Breast B-Disease 1 0.9999984502792358
Cancer I-Disease 1 0.9999881982803345
Linkage O 0 0.03547561168670654
Consortium O 0 1.8268177882418968e-05
. O 0 9.268320155797483e-08

The O 0 5.08950548372411e-10
contribution O 0 7.856153505514385e-10
of O 0 3.296149117537617e-11
BRCA1 O 0 4.727623945655068e-06
and O 0 1.3736169535150111e-08
BRCA2 O 0 0.001764816464856267
to O 0 2.1715013645007275e-05
inherited B-Disease 1 1.0
breast I-Disease 1 0.9999998807907104
cancer I-Disease 1 1.0
was O 0 2.6740297471405938e-05
assessed O 0 2.4412202037638053e-07
by O 0 3.134923917680332e-11
linkage O 0 1.6119994938890159e-07
and O 0 7.033186533167424e-11
mutation O 0 1.8461934203628516e-09
analysis O 0 5.052051658960277e-12
in O 0 4.1781628070530763e-13
237 O 0 2.0510169083942653e-12
families O 0 4.153224205521999e-12
, O 0 2.3312623533000565e-13
each O 0 8.600745441365854e-13
with O 0 3.407855811779492e-12
at O 0 2.554307043656223e-10
least O 0 3.505747341731036e-12
four O 0 8.015399867271344e-13
cases O 0 7.85626511762283e-12
of O 0 2.769660022161613e-11
breast B-Disease 0 0.32680922746658325
cancer I-Disease 0 7.476255632354878e-06
, O 0 3.063575651843231e-12
collected O 0 2.8257413769994244e-11
by O 0 8.552936830996671e-11
the O 0 1.8597289681565599e-06
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999980926513672
Linkage O 0 0.0007514567114412785
Consortium O 0 2.8844377197856375e-07
. O 0 2.223645045873468e-09

Families O 0 5.057229657268181e-08
were O 0 1.0110031561927357e-10
included O 0 9.181173182826186e-12
without O 0 2.3229113077505303e-11
regard O 0 7.848252429887292e-12
to O 0 3.24717981453268e-13
the O 0 1.508349543356824e-12
occurrence O 0 4.771721240359739e-09
of O 0 9.407673945416306e-11
ovarian B-Disease 0 0.0001763253239914775
or I-Disease 0 6.525669249413113e-08
other I-Disease 0 6.264310847825527e-09
cancers I-Disease 0 0.021211376413702965
. O 0 2.1723424836750382e-08

Overall O 0 5.085719749331474e-06
, O 0 7.269722601677131e-09
disease O 0 1.245665430360532e-06
was O 0 2.073590410489601e-09
linked O 0 1.4905955936228565e-07
to O 0 4.252122612347087e-11
BRCA1 O 0 5.6052787300586715e-08
in O 0 6.083021673181088e-12
an O 0 3.5113529922234377e-13
estimated O 0 1.9134917608742974e-11
52 O 0 3.2706652056818664e-12
% O 0 3.3832566739486203e-13
of O 0 2.6109098064976133e-13
families O 0 9.253728859570653e-12
, O 0 4.964805693299934e-13
to O 0 1.3665949882141204e-12
BRCA2 O 0 1.884535638652096e-09
in O 0 2.8392247320568886e-12
32 O 0 2.364418990458139e-12
% O 0 1.8410383081316622e-13
of O 0 4.432015464263944e-13
families O 0 4.131270325835601e-11
, O 0 2.300783261827144e-12
and O 0 1.678486342970853e-12
to O 0 6.606089915546509e-13
neither O 0 8.242176385842015e-11
gene O 0 8.113074448368174e-12
in O 0 5.722603380747815e-13
16 O 0 3.436436519458491e-13
% O 0 1.3108536879666982e-13
( O 0 7.285111506020667e-14
95 O 0 6.680723140493894e-13
% O 0 1.9005964337071024e-12
confidence O 0 1.3692537770282343e-08
interval O 0 2.1898191704394776e-08
[ O 0 7.292563775074257e-10
CI O 0 9.92020865453469e-09
] O 0 8.803069384555329e-11
6 O 0 1.5070324545576885e-12
% O 0 4.2838337586427466e-13
- O 0 4.793054841911726e-10
28 O 0 2.8399952528568306e-11
% O 0 7.112012801596679e-13
) O 0 1.922456199223918e-13
, O 0 2.68787650557073e-13
suggesting O 0 6.440687427833325e-10
other O 0 3.4497189826954155e-11
predisposition O 0 6.322995318441826e-07
genes O 0 2.7968122040533672e-08
. O 0 1.3826322309284933e-09

The O 0 4.4573361668298617e-10
majority O 0 2.980506397243232e-10
( O 0 5.7969137302882334e-12
81 O 0 7.361973010377998e-12
% O 0 3.651696187188108e-13
) O 0 4.4387640129239445e-14
of O 0 1.5633780619909998e-13
the O 0 1.2657491055279024e-08
breast B-Disease 1 0.9999971389770508
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 1.7822502584863287e-08
were O 0 4.114538154631475e-10
due O 0 1.208769057070569e-10
to O 0 5.4122737541684174e-11
BRCA1 O 0 2.561040162163408e-07
, O 0 2.0506649763690765e-12
with O 0 1.5964989746874991e-12
most O 0 5.33461599547258e-12
others O 0 2.0706873715692353e-11
( O 0 1.0857087798243903e-12
14 O 0 3.5367221304372087e-12
% O 0 1.5203594676618803e-12
) O 0 5.452615897856561e-13
due O 0 8.422022107490434e-11
to O 0 6.626948434451663e-10
BRCA2 O 0 1.1324920706101693e-05
. O 0 1.0010531070747675e-08

Conversely O 0 6.91639479555306e-06
, O 0 5.192479085591728e-11
the O 0 2.5697170086269594e-12
majority O 0 5.929699439799485e-12
of O 0 8.68489958769092e-13
families O 0 1.004804746351784e-11
with O 0 1.9817173943503796e-11
male B-Disease 0 1.666127360522296e-07
and I-Disease 0 2.7089336995800295e-08
female I-Disease 0 0.0006755298236384988
breast I-Disease 1 0.7672773003578186
cancer I-Disease 0 5.662986950483173e-05
were O 0 3.951755811471003e-09
due O 0 8.109632410047141e-10
to O 0 2.006038390955922e-10
BRCA2 O 0 7.497172305193089e-07
( O 0 4.977924322746574e-11
76 O 0 4.5230147405206367e-10
% O 0 5.706445385667003e-11
) O 0 4.8156773707619394e-11
. O 0 1.2198382304262623e-09

The O 0 6.035850153018885e-10
largest O 0 6.901550997362449e-10
proportion O 0 2.0488069019108934e-09
( O 0 2.2417530071844327e-12
67 O 0 8.254837785548474e-12
% O 0 5.776117431577354e-13
) O 0 9.099626163255187e-14
of O 0 2.466538800462159e-13
families O 0 1.8448470182064192e-11
due O 0 1.6792502111062646e-10
to O 0 3.4233284609830328e-12
other O 0 2.4410517010520216e-12
genes O 0 8.55758727769107e-11
was O 0 3.876066412278334e-10
found O 0 7.920530203930909e-11
in O 0 8.966337221305576e-12
families O 0 1.1530513956831134e-12
with O 0 1.123500164429414e-12
four O 0 4.211264149900362e-12
or O 0 3.948963725464161e-11
five O 0 1.895455580686045e-12
cases O 0 1.8205981860974774e-11
of O 0 3.214823199315653e-11
female O 0 0.00021476585243362933
breast B-Disease 1 0.8020912408828735
cancer I-Disease 0 2.998064701387193e-05
only O 0 1.4002757842135338e-09
. O 0 3.1729880944908473e-09

These O 0 5.859638885219454e-10
estimates O 0 4.043548162968591e-09
were O 0 8.832804626601742e-11
not O 0 6.88624157696438e-11
substantially O 0 1.6942270919528823e-09
affected O 0 1.851703686217565e-11
either O 0 2.701338501845396e-12
by O 0 1.2165508401010272e-12
changing O 0 1.9165280473742996e-10
the O 0 4.400463934212118e-12
assumed O 0 1.2241081481789706e-09
penetrance O 0 1.6230412569484542e-09
model O 0 5.161060120939531e-11
for O 0 9.608065211497152e-13
BRCA1 O 0 3.670733050853414e-09
or O 0 4.842249171077562e-11
by O 0 3.0997589477860243e-12
including O 0 4.23724813916615e-12
or O 0 2.001113719174441e-09
excluding O 0 4.231062078474679e-08
BRCA1 O 0 8.709580470167566e-06
mutation O 0 4.154627788466314e-07
data O 0 5.570576178115516e-08
. O 0 1.954224559952422e-09

Among O 0 2.1922712534205857e-09
those O 0 7.310483468581097e-11
families O 0 7.777057470237381e-11
with O 0 1.2227796553077042e-10
disease O 0 4.710279100095249e-08
due O 0 4.3977668728878427e-10
to O 0 2.028384682439821e-10
BRCA1 O 0 1.0465703326190123e-06
that O 0 2.5504041101243047e-09
were O 0 2.211084204617464e-09
tested O 0 3.6216138976641332e-09
by O 0 1.1272177852586496e-12
one O 0 2.4385992357378594e-12
of O 0 4.929766650777455e-14
the O 0 2.3854450858194765e-13
standard O 0 6.317167275393665e-12
screening O 0 3.4665035598957505e-12
methods O 0 7.13209769021006e-11
, O 0 5.809828529726446e-13
mutations O 0 1.0577453496418698e-10
were O 0 3.658873898304549e-11
detected O 0 4.647169760119141e-08
in O 0 2.681916971489229e-12
the O 0 3.4474350457669445e-12
coding O 0 4.156548993883291e-10
sequence O 0 2.8451078298852295e-11
or O 0 1.2098865746074106e-12
splice O 0 3.059658776338736e-11
sites O 0 1.5517283638577517e-11
in O 0 6.998707711459995e-13
an O 0 1.8972449750565695e-13
estimated O 0 1.7114096598214168e-11
63 O 0 7.586632710943064e-12
% O 0 4.3109726942727744e-13
( O 0 2.3642107152208047e-13
95 O 0 9.78029723180951e-13
% O 0 1.855450255244806e-12
CI O 0 5.919109646868037e-09
51 O 0 5.008705603049002e-11
% O 0 6.790554663710369e-12
- O 0 1.1390464571547909e-08
77 O 0 1.3127196551998566e-10
% O 0 2.002955960811459e-11
) O 0 4.10827066810171e-11
. O 0 4.0984343696592873e-10

The O 0 6.011817266227126e-09
estimated O 0 1.3604497084429568e-08
sensitivity O 0 2.4451210265397094e-06
was O 0 1.3974589485599154e-08
identical O 0 7.994696460400519e-09
for O 0 1.5773146677666716e-13
direct O 0 1.922607472532034e-12
sequencing O 0 3.351570063148124e-11
and O 0 8.9339022291135e-12
other O 0 7.958000577956703e-13
techniques O 0 3.259255310084086e-09
. O 0 4.0614708818331735e-10

The O 0 4.855053692409683e-09
penetrance O 0 2.0301381482568104e-06
of O 0 1.7944734587160838e-10
BRCA2 O 0 5.965893706161296e-06
was O 0 6.937796559469689e-09
estimated O 0 4.515840479335509e-11
by O 0 1.0701882088848258e-12
maximizing O 0 7.32036598005692e-10
the O 0 4.805354725245792e-11
LOD O 0 2.488237078068778e-05
score O 0 9.295487157778837e-10
in O 0 1.4686817734199664e-11
BRCA2 O 0 8.104799320562961e-08
- O 0 1.6618047027350258e-07
mutation O 0 7.0878982683098e-08
families O 0 4.50236375959534e-11
, O 0 7.75211004330062e-13
over O 0 4.278348508801599e-12
all O 0 4.660866310957079e-12
possible O 0 1.2159078188744843e-09
penetrance O 0 2.0360933206120535e-07
functions O 0 1.3616275884587026e-09
. O 0 7.402263801914444e-10

The O 0 2.326908887795298e-09
estimated O 0 1.2664415072194402e-09
cumulative O 0 2.9189610728508342e-08
risk O 0 3.153261118882256e-08
of O 0 7.052584211075796e-11
breast B-Disease 0 0.1477784663438797
cancer I-Disease 0 0.00012026668264297768
reached O 0 5.45584155631218e-09
28 O 0 1.0409249850962254e-11
% O 0 1.741428317736729e-13
( O 0 5.686694604795095e-14
95 O 0 2.5697155449540265e-13
% O 0 4.314180848501159e-13
CI O 0 1.8010408719959514e-09
9 O 0 3.9332365489586074e-12
% O 0 1.5164113725558287e-13
- O 0 2.5558458127683537e-11
44 O 0 4.1778437805638224e-13
% O 0 3.7477230249282484e-14
) O 0 3.7250298264251795e-15
by O 0 1.1053664087561435e-13
age O 0 1.8633209558638342e-11
50 O 0 3.1365237013539216e-13
years O 0 1.1151674202125594e-12
and O 0 5.328704599967538e-13
84 O 0 2.307299316883782e-13
% O 0 5.091175216327161e-14
( O 0 3.472906234510201e-14
95 O 0 5.684918681636564e-13
% O 0 3.621820454224184e-13
CI O 0 1.1271980016047678e-09
43 O 0 3.310891491525858e-12
% O 0 6.214529758852283e-13
- O 0 6.006493219468112e-11
95 O 0 9.34681802441939e-13
% O 0 2.9087718561929266e-13
) O 0 5.3126675557705824e-14
by O 0 3.968026428269322e-12
age O 0 2.2371049457348136e-09
70 O 0 2.1067488031878412e-11
years O 0 3.186499120122477e-10
. O 0 3.65354108078364e-10

The O 0 1.8955648783958168e-07
corresponding O 0 0.14190565049648285
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
risks O 1 0.9144622087478638
were O 0 4.4896104611780174e-08
0 O 0 8.79086314853339e-09
. O 0 2.059974413270993e-09

4 O 0 1.2805122517889345e-09
% O 0 2.511972574392729e-11
( O 0 1.857532357096847e-12
95 O 0 4.196694207425633e-12
% O 0 3.774930888711392e-12
CI O 0 1.1772767649631533e-08
0 O 0 1.9966927417014446e-11
% O 0 8.039683285429589e-13
- O 0 5.5910481105980736e-11
1 O 0 6.5009473498856e-12
% O 0 2.3526764304088177e-13
) O 0 1.3949832195143171e-14
by O 0 2.2524583381203916e-13
age O 0 1.4287748067998152e-11
50 O 0 4.080908516928411e-13
years O 0 1.471033147723566e-12
and O 0 7.543830469157464e-13
27 O 0 4.694034332237973e-13
% O 0 3.508833984000939e-14
( O 0 8.636769752612579e-15
95 O 0 8.948747911305746e-14
% O 0 9.184159373764808e-14
CI O 0 3.72940456294657e-10
0 O 0 3.58438214005663e-12
% O 0 1.8527546033833553e-13
- O 0 1.0433704594747795e-10
47 O 0 1.0294770244612117e-11
% O 0 2.9920529487185987e-13
) O 0 2.8493016052035663e-14
by O 0 1.1645133642101957e-12
age O 0 8.727473188585577e-10
70 O 0 2.2604184149455087e-11
years O 0 1.3859741132549175e-10
. O 0 4.756053884058531e-10

The O 0 5.362555732801866e-09
lifetime O 0 3.5264778830423893e-07
risk O 0 2.2078387473811745e-07
of O 0 4.94466523282e-10
breast B-Disease 1 0.9952946305274963
cancer I-Disease 0 0.005428866483271122
appears O 0 2.920720909571628e-08
similar O 0 9.554547431012139e-11
to O 0 1.2088070345042667e-12
the O 0 6.6602040722785194e-12
risk O 0 4.108391848944848e-09
in O 0 2.059532405729314e-11
BRCA1 O 0 8.14155072248468e-08
carriers O 0 5.375674128060837e-09
, O 0 1.013218762363488e-11
but O 0 3.1993473842417686e-11
there O 0 8.2622086255979e-12
was O 0 2.1463716221026274e-11
some O 0 3.538661741018731e-14
suggestion O 0 3.617875096728618e-11
of O 0 1.8093041171188262e-13
a O 0 7.731268403254887e-11
lower O 0 1.543730476782912e-08
risk O 0 6.93856394562431e-09
in O 0 1.6489825130361346e-11
BRCA2 O 0 1.0676255435271287e-08
carriers O 0 4.636187267426095e-10
< O 0 2.059008297194964e-09
50 O 0 9.908619931497942e-12
years O 0 2.2772380769281453e-12
of O 0 2.9570829292169254e-12
age O 0 4.7356079058147316e-09
. O 0 8.919812666263738e-10

Eye B-Disease 1 0.7616052627563477
movement I-Disease 0 3.900205683748936e-06
abnormalities I-Disease 0 0.013479911722242832
correlate O 0 1.4561995840267627e-06
with O 0 3.5259573039070347e-09
genotype O 0 0.01934313401579857
in O 0 4.668607544999759e-08
autosomal O 1 0.9930054545402527
dominant O 1 0.9032850861549377
cerebellar B-Disease 1 0.9990239143371582
ataxia I-Disease 1 0.999818742275238
type I-Disease 1 0.9986963868141174
I I-Disease 1 0.5959944128990173
. O 0 4.13655918407585e-08

We O 0 1.7561065135396348e-07
compared O 0 4.7327027630217344e-08
horizontal O 0 0.0003164486843161285
eye O 0 0.21776768565177917
movements O 0 2.5724453735165298e-05
( O 0 2.5684260274161375e-10
visually O 0 3.146172034007577e-08
guided O 0 2.6077611181563043e-08
saccades O 0 1.0252468200633302e-05
, O 0 4.041284668021561e-11
antisaccades O 0 1.2636744983751669e-08
, O 0 9.763672075696617e-13
and O 0 1.0153734407089554e-12
smooth O 0 4.0827677350030456e-10
pursuit O 0 2.796149312089824e-09
) O 0 9.984177113536719e-13
in O 0 2.0300972274761575e-12
control O 0 5.735856789534921e-10
subjects O 0 1.7102571803206956e-08
( O 0 2.3241068358020867e-12
n O 0 4.501003125767511e-09
= O 0 1.712511799034644e-09
14 O 0 2.4372229495001063e-12
) O 0 1.4523201163820637e-13
and O 0 1.9937397219282893e-11
patients O 0 3.496633538269123e-11
with O 0 1.2703563244745308e-12
three O 0 2.383913596040732e-12
forms O 0 5.548511650133037e-11
of O 0 6.421622261720827e-11
autosomal O 0 0.00016021396731957793
dominant O 0 3.064585689571686e-05
cerebellar B-Disease 0 0.0007535506156273186
ataxias I-Disease 0 0.0005001489189453423
type I-Disease 0 0.004039502702653408
I I-Disease 0 0.00016233020869549364
spinocerebellar B-Disease 0 6.374525401042774e-05
ataxias I-Disease 0 1.863375359789643e-06
1 I-Disease 0 2.7359320364794826e-10
and I-Disease 0 4.5046230634504525e-11
2 I-Disease 0 3.053386016249604e-11
( O 0 2.6898676428604995e-12
SCA1 B-Disease 0 1.6101358824016643e-07
, O 0 4.161066022995152e-12
n O 0 9.259905731084928e-09
= O 0 2.2286170686669493e-09
11 O 0 2.102797536790435e-12
; O 0 3.031707914227799e-13
SCA2 B-Disease 0 6.8283729781626334e-09
, O 0 6.992409581040027e-13
n O 0 8.411976670785748e-10
= O 0 8.247008631556696e-10
10 O 0 1.3254237117565904e-12
) O 0 2.3407973693059803e-13
and O 0 2.9574356852357653e-10
SCA3 B-Disease 1 0.9999974966049194
/ O 0 1.1991116934950696e-06
Machado B-Disease 0 6.463324098149315e-07
- I-Disease 0 6.043573193892371e-06
Joseph I-Disease 0 1.1137178262288217e-05
disease I-Disease 0 1.0614696293487214e-05
( O 0 1.1539523503412141e-10
MJD B-Disease 1 0.9999918937683105
) O 0 5.977406764001714e-11
( O 0 3.7891708000448165e-12
n O 0 4.1211084322867464e-08
= O 0 5.7128143993168123e-08
16 O 0 2.8682207650621017e-11
) O 0 1.6153557658160622e-11
. O 0 3.6576477957517284e-10

In O 0 1.3703380652430042e-08
SCA1 B-Disease 0 2.006800059461966e-06
, O 0 6.226910653772677e-11
saccade O 0 7.630212195408603e-08
amplitude O 0 7.666214685286832e-08
was O 0 6.588973255894359e-10
significantly O 0 3.2203972821776006e-10
increased O 0 1.746756905784963e-10
, O 0 5.7242877972429884e-12
resulting O 0 2.392488707148033e-10
in O 0 2.570229584719641e-10
hypermetria B-Disease 0 1.8584311192171299e-06
. O 0 4.394213881653286e-09

The O 0 4.357656457898429e-09
smooth O 0 3.420182892455159e-08
pursuit O 0 5.140682191040469e-08
gain O 0 1.00315219242475e-07
was O 0 5.944739456253956e-08
decreased O 0 3.9659843764638936e-07
. O 0 6.654716777632075e-09

In O 0 5.9002296382004715e-09
SCA2 B-Disease 0 1.0730353778853896e-06
, O 0 2.947742050452007e-11
saccade O 0 1.6945583070082648e-07
velocity O 0 1.1000001620686817e-07
was O 0 1.0845167430773017e-08
markedly O 0 2.1554831164394272e-07
decreased O 0 2.128882243823682e-07
. O 0 1.8132910728496654e-09

The O 0 1.821016670788822e-09
percentage O 0 1.1562184099034312e-08
of O 0 6.494366676379482e-12
errors O 0 2.4580104618365795e-09
in O 0 2.5996671829120466e-11
antisaccades O 0 7.11078200765769e-07
was O 0 8.804958540054031e-09
greatly O 0 8.54144754924846e-10
increased O 0 2.293341766490542e-10
and O 0 3.8250878159340473e-11
was O 0 4.0729677963646793e-10
significantly O 0 3.954860328114762e-10
correlated O 0 4.4928030185076295e-09
with O 0 1.3223090677971783e-10
age O 0 9.867558325993286e-09
at O 0 3.783514390676146e-09
disease O 0 8.686859587214713e-08
onset O 0 8.603046808275394e-08
. O 0 5.702131655738185e-09

In O 0 2.8658670991887902e-09
addition O 0 1.8016411973409419e-10
, O 0 1.7960263267932652e-12
a O 0 4.413071904435517e-12
correlation O 0 2.4422057709472256e-09
between O 0 3.68752181567622e-11
smooth O 0 1.1855329162813177e-08
pursuit O 0 3.486842103939125e-08
gain O 0 1.8806012747063505e-08
and O 0 5.426103663608295e-11
the O 0 2.0038643053915672e-12
number O 0 6.778830535097979e-12
of O 0 6.344650499423565e-12
trinucleotide O 0 4.547217997696862e-07
repeats O 0 4.991470703430423e-08
was O 0 1.613334466021854e-09
found O 0 1.0631240332514835e-09
. O 0 1.2647155545053579e-09

In O 0 1.3307437995990767e-07
SCA3 B-Disease 1 0.9999607801437378
, O 0 2.295605483482177e-09
gaze B-Disease 0 0.00018585554789751768
- I-Disease 0 1.940500078490004e-05
evoked I-Disease 0 2.44128932536114e-05
nystagmus I-Disease 0 1.824764876801055e-05
was O 0 2.724707393042536e-08
often O 0 3.712421203783123e-10
present O 0 1.3853339482505778e-11
as O 0 5.4444712627166325e-12
was O 0 1.4046672158762874e-10
saccade O 0 7.051030870286468e-09
hypometria O 0 1.647438274687829e-08
and O 0 5.892662226225642e-12
smooth O 0 3.770250500689798e-10
pursuit O 0 3.494216915811421e-09
gain O 0 8.540506968301997e-09
was O 0 2.212730620954062e-08
markedly O 0 2.2524238829646492e-07
decreased O 0 8.223847913768623e-08
. O 0 1.5494762140022544e-09

Three O 0 1.6236172406536298e-09
major O 0 1.8685215874558736e-10
criteria O 0 1.1621209550227718e-09
, O 0 1.4621656749952416e-12
saccade O 0 7.568244697608861e-09
amplitude O 0 3.759932809543898e-09
, O 0 8.184222071751235e-13
saccade O 0 4.26900559347132e-09
velocity O 0 8.714868826587008e-09
, O 0 4.4451714444754264e-13
and O 0 8.099278626244599e-13
presence O 0 1.0911880773956106e-11
of O 0 6.224188699166522e-12
gaze B-Disease 0 0.00013668491737917066
- I-Disease 0 1.4165116226649843e-06
evoked I-Disease 0 4.138391034302913e-07
nystagmus I-Disease 0 2.2872546523444726e-08
, O 0 6.954422389522652e-13
permitted O 0 2.822185193873672e-12
the O 0 7.697991007658833e-13
correct O 0 1.824001782946283e-10
assignment O 0 4.072396499882336e-12
of O 0 1.7888995338766027e-14
90 O 0 7.692174534053992e-14
% O 0 1.341798190162809e-14
of O 0 1.2892680019828233e-14
the O 0 1.0957654054954968e-12
SCA1 B-Disease 0 3.783624435982347e-08
, O 0 4.762864365057129e-13
90 O 0 1.0428873612128645e-13
% O 0 4.5447108939665123e-14
of O 0 3.436159912379236e-14
the O 0 2.055446091109303e-12
SCA2 B-Disease 0 1.2250083614162577e-07
, O 0 2.2979797860596396e-13
and O 0 2.1101248190175809e-13
93 O 0 8.548079643211012e-14
% O 0 2.2210706513456184e-14
of O 0 3.013517576753652e-14
the O 0 1.554414930104997e-11
patients O 0 1.2698368745400757e-10
with O 0 3.0528982120081594e-10
SCA3 B-Disease 1 0.9999983310699463
to O 0 8.22460363703037e-11
their O 0 2.1391988874741585e-11
genetically O 0 8.157144404385974e-11
confirmed O 0 9.540694900778135e-10
patient O 0 2.2173769487210393e-09
group O 0 2.7284008385919378e-11
and O 0 2.038568792939177e-11
, O 0 7.749685767242942e-13
therefore O 0 3.495726624835882e-11
, O 0 2.6103483524025917e-12
may O 0 5.368045591369608e-11
help O 0 9.500390057981534e-12
orient O 0 6.5750915823059586e-09
diagnoses O 0 5.3304056280012446e-08
of O 0 1.0596161535009196e-12
SCA1 B-Disease 0 1.4974589248595294e-06
, O 0 5.795277886050387e-12
SCA2 B-Disease 0 1.8799275380843028e-07
, O 0 3.3197951766067435e-12
and O 0 8.86169471137066e-11
SCA3 B-Disease 1 0.9999853372573853
at O 0 1.3173120927412185e-10
early O 0 2.994859221727708e-11
clinical O 0 6.594891993616514e-11
stages O 0 9.470687428736468e-11
of O 0 6.826331600678914e-12
the O 0 1.6647314637907584e-09
diseases O 0 3.779103110446158e-07
. O 0 2.7495637711094645e-11
. O 0 7.818855563002103e-10

Genetic O 0 1.530974486740888e-06
basis O 0 1.1517765408086689e-08
and O 0 1.5383889717668353e-09
molecular O 0 4.6456898417090997e-07
mechanism O 0 4.817999865736056e-07
for O 0 6.595995500902063e-07
idiopathic B-Disease 1 0.9999997615814209
ventricular I-Disease 1 0.9999786615371704
fibrillation I-Disease 1 0.9999974966049194
. O 0 7.019507756922394e-05

Ventricular B-Disease 0 0.02589106373488903
fibrillation I-Disease 0 0.0017192960949614644
causes O 0 1.090315890905913e-06
more O 0 9.961698133054142e-12
than O 0 6.95312644266588e-12
300 O 0 4.909203685926622e-12
, O 0 6.471919354600342e-13
000 O 0 6.20172056070567e-12
sudden O 0 7.42276462517566e-10
deaths O 0 2.5524660163256385e-10
each O 0 1.3675343843444487e-11
year O 0 5.862229451869538e-11
in O 0 5.413757983574463e-12
the O 0 3.736508324969634e-11
USA O 0 9.617512120030369e-08
alone O 0 3.9018168251914176e-08
. O 0 4.771345540888206e-10

In O 0 5.521635926264423e-10
approximately O 0 2.1656291343541412e-11
5 O 0 4.749839410678192e-12
- O 0 4.022522592794786e-10
12 O 0 3.3184024104959686e-12
% O 0 2.0895424605003876e-13
of O 0 4.6399285780727995e-14
these O 0 6.526739218526423e-12
cases O 0 4.9356262132871365e-11
, O 0 2.0191918883444293e-12
there O 0 4.604334708641078e-12
are O 0 1.7765583925841155e-12
no O 0 1.5139658970930725e-10
demonstrable O 0 4.9197024054592475e-06
cardiac O 0 2.4001749920898874e-07
or O 0 1.770685043034348e-09
non O 0 5.6640416801201354e-09
- O 0 1.5898125639068894e-05
cardiac O 0 3.32476861331088e-06
causes O 0 4.839975886739012e-08
to O 0 7.272651231238214e-12
account O 0 7.218454306512356e-11
for O 0 4.568492394281531e-13
the O 0 1.1883513921159827e-12
episode O 0 1.2253135173168062e-09
, O 0 9.202914472150603e-12
which O 0 2.901687570777689e-11
is O 0 1.964799850595611e-11
therefore O 0 3.963665506923064e-10
classified O 0 3.5106655360550576e-08
as O 0 1.642917197841598e-07
idiopathic B-Disease 1 0.9999990463256836
ventricular I-Disease 1 0.9999542236328125
fibrillation I-Disease 1 0.9999996423721313
( O 0 5.84909821554902e-06
IVF B-Disease 1 0.9999909400939941
) O 0 9.044244464462281e-09
. O 0 9.821854440872357e-09

A O 0 3.3757814321688784e-08
distinct O 0 1.778632796600732e-09
group O 0 2.7070043429056057e-10
of O 0 3.5238225531974976e-11
IVF B-Disease 1 0.9999923706054688
patients O 0 1.1807993587353849e-06
has O 0 3.910546997332176e-09
been O 0 2.550490374453318e-10
found O 0 1.071985000766773e-10
to O 0 5.144673749513107e-12
present O 0 2.237196539134345e-11
with O 0 5.402782388141958e-12
a O 0 6.41090458497473e-10
characteristic O 0 9.946440968633397e-07
electrocardiographic O 0 3.1751255846756976e-06
pattern O 0 1.0211047083430458e-06
. O 0 3.6926637303480447e-09

Because O 0 1.0800743410754876e-08
of O 0 2.523751607003133e-12
the O 0 5.70760452789365e-13
small O 0 4.871185486227114e-12
size O 0 1.548569983356174e-08
of O 0 1.9608715692842615e-12
most O 0 5.5316862201948425e-12
pedigrees O 0 1.984326480908294e-08
and O 0 1.8982386842947285e-11
the O 0 6.83108517668396e-12
high O 0 6.588172674071302e-09
incidence O 0 1.1133545285701985e-06
of O 0 2.989829521113374e-12
sudden B-Disease 0 1.6289601489916095e-07
death I-Disease 0 2.4806091403206665e-08
, O 0 2.0740223774518007e-12
however O 0 1.9124801568792815e-12
, O 0 9.95828853406211e-14
molecular O 0 3.9471943075186644e-11
genetic O 0 4.650443571896368e-11
studies O 0 6.20315214125422e-12
of O 0 3.461033326254692e-12
IVF B-Disease 1 0.9999852180480957
have O 0 9.181348303854975e-08
not O 0 7.080163122452632e-10
yet O 0 8.445060761808065e-10
been O 0 2.9567023829280004e-10
done O 0 1.8367138920893922e-09
. O 0 1.557650675110267e-10

Because O 0 7.5111156547791325e-06
IVF B-Disease 1 0.9999449253082275
causes O 0 0.0016040853224694729
cardiac O 0 0.004598969127982855
rhythm O 0 3.9444465073756874e-05
disturbance O 0 4.5419650973599346e-07
, O 0 3.477299351239971e-11
we O 0 5.0916104665788e-11
investigated O 0 3.197483833261572e-09
whether O 0 9.66651536593588e-10
malfunction O 0 2.5464228770033515e-07
of O 0 2.725252749163909e-12
ion O 0 1.5999964375623676e-07
channels O 0 7.9186229129391e-08
could O 0 7.993340886969236e-07
cause O 0 4.601200842557773e-08
the O 0 7.696648179900123e-11
disorder O 0 3.242490365096273e-08
by O 0 3.065498809656786e-12
studying O 0 1.8557566594523678e-10
mutations O 0 2.2969544044570966e-09
in O 0 3.160028228671452e-12
the O 0 1.6471530736583695e-11
cardiac O 0 1.7414103581359086e-07
sodium O 0 6.96479389716842e-08
channel O 0 4.0031320480693466e-08
gene O 0 7.810665181295917e-08
SCN5A O 0 9.738335393194575e-06
. O 0 7.927778433725052e-09

We O 0 1.1590716297860126e-07
have O 0 1.3855672165163924e-10
now O 0 2.035518628651367e-11
identified O 0 1.5456469437680198e-10
a O 0 6.719528405918496e-11
missense O 0 1.3231526281742845e-05
mutation O 0 3.2550437936151866e-06
, O 0 5.297838123058396e-12
a O 0 4.890717605204875e-12
splice O 0 1.1985086700860847e-07
- O 0 1.4559690271198633e-06
donor O 0 4.434851064161194e-08
mutation O 0 6.5402623476984445e-06
, O 0 7.754199192466782e-12
and O 0 3.108136144291951e-12
a O 0 1.006439515061075e-10
frameshift O 0 0.00011044064012821764
mutation O 0 1.7736611823693238e-07
in O 0 1.044385411486104e-11
the O 0 2.1926566465269026e-12
coding O 0 1.5168742928395318e-09
region O 0 7.422802650314253e-11
of O 0 1.8343796533842882e-12
SCN5A O 0 7.921340170469193e-07
in O 0 4.1720193272309913e-11
three O 0 1.6149992454472795e-10
IVF B-Disease 1 0.9993451237678528
families O 0 5.499880550985381e-09
. O 0 1.1611305250625037e-09

We O 0 1.5696656419095234e-08
show O 0 4.624194083202582e-10
that O 0 5.22834293220642e-12
sodium O 0 4.5669024117955814e-11
channels O 0 2.6908952496795813e-11
with O 0 1.6905090608615447e-12
the O 0 6.9616192151233935e-12
missense O 0 2.5496618150100403e-07
mutation O 0 7.08641181290659e-08
recover O 0 4.425883215475324e-09
from O 0 4.538747416099609e-12
inactivation O 0 3.0288589414340095e-09
more O 0 3.83353450979923e-13
rapidly O 0 6.050855649863962e-11
than O 0 4.187419508361323e-12
normal O 0 7.720172418013149e-11
and O 0 6.36350824465004e-12
that O 0 3.0856313597976692e-12
the O 0 1.3631619270870754e-11
frameshift O 0 8.436714779236354e-06
mutation O 0 7.491355091815421e-08
causes O 0 6.121634865685621e-10
the O 0 2.720002608563865e-12
sodium O 0 6.854637968345401e-10
channel O 0 2.328591763856025e-09
to O 0 1.1705114655313764e-10
be O 0 1.0518270698867127e-09
non O 0 1.0849858789185873e-09
- O 0 1.5261740315963834e-07
functional O 0 5.313616213697969e-08
. O 0 4.610774428925879e-09

Our O 0 2.7283249437459745e-07
results O 0 1.514579750505618e-08
indicate O 0 9.626005770257962e-09
that O 0 7.597467793774015e-11
mutations O 0 2.7454804651938503e-08
in O 0 1.173083991057311e-10
cardiac O 0 1.6426226068233518e-07
ion O 0 1.3964250683784485e-05
- O 0 5.324341600498883e-06
channel O 0 8.607573320773554e-09
genes O 0 2.641932228542032e-10
contribute O 0 2.6639205164685764e-12
to O 0 1.1512537884811325e-12
the O 0 3.478000873413656e-12
risk O 0 7.665256762656725e-10
of O 0 2.3938511763132997e-12
developing O 0 1.6395004243108247e-09
IVF B-Disease 1 0.9875176548957825
. O 0 3.2193900323385094e-10
. O 0 4.502821171481486e-10

Molecular O 0 1.278106765312259e-06
heterogeneity O 0 3.5757793170887453e-07
in O 0 5.1690618452227e-10
mucopolysaccharidosis B-Disease 0 5.195220751375018e-07
IVA I-Disease 0 3.247187487431802e-05
in O 0 3.8033540761261975e-09
Australia O 0 5.034607730713958e-10
and O 0 8.20490897446291e-11
Northern O 0 2.529595144462604e-10
Ireland O 0 1.1672998567746617e-08
: O 0 1.1076743688942514e-11
nine O 0 1.3435871339118055e-12
novel O 0 5.636218054771991e-12
mutations O 0 2.131941428951123e-10
including O 0 1.0158809557458959e-12
T312S O 0 1.8826209480238276e-09
, O 0 7.626599005106094e-13
a O 0 7.809845652129166e-12
common O 0 2.0476026429960825e-10
allele O 0 1.6536076952178291e-09
that O 0 1.2502970013483772e-11
confers O 0 6.3425544816198e-09
a O 0 2.1617438950016776e-09
mild O 0 7.981214366736822e-06
phenotype O 0 8.970911039796192e-06
. O 0 8.440555809841044e-09

Mucopolysaccharidosis B-Disease 0 0.004710793029516935
IVA I-Disease 0 0.15032897889614105
( O 0 1.5163795978878625e-06
MPS B-Disease 1 0.9998149275779724
IVA I-Disease 1 0.999991774559021
) O 0 5.1400816936109095e-09
is O 0 5.20799403602723e-10
an O 0 4.3434980612211405e-10
autosomal B-Disease 1 0.9997636675834656
recessive I-Disease 1 0.9999597072601318
lysosomal I-Disease 1 0.9999780654907227
storage I-Disease 1 0.9999728202819824
disorder I-Disease 1 0.9999260902404785
caused O 0 9.002062142826617e-06
by O 0 4.177133083871354e-10
a O 0 9.06570392089634e-07
genetic B-Disease 1 0.9999992847442627
defect I-Disease 1 0.9999996423721313
in O 0 1.1379499120778291e-08
N O 0 3.061871757381596e-05
- O 0 8.103097570710815e-06
acetylgalactosamine O 0 0.0001815946161514148
- O 0 0.00011591844668146223
6 O 0 5.585513918049401e-08
- O 0 0.00017431232845410705
sulfate O 0 0.00029556293156929314
sulfatase O 0 1.0850550097529776e-05
( O 0 1.952949330030762e-10
GALNS O 0 3.243227126858983e-07
) O 0 6.539403046845749e-11
. O 0 5.43256828411387e-10

Previous O 0 2.465279891339378e-08
studies O 0 9.717980864465403e-10
of O 0 6.5873456862874935e-12
patients O 0 7.622025927078724e-11
from O 0 1.894613589278893e-12
a O 0 7.041534716423214e-11
British O 0 3.475971865896099e-08
- O 0 2.1968897101487528e-07
Irish O 0 2.622275374619676e-08
population O 0 4.310539338664432e-12
showed O 0 2.2535748267493716e-10
that O 0 7.063669853028809e-13
the O 0 2.2269256480089011e-13
I113F O 0 2.353479078287535e-10
mutation O 0 3.300737183575819e-10
is O 0 1.3828015338682165e-12
the O 0 4.110703747881028e-13
most O 0 4.3628707417642243e-13
common O 0 9.54244929601833e-12
single O 0 1.6240632172426217e-09
mutation O 0 1.3111124985698552e-07
among O 0 1.2690094530753981e-09
MPS B-Disease 1 0.9998575448989868
IVA I-Disease 1 0.9999982118606567
patients O 0 0.00010071534052258357
and O 0 1.0923725035638654e-08
produces O 0 3.8427906190463545e-08
a O 0 2.0060673122657136e-08
severe O 0 6.427380139939487e-05
clinical O 0 3.862694029521663e-06
phenotype O 0 7.59235117584467e-05
. O 0 3.355035360641523e-08

We O 0 1.0719720933138888e-07
studied O 0 1.8386531408509654e-08
mutations O 0 2.029733536801359e-08
in O 0 3.979554533128926e-12
the O 0 2.7260325073663605e-12
GALNS O 0 2.5440456852265925e-08
gene O 0 1.1653300546754508e-10
from O 0 3.1172436593812636e-12
23 O 0 1.4518700477972324e-11
additional O 0 5.631170529873941e-11
MPS B-Disease 1 0.9997739195823669
IVA I-Disease 1 0.9999947547912598
patients O 0 2.009442823691643e-06
( O 0 1.539825905672032e-11
15 O 0 4.46894301078804e-12
from O 0 2.500670460633958e-12
Australia O 0 1.422971202674761e-11
, O 0 2.3176203794647576e-13
8 O 0 4.965080538550659e-13
from O 0 6.431617391444711e-13
Northern O 0 2.9029717865669546e-11
Ireland O 0 1.2704260976548198e-09
) O 0 4.633987421218122e-13
, O 0 1.8108292168810165e-14
with O 0 4.173365890066186e-14
various O 0 1.4972738760637982e-12
clinical O 0 7.561131276645483e-09
phenotypes O 0 3.3914261621248443e-07
( O 0 3.6950130455348784e-11
severe O 0 9.020470770337852e-07
, O 0 2.5811340911841008e-11
16 O 0 7.37705469627814e-12
cases O 0 2.713330081449694e-11
; O 0 3.805612075469256e-12
intermediate O 0 5.689176907353044e-11
, O 0 9.888640470703813e-13
4 O 0 4.574240292098963e-12
cases O 0 3.348324395524571e-11
; O 0 1.0460206312234988e-10
mild O 0 1.6251586032467458e-07
, O 0 1.7660555309828574e-11
3 O 0 8.964153030976973e-11
cases O 0 4.638593120720458e-10
) O 0 3.806586990062755e-11
. O 0 7.476274599405031e-10

We O 0 2.40683100116712e-08
found O 0 1.0433425651212858e-10
two O 0 2.5245170537369077e-12
common O 0 6.846480327116211e-11
mutations O 0 2.395179166114758e-09
that O 0 2.1594575086436585e-12
together O 0 9.462299650417338e-13
accounted O 0 8.352000514799673e-12
for O 0 5.2755482003296467e-14
32 O 0 7.959260962982218e-13
% O 0 6.007160372432929e-14
of O 0 5.867813965840588e-14
the O 0 9.748622048499911e-12
44 O 0 5.382437551215702e-12
unrelated O 0 6.688217757400139e-10
alleles O 0 7.911882260458469e-10
in O 0 1.0200292693829383e-10
these O 0 2.9561950110057467e-10
patients O 0 3.6759388866158815e-09
. O 0 1.2747272126745202e-09

One O 0 3.0181612764579313e-09
is O 0 3.07363266782712e-11
the O 0 2.166512195339587e-12
T312S O 0 1.731371135349491e-08
mutation O 0 8.360781578176102e-08
, O 0 1.711408900879896e-12
a O 0 6.693047158168319e-12
novel O 0 2.884225080990177e-10
mutation O 0 4.56854749586455e-08
found O 0 6.78913383844737e-11
exclusively O 0 2.3479554411842685e-10
in O 0 4.1216621782247387e-10
milder O 0 3.501287721974222e-07
patients O 0 2.7891143616898262e-08
. O 0 4.8506842986739684e-09

The O 0 1.5363216254726808e-09
other O 0 1.964582489744071e-11
is O 0 5.634917445845877e-12
the O 0 1.3875174880578767e-12
previously O 0 5.014960113847167e-10
described O 0 3.833140027609261e-09
I113F O 0 5.367314148685409e-09
that O 0 3.092715319952255e-11
produces O 0 3.4438762952504476e-10
a O 0 2.0045631821119514e-09
severe O 0 2.4625016521895304e-05
phenotype O 0 1.7630312868277542e-05
. O 0 1.3664544162850234e-08

The O 0 2.004475252448401e-09
I113F O 0 3.6523186253134554e-08
and O 0 4.7513094153517343e-11
T312S O 0 1.5289288723963068e-09
mutations O 0 1.9055137467915984e-09
accounted O 0 9.995754224334519e-11
for O 0 2.762776986353632e-13
8 O 0 4.960378462148807e-12
( O 0 2.747024070888504e-13
18 O 0 2.0419844200952886e-12
% O 0 1.916013327813923e-13
) O 0 1.0796802362746105e-13
and O 0 1.2640606443514724e-11
6 O 0 8.290339768846078e-12
( O 0 1.3223070641915635e-13
14 O 0 2.5680789417746597e-13
% O 0 3.628622738654358e-14
) O 0 1.2370941605637474e-14
of O 0 1.0575440127563382e-13
44 O 0 2.3452316477712287e-12
unrelated O 0 3.9661840478544264e-10
alleles O 0 1.4577012930061528e-09
, O 0 6.851366696203343e-11
respectively O 0 6.413146014239146e-09
. O 0 1.3712421198519564e-09

The O 0 5.511757716902821e-09
relatively O 0 5.2910906767067445e-09
high O 0 3.184045915816114e-09
residual O 0 1.8044445369014284e-06
GALNS O 0 1.542284917377401e-05
activity O 0 8.353891800538804e-09
seen O 0 3.0128122219252873e-09
when O 0 8.348766990240453e-12
the O 0 5.602474864238594e-13
T312S O 0 8.232765857929536e-11
mutant O 0 3.839926987492248e-11
cDNA O 0 5.4980502789403474e-11
is O 0 7.414182115472734e-12
overexpressed O 0 8.53993675775655e-09
in O 0 1.1901076478471051e-11
mutant O 0 7.400866586237953e-10
cells O 0 6.399173552162907e-11
provides O 0 1.0852594864441123e-12
an O 0 7.530269946010373e-14
explanation O 0 3.8145018393942465e-11
for O 0 7.497054734829922e-13
the O 0 1.1782588793529669e-11
mild O 0 1.2393184078973718e-07
phenotype O 0 1.1492469553786577e-07
in O 0 4.961771618572364e-11
patients O 0 8.310101218267363e-11
with O 0 1.028036770295282e-11
this O 0 3.5693356603694326e-10
mutation O 0 4.394006793972949e-07
. O 0 2.961179523808255e-09

The O 0 8.75391426014005e-10
distribution O 0 1.1077889300326049e-10
and O 0 1.5763237937171937e-11
relative O 0 1.322395526415221e-09
frequencies O 0 7.582141026141187e-10
of O 0 2.0188134475761232e-13
the O 0 9.776846216294488e-13
I113F O 0 3.58509000264462e-10
and O 0 3.6209106459711426e-12
T312S O 0 2.978682023258017e-10
mutations O 0 6.228185189804947e-10
in O 0 1.9251577328821545e-12
Australia O 0 8.286035160960659e-13
corresponded O 0 2.984315919385416e-11
to O 0 6.306942273125171e-13
those O 0 5.883958684865798e-12
observed O 0 2.493357187383083e-10
in O 0 2.671542674581584e-12
Northern O 0 2.5748255957913635e-11
Ireland O 0 1.4242813595188863e-09
and O 0 1.8389624892312106e-11
are O 0 4.371241866737985e-13
unique O 0 8.448560319222753e-13
to O 0 2.8579680397440577e-13
these O 0 1.1623625781505276e-13
two O 0 1.7176212709080207e-13
populations O 0 2.3656460904769583e-12
, O 0 8.459957045884106e-14
suggesting O 0 4.249528159916416e-11
that O 0 1.1733490698148663e-12
both O 0 1.4577770414414548e-12
mutations O 0 1.8826233627589062e-10
were O 0 1.7388247092187115e-11
probably O 0 7.424941217415437e-11
introduced O 0 1.1182308551349607e-11
to O 0 6.802815147137486e-13
Australia O 0 2.180283297653629e-12
by O 0 1.2071388810416805e-12
Irish O 0 1.48326295690282e-09
migrants O 0 1.131815908356204e-11
during O 0 8.835496570491763e-12
the O 0 1.4373623818952908e-12
19th O 0 8.599478906745617e-10
century O 0 1.6912405920166407e-09
. O 0 1.673961858017492e-09

Haplotype O 0 2.9130907932994887e-05
analysis O 0 7.481213870619285e-09
using O 0 4.6017054056157747e-10
6 O 0 1.5228773797559825e-10
RFLPs O 0 5.911831912897014e-09
provides O 0 8.482311207591575e-12
additional O 0 3.6355244986338575e-13
data O 0 5.855837342805259e-11
that O 0 1.5128731600810852e-12
the O 0 1.2340600546653646e-12
I113F O 0 3.2642570868546272e-09
mutation O 0 5.2676183415201194e-09
originated O 0 7.523204281767448e-11
from O 0 1.671917053587546e-12
a O 0 2.8748536537448466e-11
common O 0 2.3280842531558932e-10
ancestor O 0 3.981620011472842e-08
. O 0 4.325296121265865e-09

The O 0 6.015324349739615e-10
other O 0 1.5198210745470675e-11
9 O 0 1.6661940924200813e-11
novel O 0 2.102124897762625e-11
mutations O 0 2.7167921246018523e-09
identified O 0 6.49457043699897e-10
in O 0 3.63896759947302e-12
these O 0 2.2343552789211296e-12
23 O 0 1.9251513577733803e-11
patients O 0 2.6055296808991102e-11
were O 0 2.9503465642788385e-11
each O 0 2.323123984848685e-11
limited O 0 8.489400155076154e-12
to O 0 3.1145810756860737e-12
a O 0 1.5993746604880954e-10
single O 0 1.5250209983719287e-08
family O 0 7.937672741320512e-09
. O 0 1.6343052466893937e-09

These O 0 5.772635147671679e-10
data O 0 5.125227464652937e-10
provide O 0 3.5707415756841554e-12
further O 0 5.883977658403816e-13
evidence O 0 9.611167764433937e-12
for O 0 4.3269622368620475e-13
extensive O 0 1.1841802538548052e-10
allelic O 0 1.514955982884203e-07
heterogeneity O 0 2.9401726919786597e-07
in O 0 5.396178615058034e-09
MPS B-Disease 1 0.9996190071105957
IVA I-Disease 1 0.9999688863754272
in O 0 2.9580197846712508e-08
British O 0 1.806865611797548e-06
- O 0 1.1497151717776433e-05
Irish O 0 8.16345846033073e-07
patients O 0 6.779936612133497e-10
and O 0 2.326226451049296e-12
provide O 0 4.034610915758935e-13
evidence O 0 7.595435565221909e-12
for O 0 2.1070763135590947e-13
their O 0 3.0024589585397887e-12
transmission O 0 4.543116993716012e-10
to O 0 7.57241762783939e-13
Australia O 0 9.560462230912004e-13
by O 0 6.915019772069098e-13
British O 0 2.0298420722042465e-08
- O 0 4.845439320888545e-07
Irish O 0 8.583718624777248e-09
migrants O 0 2.7537638835894995e-10
. O 0 2.7521400089436376e-11
. O 0 3.1262259447828455e-10

Identification O 0 9.407651191395416e-08
of O 0 4.204029346865923e-10
constitutional O 0 3.1606013806140254e-08
WT1 O 0 7.029146217973903e-05
mutations O 0 1.5080469211170566e-06
, O 0 3.6951466192425286e-11
in O 0 4.467760883475336e-11
patients O 0 7.726039252808903e-10
with O 0 1.7851004008306859e-09
isolated O 0 0.0005861888057552278
diffuse B-Disease 1 0.9996377229690552
mesangial I-Disease 1 0.9999996423721313
sclerosis I-Disease 1 0.9999998807907104
, O 0 1.5419081567102921e-09
and O 0 4.878531172786138e-12
analysis O 0 2.8154336501051702e-11
of O 0 8.47521185176614e-12
genotype O 0 4.1389590478502214e-05
/ O 0 2.221298416316131e-07
phenotype O 0 8.83214426039558e-08
correlations O 0 8.54218562551523e-09
by O 0 5.591130423227009e-12
use O 0 6.195836205202809e-11
of O 0 3.88240351326119e-12
a O 0 5.202870911880098e-10
computerized O 0 2.222553803221672e-06
mutation O 0 3.6062931485503213e-07
database O 0 2.444303959237004e-08
. O 0 3.995204611584313e-09

Constitutional O 0 4.276791116808454e-07
mutations O 0 1.2953770465173875e-06
of O 0 1.3214215832668685e-10
the O 0 9.306729692459825e-11
WT1 O 0 1.0900798770308029e-06
gene O 0 8.057861045074333e-09
, O 0 2.5793022231934692e-12
encoding O 0 1.4420073468635053e-10
a O 0 1.282252415357732e-09
zinc O 0 0.046985507011413574
- O 0 1.7393202824678156e-06
finger O 0 3.6089084005652694e-06
transcription O 0 1.0733439692600655e-09
factor O 0 2.0127072231090892e-10
involved O 0 1.6318343898369392e-10
in O 0 2.0957524604625632e-10
renal O 0 3.056058631045744e-06
and O 0 4.9527280054917355e-09
gonadal O 0 1.9144337784382515e-05
development O 0 3.674429649436206e-10
, O 0 7.612607592910603e-12
are O 0 1.623227702425567e-12
found O 0 1.4383997465339249e-11
in O 0 3.1082489013178893e-12
most O 0 1.1323707596599952e-11
patients O 0 1.7046929146058432e-10
with O 0 3.2816303008331715e-09
Denys B-Disease 1 0.9999356269836426
- I-Disease 1 0.9999822378158569
Drash I-Disease 1 0.9999746084213257
syndrome I-Disease 1 0.9999903440475464
( O 0 5.179911166663942e-09
DDS B-Disease 1 0.9999926090240479
) O 0 6.184442541412594e-11
, O 0 1.0314227770480411e-11
or O 0 1.4666711400934673e-08
diffuse B-Disease 1 0.9808874130249023
mesangial I-Disease 1 0.9999997615814209
sclerosis I-Disease 1 0.9999998807907104
( O 0 2.4873517645573884e-07
DMS B-Disease 0 0.11145848035812378
) O 0 6.161236104640366e-11
associated O 0 2.408629740102697e-09
with O 0 7.03528235668216e-10
pseudohermaphroditism B-Disease 1 0.9999994039535522
and O 0 6.110710728535196e-07
/ O 0 3.945811386074638e-06
or O 0 7.562720725218242e-07
Wilms B-Disease 0 0.4991603195667267
tumor I-Disease 0 0.11231439560651779
( O 0 7.555167513828565e-08
WT B-Disease 1 0.9999852180480957
) O 0 1.3812799792844999e-09
. O 0 2.0001824641013854e-09

Most O 0 2.690222267176523e-08
mutations O 0 7.61816500016721e-06
in O 0 1.7205241675810612e-08
DDS B-Disease 1 0.999998927116394
patients O 0 1.7519309039926156e-05
lie O 0 7.165729766711593e-05
in O 0 3.2011249206931325e-10
exon O 0 6.207898195498274e-08
8 O 0 1.2481080058357463e-10
or O 0 5.42335135134131e-11
exon O 0 2.0556894853029917e-08
9 O 0 4.1979955622828413e-10
, O 0 4.836623180952404e-13
encoding O 0 5.423716475938534e-10
zinc O 0 5.3684805607190356e-05
finger O 0 3.4671436424105195e-06
2 O 0 2.639846674590274e-10
or O 0 3.49915230124509e-09
zinc O 0 6.689356087008491e-05
finger O 0 1.428807809134014e-05
3 O 0 1.285339612522307e-10
, O 0 3.0643528079604687e-12
respectively O 0 2.904186058305669e-10
, O 0 4.568902222702731e-13
with O 0 9.27935354423648e-13
a O 0 7.645019617363857e-10
hot O 0 1.764831267792033e-06
spot O 0 2.144432755812886e-06
( O 0 8.753304504838244e-12
R394W O 0 3.1950922463330755e-10
) O 0 4.669744408866694e-13
in O 0 2.4599107473211035e-12
exon O 0 1.1364489793663779e-08
9 O 0 6.372068206417225e-09
. O 0 1.8822654546113426e-09

We O 0 8.515197436054223e-09
analyzed O 0 1.976634633749086e-09
a O 0 7.338252401567491e-12
series O 0 1.1054665863263757e-11
of O 0 3.5614777186415703e-12
24 O 0 1.8112128463698696e-10
patients O 0 3.1316865767294644e-10
, O 0 8.90078722531884e-12
10 O 0 6.211842238507126e-12
with O 0 5.3688442580579476e-11
isolated B-Disease 0 4.848309799854178e-06
DMS I-Disease 1 0.7354985475540161
( O 0 4.4362932771768726e-10
IDMS B-Disease 0 9.957905604096595e-06
) O 0 7.440660067248306e-12
, O 0 9.714723600215414e-13
10 O 0 2.1301346103674845e-12
with O 0 3.165714357322713e-10
DDS B-Disease 1 0.9999997615814209
, O 0 2.638719243108767e-10
and O 0 8.144443452984262e-11
4 O 0 6.531263030407075e-11
with O 0 8.42851843874115e-10
urogenital B-Disease 0 0.02677360363304615
abnormalities I-Disease 1 0.9968006610870361
and O 0 1.1822704237829385e-07
/ O 0 4.028072908113245e-06
or O 0 1.156202324636979e-05
WT B-Disease 1 0.9999864101409912
. O 0 5.471517994237729e-08

We O 0 1.888543863515224e-07
report O 0 5.7895639393734655e-09
WT1 O 0 1.3256155853014207e-06
heterozygous O 0 2.4990404767777363e-07
mutations O 0 2.8143864483354264e-07
in O 0 1.9235740778000832e-10
16 O 0 1.439059010843735e-10
patients O 0 7.902652421343248e-10
, O 0 5.681170811566716e-12
4 O 0 2.6258249047339532e-11
of O 0 1.4768982911639306e-11
whom O 0 8.667529272088359e-08
presented O 0 5.936569635878186e-08
with O 0 1.9883501067852194e-08
IDMS B-Disease 0 0.009454412385821342
. O 0 1.3860232073170664e-08

One O 0 4.606337711265951e-08
male O 0 1.2418952621828794e-07
and O 0 2.2316830328161785e-10
two O 0 2.4259413922145256e-10
female O 0 6.100518658058718e-05
IDMS B-Disease 1 0.9448091387748718
patients O 0 2.475377698374359e-07
with O 0 3.3533638088556472e-09
WT1 O 0 0.005774858873337507
mutations O 0 0.00017555465456098318
underwent O 0 9.634735761210322e-06
normal O 0 1.8284973748450284e-06
puberty O 0 5.4271645240078215e-06
. O 0 9.504174336427695e-09

Two O 0 2.3324377096400895e-08
mutations O 0 5.758060524385655e-06
associated O 0 2.0313679627292913e-08
with O 0 2.336901783195344e-10
IDMS B-Disease 0 0.00072177016409114
are O 0 1.2420191264350677e-10
different O 0 1.1566731947243447e-11
from O 0 1.708891535223689e-11
those O 0 1.6742292274773973e-10
described O 0 3.734220044293579e-08
in O 0 1.143423933314125e-08
DDS B-Disease 1 0.9999978542327881
patients O 0 4.5709879259447916e-07
. O 0 8.860284061995571e-09

No O 0 3.3760619544409565e-07
WT1 O 0 5.195880657993257e-05
mutations O 0 1.59851315402193e-05
were O 0 3.418296756763084e-09
detected O 0 6.925212119313073e-07
in O 0 1.8757837297322943e-11
the O 0 6.167723883704346e-12
six O 0 1.3436091128582461e-10
other O 0 3.035479367863303e-10
IDMS B-Disease 0 0.04397346451878548
patients O 0 2.375036523005747e-08
, O 0 8.451819973054331e-12
suggesting O 0 1.2324576914579666e-09
genetic O 0 7.11650238738315e-10
heterogeneity O 0 1.0807647221611205e-08
of O 0 3.907828921567713e-11
this O 0 9.339173878686324e-09
disease O 0 2.390663212281652e-06
. O 0 3.6034715211741286e-09

We O 0 1.1275699307589093e-07
analyzed O 0 4.3568863361542753e-07
genotype O 0 5.147818228579126e-05
/ O 0 7.200752065728011e-07
phenotype O 0 1.1808253930212231e-06
correlations O 0 8.169268426172493e-07
, O 0 2.0407862899585183e-11
on O 0 7.855696128322709e-12
the O 0 3.78824386139745e-13
basis O 0 3.736798630943339e-12
of O 0 5.330341203146904e-13
the O 0 1.076631665763994e-11
constitution O 0 7.622647305027819e-12
of O 0 1.2771583107491075e-13
a O 0 7.865805229378964e-11
WT1 O 0 7.645041222303917e-08
mutation O 0 1.2335159560450393e-09
database O 0 4.158053415470597e-11
of O 0 8.39622262775036e-13
84 O 0 3.018566993584493e-11
germ O 0 1.843740392359905e-06
- O 0 2.002567271119915e-06
line O 0 4.5992092623237113e-07
mutations O 0 1.728886367402538e-08
, O 0 1.8526308688104204e-13
to O 0 7.544920227866084e-14
compare O 0 8.294804426656199e-11
the O 0 2.0679381059103552e-13
distribution O 0 1.8127316054467046e-12
and O 0 7.285340733464984e-12
type O 0 2.2468547022924668e-09
of O 0 4.496679938126302e-12
mutations O 0 1.5358830651734934e-08
, O 0 1.8331588417380695e-12
according O 0 1.410849627229982e-12
to O 0 1.4573432521522434e-12
the O 0 1.5929075766751843e-11
different O 0 8.319875344220407e-10
symptoms O 0 2.2424724477332347e-07
. O 0 1.0709944042730513e-09

This O 0 4.01049726761471e-09
demonstrated O 0 1.4441969398149013e-08
( O 0 5.9880047968696726e-12
1 O 0 1.560376827747234e-11
) O 0 5.046944849887436e-13
the O 0 3.7931333421448166e-12
association O 0 1.179491140174127e-11
between O 0 6.655099648450458e-12
mutations O 0 1.3875883775327225e-09
in O 0 9.298315589711947e-12
exons O 0 1.0340159839472562e-09
8 O 0 4.7458932617150396e-11
and O 0 3.980239748901937e-11
9 O 0 6.364676841119632e-11
and O 0 6.773871047416336e-11
DMS B-Disease 0 5.0304985052207485e-05
; O 0 3.233596767085456e-12
( O 0 8.763385254007688e-14
2 O 0 5.678405337085357e-13
) O 0 2.3849447265168744e-13
among O 0 2.4282119284041448e-12
patients O 0 5.1044161952784606e-11
with O 0 9.928224214972303e-11
DMS B-Disease 0 0.00047553755575791
, O 0 1.7132966052824106e-12
a O 0 9.615421306397032e-12
higher O 0 2.2714924385880408e-10
frequency O 0 7.096888077207097e-10
of O 0 4.0341186879726265e-13
exon O 0 2.572643653664386e-09
8 O 0 4.524263602645462e-11
mutations O 0 3.801533754455022e-09
among O 0 1.7751029812718144e-11
46 O 0 1.8855558781005755e-10
, O 0 6.432262361633079e-11
XY O 0 4.551983238343382e-06
patients O 0 8.771949278063573e-10
with O 0 4.008137571842596e-11
female O 0 1.0295221386513731e-07
phenotype O 0 4.566055977761607e-08
than O 0 1.8825005790312765e-11
among O 0 1.202183318171901e-11
46 O 0 2.2123484988423314e-10
, O 0 5.917941137134619e-11
XY O 0 5.971614882582799e-06
patients O 0 1.4039816531585814e-10
with O 0 3.9428811778041695e-12
sexual O 0 1.2157223006070694e-09
ambiguity O 0 3.6332652442183644e-09
or O 0 8.811847251877225e-09
male O 0 1.249915584367045e-07
phenotype O 0 5.7681287302102646e-08
; O 0 1.757919330935831e-11
and O 0 4.0411844010046494e-11
( O 0 2.0001222900134508e-12
3 O 0 4.9944224103648516e-12
) O 0 1.0103905017343207e-13
statistically O 0 1.9222234914906267e-11
significant O 0 7.295909536242373e-12
evidence O 0 8.722713662479009e-10
that O 0 1.3251849617645917e-10
mutations O 0 3.3490301643013254e-09
in O 0 8.591829504800419e-12
exons O 0 1.4816597948552612e-09
8 O 0 7.49976539204944e-11
and O 0 4.346164400592656e-11
9 O 0 1.7177548272684362e-10
preferentially O 0 6.451156053799423e-08
affect O 0 6.614992997810987e-09
amino O 0 2.188234454747473e-10
acids O 0 1.0512402580376001e-11
with O 0 1.8311623105424918e-13
different O 0 6.532627628945409e-13
functions O 0 2.4851705762718446e-11
. O 0 1.2272371487098699e-11
. O 0 1.3047692093426377e-10

The O 0 6.2896563512993e-09
185delAG O 0 1.6338468640242354e-06
BRCA1 O 0 8.565226380596869e-06
mutation O 0 2.55490959943927e-07
originated O 0 1.3168128809581958e-09
before O 0 7.066233015384782e-12
the O 0 7.008257906296333e-13
dispersion O 0 7.414133196270711e-10
of O 0 6.12351749168516e-13
Jews O 0 6.204871338955087e-11
in O 0 5.0871711357314275e-12
the O 0 2.639572371440635e-12
diaspora O 0 8.040366289430168e-11
and O 0 6.0041110971909e-11
is O 0 1.1497664799409169e-11
not O 0 3.8407090008352185e-12
limited O 0 3.536337455506411e-12
to O 0 3.9053399403243816e-11
Ashkenazim O 0 1.504395470419695e-07
. O 0 9.915341880883943e-10

The O 0 6.35431218753979e-09
185delAG O 0 4.2215103235321294e-07
mutation O 0 4.1975914655267843e-07
in O 0 2.20927026672868e-10
BRCA1 O 0 1.3193134691391606e-06
is O 0 5.149941029181093e-10
detected O 0 1.1276677724936235e-07
in O 0 3.6405104625325535e-11
Ashkenazi O 0 3.2504769986729798e-09
Jews O 0 1.75812808755893e-10
both O 0 2.3581825728258288e-11
in O 0 2.1349200185483141e-10
familial B-Disease 0 0.43072059750556946
breast I-Disease 1 0.9999946355819702
and I-Disease 1 0.9999439716339111
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.59863898072399e-08
in O 0 1.7144907021870992e-11
the O 0 4.859511664595528e-12
general O 0 8.768581694074129e-11
population O 0 1.2814596606069983e-10
. O 0 5.037604777768934e-10

All O 0 8.358625791515806e-09
tested O 0 2.632373821143119e-07
Ashkenazi O 0 1.6764236931976484e-07
mutation O 0 8.610845014800361e-08
carriers O 0 1.2768978097099648e-09
share O 0 1.1628233098637253e-10
the O 0 6.5025220451209176e-12
same O 0 8.853754535076419e-11
allelic O 0 3.84345000270514e-08
pattern O 0 3.5447564528112707e-07
at O 0 9.67821045527728e-10
the O 0 1.4901131717426352e-10
BRCA1 O 0 2.14437568502035e-06
locus O 0 3.3336714295728598e-06
. O 0 1.8245952304596358e-08

Our O 0 2.8330259027598004e-08
previous O 0 6.863272727919423e-10
study O 0 7.72413383254289e-11
showed O 0 1.14454046240553e-09
that O 0 4.222645236945377e-12
this O 0 2.940070496088021e-12
Ashkenazi O 0 9.22533605063336e-09
mutation O 0 9.75855218854349e-09
also O 0 5.676289299705317e-11
occurs O 0 3.149565677706967e-11
in O 0 1.527568111066302e-12
Iraqi O 0 2.6797825070090653e-10
Jews O 0 4.0164337133941075e-11
with O 0 3.738744990683385e-12
a O 0 8.559578740241491e-11
similar O 0 2.3705231111392777e-09
allelic O 0 9.799082363315392e-07
pattern O 0 6.116136773925973e-06
. O 0 1.4754477639655761e-08

We O 0 1.7681514918876928e-08
extended O 0 2.2181709247171e-10
our O 0 2.0202521947010332e-11
analysis O 0 2.504231197408835e-12
to O 0 1.152364743342224e-13
other O 0 3.149418388841835e-13
non O 0 2.7087538809200673e-11
- O 0 8.854433852789612e-10
Ashkenazi O 0 2.9277621993450964e-10
subsets O 0 1.6402315616836916e-10
354 O 0 1.1080842840516247e-11
of O 0 4.890267336042642e-13
Moroccan O 0 6.568373400739347e-09
origin O 0 1.3574001644922618e-10
, O 0 1.4215706519923876e-12
200 O 0 1.1235473272239171e-12
Yemenites O 0 7.397747414650269e-10
and O 0 1.616339007082246e-11
150 O 0 2.1238110228805063e-11
Iranian O 0 4.231003547516821e-09
Jews O 0 3.210408383580443e-09
. O 0 2.1440620390222875e-09

Heteroduplex O 0 3.9679507608525455e-06
analysis O 0 3.1862572580365622e-09
complemented O 0 8.896756664711347e-10
by O 0 1.0930455759255997e-12
direct O 0 3.535481152630582e-12
DNA O 0 1.3552220456958253e-10
sequencing O 0 5.608072339846615e-11
of O 0 3.598644385954808e-12
abnormally O 0 2.2228913820754315e-08
migrating O 0 1.1016972750743648e-10
bands O 0 1.6271048952631872e-09
were O 0 8.784389327054498e-10
employed O 0 1.617473266435354e-08
. O 0 2.0577517467756934e-09

Four O 0 2.186750114319125e-09
of O 0 1.706077640273307e-11
Moroccan O 0 1.1800491250824052e-07
origin O 0 4.2864312099766266e-10
( O 0 1.0590882554631365e-13
1 O 0 8.935921121978885e-14
. O 0 2.671845831061538e-14
1 O 0 5.3507648615711e-13
% O 0 2.089702109270286e-13
) O 0 1.5969610887584668e-13
and O 0 5.67898289158264e-12
none O 0 5.6546663185219614e-11
of O 0 7.118388316946708e-14
the O 0 4.929790083096908e-12
Yemenites O 0 3.1801736799508262e-09
or O 0 4.167295328261211e-11
Iranians O 0 6.390488832552776e-11
was O 0 5.981649897623953e-11
a O 0 1.2193764227508286e-11
carrier O 0 1.2693700535137964e-09
of O 0 5.315284887577598e-13
the O 0 2.785808562999481e-11
185delAG O 0 1.3949906474408635e-07
mutation O 0 2.1832282470768405e-07
. O 0 2.2593344972676732e-09

BRCA1 O 0 0.0013297656551003456
allelic O 0 0.00018419719708617777
patterns O 0 7.977618224686012e-05
were O 0 4.6364547756638785e-09
determined O 0 6.154524001544814e-09
for O 0 6.939780781284322e-13
four O 0 4.935602165682951e-13
of O 0 6.651260488557686e-14
these O 0 5.83475975868275e-13
individuals O 0 6.983253493693387e-13
and O 0 1.5510320892225815e-12
for O 0 3.0254287573458494e-13
12 O 0 7.152088708599347e-13
additional O 0 1.3049545168411503e-12
non O 0 2.0560794733448517e-10
- O 0 2.114211028469981e-08
Ashkenazi O 0 6.438111821438497e-09
185delAG O 0 1.113968561838874e-08
mutation O 0 2.140781951709414e-08
carriers O 0 7.221670372814515e-09
who O 0 1.010183048322233e-08
had O 0 2.382705815762165e-06
breast B-Disease 1 0.9998520612716675
/ I-Disease 1 0.9999561309814453
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999982118606567
. O 0 2.657149480000953e-06

Six O 0 2.604728699395764e-08
non O 0 1.5980255341219163e-08
- O 0 5.281469270812522e-07
Ashkenazi O 0 1.1913704156540916e-07
individuals O 0 7.647261990317844e-11
shared O 0 6.381719458437018e-11
the O 0 6.2934748558396425e-12
common O 0 3.239544466016042e-10
Ashkenazi O 0 9.376870835353657e-09
haplotype O 0 5.4667300020128096e-08
, O 0 5.260270951462642e-12
four O 0 2.303409199488904e-12
had O 0 1.0866545857579624e-10
a O 0 3.455580266376046e-11
closely O 0 4.325411584460426e-09
related O 0 1.5344007175954744e-09
pattern O 0 1.5819381360415719e-07
, O 0 2.429963348593578e-12
and O 0 5.011092235607251e-12
the O 0 3.802202476477223e-12
rest O 0 1.2304629537496226e-10
( O 0 5.2966056020287144e-12
n O 0 2.3515790203987308e-08
= O 0 2.409476707043723e-08
6 O 0 2.788727235247812e-11
) O 0 5.815616000923174e-13
displayed O 0 6.376116967743428e-09
a O 0 5.259513935484961e-10
distinct O 0 3.2699915664125e-08
BRCA1 O 0 1.4326037671708036e-05
allelic O 0 1.3784857401333284e-05
pattern O 0 4.8585785407340154e-05
. O 0 3.9223813530497864e-08

We O 0 1.8925765843391673e-08
conclude O 0 1.800535942564352e-09
that O 0 6.585147357962562e-12
the O 0 6.042225747515673e-12
185delAG O 0 2.3369227619696176e-07
BRCA1 O 0 4.2396677599754184e-06
mutation O 0 4.982429686606338e-07
occurs O 0 4.643523621172818e-10
in O 0 6.832593301905887e-13
some O 0 7.967690634873292e-13
non O 0 3.2247307601984687e-10
- O 0 1.3707176549360156e-07
Ashkenazi O 0 6.974018873506793e-08
populations O 0 8.821747776721622e-10
at O 0 4.305194534204304e-10
rates O 0 1.5615968962379156e-08
comparable O 0 1.6336695329854933e-09
with O 0 2.134799715475255e-12
that O 0 1.3295616344000116e-11
of O 0 2.657202929912117e-11
Ashkenazim O 0 6.777285079806461e-07
. O 0 4.456811364406121e-09

The O 0 8.568207254811e-10
majority O 0 8.982174726224201e-11
of O 0 3.282883730484909e-12
Jewish O 0 1.6261709756548726e-09
185delAG O 0 1.5876783265866834e-07
mutation O 0 1.2769318402661156e-07
carriers O 0 1.3674626986315275e-09
have O 0 3.1065611888481115e-11
a O 0 4.560774327644346e-11
common O 0 2.3294521867001095e-10
allelic O 0 9.32082997451289e-08
pattern O 0 2.1969538011035183e-06
, O 0 7.279743648169745e-12
supporting O 0 4.9108449945434174e-11
the O 0 6.1286266860027805e-12
founder O 0 1.0952692919286022e-10
effect O 0 6.337964875147151e-11
notion O 0 9.390678512577466e-11
, O 0 1.0222720022920462e-12
but O 0 1.6439193756268011e-12
dating O 0 2.465912196658593e-10
the O 0 6.013547949532128e-13
mutations O 0 9.579967374939713e-11
origin O 0 4.345963259405616e-12
to O 0 3.958786423674532e-13
an O 0 4.3160158606780907e-13
earlier O 0 1.3449474867144318e-10
date O 0 1.5420611454430855e-09
than O 0 2.5479897705626975e-11
currently O 0 2.77298479317567e-11
estimated O 0 1.2730744236577607e-10
. O 0 5.523763113579605e-10

However O 0 1.65346030200908e-08
, O 0 2.536530447488916e-12
the O 0 3.212956430857089e-13
different O 0 4.4056377469792185e-12
allelic O 0 6.8877987757787196e-09
pattern O 0 5.3203095262688294e-08
at O 0 2.1647629522281164e-10
the O 0 2.1611644765440197e-11
BRCA1 O 0 5.7298596090049614e-08
locus O 0 8.654114935779944e-08
even O 0 1.5069543390922036e-09
in O 0 6.688210315436427e-12
some O 0 1.0556723680985036e-12
Jewish O 0 1.7543963504174087e-10
mutation O 0 1.0853403509258897e-08
carriers O 0 3.278463056588521e-10
, O 0 1.3819500014819464e-12
might O 0 7.880341518218259e-11
suggest O 0 1.720171366459411e-10
that O 0 2.8799013954833308e-12
the O 0 1.9371472741863682e-12
mutation O 0 1.933252224972648e-09
arose O 0 2.1261951921314193e-10
independently O 0 4.197267255978687e-10
. O 0 4.1780398585267164e-11
. O 0 3.3467550952792635e-10

Crystal O 0 0.00019487073586788028
structure O 0 4.0710617099648516e-07
of O 0 7.440748711617928e-11
the O 0 3.0109510440468057e-09
hemochromatosis B-Disease 1 0.9999995231628418
protein O 0 3.7429379062814405e-06
HFE O 0 0.00010252358333673328
and O 0 2.6852878254324253e-10
characterization O 0 9.237942855122583e-09
of O 0 1.9369217601344912e-12
its O 0 6.441172248350391e-12
interaction O 0 7.086779774123642e-11
with O 0 8.043281318759199e-11
transferrin O 0 2.8475017188611673e-07
receptor O 0 2.8530951823313444e-08
. O 0 1.4862450159469631e-09

HFE O 0 0.004319316241890192
is O 0 1.942919780617558e-08
an O 0 2.4365839901285824e-10
MHC O 0 2.075169686577283e-05
- O 0 4.547673313481937e-07
related O 0 6.256191120712629e-09
protein O 0 1.435446761455239e-09
that O 0 1.478643076036068e-11
is O 0 4.766402116745949e-12
mutated O 0 3.3363917184559e-10
in O 0 1.2383307053387416e-11
the O 0 2.0203690109799055e-10
iron B-Disease 1 0.989342451095581
- I-Disease 1 0.9998737573623657
overload I-Disease 1 0.9996459484100342
disease I-Disease 1 0.9975628852844238
hereditary B-Disease 1 0.9999997615814209
hemochromatosis I-Disease 1 1.0
. O 0 9.924693586071953e-05

HFE O 0 0.00023728254018351436
binds O 0 2.296378056598769e-07
to O 0 4.826972155314024e-10
transferrin O 0 3.234424070797104e-07
receptor O 0 6.765991145130101e-08
( O 0 2.0340062967250105e-10
TfR O 0 7.521392149101302e-07
) O 0 5.480225106178904e-13
and O 0 5.383892658951395e-13
reduces O 0 1.1848966252614446e-10
its O 0 3.50834080753773e-13
affinity O 0 5.466388106056819e-11
for O 0 9.862839711605176e-12
iron O 0 1.1537460522959009e-05
- O 0 1.3130010074746679e-06
loaded O 0 5.4919794933994126e-08
transferrin O 0 9.826673874613334e-08
, O 0 2.1228510269089007e-11
implicating O 0 5.368810320760531e-07
HFE O 0 2.543305527069606e-05
in O 0 2.0068700035125175e-09
iron O 0 0.00010742246377049014
metabolism O 0 2.187766403949354e-05
. O 0 4.142700404941024e-09

The O 0 2.269926824283175e-08
2 O 0 1.553119410857562e-08
. O 0 5.143062864476633e-09

6 O 0 1.0659635307774806e-07
A O 0 2.8114991224015284e-08
crystal O 0 0.00039209972601383924
structure O 0 1.4831201724518905e-06
of O 0 9.644263859742708e-11
HFE O 0 6.210176070453599e-05
reveals O 0 5.0275495766527456e-08
the O 0 5.173900370636364e-12
locations O 0 2.796862741405448e-10
of O 0 2.1184352883008017e-10
hemochromatosis B-Disease 1 0.9999997615814209
mutations O 0 0.0005460625397972763
and O 0 4.848564327808447e-10
a O 0 3.0645663784412136e-10
patch O 0 2.2735202946932986e-06
of O 0 9.697788579121625e-12
histidines O 0 8.671660225445521e-07
that O 0 2.0773026354614643e-10
could O 0 6.506249983218027e-10
be O 0 2.3564334511450014e-11
involved O 0 6.631357962749718e-11
in O 0 2.7399951751938545e-10
pH O 0 5.630398300127126e-05
- O 0 4.973690010956489e-07
dependent O 0 2.0049084170636888e-08
interactions O 0 1.8020692493792012e-08
. O 0 1.4225709499271488e-09

We O 0 2.37199433428259e-08
also O 0 4.452465132698258e-11
demonstrate O 0 7.324150730347867e-10
that O 0 4.838863199019272e-10
soluble O 0 2.0391257748997305e-06
TfR O 0 3.311863338240073e-06
and O 0 7.221424846992619e-12
HFE O 0 1.3010483712605492e-07
bind O 0 3.5906349005188076e-09
tightly O 0 4.136969522505751e-08
at O 0 1.1904624508396466e-10
the O 0 2.278467562191744e-12
basic O 0 1.457055726072909e-10
pH O 0 2.9304398907470386e-09
of O 0 1.050417551876591e-13
the O 0 2.4253188433270845e-12
cell O 0 7.632365850440692e-08
surface O 0 5.367006906453753e-06
, O 0 1.009931027695643e-11
but O 0 1.8229608794717578e-11
not O 0 5.503019914754326e-12
at O 0 9.606567277775646e-12
the O 0 2.7108006811493723e-11
acidic O 0 1.497860324661815e-07
pH O 0 1.5715896495294146e-07
of O 0 7.461982420853275e-11
intracellular O 0 1.228100472872029e-06
vesicles O 0 5.301374585542362e-06
. O 0 1.652520786876721e-08

TfR O 0 0.07617704570293427
HFE O 0 0.00024782976834103465
stoichiometry O 0 5.085928933112882e-06
( O 0 1.1371090874456868e-10
2 O 0 1.6805182245782646e-11
1 O 0 2.37439876787926e-11
) O 0 3.5849908111562634e-12
differs O 0 2.670536569659987e-10
from O 0 5.02900984744592e-11
TfR O 0 1.3368703548621852e-06
transferrin O 0 6.533213969817098e-09
stoichiometry O 0 6.584881084847893e-09
( O 0 2.0825331476653774e-12
2 O 0 1.260763737333248e-12
2 O 0 8.525650671553642e-12
) O 0 5.643390485823851e-13
, O 0 4.805478389345585e-13
implying O 0 4.329172853534402e-10
a O 0 3.055691550485351e-12
different O 0 2.937978094315341e-13
mode O 0 2.1830806259948154e-11
of O 0 8.812933970916634e-14
binding O 0 9.652342120025637e-11
for O 0 5.217673515467425e-12
HFE O 0 2.9375354415606125e-07
and O 0 1.1454375642427905e-10
transferrin O 0 9.123076516459605e-09
to O 0 1.2663563253578758e-10
TfR O 0 2.450959755151416e-06
, O 0 1.6728420948811107e-12
consistent O 0 2.596234338625436e-10
with O 0 1.4291693913384695e-12
our O 0 4.10501181657974e-11
demonstration O 0 2.3114302138971254e-10
that O 0 1.5170869768765805e-11
HFE O 0 8.580350652209745e-08
, O 0 2.0306354254345793e-12
transferrin O 0 3.6001603920254865e-09
, O 0 1.0951287619798133e-11
and O 0 2.0379982423879284e-10
TfR O 0 1.090264845515776e-06
form O 0 1.678641947666648e-10
a O 0 1.325756837644576e-09
ternary O 0 3.5824558608510415e-07
complex O 0 1.0832064845089917e-07
. O 0 8.42350811325332e-09

Identification O 0 1.1670732646962279e-07
of O 0 4.0060128825292196e-11
three O 0 2.3421752384789052e-11
novel O 0 4.701424805020338e-10
mutations O 0 1.3174798141335486e-07
and O 0 5.972814604016108e-11
a O 0 3.4438762952504476e-10
high O 0 6.02430594298653e-09
frequency O 0 2.970378965017062e-08
of O 0 1.5918863449648768e-12
the O 0 1.5345717752079935e-11
Arg778Leu O 0 1.8289092906798032e-07
mutation O 0 1.9709510468146618e-08
in O 0 6.708643363051436e-11
Korean O 0 2.4011452381955678e-08
patients O 0 1.1628571439104007e-09
with O 0 1.6496888299855073e-09
Wilson B-Disease 0 0.0001488308043917641
disease I-Disease 0 4.027907834824873e-06
. O 0 4.780274842630661e-09

Four O 0 1.7349412573253176e-08
mutations O 0 8.136798328450823e-07
- O 0 8.075048754108138e-07
- O 0 2.201115307798318e-07
R778L O 0 1.6407399883178186e-08
, O 0 2.1985907018573503e-12
A874V O 0 1.5356764471174955e-10
, O 0 1.521582881393313e-13
L1083F O 0 2.235997845212445e-11
, O 0 1.0738803645155351e-13
and O 0 1.563846301804242e-13
2304delC O 0 2.3350216205031415e-10
- O 0 7.522289457995157e-10
- O 0 1.0581938658660306e-09
in O 0 7.61372562219087e-12
the O 0 7.411509773957992e-12
copper O 0 1.2396967008498905e-07
- O 0 4.061563863011486e-10
transporting O 0 3.8895730386512284e-11
enzyme O 0 6.708153563877994e-12
, O 0 3.810447779788867e-13
P O 0 5.3922100562431297e-08
- O 0 1.0298183639179115e-08
type O 0 4.444937076186761e-07
ATPase O 0 1.3495605344360229e-07
( O 0 3.866338239150169e-12
ATP7B O 0 5.130220870341873e-08
) O 0 1.2095773601478177e-12
, O 0 1.7857914311799478e-13
were O 0 3.105441598316716e-11
identified O 0 1.0430332153532618e-08
in O 0 3.1610802864179277e-10
Korean O 0 1.6715290485080914e-07
Patients O 0 1.3469402260213315e-09
with O 0 1.7178967137709833e-09
Wilson B-Disease 0 0.0001275275571970269
disease I-Disease 0 1.811114771044231e-06
. O 0 2.204935567462485e-09

Arg778Leu O 0 2.8857282813987695e-05
, O 0 1.4129111769456415e-10
the O 0 2.7329878811432895e-12
most O 0 3.3747121850474793e-12
frequently O 0 2.474823457276898e-09
reported O 0 1.324147125281172e-09
mutation O 0 3.2307023722921713e-10
of O 0 7.534335704157194e-14
this O 0 5.062370336296473e-13
enzyme O 0 7.012594498145841e-12
, O 0 3.6122932986840106e-13
was O 0 1.0220975454888759e-10
found O 0 7.184938061177704e-11
in O 0 2.711564479895845e-12
six O 0 1.063148701019312e-12
of O 0 2.0548100439048145e-13
eight O 0 1.0215005924463227e-11
unrelated O 0 8.135493168026642e-09
patients O 0 2.013645250542595e-09
studied O 0 1.1963402490877684e-09
, O 0 7.541759100906931e-13
an O 0 3.061091690455958e-13
allele O 0 3.5583919144599463e-10
frequency O 0 3.5902858463998655e-09
of O 0 7.578042360290027e-12
37 O 0 3.855377406214444e-10
. O 0 6.923582263063111e-10

5 O 0 7.459413531307746e-09
% O 0 1.6269581515349074e-10
, O 0 3.175453389819838e-12
which O 0 1.41402115710898e-11
is O 0 9.376893359003269e-12
considerably O 0 5.70494651519482e-10
higher O 0 1.6577976491571889e-10
than O 0 4.083308777907968e-12
those O 0 2.1629531932881862e-12
in O 0 7.890410330321784e-13
other O 0 5.67463773453597e-13
Asian O 0 1.0977429035219366e-11
populations O 0 4.3688708900591067e-11
. O 0 2.4902110928870513e-10

The O 0 2.3410744454110954e-09
novel O 0 2.9307249960197623e-09
single O 0 1.5003521758316651e-09
nucleotide O 0 9.85546400045223e-09
deletion O 0 2.038921742553157e-08
, O 0 1.112268350339507e-11
2304delC O 0 1.2829063145147757e-08
, O 0 1.2551330634547053e-11
was O 0 1.3161700618269379e-09
found O 0 1.0008936734973162e-10
in O 0 4.4007516381006084e-11
one O 0 1.4604787379468576e-09
patient O 0 2.5537843839629204e-07
. O 0 3.0047377919117935e-09

Since O 0 3.9717217958923356e-08
a O 0 9.51712153529627e-10
mutation O 0 9.766525721488506e-08
at O 0 4.463044378510972e-10
cDNA O 0 2.882072358545429e-08
nucleotide O 0 1.0618709893606137e-06
2302 O 0 8.002196409506723e-06
( O 0 4.997560004715851e-11
2302insC O 0 1.9780610927000453e-08
) O 0 3.887459104623403e-11
had O 0 2.257602771393863e-09
been O 0 1.575988561874908e-09
previously O 0 4.407325171484899e-09
described O 0 2.005114829728427e-08
, O 0 4.3196995459793275e-12
this O 0 6.067363950666704e-13
region O 0 3.192244428865121e-12
of O 0 4.2732329719012696e-13
the O 0 2.3783783970054984e-11
ATP7B O 0 6.85638894992735e-07
gene O 0 4.954542109913973e-09
may O 0 2.429053846952911e-09
be O 0 1.3915341101622403e-10
susceptible O 0 1.5996394608919218e-07
to O 0 2.357778972061908e-10
gene O 0 1.6912873945784668e-07
rearrangements O 0 0.00028300078702159226
causing O 0 0.00018368680321145803
Wilson B-Disease 0 0.0008925888105295599
disease I-Disease 0 9.131278784479946e-05
. O 0 1.6314967155039994e-08

Disruption O 0 8.462723144475603e-07
of O 0 2.001413097751925e-11
splicing O 0 2.238154772626899e-09
regulated O 0 4.404770326260632e-09
by O 0 5.256349609045197e-12
a O 0 1.492263396185578e-10
CUG O 0 3.368803663761355e-05
- O 0 3.698452815115161e-07
binding O 0 2.1327895893819004e-08
protein O 0 2.9147550151265023e-08
in O 0 6.664395701960757e-09
myotonic B-Disease 1 0.9999979734420776
dystrophy I-Disease 1 0.9999992847442627
. O 0 1.5922469174256548e-06

Myotonic B-Disease 1 0.9999895095825195
dystrophy I-Disease 1 0.9999985694885254
( O 0 0.00022706847812514752
DM B-Disease 1 0.9999997615814209
) O 0 2.51310741106181e-08
is O 0 3.1105131803599306e-09
caused O 0 6.807891139715139e-09
by O 0 1.211609805540359e-11
a O 0 2.0006889200896438e-10
CTG O 0 4.111231888259681e-08
expansion O 0 8.486360919546243e-11
in O 0 2.2939213462774832e-12
the O 0 9.847383325434222e-13
3 O 0 1.4968377232138508e-11
untranslated O 0 1.32567405941586e-08
region O 0 1.0134416222884468e-10
of O 0 5.304633034913797e-12
the O 0 6.259987195278427e-09
DM B-Disease 1 0.9999971389770508
gene O 0 1.0047921250588843e-06
. O 0 6.6488801131470154e-09

One O 0 3.4695317729926956e-09
model O 0 8.828855868614482e-09
of O 0 1.4543770632258202e-09
DM B-Disease 1 0.9999996423721313
pathogenesis O 0 6.420139834517613e-05
suggests O 0 2.459531245335711e-08
that O 0 7.47382884747072e-12
RNAs O 0 4.967408706590959e-10
from O 0 1.2158224730815514e-12
the O 0 8.804084306208992e-13
expanded O 0 1.5167485323264174e-11
allele O 0 4.7842473038794964e-11
create O 0 1.423353188784171e-12
a O 0 7.416968081375153e-12
gain O 0 3.9951267294391357e-10
- O 0 1.7749014480372693e-09
of O 0 5.240412704471398e-12
- O 0 3.89133738565306e-08
function O 0 9.135468492793564e-10
mutation O 0 2.582135061324209e-10
by O 0 5.642852179445212e-13
the O 0 4.309821813666681e-13
inappropriate O 0 2.86128870596869e-10
binding O 0 5.024397911612688e-11
of O 0 1.2666152577733153e-13
proteins O 0 9.83927349318403e-13
to O 0 9.969619530966756e-13
the O 0 2.1390562932044332e-11
CUG O 0 3.998441570729483e-06
repeats O 0 7.6477689958665e-08
. O 0 1.143554140270453e-09

Data O 0 1.4141615167773125e-07
presented O 0 2.2589691894836506e-08
here O 0 2.949740174340576e-10
indicate O 0 5.938398661697875e-10
that O 0 4.163590913014437e-12
the O 0 3.971501946753442e-12
conserved O 0 6.418530595908578e-09
heterogeneous O 0 3.561573080901326e-08
nuclear O 0 1.4852038248136523e-06
ribonucleoprotein O 0 2.472188214142079e-07
, O 0 7.562404695515834e-12
CUG O 0 1.0700417618636493e-07
- O 0 1.0738073541460835e-08
binding O 0 2.4032515977268076e-09
protein O 0 2.767717999230257e-10
( O 0 2.5757872397502712e-12
CUG O 0 3.44911995853181e-07
- O 0 8.706746257303166e-07
BP O 0 1.2906198207929265e-06
) O 0 1.8163829815232013e-12
, O 0 8.36508379925549e-13
may O 0 4.07720940343026e-11
mediate O 0 1.4842308493356882e-09
the O 0 1.0501906982929299e-10
trans O 0 1.0455189602964765e-08
- O 0 6.784017045902146e-07
dominant O 0 7.582361405411575e-09
effect O 0 3.267818793339927e-10
of O 0 1.024536250109065e-12
the O 0 1.2721731654230517e-11
RNA O 0 3.653187530261448e-09
. O 0 6.51068199353233e-10

CUG O 0 0.00035300233867019415
- O 0 3.55770462192595e-05
BP O 0 4.387163062347099e-05
was O 0 1.2073801958223385e-09
found O 0 4.010026685707935e-11
to O 0 6.871841420549862e-13
bind O 0 3.2680058659195765e-10
to O 0 3.3841488639163586e-12
the O 0 4.206473364076757e-11
human O 0 3.958258609770837e-09
cardiac O 0 4.64849108539056e-06
troponin O 0 0.0024285351391881704
T O 0 4.926688689010916e-06
( O 0 4.027723900928981e-12
cTNT O 0 9.99368032772452e-10
) O 0 2.0775857163118916e-12
pre O 0 1.1771285279849053e-08
- O 0 6.155195819701476e-08
messenger O 0 1.1051852766286174e-09
RNA O 0 6.642640881793227e-10
and O 0 3.2181774606288016e-12
regulate O 0 9.947065393589583e-11
its O 0 5.1360946745626634e-12
alternative O 0 6.055623363865337e-11
splicing O 0 3.3745244376603978e-09
. O 0 1.2565068985281869e-09

Splicing O 0 7.398331831609539e-07
of O 0 2.31002106332312e-09
cTNT O 0 2.7385201519791735e-06
was O 0 6.145681652469648e-08
disrupted O 0 2.0877407678199233e-06
in O 0 2.1158085061756537e-08
DM B-Disease 1 0.9999991655349731
striated O 1 0.8141024708747864
muscle O 0 6.456997653003782e-05
and O 0 1.1642002917255923e-08
in O 0 1.418744149939144e-10
normal O 0 1.5071153214307742e-09
cells O 0 5.779697276331319e-10
expressing O 0 5.507036493490602e-10
transcripts O 0 1.4619948585092857e-09
that O 0 3.946238127938706e-11
contain O 0 3.0473787937523866e-09
CUG O 0 4.309966243454255e-06
repeats O 0 1.795931154902064e-07
. O 0 2.1892248014410143e-09

Altered O 0 1.35294226311089e-06
expression O 0 2.7396321655714928e-08
of O 0 1.8520993766424354e-11
genes O 0 2.328121029293584e-09
regulated O 0 8.055541123042076e-09
posttranscriptionally O 0 5.343720488326653e-08
by O 0 8.648261273780378e-11
CUG O 0 1.7913203919306397e-05
- O 0 2.1636171823047334e-06
BP O 0 2.529909806980868e-06
therefore O 0 8.055660027928013e-10
may O 0 2.1397957017388336e-10
contribute O 0 4.0660419475813114e-11
to O 0 7.400838275550825e-10
DM B-Disease 1 0.9999935626983643
pathogenesis O 0 3.296134082120261e-06
. O 0 5.098989008800459e-10
. O 0 1.0440218689566905e-09

Identification O 0 3.5755061134068455e-08
of O 0 4.0153151636967976e-11
a O 0 1.6836665395203454e-10
novel O 0 1.2928911274912025e-09
nonsense O 0 5.701139798475197e-06
mutation O 0 1.243274709850084e-07
and O 0 8.393889749935823e-12
a O 0 6.206453753709873e-12
missense O 0 5.749485776362917e-09
substitution O 0 1.1400234228853279e-10
in O 0 2.686996241826889e-12
the O 0 6.329734479615379e-12
vasopressin O 0 1.6087474463688523e-08
- O 0 8.160439790572127e-08
neurophysin O 0 2.511979459995928e-07
II O 0 1.1324809179313888e-07
gene O 0 3.880993304505864e-10
in O 0 1.2673076997538057e-11
two O 0 6.675249762666535e-12
Spanish O 0 1.9432710995914704e-09
kindreds O 0 8.751585767186043e-08
with O 0 3.005017068513638e-10
familial B-Disease 0 0.000855922291520983
neurohypophyseal I-Disease 1 0.9871861934661865
diabetes I-Disease 1 0.9801090359687805
insipidus I-Disease 1 0.5685165524482727
. O 0 2.728738763835281e-07

Familial B-Disease 1 0.9964656829833984
neurohypophyseal I-Disease 1 0.9994363188743591
diabetes I-Disease 1 0.9999030828475952
insipidus I-Disease 1 0.9993053674697876
( O 0 9.917712304741144e-07
FNDI B-Disease 1 0.9999988079071045
) O 0 3.076472965268806e-10
is O 0 7.735000140396409e-11
an O 0 9.812033130440767e-11
autosomal B-Disease 1 0.9998297691345215
dominant I-Disease 1 0.9999793767929077
disease I-Disease 1 0.9929810762405396
caused O 0 4.16786533605773e-05
by O 0 2.7573364036470593e-07
deficiency O 1 0.639196515083313
in O 0 2.7558183512965684e-10
the O 0 8.073780533024433e-10
antidiuretic O 0 8.48772979225032e-05
hormone O 0 1.705100203253096e-07
arginine O 0 2.553583833275752e-08
vasopressin O 0 4.341282888731257e-08
( O 0 1.0167111944014984e-11
AVP O 0 2.543941168831054e-10
) O 0 2.6767084100425e-13
encoded O 0 3.554528416396807e-12
by O 0 1.086402669214781e-12
the O 0 4.636253186918182e-12
AVP O 0 1.137672089868147e-08
- O 0 7.476979249076976e-07
neurophysin O 0 7.476262453565141e-06
II O 0 6.533897249028087e-06
( O 0 2.8248577088607618e-11
AVP O 0 9.737783024377222e-09
- O 0 3.438921396536898e-07
NPII O 0 1.8578143681224901e-06
) O 0 3.718966107291166e-12
gene O 0 4.2361938956680945e-10
on O 0 4.266837994038042e-10
chromosome O 0 1.4270933661464369e-06
20p13 O 0 6.140257937659044e-07
. O 0 5.609628761504837e-09

In O 0 3.6758035504291797e-10
this O 0 7.0005936811390335e-12
study O 0 2.2222097426083387e-11
, O 0 1.8885953998598604e-12
we O 0 2.0952918219907524e-11
analyzed O 0 2.57419835447692e-10
two O 0 1.2532259301492599e-12
families O 0 4.0027881183235525e-12
with O 0 1.35734505232743e-11
FNDI B-Disease 1 0.9994718432426453
using O 0 3.27576750447367e-11
direct O 0 8.876220938813795e-12
automated O 0 3.4727958286850935e-09
fluorescent O 0 6.57450556218464e-08
, O 0 7.20675364003498e-13
solid O 0 9.554894375707335e-11
phase O 0 7.535267548819391e-11
, O 0 4.331132078417427e-13
single O 0 5.067930797242326e-11
- O 0 4.602787040397516e-09
stranded O 0 2.2857477022242279e-10
DNA O 0 2.2978242572579965e-11
sequencing O 0 3.5590397816365194e-12
of O 0 5.228319947120363e-13
PCR O 0 1.0977487363561522e-08
- O 0 6.744023295368606e-08
amplified O 0 5.075019089417765e-07
AVP O 0 7.522812950355728e-08
- O 0 2.433521615330392e-07
NPII O 0 2.2558795080840355e-06
DNA O 0 1.137564069608743e-07
. O 0 4.758606397814447e-09

In O 0 9.1739005281255e-10
one O 0 1.4582394319839764e-11
of O 0 6.411359615952905e-13
the O 0 6.089522115726442e-12
families O 0 3.2470963418074206e-11
, O 0 6.786204410913488e-12
affected O 0 6.8453940432755545e-12
individuals O 0 2.8466643105240497e-12
presented O 0 5.277941625414506e-11
a O 0 3.2522533277568044e-11
novel O 0 3.256823699615552e-10
nonsense O 0 3.567610562527079e-08
mutation O 0 1.576902830535687e-09
in O 0 1.4089806795250515e-12
exon O 0 3.530579162358549e-10
3 O 0 4.416827580761007e-12
of O 0 2.536243784434511e-13
the O 0 2.7556787147303696e-12
gene O 0 3.3418817713126714e-10
, O 0 3.074327088476575e-13
consisting O 0 5.157138821890173e-13
in O 0 3.5319761438473707e-12
a O 0 1.0932676292041421e-10
G O 0 9.987932116928278e-07
to O 0 4.602369874096013e-11
T O 0 1.6836894474181463e-06
transition O 0 4.6007925247337766e-10
at O 0 8.524013439537015e-11
nucleotide O 0 3.058419073553864e-09
2101 O 0 1.2568454721417766e-08
, O 0 5.234876117657383e-13
which O 0 1.139450621530369e-12
produces O 0 6.603221441858764e-12
a O 0 1.436941017562976e-11
stop O 0 1.828903417600003e-10
signal O 0 1.3874568161043044e-08
in O 0 5.74349526272222e-11
codon O 0 1.8266556045531956e-09
82 O 0 1.6927952095624477e-10
( O 0 1.2606032537276768e-11
Glu O 0 7.76313768824366e-08
) O 0 8.533459529280751e-12
of O 0 2.5321860927518536e-11
NPII O 0 2.3143911676015705e-05
. O 0 5.041374873115956e-09

The O 0 2.4079787053210566e-08
premature O 0 3.149697249682504e-07
termination O 0 1.5721765223020157e-08
eliminates O 0 7.2314425558772655e-09
part O 0 4.2373392988848124e-11
of O 0 8.303220958016944e-12
the O 0 2.9294883185926324e-10
C O 0 8.755598628340522e-07
- O 0 3.049211727557122e-08
terminal O 0 1.3565001344417738e-09
domain O 0 2.1274516870395388e-11
of O 0 5.288325116356574e-13
NPII O 0 1.1313895953435349e-07
, O 0 1.136851504319851e-13
including O 0 4.082035409561438e-14
a O 0 8.504273132058093e-13
cysteine O 0 6.583188421477315e-12
residue O 0 6.086834924978746e-10
in O 0 1.3772160495362229e-12
position O 0 8.517890282000451e-10
85 O 0 3.4286933101729256e-12
, O 0 5.968218540902681e-13
which O 0 1.8298550175099848e-11
could O 0 8.060824230327057e-10
be O 0 2.710004443073899e-11
involved O 0 1.5318754945092827e-11
in O 0 7.763404502592053e-12
the O 0 2.475604617135918e-11
correct O 0 4.334382452952923e-08
folding O 0 1.3214028093955221e-08
of O 0 5.950047312491824e-12
the O 0 2.2801044385900582e-10
prohormone O 0 5.389194484450854e-06
. O 0 4.766418371104919e-09

In O 0 1.7773745808469243e-09
the O 0 3.427694586499719e-11
second O 0 9.259613908962905e-11
family O 0 1.836881063921325e-10
, O 0 2.1196121301279153e-13
a O 0 4.793559754863452e-13
G279A O 0 1.2466703884495e-11
substitution O 0 4.159725081748222e-12
at O 0 6.232837163056004e-12
position O 0 1.0524968396818934e-10
- O 0 1.2800746573837785e-10
1 O 0 5.695261970362075e-13
of O 0 6.450878243038916e-14
the O 0 2.0673870601561894e-12
signal O 0 5.795582347367656e-10
peptide O 0 1.9786630667262273e-10
was O 0 1.3312566327083886e-11
observed O 0 4.673562925550101e-11
in O 0 7.123593707102083e-13
all O 0 2.2058659152751625e-12
affected O 0 5.008552947383116e-11
individuals O 0 1.954343076260301e-10
. O 0 8.896026693072656e-10

This O 0 5.041413064788003e-09
missense O 0 5.257626253296621e-05
mutation O 0 5.142289228388108e-05
, O 0 1.0298919356221958e-10
which O 0 1.1249616516106897e-10
replaces O 0 5.95130806857469e-08
Ala O 0 1.8618706576489785e-08
with O 0 1.16603920963243e-10
Thr O 0 3.8755119931010995e-06
, O 0 1.9671098083762217e-11
is O 0 7.816894700973798e-12
frequent O 0 1.3704027912453398e-09
among O 0 2.2480637351662835e-09
FNDI B-Disease 1 0.9999998807907104
patients O 0 1.3894540984438208e-07
and O 0 3.916441893014877e-10
is O 0 4.41607167500635e-11
thought O 0 5.4897301982048674e-11
to O 0 6.074740320147209e-13
reduce O 0 7.410495828086283e-11
the O 0 1.6212659470146717e-12
efficiency O 0 3.001608961383795e-10
of O 0 7.293039327831152e-13
cleavage O 0 3.3486358574918995e-08
by O 0 2.6768894392792397e-11
signal O 0 4.16353529431035e-08
peptidases O 0 1.3456639180731145e-07
. O 0 5.675217587541859e-11
. O 0 3.1795049926230945e-10

Genetic O 0 1.126306528931309e-06
heterogeneity O 0 1.117348688239872e-06
of O 0 3.3542721933343955e-09
Saethre B-Disease 0 0.4284839332103729
- I-Disease 1 0.9997962117195129
Chotzen I-Disease 1 0.9999381303787231
syndrome I-Disease 1 0.9999887943267822
, O 0 8.806595730437294e-11
due O 0 1.227638130041342e-10
to O 0 3.2175838382553223e-11
TWIST O 0 1.8961194427902228e-06
and O 0 1.1306135583311061e-08
FGFR O 0 0.00013895469601266086
mutations O 0 2.2960241494729416e-06
. O 0 8.004095164437786e-09

Thirty O 0 6.751050136699632e-07
- O 0 4.903552053292515e-07
two O 0 9.629558261892157e-11
unrelated O 0 5.8421687043619386e-08
patients O 0 2.5689219640412375e-09
with O 0 3.3861633115528367e-12
features O 0 1.672704308397499e-09
of O 0 3.767368084162115e-10
Saethre B-Disease 0 0.4070570170879364
- I-Disease 1 0.9987209439277649
Chotzen I-Disease 1 0.9995706677436829
syndrome I-Disease 1 0.9997275471687317
, O 0 1.1982138371779971e-11
a O 0 2.3787655178963973e-10
common O 0 2.2135409949441964e-08
autosomal B-Disease 0 0.029339199885725975
dominant I-Disease 0 0.020064905285835266
condition I-Disease 0 0.0001127094219555147
of O 0 7.703511162304721e-10
craniosynostosis B-Disease 1 0.8439409732818604
and O 0 1.3336214976789051e-07
limb B-Disease 0 0.06919592618942261
anomalies I-Disease 0 0.00678471801802516
, O 0 6.991190265592806e-11
were O 0 5.6486298277702574e-11
screened O 0 6.356045467725835e-09
for O 0 4.5426207934129437e-11
mutations O 0 2.3763234935358923e-08
in O 0 2.0129595906803743e-11
TWIST O 0 1.3981473045987514e-07
, O 0 3.591829958460302e-11
FGFR2 O 0 4.1127461258838593e-07
, O 0 1.0346621129309064e-11
and O 0 1.8067893015061287e-10
FGFR3 O 0 2.725383637880441e-06
. O 0 1.4537530068636784e-09

Nine O 0 5.65357183290871e-09
novel O 0 1.4922156843510948e-09
and O 0 7.225645082264975e-11
three O 0 2.1555039003695597e-11
recurrent O 0 8.649244023217761e-07
TWIST O 0 7.326138529606396e-06
mutations O 0 4.732107299787458e-06
were O 0 2.642225771509743e-09
found O 0 9.420750846089732e-10
in O 0 1.1966455604195403e-10
12 O 0 1.335835747573455e-10
families O 0 8.000290985243907e-10
. O 0 3.5841141166059742e-09

Seven O 0 5.67377300697558e-09
families O 0 1.0149296958417153e-09
were O 0 1.0357249086156983e-10
found O 0 1.0957937335298595e-10
to O 0 7.796732877374257e-12
have O 0 3.1354443347231253e-11
the O 0 3.6103320853742016e-12
FGFR3 O 0 1.4829149108663842e-07
P250R O 0 6.554878861919633e-10
mutation O 0 9.305527459702034e-10
, O 0 1.6219766144336817e-13
and O 0 2.1464512838572508e-13
one O 0 4.527202451896223e-13
individual O 0 1.6733503471755284e-11
was O 0 1.5887400284242403e-09
found O 0 5.092066698852982e-11
to O 0 8.481243485292111e-12
have O 0 5.1943213619232154e-11
an O 0 3.5405964184803684e-12
FGFR2 O 0 1.5922879015306535e-07
VV269 O 0 3.808566351182208e-09
- O 0 1.1670283406317594e-08
270 O 0 9.662294297996254e-10
deletion O 0 1.7081845271604834e-07
. O 0 7.799957124632328e-09

To O 0 1.3586856084657484e-09
date O 0 3.6151883708868127e-09
, O 0 2.679130571905941e-12
our O 0 1.1148617619360923e-11
detection O 0 1.6149138692966858e-09
rate O 0 1.522532322439929e-09
for O 0 2.438086353900165e-13
TWIST O 0 1.8742549734440672e-09
or O 0 1.4208240139979011e-10
FGFR O 0 2.3252226810654975e-07
mutations O 0 2.9623714592474926e-09
is O 0 5.401968369150856e-12
68 O 0 5.27832118291105e-12
% O 0 7.901916967978373e-13
in O 0 1.0865110026958558e-11
our O 0 5.138512726432509e-09
Saethre B-Disease 0 0.00015165875083766878
- I-Disease 1 0.8783864974975586
Chotzen I-Disease 1 0.9988006353378296
syndrome I-Disease 1 0.9997684359550476
patients O 0 5.891491738907462e-09
, O 0 2.956338516005297e-12
including O 0 1.2485091085978617e-12
our O 0 3.124115410813033e-10
five O 0 4.981666468228951e-11
patients O 0 4.2801404087633443e-10
elsewhere O 0 5.137131164900666e-09
reported O 0 1.719473452510556e-09
with O 0 3.8567062737859814e-11
TWIST O 0 2.376807515247492e-06
mutations O 0 1.2181529882582254e-06
. O 0 4.883100146457764e-09

More O 0 2.484380479117476e-10
than O 0 2.1087187551671605e-11
35 O 0 9.145362418749858e-12
different O 0 4.9496986370689555e-12
TWIST O 0 1.6909808664422599e-07
mutations O 0 1.7457934120557184e-07
are O 0 9.735563744062148e-11
now O 0 4.011641019374679e-11
known O 0 2.7335002317219192e-11
in O 0 9.988810993621922e-12
the O 0 3.2137199151849316e-11
literature O 0 9.045481585978621e-10
. O 0 5.649505308014113e-10

The O 0 6.066042113062053e-10
most O 0 2.2368808194617174e-11
common O 0 3.2298753949167036e-11
phenotypic O 0 2.6399740171711983e-09
features O 0 4.0649158705718946e-08
, O 0 3.125926253955136e-11
present O 0 4.947291708246038e-12
in O 0 2.0589185738273397e-12
more O 0 1.9362670375475816e-13
than O 0 1.4401779465170184e-12
a O 0 6.467357031858523e-12
third O 0 4.5992723518573086e-11
of O 0 2.5782004569457895e-12
our O 0 2.0492447738718056e-09
patients O 0 4.053528346315005e-11
with O 0 8.430326749186978e-12
TWIST O 0 4.457655506939773e-07
mutations O 0 1.5053412028009916e-07
, O 0 1.552965113275906e-12
are O 0 9.677200447227863e-13
coronal B-Disease 0 5.406668890373112e-08
synostosis I-Disease 0 1.2983330179849872e-06
, O 0 1.1332501777261417e-11
brachycephaly B-Disease 0 2.3307707408548595e-07
, O 0 3.088507782855743e-10
low B-Disease 0 3.8997139199636877e-05
frontal I-Disease 1 0.9999430179595947
hairline I-Disease 1 0.9999988079071045
, O 0 3.0292420660771313e-07
facial B-Disease 1 0.9965393543243408
asymmetry I-Disease 0 0.042205389589071274
, O 0 2.217673866766745e-08
ptosis B-Disease 0 0.4922977685928345
, O 0 5.568403516065246e-10
hypertelorism B-Disease 0 1.7417421986465342e-05
, O 0 1.2402957827450933e-10
broad B-Disease 0 6.063477275830564e-09
great I-Disease 0 7.921611313577159e-07
toes I-Disease 0 0.01907641813158989
, O 0 6.992550288797972e-11
and O 0 9.736417921901719e-11
clinodactyly B-Disease 0 5.329185910341039e-07
. O 0 3.6024683236490773e-09

Significant O 0 1.3939715159949628e-08
intra O 0 6.051140388763088e-08
- O 0 6.141926860436797e-07
and O 0 9.203222073317363e-10
interfamilial O 0 2.6073487902067427e-07
phenotypic O 0 3.522175688885909e-07
variability O 0 2.02282790269237e-05
is O 0 1.5707181388879832e-10
present O 0 1.305084599417805e-11
for O 0 1.3567128106725668e-12
either O 0 1.1772289809641734e-09
TWIST O 0 4.549387995211873e-06
mutations O 0 1.0686726454878226e-06
or O 0 1.4797512548625491e-08
FGFR O 0 5.2744089771294966e-05
mutations O 0 4.578999778459547e-06
. O 0 5.028237826110171e-09

The O 0 8.077599700229143e-10
overlap O 0 3.8745682218177535e-09
in O 0 4.91432103344458e-11
clinical O 0 1.978301744642863e-09
features O 0 8.515327110103499e-09
and O 0 3.1661609445343686e-10
the O 0 5.122681792646411e-12
presence O 0 1.7911326588571086e-10
, O 0 1.9962386778316077e-12
in O 0 3.7166165869732815e-13
the O 0 2.2156389678680555e-13
same O 0 2.0422620192195318e-11
genes O 0 2.200593179901844e-11
, O 0 3.7380424547806684e-14
of O 0 1.1644766707429206e-14
mutations O 0 2.0577419976297584e-11
for O 0 7.8586849484516e-14
more O 0 2.3293953571590365e-13
than O 0 3.3087957287264436e-12
one O 0 3.7288477860997205e-11
craniosynostotic B-Disease 0 7.142467097764893e-07
condition I-Disease 0 2.270693322259376e-08
- O 0 1.936919930001224e-10
such O 0 2.6016250785632078e-12
as O 0 1.1833714563813658e-11
Saethre B-Disease 0 2.8174794053370533e-08
- I-Disease 0 1.6862937712858184e-08
Chotzen I-Disease 0 2.9555158320704322e-08
, I-Disease 0 2.0669809180223764e-12
Crouzon I-Disease 0 2.0630019914591458e-09
, I-Disease 0 1.4494925442212758e-12
and I-Disease 0 2.4068318518755127e-11
Pfeiffer I-Disease 0 2.783224601898837e-07
syndromes I-Disease 0 3.833128232599847e-07
- O 0 1.216450717933526e-09
support O 0 2.1202208391746247e-11
the O 0 1.477337870092743e-11
hypothesis O 0 1.1894372153875565e-09
that O 0 1.3081044494128724e-12
TWIST O 0 2.411424615544888e-09
and O 0 5.4543276145624375e-11
FGFRs O 0 1.0416633777765583e-08
are O 0 2.6460595867194847e-12
components O 0 3.6182615931190654e-11
of O 0 1.1234052967393215e-13
the O 0 6.556094100766685e-13
same O 0 3.342587664989516e-11
molecular O 0 1.24439092363815e-09
pathway O 0 7.286258402183776e-12
involved O 0 2.1120544549391163e-12
in O 0 8.154461264217594e-13
the O 0 1.1883513921159827e-12
modulation O 0 2.6002053843399153e-09
of O 0 5.776608011376361e-11
craniofacial O 0 0.18576839566230774
and O 0 2.9633788756200374e-08
limb O 0 3.1560043680656236e-06
development O 0 3.239821258493869e-11
in O 0 3.4697335282718456e-11
humans O 0 6.562909660168259e-10
. O 0 4.096244177187458e-11
. O 0 5.438487993281171e-10

Mutation O 0 2.8326578103587963e-05
analysis O 0 8.095545211972421e-08
of O 0 3.936724723985208e-09
UBE3A O 1 0.973730206489563
in O 0 0.0019583755638450384
Angelman B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
patients O 0 0.0017174866516143084
. O 0 2.283462805507952e-07

Angelman B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 0 6.215852408786304e-06
AS B-Disease 1 0.9992914199829102
) O 0 4.031986411412447e-10
is O 0 1.9762605441009384e-10
caused O 0 1.2275316763066257e-08
by O 0 2.669915399877709e-10
chromosome O 0 2.8283933716011234e-05
15q11 O 0 5.487461294251261e-07
- O 0 8.611205970510127e-08
q13 O 0 3.1608589079468175e-09
deletions O 0 4.814432852384698e-09
of O 0 1.672792113160959e-11
maternal O 0 3.8691499071319413e-07
origin O 0 6.528078078105182e-10
, O 0 1.16842017831853e-12
by O 0 1.2568315312100342e-11
paternal O 0 7.839013051125221e-06
uniparental B-Disease 0 0.006628972012549639
disomy I-Disease 0 0.0002018130326177925
( O 0 6.490050719065721e-10
UPD B-Disease 1 0.9998056292533875
) O 0 1.0255769324063468e-11
15 O 0 2.344990087527199e-12
, O 0 2.0142631865834731e-13
by O 0 5.296002525412291e-11
imprinting O 0 0.04508131369948387
defects O 1 0.9900627732276917
, O 0 1.571487558138518e-11
and O 0 5.978031004244544e-12
by O 0 1.5394617872144245e-11
mutations O 0 4.047724644351547e-08
in O 0 4.413435936156951e-11
the O 0 2.670424714690256e-10
UBE3A O 0 1.953991159098223e-05
gene O 0 7.850334071690668e-08
. O 0 4.010604293114284e-09

UBE3A O 0 0.0005523920408450067
encodes O 0 4.904253501081257e-07
a O 0 1.6005534675400668e-09
ubiquitin O 0 1.0581423026678749e-07
- O 0 2.0352389640265756e-07
protein O 0 9.003569001464484e-10
ligase O 0 3.7009344477922923e-09
and O 0 2.7858737539077083e-10
shows O 0 1.0350647272616698e-07
brain O 0 2.214969390479382e-05
- O 0 1.54978494038005e-07
specific O 0 3.4747307253724102e-09
imprinting O 0 2.425649199722102e-06
. O 0 3.4878711030472687e-09

Here O 0 8.012072783003532e-08
we O 0 6.729805601679573e-10
describe O 0 2.4459676506438655e-09
UBE3A O 0 3.6104745504417224e-06
coding O 0 4.2727796767394466e-07
- O 0 2.772468633338576e-06
region O 0 8.72265193407884e-09
mutations O 0 3.275454218965024e-07
detected O 0 1.3446954483242735e-07
by O 0 1.0499818896281266e-11
SSCP O 0 1.0306735731546723e-07
analysis O 0 1.323979675893483e-10
in O 0 1.2748329301925931e-11
13 O 0 4.179936952120045e-11
AS B-Disease 0 0.49707117676734924
individuals O 0 2.498875550926982e-10
or O 0 2.29193930501026e-09
families O 0 1.018971906852073e-09
. O 0 1.1378517017490708e-09

Two O 0 1.1030503621611842e-08
identical O 0 4.218765354835341e-07
de O 0 6.527449158966192e-08
novo O 0 6.578456179795467e-08
5 O 0 5.094730748389509e-10
- O 0 3.238442403130648e-08
bp O 0 4.564993361100278e-08
duplications O 0 3.606801612932031e-08
in O 0 4.738621300903745e-11
exon O 0 3.543116733339957e-08
16 O 0 4.76394368398303e-10
were O 0 3.905491208211487e-10
found O 0 6.619283787756558e-09
. O 0 6.441931432732417e-09

Among O 0 1.9116150884457284e-09
the O 0 8.824448116673267e-12
other O 0 2.36822388956226e-12
11 O 0 4.86424095447191e-12
unique O 0 4.153978896970223e-11
mutations O 0 2.7280041337007788e-08
, O 0 3.0936694178640423e-12
8 O 0 3.3279609536890353e-12
were O 0 2.9069873678372327e-12
small O 0 5.048006283814299e-12
deletions O 0 1.088638956758814e-08
or O 0 6.577697275744754e-10
insertions O 0 3.250082158956502e-07
predicted O 0 6.017188525220263e-08
to O 0 2.8938998766769863e-11
cause O 0 1.1789485832025548e-08
frameshifts O 0 9.789089290279662e-07
, O 0 6.603737522092867e-12
1 O 0 6.262186949546056e-12
was O 0 9.85329248748279e-11
a O 0 4.136056080961126e-11
mutation O 0 3.5546083854143262e-09
to O 0 1.8544031327866195e-12
a O 0 2.699675899497933e-11
stop O 0 1.4446115137456417e-10
codon O 0 5.2464161487408845e-11
, O 0 1.1579655962400126e-13
1 O 0 7.464920608740711e-13
was O 0 2.5768692735184118e-11
a O 0 1.4442809448400595e-10
missense O 0 5.573978341999464e-06
mutation O 0 1.4167818562782486e-06
, O 0 2.4436000098382316e-12
and O 0 1.3070276631832467e-11
1 O 0 3.515209998083968e-11
was O 0 1.0592242638551852e-08
predicted O 0 1.1627756535403933e-08
to O 0 5.630877708551196e-12
cause O 0 5.716350726103769e-10
insertion O 0 2.705832502503114e-10
of O 0 1.5273299985851807e-11
an O 0 8.009631152772201e-11
isoleucine O 0 2.450424517519423e-06
in O 0 1.1037348118803081e-11
the O 0 2.562532000829898e-12
hect O 0 3.8867442597734225e-09
domain O 0 2.5795936567374333e-11
of O 0 3.428318826742549e-13
the O 0 1.8776235774509153e-11
UBE3A O 0 8.138815701386193e-07
protein O 0 3.965941741679302e-10
, O 0 1.9800957748450365e-12
which O 0 1.5524467562172406e-12
functions O 0 2.9947832408394603e-12
in O 0 4.002665820318496e-12
E2 O 0 3.3481359906772923e-09
binding O 0 1.2561786055798052e-09
and O 0 4.776351189561545e-11
ubiquitin O 0 5.4033471030834335e-09
transfer O 0 4.240059858773293e-09
. O 0 3.0220670410585626e-09

Eight O 0 2.0398620570460935e-09
of O 0 2.7123830959041584e-11
the O 0 2.0829751118389694e-11
cases O 0 2.54232107588237e-10
were O 0 2.794185993693077e-10
familial O 0 5.203281034482643e-06
, O 0 1.969288954128956e-09
and O 0 1.64771626898208e-10
five O 0 2.6287314339179524e-11
were O 0 6.893407511476823e-10
sporadic O 0 1.6781575595814502e-07
. O 0 8.606472867711545e-09

In O 0 2.5958295513106577e-09
two O 0 1.91992984011069e-11
familial O 0 3.1607812616130104e-06
cases O 0 3.1667262589962775e-08
and O 0 2.4739069126589186e-10
one O 0 4.749062601505649e-11
sporadic O 0 1.3262002163116904e-08
case O 0 1.820385442385941e-08
, O 0 3.4518564222263404e-12
mosaicism O 0 2.4747022209226088e-08
for O 0 2.5851794663300787e-11
UBE3A O 0 1.0288473276887089e-05
mutations O 0 1.6949074677086173e-07
was O 0 1.3083958361193027e-09
detected O 0 2.500718210285413e-08
in O 0 4.059220841401423e-12
the O 0 8.340266845208166e-12
mother O 0 1.8873279827857914e-08
of O 0 1.1082274421064797e-12
three O 0 2.6611199355208726e-10
AS B-Disease 1 0.9996874332427979
sons O 0 1.2830011542064312e-07
, O 0 6.126636741335401e-13
in O 0 4.578951692639499e-13
the O 0 3.940219678311152e-12
maternal O 0 2.848511293507272e-08
grandfather O 0 1.92312850089138e-08
of O 0 4.3540588886073484e-13
two O 0 8.851656387032225e-12
AS B-Disease 1 0.8024420738220215
first O 0 1.1472654076749578e-10
cousins O 0 5.89797082284349e-08
, O 0 1.547518623662425e-12
and O 0 5.4845572527995046e-12
in O 0 1.984057666423733e-12
the O 0 1.0198380334669466e-11
mother O 0 4.06883309267414e-08
of O 0 3.498019148645559e-12
an O 0 1.335840882354944e-10
AS B-Disease 1 0.9999768733978271
daughter O 0 0.0010093825403600931
. O 0 1.0940572892081946e-08

The O 0 7.180639971515745e-10
frequencies O 0 1.70525069620453e-08
with O 0 1.6975343006264687e-11
which O 0 5.210893175289222e-11
we O 0 1.4619189192544013e-10
detected O 0 1.3847680335743462e-08
mutations O 0 5.526619162310453e-10
were O 0 1.1531311495949215e-11
5 O 0 1.2897316678181503e-12
( O 0 9.005474046596545e-14
14 O 0 3.4736368512491844e-13
% O 0 6.409742934988458e-14
) O 0 1.058114489446314e-14
of O 0 3.122083822482309e-14
35 O 0 1.1932369155254197e-12
in O 0 5.424349663017691e-13
sporadic O 0 9.528855482443532e-10
cases O 0 2.4688723287979997e-10
and O 0 4.102890943658011e-11
8 O 0 3.916198962339301e-12
( O 0 6.924981557155166e-14
80 O 0 2.1248622436229048e-13
% O 0 1.6008402286063483e-13
) O 0 2.2405923890875777e-14
of O 0 9.064565097876079e-14
10 O 0 2.9337461279754784e-12
in O 0 6.4302716797082216e-12
familial O 0 2.319685421525719e-07
cases O 0 2.010644806205164e-08
. O 0 4.911306361599088e-10
. O 0 1.495461088296679e-09

The O 0 5.445749451382653e-08
hemochromatosis B-Disease 1 0.9993164539337158
845 O 0 1.5557794768028543e-06
G O 0 1.7145825040643103e-05
- O 0 3.1872806971477985e-07
- O 0 1.1489729700997486e-07
> O 0 1.3953539435007656e-09
A O 0 1.0919942727838361e-10
and O 0 2.0826253915862125e-11
187 O 0 3.602533202307079e-11
C O 0 1.8376108412709868e-09
- O 0 6.87923851216965e-09
- O 0 1.408885879072841e-07
> O 0 1.8098194942695045e-08
G O 0 1.038704226630216e-06
mutations O 0 2.1535964123131635e-08
: O 0 4.0685552149533066e-11
prevalence O 0 4.327600322540093e-08
in O 0 3.863406469739594e-11
non O 0 3.557701466760932e-09
- O 0 3.0306516691780416e-06
Caucasian O 0 2.8880899662908632e-06
populations O 0 4.137624287636754e-08
. O 0 1.944527872055346e-09

Hemochromatosis B-Disease 1 0.8066388964653015
, O 0 3.203394527417913e-08
the O 0 7.723954098537433e-08
inherited B-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999992847442627
of I-Disease 0 8.516106930755996e-09
iron I-Disease 0 0.31743696331977844
metabolism I-Disease 0 2.369902176724281e-05
, O 0 7.026371671992049e-12
leads O 0 7.169113219740453e-11
, O 0 6.856853626557857e-12
if O 0 1.1042748937484248e-09
untreated O 0 3.347920696228357e-08
, O 0 1.2802076022541686e-12
to O 0 5.3578651931784904e-12
progressive O 0 2.9877125484745193e-07
iron B-Disease 1 0.9563974738121033
overload I-Disease 0 0.010097356513142586
and O 0 1.7664492091284956e-08
premature B-Disease 0 2.3971304585757025e-07
death I-Disease 0 3.1624704632804423e-08
. O 0 7.60115304032638e-10

The O 0 1.6365058286282874e-07
hemochromatosis B-Disease 1 0.9999877214431763
gene O 0 2.93821517516335e-06
, O 0 4.5248699231947853e-10
HFE O 0 1.0647199815139174e-05
, O 0 1.6767411070706117e-10
recently O 0 4.1926364602318245e-09
has O 0 6.51253273531438e-10
been O 0 5.820796067368406e-10
identified O 0 1.7821855990973745e-08
, O 0 1.4927913506018742e-12
and O 0 6.36877432302202e-13
characterization O 0 1.4204500076164805e-10
of O 0 9.306857855998635e-14
this O 0 1.1646467210774114e-12
gene O 0 1.1331815347181973e-10
has O 0 2.933943712979392e-11
shown O 0 2.2780961839163894e-10
that O 0 7.347341485219872e-12
it O 0 7.467897285805269e-13
contains O 0 4.685321683579879e-13
two O 0 1.260903274152847e-12
mutations O 0 9.678616796904294e-10
that O 0 1.1368525912325289e-11
result O 0 1.952792927362168e-10
in O 0 1.9574833073909836e-11
amino O 0 1.534443058726076e-11
acid O 0 5.114783162979419e-12
substitutions O 0 2.889338594769253e-11
- O 0 4.5732570508327797e-11
cDNA O 0 1.2917074354579228e-10
nucleotides O 0 5.3280796441512734e-11
845 O 0 2.577770219502895e-10
G O 0 5.6910711698776595e-09
- O 0 1.8827071013305385e-09
- O 0 6.911342165238921e-09
> O 0 5.758130638966463e-10
A O 0 2.0259990907156578e-10
( O 0 4.88098602334508e-13
C282Y O 0 3.888719901645743e-11
) O 0 7.752860717779794e-14
and O 0 9.669081941360291e-13
187 O 0 1.1145450881655528e-11
C O 0 2.7619291298464077e-09
- O 0 1.0523697824282863e-07
- O 0 4.685647127189441e-06
> O 0 2.734381325808499e-07
G O 0 3.1216402476275107e-06
( O 0 9.759543000142923e-12
H63D O 0 2.536280021558923e-07
) O 0 6.307213779033205e-11
. O 0 3.154906336177987e-10

Although O 0 7.9444216680713e-06
hemochromatosis B-Disease 1 0.9999831914901733
is O 0 3.59319223264265e-08
common O 0 2.57577137396936e-09
in O 0 7.546371166844423e-11
Caucasians O 0 4.3766399393518896e-09
, O 0 2.8071371182408766e-12
affecting O 0 4.254726779229223e-11
> O 0 1.1124642179671795e-10
= O 0 2.2504434427084163e-10
1 O 0 1.189324246725354e-12
/ O 0 1.9952232574449447e-11
300 O 0 6.862567697267508e-13
individuals O 0 3.2158564006179446e-13
of O 0 3.0438927203432775e-13
northern O 0 4.0043628135588705e-11
European O 0 1.6207357678155176e-10
origin O 0 1.559455203858917e-10
, O 0 1.9704019232208436e-12
it O 0 6.418948705899652e-12
has O 0 2.8686093431207205e-11
not O 0 1.0566357684649308e-11
been O 0 4.718301790940238e-11
recognized O 0 1.732461916981176e-11
in O 0 3.4198368963067605e-12
other O 0 6.043008975165076e-12
populations O 0 2.3169564877800752e-10
. O 0 3.9364375647998884e-10

The O 0 5.432900240798233e-10
present O 0 1.2468016896693968e-10
study O 0 8.146288331400964e-12
used O 0 1.1227531057644846e-11
PCR O 0 3.0750957336067586e-09
and O 0 1.1372298935885539e-11
restriction O 0 3.157843084244938e-11
- O 0 9.746079637773519e-11
enzyme O 0 7.0187636085072835e-12
digestion O 0 1.2400301271919822e-11
to O 0 1.1654015968400044e-13
analyze O 0 4.401910086437866e-11
the O 0 6.530359478000569e-13
frequency O 0 1.8842687132814007e-10
of O 0 3.94709018616303e-14
the O 0 7.815876851974268e-13
845 O 0 1.275490268959345e-10
G O 0 1.4855995544849065e-08
- O 0 1.5002035169686678e-09
- O 0 1.361300294711043e-09
> O 0 4.733878566920424e-11
A O 0 1.032127334987809e-11
and O 0 2.1192737235248282e-12
187 O 0 4.824592114704984e-12
C O 0 2.1698061403174762e-10
- O 0 6.238266569980055e-10
- O 0 6.578892541853065e-09
> O 0 1.0009399975530187e-09
G O 0 1.9673978002288095e-08
mutations O 0 1.097949176021018e-09
in O 0 3.0652119297619462e-12
HLA O 0 2.4049251479141276e-09
- O 0 1.2753765821216234e-09
typed O 0 3.482998334192189e-09
samples O 0 7.44959580134541e-11
from O 0 3.1319757985009966e-12
non O 0 1.140508451569211e-10
- O 0 3.83970615303042e-08
Caucasian O 0 1.4604961684483442e-08
populations O 0 5.569678052097515e-10
, O 0 5.90231097503946e-13
comprising O 0 7.021638045306977e-13
Australian O 0 5.4875316096714144e-11
Aboriginal O 0 1.7444494460061577e-10
, O 0 1.0335156125015899e-12
Chinese O 0 9.357110355642795e-13
, O 0 5.842488493869313e-13
and O 0 1.0921270832131569e-11
Pacific O 0 7.936453577661595e-11
Islanders O 0 6.4014753498042865e-09
. O 0 8.692718211911199e-10

Results O 0 3.3602199778215436e-07
showed O 0 7.868293039337004e-08
that O 0 1.5497643099382508e-11
the O 0 3.5439609146620255e-12
845 O 0 1.675022121006009e-09
G O 0 2.5577085693839763e-07
- O 0 4.12228757795674e-08
- O 0 1.6448957751435955e-07
> O 0 1.3700289791529485e-09
A O 0 1.8501089549260996e-10
mutation O 0 1.9659498917690144e-08
was O 0 8.85027606756239e-11
present O 0 1.0664144263830555e-12
in O 0 8.794736315077822e-13
these O 0 1.1942090111932702e-12
populations O 0 2.647650111306521e-12
( O 0 7.429817259476876e-14
allele O 0 4.60597046614275e-11
frequency O 0 3.957637551010862e-10
0 O 0 1.8813936953493426e-12
. O 0 5.6490199345539394e-14
32 O 0 3.8420842570809077e-13
% O 0 6.789589777986965e-14
) O 0 5.2701878370262425e-14
, O 0 1.8197768324786784e-13
and O 0 1.4384381706589178e-11
, O 0 1.2352610254118268e-12
furthermore O 0 1.9166888909349922e-10
, O 0 1.2360482646092685e-12
it O 0 2.0643226711358764e-11
was O 0 7.3161539049237945e-09
always O 0 2.2708320557285333e-08
seen O 0 7.277112246129036e-10
in O 0 4.497758773498034e-13
conjunction O 0 2.4923277417571166e-12
with O 0 6.703382640638189e-12
HLA O 0 4.70009986486275e-09
haplotypes O 0 3.1200739769587926e-09
common O 0 9.06409530765373e-11
in O 0 2.42725457788584e-11
Caucasians O 0 3.7749062209435635e-10
, O 0 3.6109637957700003e-13
suggesting O 0 7.946875102415873e-11
that O 0 4.4382522830510585e-12
845 O 0 2.35826913552728e-10
G O 0 7.871054208408168e-08
- O 0 3.141321158750543e-08
- O 0 1.2900619594802265e-07
> O 0 2.5097146583163976e-09
A O 0 2.1289894291953715e-08
may O 0 5.984477269294075e-08
have O 0 2.7674737501648394e-11
been O 0 8.510703426722888e-12
introduced O 0 5.821700760355597e-12
into O 0 4.5063285785199025e-13
these O 0 8.246775658193872e-13
populations O 0 6.3100861341647274e-12
by O 0 1.2069921451196564e-11
Caucasian O 0 1.3417382760394503e-08
admixture O 0 1.1078559936095189e-07
. O 0 5.318733897752281e-09

187 O 0 2.0295676961268327e-07
C O 0 1.6773672939507378e-07
- O 0 2.9276257862420607e-08
- O 0 2.06102953370646e-07
> O 0 7.493556353210806e-08
G O 0 1.440301161892421e-06
was O 0 5.755494969506003e-10
present O 0 1.669744550958363e-11
at O 0 3.907157930527205e-11
an O 0 5.751064229876646e-13
allele O 0 6.089226900485301e-10
frequency O 0 2.3488522238324094e-09
of O 0 2.2187527422973252e-12
2 O 0 3.9608016866310436e-10
. O 0 1.586066611380943e-09

68 O 0 2.821754740978122e-08
% O 0 2.3374280289090166e-10
in O 0 6.621622087449319e-12
the O 0 9.698509356725893e-12
two O 0 3.8953416880982417e-11
populations O 0 3.752866073458705e-10
analyzed O 0 6.2729554883844685e-09
( O 0 2.4462673640229804e-12
Australian O 0 1.9521152749835124e-10
Aboriginal O 0 6.183160095041274e-10
and O 0 2.212466737594454e-10
Chinese O 0 3.735240242108695e-11
) O 0 9.568038202012463e-12
. O 0 1.1156982976379126e-10

In O 0 1.2047807196324811e-09
the O 0 3.605475640267031e-11
Australian O 0 2.3852123054446395e-10
Aboriginal O 0 3.135104953422285e-10
samples O 0 1.2797279902443393e-10
, O 0 4.951480848600087e-13
187 O 0 5.529449727953439e-12
C O 0 3.458285324775545e-10
- O 0 8.266631268405433e-10
- O 0 2.0567288316897248e-08
> O 0 2.996822123790821e-09
G O 0 1.8839513415969122e-07
was O 0 3.9730058132292356e-10
found O 0 4.0657546773736897e-11
to O 0 6.719230206952975e-12
be O 0 4.2971218250364984e-10
associated O 0 1.8798927692298406e-10
with O 0 1.1804632792100644e-11
HLA O 0 1.4278045412652318e-08
haplotypes O 0 4.075689563620699e-09
common O 0 1.4433913786415786e-10
in O 0 1.6732833868493557e-11
Caucasians O 0 1.4791551317117069e-09
, O 0 4.2167857747243964e-12
suggesting O 0 1.2739154175989142e-09
that O 0 8.208962676281573e-11
it O 0 8.826940046946508e-12
was O 0 8.438809373512157e-11
introduced O 0 1.757128123558438e-11
by O 0 3.2053619741095885e-12
recent O 0 4.4235684559801314e-10
admixture O 0 5.739364894452592e-08
. O 0 5.3299555879959826e-09

In O 0 2.2987909353844316e-09
the O 0 1.3204735915817167e-11
Chinese O 0 6.302712692030088e-12
samples O 0 1.1024786986113533e-11
analyzed O 0 1.837939384019549e-10
, O 0 2.382471390310892e-13
187 O 0 3.546422270434002e-12
C O 0 3.559423589205579e-10
- O 0 1.0305467590399076e-09
- O 0 3.3222786299802465e-08
> O 0 6.483558578906923e-09
G O 0 7.727091428932908e-07
was O 0 1.8665526901884277e-09
present O 0 5.520737339503867e-11
in O 0 6.923750461851341e-11
association O 0 2.0852874548643596e-12
with O 0 7.426846138948451e-13
a O 0 2.4562832670604884e-11
wide O 0 5.920834378336792e-10
variety O 0 1.3878577453940721e-10
of O 0 1.0692256108280063e-11
HLA O 0 9.806655043576029e-09
haplotypes O 0 7.440898119881467e-09
, O 0 1.4930133952067992e-12
showing O 0 2.2688338707776978e-10
this O 0 1.7678139768023682e-12
mutation O 0 1.972054464172146e-10
to O 0 1.8852950884468145e-12
be O 0 2.997539369498092e-11
widespread O 0 3.597809203337299e-11
and O 0 1.1193987403679273e-10
likely O 0 1.4219192490116939e-10
to O 0 9.038155965833405e-13
predate O 0 6.301372756922774e-10
the O 0 9.448954205876214e-13
more O 0 2.718512806358653e-13
genetically O 0 3.2923711500154607e-12
restricted O 0 9.02381207951164e-12
845 O 0 3.5929761943442884e-10
G O 0 1.381744993977918e-07
- O 0 5.36900621739278e-08
- O 0 1.9000823670012323e-07
> O 0 6.592873802446775e-09
A O 0 3.315585805907517e-09
mutation O 0 7.354660169767158e-07
. O 0 2.1829453800137344e-09

Genotype O 1 0.9506088495254517
- O 0 0.007612576708197594
phenotype O 0 0.0007353678229264915
correlations O 0 0.0001720418658806011
in O 0 1.8789019122777972e-06
attenuated B-Disease 1 0.9981270432472229
adenomatous I-Disease 1 0.9999902248382568
polyposis I-Disease 1 0.9998347759246826
coli I-Disease 1 0.9999185800552368
. O 0 9.300376405008137e-06

Germ O 0 0.012441818602383137
- O 0 0.00019326733308844268
line O 0 5.518160719475418e-07
mutations O 0 1.8822985836663975e-08
of O 0 1.3677769854225641e-11
the O 0 1.3969618517517546e-10
tumor B-Disease 0 2.386110054430901e-06
suppressor O 0 9.557315024721902e-06
APC O 0 4.2146314171986887e-07
are O 0 1.6717601747373578e-09
implicated O 0 7.261822702275822e-06
in O 0 4.2827417701118975e-07
attenuated B-Disease 1 0.9994007349014282
adenomatous I-Disease 1 0.999997615814209
polyposis I-Disease 1 0.9999860525131226
coli I-Disease 1 0.9999974966049194
( O 0 1.1173134225828107e-05
AAPC B-Disease 1 0.9999918937683105
) O 0 1.7081762671011802e-09
, O 0 1.7538200058897502e-11
a O 0 2.0594234650950227e-10
variant O 0 1.4054993698664475e-05
of O 0 3.9638064208702417e-07
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.9999932050704956
polyposis I-Disease 1 0.9999991655349731
( O 0 4.427008377660968e-07
FAP B-Disease 0 1.4713338714500424e-05
) O 0 8.763770820152672e-10
. O 0 2.7546056546867703e-09

AAPC B-Disease 1 0.9999154806137085
is O 0 2.76235212481879e-08
recognized O 0 2.776325558340176e-10
by O 0 1.885071959639717e-12
the O 0 6.253974768610782e-12
occurrence O 0 1.4367238954093864e-08
of O 0 2.62854096128029e-11
< O 0 1.508661142679557e-07
100 O 0 7.142635094492533e-11
colonic B-Disease 0 6.946617077119299e-07
adenomas I-Disease 0 6.668886385341466e-07
and O 0 4.582215509807419e-11
a O 0 5.041561959573393e-11
later O 0 1.3106863372414068e-09
onset O 0 3.928315095436119e-07
of O 0 3.6279948290030006e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 2.7828690463138628e-09
age O 0 9.23462584179191e-10
> O 0 1.0519112247919793e-09
40 O 0 2.9065786236182056e-11
years O 0 2.077813615608548e-10
) O 0 1.1032296604041036e-11
. O 0 2.5242019585647313e-10

The O 0 6.386410289493938e-10
aim O 0 4.939715858576221e-10
of O 0 7.259066394857405e-13
this O 0 1.779267922233374e-12
study O 0 3.0914340098248116e-12
was O 0 4.225370400789963e-11
to O 0 1.0691970746268264e-11
assess O 0 1.7641586680383625e-07
genotype O 0 0.00028446342912502587
- O 0 3.3848922612378374e-05
phenotype O 0 2.836345629475545e-06
correlations O 0 1.2657257002501865e-06
in O 0 5.4120345538422043e-08
AAPC B-Disease 1 0.9999134540557861
families O 0 1.8968052017953596e-07
. O 0 9.822303859152726e-09

By O 0 8.054768518839239e-10
protein O 0 4.670992037603128e-09
- O 0 1.872869326291493e-08
truncation O 0 7.216756614525366e-08
test O 0 1.6513267198092763e-08
( O 0 7.1195089754172436e-12
PTT O 0 2.8795374973356047e-09
) O 0 1.0237856162874717e-13
assay O 0 1.343439942624869e-10
, O 0 1.7148781038863609e-13
the O 0 3.082982274419527e-13
entire O 0 4.400617717448263e-11
coding O 0 1.256672321758856e-09
region O 0 1.9403319229116534e-11
of O 0 1.7352711335991838e-13
the O 0 1.3598476728340914e-12
APC B-Disease 0 2.2846144420718417e-10
gene O 0 7.839220245164924e-11
was O 0 1.0342956352493715e-10
screened O 0 2.6004085551534217e-09
in O 0 3.6595303176678584e-11
affected O 0 6.678360642276004e-11
individuals O 0 1.0078163130422535e-11
from O 0 1.1762431306738819e-10
11 O 0 9.214959462156003e-09
AAPC B-Disease 1 0.9999548196792603
kindreds O 0 4.4622593122767285e-06
, O 0 1.4716849267015775e-11
and O 0 6.4168921912188814e-12
their O 0 4.9341364327659676e-12
phenotypic O 0 3.3186118741923565e-08
differences O 0 1.9193596472177887e-06
were O 0 3.9267227691652806e-08
examined O 0 1.4773845578019973e-06
. O 0 3.348104016254183e-09

Five O 0 1.2971007379292132e-08
novel O 0 2.1500010660702173e-08
germ O 0 7.241671846713871e-05
- O 0 1.0131343515240587e-05
line O 0 5.985139637232351e-07
APC B-Disease 0 2.4149976241005788e-08
mutations O 0 1.1448493353327649e-07
were O 0 3.044664242946027e-10
identified O 0 5.964396088131707e-09
in O 0 9.125206840154831e-11
seven O 0 3.6336444964035763e-10
kindreds O 0 1.0017121212513302e-06
. O 0 2.7406343861002824e-09

Mutations O 0 0.00045501237036660314
were O 0 4.022801203262816e-09
located O 0 4.658000651858174e-10
in O 0 2.175291544115332e-11
three O 0 1.6889041163856144e-12
different O 0 2.5064674728098035e-12
regions O 0 1.4193849220967003e-11
of O 0 7.335953676121387e-13
the O 0 3.1542173387077987e-12
APC B-Disease 0 1.1557828999420039e-10
gene O 0 2.204735526090129e-11
( O 0 1.1192988132483969e-13
1 O 0 3.9079143024887963e-13
) O 0 3.0836983221918177e-14
at O 0 4.098243012312652e-12
the O 0 1.2669662411216032e-12
5 O 0 3.07798404819426e-12
end O 0 1.5653639842683198e-11
spanning O 0 1.273057353978757e-10
exons O 0 2.531086451540432e-10
4 O 0 4.253401884174446e-12
and O 0 4.917347345284595e-12
5 O 0 3.4328813663248026e-12
, O 0 9.061907582826045e-13
( O 0 8.419150386617183e-14
2 O 0 6.225538747711701e-13
) O 0 3.744893257258061e-14
within O 0 1.0883579871752772e-13
exon O 0 3.488701272313932e-10
9 O 0 4.6351061877558664e-11
, O 0 5.309286539058322e-13
and O 0 3.942549845620258e-12
( O 0 1.639384564515109e-13
3 O 0 6.224803116537669e-13
) O 0 1.4387220527347505e-13
at O 0 3.5679842327190903e-12
the O 0 9.256902969850822e-13
3 O 0 3.4260261728286112e-12
distal O 0 4.329982206119354e-10
end O 0 2.1910870340313693e-10
of O 0 8.920820354120507e-13
the O 0 2.7078651820833244e-11
gene O 0 5.761055632547141e-09
. O 0 9.169667247732605e-10

Variability O 0 6.393740477506071e-05
in O 0 4.0492650899004445e-10
the O 0 1.9173900314695125e-11
number O 0 3.435937367957109e-10
of O 0 1.1345391470740651e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
was O 0 2.172021231672261e-05
most O 0 6.754866110902924e-11
apparent O 0 6.200854940630052e-09
in O 0 2.22067590011088e-11
individuals O 0 4.755260421540619e-12
with O 0 7.771730307915004e-12
mutations O 0 8.722318867171452e-09
in O 0 3.261254113984258e-11
region O 0 3.036127738109684e-10
1 O 0 7.622810715979256e-11
, O 0 5.852685523721757e-12
and O 0 9.928778910150982e-10
upper O 0 1.5379724572994746e-05
- O 0 0.08469392359256744
gastrointestinal O 0 0.009679668582975864
manifestations O 0 3.987285708717536e-06
were O 0 1.001207228235046e-09
more O 0 3.286055108575603e-11
severe O 0 1.6851033990405995e-07
in O 0 1.9210515123102567e-10
them O 0 3.1972746672437324e-10
. O 0 2.756787020885554e-09

In O 0 1.124419335418736e-09
individuals O 0 5.649890624792597e-11
with O 0 3.4676164717417635e-11
mutations O 0 1.9232390968682012e-07
in O 0 1.0699259533897276e-10
either O 0 5.908413758248798e-10
region O 0 7.623527364941651e-10
2 O 0 4.9745169788950605e-11
or O 0 1.3057731562682307e-09
region O 0 2.8438398858021685e-10
3 O 0 1.6428232038623314e-11
, O 0 2.186353718512321e-13
the O 0 5.485830431410654e-13
average O 0 1.1072291694613767e-10
number O 0 5.228998657680339e-13
of O 0 2.187338174084938e-13
adenomas B-Disease 0 4.4339691918082735e-09
tended O 0 4.639621575819319e-09
to O 0 2.6863311922142863e-11
be O 0 7.543837776680107e-11
lower O 0 1.1779538455769512e-10
than O 0 2.7563359580873303e-12
those O 0 1.2329730335672306e-12
in O 0 5.251296359559676e-13
individuals O 0 2.915765231256001e-13
with O 0 8.244086294705022e-13
mutations O 0 6.614434000518088e-10
in O 0 7.294462776863408e-12
region O 0 2.830531468933639e-11
1 O 0 3.947254328950933e-11
, O 0 6.27441761741343e-12
although O 0 2.06421338355689e-10
age O 0 1.1509744268778377e-09
at O 0 5.398976266057787e-10
diagnosis O 0 3.0622240387856436e-07
was O 0 1.6054362284023682e-09
similar O 0 1.0201698374956436e-09
. O 0 1.0806796568729737e-09

In O 0 8.677718454919159e-08
all O 0 1.2585942954501661e-08
AAPC B-Disease 1 0.9998946189880371
kindreds O 0 3.2256961276289076e-05
, O 0 3.625362857140324e-11
a O 0 2.7991026163576294e-11
predominance O 0 8.061324052732743e-08
of O 0 7.80153108781434e-10
right O 0 0.47483769059181213
- O 1 0.9996405839920044
sided O 1 0.9999924898147583
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.999998927116394
and O 0 4.6698700316483155e-05
rectal B-Disease 1 0.9947839379310608
polyp I-Disease 0 0.07194812595844269
sparing O 0 4.1608868741604965e-06
was O 0 8.760270020502503e-08
observed O 0 2.5691909399938595e-07
. O 0 6.5118777037298514e-09

No O 0 3.845485480269417e-06
desmoid B-Disease 0 0.47406744956970215
tumors I-Disease 1 0.9999995231628418
were O 0 1.1601619576140365e-07
found O 0 7.435436266689521e-09
in O 0 1.3226295059176607e-10
these O 0 1.9801126016627535e-10
kindreds O 0 2.068580442937673e-06
. O 0 1.0342986023204048e-08

Our O 0 2.073100979771425e-08
data O 0 6.954327114172543e-10
suggest O 0 1.4784697910386058e-09
that O 0 1.379980331395192e-11
, O 0 5.040001836015273e-12
in O 0 1.7165922849837756e-10
AAPC B-Disease 1 0.9999957084655762
families O 0 7.436325444309944e-10
, O 0 6.842531099018889e-13
the O 0 2.7452535687408353e-13
location O 0 7.124973527838918e-11
of O 0 1.4523927850326745e-12
the O 0 8.096846110250411e-11
APC B-Disease 0 2.9811121748934966e-07
mutation O 0 6.165230956867163e-07
may O 0 1.0205498668369728e-08
partially O 0 2.2137649935416448e-08
predict O 0 1.197559917898161e-08
specific O 0 4.6359571737042415e-10
phenotypic O 0 6.738352453794505e-07
expression O 0 5.103555849927943e-06
. O 0 1.567134688684746e-08

This O 0 9.218523722154259e-10
should O 0 2.496003126406521e-10
help O 0 1.3245145431828309e-11
in O 0 1.5074378377499809e-12
the O 0 1.3508927049904473e-12
design O 0 9.176350790340848e-10
of O 0 4.0721944045973846e-12
tailored O 0 1.6848670725266857e-07
clinical O 0 3.7192641855199327e-08
- O 0 8.980659913504496e-07
management O 0 1.1624529117071347e-10
protocols O 0 5.644276278998772e-12
in O 0 2.6835120497253895e-13
this O 0 1.4217976568222518e-13
subset O 0 1.3937779749784163e-11
of O 0 2.4965111575236953e-11
FAP B-Disease 0 4.3642469904625614e-07
patients O 0 6.5011676042558975e-09
. O 0 7.404138413491523e-11
. O 0 8.811590346269327e-10

Wilms B-Disease 0 0.06800756603479385
' I-Disease 0 2.495035687388736e-06
tumor I-Disease 0 1.0923015452135587e-06
1 O 0 6.323260803853259e-10
and O 0 3.2519945070141887e-10
Dax O 0 0.013869503512978554
- O 0 8.110070552902471e-07
1 O 0 9.294365277412453e-11
modulate O 0 6.881863079399864e-09
the O 0 1.980481924290789e-11
orphan O 0 3.519540880958516e-09
nuclear O 0 1.019337947383292e-08
receptor O 0 1.1287514256608233e-09
SF O 0 4.752313998324098e-06
- O 0 6.297591337300901e-09
1 O 0 1.6767882221602193e-11
in O 0 8.8964755701193e-12
sex O 0 6.63737553807664e-09
- O 0 1.4360608702190802e-08
specific O 0 4.899844419092858e-10
gene O 0 4.1168637388011575e-09
expression O 0 3.671231851853918e-08
. O 0 1.0752598811336611e-09

Products O 0 2.893617256916059e-08
of O 0 2.4884305727113087e-10
steroidogenic O 0 1.2846444406022783e-06
factor O 0 1.679165428924989e-08
1 O 0 5.059443419774823e-10
( O 0 7.591528794481661e-11
SF O 0 0.005494287237524986
- O 0 8.711995178600773e-07
1 O 0 2.5992469288027564e-10
) O 0 2.4558978982403e-12
and O 0 2.2366943019935803e-10
Wilms B-Disease 0 6.247812416404486e-05
tumor I-Disease 0 4.9472350838186685e-06
1 O 0 1.3070090565392434e-09
( O 0 2.841723731328294e-11
WT1 O 0 1.883020956938708e-07
) O 0 5.083330024274746e-12
genes O 0 4.485940091614182e-11
are O 0 6.30637686169222e-13
essential O 0 1.305026833126055e-12
for O 0 4.0238979140926057e-13
mammalian O 0 3.0909297343839626e-10
gonadogenesis O 0 4.049637958303265e-09
prior O 0 1.8574058957554485e-11
to O 0 6.4380523481788465e-12
sexual O 0 1.1122907039862184e-09
differentiation O 0 1.6630494759084513e-09
. O 0 7.769070387020349e-10

In O 0 7.334834961625347e-09
males O 0 5.799214974899769e-08
, O 0 5.367687197499471e-11
SF O 0 9.522411710349843e-05
- O 0 3.916983359886217e-08
1 O 0 4.673482781325511e-11
participates O 0 6.305818367469129e-11
in O 0 3.94589048935412e-12
sexual O 0 5.459271229524276e-11
development O 0 1.8743405265364554e-13
by O 0 8.703190620441836e-13
regulating O 0 8.987560695672414e-10
expression O 0 2.290120315606714e-10
of O 0 7.234724971882933e-13
the O 0 8.623652486550171e-11
polypeptide O 0 3.7666102343791863e-06
hormone O 0 1.5679098908094602e-07
Mullerian O 0 3.97922150341401e-07
inhibiting O 0 3.759855715657068e-08
substance O 0 1.4572206055163406e-06
( O 0 5.55959500658787e-10
MIS O 0 2.4477994884364307e-06
) O 0 1.0326122595882836e-10
. O 0 5.008192194289052e-10

Here O 0 7.542093527490579e-08
, O 0 4.525937957744475e-11
we O 0 6.089154180877188e-11
show O 0 8.850989385855712e-10
that O 0 1.8201058715749951e-10
WT1 O 0 2.28326780415955e-06
- O 0 4.735177014936198e-07
KTS O 0 2.0286247490730602e-06
isoforms O 0 2.0816028900583206e-09
associate O 0 1.3348017136038948e-10
and O 0 2.4461691353061532e-12
synergize O 0 2.025804057836922e-08
with O 0 3.4815220151251935e-10
SF O 0 0.06966093182563782
- O 0 4.096595205282938e-07
1 O 0 9.931595129630821e-11
to O 0 1.0361156377314273e-11
promote O 0 4.4275125787862635e-09
MIS O 0 5.429387601907365e-05
expression O 0 1.3483396799074399e-07
. O 0 1.226159840328478e-09

In O 0 7.238107890827905e-09
contrast O 0 7.670646340329768e-08
, O 0 7.90424600771722e-11
WT1 O 0 3.8089026475063292e-06
missense O 0 5.174114630790427e-05
mutations O 0 4.721513960248558e-06
, O 0 1.70416528111339e-11
associated O 0 3.986958263535456e-10
with O 0 5.382463363901024e-10
male B-Disease 0 0.00010070353164337575
pseudohermaphroditism I-Disease 1 0.9999990463256836
in O 0 4.969754741068755e-07
Denys B-Disease 1 0.9999182224273682
- I-Disease 1 0.9999617338180542
Drash I-Disease 1 0.9999343156814575
syndrome I-Disease 1 0.999948263168335
, O 0 1.5176722378829055e-10
fail O 0 1.6540091962724546e-08
to O 0 1.6085240778229704e-11
synergize O 0 6.995774128881749e-07
with O 0 1.4854691698928946e-08
SF O 1 0.9632296562194824
- O 0 1.4976338206906803e-05
1 O 0 2.9556779246320275e-09
. O 0 2.9961135794565052e-09

Additionally O 0 1.4542807846851247e-08
, O 0 1.8509268770450227e-11
the O 0 3.5450021824284805e-12
X O 0 9.815285011427477e-06
- O 0 7.885988679845468e-07
linked O 0 2.351259581701015e-06
, O 0 4.8461087573392625e-12
candidate O 0 6.888793424586481e-10
dosage O 0 4.440039447217714e-07
- O 0 1.0043426534878108e-08
sensitive O 0 2.427305219043774e-07
sex O 0 1.1029999136269453e-08
- O 0 1.015657891123567e-09
reversal O 0 4.372057438306598e-10
gene O 0 2.2829982349037437e-10
, O 0 1.5013576319666821e-12
Dax O 0 3.4168233469245024e-06
- O 0 1.3841949808579557e-08
1 O 0 2.470076920779718e-11
, O 0 6.572407548754988e-13
antagonizes O 0 1.4295287176224747e-09
synergy O 0 6.274866737321361e-10
between O 0 3.4335265186591357e-10
SF O 0 0.0016423433553427458
- O 0 1.1771783903213873e-07
1 O 0 9.849271398465476e-11
and O 0 3.6240423856304105e-11
WT1 O 0 3.1303937220172884e-08
, O 0 1.0251012278611471e-12
most O 0 5.372331811186182e-13
likely O 0 8.500579580517087e-12
through O 0 9.209138714192516e-14
a O 0 1.289210274993402e-12
direct O 0 4.330853384248989e-12
interaction O 0 1.2708617491696828e-10
with O 0 1.2261667237112306e-09
SF O 1 0.513670802116394
- O 0 4.351622465037508e-06
1 O 0 2.554961353595786e-09
. O 0 2.024346912321562e-09

We O 0 3.6602266106910974e-08
propose O 0 7.753235387042423e-09
that O 0 1.0448321374756375e-10
WT1 O 0 1.0974412845143888e-07
and O 0 9.236700293513422e-11
Dax O 0 0.00044172239722684026
- O 0 1.382316980880205e-07
1 O 0 5.242834985597078e-11
functionally O 0 6.658255058411555e-10
oppose O 0 2.3026998363651074e-10
each O 0 4.4105058147336784e-12
other O 0 1.358020250072367e-12
in O 0 5.3188876913967675e-12
testis O 0 9.626777597304681e-09
development O 0 3.6611200182612436e-12
by O 0 1.2148912084675167e-11
modulating O 0 4.918361469208321e-07
SF O 0 0.0031138139311224222
- O 0 2.1452478904393502e-07
1 O 0 2.796947951022588e-10
- O 0 1.8201147256036165e-08
mediated O 0 1.1908610986210988e-08
transactivation O 0 3.395594205812813e-07
. O 0 1.5568309141844594e-10
. O 0 1.9985609001071936e-10

A O 0 2.389394815338619e-08
mouse O 0 1.4878162346576573e-07
model O 0 2.0920249710343342e-07
for O 0 1.2188415610125958e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999985694885254
imprinting O 0 0.08431291580200195
- O 0 0.0016864633653312922
centre O 0 1.1116804898847477e-06
mutations O 0 1.2689984032476787e-05
. O 0 1.0488605539649143e-08

Imprinting O 0 1.226900531037245e-05
in O 0 7.893944942161113e-10
the O 0 8.328110423505564e-11
15q11 O 0 3.097596135148706e-08
- O 0 1.4419033789181412e-07
q13 O 0 1.790666459555723e-08
region O 0 2.1714953446494434e-10
involves O 0 1.166742258362774e-10
an O 0 4.423420397331457e-12
imprinting O 0 1.2932943604937464e-07
centre O 0 3.3793552400851468e-09
( O 0 7.165828260630169e-12
IC O 0 6.0608411622808944e-09
) O 0 1.7302319516368514e-12
, O 0 1.7705158357212564e-13
mapping O 0 7.82328229975704e-11
in O 0 8.803278201893749e-13
part O 0 2.2295195203914098e-12
to O 0 2.2686626882650884e-12
the O 0 4.794403155733429e-12
promoter O 0 1.1090547502590198e-07
and O 0 3.812355986454463e-11
first O 0 9.1356687839661e-12
exon O 0 3.99044486343314e-09
of O 0 1.142522396135881e-10
SNRPN O 0 3.754560384550132e-05
. O 0 1.1819792256062556e-08

Deletion O 0 3.413156264286954e-06
of O 0 3.9739378454584084e-10
this O 0 1.33312749728276e-10
IC O 0 3.843138927095424e-07
abolishes O 0 2.541020194257726e-07
local O 0 3.339983012384806e-10
paternally O 0 2.353849737346536e-08
derived O 0 2.170493229591841e-10
gene O 0 4.954586740879563e-10
expression O 0 1.1752995243696773e-09
and O 0 4.562827546350512e-11
results O 0 4.241499595991627e-09
in O 0 1.0296415666743997e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
( O 0 4.966403594153235e-06
PWS B-Disease 1 0.9999804496765137
) O 0 1.1441176894777527e-08
. O 0 6.5708416485676935e-09

We O 0 8.280573382535295e-08
have O 0 1.0639978481608026e-10
created O 0 1.5792549559745517e-11
two O 0 4.715771176333483e-12
deletion O 0 2.438934387782865e-08
mutations O 0 7.687987846338729e-08
in O 0 2.2939412869238396e-10
mice O 0 4.2720540704976884e-07
to O 0 3.076128018975055e-09
understand O 0 7.979298970894888e-05
PWS B-Disease 1 0.9999977350234985
and O 0 8.395979467223924e-10
the O 0 4.741566080740389e-12
mechanism O 0 5.89568949216357e-11
of O 0 1.1855306233238272e-12
this O 0 3.7642632066958726e-11
IC O 0 3.3337622085127805e-07
. O 0 1.2978795815854482e-09

Mice O 0 0.00038258740096352994
harbouring O 0 2.5090635972446762e-05
an O 0 2.3021463901873318e-10
intragenic O 0 1.6171067329651123e-07
deletion O 0 2.2050842574117269e-07
in O 0 6.991620060681214e-10
Snrpn O 0 6.692524948448408e-06
are O 0 1.1543271893899032e-09
phenotypically O 0 1.7908394056576071e-06
normal O 0 3.487917954458908e-09
, O 0 1.7374579422760328e-12
suggesting O 0 2.912568242141589e-10
that O 0 2.0982151779924685e-11
mutations O 0 8.779146853932218e-10
of O 0 3.0681193263076834e-12
SNRPN O 0 2.337797013751697e-06
are O 0 2.56500740786203e-11
not O 0 1.3405927409837481e-11
sufficient O 0 9.865497307970372e-11
to O 0 1.66045274752058e-10
induce O 0 1.6533805364815635e-06
PWS B-Disease 1 0.9999313354492188
. O 0 3.5383148855316904e-08

Mice O 0 6.051880700397305e-05
with O 0 2.489308759123787e-10
a O 0 9.401682210530282e-11
larger O 0 1.1059485549580472e-09
deletion O 0 7.662617917958414e-08
involving O 0 4.693631705521284e-09
both O 0 2.6013002862868007e-10
Snrpn O 0 3.188416258126381e-06
and O 0 2.0582335835683807e-10
the O 0 1.166372970429208e-10
putative O 0 1.3781268535240088e-05
PWS O 1 0.9999837875366211
- O 0 6.088563168304972e-06
IC O 0 3.435663757045404e-06
lack O 0 5.425188298602279e-09
expression O 0 2.9669855461378347e-09
of O 0 3.465802731611456e-12
the O 0 7.287984798987068e-11
imprinted O 0 4.530947535386076e-06
genes O 0 6.513604766666958e-09
Zfp127 O 0 5.121597723700688e-08
( O 0 6.447146202320786e-12
mouse O 0 1.5134584696596676e-09
homologue O 0 6.658741558140946e-09
of O 0 1.6857671508718752e-11
ZNF127 O 0 3.707587529788725e-05
) O 0 2.634272661117265e-11
, O 0 4.606108897076133e-12
Ndn O 0 3.32319132212433e-08
and O 0 1.716101150073257e-10
Ipw O 0 5.2696911723160156e-08
, O 0 2.0176761303392077e-11
and O 0 6.23931115106835e-11
manifest O 0 7.174861815784084e-10
several O 0 5.281110618260421e-12
phenotypes O 0 5.5944060051160704e-08
common O 0 2.1462960297924383e-09
to O 0 7.72115598124401e-08
PWS B-Disease 1 0.9999983310699463
infants O 0 0.053638115525245667
. O 0 3.482162824752777e-08

These O 0 2.1705015562645258e-10
data O 0 1.0707568859347205e-10
demonstrate O 0 2.856691549979473e-10
that O 0 3.179107584821983e-12
both O 0 1.0015896532294954e-12
the O 0 4.216005582841076e-12
position O 0 1.1382076392507656e-09
of O 0 1.903613714143021e-13
the O 0 1.530767700097524e-12
IC O 0 3.746846388708036e-09
and O 0 8.998597873788317e-12
its O 0 5.709193968278514e-13
role O 0 6.399145970059639e-12
in O 0 9.91509934052115e-13
the O 0 2.6766162528578386e-13
coordinate O 0 5.412593984122083e-11
expression O 0 4.556956895163111e-11
of O 0 2.1203804228923928e-13
genes O 0 2.4959588215689443e-11
is O 0 6.863811819260435e-13
conserved O 0 1.9641330228914455e-11
between O 0 4.370818811050281e-12
mouse O 0 7.178877048374943e-09
and O 0 8.396359302276224e-11
human O 0 4.2110894632463314e-11
, O 0 1.8825928229521116e-12
and O 0 1.1513707522115002e-11
indicate O 0 9.091005725991863e-10
that O 0 2.5278030536812768e-12
the O 0 6.889834839804432e-13
mouse O 0 6.966939802843797e-10
is O 0 1.3840285254668183e-12
a O 0 1.6805429660718407e-12
suitable O 0 4.345818149786851e-10
model O 0 1.9551866792255623e-09
system O 0 6.925732209950297e-11
in O 0 8.94687427442642e-13
which O 0 8.652145840060133e-13
to O 0 2.4824014913972514e-13
investigate O 0 6.938384589094682e-11
the O 0 4.69693858459741e-12
molecular O 0 1.5418287757640314e-09
mechanisms O 0 2.5542229789565774e-11
of O 0 2.176434759412066e-13
imprinting O 0 6.84301548758981e-09
in O 0 1.1481010586678053e-11
this O 0 5.4148525940878045e-12
region O 0 8.367626036509535e-12
of O 0 5.264584341385659e-13
the O 0 1.530526226589668e-11
genome O 0 3.7883726711207544e-10
. O 0 1.9505211681924983e-11
. O 0 1.2115318470673486e-10

Mutations O 0 6.3366478570969775e-06
of O 0 9.175944032380201e-11
the O 0 4.677031678612664e-11
ATM O 0 3.219480220195692e-07
gene O 0 1.601901971071129e-07
detected O 0 2.0569799744407646e-05
in O 0 2.582954072849475e-09
Japanese O 0 0.0005237649893388152
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999984502792358
telangiectasia I-Disease 1 1.0
patients O 0 2.042103915300686e-05
: O 0 4.335748773898196e-11
possible O 0 4.831400210458803e-11
preponderance O 0 6.369856642152172e-09
of O 0 3.539596784077337e-12
the O 0 9.379486770599854e-12
two O 0 1.9456315031307625e-11
founder O 0 2.261615339449463e-09
mutations O 0 1.3408966381689424e-08
4612del165 O 0 3.4457574571433724e-09
and O 0 1.5771546568732475e-10
7883del5 O 0 4.399264597054753e-08
. O 0 1.3387467800995978e-09

The O 0 2.845040203425242e-09
ATM O 0 2.4029470750974724e-06
( O 0 2.109774799308184e-09
A O 1 0.9999117851257324
- O 1 0.9999963045120239
T O 1 1.0
, O 0 8.070700774354123e-10
mutated O 0 1.501349267130081e-08
) O 0 1.9746645724821876e-12
gene O 0 1.0839655562033812e-10
on O 0 4.538405484755259e-10
human O 0 9.51323797515613e-10
chromosome O 0 7.947430162857927e-07
11q22 O 0 3.8339325669767277e-07
. O 0 5.750966369788557e-09

3 O 0 1.4449463847654442e-08
has O 0 1.318793518834127e-09
recently O 0 2.535421650406988e-09
been O 0 9.844312864881744e-11
identified O 0 2.7417412784558337e-10
as O 0 5.937460267370354e-13
the O 0 3.884134767290215e-13
gene O 0 1.748285891056689e-11
responsible O 0 6.339487962359058e-11
for O 0 8.356855246867412e-13
the O 0 3.3727191178778426e-11
human O 0 1.904944895159133e-07
recessive B-Disease 1 0.9989176988601685
disease I-Disease 1 0.9996312856674194
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.999998927116394
telangiectasia I-Disease 1 1.0
( O 0 1.9941206119256094e-05
A B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999988079071045
T I-Disease 1 0.9999997615814209
) O 0 7.970351489916538e-09
. O 0 1.7352217440702589e-09

In O 0 2.0454413718340447e-09
order O 0 3.36415513502164e-11
to O 0 2.572149090940279e-12
define O 0 8.238738580246263e-10
the O 0 6.293307021343342e-12
types O 0 1.8420465153212717e-09
of O 0 1.4531147118912457e-10
disease O 0 1.1753201079045539e-06
- O 0 7.044782250886783e-07
causing O 0 8.339599588680358e-08
ATM O 0 7.680966405132494e-07
mutations O 0 4.760151739446883e-08
in O 0 3.389098723882711e-11
Japanese O 0 1.8829454973001702e-07
A B-Disease 1 0.999962329864502
- I-Disease 1 0.9999945163726807
T I-Disease 1 0.9999998807907104
patients O 0 5.157249916010187e-08
as O 0 2.1910565375926616e-11
well O 0 9.427751981871957e-12
as O 0 8.659757481412067e-13
to O 0 1.4575963049393015e-12
look O 0 9.378310628083142e-11
for O 0 1.8372671819252145e-13
possible O 0 5.7800687847109344e-11
mutational O 0 5.438224448539586e-08
hotspots O 0 5.1040509596589345e-09
, O 0 5.243912509084181e-12
reverse O 0 2.267450671666893e-09
- O 0 3.1680171819203906e-09
transcribed O 0 2.621403760727503e-09
RNA O 0 2.3241709945498457e-10
derived O 0 3.7797438789954896e-12
from O 0 3.125934569785799e-13
ten O 0 9.68135814571891e-12
patients O 0 3.617778299158658e-11
belonging O 0 1.7647465433423548e-10
to O 0 9.919891297283101e-12
eight O 0 3.6459377183994945e-11
unrelated O 0 7.219948194858716e-09
Japanese O 0 7.948157758619345e-07
A B-Disease 1 0.9988977909088135
- I-Disease 1 0.9986950755119324
T I-Disease 1 0.9999995231628418
families O 0 4.58882309928299e-09
was O 0 2.3842037233379187e-09
analyzed O 0 1.3686526356693207e-09
for O 0 1.5831414955022605e-12
mutations O 0 3.2769689739531316e-10
by O 0 1.152866647632922e-12
the O 0 1.5796397393255668e-12
restriction O 0 2.16595127250363e-11
endonuclease O 0 2.7175641736931766e-09
fingerprinting O 0 1.5102576966796732e-09
method O 0 1.4910975787429948e-09
. O 0 1.0815952578013821e-09

As O 0 5.405367264899041e-09
has O 0 5.01232055860612e-10
been O 0 1.0418113594035106e-10
reported O 0 2.726071590686274e-10
by O 0 2.3323576143347013e-12
others O 0 9.482417628881024e-11
, O 0 2.122121272110644e-12
mutations O 0 1.159594087418725e-10
that O 0 1.1707089291046469e-12
lead O 0 9.765538204475899e-12
to O 0 2.270706192519789e-12
exon O 0 7.667775747677297e-09
skipping O 0 7.461135709263544e-09
or O 0 4.886109294943708e-09
premature O 0 7.290022363548587e-09
protein O 0 1.5829650090726233e-10
truncation O 0 1.7657778572655047e-09
were O 0 1.421675888124696e-09
also O 0 2.0412310730577587e-10
predominant O 0 8.191610056940135e-09
in O 0 3.693969782836426e-11
our O 0 7.296639958909168e-10
mutants O 0 6.659020890253942e-09
. O 0 4.177268531080358e-10

Six O 0 2.5753732479927294e-09
different O 0 3.0417968144291763e-10
mutations O 0 6.86267611627045e-08
were O 0 1.2689627126860614e-10
identified O 0 4.384661522749411e-09
on O 0 2.952222633023638e-10
12 O 0 3.70235526264695e-12
of O 0 2.455877840500109e-13
the O 0 9.246601748169603e-12
16 O 0 1.1410893757668461e-10
alleles O 0 5.769611011174902e-09
examined O 0 4.643683269023313e-07
. O 0 5.444728667924892e-09

Four O 0 2.1460260235528494e-09
were O 0 2.9003265067384376e-11
deletions O 0 4.166790912307761e-09
involving O 0 8.993635169929348e-09
a O 0 5.586022311376837e-09
loss O 0 7.097042953319033e-08
of O 0 1.4212669669638744e-12
a O 0 1.6254754486855205e-10
single O 0 1.9881214452510676e-09
exon O 0 2.0747147999600202e-08
exon O 0 1.4893082322942064e-07
7 O 0 1.9227670844390587e-10
, O 0 5.908336428613048e-13
exon O 0 1.2595999798747926e-09
16 O 0 3.1710002679208316e-11
, O 0 9.067060253650783e-13
exon O 0 2.0390140686998848e-09
33 O 0 1.1544873390612054e-10
or O 0 1.6702710048388525e-10
exon O 0 1.7337015378871e-07
35 O 0 4.848390577905093e-09
. O 0 4.2472230177281745e-09

The O 0 1.3678175259101977e-09
others O 0 2.030405427122517e-10
were O 0 2.3615132418997042e-11
minute O 0 7.002587398829974e-11
deletions O 0 1.8572775317693413e-08
, O 0 4.827676019364402e-12
4649delA O 0 5.425278559734181e-10
in O 0 2.5710308448195773e-12
exon O 0 8.689970520947554e-09
33 O 0 3.2554198226009134e-10
and O 0 2.008211999471321e-11
7883del5 O 0 1.443513308885258e-09
in O 0 2.782855890171021e-11
exon O 0 7.072449648148904e-08
55 O 0 1.9255645966609336e-09
. O 0 1.2633678547757654e-09

The O 0 5.784265511010744e-09
mutations O 0 1.2097150658973987e-07
4612del165 O 0 1.2065428656171662e-08
and O 0 3.0021055086315585e-11
7883del5 O 0 2.21721196957958e-09
were O 0 9.027931180405346e-11
found O 0 3.6014340815127e-11
in O 0 1.4350887015193714e-12
more O 0 3.9046654906789435e-13
than O 0 1.1345948052604582e-12
two O 0 2.6794460205280257e-13
unrelated O 0 9.456049138156786e-11
families O 0 3.137692146035209e-12
; O 0 1.1560720371457667e-13
44 O 0 1.2298439989923832e-13
% O 0 1.091424178681702e-13
( O 0 6.630576621612094e-14
7 O 0 1.0409403373989878e-12
of O 0 5.111386574413457e-13
16 O 0 9.711892748343054e-12
) O 0 3.9643452637381366e-14
of O 0 4.8098589726982416e-14
the O 0 1.8227897490008527e-12
mutant O 0 8.638373905078822e-10
alleles O 0 6.873621116731954e-10
had O 0 8.412296970128352e-10
one O 0 7.862531806179796e-12
of O 0 3.8809431471449607e-13
the O 0 7.328545756357663e-12
two O 0 7.759425740827552e-11
mutations O 0 1.0990333976224065e-07
. O 0 1.263854576549761e-09

The O 0 1.8555273983977827e-09
4612del165 O 0 2.5788747137767132e-08
mutations O 0 3.684181137941778e-08
in O 0 1.4971033093780228e-11
three O 0 2.593460168842654e-12
different O 0 8.972718401611957e-12
families O 0 1.8808387139412908e-11
were O 0 2.1516099665830346e-11
all O 0 3.150499609458346e-13
ascribed O 0 9.085766167205023e-11
to O 0 1.4168146907425627e-12
the O 0 2.2939126726601033e-12
same O 0 1.6256490598109963e-10
T O 0 4.05283877569218e-08
- O 0 1.4549236260208431e-09
- O 0 2.032227275350351e-09
> O 0 4.8945739822281453e-11
A O 0 2.4106391795924997e-12
substitution O 0 4.335001975441788e-12
at O 0 2.702745145743979e-12
the O 0 1.4864036379774043e-13
splice O 0 5.335852315546674e-10
donor O 0 1.6900594812518932e-10
site O 0 1.052569587045582e-09
in O 0 1.0277999978880459e-10
intron O 0 1.5724996274002478e-06
33 O 0 1.4036939610662102e-08
. O 0 2.8257873818660073e-09

Microsatellite O 0 4.066699693794362e-05
genotyping O 0 7.664044460398145e-06
around O 0 1.4604842890619807e-09
the O 0 1.4249103633123816e-11
ATM O 0 1.6729707397189486e-07
locus O 0 4.363240009297442e-07
also O 0 1.2435819041201057e-09
indicated O 0 2.527075437797066e-08
that O 0 7.952709671354974e-12
a O 0 3.329492584414062e-11
common O 0 7.666426382613167e-10
haplotype O 0 3.678136124563025e-07
was O 0 2.8482762814974194e-09
shared O 0 3.1726215404814795e-11
by O 0 2.458006888306219e-12
the O 0 2.164814334737475e-12
mutant O 0 8.043223309606162e-10
alleles O 0 3.58273882783422e-10
in O 0 2.119113044762866e-11
both O 0 2.639167218099203e-10
mutations O 0 3.189257142821589e-07
. O 0 5.910197220515556e-09

This O 0 4.172228396104316e-10
suggests O 0 2.3651802738555716e-09
that O 0 6.6349222123396334e-12
these O 0 5.201494074867641e-13
two O 0 1.2933825017935607e-12
founder O 0 3.824508265637405e-09
mutations O 0 2.838007731043035e-07
may O 0 8.025834219438366e-09
be O 0 4.017015886592645e-11
predominant O 0 4.244639750794477e-09
among O 0 2.4006194601633446e-11
Japanese O 0 3.721561503411408e-09
ATM O 0 8.123526384906654e-08
mutant O 0 5.305453498749557e-08
alleles O 0 4.9111054778450125e-08
. O 0 4.372434858623819e-09

W474C O 0 1.8065452422888484e-06
amino O 0 9.107723464296669e-09
acid O 0 9.73037095342022e-10
substitution O 0 2.6745639036818147e-10
affects O 0 3.3346678196544133e-10
early O 0 1.3374610663766107e-12
processing O 0 1.170798375783877e-12
of O 0 6.987499364926111e-14
the O 0 3.8331908177105523e-13
alpha O 0 4.162336274260436e-12
- O 0 2.120568651231558e-11
subunit O 0 3.1781315860263115e-12
of O 0 1.6055799539286403e-13
beta O 0 1.1645784163405448e-11
- O 0 2.017874312087997e-09
hexosaminidase O 0 4.1981280674008303e-08
A O 0 1.0510649017803075e-09
and O 0 7.619439107431347e-11
is O 0 3.5376212376148075e-11
associated O 0 3.9504727267214435e-10
with O 0 3.5671035569784237e-10
subacute O 0 0.00201043882407248
G B-Disease 0 0.0004939297796227038
( I-Disease 0 7.663104178989855e-11
M2 I-Disease 0 5.871700068382779e-06
) I-Disease 0 1.1102538888252411e-09
gangliosidosis I-Disease 0 6.637822025368223e-06
. O 0 1.4784450996785381e-08

Mutations O 0 0.00013138412032276392
in O 0 3.3589138137557484e-09
the O 0 2.366979945378489e-10
HEXA O 0 1.1998886293440592e-05
gene O 0 3.6270473291466487e-09
, O 0 8.214060941841295e-13
encoding O 0 5.3734924496118275e-12
the O 0 1.1525171008525126e-12
alpha O 0 6.787266061680786e-12
- O 0 4.7620060672493025e-11
subunit O 0 1.9758448349671554e-11
of O 0 5.816991853480058e-13
beta O 0 1.6399062663374764e-10
- O 0 6.554634524036373e-08
hexosaminidase O 0 1.565369842637665e-07
A O 0 2.1017341200746387e-09
( O 0 1.4394475195134149e-12
Hex O 0 1.548337985601833e-10
A O 0 1.6694429172403602e-10
) O 0 3.174603863207587e-13
, O 0 5.346426562103171e-14
that O 0 7.095916194042873e-13
abolish O 0 3.6765329669563585e-10
Hex O 0 3.6637504141623367e-10
A O 0 1.3076942306788908e-10
enzyme O 0 1.3791423558728866e-09
activity O 0 7.088371489771816e-08
cause O 0 0.00014568994811270386
Tay B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
Sachs I-Disease 1 0.9999997615814209
disease I-Disease 0 0.0019704443402588367
( O 0 1.5613452197804634e-10
TSD B-Disease 0 1.083129632206692e-06
) O 0 1.6312236283955173e-11
, O 0 1.902075935991676e-12
the O 0 1.658207945953727e-11
fatal O 0 0.00011714118591044098
infantile B-Disease 0 0.0002901940606534481
form I-Disease 0 9.46242639798811e-09
of I-Disease 0 3.907070500464016e-10
G I-Disease 0 2.754199340415653e-05
( I-Disease 0 1.2884980409022528e-11
M2 I-Disease 0 4.081955182755337e-07
) I-Disease 0 1.9823828342757643e-11
gangliosidosis I-Disease 0 1.252822698916134e-07
, I-Disease 0 2.3666988507864417e-11
Type I-Disease 0 2.5302636430524217e-08
1 I-Disease 0 1.5244444595552409e-09
. O 0 3.927544955928397e-09

Less O 0 1.624801825528266e-06
severe O 0 7.591727626277134e-05
, O 0 1.7318690925804958e-09
subacute O 0 0.00020601210417225957
( O 0 1.1329962523731751e-09
juvenile O 0 0.0001080025831470266
- O 0 0.00887925736606121
onset O 0 8.398226054850966e-05
) O 0 1.0760046187385797e-09
and O 0 3.196796427573645e-08
chronic O 0 0.0008483825949952006
( O 0 2.0072785100744284e-10
adult O 0 4.172514991296339e-07
- O 0 6.0385067627066746e-05
onset O 0 1.094668846235436e-06
) O 0 6.8026760439987566e-12
variants O 0 3.684465510467305e-10
are O 0 2.951438399234618e-11
characterized O 0 1.1019431894743192e-10
by O 0 1.4608695112980352e-12
a O 0 1.808629634947323e-11
broad O 0 1.0942315109563339e-10
spectrum O 0 1.2259422366156514e-09
of O 0 7.780462472212202e-13
clinical O 0 1.9122012306915792e-10
manifestations O 0 7.081544683984475e-09
and O 0 5.1125815386798834e-11
are O 0 3.848371708109477e-12
associated O 0 2.9836043358155706e-11
with O 0 2.2260191953615838e-11
residual O 0 6.421547732315958e-05
levels O 0 3.021872529984648e-08
of O 0 1.5225649517211504e-12
Hex O 0 2.189675996078222e-09
A O 0 4.524956520590706e-10
enzyme O 0 7.152849978986353e-10
activity O 0 4.064386605051595e-09
. O 0 8.468870049682664e-10

We O 0 3.600120734859047e-08
identified O 0 3.958522842850698e-09
a O 0 1.4279774585013172e-10
1422 O 0 6.301715416157094e-07
G O 0 1.635039552638773e-05
- O 0 4.381388407637132e-06
- O 0 2.3512804546044208e-05
> O 0 3.755971533792035e-07
C O 0 4.8044821454595876e-08
( O 0 1.0509050227258676e-12
amino O 0 3.9253071279499174e-12
acid O 0 1.1774770394823442e-11
W474C O 0 5.3198617386285285e-12
) O 0 9.992988932812277e-15
substitution O 0 1.4274822643378648e-13
in O 0 9.050709671738072e-14
the O 0 1.998717895834376e-13
first O 0 5.578092675262436e-12
position O 0 4.0040823434672745e-10
of O 0 1.5565554487700917e-13
exon O 0 9.85414305709753e-10
13 O 0 3.481956910300621e-12
of O 0 3.28168617497529e-13
HEXA O 0 2.0106723752633116e-07
of O 0 2.7679527506846435e-12
a O 0 1.0322262489204093e-10
non O 0 5.215747833631212e-10
- O 0 2.6508084616239103e-08
Jewish O 0 1.1551575251900204e-09
proband O 0 2.121394800269627e-06
who O 0 1.2804902693730469e-09
manifested O 0 2.656040276605154e-09
a O 0 2.589004843844833e-10
subacute O 0 1.8177819356424152e-06
variant O 0 1.3559779290517326e-06
of O 0 1.0575985642802266e-09
G B-Disease 0 0.00017649790970608592
( I-Disease 0 7.136683605191152e-11
M2 I-Disease 0 5.305258127918933e-06
) I-Disease 0 8.313212895849631e-10
gangliosidosis I-Disease 0 4.630130661098519e-06
. O 0 6.568485755309439e-09

On O 0 4.554528754141529e-09
the O 0 1.5248072249285372e-10
second O 0 1.3183860669840897e-09
maternally O 0 3.110499892500229e-05
inherited O 0 5.1613464165711775e-05
allele O 0 3.4517753988438926e-07
, O 0 1.3261172542022859e-11
we O 0 1.6065740751636248e-11
identified O 0 1.5867072933328785e-10
the O 0 1.864671958506925e-11
common O 0 2.365993800879096e-08
infantile O 0 0.41749826073646545
disease O 0 8.97927166079171e-05
- O 0 1.511170921730809e-06
causing O 0 4.966968276676198e-07
4 O 0 5.07977881980537e-10
- O 0 8.24987935743593e-08
bp O 0 5.743109809941416e-08
insertion O 0 1.0642743353272976e-09
, O 0 1.4395030306646461e-11
+ O 0 3.060915410024734e-10
TATC O 0 9.569060210878888e-08
1278 O 0 7.662077194936501e-08
, O 0 1.4383091939684789e-11
in O 0 2.7243497388584892e-11
exon O 0 2.2024823920219205e-07
11 O 0 6.126064988620783e-09
. O 0 1.7276987618330963e-09

Pulse O 0 0.00044149041059426963
- O 0 4.258683361513249e-07
chase O 0 9.48345846296661e-09
analysis O 0 2.1639620650937275e-10
using O 0 8.168292431331992e-11
proband O 0 2.2823954282102932e-08
fibroblasts O 0 2.8774018723254358e-09
revealed O 0 1.8741914686870587e-08
that O 0 6.415570765611056e-12
the O 0 9.50096555249469e-13
W474C O 0 4.6563394806575786e-10
- O 0 2.9389130018486753e-10
containing O 0 6.681138281505739e-11
alpha O 0 2.924116851432679e-11
- O 0 4.2435267105789265e-11
subunit O 0 1.3982139231150104e-11
precursor O 0 3.648525578880957e-11
was O 0 1.1746222050579291e-10
normally O 0 2.793699646619352e-11
synthesized O 0 1.1088459317409871e-10
, O 0 3.830954379679258e-13
but O 0 4.559978154621003e-13
not O 0 1.8996891733291665e-13
phosphorylated O 0 7.19291466666494e-12
or O 0 3.643634872985135e-12
secreted O 0 9.171814696617986e-11
, O 0 1.0328791858263409e-12
and O 0 1.5746702986679795e-12
the O 0 3.1629286863232853e-12
mature O 0 4.0314632188120925e-10
lysosomal O 0 4.103583250980591e-09
alpha O 0 4.853835389173611e-11
- O 0 3.9787539929392324e-10
subunit O 0 7.743236607460346e-11
was O 0 4.7418988735614676e-09
not O 0 3.9596456669066527e-10
detected O 0 2.1700530794532824e-07
. O 0 1.0746981082832008e-09

When O 0 1.507133262634852e-08
the O 0 4.313888829488022e-11
W474C O 0 6.072481628649484e-09
- O 0 1.425080387029709e-09
containing O 0 5.478832942884537e-10
alpha O 0 2.0311877180212434e-10
- O 0 1.0925157445385025e-09
subunit O 0 2.509880914214335e-10
was O 0 7.102982091389265e-10
transiently O 0 2.2306043234721074e-08
co O 0 1.1522621967685609e-08
- O 0 4.751975701822175e-09
expressed O 0 1.5564589547767405e-11
with O 0 7.132607763964127e-13
the O 0 6.26860108959848e-13
beta O 0 4.1167004700970455e-12
- O 0 3.561642647476049e-11
subunit O 0 6.991946518292158e-12
to O 0 1.4970455430862728e-12
produce O 0 1.663761489689719e-11
Hex O 0 5.999511998311391e-10
A O 0 3.9497494164209e-10
( O 0 2.422909962940256e-12
alphabeta O 0 4.307841638961918e-09
) O 0 9.877858080098445e-13
in O 0 5.518471096754851e-12
COS O 0 4.3344942923795315e-07
- O 0 2.9569761750281032e-08
7 O 0 2.7839175409383188e-11
cells O 0 2.8110980557216614e-11
, O 0 1.7816339224242805e-13
the O 0 3.0728143553954146e-13
mature O 0 1.477884654932371e-11
alpha O 0 1.2456143972175426e-12
- O 0 1.887296395552962e-11
subunit O 0 1.1737145109991243e-11
was O 0 7.072965130250353e-11
present O 0 2.9802813862611632e-12
, O 0 1.7027339553523507e-13
but O 0 4.0887776562963107e-13
its O 0 1.7046543484503657e-13
level O 0 2.0596697958286114e-11
was O 0 9.316990755292576e-12
much O 0 4.1554507231034155e-12
lower O 0 7.614920499721123e-11
than O 0 2.517439165114488e-12
that O 0 4.852433017031588e-13
from O 0 3.322770932099456e-13
normal O 0 7.352739077315373e-12
alpha O 0 9.511009601420595e-13
- O 0 8.600274138681474e-12
subunit O 0 1.9847086214080933e-12
transfections O 0 4.2191874993768863e-10
, O 0 1.2421025308555905e-13
although O 0 1.1116591588228308e-12
higher O 0 9.263901278033781e-12
than O 0 7.656843366808663e-13
in O 0 1.8420928844797846e-12
those O 0 5.3487266699070446e-12
cells O 0 3.611436150130487e-11
transfected O 0 1.0293484953294296e-09
with O 0 1.9289509226028123e-12
an O 0 1.17520804285981e-12
alpha O 0 9.441739751148148e-11
- O 0 1.3921753527768033e-08
subunit O 0 1.465216503682143e-09
associated O 0 9.258934063893776e-09
with O 0 5.784111412054926e-09
infantile O 0 0.0187135711312294
TSD B-Disease 0 0.0006086995708756149
. O 0 4.958108590358279e-08

Furthermore O 0 3.297946875591151e-07
, O 0 2.3762745243738337e-11
the O 0 7.128609226352001e-13
precursor O 0 2.8069510257799912e-11
level O 0 6.152288400951278e-11
of O 0 8.685441959827706e-14
the O 0 5.722603380747815e-13
W474C O 0 5.400147343181949e-11
alpha O 0 2.8286737101951287e-12
- O 0 2.0587703417063175e-11
subunit O 0 6.4835242209737576e-12
was O 0 7.420424691373384e-11
found O 0 4.405536699336743e-12
to O 0 4.2692574735853084e-13
accumulate O 0 1.8034806981148677e-10
in O 0 4.080830725422535e-13
comparison O 0 1.6846518971491697e-11
to O 0 1.4393595907172263e-12
the O 0 3.306455153076482e-12
normal O 0 1.4540933734874528e-10
alpha O 0 1.1316626455371015e-11
- O 0 1.4090412170375544e-10
subunit O 0 6.479274755610831e-11
precursor O 0 4.6338707870852147e-10
levels O 0 4.156178068370764e-09
. O 0 2.1180192322223235e-10

We O 0 9.321733607237093e-09
conclude O 0 7.942484447909237e-10
that O 0 6.139952695577433e-12
the O 0 3.000306383546536e-12
1422 O 0 1.0019876128808392e-07
G O 0 1.25282190310827e-06
- O 0 3.0028863307052234e-07
- O 0 8.845653951539134e-07
> O 0 3.383149049795975e-08
C O 0 4.845167111966475e-08
mutation O 0 5.579143813605469e-09
is O 0 4.4956169863163975e-12
the O 0 1.87025958955922e-12
cause O 0 8.804182383137515e-10
of O 0 5.808180759264703e-12
Hex B-Disease 0 2.655669959494844e-07
A I-Disease 0 8.520613846485503e-06
enzyme I-Disease 1 0.9999936819076538
deficiency I-Disease 1 0.9999986886978149
in O 0 4.875131964787727e-10
the O 0 3.6496478061920357e-10
proband O 0 1.4244244084693491e-05
. O 0 1.1189515092269176e-08

The O 0 1.5859425994690923e-09
resulting O 0 4.18432799520474e-09
W474C O 0 5.28420196488355e-09
substitution O 0 7.047611938482135e-10
clearly O 0 2.1121422388858946e-09
interferes O 0 2.361524753524691e-09
with O 0 8.12375449028846e-13
alpha O 0 1.0662279219253445e-11
- O 0 3.232290823884654e-11
subunit O 0 8.297648158850368e-12
processing O 0 2.6040492678847116e-11
, O 0 3.179421244510483e-13
but O 0 6.779990523002322e-13
because O 0 3.7927045401855985e-13
the O 0 3.977926251201233e-14
base O 0 1.2279273734969176e-12
substitution O 0 2.0447361252090568e-12
falls O 0 1.6825299486988854e-10
at O 0 1.2893504623343044e-12
the O 0 8.478743559027849e-14
first O 0 4.005697683273635e-12
position O 0 1.2298317919601232e-10
of O 0 7.859314463337999e-14
exon O 0 8.547592078578248e-10
13 O 0 1.577472701075333e-11
, O 0 2.4540143680161497e-13
aberrant O 0 1.801792465228047e-10
splicing O 0 1.2620455791534368e-09
may O 0 1.5283545540256682e-09
also O 0 4.21402019182282e-12
contribute O 0 7.522425390926735e-12
to O 0 2.1621622894874015e-11
Hex B-Disease 0 8.55492388041057e-08
A I-Disease 0 3.003760014053114e-07
deficiency I-Disease 0 6.365135050145909e-05
in O 0 9.411294660255365e-12
this O 0 1.590882460489329e-11
proband O 0 1.7406100027983484e-07
. O 0 7.481178176949044e-11
. O 0 1.1234504437851456e-09

Two O 0 3.781480018005823e-09
frequent O 0 7.408612532344705e-07
missense O 0 0.014843338169157505
mutations O 0 0.13862836360931396
in O 0 5.289469117997214e-05
Pendred B-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
. O 0 1.7528381022202666e-06

Pendred B-Disease 1 0.999998927116394
syndrome I-Disease 1 1.0
is O 0 1.0700590792112052e-05
an O 0 5.223213884164579e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.996778666973114
by O 0 9.555635926972172e-08
early O 0 2.548365227994509e-05
childhood O 1 0.999846339225769
deafness B-Disease 1 1.0
and O 0 0.059862665832042694
goiter B-Disease 1 0.9999997615814209
. O 0 2.4493849650752963e-06

A O 0 2.277194965927265e-08
century O 0 8.5200024813048e-10
after O 0 3.7412791614732654e-11
its O 0 1.1918243085148883e-12
recognition O 0 3.485779373479936e-11
as O 0 8.24362314522098e-11
a O 0 7.791886957875249e-08
syndrome O 0 0.021057240664958954
by O 0 3.0216603524868546e-11
Vaughan O 0 2.8488631453882363e-09
Pendred O 0 9.870893791230628e-08
, O 0 4.094523765180158e-12
the O 0 1.57776465503634e-11
disease O 0 1.9712176779762558e-08
gene O 0 1.5747687598377524e-09
( O 0 1.5587140952955103e-11
PDS O 0 1.068677164539622e-07
) O 0 4.3510308203598136e-12
was O 0 9.069737738620631e-10
mapped O 0 3.8035017269066884e-07
to O 0 3.4786079572413087e-10
chromosome O 0 6.237919478735421e-06
7q22 O 0 3.493393023745739e-07
- O 0 2.3488055376219563e-06
q31 O 0 3.194352871105366e-07
. O 0 1.842341612601217e-09

1 O 0 1.722284004301855e-08
and O 0 5.23103060867669e-10
, O 0 3.3027695162113346e-11
recently O 0 2.3940192050986298e-09
, O 0 1.530893359129315e-12
found O 0 1.1545661128542495e-11
to O 0 1.21291800388168e-12
encode O 0 2.362568474190141e-10
a O 0 2.2054991166697846e-09
putative O 0 1.1151748367410619e-05
sulfate O 0 0.001233500661328435
transporter O 0 3.297528382972814e-05
. O 0 1.2060297649441054e-08

We O 0 6.439698552185291e-08
performed O 0 5.8988197659815e-10
mutation O 0 1.1048290060600152e-09
analysis O 0 1.5371877382097665e-11
of O 0 5.492279808033684e-13
the O 0 4.040527894905166e-12
PDS B-Disease 0 8.037602583499392e-08
gene O 0 1.00884434139914e-09
in O 0 2.747650371115462e-11
patients O 0 5.415020168375584e-11
from O 0 3.164412959097418e-12
14 O 0 8.470443964292418e-12
Pendred B-Disease 0 6.1834697362428415e-09
families O 0 1.1070195107820702e-11
originating O 0 1.451319186357436e-11
from O 0 1.9797785372893673e-12
seven O 0 1.6222775076416007e-12
countries O 0 3.598642651231332e-13
and O 0 9.446993534667492e-12
identified O 0 1.9421333430358345e-09
all O 0 3.188211847304778e-11
mutations O 0 1.7303971588944478e-08
. O 0 6.740262237237005e-10

The O 0 2.9989950522946174e-09
mutations O 0 3.1802176891915224e-08
include O 0 3.934273740124894e-11
three O 0 1.4168504910982982e-11
single O 0 5.832031524377612e-10
base O 0 1.158484280727734e-10
deletions O 0 3.225058442524187e-09
, O 0 1.4008585957903108e-12
one O 0 6.911287948191402e-13
splice O 0 2.003500698677385e-09
site O 0 9.639822273754817e-09
mutation O 0 1.2436446183983207e-07
and O 0 1.9959170427519268e-10
10 O 0 1.5293451227638144e-10
missense O 0 1.201539907924598e-05
mutations O 0 1.707271258055698e-05
. O 0 2.0355761520818305e-08

One O 0 3.706559681404542e-08
missense O 0 2.653387673490215e-05
mutation O 0 5.066612629889278e-06
( O 0 8.562289766089748e-11
L236P O 0 9.048902960273608e-09
) O 0 6.223904204516462e-12
was O 0 4.1260983518753847e-10
found O 0 1.5876579217977138e-10
in O 0 1.9611109611239463e-12
a O 0 1.6751867254471975e-11
homozygous O 0 2.1674132710813865e-08
state O 0 8.094144104964229e-11
in O 0 1.629217941112593e-11
two O 0 4.0101160239669476e-12
consanguineous O 0 3.5074072002316825e-07
families O 0 9.476271156660943e-11
and O 0 2.5491077998429645e-11
in O 0 3.7473691684442034e-12
a O 0 1.648633486672768e-11
heterozygous O 0 1.6692495163894705e-09
state O 0 3.762095496240292e-11
in O 0 7.835494406083221e-12
five O 0 3.128232482080273e-12
additional O 0 1.4442966787819866e-11
non O 0 1.7575925159718508e-09
- O 0 9.02594365470577e-07
consanguineous O 0 3.9190181269077584e-05
families O 0 1.5353558424635594e-08
. O 0 3.4719216390755037e-09

Another O 0 1.1955405909702677e-07
missense O 0 0.00021409077453427017
mutation O 0 3.010260479641147e-05
( O 0 1.7652380945865076e-10
T416P O 0 2.3741852928083063e-08
) O 0 1.6120471277303317e-11
was O 0 5.019419324625574e-10
found O 0 1.2079554023713968e-10
in O 0 5.4995890653997126e-12
a O 0 1.728474828543991e-11
homozygous O 0 3.128280923192506e-08
state O 0 5.458531890378815e-11
in O 0 1.2397794596497036e-11
one O 0 9.907638078010539e-12
family O 0 6.390001722200722e-11
and O 0 2.9533250844870906e-11
in O 0 2.978866285585635e-12
a O 0 2.4420030234062473e-11
heterozygous O 0 6.462730350875745e-09
state O 0 1.0166825714641448e-10
in O 0 1.5507792272551058e-10
four O 0 1.1292998480794125e-10
families O 0 8.516704008698639e-10
. O 0 1.0910371495143067e-09

Pendred B-Disease 0 0.0002166545164072886
patients O 0 9.146127695203177e-07
in O 0 3.092504308188637e-10
three O 0 4.6535938297287416e-11
non O 0 1.7959261855438058e-09
- O 0 3.6164769312563294e-07
consanguineous O 0 1.7952743291971274e-05
families O 0 3.9055074729787975e-09
were O 0 2.440136981363139e-10
shown O 0 1.255951009859757e-09
to O 0 4.9570304458401715e-12
be O 0 1.9932415093459888e-11
compound O 0 1.6495621535383975e-10
heterozygotes O 0 3.6392366897786133e-09
for O 0 3.0063440886046733e-12
L236P O 0 2.2529098586687724e-09
and O 0 2.1594266652602556e-10
T416P O 0 1.679450534197713e-08
. O 0 5.509326883590404e-10

In O 0 8.32676538831123e-10
total O 0 4.960172550472208e-11
, O 0 3.5472883311293835e-12
one O 0 2.7392922999358582e-12
or O 0 7.370402899109507e-12
both O 0 8.29693247699631e-13
of O 0 2.1655112869990029e-13
these O 0 7.712735831943984e-12
mutations O 0 1.177258179829721e-09
were O 0 8.841265913828167e-11
found O 0 6.7798815173159e-11
in O 0 3.863728781361431e-12
nine O 0 2.0426076195040332e-12
of O 0 3.8336293774893226e-13
the O 0 5.83888189534254e-12
14 O 0 5.6885256921601624e-11
families O 0 5.50558452994121e-11
analyzed O 0 1.99009537737993e-08
. O 0 3.5635761008734335e-09

The O 0 7.49533601851482e-10
identification O 0 2.948920441170344e-09
of O 0 6.84970353007075e-12
two O 0 4.956087276686283e-11
frequent O 0 1.6275750169825187e-07
PDS B-Disease 0 6.331493932520971e-05
mutations O 0 3.1243993703355954e-07
will O 0 8.878608785678477e-12
facilitate O 0 2.9312979127338323e-11
the O 0 8.466119472139155e-11
molecular O 0 1.2956344107806217e-05
diagnosis O 0 0.00032457380439154804
of O 0 6.502584142253909e-07
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 0 1.2528911383924424e-06

Insertional O 0 2.8432292310753837e-05
mutation O 0 5.320938498698524e-07
by O 0 1.464997706479565e-10
transposable O 0 1.3577727031588438e-06
element O 0 4.198464154114845e-08
, O 0 1.1853847070586454e-10
L1 O 0 2.060728093056241e-06
, O 0 1.8883405256131525e-11
in O 0 9.219797668380547e-12
the O 0 8.519705774201469e-11
DMD B-Disease 1 0.9999890327453613
gene O 0 4.88990643532361e-08
results O 0 5.026377536410109e-09
in O 0 1.1341919625706964e-09
X B-Disease 1 0.9969785213470459
- I-Disease 1 0.9982448816299438
linked I-Disease 1 0.9998922348022461
dilated I-Disease 1 0.999716579914093
cardiomyopathy I-Disease 1 0.9999994039535522
. O 0 3.8771025856476626e-07

X B-Disease 1 0.9987455606460571
- I-Disease 1 0.9996781349182129
linked I-Disease 1 0.9998899698257446
dilated I-Disease 1 0.9999706745147705
cardiomyopathy I-Disease 1 1.0
( O 0 4.664913433316542e-08
XLDCM B-Disease 0 8.01852802396752e-05
) O 0 1.3555443226231922e-11
is O 0 7.973319053611316e-12
a O 0 6.161542109861529e-11
clinical O 0 2.902149853767355e-09
phenotype O 0 2.5170985296085746e-08
of O 0 3.748277296183877e-12
dystrophinopathy B-Disease 0 1.779049307515379e-05
which O 0 2.0237291842306604e-09
is O 0 3.3012578781743684e-11
characterized O 0 5.677429082417973e-10
by O 0 2.1065277994170017e-11
preferential O 0 2.603561632952278e-08
myocardial B-Disease 0 0.0020771545823663473
involvement I-Disease 0 8.09093023690366e-08
without O 0 2.6362692584491754e-10
any O 0 3.0904570569312284e-11
overt O 0 1.5132953024021845e-07
clinical O 0 1.2298886531425524e-07
signs O 0 9.223489314535982e-07
of O 0 3.586878705164054e-08
skeletal B-Disease 1 0.9999992847442627
myopathy I-Disease 1 1.0
. O 0 4.036173049826175e-05

To O 0 7.631922316342354e-10
date O 0 2.086396833078652e-09
, O 0 1.2604535470917e-12
several O 0 6.632565048396433e-13
mutations O 0 2.8366957671721593e-09
in O 0 5.454806051297112e-11
the O 0 4.588893265378147e-09
Duchenne B-Disease 1 0.9999281167984009
muscular I-Disease 1 0.9986214637756348
dystrophy I-Disease 1 0.9684537649154663
gene O 0 2.1733803805545904e-06
, O 0 1.266511562292294e-09
DMD O 1 0.9999969005584717
, O 0 5.242387635107093e-10
have O 0 6.319246237396214e-10
been O 0 1.0713191445077541e-09
identified O 0 3.499447842614245e-08
in O 0 1.3340228921521202e-10
patients O 0 9.514176252389817e-11
with O 0 1.7225540438481346e-11
XLDCM B-Disease 0 7.68519748817198e-06
, O 0 6.20877481372073e-12
but O 0 3.590321182717071e-12
a O 0 3.3800785521204135e-12
pathogenic O 0 4.0467557083090355e-10
correlation O 0 5.6365110495670834e-11
of O 0 2.7162427580600113e-13
these O 0 1.0939012716482122e-11
cardiospecific O 0 1.7803925800308207e-07
mutations O 0 2.263994502982314e-08
in O 0 2.1246467085678233e-10
DMD O 1 0.9999854564666748
with O 0 1.6607694386383542e-10
the O 0 2.9488067543326224e-10
XLDCM B-Disease 0 0.0007362519972957671
phenotype O 0 6.164093974803109e-06
has O 0 1.2670575699758047e-09
remained O 0 4.69726535445858e-10
to O 0 7.557256903600873e-12
be O 0 1.168711794008459e-09
elucidated O 0 3.632879668202804e-07
. O 0 1.8880541574617382e-09

We O 0 9.746222673356897e-08
report O 0 2.9648006272253724e-10
here O 0 6.7432903878839046e-12
the O 0 1.326039972271431e-13
identification O 0 2.429482483246037e-11
of O 0 4.591720883725947e-13
a O 0 3.416552804558215e-11
unique O 0 4.794993291312721e-10
de O 0 6.562562937517669e-09
novo O 0 1.1607282246473005e-08
L1 O 0 6.006673203273749e-08
insertion O 0 2.1010596040760277e-10
in O 0 5.446766735556219e-12
the O 0 2.5237949750900324e-12
muscle O 0 9.959827407257649e-10
exon O 0 5.717771145441475e-09
1 O 0 2.634977236404268e-10
in O 0 4.195642167026392e-10
DMD O 1 0.999998927116394
in O 0 1.1352719875290518e-09
three O 0 1.9553161867413849e-10
XLDCM B-Disease 0 0.00032338342862203717
patients O 0 2.1978645570186472e-09
from O 0 7.033370413855877e-12
two O 0 1.612508390702594e-11
unrelated O 0 9.354880425860301e-09
Japanese O 0 8.377894289424148e-08
families O 0 1.3108838459174876e-09
. O 0 1.3664146480962813e-09

The O 0 3.041988050345168e-10
insertion O 0 3.2461708876496687e-09
was O 0 7.560565506992134e-10
a O 0 8.176241628188308e-11
5 O 0 2.3917392372174717e-11
- O 0 4.031726952291592e-09
truncated O 0 5.040776129838775e-10
form O 0 8.433499038007497e-11
of O 0 4.241290912226914e-12
human O 0 8.585544081229912e-11
L1 O 0 2.411182009609547e-08
inversely O 0 1.932103010915398e-08
integrated O 0 1.0973963959770572e-09
in O 0 1.4512471085970091e-11
the O 0 1.7366736521085002e-11
5 O 0 1.0396537103440906e-10
- O 0 2.051236691613667e-07
untranslated O 0 1.3326263115231995e-06
region O 0 1.4071243059632366e-09
in O 0 1.298658316301049e-11
the O 0 2.640554224928038e-12
muscle O 0 7.680681646249354e-10
exon O 0 2.119341591111379e-09
1 O 0 3.4754379929502477e-10
, O 0 4.677163170652143e-12
which O 0 2.3969272747170756e-11
affected O 0 2.320325181992544e-11
the O 0 4.557048098249861e-13
transcription O 0 1.045218425699268e-11
or O 0 8.295385212075956e-12
the O 0 2.2235739725179338e-12
stability O 0 3.5215133586952163e-10
of O 0 4.802491412360388e-13
the O 0 6.960995148352911e-12
muscle O 0 1.0395887484193622e-09
form O 0 2.444952920677146e-11
of O 0 1.768717767733352e-12
dystrophin O 0 3.9806611340509335e-09
transcripts O 0 1.3450353053556796e-09
but O 0 1.9480163315765964e-10
not O 0 5.368964387658659e-12
that O 0 5.437287447541961e-13
of O 0 1.7993443649118313e-13
the O 0 5.659165497329255e-11
brain O 0 5.296242875374446e-07
or O 0 9.188190208675451e-10
Purkinje O 0 3.155514889385813e-07
cell O 0 3.68177893506072e-07
form O 0 1.3322030145701547e-09
, O 0 4.871151051966116e-11
probably O 0 8.574212451151197e-09
due O 0 7.731636858521185e-11
to O 0 3.1211166463818163e-12
its O 0 4.494176298469599e-12
unique O 0 5.3349540063418743e-11
site O 0 1.3057227521429127e-10
of O 0 2.8605872011422395e-12
integration O 0 4.129050712453619e-10
. O 0 1.312427388988624e-09

We O 0 1.825190310000835e-08
speculate O 0 8.486110480987463e-09
that O 0 5.088723713242427e-12
this O 0 1.8045824166576518e-13
insertion O 0 7.849914294977278e-12
of O 0 3.6774671307270024e-13
an O 0 2.736649665560642e-12
L1 O 0 2.9131490464351373e-06
sequence O 0 2.5405979542370005e-08
in O 0 3.645809210084394e-09
DMD O 1 0.999998927116394
is O 0 1.4602531406282537e-09
responsible O 0 1.2080360323185602e-10
for O 0 2.449151179171466e-13
some O 0 4.805934160833844e-14
of O 0 1.4610108099461644e-13
the O 0 3.679531505873523e-12
population O 0 6.317115342109603e-13
of O 0 4.733973087665821e-13
Japanese O 0 2.070974858270347e-08
patients O 0 7.825401437955293e-11
with O 0 1.1112845019201067e-11
XLDCM B-Disease 0 1.905425961012952e-06
. O 0 1.1459969084803845e-10
. O 0 4.4503617457891664e-10

Severe O 0 0.00047368952073156834
early O 0 1.079621142707765e-06
- O 1 0.9790486097335815
onset O 1 0.9980798959732056
obesity B-Disease 1 0.9999998807907104
, O 0 2.3896422135294415e-05
adrenal B-Disease 1 0.9999995231628418
insufficiency I-Disease 1 0.9999995231628418
and O 0 3.717910033174121e-07
red O 0 0.00021129664673935622
hair O 1 0.9990737438201904
pigmentation O 0 0.19824866950511932
caused O 0 2.816770745539543e-07
by O 0 6.330864166237404e-10
POMC O 0 5.472385237226263e-05
mutations O 0 6.188498673509457e-07
in O 0 3.3300595614349504e-10
humans O 0 5.843982187059282e-09
. O 0 1.0348880641330993e-09

Sequential O 0 1.2389780579269427e-07
cleavage O 0 2.646414031914901e-06
of O 0 3.772651288591611e-11
the O 0 1.879156118905767e-12
precursor O 0 3.68688204965828e-11
protein O 0 1.93864965747359e-10
pre O 0 3.537944621712086e-07
- O 0 0.00013180146925151348
pro O 0 6.611900516872993e-06
- O 0 4.530747537501156e-05
opiomelanocortin O 0 1.2044401955790818e-05
( O 0 6.117779893788367e-11
POMC O 0 7.274343971630515e-08
) O 0 2.6007817861134486e-12
generates O 0 9.23293039245543e-11
the O 0 3.002992993161868e-11
melanocortin O 0 6.499558367067948e-07
peptides O 0 8.870467382848801e-08
adrenocorticotrophin O 0 4.837474989471957e-07
( O 0 9.063715056267796e-11
ACTH O 0 2.026053920189952e-07
) O 0 5.216847353411991e-12
, O 0 3.787479878336608e-12
melanocyte O 0 4.133376023673918e-06
- O 0 9.066284292202909e-06
stimulating O 0 5.524318567040609e-06
hormones O 0 8.752217581786681e-07
( O 0 1.3903608299392634e-11
MSH O 0 3.0689800922800714e-08
) O 0 6.853372036541572e-13
alpha O 0 3.1771740186675723e-12
, O 0 1.3508584442017968e-13
beta O 0 1.3687914733953588e-12
and O 0 1.260100205603687e-12
gamma O 0 1.886059503020121e-10
as O 0 5.589293676326601e-13
well O 0 9.494914620170047e-13
as O 0 2.279709624200543e-13
the O 0 1.083923207266524e-12
opioid O 0 3.4343061727781787e-10
- O 0 2.861448411550782e-09
receptor O 0 4.905623685047544e-10
ligand O 0 1.5158658328573438e-08
beta O 0 5.601097363694407e-09
- O 0 1.6809684666441171e-06
endorphin O 0 0.00022087468823883682
. O 0 2.0650503529395792e-08

While O 0 3.37897487767691e-09
a O 0 8.138029833348881e-11
few O 0 5.226779425937522e-11
cases O 0 2.978987195811911e-11
of O 0 3.6938500869165836e-11
isolated O 0 0.0001119496810133569
ACTH B-Disease 1 0.9999140501022339
deficiency I-Disease 1 0.9906649589538574
have O 0 4.638966988324e-09
been O 0 4.998670810607564e-09
reported O 0 1.496829327152227e-07
( O 0 7.80492059870852e-11
OMIM O 0 3.586048933357233e-06
201400 O 0 1.9573219489643634e-08
) O 0 5.480698360427194e-12
, O 0 1.2728326422364877e-12
an O 0 2.1082120424398276e-11
inherited O 0 0.00390429119579494
POMC O 0 0.10395479947328568
defect O 0 0.012920326553285122
has O 0 1.2440143137837367e-08
not O 0 2.2218124562378705e-10
been O 0 7.734439477768973e-11
described O 0 1.6922860890389302e-09
so O 0 4.935835629105156e-10
far O 0 3.7899552940423575e-10
. O 0 3.014006544344028e-10

Recent O 0 6.926428142151053e-08
studies O 0 4.7996251417714575e-09
in O 0 2.368708527933361e-11
animal O 0 6.010633657460573e-10
models O 0 1.9110426574542316e-09
elucidated O 0 1.7717772138325927e-08
a O 0 2.1744534992040876e-11
central O 0 9.942849495125916e-12
role O 0 1.5217238927278665e-11
of O 0 5.722254809749361e-13
alpha O 0 7.06928404703433e-11
- O 0 1.095193091771307e-08
MSH O 0 4.0063781625576667e-08
in O 0 1.4178122651614666e-12
the O 0 2.690903055935223e-13
regulation O 0 1.85078914000103e-11
of O 0 1.2616459526409995e-13
food O 0 1.3110675739502753e-11
intake O 0 1.808715850704079e-11
by O 0 1.4719472927852972e-13
activation O 0 1.6902930877887856e-12
of O 0 7.235631907000217e-14
the O 0 1.1133339042346257e-11
brain O 0 9.104305576101979e-08
melanocortin O 0 7.050011419096336e-08
- O 0 6.084959380814325e-08
4 O 0 1.378134550922283e-10
- O 0 1.203922206371999e-08
receptor O 0 1.8059977957562978e-09
( O 0 2.8286479061834235e-11
MC4 O 0 1.891773763418314e-06
- O 0 7.477436980707353e-08
R O 0 6.685710900455888e-07
; O 0 3.735579987701465e-12
refs O 0 1.281391881491345e-09
3 O 0 3.4620633183185534e-12
- O 0 5.106015610323311e-10
5 O 0 1.9609949514914904e-12
) O 0 5.938352836808852e-14
and O 0 1.5150497501524585e-13
the O 0 1.72829171763908e-13
linkage O 0 1.3533989484670883e-09
of O 0 7.608092975064373e-12
human O 0 6.639999128310592e-08
obesity B-Disease 1 0.9999818801879883
to O 0 1.0210609441285712e-10
chromosome O 0 1.0014048257289687e-07
2 O 0 1.8416336164395197e-11
in O 0 2.9104826188008914e-12
close O 0 1.4230235045875617e-10
proximity O 0 2.5739185782747143e-10
to O 0 1.3977445936785848e-11
the O 0 2.000916793365448e-11
POMC O 0 1.733361187916671e-07
locus O 0 6.193833446133112e-09
, O 0 1.1896304254188639e-12
led O 0 1.4418876249228108e-12
to O 0 7.331421168939312e-13
the O 0 2.0490382394294793e-12
proposal O 0 8.761761455255979e-11
of O 0 5.721643319724079e-13
an O 0 1.85099656956067e-12
association O 0 5.903282203345572e-12
of O 0 4.313928120974753e-12
POMC O 0 1.2483685623010388e-06
with O 0 2.4151991517840088e-09
human O 0 4.485811132326489e-06
obesity B-Disease 1 0.9999798536300659
. O 0 5.539637371043682e-08

The O 0 1.194662035963745e-09
dual O 0 1.563754814526419e-08
role O 0 4.710669632146391e-10
of O 0 8.612289700837827e-12
alpha O 0 2.339556548491828e-09
- O 0 2.2883810402163363e-07
MSH O 0 7.984685908013489e-07
in O 0 7.553826487927129e-12
regulating O 0 3.5450123392344324e-10
food O 0 8.478028695746431e-11
intake O 0 4.0511421994793295e-10
and O 0 1.1036295141653163e-11
influencing O 0 7.215378072800149e-09
hair O 0 0.00014095187361817807
pigmentation O 0 3.642166348072351e-06
predicts O 0 3.376302970536926e-08
that O 0 5.197628785702513e-12
the O 0 5.949706873009664e-12
phenotype O 0 4.2622303908501635e-08
associated O 0 2.5185512009251454e-10
with O 0 1.324863309337676e-11
a O 0 8.584406963052515e-09
defect O 0 8.115664968499914e-06
in O 0 6.865026880298331e-10
POMC O 0 2.2777956019126577e-06
function O 0 1.6135661695670933e-08
would O 0 3.508894841353083e-10
include O 0 2.108101471165469e-09
obesity B-Disease 1 0.9999938011169434
, O 0 9.822144486637541e-11
alteration O 0 7.582755756629922e-08
in O 0 1.492173673511843e-08
pigmentation O 1 0.5260064601898193
and O 0 0.00015810241166036576
ACTH B-Disease 1 0.9994021654129028
deficiency I-Disease 1 0.6726964116096497
. O 0 1.7333571022959404e-08

The O 0 2.0785162480052577e-09
observation O 0 3.176477747501849e-08
of O 0 3.3772384194774574e-11
these O 0 4.064229786049367e-10
symptoms O 0 2.8989756373221098e-08
in O 0 2.5395462642519018e-12
two O 0 1.0424106239650954e-12
probands O 0 1.0605322842138776e-08
prompted O 0 1.2591117037885624e-10
us O 0 8.373197968314372e-12
to O 0 1.9679219462765546e-13
search O 0 1.4098066464240944e-11
for O 0 7.659782530478054e-12
mutations O 0 6.0118403588660385e-09
within O 0 2.3785508285190105e-11
their O 0 3.6663300173600533e-10
POMC O 0 4.538225311989663e-06
genes O 0 2.4670674392268666e-08
. O 0 9.272749790234514e-10

Patient O 0 3.104578718193807e-05
1 O 0 6.851974543309325e-09
was O 0 4.219028237884004e-09
found O 0 3.7329200841540455e-10
to O 0 1.0047855776573744e-11
be O 0 5.5861978237592425e-11
a O 0 1.3712642132901465e-11
compound O 0 3.139533355511759e-10
heterozygote O 0 2.0797337185740616e-09
for O 0 9.492107620745482e-13
two O 0 3.5163614641592345e-12
mutations O 0 1.0495605495819404e-09
in O 0 8.671562599926741e-12
exon O 0 1.229408486125294e-08
3 O 0 3.414339644347564e-10
( O 0 2.1383042905775973e-12
G7013T O 0 1.0253197180176699e-09
, O 0 4.459066362677566e-12
C7133delta O 0 5.411226577933803e-09
) O 0 4.2396064415216317e-13
which O 0 1.2219088588172333e-12
interfere O 0 3.56073920348976e-11
with O 0 8.763339988566987e-13
appropriate O 0 4.7870679642514347e-11
synthesis O 0 2.8458459547242576e-11
of O 0 9.099219641650613e-12
ACTH O 0 5.555529583034513e-07
and O 0 7.341167951313565e-11
alpha O 0 9.494982577962219e-10
- O 0 1.5455814263987122e-06
MSH O 0 8.495817382936366e-06
. O 0 3.4128699866187162e-09

Patient O 0 3.09778843075037e-05
2 O 0 1.8509427324175931e-09
was O 0 1.9360077430086164e-10
homozygous O 0 2.0487835872273763e-09
for O 0 2.310881087180805e-12
a O 0 1.300468344123118e-10
mutation O 0 5.9145644826230637e-08
in O 0 3.273968249284387e-11
exon O 0 1.1707565050755875e-07
2 O 0 2.806397114696324e-09
( O 0 3.4553627320521585e-11
C3804A O 0 2.546448740758933e-08
) O 0 2.6972878791609034e-11
which O 0 1.1856267356780137e-10
abolishes O 0 1.716556880637654e-06
POMC O 0 2.5482411729171872e-05
translation O 0 1.0686038365292916e-07
. O 0 5.8844165096161305e-09

These O 0 5.470708885901843e-10
findings O 0 2.572033974690413e-10
represent O 0 1.5836587249906664e-11
the O 0 1.0108247789145097e-12
first O 0 2.6689095811854857e-12
examples O 0 5.7638852024588516e-11
of O 0 3.677553053749172e-12
a O 0 1.2764168388912367e-07
genetic B-Disease 1 0.999997615814209
defect I-Disease 1 0.999997615814209
within O 0 6.864960822028365e-10
the O 0 6.744438341144132e-11
POMC O 0 4.0066080941869586e-07
gene O 0 2.381958186248312e-09
and O 0 3.504632348216852e-11
define O 0 1.1928359411328415e-09
a O 0 3.1717883874904373e-10
new O 0 1.936459437246185e-09
monogenic B-Disease 0 0.012766323983669281
endocrine I-Disease 0 0.0016459390753880143
disorder I-Disease 0 4.009580152342096e-05
resulting O 0 3.5233018724767362e-09
in O 0 1.6730800078690322e-10
early O 0 4.016592924926954e-08
- O 1 0.9894157648086548
onset O 1 0.9992966651916504
obesity B-Disease 1 1.0
, O 0 4.5508245420933235e-06
adrenal B-Disease 1 0.9999994039535522
insufficiency I-Disease 1 0.999998927116394
and O 0 2.626565844821016e-07
red O 0 1.383441576763289e-05
hair O 0 0.12232914566993713
pigmentation O 0 6.182061770232394e-05
. O 0 6.341438485435447e-10
. O 0 2.2849293568327766e-09

A O 0 1.0197720001769994e-07
European O 0 2.25220642136037e-08
multicenter O 0 4.613984128809534e-05
study O 0 1.0454236587520427e-07
of O 0 1.4917817736659345e-07
phenylalanine B-Disease 1 0.9999994039535522
hydroxylase I-Disease 1 0.9999961853027344
deficiency I-Disease 1 0.9999998807907104
: O 0 3.069175746883701e-10
classification O 0 4.793420105286827e-10
of O 0 1.7950365586300032e-12
105 O 0 9.300341746731888e-11
mutations O 0 6.300381016899337e-08
and O 0 3.546856905400908e-11
a O 0 2.4265279022217534e-11
general O 0 1.482169768862729e-11
system O 0 4.891148944197177e-11
for O 0 1.6583872946770994e-12
genotype O 0 9.885307861168258e-08
- O 0 1.5679002984825274e-08
based O 0 2.9849892002609124e-10
prediction O 0 1.0317431353712436e-08
of O 0 1.1876427792600897e-11
metabolic O 0 7.419836947519798e-06
phenotype O 0 2.167493676097365e-06
. O 0 5.094004773553706e-09

Phenylketonuria B-Disease 0 0.3711245357990265
( O 0 3.819349103650893e-08
PKU B-Disease 0 2.0392877559061162e-05
) O 0 2.6624602522673513e-10
and O 0 3.5491480865346148e-09
mild B-Disease 0 0.0024230945855379105
hyperphenylalaninemia I-Disease 1 1.0
( O 0 5.957837743153505e-07
MHP B-Disease 1 0.9999984502792358
) O 0 7.049302114259248e-11
are O 0 1.5599223301965282e-10
allelic B-Disease 0 0.00042418992961756885
disorders I-Disease 1 0.700814962387085
caused O 0 4.7201271513586107e-07
by O 0 2.831391510138559e-10
mutations O 0 3.1202901595861476e-07
in O 0 3.420021210676083e-11
the O 0 1.953574454982565e-11
gene O 0 2.1554702911430468e-08
encoding O 0 2.0187459881526593e-07
phenylalanine O 0 0.0008199996664188802
hydroxylase O 0 0.00420899735763669
( O 0 4.379729912074026e-09
PAH O 0 1.1921872101083864e-05
) O 0 6.166056554235411e-11
. O 0 6.177819367181314e-10

Previous O 0 1.6280345960240084e-07
studies O 0 1.0458500732113407e-08
have O 0 1.4890334798511873e-10
suggested O 0 4.95201768480058e-10
that O 0 1.3420177295830893e-11
the O 0 1.1054033556556764e-11
highly O 0 1.1438928915197266e-08
variable O 0 1.5895335309323855e-05
metabolic O 0 0.0001549575390527025
phenotypes O 0 1.3654112080985215e-05
of O 0 1.1678566558259718e-08
PAH B-Disease 1 0.9988549947738647
deficiency I-Disease 0 0.34647446870803833
correlate O 0 8.005998097360134e-06
with O 0 1.1342794437041448e-07
PAH O 0 0.05378520488739014
genotypes O 0 3.8719292206224054e-05
. O 0 3.0252458316226694e-08

We O 0 3.064218745407743e-08
identified O 0 3.123926450854242e-09
both O 0 2.3893364717308962e-11
causative O 0 3.5022456046363004e-08
mutations O 0 3.2223791635033194e-08
in O 0 7.307431049152768e-11
686 O 0 2.4522144315142214e-08
patients O 0 1.91166971141854e-09
from O 0 3.3949926203646896e-11
seven O 0 1.6875147113015743e-10
European O 0 1.9701531517313242e-09
centers O 0 2.85995871429634e-09
. O 0 2.9135638346389214e-09

On O 0 2.7678777048123493e-09
the O 0 7.211019108221972e-12
basis O 0 7.1592302398892915e-12
of O 0 1.5841314534009027e-13
the O 0 1.9857234346415398e-12
phenotypic O 0 8.711993793042438e-09
characteristics O 0 2.155860912012031e-08
of O 0 8.850440345875565e-12
297 O 0 2.0821309121288323e-09
functionally O 0 3.07964036494468e-08
hemizygous O 0 6.407867090274522e-07
patients O 0 1.2402726623506055e-09
, O 0 1.1868700466877158e-12
105 O 0 5.059001720146561e-13
of O 0 1.263396532573749e-13
the O 0 5.3864321857000075e-12
mutations O 0 6.211839931324903e-09
were O 0 4.59764969151788e-11
assigned O 0 1.2163828277955702e-10
to O 0 4.000635326489865e-12
one O 0 5.792912590590893e-12
of O 0 3.3174577993531906e-13
four O 0 7.007660944580163e-12
arbitrary O 0 3.824581096267821e-09
phenotype O 0 1.5884991455550335e-07
categories O 0 9.257909994175861e-09
. O 0 1.093211965397245e-09

We O 0 1.606512256557835e-08
proposed O 0 6.210557623731461e-10
and O 0 2.0432955327720492e-10
tested O 0 7.858959705231428e-09
a O 0 1.2724764818228262e-11
simple O 0 2.6821858623016226e-10
model O 0 1.9416213081768774e-10
for O 0 3.4627812769971733e-13
correlation O 0 7.472397145491527e-10
between O 0 1.436922525410722e-10
genotype O 0 4.951238565809035e-07
and O 0 1.6791412704719733e-10
phenotypic O 0 1.3319856861926382e-07
outcome O 0 1.7519947448363382e-07
. O 0 1.4485667776398259e-08

The O 0 1.8288622838369406e-09
observed O 0 2.1464977351115522e-08
phenotype O 0 6.486554582352255e-08
matched O 0 1.3074136440138773e-08
the O 0 1.0215902776500307e-11
predicted O 0 1.4015154592428303e-09
phenotype O 0 1.1813565681251248e-09
in O 0 1.679367040395563e-12
79 O 0 3.4318995128373997e-12
% O 0 1.1755907933317516e-13
of O 0 7.452696635821751e-14
the O 0 3.633183597723244e-12
cases O 0 2.053410497193653e-10
, O 0 1.6016962062215256e-12
and O 0 4.846497335397881e-12
in O 0 7.5108945755617e-13
only O 0 2.247137344908376e-13
5 O 0 5.2267814642376065e-14
of O 0 2.5130515480002377e-14
184 O 0 8.492298878004512e-12
patients O 0 3.571206524943804e-11
was O 0 2.7106675237753564e-10
the O 0 3.0001918917971215e-12
observed O 0 6.290157283928011e-10
phenotype O 0 2.5752738830320254e-10
more O 0 1.0739357265889676e-13
than O 0 7.258152412426e-13
one O 0 1.945741744807661e-12
category O 0 3.4022093475805093e-10
away O 0 7.261843210093488e-11
from O 0 2.7881672665097668e-12
that O 0 3.637303999659558e-11
expected O 0 3.2867963906113573e-10
. O 0 3.8349370901080704e-10

Among O 0 2.4805795195703695e-09
the O 0 1.5646803297464373e-11
seven O 0 6.0538995691472586e-12
contributing O 0 9.716265986225991e-12
centers O 0 4.381812187398415e-12
, O 0 1.7673747665022943e-13
the O 0 3.011565064166277e-13
proportion O 0 2.2257104492773294e-10
of O 0 1.715605196968284e-12
patients O 0 4.93131646628342e-11
for O 0 3.6848253398211184e-13
whom O 0 7.742453900227986e-11
the O 0 3.2650368953640596e-12
observed O 0 5.576377581917313e-09
phenotype O 0 1.2407795679791889e-08
did O 0 1.6982930339803914e-10
not O 0 2.313716926383158e-12
match O 0 4.530265051982951e-11
the O 0 2.3091010440540183e-12
predicted O 0 4.0163433689954786e-10
phenotype O 0 5.054774931956274e-10
was O 0 2.4697709155585557e-11
4 O 0 1.7174026957500477e-12
% O 0 1.546937166037321e-12
- O 0 6.229626148268608e-09
23 O 0 5.033855970948409e-11
% O 0 1.3110669234289718e-12
( O 0 7.236215207769015e-13
P O 0 5.574837587118964e-07
< O 0 7.0102115223846795e-09
. O 0 3.7185619167212636e-12
0001 O 0 4.745877579814817e-10
) O 0 8.084858330774727e-14
, O 0 3.586587203987558e-14
suggesting O 0 6.196758384202639e-11
that O 0 3.945995440124417e-12
differences O 0 9.558193125869252e-11
in O 0 9.600188482714045e-13
methods O 0 5.535634017145297e-12
used O 0 1.029783463363243e-11
for O 0 7.22580307220555e-13
mutation O 0 3.0122548899669255e-09
detection O 0 1.3402676302121108e-08
or O 0 5.885449017029032e-09
phenotype O 0 6.617839858336083e-07
classification O 0 8.946042839852453e-08
may O 0 7.87712950423014e-10
account O 0 2.0224882532615673e-11
for O 0 1.0308159897496824e-13
a O 0 3.424706481944262e-12
considerable O 0 3.7513062101091066e-10
proportion O 0 9.007248280568092e-09
of O 0 1.5407757014695989e-10
genotype O 0 0.00380475795827806
- O 0 0.00022438961605075747
phenotype O 0 1.877708564279601e-05
inconsistencies O 0 5.854690243722871e-07
. O 0 7.994742645678343e-09

Our O 0 9.147752422222766e-08
data O 0 8.118983707561256e-09
indicate O 0 9.746331741666836e-09
that O 0 2.5842279705035054e-11
the O 0 1.555409412379305e-10
PAH O 0 6.372574716806412e-05
- O 0 6.06146215886838e-07
mutation O 0 4.0700331283005653e-07
genotype O 0 1.2138910960857174e-06
is O 0 5.1674302857518395e-12
the O 0 2.006073665473604e-13
main O 0 5.081314275595661e-12
determinant O 0 1.2667048521208812e-09
of O 0 1.2787073483400135e-11
metabolic O 0 5.745372618548572e-06
phenotype O 0 3.0277865903372003e-07
in O 0 8.25078061428286e-11
most O 0 4.1610626055899047e-10
patients O 0 3.509286727876315e-08
with O 0 2.0365994259918807e-06
PAH B-Disease 1 0.9994780421257019
deficiency I-Disease 0 0.10317575931549072
. O 0 8.589450928297993e-09

In O 0 1.1187866189033002e-09
the O 0 1.6786249473765835e-11
present O 0 1.5354354940266823e-11
study O 0 2.6399460742454472e-11
, O 0 1.7916605699053179e-12
the O 0 1.1685472468131453e-12
classification O 0 1.7426271536891136e-10
of O 0 2.0310539274731587e-12
105 O 0 2.75104439229068e-10
PAH O 0 6.949751423235284e-07
mutations O 0 8.301427989465537e-09
may O 0 4.8279918257732035e-11
allow O 0 5.851565976558448e-13
the O 0 2.7308203441600565e-12
prediction O 0 3.701377260245664e-10
of O 0 3.112487278003097e-14
the O 0 1.235390695991656e-12
biochemical O 0 4.547159093704067e-09
phenotype O 0 8.012446262029016e-10
in O 0 1.269402009722309e-12
> O 0 1.7579639133291636e-10
10 O 0 2.9465603134520846e-12
, O 0 5.53189438701196e-13
000 O 0 2.2117356557327383e-11
genotypes O 0 6.3642944247988e-09
, O 0 8.386911824753707e-12
which O 0 1.951370592889745e-10
may O 0 4.297287858889831e-09
be O 0 1.8081732942529238e-12
useful O 0 3.1010305000939153e-12
for O 0 1.9876323351965264e-13
the O 0 2.3029347526182242e-12
management O 0 3.1032329483871024e-11
of O 0 5.68158280839226e-12
hyperphenylalaninemia B-Disease 1 0.999987006187439
in O 0 4.7259106850106036e-08
newborns O 0 7.593756436108379e-06
. O 0 1.7667782792329945e-09

Somatic O 0 2.0927640434820205e-05
instability O 0 1.2790170330845285e-05
of O 0 2.68033456540806e-10
the O 0 1.5018146448664282e-10
CTG O 0 1.2651596534851706e-06
repeat O 0 2.726168872868584e-07
in O 0 1.702973734252211e-10
mice O 0 1.2101383006779542e-08
transgenic O 0 2.3210933175477066e-09
for O 0 3.0095641256888683e-11
the O 0 2.7373339150926768e-08
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999998807907104
region O 0 6.371450922415534e-07
is O 0 1.4376441148655772e-09
age O 0 3.7670230823572126e-10
dependent O 0 2.601563409143637e-10
but O 0 4.9910825472565534e-11
not O 0 1.3163319392828221e-11
correlated O 0 5.530436664180627e-10
to O 0 7.444659038541301e-13
the O 0 3.4949849004456413e-12
relative O 0 2.9635469633859657e-09
intertissue O 0 1.9377976556711474e-08
transcription O 0 1.2409802074841991e-09
levels O 0 5.742613495840487e-09
and O 0 2.0872355233070294e-10
proliferative O 0 1.6012241758289747e-05
capacities O 0 1.4638072798334179e-07
. O 0 2.114859398716362e-09

A O 0 1.826148547934281e-07
( O 0 3.7215594494988125e-10
CTG O 0 9.468225670161701e-08
) O 0 5.63545521012343e-12
nexpansion O 0 1.0695087482304189e-08
in O 0 8.850592134179713e-12
the O 0 8.26674926429627e-12
3 O 0 3.0248795135356943e-10
- O 0 4.959809757565381e-06
untranslated O 0 1.4533607100020163e-05
region O 0 7.080977137974287e-09
( O 0 1.3536247643608501e-11
UTR O 0 3.987523200521537e-09
) O 0 2.909348922799232e-13
of O 0 3.0942341245655813e-13
the O 0 2.623173067650697e-10
DM O 1 0.9999978542327881
protein O 0 1.7919409955879928e-08
kinase O 0 2.453831484672264e-07
gene O 0 1.3213372618281483e-08
( O 0 2.434552733021622e-11
DMPK O 0 2.1080861642985838e-06
) O 0 5.5805295280653144e-12
is O 0 2.083865198454493e-11
responsible O 0 1.9412742524593796e-09
for O 0 1.4004626347485782e-09
causing O 0 0.0358625203371048
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 9.18831501621753e-05
DM B-Disease 1 0.9999991655349731
) O 0 2.270403243187502e-08
. O 0 8.144979801727459e-09

Major O 0 1.0470161271314282e-07
instability O 0 6.009847766108578e-06
, O 0 3.891108962816858e-11
with O 0 3.791961536436794e-12
very O 0 1.3138186719108269e-11
large O 0 1.9259005848426547e-11
expansions O 0 1.4019699845491118e-09
between O 0 4.480578408294633e-11
generations O 0 8.610491208926874e-10
and O 0 4.594531421986403e-10
high O 0 1.9797286032741113e-09
levels O 0 2.0865230376809762e-10
of O 0 5.697336591219127e-13
somatic O 0 1.6164023453058007e-09
mosaicism O 0 3.5583960311669216e-07
, O 0 2.896102975491477e-11
is O 0 2.240044608137204e-11
observed O 0 1.718922559845737e-09
in O 0 2.0311180515264482e-10
patients O 0 5.270572867033252e-09
. O 0 2.2185402404062415e-09

There O 0 1.0449886289620736e-08
is O 0 7.671893675897934e-11
a O 0 2.0096910247069388e-11
good O 0 1.5546826326318097e-10
correlation O 0 1.2304612884150856e-09
between O 0 2.8458567100098087e-11
repeat O 0 5.194844732159254e-08
size O 0 1.750151028545588e-07
( O 0 4.445317811768712e-12
at O 0 5.4455957104737607e-11
least O 0 4.317665149022876e-12
in O 0 6.101288311383124e-12
leucocytes O 0 4.684716969904912e-08
) O 0 5.563830104103606e-13
, O 0 2.446732595175194e-13
clinical O 0 1.6555130877282664e-10
severity O 0 1.6241187950072344e-06
and O 0 1.195968324374519e-09
age O 0 2.2494436868747414e-10
of O 0 1.6586855153266633e-11
onset O 0 1.2974253138509084e-07
. O 0 5.773893363425486e-09

The O 0 2.9138767843051028e-08
trinucleotide O 0 1.7014443074003793e-05
repeat O 0 9.95035975392966e-07
instability O 0 1.3578811319803208e-07
mechanisms O 0 3.755997735055416e-09
involved O 0 6.874749103324973e-10
in O 0 3.757516964242313e-09
DM B-Disease 1 0.9999996423721313
and O 0 3.3669251831014435e-09
other O 0 1.0737877947919472e-10
human O 0 1.989454574413685e-07
genetic B-Disease 1 0.9999967813491821
diseases I-Disease 1 0.9999990463256836
are O 0 1.4092469413640174e-08
unknown O 0 9.045955806641359e-08
. O 0 6.797999940744148e-10

We O 0 2.8477780134039676e-08
studied O 0 4.031619038613599e-09
somatic O 0 1.3857218483792622e-08
instability O 0 3.368320733443397e-08
by O 0 1.8794509351605093e-11
measuring O 0 5.257109933154425e-06
the O 0 7.823476588786349e-11
CTG O 0 4.2746381723191007e-07
repeat O 0 9.000708445228156e-08
length O 0 2.4599144943238116e-09
at O 0 5.491803539703355e-11
several O 0 3.5098419396556446e-12
ages O 0 4.5114265101453555e-10
in O 0 1.7158047985882385e-12
various O 0 2.6455701778588248e-12
tissues O 0 1.6403386426944166e-09
of O 0 1.0832328957433024e-12
transgenic O 0 3.849743190897925e-09
mice O 0 1.7992871192973325e-08
carrying O 0 8.41505337634274e-11
a O 0 1.4525383673635872e-10
( O 0 9.474259918262895e-12
CTG O 0 8.557628383698557e-09
) O 0 4.626057566528563e-13
55expansion O 0 1.3297253298460987e-09
surrounded O 0 2.52696696900756e-10
by O 0 3.662936273740591e-12
45 O 0 1.7985218349336751e-12
kb O 0 9.801414124765984e-10
of O 0 4.799929551047022e-12
the O 0 2.584583935760776e-10
human O 0 1.6746787423471687e-07
DM B-Disease 1 0.9999997615814209
region O 0 1.923913650614395e-08
, O 0 2.0040095884826803e-12
using O 0 1.8244532620781406e-11
small O 0 4.839768030784342e-10
- O 0 7.976496476658212e-07
pool O 0 2.3631847057004052e-07
PCR O 0 9.356682539873873e-07
. O 0 3.3405322952262395e-09

These O 0 6.604654601005677e-09
mice O 0 1.4247298167902045e-06
have O 0 2.6572752331865956e-10
been O 0 3.0778622706062464e-11
shown O 0 1.9981186150097585e-10
to O 0 1.4750657292839087e-11
reproduce O 0 4.37842082590123e-08
the O 0 1.703085589221942e-12
intergenerational O 0 1.4804478754015804e-09
and O 0 1.8575689597621903e-11
somatic O 0 7.947454916390484e-10
instability O 0 5.059368479720661e-09
of O 0 8.547220548514589e-13
the O 0 9.364667027944584e-12
55 O 0 1.947695824067175e-11
CTG O 0 4.078224424830523e-09
repeat O 0 3.534839310148641e-09
suggesting O 0 8.2888025332295e-09
that O 0 4.869281193531361e-12
surrounding O 0 3.345394100628951e-11
sequences O 0 1.4426875249995419e-09
and O 0 2.4714201171671668e-11
the O 0 3.1172553687647264e-12
chromatin O 0 1.1363942009623429e-09
environment O 0 6.3243135173252085e-09
are O 0 4.775364999265452e-12
involved O 0 7.375623722882807e-11
in O 0 9.343761181446197e-11
instability O 0 2.481214878002902e-08
mechanisms O 0 2.9389383371380973e-08
. O 0 2.4767878858966696e-09

As O 0 1.4290651995096937e-09
observed O 0 3.191841457805822e-09
in O 0 2.007475565987682e-12
some O 0 1.210188362282122e-13
of O 0 1.4060589715106375e-13
the O 0 9.000519947399699e-12
tissues O 0 1.2223337364503095e-07
of O 0 4.40000702539578e-10
DM B-Disease 1 0.9999998807907104
patients O 0 1.9977896670297923e-07
, O 0 1.4505690919264236e-11
there O 0 8.089432769475824e-12
is O 0 2.5313733314352715e-12
a O 0 5.068575333749825e-12
tendency O 0 4.737141789945554e-10
for O 0 2.2097232897644314e-12
repeat O 0 1.0387329218985997e-08
length O 0 1.306052155314319e-09
and O 0 1.2033694353486002e-11
somatic O 0 6.235147120836615e-11
mosaicism O 0 2.8703033283505874e-09
to O 0 3.303964957526717e-12
increase O 0 3.089190014904375e-11
with O 0 6.8202535632999606e-12
the O 0 5.4916571290419824e-11
age O 0 2.690640210634143e-10
of O 0 4.935781601142497e-13
the O 0 2.292295520067711e-11
mouse O 0 6.584632927797429e-08
. O 0 2.646947105944264e-09

Furthermore O 0 7.171625497903733e-07
, O 0 1.3594106396119798e-10
we O 0 4.4864535697630714e-11
observed O 0 2.1022983354157532e-10
no O 0 9.59391507210361e-12
correlation O 0 1.0780110831776213e-10
between O 0 2.328019721442587e-12
the O 0 3.8309854420714995e-12
somatic O 0 8.93880791608126e-09
mutation O 0 1.0413017434984795e-06
rate O 0 4.2072903738699097e-07
and O 0 1.5462396640852916e-10
tissue O 0 8.607171935182123e-07
proliferation O 0 2.3761201362049178e-07
capacity O 0 2.1223511836865327e-09
. O 0 2.2636209573434485e-10

The O 0 2.5999771224860524e-09
somatic O 0 2.87661407583073e-07
mutation O 0 7.44398448659922e-06
rates O 0 6.882954721731949e-07
in O 0 2.7472574562481533e-11
different O 0 2.928313841410457e-11
tissues O 0 2.2264217136580555e-08
were O 0 1.2064403642764177e-10
also O 0 2.308089656899437e-11
not O 0 6.7783001433951995e-12
correlated O 0 2.4217342020627086e-10
to O 0 2.5927567384731454e-13
the O 0 1.608271783977433e-12
relative O 0 2.6252116036573625e-09
inter O 0 4.5001941062494666e-10
- O 0 6.532418694860098e-08
tissue O 0 1.8580576011117955e-07
difference O 0 2.9556215253023765e-09
in O 0 4.2004079251270476e-13
transcriptional O 0 1.1215486872551139e-10
levels O 0 1.3467853221538206e-10
of O 0 1.823783366081827e-13
the O 0 7.882077152424061e-13
three O 0 3.345309272650976e-12
genes O 0 1.0246916509748516e-10
( O 0 7.648027718944184e-13
DMAHP O 0 2.37871784491972e-08
, O 0 7.909847906870104e-13
DMPK O 0 3.854873753539323e-08
and O 0 2.9076432234154126e-11
59 O 0 3.2345343851242214e-12
) O 0 4.4893999813239854e-14
surrounding O 0 1.5430540525884773e-11
the O 0 3.9680207036818516e-11
repeat O 0 2.8894265824419563e-07
. O 0 1.473989263978126e-10
. O 0 5.359362953427649e-10

A O 0 1.6951499048900587e-07
novel O 0 1.3137584176092787e-07
missense O 0 0.0003988673270214349
mutation O 0 3.0405866709770635e-05
in O 0 2.5469428788227333e-09
patients O 0 5.817147652464882e-09
from O 0 5.014058612751171e-11
a O 0 3.7354008775025704e-09
retinoblastoma B-Disease 0 4.160796743235551e-05
pedigree O 0 0.0001590562314959243
showing O 0 3.364104259162559e-06
only O 0 3.0746602486253494e-10
mild O 0 1.3969792433954353e-08
expression O 0 1.054971443537056e-09
of O 0 5.8370669409057996e-12
the O 0 2.7028254634409166e-10
tumor B-Disease 0 3.9857345655036625e-06
phenotype O 0 1.298771280744404e-06
. O 0 1.42529232860511e-09

We O 0 8.505884352416615e-08
have O 0 5.471989528160748e-11
used O 0 1.12147964526077e-11
single O 0 5.346505529968404e-11
strand O 0 3.082283317468182e-09
conformation O 0 7.651165034872065e-09
polymorphism O 0 1.4063657793883522e-08
analysis O 0 5.928639523755663e-11
to O 0 3.4428614473225316e-12
study O 0 8.463596143371e-12
the O 0 2.8525669239914953e-12
27 O 0 1.873888370862442e-11
exons O 0 4.797771555042907e-11
of O 0 6.695661278026399e-13
the O 0 4.9998290230224285e-11
RB1 O 0 1.9062861156271538e-07
gene O 0 4.6445777779346997e-10
in O 0 4.746017814860615e-12
individuals O 0 2.1738676397181633e-12
from O 0 2.1788116016246972e-12
a O 0 3.7771386018903286e-10
family O 0 4.62649873966825e-09
showing O 0 5.570040229940787e-06
mild O 0 6.502931455543148e-07
expression O 0 6.292116161432659e-09
of O 0 6.35933449996684e-12
the O 0 4.595749336644417e-10
retinoblastoma B-Disease 0 3.078388772337348e-06
phenotype O 0 2.80586368717195e-06
. O 0 7.769874521557085e-09

In O 0 1.5089044458349576e-09
this O 0 3.20786522345351e-11
family O 0 8.842603316239206e-10
affected O 0 4.614378878997627e-10
individuals O 0 3.785538896239338e-11
developed O 0 4.116165186474063e-09
unilateral B-Disease 0 0.0015758647350594401
tumors I-Disease 1 1.0
and O 0 1.2014177741548338e-07
, O 0 2.7029103781550656e-12
as O 0 5.289273793257498e-13
a O 0 3.733842228459405e-12
result O 0 1.6078799749963402e-11
of O 0 3.2928529152508046e-13
linkage O 0 9.943831535963454e-09
analysis O 0 6.525600615425731e-10
, O 0 4.64629203167366e-12
unaffected O 0 3.597970366087111e-09
mutation O 0 9.358949171200948e-09
carriers O 0 1.6485564025003896e-09
were O 0 5.24339738294799e-10
also O 0 1.5915570250601974e-10
identified O 0 1.0281475670836926e-09
within O 0 1.0491572020876472e-11
the O 0 4.7877889153280506e-11
pedigree O 0 1.5547515204161755e-06
. O 0 7.855104344756114e-10

A O 0 9.226148023344649e-08
single O 0 2.132109155894568e-09
band O 0 4.2257430887815417e-10
shift O 0 1.066627064449932e-10
using O 0 2.375998009451763e-11
SSCP O 0 6.79230993227975e-07
was O 0 1.1248526554652472e-09
identified O 0 4.1491349245248443e-10
in O 0 2.845790226732592e-12
exon O 0 5.496052946085683e-09
21 O 0 4.9299151566595256e-11
which O 0 3.8536530737320884e-12
resulted O 0 6.393878482224835e-11
in O 0 4.360701470057515e-12
a O 0 1.1158259732857445e-10
missense O 0 1.0428998393763322e-06
mutation O 0 2.035409174538927e-08
converting O 0 1.214794653758844e-10
a O 0 2.7483382236681564e-10
cys O 0 8.360665560758207e-06
- O 0 2.384210233685735e-07
- O 0 7.130802259780467e-08
> O 0 1.6796611879144052e-09
arg O 0 4.1866091149422857e-10
at O 0 1.0909008071879889e-11
nucleotide O 0 5.047895990095697e-10
position O 0 6.471780888972489e-10
28 O 0 7.638394257380998e-12
in O 0 1.4060302401530667e-12
the O 0 1.544991912183491e-11
exon O 0 1.3676596211098513e-07
. O 0 6.2412937040789984e-09

The O 0 7.807667401493745e-09
mutation O 0 3.5121064456689055e-07
destroyed O 0 4.868334713137301e-08
an O 0 5.2230521990770384e-11
NdeI O 0 3.061362576772808e-07
restriction O 0 4.652675134053652e-09
enzyme O 0 1.6487105014562076e-09
site O 0 5.292513538535104e-09
. O 0 1.3550468525025394e-09

Analysis O 0 2.4014656929693956e-08
of O 0 2.7445129502368104e-11
all O 0 7.978217912707475e-12
family O 0 4.908195030961515e-11
members O 0 8.273417758178359e-13
demonstrated O 0 1.0548984602509748e-10
that O 0 4.821823062356456e-12
the O 0 6.213951662253914e-12
missense O 0 6.744074312337034e-07
mutation O 0 2.515673998004786e-07
co O 0 2.291027101364307e-08
- O 0 6.921301309859018e-09
segregated O 0 1.042062325318227e-09
with O 0 3.3823585599002115e-10
patients O 0 3.6782390466783e-09
with O 0 1.6698935567660556e-08
tumors B-Disease 1 0.9999998807907104
or O 0 5.838564902660437e-07
who O 0 4.9603311680357365e-08
, O 0 1.1394918212129235e-12
as O 0 4.055473405012444e-13
a O 0 6.806815961574175e-12
result O 0 5.956909271409572e-11
of O 0 4.577310752651442e-13
linkage O 0 1.5036762945896953e-08
analysis O 0 1.985143383009813e-09
had O 0 1.4736245557145367e-09
been O 0 3.426670336370563e-10
predicted O 0 4.185890245533841e-10
to O 0 2.5040494851247264e-12
carry O 0 3.8597697260556174e-10
the O 0 4.342510032118163e-11
predisposing O 0 9.093701436313495e-08
mutation O 0 5.887101792723115e-07
. O 0 4.1219552215920885e-09

These O 0 5.237060785034942e-10
observations O 0 6.664687912660838e-09
point O 0 1.6331171137640155e-10
to O 0 1.5032746098278538e-12
another O 0 2.117682765256923e-11
region O 0 5.4018369638475505e-11
of O 0 9.786752571544488e-13
the O 0 4.1497975195037284e-11
RB1 O 0 5.313889772651237e-08
gene O 0 2.583573632808367e-10
where O 0 6.014724829306317e-11
mutations O 0 4.878656922890912e-10
only O 0 1.65209827155538e-12
modify O 0 6.226851673174494e-11
the O 0 8.60540480020211e-13
function O 0 1.0014373878763916e-11
of O 0 6.145207091671004e-14
the O 0 7.904554289762944e-13
gene O 0 8.044078597668758e-11
and O 0 3.4274575365367266e-12
raise O 0 7.838603030552171e-12
important O 0 5.399997940122581e-13
questions O 0 8.060969426681996e-12
for O 0 2.550194755888968e-13
genetic O 0 1.0799620919765829e-10
counseling O 0 7.226058640341648e-11
in O 0 8.055928320260808e-12
families O 0 1.049033082622941e-11
with O 0 1.0728373918411638e-11
these O 0 1.0145034118336227e-10
distinctive O 0 8.724535405235656e-08
phenotypes O 0 1.5967069089128927e-07
. O 0 8.41489308789356e-11
. O 0 6.572305477625662e-10

Maternal B-Disease 0 0.004065883811563253
disomy I-Disease 0 0.004400754347443581
and O 0 0.00010149589797947556
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999995231628418
consistent O 0 2.0724741261801682e-05
with O 0 9.342068785223034e-11
gamete O 0 1.0832788177594921e-07
complementation O 0 2.4772504048087285e-07
in O 0 1.9330327269417857e-11
a O 0 2.983143593260351e-11
case O 0 2.887053929256922e-10
of O 0 3.5474169175070402e-12
familial O 0 4.936057393933879e-07
translocation O 0 3.518674247970921e-06
( O 0 8.491801706256297e-11
3 O 0 8.2329851269769e-11
; O 0 4.160004632436376e-11
15 O 0 3.215810603918179e-11
) O 0 1.044123880238057e-12
( O 0 3.8174747651192886e-13
p25 O 0 9.417296803482245e-11
; O 0 2.875767983120947e-12
q11 O 0 4.890293170412008e-10
. O 0 4.486288510824332e-12
2 O 0 1.567927732093466e-11
) O 0 8.904420603639274e-12
. O 0 1.890662487680217e-10

Maternal B-Disease 0 0.02647092007100582
uniparental I-Disease 1 0.6065834760665894
disomy I-Disease 0 0.02093341574072838
( I-Disease 0 1.6720766993216785e-08
UPD I-Disease 1 0.9998308420181274
) I-Disease 0 1.9385156674323056e-11
for I-Disease 0 3.8135614457979194e-12
chromosome I-Disease 0 4.712211421065149e-07
15 I-Disease 0 5.543328296386818e-11
is O 0 9.195211432555528e-12
responsible O 0 4.319429883214987e-11
for O 0 1.4272509226993108e-13
an O 0 1.0122056594589687e-13
estimated O 0 3.3220123700494764e-12
30 O 0 3.755137748060605e-13
% O 0 8.593082842511812e-14
of O 0 4.4130527682671727e-13
cases O 0 8.894889269583928e-10
of O 0 5.585310418609879e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
( O 0 3.5447872051008744e-06
PWS B-Disease 1 0.9999910593032837
) O 0 9.849525639538115e-09
. O 0 3.9831902221010296e-09

We O 0 9.33217876308845e-08
report O 0 1.183229764167848e-10
on O 0 2.1007850407178674e-12
an O 0 3.4495294804186977e-14
unusual O 0 5.604575831208436e-11
case O 0 8.327650374839735e-11
of O 0 3.154229264931696e-12
maternal B-Disease 0 1.4197341613453318e-07
disomy I-Disease 0 7.307691021196661e-07
15 I-Disease 0 6.071143587860206e-11
in O 0 1.2034961915929898e-10
PWS B-Disease 1 0.9999920129776001
that O 0 1.6331118679602241e-09
is O 0 7.246456906750964e-11
most O 0 7.08604344906022e-13
consistent O 0 2.5937793579622337e-10
with O 0 2.7426119101475743e-12
adjacent O 0 2.83397944000896e-10
- O 0 3.688807481694312e-08
1 O 0 3.571390752576953e-11
segregation O 0 1.492291706872706e-10
of O 0 4.047683683453679e-13
a O 0 7.614948949186129e-11
paternal O 0 3.376310075964284e-07
t O 0 1.341656883369069e-07
( O 0 5.623308351083989e-13
3 O 0 7.931361188477648e-13
; O 0 1.1039152448058531e-12
15 O 0 1.8422615863378233e-12
) O 0 8.246677537897262e-14
( O 0 3.992947194674662e-14
p25 O 0 1.9329590011940567e-11
; O 0 3.6166227890092884e-13
q11 O 0 4.1422535540514005e-11
. O 0 2.288331199876148e-13
2 O 0 2.943676931984468e-13
) O 0 5.734992423447535e-14
with O 0 7.394985231806706e-13
simultaneous O 0 5.283859572102756e-09
maternal O 0 1.8353038058194215e-06
meiotic O 0 9.018217497214209e-07
nondisjunction O 0 1.5976040685927728e-06
for O 0 9.875644746415446e-11
chromosome O 0 1.4257982456911122e-06
15 O 0 5.193441787731956e-10
. O 0 1.250016978815438e-09

The O 0 1.0972504682627005e-08
patient O 0 7.416345511046529e-07
( O 0 7.730147078000016e-11
J O 0 2.0988180040149018e-05
. O 0 1.4204175335930103e-10
B O 0 6.8756702553685045e-09
. O 0 8.521029476633857e-13
) O 0 6.934735988575746e-14
, O 0 2.108723589353597e-14
a O 0 2.824015977662131e-12
17 O 0 9.96798997510151e-12
- O 0 1.9779924365082024e-09
year O 0 1.1875642136338627e-10
- O 0 1.7978429411869e-08
old O 0 3.05791303389924e-08
white O 0 4.8120021745035046e-08
male O 0 1.4662403735599128e-08
with O 0 4.842159451179384e-10
PWS B-Disease 1 0.9999815225601196
, O 0 5.953876280884174e-11
was O 0 2.079332123150479e-10
found O 0 1.927980865235046e-11
to O 0 1.848766582532302e-12
have O 0 1.9199379586165577e-10
47 O 0 1.9669632242425017e-11
chromosomes O 0 3.3925345865881695e-10
with O 0 3.2185643039639444e-12
a O 0 2.2268525912139125e-10
supernumerary O 0 3.8781786315666977e-07
, O 0 4.663127523008015e-11
paternal O 0 2.3142033001022355e-07
der O 0 0.001504952204413712
( O 0 1.708226615715347e-11
15 O 0 1.0452856028658752e-12
) O 0 3.795966633472064e-14
consisting O 0 1.064961161791056e-12
of O 0 1.8094602422316641e-12
the O 0 6.967414839520458e-11
short O 0 2.3897046119714105e-08
arm O 0 2.4231189854617696e-07
and O 0 5.475570691304554e-11
the O 0 4.532605193952044e-12
proximal O 0 1.8037646043467248e-08
long O 0 5.101406941321329e-08
arm O 0 2.619731560571381e-07
of O 0 1.6225536539349328e-11
chromosome O 0 9.032186198965064e-07
15 O 0 9.872405670741102e-11
, O 0 5.914800767226058e-12
and O 0 2.5991972463224045e-10
distal O 0 2.3138571123126894e-05
chromosome O 1 0.8329889178276062
arm O 0 0.0019748322665691376
3p O 0 0.0003750474425032735
. O 0 3.606677623224641e-08

The O 0 1.1211369610464317e-08
t O 0 2.8666184448411514e-07
( O 0 3.055551471564666e-12
3 O 0 1.7181005966884766e-12
; O 0 2.6219501830099246e-12
15 O 0 8.573000707771949e-13
) O 0 1.3449915551959346e-13
was O 0 6.040361960613083e-11
present O 0 7.729422137059405e-12
in O 0 1.4672949270530533e-12
the O 0 1.1904498654208284e-12
balanced O 0 1.4188152874794469e-09
state O 0 8.583934778261249e-12
in O 0 3.1572689341424764e-12
the O 0 3.140567667037075e-11
patients O 0 4.868348502107267e-10
father O 0 9.310681114982344e-09
and O 0 1.8247393873682682e-10
a O 0 1.1765420859788378e-09
sister O 0 1.891515694296686e-06
. O 0 5.912362155413575e-09

Fluorescent O 0 3.5963371374236885e-06
in O 0 8.988040312019052e-10
situ O 0 9.033727543794612e-09
hybridization O 0 6.729882762179784e-10
analysis O 0 7.411121161204903e-10
demonstrated O 0 1.2557090922626912e-09
that O 0 2.586200351095691e-11
the O 0 1.261448168143886e-10
PWS B-Disease 1 0.999972939491272
critical O 0 5.077775533379736e-09
region O 0 7.746667751717951e-10
resided O 0 1.059326737440358e-09
on O 0 1.4733251077481135e-11
the O 0 5.73146293880028e-13
derivative O 0 1.1880223471649742e-09
chromosome O 0 7.11257008845223e-09
3 O 0 5.774776924011293e-12
and O 0 1.636683844008502e-11
that O 0 3.578461485465034e-11
there O 0 9.615554880104682e-11
was O 0 2.239683771776413e-09
no O 0 7.460501660894181e-11
deletion O 0 2.3731325238252055e-10
of O 0 7.036483375133518e-12
the O 0 2.63209054551794e-09
PWS B-Disease 1 0.999995231628418
region O 0 5.5412407995447666e-09
on O 0 6.845335409622066e-10
the O 0 2.6702093661179482e-11
normal O 0 1.963032791874042e-10
pair O 0 8.475785628903054e-10
of O 0 1.3376701005554659e-12
15s O 0 5.209593867405715e-10
present O 0 8.947873691989017e-11
in O 0 1.0977816433666021e-09
J O 0 0.00011067089508287609
. O 0 7.39184136122617e-09

B O 0 0.00021972447575535625
. O 0 4.21886170443031e-07

Methylation O 0 6.100014502408158e-07
analysis O 0 2.1506942005089513e-08
at O 0 2.7198029939334845e-10
exon O 0 2.2557176126980494e-09
alpha O 0 1.8490295405904078e-10
of O 0 2.195472970090151e-12
the O 0 1.0310333316276843e-11
small O 0 2.219365580202748e-09
nuclear O 0 2.726857019297313e-05
ribonucleoprotein O 0 0.00014855731569696218
- O 0 1.2106609574402682e-05
associated O 0 6.152777842771684e-08
polypeptide O 0 7.408449960166763e-07
N O 0 9.726916232466465e-07
( O 0 4.592117051199773e-12
SNRPN O 0 2.4899476258610775e-08
) O 0 8.015766327605645e-13
gene O 0 3.3346614358720217e-10
showed O 0 9.934105982267738e-09
a O 0 2.1614580958395635e-10
pattern O 0 2.6329360025556525e-07
characteristic O 0 6.15938802184246e-08
of O 0 1.0766373686674213e-12
only O 0 1.5466990535561997e-11
the O 0 8.269371298830208e-11
maternal O 0 1.7431096921427525e-06
chromosome O 0 9.329222052656405e-07
15 O 0 1.8111367960926827e-10
in O 0 4.658524677125797e-10
J O 0 0.0012042942689731717
. O 0 2.0180447535267376e-08

B O 0 0.0002239258319605142
. O 0 1.1585322567952971e-07

Maternal B-Disease 0 0.0020186861511319876
disomy I-Disease 0 0.00011473035556264222
was O 0 1.6153274273733587e-08
confirmed O 0 2.1101037583903803e-10
by O 0 1.863195578724608e-12
polymerase O 0 7.482737207631374e-10
chain O 0 2.0569524750158052e-08
reaction O 0 2.8767527249229374e-10
analysis O 0 2.3628559178701103e-11
of O 0 5.512471989294054e-13
microsatellite O 0 5.3190710502803995e-08
repeats O 0 3.672835546808528e-08
at O 0 1.4770146217202296e-10
the O 0 6.857638588930737e-12
gamma O 0 7.83042963803382e-08
- O 0 1.437332883824638e-07
aminobutyric O 0 3.7007251307841216e-07
acid O 0 1.9894603742187655e-09
receptor O 0 1.852776154720459e-09
beta3 O 0 1.974898289347493e-08
subunit O 0 4.00380217868701e-09
( O 0 8.498914072507802e-11
GABRB3 O 0 4.735109371267754e-07
) O 0 7.417481906468737e-11
locus O 0 1.2970171781034878e-07
. O 0 1.0580691878203652e-08

A O 0 4.0646452248438436e-07
niece O 0 7.332144741667435e-05
( O 0 3.9362499371087267e-10
B O 0 3.978120588499223e-08
. O 0 9.953759171066334e-12
B O 0 5.368304134556467e-10
. O 0 8.114830422206731e-14
) O 0 4.326652341387965e-15
with O 0 1.5806002069251174e-13
45 O 0 8.797168722651794e-13
chromosomes O 0 5.1358032410186993e-11
and O 0 3.417489381762895e-12
the O 0 9.251712894051134e-13
derivative O 0 2.0893515806363894e-09
3 O 0 9.873679998606555e-12
but O 0 4.6562663447158315e-11
without O 0 2.6365848740383946e-11
the O 0 1.1764937982161605e-11
der O 0 1.8634944353834726e-05
( O 0 5.7116368926135586e-12
15 O 0 2.5615154528729756e-12
) O 0 2.2437325435109567e-13
demonstrated O 0 9.821470026150081e-11
a O 0 2.581268532253489e-10
phenotype O 0 9.17894794838503e-07
consistent O 0 6.058670720676673e-08
with O 0 3.855596050761356e-11
that O 0 2.7830590609845274e-10
reported O 0 7.986386552083502e-10
for O 0 9.876822667023721e-13
haploinsufficiency O 0 1.0229411095963314e-08
of O 0 5.534915841626242e-12
distal O 0 8.451498700878801e-08
3 O 0 2.1837003316704795e-08
p O 0 1.8562896002549678e-05
. O 0 1.4179610374753793e-08

Uniparental B-Disease 1 0.9998887777328491
disomy I-Disease 1 0.9998602867126465
associated O 0 3.3014698601618875e-06
with O 0 7.959530257117819e-10
unbalanced O 0 4.2652234810702794e-07
segregation O 0 8.439815069039014e-09
of O 0 9.914877946437528e-12
non O 0 1.1496229523899615e-09
- O 0 8.40774916355258e-08
Robertsonian O 0 9.14088076342523e-08
translocations O 0 1.2428199624991976e-06
has O 0 1.0958967067153935e-09
been O 0 1.0078668455371087e-10
reported O 0 6.192094059720432e-10
previously O 0 2.143909494378704e-10
but O 0 2.923895014994571e-10
has O 0 3.678944301976905e-11
not O 0 3.496838669320157e-12
, O 0 4.230960742347689e-14
to O 0 1.013428436221625e-13
our O 0 9.38134726152784e-12
knowledge O 0 3.889518915278778e-12
, O 0 4.014039805839281e-13
been O 0 2.7908928640352215e-11
observed O 0 1.5198566016838555e-10
in O 0 1.2523944555031807e-12
a O 0 2.9068891391204055e-11
case O 0 1.984287845147037e-09
of O 0 1.3362925210813614e-09
PWS B-Disease 1 0.9999604225158691
. O 0 6.295216081753097e-08

Furthermore O 0 2.321707142982632e-06
, O 0 2.444478786056692e-10
our O 0 1.9170326437389917e-10
findings O 0 5.462677185597009e-11
are O 0 1.844149399160555e-12
best O 0 7.755737892189973e-12
interpreted O 0 3.1921302406923147e-11
as O 0 1.0537210210284642e-12
true O 0 1.4366456635439562e-10
gamete O 0 1.2906005153467959e-08
complementation O 0 2.554338962568181e-08
resulting O 0 2.3225237288926337e-09
in O 0 1.2676958371926617e-09
maternal B-Disease 0 0.0007932033040560782
UPD I-Disease 1 0.9999889135360718
15 I-Disease 0 5.8431940175296404e-08
and O 0 4.868994665230275e-07
PWS B-Disease 1 0.9999536275863647

Schwartz B-Disease 0 0.22029772400856018
- I-Disease 1 0.9718903303146362
Jampel I-Disease 1 0.991411566734314
syndrome I-Disease 1 0.9998171925544739
type I-Disease 0 8.68372808326967e-06
2 I-Disease 0 2.7493305410075664e-09
and O 0 1.7762197046522488e-08
Stuve B-Disease 1 0.9170589447021484
- I-Disease 1 0.9999662637710571
Wiedemann I-Disease 1 0.9999794960021973
syndrome I-Disease 1 0.9999566078186035
: O 0 5.6199364606435154e-11
a O 0 4.1005907003288655e-11
case O 0 4.756970373165359e-10
for O 0 6.0306429988665755e-12
" O 0 2.2240044528221148e-10
lumping O 0 1.9899813352708406e-08
" O 0 1.2088756662365086e-09
. O 0 3.1540400846630234e-10

Recent O 0 5.7396277952648234e-08
studies O 0 3.0279521112674956e-09
demonstrated O 0 1.7890815495746892e-09
the O 0 5.075947474841858e-12
existence O 0 1.0422804980203537e-10
of O 0 7.866127454264626e-13
a O 0 3.798326236870153e-11
genetically O 0 3.3456257209074636e-10
distinct O 0 1.507232533226599e-10
, O 0 4.1885058789381535e-12
usually O 0 6.768343524532483e-11
lethal O 0 4.521244489907872e-11
form O 0 3.5587409755177823e-12
of O 0 1.017591393093209e-12
the O 0 3.5775898910017645e-10
Schwartz B-Disease 0 0.0022255629301071167
- I-Disease 1 0.9964726567268372
Jampel I-Disease 1 0.9988507032394409
syndrome I-Disease 1 0.9997665286064148
( O 0 5.774573597072674e-10
SJS B-Disease 0 0.0005097519024275243
) O 0 2.6477826875481725e-11
of O 0 6.826308962537553e-11
myotonia B-Disease 0 0.06669344753026962
and O 0 1.659046233726258e-07
skeletal B-Disease 0 0.10136644542217255
dysplasia I-Disease 1 0.6324437260627747
, O 0 1.1866997384757383e-09
which O 0 7.218182163093445e-10
we O 0 2.2270534305590672e-09
called O 0 5.4453517250863115e-09
SJS B-Disease 0 0.01869497448205948
type I-Disease 0 1.491305170020496e-06
2 I-Disease 0 4.169875555959379e-09
. O 0 3.3239186958411437e-09

This O 0 1.1159765023194268e-07
disorder O 0 7.762570021441206e-05
is O 0 3.235308687621341e-10
reminiscent O 0 7.176538474595873e-08
of O 0 8.526154608723413e-12
another O 0 4.1885100943162e-10
rare O 0 1.41616155246993e-07
condition O 0 3.1312470127886627e-06
, O 0 1.1036168506839417e-11
the O 0 1.6704429506297913e-10
Stuve B-Disease 0 0.12399671226739883
- I-Disease 1 0.999900221824646
Wiedemann I-Disease 1 0.9999675750732422
syndrome I-Disease 1 0.9999637603759766
( O 0 2.4466069170614446e-09
SWS B-Disease 0 0.00011872161121573299
) O 0 2.6382247081402355e-11
, O 0 1.0684178151573742e-12
which O 0 1.3348952151992499e-11
comprises O 0 8.49918573020414e-12
campomelia B-Disease 0 3.163140718243085e-07
at O 0 4.3251309200798005e-09
birth O 0 8.318105670923615e-08
with O 0 7.733720330804772e-10
skeletal B-Disease 0 0.33105748891830444
dysplasia I-Disease 1 0.522921621799469
, O 0 2.0335300110474464e-09
contractures B-Disease 0 0.0021283591631799936
, O 0 1.5702929234695517e-10
and O 0 1.307764035951564e-10
early B-Disease 0 2.9443008031648787e-09
death I-Disease 0 1.3016514799346623e-07
. O 0 5.90834936531337e-09

To O 0 5.630110266885424e-10
test O 0 5.194816452003259e-11
for O 0 3.9930710647728684e-13
possible O 0 7.489244641112336e-11
nosologic O 0 1.0227888651570538e-06
identity O 0 1.076539248856534e-07
between O 0 2.2588336756612648e-10
these O 0 3.499644463111906e-10
disorders O 0 8.838410394673701e-07
, O 0 2.02690533628036e-12
we O 0 3.698832906628979e-12
reviewed O 0 2.9706220122660554e-12
the O 0 3.024171082825766e-13
literature O 0 1.3529117062760498e-12
and O 0 1.8199505758768192e-13
obtained O 0 6.329755513137525e-13
a O 0 7.178191418003022e-13
follow O 0 1.7993796556925457e-12
- O 0 1.1787269771357245e-10
up O 0 5.203362046790616e-12
of O 0 3.7633812759911914e-14
the O 0 1.8659080086146779e-13
only O 0 1.9167042356483394e-13
two O 0 3.098427276467669e-13
surviving O 0 3.1600391192654342e-09
patients O 0 5.979802070177342e-11
, O 0 1.6838693796521892e-13
one O 0 1.0471893534605425e-12
with O 0 2.3321717820823373e-11
SJS B-Disease 0 2.766990292002447e-06
type I-Disease 0 8.511982230174908e-09
2 I-Disease 0 5.714513497817597e-12
at O 0 9.243291548832744e-11
age O 0 1.1947479117146997e-10
10 O 0 7.752065591011548e-13
years O 0 5.7718586854438314e-12
and O 0 2.8640048232303483e-12
another O 0 4.480405196155557e-12
with O 0 1.829395246399912e-10
SWS B-Disease 0 8.699659701960627e-06
at O 0 1.2478967859053114e-09
age O 0 6.813499209279428e-10
7 O 0 5.548966494628438e-11
years O 0 9.852878929406117e-11
. O 0 7.216998665349195e-10

Patients O 0 1.870293817773927e-05
reported O 0 1.2673487503889191e-07
as O 0 1.815667755034056e-10
having O 0 2.2857413739529875e-08
either O 0 3.236014663343667e-06
neonatal O 1 0.9999260902404785
SJS B-Disease 1 0.9994426369667053
or O 0 2.6820484322342963e-07
SWS B-Disease 0 3.732210097950883e-05
presented O 0 4.852292456725138e-10
a O 0 1.4410111992546604e-11
combination O 0 2.287710298976009e-10
of O 0 2.196369388446362e-12
a O 0 3.096141565350763e-09
severe O 0 1.3166401004127692e-05
, O 0 1.1654083253986869e-09
prenatal O 0 0.4516617953777313
- O 1 0.9703787565231323
onset O 0 0.06806483119726181
neuromuscular B-Disease 1 0.9995871186256409
disorder I-Disease 1 0.9979875087738037
( O 0 2.3809225702109416e-09
with O 0 1.541168757057676e-07
congenital B-Disease 1 0.9999802112579346
joint I-Disease 0 0.021193623542785645
contractures I-Disease 1 0.999988317489624
, O 0 8.368315320694819e-06
respiratory O 1 0.8338752388954163
and O 0 9.028887859585666e-09
feeding O 0 6.557879146384948e-07
difficulties O 0 1.5541422726528253e-07
, O 0 1.0109216415365996e-11
tendency O 0 3.589359365285816e-10
to O 0 1.7534119989282004e-11
hyperthermia B-Disease 0 9.380911251355428e-06
, O 0 4.596930822109435e-11
and O 0 2.3111292393740435e-11
frequent O 0 2.7581453565517222e-08
death O 0 1.287033228436485e-06
in O 0 1.4655994196033362e-09
infancy O 0 1.4122126401616697e-07
) O 0 3.120043557281599e-13
with O 0 8.683557887502469e-13
a O 0 1.601190846578504e-10
distinct O 0 6.541704955509431e-09
campomelic B-Disease 0 7.532236486440524e-05
- I-Disease 0 0.0005467244773171842
metaphyseal I-Disease 0 0.000993268215097487
skeletal I-Disease 0 0.03937448188662529
dysplasia I-Disease 0 0.06366349756717682
. O 0 5.113271939194419e-08

The O 0 6.689544473914566e-10
similarity O 0 1.749899003478106e-09
of O 0 2.375715943414569e-12
the O 0 1.4855094584986794e-11
clinical O 0 1.1178651337928613e-09
and O 0 1.7901900795092018e-10
radiographic O 0 4.005467417300679e-05
findings O 0 1.948728112211029e-08
is O 0 3.1913145737139104e-11
so O 0 5.440142693963201e-12
extensive O 0 3.389809960507861e-11
that O 0 2.9857309957748157e-09
these O 0 7.736715712525211e-10
disorders O 0 1.3742375131187146e-06
appear O 0 6.920469974858179e-09
to O 0 5.3774325270428136e-11
be O 0 6.372186667213953e-10
a O 0 2.4750962390740483e-10
single O 0 1.9494233782779702e-08
entity O 0 9.806414880131342e-08
. O 0 3.3778535524220388e-09

The O 0 7.896429621290224e-10
follow O 0 3.902170253589077e-10
- O 0 1.0964178898120736e-08
up O 0 1.9059308298263744e-10
observation O 0 5.5855320368891626e-09
of O 0 1.8967503349204273e-12
an O 0 5.284396184523921e-12
identical O 0 3.409027158340905e-07
and O 0 6.42461153721463e-11
unique O 0 4.194591896045097e-11
pattern O 0 6.7295395922428725e-09
of O 0 6.571771772601043e-12
progressive O 0 2.569235277860571e-07
bone B-Disease 0 0.0007019058102741838
dysplasia I-Disease 0 0.0002947504981420934
in O 0 1.6931246682450052e-10
the O 0 1.1053716969522398e-11
two O 0 1.8648543820276586e-10
patients O 0 1.8278789593040301e-09
( O 0 1.0442255784018362e-12
one O 0 1.3525795067304003e-11
with O 0 6.338342628531279e-10
SJS B-Disease 0 0.00289138569496572
type I-Disease 0 2.455962430758518e-06
2 I-Disease 0 1.4179109275591628e-10
, O 0 4.234824296789341e-12
one O 0 1.5548390699948733e-11
with O 0 2.4028012912680197e-10
SWS B-Disease 0 1.165063713415293e-05
) O 0 2.6817480527907556e-12
surviving O 0 1.4348335852787386e-09
beyond O 0 2.3353436962025853e-09
infancy O 0 1.4355734379023488e-08
adds O 0 1.5772508299427557e-10
to O 0 2.928310805644374e-13
the O 0 1.1313533660253783e-12
evidence O 0 9.264118638885321e-11
in O 0 5.328870157639276e-12
favor O 0 1.9971498413373645e-11
of O 0 1.0513065244743824e-11
identity O 0 1.5110384765648632e-07
. O 0 1.5828329757994197e-09

The O 0 3.4818823380078356e-09
hypothesis O 0 8.987431243667743e-08
that O 0 5.83776305074224e-10
SWS B-Disease 0 1.7138452676590532e-05
and O 0 3.1505422715127906e-09
SJS B-Disease 0 0.00036691103014163673
type I-Disease 0 5.321831508808827e-07
2 I-Disease 0 5.5339680754551424e-11
are O 0 9.293138307497895e-12
the O 0 1.089175191010261e-11
same O 0 1.888519918225029e-08
disorder O 0 9.512127121524827e-07
should O 0 2.9673352663905916e-10
be O 0 1.3457421808860115e-11
testable O 0 2.077231164854254e-10
by O 0 1.823092241406976e-12
molecular O 0 1.5185214197188657e-09
methods O 0 9.236545972512999e-10
. O 0 5.0095465969901554e-11
. O 0 6.471496671878185e-10

A O 0 6.191567791802299e-08
mouse O 0 5.241133749223081e-07
model O 0 2.961967027204082e-07
of O 0 2.693841949508169e-08
severe O 1 0.999038815498352
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.11488346755504608
defects O 1 0.9999122619628906
in O 0 8.146164276467971e-08
hemostasis O 0 0.4074374735355377
and O 0 4.2481269701966085e-06
thrombosis B-Disease 1 0.6774668097496033
. O 0 2.124580333884296e-07

von B-Disease 0 0.2513183355331421
Willebrand I-Disease 1 0.7566238045692444
factor I-Disease 0 1.714193422230892e-05
( I-Disease 0 6.12658155318968e-08
vWf I-Disease 0 0.0005762815126217902
) I-Disease 0 1.9892015643563354e-06
deficiency I-Disease 1 0.9991458654403687
causes O 0 0.2721219062805176
severe O 1 0.9998989105224609
von B-Disease 1 1.0
Willebrand I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
in O 0 2.170629613829078e-06
humans O 0 1.3958119779999834e-06
. O 0 1.807508098750077e-08

We O 0 4.036404988028153e-09
generated O 0 1.474914496091273e-10
a O 0 1.0389851305692144e-11
mouse O 0 6.256549500704978e-09
model O 0 4.798481167966884e-09
for O 0 7.365470212905567e-12
this O 0 1.1319890858008108e-10
disease O 0 2.2965997992230314e-09
by O 0 5.918769706118876e-13
using O 0 2.1166339514433474e-10
gene O 0 1.7253046769027947e-09
targeting O 0 3.2111390879663304e-08
. O 0 2.8051663214512246e-09

vWf B-Disease 0 0.009226960130035877
- I-Disease 0 0.4874584674835205
deficient I-Disease 0 0.03844759240746498
mice O 0 6.372926873154938e-05
appeared O 0 1.7691270670638914e-07
normal O 0 1.9940165074672223e-08
at O 0 8.810027707362167e-10
birth O 0 3.675008031223115e-08
; O 0 1.7662543302932043e-11
they O 0 2.3805023924294844e-11
were O 0 4.482980653364166e-11
viable O 0 1.0293131902372465e-09
and O 0 5.169436545493511e-10
fertile O 0 4.800305219987422e-08
. O 0 2.976939583732019e-09

Neither O 0 5.880296157556586e-05
vWf O 0 0.0004327452916186303
nor O 0 1.5570838513667695e-05
vWf O 0 5.51499797438737e-05
propolypeptide O 0 6.993355782469735e-05
( O 0 5.932514035578151e-09
von B-Disease 0 0.00042700915946625173
Willebrand I-Disease 0 0.0025097369216382504
antigen O 0 0.00018841818382497877
II O 0 0.00034525187220424414
) O 0 1.2913133062841808e-10
were O 0 4.757614302519642e-10
detectable O 0 3.5519715311238542e-06
in O 0 3.962099051624257e-11
plasma O 0 1.598145047410071e-07
, O 0 5.535382568977454e-11
platelets O 0 3.917937974051711e-09
, O 0 4.647107351707369e-12
or O 0 2.230256257451657e-11
endothelial O 0 1.2503811874786663e-10
cells O 0 2.182131385308761e-11
of O 0 3.8317290421314987e-13
the O 0 1.5042878401261284e-11
homozygous O 0 1.0843202744581504e-06
mutant O 0 1.411166863363178e-06
mice O 0 6.689213478239253e-06
. O 0 4.900370775828833e-09

The O 0 3.7832492694178654e-08
mutant O 0 1.8583054043119773e-05
mice O 0 0.003299520118162036
exhibited O 0 0.0025940840132534504
defects O 1 0.9818520545959473
in O 0 6.455950218864359e-10
hemostasis O 0 3.59038713213522e-05
with O 0 9.222199115477281e-10
a O 0 1.427472362536264e-08
highly O 0 1.292363776883576e-06
prolonged O 0 0.0003966377698816359
bleeding O 0 0.008378488011658192
time O 0 4.754932003692147e-09
and O 0 3.4459590736446444e-10
spontaneous O 0 1.9889606406309213e-08
bleeding O 0 2.6461214019946055e-06
events O 0 2.1809258565763656e-10
in O 0 7.529416326534921e-12
approximately O 0 5.661505986243043e-12
10 O 0 4.8369849792173625e-12
% O 0 3.7971726457586286e-12
of O 0 5.067292765947862e-11
neonates O 0 0.00017776191816665232
. O 0 1.809598515478683e-08

As O 0 1.2734733267905085e-09
in O 0 3.5172354612145185e-11
the O 0 1.986080397364809e-11
human O 0 1.5031822453437371e-09
disease O 0 3.7751977544076e-08
, O 0 2.69713071321398e-13
the O 0 4.162389562797214e-13
factor O 0 2.8239955512932013e-11
VIII O 0 3.4173504559475987e-07
level O 0 1.0698413710485966e-08
in O 0 9.977043496922633e-12
these O 0 2.434947382612407e-11
mice O 0 5.353248866413196e-08
was O 0 6.677586816827841e-10
reduced O 0 1.7996663881358899e-10
strongly O 0 1.954123113323547e-10
as O 0 1.0547143670588954e-12
a O 0 5.294605899541782e-12
result O 0 5.237018457782128e-11
of O 0 3.3892374041825934e-13
the O 0 7.891678630023158e-12
lack O 0 1.4561694905435019e-10
of O 0 1.1644156775944547e-12
protection O 0 2.8736271695528615e-10
provided O 0 2.7321500964405665e-11
by O 0 7.108535288180562e-11
vWf O 0 1.99797639766075e-07
. O 0 3.0008604490205926e-09

Defective O 0 0.21733252704143524
thrombosis B-Disease 0 0.1382981687784195
in O 0 1.6422335491483864e-08
mutant O 0 3.3563587749085855e-06
mice O 0 7.223298598546535e-05
was O 0 1.8241850341382815e-07
also O 0 3.624874012064794e-10
evident O 0 5.820632864583786e-09
in O 0 5.2052776151889635e-12
an O 0 6.696376309359153e-13
in O 0 2.4568831344384812e-11
vivo O 0 1.7498932081139174e-08
model O 0 2.6822946086468846e-09
of O 0 5.794628665789503e-11
vascular B-Disease 0 0.0005259327008388937
injury I-Disease 0 0.003983051050454378
. O 0 5.8830952553989846e-08

In O 0 4.8653987505531404e-09
this O 0 4.242369303075755e-11
model O 0 2.7453324058512862e-09
, O 0 5.708892126393694e-12
the O 0 6.746532152379636e-12
exteriorized O 0 2.9999296202731784e-07
mesentery O 0 2.140234300895827e-06
was O 0 1.9527492955973003e-09
superfused O 0 1.836581553504857e-08
with O 0 2.5161586356126087e-11
ferric O 0 2.950626765141351e-08
chloride O 0 1.8877635454828123e-08
and O 0 3.622998775987263e-11
the O 0 2.8552288571653817e-12
accumulation O 0 5.362849608836484e-10
of O 0 3.0939289758641353e-12
fluorescently O 0 1.8444912939230562e-06
labeled O 0 5.969395147076284e-07
platelets O 0 9.096407893594005e-08
was O 0 2.280914790375732e-09
observed O 0 6.020650089588742e-10
by O 0 2.407056845510347e-11
intravital O 0 2.3316289343711105e-07
microscopy O 0 1.475209217005613e-07
. O 0 1.720247611025627e-09

We O 0 4.5989018815362215e-08
conclude O 0 2.173974555930158e-09
that O 0 1.4973232723147767e-11
these O 0 6.248585416451791e-12
mice O 0 1.1129194454895242e-08
very O 0 5.366707078735544e-10
closely O 0 1.677904890584614e-07
mimic O 0 0.00019751697254832834
severe O 0 9.134118590736762e-05
human O 0 2.4168413801817223e-05
von B-Disease 1 0.9999998807907104
Willebrand I-Disease 1 0.9999971389770508
disease I-Disease 1 1.0
and O 0 9.448054356653302e-07
will O 0 2.318130221112824e-08
be O 0 7.273199820190257e-10
very O 0 1.023212677780938e-11
useful O 0 4.524243826797836e-12
for O 0 7.380664953987245e-14
investigating O 0 2.4928567890492026e-11
the O 0 6.70445361554417e-13
role O 0 6.173537809434082e-12
of O 0 3.077964586765264e-13
vWf O 0 8.365288461931186e-10
in O 0 4.584287463527126e-11
normal O 0 2.728341108593213e-09
physiology O 0 7.113710065453915e-09
and O 0 4.458031166443277e-11
in O 0 2.483897254546008e-10
disease O 0 1.5782214646264947e-08
models O 0 4.510800621915223e-09
. O 0 6.816992803582167e-11
. O 0 8.118113403732252e-10

Oral O 0 9.025396138895303e-05
contraceptives O 0 0.0031429182272404432
and O 0 2.646381780380125e-09
the O 0 2.9343366625411704e-10
risk O 0 3.5909832263314456e-07
of O 0 1.3471952442500879e-08
hereditary B-Disease 1 0.9999947547912598
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 1.525592142570531e-05

Hereditary B-Disease 1 0.9999210834503174
Ovarian I-Disease 1 0.9999821186065674
Cancer I-Disease 1 0.9970390796661377
Clinical O 0 0.0001381200854666531
Study O 0 3.398736794224533e-07
Group O 0 8.228726500192352e-08
. O 0 1.1283859180366562e-08

BACKGROUND O 0 0.000209169476875104
Women O 0 1.1704300639792109e-08
with O 0 6.862614643221576e-11
mutations O 0 1.4095049571949403e-08
in O 0 1.9516452690049313e-11
either O 0 1.6432627480966744e-10
the O 0 1.0387438825754103e-10
BRCA1 O 0 4.34313420782928e-07
or O 0 1.169550234436656e-09
the O 0 8.778756888094819e-11
BRCA2 O 0 1.852138069580178e-07
gene O 0 1.0592848376234087e-08
have O 0 2.402370524734465e-10
a O 0 3.1507810249742363e-10
high O 0 2.6839794387001348e-08
lifetime O 0 7.78419064317859e-07
risk O 0 1.5902377299426007e-06
of O 0 3.8932830648263916e-07
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999992847442627
. O 0 1.3578491007137927e-06

Oral O 0 7.086130790412426e-05
contraceptives O 0 0.03221510350704193
protect O 0 2.229583878943231e-05
against O 0 0.003255525603890419
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
in O 0 2.8594566714446046e-09
general O 0 6.806793323432814e-11
, O 0 1.0533056198080981e-11
but O 0 5.528007565591686e-11
it O 0 5.409102853126679e-12
is O 0 1.7071477695015935e-12
not O 0 9.637781024640635e-13
known O 0 1.3446818528453641e-12
whether O 0 6.722156165039905e-11
they O 0 6.752921138941659e-11
also O 0 4.8937034979879e-12
protect O 0 9.473885564936779e-11
against O 0 6.77501166279626e-10
hereditary B-Disease 0 1.0493384252185933e-05
forms I-Disease 0 1.716498161385971e-07
of I-Disease 0 1.0545118129812181e-05
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999977350234985
. O 0 5.552383868234756e-07

METHODS O 0 7.441511229444586e-08
We O 0 8.66527238851944e-10
enrolled O 0 2.2374452290918612e-10
207 O 0 5.115783352493963e-10
women O 0 9.946424794904374e-10
with O 0 2.7095021337686376e-08
hereditary B-Disease 1 0.9999985694885254
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 3.193247888333417e-09
161 O 0 3.958669503312251e-11
of O 0 2.399245082121415e-12
their O 0 5.092943289319862e-10
sisters O 0 6.066415370042932e-09
as O 0 7.394904133484204e-12
controls O 0 8.614384761074234e-10
in O 0 7.262089367354729e-12
a O 0 8.419773211976178e-11
case O 0 2.6729649604817496e-08
- O 0 1.4215431747288676e-06
control O 0 7.960509407212157e-08
study O 0 2.548357080911501e-09
. O 0 1.4870871201111413e-09

All O 0 5.685794612908524e-10
the O 0 9.534831257873577e-11
patients O 0 7.337784269090264e-10
carried O 0 4.751275484160544e-10
a O 0 3.1376715114994624e-10
pathogenic O 0 7.418369563083616e-08
mutation O 0 4.4386592179535e-08
in O 0 1.3448568647600467e-11
either O 0 1.2408121197182709e-09
BRCA1 O 0 3.3405348176529515e-07
( O 0 1.1329130342185856e-11
179 O 0 9.012910556771558e-11
women O 0 5.291370119842043e-10
) O 0 1.0012367671063949e-11
or O 0 6.288010112598386e-10
BRCA2 O 0 4.946613216816331e-07
( O 0 8.700792170079907e-11
28 O 0 3.9329253742614867e-10
women O 0 6.499403792936675e-10
) O 0 7.375750704641248e-11
. O 0 1.1828265034097285e-09

The O 0 1.6949543990563143e-09
control O 0 1.3782463170741721e-08
women O 0 5.133945490953806e-10
were O 0 9.92614115902235e-11
enrolled O 0 9.317920046658656e-11
regardless O 0 1.6323573048815376e-10
of O 0 1.8359431000220666e-13
whether O 0 5.354547361058337e-11
or O 0 5.992661367137941e-10
not O 0 1.045083325434959e-10
they O 0 5.5008508165199643e-11
had O 0 1.804950078287959e-10
either O 0 8.334089529604682e-10
mutation O 0 7.188648964984168e-08
. O 0 7.101152998956195e-10

Lifetime O 0 4.380160135042388e-06
histories O 0 5.433821570477448e-07
of O 0 2.5227339661704207e-10
oral O 0 6.591782408804647e-08
- O 0 4.2612714423739817e-07
contraceptive O 0 1.5826201149593544e-07
use O 0 1.5913384499022243e-10
were O 0 7.244466831979324e-11
obtained O 0 5.516853293641155e-11
by O 0 3.7514028342067185e-12
interview O 0 3.550118066186769e-08
or O 0 5.124804747236311e-11
by O 0 7.894625708368408e-13
written O 0 2.3712939598019567e-11
questionnaire O 0 1.2312070807318776e-10
and O 0 1.3495252007902914e-12
were O 0 6.252794289285379e-12
compared O 0 8.50455747491985e-11
between O 0 3.422873096070589e-11
patients O 0 1.7025904297529593e-10
and O 0 3.255934064028132e-11
control O 0 6.445753708561597e-09
women O 0 1.4869701303599214e-10
, O 0 2.2870526544642444e-13
after O 0 1.085843437734213e-12
adjustment O 0 4.598798425403672e-11
for O 0 1.7088311017945945e-13
year O 0 1.8296900453074194e-12
of O 0 6.999962675474647e-13
birth O 0 1.5175320555727012e-08
and O 0 3.8926104006797857e-10
parity O 0 6.118453654835321e-08
. O 0 9.434453218659655e-10

RESULTS O 0 8.569458032070543e-08
The O 0 1.265356847079957e-10
adjusted O 0 2.2706665276928106e-06
odds O 0 0.0001944295654539019
ratio O 0 6.4938809373416e-05
for O 0 6.130696874606656e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
associated O 0 7.62244326324435e-07
with O 0 1.9448782861974934e-11
any O 0 4.079060700323822e-11
past O 0 1.0606504563526187e-10
use O 0 8.438355049433799e-12
of O 0 3.897019425908033e-12
oral O 0 8.918630811649564e-08
contraceptives O 0 0.002291538519784808
was O 0 2.6487667170727036e-08
0 O 0 5.811976455660783e-10
. O 0 2.380512731381401e-10

5 O 0 2.190377657029785e-09
( O 0 1.4240518486641207e-11
95 O 0 8.813295579446212e-12
percent O 0 6.737357893804585e-10
confidence O 0 1.556921702672298e-08
interval O 0 6.55020793161043e-09
, O 0 4.5042490787530753e-13
0 O 0 1.5201187747795886e-12
. O 0 7.58902692749551e-14
3 O 0 2.2099917653273932e-13
to O 0 3.1760390758334145e-13
0 O 0 1.884102596161341e-11
. O 0 2.671461142578213e-12
8 O 0 2.6642214476235715e-11
) O 0 5.248325211926197e-12
. O 0 2.350495909020367e-10

The O 0 2.4939307508020647e-08
risk O 0 5.485990186571144e-07
decreased O 0 5.364551025621722e-09
with O 0 3.2119901356708613e-12
increasing O 0 9.193742989133113e-11
duration O 0 2.8628130976926514e-09
of O 0 4.223980106660141e-13
use O 0 9.636797609902104e-11
( O 0 4.710413482877929e-12
P O 0 2.7659423196269017e-08
for O 0 4.176808367489099e-13
trend O 0 6.811897573788528e-11
, O 0 3.552086738894261e-13
< O 0 4.1205518164222354e-11
0 O 0 1.3614982622214833e-12
. O 0 4.4954234020185e-14
001 O 0 6.013390740217117e-12
) O 0 1.0775031583122596e-14
; O 0 4.155000267593934e-15
use O 0 1.376388152757313e-13
for O 0 2.388240430070687e-13
six O 0 4.3351487764159424e-13
or O 0 4.855471927300847e-12
more O 0 7.448266721270247e-13
years O 0 4.2440363723361685e-11
was O 0 1.7949733366329212e-10
associated O 0 1.2585611372517569e-11
with O 0 2.976451008405989e-13
a O 0 5.071005421131147e-11
60 O 0 3.8115274825223366e-11
percent O 0 3.958181005181416e-10
reduction O 0 3.920312963145989e-10
in O 0 2.9848298832568787e-10
risk O 0 1.320591991316178e-07
. O 0 2.533280252237091e-09

Oral O 0 7.997482498467434e-06
- O 0 8.716383490536828e-07
contraceptive O 0 7.891270001891826e-07
use O 0 1.8589813022273916e-09
protected O 0 5.345905083231628e-05
against O 0 0.009760642424225807
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
both O 0 2.3342824895244974e-10
for O 0 4.4900810500236865e-12
carriers O 0 2.6965471522366613e-11
of O 0 1.0550256143975617e-13
the O 0 2.0995883850960517e-11
BRCA1 O 0 2.735189582381281e-06
mutation O 0 7.942158930518417e-08
( O 0 1.537583775579332e-11
odds O 0 1.145364080912259e-06
ratio O 0 2.4001103327009332e-08
, O 0 3.4905593498078813e-13
0 O 0 1.0458859256087805e-12
. O 0 2.102322053151428e-14
5 O 0 6.417131095167589e-14
; O 0 6.585995583532206e-14
95 O 0 6.6334253628203e-13
percent O 0 9.044735793661829e-11
confidence O 0 1.0274262551845936e-09
interval O 0 2.4931007258643945e-10
, O 0 3.916754887003243e-14
0 O 0 7.064433673459325e-14
. O 0 5.31736833451796e-15
3 O 0 4.8803690445462997e-14
to O 0 9.063182062479802e-14
0 O 0 3.95141818571032e-12
. O 0 3.640520773295214e-13
9 O 0 3.5652906408417673e-12
) O 0 2.7217487771490252e-14
and O 0 2.2959336255096163e-13
for O 0 6.3013003560701e-14
carriers O 0 5.884845128562022e-12
of O 0 2.2332891016097617e-13
the O 0 4.316160276407466e-11
BRCA2 O 0 4.187643867226143e-07
mutation O 0 1.1140794953234945e-07
( O 0 8.357146571991159e-12
odds O 0 2.706248949380097e-07
ratio O 0 2.4708912249593595e-08
, O 0 8.257710650255018e-14
0 O 0 3.2488462332717905e-13
. O 0 3.8600267188333703e-14
4 O 0 1.9724201655649254e-13
; O 0 1.512621408336634e-13
95 O 0 7.817680964389284e-13
percent O 0 2.0301885172990808e-10
confidence O 0 4.027038702503205e-09
interval O 0 4.0081934993274615e-10
, O 0 4.767206120419483e-14
0 O 0 1.606578639654771e-13
. O 0 1.2657741879380097e-14
2 O 0 1.3204219076641543e-13
to O 0 1.0007914635901116e-12
1 O 0 5.323363711645657e-12
. O 0 3.2370460478770013e-12
1 O 0 2.7552231329774912e-11
) O 0 8.553796559951365e-12
. O 0 4.1182912635662206e-10

CONCLUSIONS O 0 3.41610643772583e-06
Oral O 0 6.980446300985932e-07
- O 0 3.3913741503965866e-07
contraceptive O 0 6.83068151374755e-07
use O 0 1.915973379951197e-09
may O 0 3.2720239850903e-09
reduce O 0 5.954299275856556e-10
the O 0 4.561000535585613e-11
risk O 0 1.9937927220325946e-07
of O 0 4.545305642977837e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
in O 0 3.728213116005463e-08
women O 0 2.3289781214685945e-09
with O 0 1.0711735665136501e-10
pathogenic O 0 1.2910787461350992e-07
mutations O 0 1.3839177803731673e-08
in O 0 2.9601654460975624e-11
the O 0 2.7145272141204657e-10
BRCA1 O 0 1.7963737263926305e-05
or O 0 6.112400683377928e-07
BRCA2 O 0 0.0003245951374992728
gene O 0 7.16586655471474e-05

A O 0 1.8036894289252814e-07
Japanese O 0 1.3221595906998118e-07
family O 0 4.518386997887092e-09
with O 0 1.3381672436807435e-09
adrenoleukodystrophy B-Disease 1 0.9999939203262329
with O 0 1.0962960539373512e-09
a O 0 9.03835950527565e-10
codon O 0 3.099781320514694e-09
291 O 0 1.4869956654894878e-10
deletion O 0 9.906027997885758e-09
: O 0 3.189136107972779e-11
a O 0 5.77334777207561e-11
clinical O 0 5.375868639134751e-09
, O 0 3.544733256921617e-11
biochemical O 0 2.2406382527151436e-07
, O 0 2.4051202002217664e-11
pathological O 0 9.751281027092773e-08
, O 0 2.0899951908015524e-11
and O 0 1.7403684049455137e-10
genetic O 0 2.234219209640287e-08
report O 0 1.1132464727836577e-08
. O 0 6.426330578790385e-10

We O 0 6.529677420985536e-08
report O 0 3.423201444530122e-10
a O 0 2.5556898611278633e-11
Japanese O 0 5.894650101367915e-09
family O 0 1.780818825736219e-09
with O 0 2.996777936914441e-08
adrenoleukodystrophy B-Disease 1 0.9999997615814209
( O 0 1.529172379832744e-07
ALD B-Disease 1 0.9999991655349731
) O 0 1.148245647869528e-11
with O 0 3.0009818414999945e-12
a O 0 4.615565221688378e-11
three O 0 3.2255843829265274e-11
base O 0 3.127895720211882e-10
pair O 0 5.595385044188106e-09
deletion O 0 5.928646018560357e-09
( O 0 2.478126211180598e-12
delGAG O 0 7.766729481772927e-10
291 O 0 7.937876744801287e-11
) O 0 1.788990179954486e-12
in O 0 3.350572944094132e-11
the O 0 3.704705653362339e-09
ALD B-Disease 1 0.9999955892562866
gene O 0 2.170714651583694e-06
. O 0 1.839063479280867e-08

A O 0 2.8047290712152062e-08
variety O 0 3.115322444458002e-09
of O 0 2.229462031655416e-10
phenotypes O 0 9.818944818107411e-06
were O 0 3.732850917259611e-09
observed O 0 4.326453151293208e-08
within O 0 3.162164280423596e-11
this O 0 4.3040428859830726e-11
family O 0 4.670377862225905e-09
. O 0 2.4009974008976087e-09

While O 0 2.285112321587235e-09
the O 0 4.8971420668619814e-11
proband O 0 1.5441375467162288e-07
( O 0 1.5925035595776293e-11
patient O 0 3.986952989976089e-09
1 O 0 1.7167264831918772e-10
) O 0 9.76196293939191e-12
was O 0 1.7966356180565413e-09
classified O 0 3.972780771022144e-09
as O 0 5.90993226579073e-11
having O 0 2.579206570541004e-10
a O 0 2.524152588334605e-11
rare O 0 1.921703907115102e-10
intermediate O 0 1.37882871786843e-10
type O 0 7.410248858974455e-09
of O 0 1.910191622933599e-11
adult O 0 6.035303385942825e-07
cerebral O 0 4.719605567515828e-05
and O 0 2.688240963166777e-09
cerebello O 0 0.0003361171402502805
- O 0 0.001018742099404335
brain O 0 3.31540395563934e-05
stem O 0 1.74565624178058e-08
forms O 0 7.139451252413664e-10
, O 0 7.011538051548971e-12
his O 0 9.049411914263672e-11
younger O 0 1.7427577159168095e-09
brother O 0 1.0969282371320332e-08
( O 0 4.840436645253687e-12
patient O 0 1.421420980918242e-09
2 O 0 1.489271206356335e-11
) O 0 1.3330651686682682e-12
and O 0 1.2226841761275864e-10
nephew O 0 1.0629358939695521e-06
( O 0 2.7164163279858045e-11
patient O 0 2.703147750082735e-08
3 O 0 8.010547780656907e-11
) O 0 8.120753201834585e-12
had O 0 6.84653977955918e-09
a O 0 4.5874429588366183e-08
childhood O 1 0.6657350659370422
ALD B-Disease 1 0.9999990463256836
type O 0 0.0028176968917250633
. O 0 4.2800550659194414e-08

Another O 0 5.3327038784800607e-08
nephew O 0 1.8296766484127147e-06
( O 0 2.8035174182150513e-10
patient O 0 3.55143185970519e-08
4 O 0 4.1208821077720614e-11
) O 0 5.632228624458113e-13
of O 0 2.7641489357826954e-12
patient O 0 4.0326523276235093e-07
1 O 0 1.2276246685871683e-09
was O 0 5.282582193899543e-08
classified O 0 2.7241359390473008e-08
as O 0 1.7106599470295691e-10
having O 0 7.565589044133958e-09
an O 0 1.228659535223997e-10
adolescent O 0 3.1094939458853332e-06
form O 0 6.1760441205649386e-09
. O 0 7.512944932841492e-09

The O 0 2.373187868442983e-09
tau O 0 8.33035862513043e-09
level O 0 3.3599325544031444e-09
in O 0 9.086476016051392e-11
the O 0 7.253513900629116e-10
cerebrospinal O 0 0.16497254371643066
fluid O 0 0.0009820809355005622
( O 0 1.055794784932118e-09
CSF O 0 1.3414843124337494e-05
) O 0 2.563622057694115e-12
in O 0 5.934813838287534e-12
patient O 0 1.451199516111501e-08
1 O 0 9.229550457234836e-11
was O 0 8.235506498976974e-09
as O 0 3.491927927368188e-11
high O 0 3.631704381668044e-10
as O 0 3.147870636030503e-12
that O 0 1.870873247988847e-12
of O 0 4.632311027819025e-12
patients O 0 1.4221694932814444e-09
with O 0 2.9898927778049256e-08
Alzheimers B-Disease 1 0.9993317723274231
disease I-Disease 0 1.502322902524611e-05
( O 0 1.2465180797283093e-11
AD B-Disease 0 2.0148602786207448e-08
) O 0 5.5388575670445306e-11
. O 0 3.334305331836873e-10

His O 0 4.3968154272988613e-07
brain O 0 2.2738804545952007e-05
magnetic O 0 3.5188354559068102e-06
resonance O 0 0.00012554948625620455
image O 0 0.00020306534133851528
( O 0 1.0545349038437735e-09
MRI O 0 0.011325366795063019
) O 0 7.482766073430014e-10
showed O 0 0.00011164711759192869
abnormalities B-Disease 0 0.06461382657289505
in I-Disease 0 1.4137631343391632e-10
the I-Disease 0 2.0827935209855042e-10
bilateral I-Disease 0 9.313806003774516e-06
cerebellar I-Disease 1 0.9366598725318909
hemispheres I-Disease 0 0.023451274260878563
and O 0 4.3587064624261984e-08
brain O 0 3.6676667605206603e-06
stem O 0 1.8413274460726825e-08
, O 0 6.031816105617205e-12
but O 0 2.394646980707904e-11
not O 0 9.035092118914179e-12
in O 0 1.2585245345864138e-12
the O 0 4.5734752790460576e-11
cerebral O 0 1.219825935550034e-05
white O 0 3.516167623729416e-08
matter O 0 2.5885025234373416e-09
, O 0 5.213969447165345e-13
where O 0 7.509820673309853e-13
marked O 0 2.875599411367169e-11
reductions O 0 1.1110312669870837e-09
of O 0 2.1643507840986287e-13
the O 0 1.1335555410996179e-10
cerebral O 0 1.1833768439828418e-05
blood O 0 2.8384398831349245e-08
flow O 0 1.0731460164947748e-08
and O 0 3.134526638248758e-09
oxygen O 0 1.0676035344658885e-07
metabolism O 0 1.0582469123221472e-08
were O 0 8.0949622005555e-11
clearly O 0 1.1029236413051535e-09
demonstrated O 0 2.339453075705933e-10
by O 0 1.808091523725075e-11
positron O 0 6.562615453731269e-05
emission O 0 5.862160833203234e-05
tomography O 0 2.381118065386545e-05
( O 0 5.082569920489277e-10
PET O 0 1.7726038095133845e-06
) O 0 3.316558139232484e-10
. O 0 1.4728377406569848e-09

In O 0 1.0735964117714047e-08
patients O 0 1.1718776171676382e-08
2 O 0 9.165378872522112e-11
and O 0 7.354383768642947e-11
3 O 0 5.1330807659955013e-11
, O 0 9.637339754356433e-13
the O 0 8.906186552137818e-12
autopsy O 0 3.2536067919863854e-06
findings O 0 1.0543182327182876e-08
showed O 0 3.0882404189469526e-07
massive O 0 1.435318154108245e-06
demyelination B-Disease 1 0.9999980926513672
of I-Disease 0 5.338560149503735e-10
the I-Disease 0 4.019594879167698e-09
cerebral I-Disease 0 0.0009852317161858082
white I-Disease 0 9.4848367382383e-08
matter I-Disease 0 7.171086502388846e-10
with O 0 5.810238900248732e-13
sparing O 0 3.4435461426785e-11
of O 0 7.877268173688001e-13
the O 0 1.333495553562658e-11
U O 0 4.543234695120191e-07
- O 0 9.180663482766249e-07
fibers O 0 1.0619712611514842e-06
, O 0 2.240543471240808e-12
compatible O 0 1.762387631665252e-11
with O 0 4.289289409764585e-12
the O 0 1.8036242638297395e-11
findings O 0 7.626537734672922e-10
of O 0 2.776622265443507e-10
childhood O 0 0.0029895142652094364
ALD B-Disease 1 0.9999867677688599
. O 0 1.1535315280752911e-07

Oleic O 0 0.004108715336769819
and O 0 4.5101145929038466e-08
erucic O 0 0.000769041245803237
acids O 0 1.5658201846235897e-08
( O 0 8.620013557114614e-12
Lorenzos O 0 9.260541666833433e-09
Oil O 0 1.3340133442341084e-09
) O 0 1.872357385237708e-13
were O 0 1.990486117944834e-12
administered O 0 8.025224582097756e-12
to O 0 4.859400642293066e-12
patients O 0 2.912405733246359e-11
1 O 0 2.436302461855666e-12
and O 0 5.011990822367807e-12
4 O 0 3.6203583533844785e-12
, O 0 2.1913886178760722e-13
but O 0 1.43206995741052e-12
sufficient O 0 2.2585351991399882e-11
effectiveness O 0 6.884879333313165e-10
was O 0 1.5436797395906865e-09
not O 0 6.685318965082843e-11
obtained O 0 2.604298721120557e-10
. O 0 2.093926421142811e-10

The O 0 1.569299579173844e-09
findings O 0 1.6362483590270926e-09
in O 0 6.798434645099993e-12
this O 0 2.1046833980492563e-12
family O 0 7.538242946525386e-11
suggest O 0 5.006138836805007e-10
that O 0 8.160845263449623e-12
delGAG291 O 0 2.524304099082997e-09
is O 0 3.5929382299210166e-12
part O 0 1.3116347201067025e-12
of O 0 4.872168207076255e-13
the O 0 2.841523197294471e-11
cause O 0 7.972357884966641e-09
of O 0 4.00082814100422e-11
Japanese O 0 1.3179037523514125e-05
ALD B-Disease 1 0.9999815225601196
with O 0 2.837516888121172e-10
phenotypic O 0 2.7742117936213617e-07
variations O 0 9.559626050759107e-07
. O 0 2.4035919921061577e-08

Moreover O 0 4.0751635310698475e-07
, O 0 2.1624179877277605e-11
although O 0 9.746372112151569e-12
the O 0 9.186372365924123e-13
scale O 0 2.9866324524618904e-08
of O 0 4.582589082507971e-12
the O 0 1.7160937601512494e-11
study O 0 3.415334334788689e-11
is O 0 7.463444792743523e-12
limited O 0 2.624722054284101e-12
, O 0 1.0467880902365057e-12
there O 0 5.774534496405526e-12
is O 0 6.554768663610822e-13
a O 0 1.137969276102102e-12
possibility O 0 4.53900909913596e-11
that O 0 7.824565995129262e-11
PET O 0 5.795079616177645e-08
can O 0 8.013195107459126e-10
detect O 0 1.455633082514396e-06
an O 0 4.189626423567461e-11
insidious B-Disease 0 2.1139741875231266e-05
lesion I-Disease 0 0.12381124496459961
which O 0 2.537187349105352e-09
is O 0 1.5549911358547774e-10
undetectable O 0 2.732908788161126e-09
by O 0 1.9862538263443197e-12
computed O 0 7.596913320639942e-08
tomogram O 0 2.1337828570722195e-07
( O 0 8.552001988515467e-12
CT O 0 8.579300470046292e-07
) O 0 7.804704148586805e-13
or O 0 1.3212898657133376e-11
MRI O 0 2.066500996988907e-07
analysis O 0 1.320335646370907e-10
, O 0 6.51657330527633e-13
and O 0 1.3771399385437144e-12
that O 0 1.588677214954537e-12
the O 0 1.1261133085055386e-12
higher O 0 4.0791717226262847e-10
level O 0 2.051949235526429e-11
of O 0 1.106028585232989e-13
tau O 0 4.560510823148345e-12
reflects O 0 1.0449452934879755e-11
the O 0 8.998005248880836e-14
process O 0 1.8099564002508478e-13
of O 0 9.284257390662631e-13
neuronal B-Disease 0 1.150510158254292e-07
degeneration I-Disease 0 3.938524969271384e-06
in O 0 1.2592431630764622e-07
ALD B-Disease 1 0.99998939037323
. O 0 8.82421247183629e-08

Lorenzos O 0 3.188399932696484e-05
Oil O 0 7.094877219060436e-07
should O 0 1.6704662098021572e-09
be O 0 1.5504236783314695e-11
given O 0 2.5054157967024926e-12
in O 0 3.304001224089387e-13
the O 0 9.874203234574996e-13
early O 0 5.721277965275995e-11
stage O 0 4.118685836829172e-09
. O 0 8.89488552258122e-11
. O 0 2.688936850958612e-10

Nonsense O 0 5.9781734307762235e-05
mutation O 0 3.3917667678906582e-06
in O 0 2.2994343928939287e-10
exon O 0 3.0228697767142876e-08
4 O 0 2.231516915696119e-10
of O 0 9.432536349218701e-12
human O 0 8.582126675982238e-10
complement O 0 4.023585731260937e-08
C9 O 0 1.4965144146117382e-05
gene O 0 4.141027432069677e-08
is O 0 9.34486654724509e-11
the O 0 7.378898707333104e-12
major O 0 8.853787841767158e-11
cause O 0 1.1060778071225741e-08
of O 0 8.043987004269226e-11
Japanese O 0 1.6648677956254687e-06
complement B-Disease 0 4.807608547707787e-06
C9 I-Disease 1 0.6513965725898743
deficiency I-Disease 0 0.09432565420866013
. O 0 9.7688319655731e-09

Deficiency B-Disease 1 0.9926700592041016
of I-Disease 0 4.884625481871296e-10
the I-Disease 0 2.185589903502816e-10
ninth I-Disease 0 7.292118575641382e-10
component I-Disease 0 3.979467311232554e-10
of I-Disease 0 2.5450451208303138e-12
human I-Disease 0 1.090880580312259e-10
complement I-Disease 0 1.7691456077884027e-09
( O 0 9.038367276836823e-12
C9 O 0 2.8708251775810822e-08
) O 0 8.284107449497979e-13
is O 0 4.900482146810714e-13
the O 0 1.6244812569773948e-13
most O 0 2.3492429789689906e-12
common O 0 3.376513735275921e-09
complement B-Disease 1 0.9999861717224121
deficiency I-Disease 1 0.9999994039535522
in O 0 8.037948084904656e-10
Japan O 0 1.512198188891034e-08
but O 0 2.1752179224510115e-10
is O 0 8.09954533997903e-12
rare O 0 4.362567251892102e-11
in O 0 6.991506332210129e-12
other O 0 1.5313751785747676e-12
countries O 0 1.1518430306778349e-11
. O 0 2.632074003194873e-10

We O 0 6.65034107782958e-08
studied O 0 1.9987598243176308e-09
the O 0 8.943773673053546e-12
molecular O 0 1.1971346136618877e-09
basis O 0 7.401258078632011e-11
of O 0 1.9189055899815344e-10
C9 B-Disease 1 0.8861783146858215
deficiency I-Disease 0 0.16884472966194153
in O 0 2.4069338189214307e-10
four O 0 2.787415021021644e-10
Japanese O 0 1.0125793181714471e-07
C9 B-Disease 0 0.00010247969476040453
- I-Disease 0 0.0002441080432618037
deficient I-Disease 0 0.00028048065723851323
patients O 0 3.153964911462026e-08
who O 0 5.474834807728257e-09
had O 0 1.1479806971692597e-07
suffered O 0 0.0014970573829486966
from O 0 2.898992534028366e-06
meningococcal B-Disease 1 0.9999992847442627
meningitis I-Disease 1 0.9999955892562866
. O 0 5.964216143183876e-08

Direct O 0 2.6222288784794046e-09
sequencing O 0 2.042345847996785e-09
of O 0 3.795509045945167e-11
amplified O 0 1.1122302367994052e-07
C9 O 0 2.5356558808198315e-07
cDNA O 0 1.5706591582898e-09
and O 0 1.0265246291885077e-10
DNA O 0 3.6153817717377024e-09
revealed O 0 1.4271591908254777e-08
a O 0 1.160324128446355e-10
nonsense O 0 1.2809233673749532e-08
substitution O 0 1.314929831686129e-10
( O 0 1.3126432449675485e-12
CGA O 0 1.9781960514109187e-09
- O 0 2.1395694105308394e-08
- O 0 2.316057390316928e-08
> O 0 5.231550193052215e-10
TGA O 0 9.665560796179307e-09
) O 0 4.085332061792152e-13
at O 0 1.3786431848558656e-12
codon O 0 9.833236655487632e-12
95 O 0 3.000877270200458e-13
in O 0 2.6237044763351147e-13
exon O 0 6.982344702421983e-10
4 O 0 3.6575412837303034e-11
in O 0 8.55595021914679e-12
the O 0 3.994065148060777e-11
four O 0 9.163426128999674e-10
C9 B-Disease 0 0.00022754960809834301
- I-Disease 0 0.00011075640941271558
deficient I-Disease 0 1.0816733265528455e-05
individuals O 0 2.594176429226991e-09
. O 0 2.7748869868560178e-09

An O 0 9.690956925823002e-10
allele O 0 9.363076713952978e-08
- O 0 3.2573164165938806e-09
specific O 0 7.599409296288329e-11
polymerase O 0 4.057214564312517e-09
chain O 0 2.429634449185869e-08
reaction O 0 7.446729344273706e-10
system O 0 9.78646469418365e-11
designed O 0 2.4852444546752395e-09
to O 0 1.4876360560078794e-11
detect O 0 1.4154082350614772e-07
exclusively O 0 8.509766502573513e-11
only O 0 3.6038234028923366e-12
one O 0 8.532316563350517e-13
of O 0 5.505576260189139e-14
the O 0 5.616694175730741e-13
normal O 0 2.4202416112895087e-11
and O 0 2.4914959418503857e-12
mutant O 0 3.5867982195458836e-11
alleles O 0 2.7719958273220158e-11
indicated O 0 1.0713538944884249e-09
that O 0 3.97950119038204e-12
all O 0 5.98477905146104e-14
the O 0 3.4118343458615363e-13
four O 0 1.110714385049727e-11
patients O 0 1.9439623522021776e-11
were O 0 9.047164059583501e-12
homozygous O 0 2.5532792546911764e-10
for O 0 4.1122880383055727e-13
the O 0 2.1166883350243193e-12
mutation O 0 7.110586008884923e-10
in O 0 2.7775568303689546e-12
exon O 0 2.8602533674870756e-09
4 O 0 9.141006701574028e-11
and O 0 8.754477698325047e-11
that O 0 5.1647526533304955e-11
the O 0 1.2332653127888893e-11
parents O 0 2.711401936306146e-10
of O 0 3.644010006936815e-12
patient O 0 1.256411685801595e-08
2 O 0 1.3411254051742816e-10
were O 0 2.6203041958439144e-09
heterozygous O 0 1.7432013521556655e-07
. O 0 4.1551482254931216e-09

The O 0 7.721648875858023e-10
common O 0 5.87407400498563e-10
mutation O 0 4.753244908783927e-09
at O 0 5.908838696111474e-11
codon O 0 2.1447889297920852e-10
95 O 0 3.1831668377557687e-12
in O 0 9.432100283104927e-13
exon O 0 4.7543062819954685e-09
4 O 0 5.672752823038252e-10
might O 0 1.6050206497197905e-08
be O 0 3.2468439048471964e-10
responsible O 0 4.754593940781149e-10
for O 0 4.8508991962181724e-12
most O 0 1.090516496549121e-10
Japanese O 0 4.849298875342356e-06
C9 B-Disease 0 0.05234812945127487
deficiency I-Disease 0 0.00021811349142808467
. O 0 5.5710141361187127e-11
. O 0 3.554518346327029e-10

BRCA1 O 0 0.00022396813437808305
required O 0 1.5809058950821964e-08
for O 0 1.0183535958940837e-10
transcription O 0 3.6078816378903866e-08
- O 0 2.5992951577791246e-06
coupled O 0 1.0762565807453939e-06
repair O 0 1.1096911975982948e-06
of O 0 6.800526114458805e-11
oxidative O 0 2.8835964258178137e-05
DNA O 0 7.147050928324461e-05
damage O 0 0.001313415472395718
. O 0 3.390390190816106e-08

The O 0 5.05636194247927e-07
breast B-Disease 1 0.9997053742408752
and I-Disease 1 0.9846673011779785
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
susceptibility O 1 0.9998350143432617
gene O 0 0.0007883459329605103
BRCA1 O 0 0.00011858651851071045
encodes O 0 2.2321965786886722e-07
a O 0 4.481499615849316e-08
zinc O 0 0.25724169611930847
finger O 0 0.00017451787425670773
protein O 0 1.7296285292900393e-08
of O 0 2.5874880363319086e-11
unknown O 0 4.3511477088031825e-08
function O 0 5.627869281710218e-09
. O 0 1.5923624641089873e-09

Association O 0 3.998217579237462e-08
of O 0 5.453724277737493e-11
the O 0 5.4616356576220326e-11
BRCA1 O 0 1.0292139052126004e-07
protein O 0 3.485907673628219e-10
with O 0 8.559705028110542e-12
the O 0 7.255692140856196e-12
DNA O 0 9.234881304109877e-08
repair O 0 8.500335297867423e-07
protein O 0 3.211400700919853e-09
Rad51 O 0 1.1945651579026162e-07
and O 0 6.924698228022441e-12
changes O 0 5.1189599434287025e-12
in O 0 3.0075814343340224e-13
the O 0 4.5591585655412395e-14
phosphorylation O 0 5.142554784787201e-12
and O 0 5.430169768699811e-12
cellular O 0 2.26070426267988e-10
localization O 0 5.4595522547273845e-11
of O 0 1.9541488856223387e-14
the O 0 1.7857914311799478e-13
protein O 0 1.0665574326496063e-11
after O 0 1.9247109114828298e-11
exposure O 0 8.980696719618209e-08
to O 0 1.018096718041761e-11
DNA O 0 4.7187317164798515e-08
- O 0 3.7473415659405873e-07
damaging O 0 2.1801113803121552e-07
agents O 0 1.0247533488438876e-08
are O 0 1.0062162908441863e-11
consistent O 0 4.837755751552208e-10
with O 0 6.907584855671278e-13
a O 0 3.825655070510692e-12
role O 0 2.635272555728818e-11
for O 0 3.2601952821426083e-12
BRCA1 O 0 2.0294239178042517e-08
in O 0 1.1358777807224385e-10
DNA O 0 2.830401797382365e-07
repair O 0 7.057234597596107e-06
. O 0 1.6926355428381612e-08

Here O 0 7.931955536832902e-08
, O 0 3.411877030901067e-11
it O 0 9.113393199811082e-12
is O 0 4.484286639933055e-12
shown O 0 1.597956766907771e-10
that O 0 8.475809464003614e-12
mouse O 0 7.517503064491393e-09
embryonic O 0 1.4775768164554393e-08
stem O 0 1.429789051599073e-07
cells O 0 2.140263255512309e-08
deficient B-Disease 0 1.0707052666703021e-07
in I-Disease 0 5.0474215085305474e-11
BRCA1 I-Disease 0 1.0457767274374419e-07
are O 0 4.387476146283653e-11
defective O 0 5.772618649757533e-08
in O 0 1.1314014829177932e-11
the O 0 1.773930828619097e-12
ability O 0 1.935985538548124e-10
to O 0 5.9797874117639704e-12
carry O 0 1.4545400994769864e-10
out O 0 1.6811498373958678e-11
transcription O 0 1.3165485368560326e-10
- O 0 8.947831808825413e-09
coupled O 0 7.455459360983241e-09
repair O 0 8.02993760373738e-09
of O 0 1.1672485894509421e-12
oxidative O 0 2.119880946338526e-07
DNA O 0 2.6951581730827456e-06
damage O 0 0.00036668701795861125
, O 0 5.872738406687006e-11
and O 0 1.6039355954511336e-10
are O 0 1.495172180510096e-10
hypersensitive O 0 1.5128513041418046e-05
to O 0 4.905832184931569e-09
ionizing O 1 0.9999514818191528
radiation O 1 0.9999768733978271
and O 0 7.57802354200976e-09
hydrogen O 0 3.6530437341752986e-07
peroxide O 0 1.5104741578397807e-05
. O 0 1.8648980137925264e-09

These O 0 6.725622281322785e-10
results O 0 8.117292948917054e-10
suggest O 0 1.2665163362512999e-09
that O 0 2.9181886074258756e-11
BRCA1 O 0 7.569880011715213e-08
participates O 0 2.942547594475542e-10
, O 0 1.2276884153381018e-12
directly O 0 1.1359097690233355e-11
or O 0 5.310264380997687e-11
indirectly O 0 4.120744634406037e-09
, O 0 1.5862941385794138e-12
in O 0 2.8818134944347262e-12
transcription O 0 2.744859894932006e-10
- O 0 5.0915495819481293e-08
coupled O 0 5.097895439121203e-08
repair O 0 2.1007130257544304e-08
of O 0 4.786280313057167e-12
oxidative O 0 1.3449342759486171e-06
DNA O 0 5.75661624679924e-06
damage O 0 0.00014841854863334447
. O 0 7.341479646427729e-10
. O 0 2.010597910384604e-09

Truncation O 0 4.31885382567998e-06
mutations O 0 3.951506005250849e-05
in O 0 4.6124082331289173e-10
the O 0 9.642976001034143e-11
transactivation O 0 2.533340648369631e-06
region O 0 1.9766950298816255e-09
of O 0 1.5153113139265706e-11
PAX6 O 0 6.830460733908694e-06
result O 0 1.0894551927265184e-08
in O 0 9.662233513285656e-11
dominant O 0 4.0524056998947344e-08
- O 0 1.6766553017077968e-06
negative O 0 1.9847378496251622e-07
mutants O 0 5.751923737307152e-08
. O 0 2.274112009814644e-09

PAX6 O 0 0.001117184292525053
is O 0 2.7333777463667275e-09
a O 0 3.287566052723179e-11
transcription O 0 2.105359914184035e-10
factor O 0 3.4773857404690744e-11
with O 0 5.956538972999581e-13
two O 0 8.365998865889068e-12
DNA O 0 1.0041092934898188e-07
- O 0 8.303029517264804e-07
binding O 0 7.926416856207652e-09
domains O 0 3.229687406403059e-09
( O 0 1.9984062148148407e-12
paired O 0 4.220356508710665e-09
box O 0 2.364641034091619e-07
and O 0 1.4411796755986472e-10
homeobox O 0 3.7131100416587515e-09
) O 0 3.694284895355837e-12
and O 0 4.307366963107739e-12
a O 0 2.2593592274855467e-10
proline O 0 2.3957302346389042e-06
- O 0 6.37586410334734e-08
serine O 0 5.071022712854756e-08
- O 0 1.2745617539167142e-07
threonine O 0 3.242917401280465e-08
( O 0 3.257443273452232e-11
PST O 0 2.829985987773398e-07
) O 0 2.2078285380477958e-11
- O 0 9.285426649796591e-09
rich O 0 7.507329868872148e-09
transactivation O 0 5.204573767514376e-07
domain O 0 1.218538869807162e-08
. O 0 9.248515842052996e-10

PAX6 O 0 0.0028722507413476706
regulates O 0 1.2795513612218201e-05
eye O 0 9.361624506709632e-06
development O 0 1.3706163981552777e-10
in O 0 4.6284007876318256e-11
animals O 0 6.237264871256087e-11
ranging O 0 4.754802662709778e-10
from O 0 7.109520871323438e-12
jellyfish O 0 3.9198044810007104e-10
to O 0 2.416347504030636e-12
Drosophila O 0 2.049833046358085e-11
to O 0 7.483872029034888e-12
humans O 0 1.4807386428117297e-09
. O 0 5.418577253557544e-10

Heterozygous O 0 7.156661013141274e-05
mutations O 0 7.235111752379453e-06
in O 0 2.344429095302303e-10
the O 0 3.5667073461365106e-11
human O 0 6.383962802836152e-10
PAX6 O 0 9.25016138353385e-07
gene O 0 9.790712240942412e-09
result O 0 9.819751678463717e-10
in O 0 4.083986621106206e-12
various O 0 3.4764754009569687e-12
phenotypes O 0 3.003633821663243e-07
, O 0 1.2517119285515577e-11
including O 0 2.788595465652577e-10
aniridia B-Disease 1 0.9999998807907104
, O 0 5.315689008966729e-07
Peters B-Disease 1 0.9999905824661255
anomaly I-Disease 1 0.9999990463256836
, O 0 6.9007124459119495e-09
autosomal B-Disease 0 0.007818888872861862
dominant I-Disease 0 0.00012793020869139582
keratitis I-Disease 0 0.49127325415611267
, O 0 6.25221918681973e-09
and O 0 1.7772805449567386e-08
familial B-Disease 0 0.08917263895273209
foveal I-Disease 1 0.9739431142807007
dysplasia I-Disease 1 0.9962555170059204
. O 0 5.394255708779383e-07

It O 0 5.624306798068801e-09
is O 0 7.328339324264022e-11
believed O 0 1.9528077765951224e-10
that O 0 1.2484209629612386e-12
the O 0 3.243851151232824e-12
mutated O 0 5.306159511775377e-09
allele O 0 1.5754115789690104e-09
of O 0 2.156115563867189e-12
PAX6 O 0 1.936169127247922e-07
produces O 0 3.041819851556937e-10
an O 0 1.215576684449049e-12
inactive O 0 5.018395143885357e-10
protein O 0 3.5379874030461167e-10
and O 0 7.447468752808106e-10
aniridia B-Disease 1 0.999998927116394
is O 0 3.3428158019432885e-08
caused O 0 3.6033771522170355e-08
due O 0 4.6127954234087554e-10
to O 0 1.0519769777506127e-10
genetic O 0 2.0484823437527666e-07
haploinsufficiency O 0 6.57511773169972e-05
. O 0 1.3334111592655518e-08

However O 0 1.222827616942368e-08
, O 0 2.939616432218184e-12
several O 0 2.2885450587546707e-13
truncation O 0 2.5561897043502313e-09
mutations O 0 3.6835209016317094e-07
have O 0 1.8686711900084418e-10
been O 0 1.7396606724617847e-11
found O 0 2.2943338201519836e-11
to O 0 4.7782624211512026e-12
occur O 0 1.9438074760902424e-10
in O 0 1.0974743249597685e-12
the O 0 4.759318633640319e-11
C O 0 7.552127101462247e-08
- O 0 1.2871194776664652e-08
terminal O 0 1.207433153460613e-09
half O 0 7.041343636632336e-12
of O 0 5.241369946569485e-13
PAX6 O 0 3.004917203952573e-08
in O 0 8.392997408179781e-11
patients O 0 2.1579116271652765e-10
with O 0 9.683967516771474e-11
Aniridia B-Disease 1 0.9999682903289795
resulting O 0 9.224420338682648e-09
in O 0 7.814822573781743e-12
mutant O 0 1.412221450891593e-10
proteins O 0 2.0121868581080005e-12
that O 0 8.35714256044312e-13
retain O 0 5.3952571577031705e-11
the O 0 1.8812143683100135e-12
DNA O 0 1.559384732452429e-09
- O 0 5.561952232113754e-09
binding O 0 7.387045974915907e-10
domains O 0 1.4138823445364324e-09
but O 0 2.345645622181536e-10
have O 0 5.425565552386047e-11
lost O 0 2.3046342612076387e-09
most O 0 1.7225367182974183e-12
of O 0 1.0416474540558829e-12
the O 0 4.3915367869962196e-11
transactivation O 0 3.096940872637788e-07
domain O 0 1.1709436087414815e-08
. O 0 1.0592317023494502e-09

It O 0 4.576245604681617e-09
is O 0 2.660925646491563e-11
not O 0 1.488279551681293e-12
clear O 0 3.260866836968246e-12
whether O 0 2.9372118886400456e-12
such O 0 3.707627087290444e-12
mutants O 0 2.5091306810054448e-09
really O 0 1.2581263142408261e-08
behave O 0 6.227852678009071e-10
as O 0 1.2767886791234528e-12
loss O 0 1.3765898143613953e-10
- O 0 6.258360496502746e-10
of O 0 1.2983016571543882e-11
- O 0 5.462893781782441e-08
function O 0 2.279782751468673e-10
mutants O 0 1.0010979545338472e-10
as O 0 1.8366341433817546e-12
predicted O 0 2.5119162305742293e-10
by O 0 1.5458349877928157e-11
haploinsufficiency O 0 3.2246177283923316e-07
. O 0 2.229216589100247e-09

Contrary O 0 9.458983640797669e-08
to O 0 1.6820895371028044e-11
this O 0 1.6575556031905858e-12
theory O 0 4.301697886788247e-10
, O 0 2.5764194380370475e-13
our O 0 1.2471739136224458e-12
data O 0 1.3089286599043959e-11
showed O 0 2.46374032286667e-10
that O 0 2.171947653195963e-13
these O 0 1.1615934722344207e-13
mutants O 0 3.083960170569e-12
are O 0 2.2547064313250403e-13
dominant O 0 7.078836822271839e-11
- O 0 1.1519694087525068e-09
negative O 0 3.7095260196906565e-10
in O 0 5.152441407557662e-12
transient O 0 2.34611108318461e-10
transfection O 0 1.3939607690360845e-08
assays O 0 4.604229530968951e-08
when O 0 3.69871661076715e-10
they O 0 1.1147703420089083e-11
are O 0 1.8607984077212425e-12
coexpressed O 0 8.604646994925247e-10
with O 0 1.0086951239551833e-11
wild O 0 3.219993605085847e-09
- O 0 2.538799435569672e-06
type O 0 1.051647723215865e-05
PAX6 O 0 4.738239658763632e-05
. O 0 6.597603796620888e-09

We O 0 1.1928547927197997e-08
found O 0 1.05272165984438e-10
that O 0 2.6976155684255154e-12
the O 0 1.5957134702135334e-12
dominant O 0 7.041125904549972e-09
- O 0 9.469508199799748e-08
negative O 0 1.7917528793987003e-08
effects O 0 3.184788610610667e-08
result O 0 9.23293039245543e-11
from O 0 2.3706904495046643e-13
the O 0 7.664101151676553e-14
enhanced O 0 5.652617610096833e-11
DNA O 0 4.745099313474554e-10
binding O 0 3.8470401864110215e-10
ability O 0 3.317986163597908e-11
of O 0 2.9571435361183673e-13
these O 0 8.94203374540714e-12
mutants O 0 1.1068687078008566e-09
. O 0 3.609784693381357e-10

Kinetic O 0 3.255795036238851e-06
studies O 0 4.859760149855674e-09
of O 0 2.0557217386696358e-11
binding O 0 3.6621191412677945e-08
and O 0 4.315240942354137e-10
dissociation O 0 3.1010954444354866e-06
revealed O 0 1.0013854634394193e-08
that O 0 8.414707732690152e-13
various O 0 1.2206713775626127e-13
truncation O 0 3.1736885341970833e-10
mutants O 0 2.3168768292780584e-10
have O 0 3.773635483955706e-12
3 O 0 1.0051109250452939e-12
- O 0 1.1272797140193802e-09
5 O 0 2.3811836183385005e-11
- O 0 2.403040655352129e-09
fold O 0 1.872439758798805e-09
higher O 0 9.898419757459198e-12
affinity O 0 3.819967779594702e-12
to O 0 3.872400853753219e-14
various O 0 6.31566671248189e-14
DNA O 0 7.34424951409629e-11
- O 0 1.6576109929111738e-10
binding O 0 2.6983786732825976e-11
sites O 0 2.4874648781730846e-12
when O 0 2.2820089567998636e-11
compared O 0 1.081911903816346e-11
with O 0 3.9357707089064664e-13
the O 0 8.128609764457284e-12
wild O 0 6.665577867437378e-09
- O 0 1.9877222712239018e-06
type O 0 6.606190254387911e-06
PAX6 O 0 1.895267268992029e-05
. O 0 7.934918500041022e-09

These O 0 1.2974612495497695e-09
results O 0 4.2301864788818477e-10
provide O 0 3.724822533746064e-12
a O 0 8.98796315151884e-12
new O 0 2.27285963487478e-12
insight O 0 3.8468766366817064e-11
into O 0 8.930984207386472e-13
the O 0 3.5500750017632143e-13
role O 0 5.622163758850496e-12
of O 0 1.5128789063525994e-12
mutant O 0 3.5458189717729738e-09
PAX6 O 0 4.4042437252755917e-07
in O 0 4.697184863289294e-10
causing O 0 1.6037269290336553e-07
aniridia B-Disease 1 0.9999723434448242
. O 0 1.9305623766285862e-09
. O 0 2.502305918028469e-09

Reversal O 0 1.620599505258724e-05
of O 0 2.0341905937470983e-08
severe O 0 0.1968095749616623
hypertrophic B-Disease 1 0.9999469518661499
cardiomyopathy I-Disease 1 0.9999998807907104
and O 0 9.953777890814308e-08
excellent O 0 7.685232361609451e-08
neuropsychologic O 0 7.598592901558732e-07
outcome O 0 8.330930612032716e-09
in O 0 1.65149505182427e-10
very B-Disease 0 2.370374119209373e-09
- I-Disease 0 1.2830711284550489e-06
long I-Disease 0 4.1132875594485085e-07
- I-Disease 0 2.843208449121448e-06
chain I-Disease 0 1.3559339322455344e-06
acyl I-Disease 0 4.4261133780310047e-07
- I-Disease 0 3.047805137157411e-07
coenzyme I-Disease 0 7.876685970131803e-08
A I-Disease 0 3.0962375774379325e-08
dehydrogenase I-Disease 0 3.974889114033431e-05
deficiency I-Disease 0 0.004009585361927748
. O 0 7.301461213415905e-09

Very B-Disease 0 8.445051093985967e-07
- I-Disease 0 1.052719380822964e-05
long I-Disease 0 3.098973309079156e-07
- I-Disease 0 3.974362698500045e-06
chain I-Disease 0 9.691627838037675e-07
acyl I-Disease 0 3.6722900631502853e-07
- I-Disease 0 6.892165060889965e-08
coenzyme I-Disease 0 1.0076005807491129e-08
A I-Disease 0 4.146674392746519e-10
dehydrogenase I-Disease 0 1.8863563155946395e-08
( I-Disease 0 9.232015152349504e-11
VLCAD I-Disease 0 0.0002919804537668824
) I-Disease 0 1.799821847114913e-09
deficiency I-Disease 0 6.029713767929934e-05
is O 0 1.1555271323127059e-10
a O 0 1.5988579349368592e-08
disorder O 0 5.0167109293397516e-05
of O 0 5.07473056632346e-11
fatty O 0 2.3777930380219914e-07
acid O 0 2.0555863677884645e-09
beta O 0 1.1302776423138816e-11
oxidation O 0 2.0299327496697828e-10
that O 0 7.088861442294814e-11
reportedly O 0 2.0616971241338433e-08
has O 0 1.4791204372421873e-10
high O 0 1.727665788209265e-09
rates O 0 1.6974981420503354e-08
of O 0 3.57266473349771e-11
morbidity O 0 0.00023750706168357283
and O 0 1.1834341506755663e-08
mortality O 0 5.99703935222351e-06
. O 0 2.4565292022771246e-09

We O 0 3.3135565402631073e-09
describe O 0 6.556666876100792e-10
the O 0 1.0564881218130817e-12
outcome O 0 8.589109458390087e-12
of O 0 7.616579215203798e-14
a O 0 6.813440870528931e-12
5 O 0 6.230983177341054e-12
- O 0 4.281694110375156e-09
year O 0 3.5888186866728233e-10
- O 0 1.8566653636753472e-07
old O 0 4.517635261436226e-07
girl O 0 1.4836147784080822e-05
with O 0 4.19052810229914e-08
VLCAD B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999997615814209
who O 0 6.715243028310169e-09
was O 0 1.1470422528470081e-10
first O 0 2.7191051060054816e-12
seen O 0 9.569179892920943e-10
at O 0 9.64675995335229e-12
5 O 0 5.396352852418684e-13
months O 0 1.4038149115380705e-11
of O 0 1.2520145510619418e-12
age O 0 6.510287864358588e-09
with O 0 1.1190881998857094e-08
severe O 1 0.9423918724060059
hypertrophic B-Disease 1 0.9999853372573853
cardiomyopathy I-Disease 1 1.0
, O 0 0.00012420013081282377
hepatomegaly B-Disease 1 0.9999998807907104
, O 0 1.8892243360824068e-06
encephalopathy B-Disease 0 0.08784513175487518
, O 0 6.527891560637045e-10
and O 0 4.061240232999808e-09
hypotonia B-Disease 0 7.266754982993007e-05
. O 0 2.0104147679944617e-08

Biochemical O 0 0.0006396091193892062
studies O 0 1.9444512872723863e-05
indicated O 0 0.4887714087963104
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
caused O 0 5.441873872769065e-05
by O 0 5.861315321986638e-10
a O 0 1.103288127524138e-08
stable O 0 1.3276830031827558e-05
yet O 0 4.3227498025544264e-08
inactive O 0 1.503911484235232e-08
enzyme O 0 2.1257868798585378e-09
. O 0 7.882134389625151e-10

Molecular O 0 2.3568518372485414e-06
genetic O 0 1.7761850301667437e-07
analysis O 0 3.3196165816207213e-09
of O 0 3.119725311417909e-11
her O 0 2.16465423363843e-07
VLCAD O 0 0.007575183641165495
gene O 0 7.358511879829166e-07
revealed O 0 1.8284104896792996e-07
a O 0 4.162943878505132e-10
T1372C O 0 3.904519019215513e-08
( O 0 2.1933982408128827e-11
F458L O 0 2.736601834030239e-09
) O 0 1.2848853925273573e-11
missense O 0 2.255264234918286e-06
mutation O 0 2.068059757220908e-06
and O 0 5.611744957612075e-10
a O 0 6.860788825946429e-09
1668 O 0 0.00016938053886406124
ACAG O 0 0.00017595953249838203
1669 O 0 1.1754277693398762e-06
splice O 0 1.931478664118913e-06
site O 0 7.444563152603223e-07
mutation O 0 2.0302259144955315e-05
. O 0 1.955176287538052e-08

After O 0 1.9825738828416206e-09
initial O 0 8.045034083359326e-10
treatment O 0 6.816203157455902e-10
with O 0 3.0815277413109854e-11
intravenous O 0 2.4299734491251e-07
glucose O 0 1.5627148286512238e-06
and O 0 3.206080678719303e-10
carnitine O 0 2.2561690116162936e-07
, O 0 3.0440222825028895e-12
the O 0 1.7809282694403183e-12
patient O 0 3.372542689561442e-09
has O 0 1.6385578657795996e-11
thrived O 0 1.4661634406554214e-10
on O 0 3.973388024852698e-12
a O 0 3.469865714200715e-11
low O 0 1.7648568473305204e-07
- O 0 4.539752040955136e-08
fat O 0 4.327608849052922e-08
diet O 0 9.341089013403803e-11
supplemented O 0 3.041957657989869e-11
with O 0 4.3747475260424995e-12
medium O 0 2.129642240333851e-09
- O 0 2.337983140421329e-08
chain O 0 7.402638146913887e-08
triglyceride O 0 2.606652742542792e-07
oil O 0 3.2122398074818648e-09
and O 0 5.787438236981579e-11
carnitine O 0 4.082624016632508e-08
and O 0 7.736017382242721e-11
avoidance O 0 2.4809594378893962e-08
of O 0 3.1752978718602165e-11
fasting O 0 2.0697584091067256e-08
. O 0 2.3417845440576457e-09

Her O 0 4.9894233598024584e-06
ventricular O 0 0.00026461074594408274
hypertrophy O 0 0.0002731028071139008
resolved O 0 3.0058001243560284e-07
significantly O 0 5.550401471765554e-09
over O 0 6.752393089115571e-11
1 O 0 3.85091437904439e-11
year O 0 1.7919016270795396e-10
, O 0 6.446850865649001e-12
and O 0 4.96774010816381e-10
cognitively O 0 2.1899711555306567e-06
, O 0 6.562477557897628e-12
she O 0 1.0526920446451982e-09
is O 0 2.1872976520287413e-12
in O 0 1.6192224698650254e-13
the O 0 1.0421005421437646e-12
superior O 0 1.692685575038766e-10
range O 0 5.074693998352586e-10
for O 0 6.201653079962455e-11
age O 0 3.663172210011112e-09
. O 0 6.001148467049688e-10

Clinical O 0 1.7251892359126941e-06
recognition O 0 1.229772408350982e-07
of O 0 1.7837473365034384e-07
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
is O 0 5.713835182774574e-09
important O 0 9.626216490588035e-11
because O 0 3.5787567354006455e-10
it O 0 8.461078192245619e-12
is O 0 1.9307363867404614e-12
one O 0 4.889036224475785e-13
of O 0 5.4505336875843025e-14
the O 0 2.287891447474988e-12
few O 0 2.382229691288984e-10
directly O 0 9.81958805823524e-07
treatable O 0 0.49588245153427124
causes O 0 6.518801853871992e-08
of O 0 2.929467557422072e-09
cardiomyopathy B-Disease 1 0.9999996423721313
in O 0 3.123481207012446e-08
children O 0 5.505674138817085e-09
. O 0 2.0043097737065807e-10
. O 0 1.9431487530141567e-09

Cloning O 0 2.0534818645501218e-07
of O 0 1.0941396400010461e-10
a O 0 1.694646367678132e-10
novel O 0 1.6141492309440508e-10
member O 0 2.0425931779310957e-11
of O 0 1.4440948437055567e-12
the O 0 7.597800860681403e-11
low O 0 4.292540779715637e-06
- O 0 2.151134822270251e-06
density O 0 2.3857515074610092e-08
lipoprotein O 0 3.369491241755895e-05
receptor O 0 1.962320226311931e-07
family O 0 6.753754888677577e-08
. O 0 9.320097582588005e-09

A O 0 1.5412767950806483e-08
gene O 0 1.2597662468749604e-08
encoding O 0 3.0850768606427437e-09
a O 0 2.7005220282205755e-10
novel O 0 1.7835858345804922e-09
transmembrane O 0 1.2883276667707833e-06
protein O 0 5.282710713316874e-09
was O 0 3.5842012691134073e-10
identified O 0 1.6054016449551511e-10
by O 0 2.8933005622421015e-13
DNA O 0 5.168941663580284e-11
sequence O 0 1.24596669787147e-11
analysis O 0 2.905978626135952e-12
within O 0 2.4987238840534776e-13
the O 0 2.4731034928282547e-11
insulin B-Disease 0 0.0030906465835869312
- I-Disease 1 0.98539137840271
dependent I-Disease 1 0.9569843411445618
diabetes I-Disease 1 0.9999995231628418
mellitus I-Disease 1 0.9999990463256836
( O 0 2.2498406693216566e-08
IDDM B-Disease 0 0.00014547268801834434
) O 0 6.904417315656275e-11
locus O 0 9.166038950070288e-08
IDDM4 O 0 9.041735211212654e-06
on O 0 1.4144711180108516e-08
chromosome O 0 1.0869752259168308e-05
11q13 O 0 7.342165417867363e-07
. O 0 1.626640155905079e-08

Based O 0 3.900936462741811e-09
on O 0 2.361248696569618e-10
its O 0 2.6130694830150958e-11
chromosomal O 0 1.4198376447893679e-05
position O 0 2.5071283289435087e-06
, O 0 5.019174745962696e-12
this O 0 4.398364268284882e-13
gene O 0 5.1595637484691537e-11
is O 0 3.876957348908361e-12
a O 0 4.726829171131097e-12
candidate O 0 1.6594774165934467e-10
for O 0 2.246003079700576e-12
conferring O 0 2.4492882388926773e-08
susceptibility O 0 4.974498369847424e-05
to O 0 8.08380278272125e-08
diabetes B-Disease 0 0.0009728132281452417
. O 0 3.5296064737622146e-08

The O 0 1.9347019541982036e-09
gene O 0 1.2637034529916491e-08
, O 0 2.6678064271590252e-11
termed O 0 2.6471708380881864e-08
low O 0 1.9801861981250113e-06
- O 0 1.5440668903465848e-06
density O 0 9.95225590827431e-09
lipoprotein O 0 5.705627245333744e-06
receptor O 0 1.087723600079471e-08
related O 0 4.444324464003557e-09
protein O 0 3.3160032497647762e-09
5 O 0 7.28260785010093e-11
( O 0 6.82020195527655e-12
LRP5 O 0 2.0005838905490236e-06
) O 0 1.7279267209777127e-12
, O 0 8.308599034473341e-14
encodes O 0 4.383625840792549e-12
a O 0 7.979831205540133e-12
protein O 0 1.4133983046449305e-11
of O 0 1.4209146012578167e-12
1615 O 0 8.359217531506147e-07
amino O 0 8.620137381676329e-10
acids O 0 2.3579981717203324e-11
that O 0 6.303586667401329e-13
contains O 0 2.736534956970793e-12
conserved O 0 4.742141124225441e-10
modules O 0 3.81584452924244e-09
which O 0 9.117290949989254e-11
are O 0 1.169184866110784e-12
characteristic O 0 1.9399702677613817e-10
of O 0 1.356932795293364e-12
the O 0 1.003910635177796e-10
low O 0 2.820291456373525e-06
- O 0 1.8792579794535413e-05
density O 0 2.2035455060631648e-07
lipoprotein O 0 0.0020769929978996515
( O 0 6.663871121581622e-10
LDL O 0 1.0774010661407374e-05
) O 0 2.8848121808033866e-11
receptor O 0 2.467089421642754e-09
family O 0 8.977268706189534e-09
. O 0 1.9481214419414528e-09

These O 0 1.7535810581392752e-09
modules O 0 2.154145750665748e-09
include O 0 7.982814929918813e-12
a O 0 3.4224751505052e-11
putative O 0 4.497012540127798e-09
signal O 0 2.19905538223486e-09
peptide O 0 3.249285007722591e-10
for O 0 5.476711410225786e-14
protein O 0 1.9602208311403357e-12
export O 0 7.555613253107385e-12
, O 0 3.239126089744915e-13
four O 0 1.9076491688391206e-12
epidermal O 0 1.911098301832226e-08
growth O 0 1.4612143717229742e-09
factor O 0 3.0526536853869857e-10
( O 0 1.777043963369085e-11
EGF O 0 1.270145766341102e-08
) O 0 9.15808336283963e-13
repeats O 0 4.1580394682938504e-10
with O 0 6.915643405158711e-12
associated O 0 1.7010429731456611e-09
spacer O 0 4.8642878169857795e-08
domains O 0 1.2579630670472852e-08
, O 0 1.170588972976283e-11
three O 0 1.5110830989262247e-11
LDL O 0 6.543981271533994e-06
- O 0 7.303330562535848e-08
receptor O 0 4.607644488174856e-09
( O 0 1.481943734393809e-11
LDLR O 0 3.06313836517802e-07
) O 0 1.4567096444026428e-12
repeats O 0 3.7588551715650453e-10
, O 0 4.5413602349150817e-13
a O 0 4.924076771328778e-12
single O 0 1.10008313569665e-09
transmembrane O 0 5.7826031962804336e-08
spanning O 0 1.3616223704104868e-09
domain O 0 7.312341843146442e-10
, O 0 4.709730435509263e-12
and O 0 5.4580086110422865e-12
a O 0 4.710595455370559e-11
cytoplasmic O 0 1.1492508278365676e-08
domain O 0 4.401900000061687e-08
. O 0 2.076352867419473e-09

The O 0 1.3090423189865419e-09
encoded O 0 2.4834012624097568e-09
protein O 0 2.3957913430905364e-09
has O 0 6.960892279250785e-11
a O 0 1.8852384930934107e-11
unique O 0 2.643489593889825e-10
organization O 0 9.672959482009968e-12
of O 0 7.34216886507516e-13
EGF O 0 3.389077818383157e-08
and O 0 8.450954519512166e-11
LDLR O 0 3.045056757855491e-07
repeats O 0 3.125273373427717e-09
; O 0 5.893415963575954e-12
therefore O 0 9.577678927730204e-12
, O 0 5.891782829843539e-13
LRP5 O 0 2.5640821021966076e-08
likely O 0 2.4757948469122937e-10
represents O 0 3.4585984250157242e-12
a O 0 2.229396138184181e-12
new O 0 1.5800826359130271e-12
category O 0 8.445910637533416e-11
of O 0 4.664572764503938e-13
the O 0 9.624049474021845e-11
LDLR O 0 1.9939816411351785e-05
family O 0 1.3369075624325433e-08
. O 0 2.467762438840282e-09

Both O 0 5.540173209084287e-09
human O 0 5.642290523688587e-10
and O 0 3.820508839846859e-11
mouse O 0 1.9721843713682574e-08
LRP5 O 0 4.10650136473123e-06
cDNAs O 0 2.3656920689063554e-07
have O 0 1.0888356882787775e-09
been O 0 2.9872218587634336e-10
isolated O 0 2.0645096743265867e-09
and O 0 1.4018188519704378e-11
the O 0 5.660552322012125e-13
encoded O 0 1.0868266703267793e-10
mature O 0 3.364996128962794e-11
proteins O 0 2.7230274242048824e-13
are O 0 1.4584659163967978e-13
95 O 0 1.6277409108089724e-13
% O 0 4.97879298552717e-13
identical O 0 2.628213735533791e-08
, O 0 5.667199348691199e-12
indicating O 0 1.3799581477513811e-09
a O 0 7.772905930014673e-11
high O 0 3.2482085909890657e-09
degree O 0 5.068870878588427e-10
of O 0 7.232972901172197e-13
evolutionary O 0 3.0961636032778017e-10
conservation O 0 3.747756965877258e-11
. O 0 9.527100462702887e-12
. O 0 1.8168561100040392e-10

The O 0 5.737785802040207e-09
APC B-Disease 0 1.8872919227419516e-08
variants O 0 1.2848916375318709e-09
I1307K O 0 8.3130897721162e-09
and O 0 5.235520003643579e-11
E1317Q O 0 5.463766328261954e-09
are O 0 1.1441447789195536e-10
associated O 0 1.4327332564789685e-07
with O 0 0.10464971512556076
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.7243092997887288e-06
but O 0 2.908912399846031e-08
not O 0 8.215561564384188e-10
always O 0 3.812127502555995e-09
with O 0 3.4735591139534172e-12
a O 0 3.679668791889412e-10
family O 0 3.997278064105103e-09
history O 0 6.247903971967617e-09
. O 0 1.5913118600607845e-09

Classical O 0 0.0659925639629364
familial B-Disease 1 0.9999934434890747
adenomatous I-Disease 1 0.9999046325683594
polyposis I-Disease 1 0.9999939203262329
( O 0 2.940105616744404e-07
FAP B-Disease 0 5.922086984355701e-06
) O 0 8.850107452440525e-11
is O 0 2.2168756413920576e-11
a O 0 5.144413783852997e-10
high O 0 1.552224057377316e-05
- O 1 0.9878981709480286
penetrance O 1 0.8905348181724548
autosomal B-Disease 1 0.9942595958709717
dominant I-Disease 0 0.10409288853406906
disease I-Disease 0 3.761122206924483e-05
that O 0 2.3798078091497032e-11
predisposes O 0 2.2037340841052355e-08
to O 0 1.1760944648719907e-11
hundreds O 0 1.5367452102510448e-11
or O 0 1.6504494992908292e-10
thousands O 0 2.048864550241447e-10
of O 0 2.527823710352095e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
and I-Disease 1 0.524411141872406
carcinoma I-Disease 1 1.0
and O 0 1.703184011603298e-07
that O 0 1.8775887788979873e-10
results O 0 2.2531450316609636e-10
from O 0 6.6664824702189485e-12
truncating O 0 4.988025281704722e-08
mutations O 0 5.74969689637328e-08
in O 0 2.8199588497646033e-11
the O 0 3.20786522345351e-11
APC B-Disease 0 1.6093183674570355e-08
gene O 0 2.8838867294211923e-08
. O 0 3.6890097643293984e-09

A O 0 1.0867058364283366e-07
variant O 0 6.916645247656561e-07
of O 0 1.4832770567352327e-09
FAP B-Disease 0 9.430960926692933e-05
is O 0 4.497615861964732e-07
attenuated B-Disease 1 0.9537163972854614
adenomatous I-Disease 1 0.9999949932098389
polyposis I-Disease 1 0.9998643398284912
coli I-Disease 1 0.999977707862854
, O 0 9.661555999684879e-10
which O 0 2.4661413536297694e-11
results O 0 1.3336463877688942e-10
from O 0 1.4606640549863492e-11
germ O 0 5.231967588770203e-05
- O 0 4.856120995100355e-06
line O 0 3.0825466978967597e-07
mutations O 0 5.444043438274093e-09
in O 0 1.8106307468970795e-12
the O 0 2.283992222781861e-13
5 O 0 2.1507145023247354e-12
and O 0 2.1987260970246503e-11
3 O 0 7.251652403561515e-12
regions O 0 8.26895669991945e-12
of O 0 2.2312039368865833e-12
the O 0 7.272099589172853e-11
APC B-Disease 0 1.2241507363341952e-08
gene O 0 6.124160734088946e-09
. O 0 1.2555773087896682e-09

Attenuated B-Disease 1 0.9979863166809082
adenomatous I-Disease 1 0.9999821186065674
polyposis I-Disease 1 0.9999270439147949
coli I-Disease 1 0.9999935626983643
patients O 0 0.09238138794898987
have O 0 9.51526004655534e-08
" O 0 5.358905763586108e-09
multiple O 0 1.2073667221557116e-06
" O 0 0.00046596419997513294
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999970197677612
( O 0 1.5076069281860782e-09
typically O 0 2.1298776076150716e-09
fewer O 0 3.0779385984391894e-11
than O 0 1.5346187862141925e-11
100 O 0 1.2107366324787261e-11
) O 0 3.112037808439966e-13
without O 0 1.2535468323082721e-11
the O 0 1.932192253417675e-11
florid O 0 2.0061227132828208e-06
phenotype O 0 3.440761275896875e-08
of O 0 9.689098481868719e-12
classical O 0 4.089287131137098e-08
FAP B-Disease 0 2.421955286990851e-06
. O 0 6.902238780526204e-09

Another O 0 1.306102603848558e-08
group O 0 4.081763538277272e-10
of O 0 1.2536807529606175e-11
patients O 0 7.267111912234725e-10
with O 0 6.76109168651351e-11
multiple O 0 2.512168748580734e-07
adenomas B-Disease 0 0.00030085290200076997
has O 0 2.0952990453793063e-08
no O 0 2.7219426712576933e-09
mutations O 0 3.0776245996122498e-09
in O 0 2.145380010795672e-12
the O 0 1.2723521238336422e-12
APC B-Disease 0 1.8168941351426326e-10
gene O 0 2.0878765383258724e-10
, O 0 6.365859987582378e-13
and O 0 1.498748174177944e-12
their O 0 1.5706934017312157e-11
phenotype O 0 9.015825419567136e-09
probably O 0 2.9431201920004924e-10
results O 0 9.170270445779671e-12
from O 0 1.084363040982847e-13
variation O 0 6.420238646276388e-11
at O 0 1.584898462470008e-10
a O 0 7.658954026545928e-11
locus O 0 1.0982241782642177e-08
, O 0 1.015679988031204e-11
or O 0 7.931395124005647e-12
loci O 0 8.439871718168845e-11
, O 0 3.2621919488634576e-12
elsewhere O 0 1.9720995669825214e-10
in O 0 2.6342612986784975e-12
the O 0 2.089712083930273e-11
genome O 0 2.9092215303450075e-09
. O 0 5.58152524199329e-10

Recently O 0 3.459282879703096e-06
, O 0 1.0930341354242756e-10
however O 0 3.3183029241046214e-11
, O 0 1.3376981813917332e-12
a O 0 2.2657797513203626e-11
missense O 0 5.742484745496768e-07
variant O 0 2.4720418423385127e-07
of O 0 5.620751086787834e-11
APC B-Disease 0 2.080671102078213e-08
( O 0 5.727061620081075e-12
I1307K O 0 1.709140939887277e-09
) O 0 1.8996939438187255e-12
was O 0 2.1160041774326288e-10
described O 0 4.118730911883972e-10
that O 0 6.743341562226446e-12
confers O 0 5.025627136667765e-10
an O 0 1.430909644245526e-12
increased O 0 7.197001661296554e-09
risk O 0 4.354204520495841e-06
of O 0 0.0006404386949725449
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 2.6453736978737652e-08
including O 0 7.465854323651655e-11
multiple O 0 3.102894936546363e-07
adenomas B-Disease 0 0.00011926534352824092
, O 0 6.250844841737546e-10
in O 0 1.1282433876047548e-09
Ashkenazim O 0 4.055742010677932e-06
. O 0 1.0297909192047427e-08

We O 0 5.358376498065809e-08
have O 0 8.676547674779655e-11
studied O 0 5.455294896372642e-11
a O 0 7.70733910721022e-12
set O 0 2.3776798238617225e-11
of O 0 5.764099592596439e-13
164 O 0 3.769423384536452e-10
patients O 0 4.1146952511894597e-10
with O 0 1.9329939870971202e-09
multiple O 1 0.9976363182067871
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
and I-Disease 0 8.133979281410575e-05
/ I-Disease 0 0.0007095297332853079
or I-Disease 0 0.00023857284395489842
carcinoma I-Disease 1 1.0
and O 0 5.290559101922554e-07
analyzed O 0 1.4232333569452749e-06
codons O 0 1.7123241491390218e-07
1263 O 0 3.608784481912153e-06
- O 0 1.5962730230967281e-06
1377 O 0 7.359627716141404e-07
( O 0 5.0907361659469075e-11
exon O 0 2.156144596199283e-08
15G O 0 7.275773583614864e-08
) O 0 1.3663395501822828e-12
of O 0 1.4405013640250708e-13
the O 0 1.3714230489084156e-12
APC B-Disease 0 2.0749227336303022e-10
gene O 0 1.3925112452017885e-10
for O 0 1.8220223940712543e-11
germ O 0 6.240321090444922e-05
- O 0 2.266586307086982e-06
line O 0 3.5032951473112917e-07
variants O 0 2.5760723332268753e-08
. O 0 1.8098254006559955e-09

Three O 0 3.906498680095183e-09
patients O 0 1.0675863526543594e-09
with O 0 1.0720927617891007e-11
the O 0 1.0053952462230065e-11
I1307K O 0 1.4510943557866085e-08
allele O 0 1.9483119118035575e-08
were O 0 4.836667177876564e-10
detected O 0 9.633172481926522e-08
, O 0 5.699825919407153e-13
each O 0 1.56572736546845e-12
of O 0 3.456562466808144e-11
Ashkenazi O 0 2.2016044454176154e-07
descent O 0 7.174957090683165e-07
. O 0 5.369935163201944e-09

Four O 0 3.726507102896903e-08
patients O 0 3.2179446662894406e-08
had O 0 8.258325689958212e-10
a O 0 4.832840239110681e-10
germ O 0 0.0002270654367748648
- O 0 5.3419189498526976e-06
line O 0 6.984068789961384e-08
E1317Q O 0 1.0352557922033157e-08
missense O 0 5.121177792943854e-08
variant O 0 3.811923665608674e-09
of O 0 3.841280592220553e-12
APC O 0 9.224486174908009e-10
that O 0 8.884575714018794e-11
was O 0 1.2264264048766904e-09
not O 0 1.3521694181006794e-11
present O 0 5.485142721972647e-12
in O 0 3.0695825655596698e-12
controls O 0 3.668983117322e-09
; O 0 2.7399087772911335e-12
one O 0 8.341694847889547e-13
of O 0 3.228293622551705e-14
these O 0 2.6468421638475848e-12
individuals O 0 7.764499980467132e-12
had O 0 2.7277202718778426e-10
an O 0 1.0207561792346942e-12
unusually O 0 1.6864121210602434e-09
large O 0 4.52346146651017e-11
number O 0 2.042760752218875e-11
of O 0 2.5862187825326233e-12
metaplastic B-Disease 0 3.6815615089835774e-07
polyps I-Disease 0 1.756537670871694e-08
of I-Disease 0 1.1609876254814466e-11
the I-Disease 0 1.2180008390760833e-10
colorectum I-Disease 0 1.8829701957656653e-06
. O 0 1.9065644618621036e-09

There O 0 6.81449119355193e-09
is O 0 1.8110943300619908e-11
increasing O 0 1.4238860958359911e-11
evidence O 0 4.542750897673642e-11
that O 0 9.048756188789753e-11
there O 0 5.241625189444932e-11
exist O 0 6.19808482316131e-10
germ O 0 1.1106134252258926e-06
- O 0 2.3640630786303518e-08
line O 0 4.852884760708776e-10
variants O 0 3.835108879773896e-12
of O 0 9.740972405861831e-14
the O 0 8.562754455140875e-13
APC B-Disease 0 8.072913171286444e-11
gene O 0 1.6030295146851614e-11
that O 0 3.0030661117563806e-12
predispose O 0 2.8774867905090318e-11
to O 0 1.510131538047521e-12
the O 0 2.219590613736222e-12
development O 0 3.0953633753383336e-12
of O 0 3.493573833002195e-11
multiple O 1 0.8553158044815063
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9776870608329773
carcinoma I-Disease 1 1.0
, O 0 6.773102523283114e-09
but O 0 1.5024706478961036e-10
without O 0 2.0067223924224997e-11
the O 0 7.538425612907407e-12
florid O 0 4.272268142813118e-06
phenotype O 0 2.9928195033335214e-08
of O 0 3.0470543622984625e-12
classical O 0 2.364675344423972e-09
FAP B-Disease 0 1.3323510295037977e-08
, O 0 2.9781789014082793e-12
and O 0 2.4990252922574285e-12
possibly O 0 1.455316249454608e-11
with O 0 1.427129031270069e-12
importance O 0 5.9605294033815426e-09
for O 0 6.25542224952369e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.0003777516831178218
in O 0 3.162616696306131e-11
the O 0 2.149766909625983e-12
general O 0 5.7257618785167e-12
population O 0 3.556250996808452e-12
. O 0 9.137882291121446e-12
. O 0 2.982968871911851e-10

Genomic O 0 9.778722187547828e-07
structure O 0 5.606005970548722e-08
of O 0 7.501110149688017e-11
the O 0 2.155218448152141e-09
human O 0 2.9237167836981826e-05
congenital B-Disease 1 0.9999988079071045
chloride I-Disease 1 0.9999985694885254
diarrhea I-Disease 1 1.0
( O 0 2.584404910521698e-06
CLD B-Disease 0 0.010915195569396019
) O 0 5.620593435118337e-10
gene O 0 3.46643780346767e-08
. O 0 3.530796321982166e-09

Congenital B-Disease 1 0.999996542930603
chloride I-Disease 1 0.9999516010284424
diarrhea I-Disease 1 0.9999998807907104
( O 0 2.905597398239479e-07
CLD B-Disease 0 0.08008051663637161
) O 0 8.617063729232655e-10
is O 0 4.731849911898678e-10
caused O 0 6.04388317171356e-09
by O 0 1.4883463905768224e-10
mutations O 0 8.586732747062342e-07
in O 0 4.0074957241564846e-11
a O 0 1.2491511991452597e-10
gene O 0 2.5726829555594577e-09
which O 0 6.264949670153896e-11
encodes O 0 2.0684709500784493e-09
an O 0 1.2400266369283486e-09
intestinal O 0 0.3265647888183594
anion O 0 0.0004535344778560102
transporter O 0 0.00016804596816655248
. O 0 4.7516429901861557e-08

We O 0 1.424763524937589e-07
report O 0 5.5820892352898e-10
here O 0 7.888609036832417e-12
the O 0 3.165600648367267e-13
complete O 0 2.888890949376277e-12
genomic O 0 4.368070835591986e-11
organization O 0 1.350761299687142e-12
of O 0 1.1361361341739179e-13
the O 0 2.605155891358124e-12
human O 0 1.8630874620839677e-10
CLD B-Disease 0 5.883588301003329e-07
gene O 0 1.9491324110276764e-09
which O 0 1.3258043274344544e-10
spans O 0 2.983624680652497e-09
approximately O 0 4.4552261185826225e-11
39kb O 0 2.0064639727479516e-07
, O 0 9.275924646445777e-12
and O 0 1.0706296960094619e-11
comprises O 0 6.314460065937055e-11
21 O 0 2.2056746706855535e-10
exons O 0 2.5288983351856587e-08
. O 0 4.999662461813159e-09

All O 0 8.089167558011923e-09
exon O 0 5.63788489671424e-07
/ O 0 1.8931078216155584e-07
intron O 0 9.90712464954413e-07
boundaries O 0 6.36598240788544e-09
conform O 0 1.763335255589027e-08
to O 0 2.0177722340197768e-11
the O 0 4.237129050399524e-11
GT O 0 3.015055582977766e-08
/ O 0 1.8532759327172244e-07
AG O 0 0.00020053285697940737
rule O 0 4.097289618698596e-08
. O 0 3.743360288410713e-09

An O 0 1.2023788908965827e-10
analysis O 0 3.267831005793198e-10
of O 0 1.311507109511001e-12
the O 0 4.172622317111241e-12
putative O 0 3.903945966499123e-08
promoter O 0 1.1915947197849164e-06
region O 0 1.1066237926016242e-09
sequence O 0 4.037527256972595e-10
shows O 0 3.297093986720512e-10
a O 0 2.506135299285006e-10
putative O 0 1.269913667556466e-07
TATA O 0 5.611054803011939e-07
box O 0 6.502417022602458e-07
and O 0 2.2631514440263345e-09
predicts O 0 4.9247443456579276e-08
multiple O 0 6.978084776676496e-10
transcription O 0 9.024148095448936e-10
factor O 0 6.462627655245967e-10
binding O 0 4.092398420141308e-09
sites O 0 1.2154284689813721e-08
. O 0 3.396349645967689e-09

The O 0 1.8720005545702634e-09
genomic O 0 3.503408052552004e-08
structure O 0 7.479434316337574e-08
was O 0 5.669940628116876e-10
determined O 0 2.0561619074044302e-10
using O 0 1.3682857798180681e-11
DNA O 0 8.033518850147914e-10
from O 0 1.8627016162148236e-12
several O 0 3.5418239521800565e-13
sources O 0 4.638685702912371e-12
including O 0 5.941063071189523e-13
multiple O 0 1.8539698942721117e-10
large O 0 2.8902236159922268e-09
- O 0 1.354653022644925e-06
insert O 0 1.4602852616008022e-07
libaries O 0 1.877641295777721e-07
and O 0 1.1063715915637928e-11
genomic O 0 1.2039691466014801e-10
DNA O 0 2.3947224203624273e-09
from O 0 3.0315217003362704e-10
Finnish O 0 6.346558075165376e-05
CLD B-Disease 0 0.01575821079313755
patients O 0 1.227000723247329e-07
and O 0 1.4754865107491355e-09
controls O 0 5.37781943421578e-07
. O 0 2.5621949006904288e-08

Exon O 0 4.500371233007172e-06
- O 0 2.4622823957543005e-07
specific O 0 5.70058500404258e-10
primers O 0 1.9596460276716243e-07
developed O 0 9.387084443090998e-10
in O 0 9.628818575802e-12
this O 0 1.9683360844013897e-12
study O 0 2.4283138434083584e-12
will O 0 1.4101798071278204e-12
facilitate O 0 4.495102207124901e-12
mutation O 0 3.8859487849762786e-10
screening O 0 8.840034954049614e-11
studies O 0 1.7775524108198937e-11
of O 0 8.904568705656035e-13
patients O 0 8.285790803475024e-11
with O 0 3.5371826995200806e-11
the O 0 6.828854814955321e-09
disease O 0 5.113206498208456e-06
. O 0 4.653465168757975e-09

Genomic O 0 2.5914886236932944e-07
sequencing O 0 1.9333048939529363e-08
of O 0 1.0956683477170159e-10
a O 0 2.7760729270909223e-09
BAC O 0 3.0253897421061993e-05
clone O 0 1.6049360056058504e-05
H O 1 0.9999996423721313
_ O 0 2.4038200319154157e-09
RG364P16 O 0 3.1119908872057067e-09
revealed O 0 1.0680364370685425e-09
the O 0 1.3523467285239676e-12
presence O 0 2.1615190540225093e-11
of O 0 2.3882951822803977e-13
another O 0 1.6528745386268362e-11
, O 0 7.314632298298374e-13
highly O 0 1.1888779023749851e-11
homologous O 0 6.538941610401139e-11
gene O 0 2.694697520677636e-10
3 O 0 5.8917523637624925e-12
of O 0 6.068578799200974e-13
the O 0 1.0806131683915865e-10
CLD B-Disease 0 1.0207843843090814e-05
gene O 0 8.050348832000509e-09
, O 0 1.2953230068418753e-12
with O 0 2.8941063955068014e-13
a O 0 6.444121278259551e-12
similar O 0 5.2487479640372925e-11
genomic O 0 1.034428320778602e-09
structure O 0 1.6267122759927588e-07
, O 0 3.2068358385428652e-12
recently O 0 4.034170775213397e-10
identified O 0 1.770066981876539e-09
as O 0 1.0729320210067783e-10
the O 0 1.5063163516515488e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 2.2255699150264263e-06
( O 0 3.943020077112891e-10
PDS B-Disease 0 2.926811646375427e-07
) O 0 2.2170024496781515e-11
. O 0 2.2937825250313182e-11
. O 0 6.584073841686688e-10

The O 0 8.107533311374482e-09
APCI1307K O 0 2.829348341037985e-05
allele O 0 7.081978310452541e-06
and O 0 7.92811061245402e-09
cancer B-Disease 0 2.329549261048669e-06
risk O 0 1.9411905327615386e-07
in O 0 6.712163463928889e-11
a O 0 9.403548079101043e-11
community O 0 1.952233513735635e-11
- O 0 1.1036143554576938e-08
based O 0 3.406668350192099e-11
study O 0 7.945068214443296e-12
of O 0 1.985409016011519e-12
Ashkenazi O 0 1.2847256591896894e-08
Jews O 0 5.208731668204791e-09
. O 0 3.949962579241628e-09

Mutations O 0 0.00010142690734937787
in O 0 6.891005099873837e-09
APC O 0 3.7979881994942843e-07
are O 0 3.494830203010224e-09
classically O 0 0.028910746797919273
associated O 0 1.8595196706883144e-06
with O 0 1.976916337298462e-06
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.999994158744812
polyposis I-Disease 1 0.9999985694885254
( O 0 3.3374013241882494e-07
FAP B-Disease 0 3.744444711628603e-06
) O 0 6.4269894961555e-11
, O 0 4.1999455129004826e-12
a O 0 9.215798679740317e-10
highly O 0 0.0010832196567207575
penetrant O 1 0.9999852180480957
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999986886978149
disorder I-Disease 1 1.0
characterized O 0 8.125714521156624e-05
by O 0 2.496032935894732e-09
multiple O 0 0.0002743175718933344
intestinal O 1 0.9903538227081299
polyps B-Disease 0 0.00023882274399511516
and O 0 1.1905356700481207e-09
, O 0 4.478756341491641e-12
without O 0 7.799053070023376e-12
surgical O 0 8.582846100502195e-10
intervention O 0 5.441424533181305e-10
, O 0 8.207577412849831e-13
the O 0 4.867774477772258e-13
development O 0 3.0045972654324515e-11
of O 0 1.5850655472604558e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.999044899203e-08
CRC B-Disease 0 1.0520891009946354e-05
) O 0 9.925762989304587e-11
. O 0 8.192168610143824e-10

APC B-Disease 0 1.2603134564415086e-05
is O 0 7.887718034282898e-09
a O 0 1.7252890671670684e-08
tumour O 1 0.999992847442627
- O 0 0.00012805384176317602
suppressor O 0 2.967231921502389e-05
gene O 0 1.862636622718128e-07
, O 0 1.3207254734304286e-11
and O 0 1.0442858383585829e-11
somatic O 0 3.758271205356323e-08
loss O 0 7.017142706899904e-07
occurs O 0 1.8578692362325455e-08
in O 0 9.643941645265386e-09
tumours B-Disease 1 0.9999923706054688
. O 0 1.867405217126361e-07

The O 0 1.110707614770945e-08
germline O 0 2.758840537353535e-06
T O 0 1.497589528298704e-05
- O 0 1.45145492069787e-07
to O 0 1.3843176605021768e-10
- O 0 5.635401834069853e-08
A O 0 1.081376543865531e-09
transversion O 0 3.657860858652384e-08
responsible O 0 1.00728834995234e-10
for O 0 2.9327264900423644e-13
the O 0 1.1146805050168962e-12
APC O 0 1.6042599193522022e-10
I1307K O 0 2.9576274762632693e-10
allele O 0 3.6322861385329475e-10
converts O 0 2.1099578681460507e-11
the O 0 3.1569499618633312e-12
wild O 0 4.005623263636515e-11
- O 0 1.2760165146730174e-09
type O 0 3.073770349359961e-09
sequence O 0 4.6664016400965735e-11
to O 0 2.973484739682286e-12
a O 0 5.85541559683378e-10
homopolymer O 0 0.00010390214447397739
tract O 0 2.9529537641792558e-05
( O 0 9.751546792280408e-11
A8 O 0 2.026030756496766e-07
) O 0 1.438896397865097e-11
that O 0 5.791236934449273e-11
is O 0 1.7820785125355343e-10
genetically O 0 9.227095532082785e-09
unstable O 0 8.57578415889293e-05
and O 0 1.673617866515542e-08
prone O 0 9.498307190369815e-05
to O 0 1.6851443851439996e-10
somatic O 0 1.045584667735966e-06
mutation O 0 7.087518497428391e-06
. O 0 3.620308497431779e-09

The O 0 5.463735242017265e-09
I1307K O 0 1.2599565479831654e-07
allele O 0 3.3269589039264247e-07
was O 0 1.344050537532837e-09
found O 0 2.514212171789154e-10
in O 0 9.132972850212084e-11
6 O 0 2.1375370362619606e-09
. O 0 3.3538629651275187e-09

1 O 0 1.4551575056032107e-08
% O 0 1.3102433027434301e-10
of O 0 1.81123952641693e-11
unselected O 0 5.376684384827968e-06
Ashkenazi O 0 8.248760536844202e-07
Jews O 0 1.0515287307555354e-08
and O 0 4.805338904567691e-10
higher O 0 1.1250678610963405e-08
proportions O 0 9.870555572888406e-08
of O 0 1.0050195051181099e-11
Ashkenazim O 0 6.467615776273306e-08
with O 0 5.299256172763833e-11
family O 0 3.121500835590041e-10
or O 0 1.8159448944565781e-10
personal O 0 5.1542802026460777e-08
histories O 0 4.238436801529133e-08
of O 0 3.2340487926552086e-11
CRC B-Disease 0 1.114542328650714e-06
( O 0 4.733327965689149e-11
ref O 0 8.568580369683332e-07
. O 0 6.471725065571032e-12
2 O 0 5.1593770922231386e-11
) O 0 2.955229463919018e-11
. O 0 6.49556186615996e-10

To O 0 3.314370167206704e-10
evaluate O 0 1.8921821887118995e-09
the O 0 3.2136630596230065e-12
role O 0 9.828004729484086e-12
of O 0 4.3381677373652283e-13
I1307K O 0 1.651256464896278e-09
in O 0 8.19350837177879e-11
cancer B-Disease 0 3.880160903690921e-08
, O 0 5.277516271218197e-12
we O 0 4.624050795043466e-11
genotyped O 0 4.77224926243025e-09
5 O 0 5.867752898153222e-12
, O 0 1.1992329872201335e-12
081 O 0 8.365164561041638e-09
Ashkenazi O 0 2.9440201387842535e-09
volunteers O 0 4.0879161167239886e-11
in O 0 5.067222249438563e-12
a O 0 9.781817716936203e-11
community O 0 5.406011402420141e-11
survey O 0 2.633568030319111e-08
. O 0 1.3245260443994766e-09

Risk O 0 1.5495586922043003e-05
of O 0 7.313402106134959e-10
developing O 0 8.135370421769039e-07
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 1.56258977312973e-07
breast I-Disease 0 0.039394311606884
and I-Disease 0 2.949957078612897e-08
other I-Disease 0 1.9958190655700037e-09
cancers I-Disease 0 0.0016253577778115869
were O 0 2.970071300012478e-09
compared O 0 2.013476052553642e-09
between O 0 3.670981227332781e-11
genotyped O 0 9.264237377237805e-08
I1307K O 0 3.131550574408948e-09
carriers O 0 1.7565661425411605e-10
and O 0 6.208324219297845e-12
non O 0 6.903048271889034e-11
- O 0 3.801309045314838e-09
carriers O 0 4.565520184129923e-10
and O 0 6.361190654086135e-12
their O 0 3.193754722491393e-12
first O 0 1.858837563040172e-11
- O 0 2.217407590876519e-08
degree O 0 3.0344040613528023e-09
relatives O 0 4.609367554309074e-09
. O 0 9.760781072287728e-10

Sperm O 0 1.0603965847622021e-06
DNA O 0 1.711710098106778e-07
analysis O 0 1.39675808696893e-08
in O 0 1.3992150493802313e-10
a O 0 5.227093868853672e-09
Friedreich B-Disease 0 0.08473971486091614
ataxia I-Disease 1 0.9637238383293152
premutation O 0 0.04406862333416939
carrier O 0 1.562963552714791e-05
suggests O 0 4.283426058293571e-09
both O 0 2.0342805565065625e-11
meiotic O 0 2.7703878302531848e-08
and O 0 4.646817305942186e-11
mitotic O 0 5.497866606418711e-09
expansion O 0 1.2324412601572021e-09
in O 0 2.9304315918299295e-11
the O 0 5.6550979177227845e-11
FRDA B-Disease 0 3.0587352739530616e-06
gene O 0 6.219809733920556e-08
. O 0 3.8264857948888675e-09

Friedreich B-Disease 1 0.983007550239563
ataxia I-Disease 1 0.9987509250640869
is O 0 6.120559646660695e-06
usually O 0 1.4239718666431145e-06
caused O 0 6.862244106287108e-08
by O 0 1.799881771402667e-11
an O 0 3.860480077971795e-12
expansion O 0 3.588326025205646e-10
of O 0 9.249229854235708e-12
a O 0 1.626003554022759e-09
GAA O 0 2.6983959742210573e-06
trinucleotide O 0 2.914867138770205e-07
repeat O 0 1.467874533034319e-08
in O 0 1.0387750555562736e-11
intron O 0 7.099477450367431e-09
1 O 0 1.0415724706336338e-11
of O 0 8.057583463297324e-13
the O 0 5.5965423267911873e-11
FRDA B-Disease 0 6.208660579432035e-06
gene O 0 5.631190092003635e-08
. O 0 2.7205619979042694e-09

Occasionally O 0 9.476768809690839e-07
, O 0 6.617105474671092e-11
a O 0 8.076640051202233e-11
fully O 0 2.163401902066653e-09
expanded O 0 1.2913255187374517e-10
allele O 0 5.695643068293066e-09
has O 0 1.79945697231787e-10
been O 0 3.064588166568072e-11
found O 0 2.2238167904364836e-11
to O 0 3.945664541621374e-12
arise O 0 2.44793130210752e-10
from O 0 3.1169920702671383e-13
a O 0 1.0097904283579151e-11
premutation O 0 2.4196069592363756e-09
of O 0 2.7262300490021874e-12
100 O 0 4.383126847584684e-11
or O 0 2.972132817635753e-10
less O 0 4.598618819073863e-09
triplet O 0 8.253635314758867e-05
repeats O 0 6.36987181223958e-07
. O 0 6.893463577739567e-09

We O 0 6.867180957215169e-08
have O 0 1.5155607324679465e-10
examined O 0 5.621697551916327e-10
the O 0 1.6072107837314387e-12
sperm O 0 4.980585943670235e-10
DNA O 0 4.589853774827901e-10
of O 0 3.0194579475617545e-12
a O 0 6.88917478619544e-10
premutation O 0 2.2192232790985145e-05
carrier O 0 5.475711532199057e-06
. O 0 4.633554873123558e-09

This O 0 8.335981349638644e-10
mans O 0 3.604181486593916e-08
leucocyte O 0 5.559451778935909e-07
DNA O 0 3.3539578225827427e-07
showed O 0 2.062441240013868e-07
one O 0 1.4102241596702925e-10
normal O 0 1.7801735641143068e-09
allele O 0 4.484259186199324e-09
and O 0 6.317010716599958e-12
one O 0 4.5010050374327815e-12
allele O 0 1.4554002447653147e-10
of O 0 1.5950501553244067e-12
approximately O 0 1.713323580232462e-11
100 O 0 6.649646805412246e-11
repeats O 0 2.3927377412746864e-08
. O 0 9.245570975480177e-10

His O 0 3.3398841026155424e-08
sperm O 0 1.8877911145409598e-07
showed O 0 3.622976763040242e-08
an O 0 1.8455180959831008e-12
expanded O 0 1.3702557144501526e-10
allele O 0 1.0809564798819338e-08
in O 0 2.4605878098937772e-11
a O 0 1.9783008564644433e-10
tight O 0 5.556717042054515e-07
range O 0 2.540672949802314e-10
centering O 0 2.3826796091697133e-10
on O 0 6.051178308430494e-11
a O 0 2.0484650434249296e-11
size O 0 2.5091786426401086e-09
of O 0 5.923132210400306e-12
approximately O 0 3.497582223843665e-10
320 O 0 2.0676504952632513e-09
trinucleotide O 0 1.6037299701565644e-06
repeats O 0 7.744575896140304e-07
. O 0 9.710704240717405e-09

His O 0 2.1788498827390868e-07
affected O 0 1.0272390227328287e-07
son O 0 3.4403680615469057e-07
has O 0 3.5651989693796793e-10
repeat O 0 1.4563347860985232e-08
sizes O 0 1.6780031586449695e-08
of O 0 9.75634070060627e-12
1040 O 0 3.9900356796351844e-08
and O 0 5.021957294459867e-10
540 O 0 6.9193220042507164e-09
. O 0 1.593282950018704e-09

These O 0 5.986937057222974e-10
data O 0 3.387303770807648e-10
suggest O 0 2.7131502600141744e-10
that O 0 9.780669113154672e-13
expansion O 0 1.475577819654017e-11
occurs O 0 1.0090876918777969e-11
in O 0 1.2979141416138984e-13
two O 0 3.6682690305461785e-13
stages O 0 4.858003582741688e-11
, O 0 2.7748812904578035e-13
the O 0 7.69883831165663e-14
first O 0 9.630099452248575e-13
during O 0 9.976530018773744e-12
meiosis O 0 2.9561894598906235e-10
followed O 0 1.4871340270339317e-11
by O 0 7.436045052280904e-13
a O 0 1.307618683471512e-11
second O 0 4.016640492432444e-11
mitotic O 0 5.8313254669428716e-08
expansion O 0 1.5372517481182513e-08
. O 0 3.045734331408312e-09

We O 0 5.10603044290292e-08
also O 0 5.617771525745496e-11
show O 0 5.646456635588493e-10
that O 0 7.740664012545473e-12
in O 0 1.3108068233277925e-12
all O 0 2.2893221606617997e-13
informative O 0 1.720706077623646e-10
carrier O 0 6.644734540373065e-09
father O 0 1.5688267351876561e-09
to O 0 6.944763340788196e-12
affected O 0 1.88476484419553e-10
child O 0 1.8542653634767703e-08
transmissions O 0 1.339549982048993e-07
, O 0 6.29442028013405e-13
with O 0 1.8742868585289174e-13
the O 0 4.975157113541739e-13
notable O 0 6.187247329064727e-12
exception O 0 1.8181482361323553e-11
of O 0 2.7425319502373535e-13
the O 0 6.830564325960298e-12
premutation O 0 7.668568713370405e-08
carrier O 0 6.0917155764173e-09
, O 0 4.698280067945426e-13
the O 0 1.2427138853556008e-13
expansion O 0 9.780991988561638e-12
size O 0 4.245619411591406e-09
decreases O 0 2.3045343411354224e-08
. O 0 3.7936705860053266e-11
. O 0 3.90932897165186e-10

The O 0 2.218231376360791e-09
R496H O 0 5.623762433515367e-08
mutation O 0 5.992220764028389e-08
of O 0 8.59515757178908e-12
arylsulfatase O 0 3.2966451612992387e-07
A O 0 2.5986054197346675e-08
does O 0 3.65091850085264e-08
not O 0 1.2907475088752562e-09
cause O 0 1.6050626072683372e-06
metachromatic B-Disease 1 0.9999818801879883
leukodystrophy I-Disease 1 0.9999845027923584
. O 0 7.181084242802172e-07

Deficiency B-Disease 1 0.9969208240509033
of I-Disease 0 3.2491502821585527e-09
arylsulfatase I-Disease 0 5.9513942687772214e-05
A I-Disease 0 2.0277607859497948e-07
( O 0 5.176461481681827e-10
ARSA O 0 5.213360782363452e-05
) O 0 1.2150888628603695e-10
enzyme O 0 4.546448106879097e-09
activity O 0 1.0055006782749842e-07
causes O 0 2.8980226488783956e-05
metachromatic B-Disease 1 0.9999939203262329
leukodystrophy I-Disease 1 0.9999964237213135
( O 0 1.6955531464191154e-05
MLD B-Disease 1 0.9999784231185913
) O 0 3.876697185489775e-09
. O 0 5.011462800297295e-09

A O 0 2.7116684009342862e-08
number O 0 2.536054144464117e-10
of O 0 8.040106080908771e-11
ARSA O 0 0.000388187647331506
gene O 0 3.463953532900632e-07
mutations O 0 1.3128158116160193e-06
responsible O 0 4.956444499271129e-08
for O 0 7.252936029544799e-09
MLD B-Disease 1 0.9999991655349731
have O 0 4.2443710412953806e-07
been O 0 1.1502486962911007e-08
identified O 0 1.9324133404552413e-07
. O 0 3.189054353924803e-09

Recently O 0 5.842848054271599e-07
, O 0 1.7558215298363322e-11
the O 0 2.4196911835305812e-12
R496H O 0 1.52670542874489e-09
mutation O 0 1.8308622395935004e-09
of O 0 4.915715837855439e-12
ARSA O 0 1.2077527571818791e-05
was O 0 1.572169727737105e-09
proposed O 0 1.2923671681430715e-11
to O 0 4.972854159707163e-12
be O 0 6.603173563490827e-11
a O 0 1.3123942210757633e-10
cause O 0 1.1453819226403539e-08
of O 0 8.793458183831149e-10
MLD B-Disease 1 0.9999988079071045
( O 0 1.667698756868674e-10
Draghia O 0 2.353365289309295e-07
et O 0 4.409126574955735e-08
al O 0 1.0621926094245282e-07
. O 0 2.472876937942292e-11
, O 0 4.204714701416812e-12
1997 O 0 2.2702525623308212e-11
) O 0 7.629236652151317e-12
. O 0 1.356535717089713e-10

We O 0 4.0038880655401954e-08
have O 0 5.045073386833465e-11
investigated O 0 1.0756743273887537e-09
the O 0 2.48680069592222e-12
R496H O 0 5.3097530816614835e-09
mutation O 0 9.285391122659803e-09
and O 0 6.231957658253684e-12
found O 0 8.416975449954123e-12
this O 0 4.846448763140554e-13
mutation O 0 4.4717102243296836e-10
at O 0 1.2135711706384722e-11
a O 0 2.8238879984376908e-11
relatively O 0 4.530898156662744e-10
high O 0 1.1557349521851279e-09
frequency O 0 1.617788036867296e-08
in O 0 7.580740505816475e-13
an O 0 1.1109146100859307e-13
African O 0 1.3900385291594486e-13
American O 0 1.5073084924308033e-12
population O 0 3.235877820036148e-13
( O 0 2.4008965930806536e-13
f O 0 3.3177238734083403e-09
= O 0 3.1956409740629965e-10
0 O 0 5.505455900195466e-12
. O 0 3.884905092933766e-13
09 O 0 1.1250961967634865e-11
, O 0 3.920314593786056e-13
n O 0 3.4572515961173167e-09
= O 0 1.1450739023644019e-08
61 O 0 3.506865631219824e-11
subjects O 0 1.5622999782749503e-08
) O 0 1.9776583148889415e-11
. O 0 2.589933267849176e-10

The O 0 2.6541274067426457e-08
ARSA O 0 1.9463865100988187e-05
enzyme O 0 9.26736198891831e-09
activity O 0 2.289160638824228e-09
in O 0 1.536601575147234e-11
subjects O 0 6.8421277532593194e-09
with O 0 2.480775827817805e-11
and O 0 3.7428563720576236e-11
without O 0 1.4866802233726162e-11
the O 0 1.1673798863340301e-12
R496H O 0 4.4322759351622665e-10
mutation O 0 1.1541841926643315e-09
was O 0 2.784258656962635e-10
determined O 0 2.5913278189904076e-09
and O 0 3.1639198205812846e-11
found O 0 8.441707055606429e-11
to O 0 1.754181348789796e-11
be O 0 1.6904536659367864e-09
normal O 0 6.696415866258576e-09
. O 0 1.0116634197032681e-09

It O 0 9.74605196546463e-09
is O 0 9.674644418922185e-11
therefore O 0 5.589811252759702e-11
concluded O 0 7.46144118712877e-11
that O 0 3.9159875429156665e-13
the O 0 5.25961652703133e-13
R496H O 0 9.487253205264778e-10
mutation O 0 5.484280252154861e-10
of O 0 1.3827910171071434e-12
ARSA O 0 1.5964374142640736e-06
does O 0 7.820511460643331e-10
not O 0 9.536336130488987e-12
negatively O 0 3.62420128630081e-11
influence O 0 7.489397990667612e-12
the O 0 1.765317059199134e-12
activity O 0 5.854296214469201e-11
of O 0 9.965893128099923e-13
ARSA O 0 5.187475380807882e-06
and O 0 4.117906293732432e-10
is O 0 4.864651390046326e-11
not O 0 1.8908850180077152e-11
a O 0 4.4443304592078903e-10
cause O 0 7.620510444894535e-08
of O 0 4.1650999094144936e-08
MLD B-Disease 1 0.9999762773513794

Down O 0 1.3630412922793766e-06
- O 0 3.0863444067108503e-07
regulation O 0 5.8026312643733036e-09
of O 0 8.041899784982931e-11
transmembrane O 0 4.765479843626963e-06
carbonic O 0 1.4005643151904223e-06
anhydrases O 0 6.7953751567984e-06
in O 0 1.6670803404394974e-08
renal B-Disease 0 0.03621840476989746
cell I-Disease 1 0.9989863038063049
carcinoma I-Disease 1 1.0
cell O 0 0.15350943803787231
lines O 0 1.2176535619801143e-06
by O 0 1.447316988478775e-10
wild O 0 6.252162165765185e-08
- O 0 7.740350702079013e-05
type O 0 0.0052442592568695545
von B-Disease 1 0.9982151985168457
Hippel I-Disease 1 0.9974899291992188
- I-Disease 0 0.22905106842517853
Lindau I-Disease 0 0.17895188927650452
transgenes O 0 0.0014177151024341583
. O 0 2.307816373559035e-07

To O 0 5.153215631992225e-09
discover O 0 9.527990840751954e-08
genes O 0 6.807137964415233e-09
involved O 0 4.902239947313092e-09
in O 0 4.071012416062558e-09
von B-Disease 1 0.9988829493522644
Hippel I-Disease 1 0.9999196529388428
- I-Disease 1 0.9998156428337097
Lindau I-Disease 1 0.9993643164634705
( O 0 3.1059201432981354e-08
VHL B-Disease 0 2.984531965921633e-05
) O 0 3.131344489260002e-11
- O 0 2.6792942975362166e-08
mediated O 0 1.1489039053458328e-07
carcinogenesis O 0 8.61047810758464e-05
, O 0 8.221875263947354e-11
we O 0 4.370006301268603e-10
used O 0 5.2439030895357064e-08
renal B-Disease 0 0.03644835203886032
cell I-Disease 1 0.9989829659461975
carcinoma I-Disease 1 1.0
cell O 1 0.9916948676109314
lines O 0 0.0001235638774232939
stably O 0 9.163701179204509e-05
transfected O 0 2.8731974452966824e-06
with O 0 6.642450478544504e-10
wild O 0 5.930005997356602e-08
- O 0 0.00018339979578740895
type O 0 0.010233744978904724
VHL O 0 0.024332286790013313
- O 0 5.850235993420938e-06
expressing O 0 3.440870273152541e-07
transgenes O 0 9.607237188902218e-06
. O 0 7.97010812902954e-09

Large O 0 1.4227833133872991e-08
- O 0 8.457917033410922e-08
scale O 0 1.2877499955266103e-07
RNA O 0 4.265400033176547e-09
differential O 0 1.5916890916400916e-08
display O 0 4.757789717757532e-09
technology O 0 4.171615552994723e-10
applied O 0 9.516680499199737e-11
to O 0 3.5803643036458332e-12
these O 0 6.038861251334016e-12
cell O 0 3.081355970380173e-08
lines O 0 1.0929227300948696e-08
identified O 0 9.75923564183745e-10
several O 0 3.6815394482969666e-12
differentially O 0 4.2166092839579505e-08
expressed O 0 1.5009554710232464e-10
genes O 0 3.823434069349929e-10
, O 0 2.349600277794933e-13
including O 0 4.118740396484577e-13
an O 0 1.5161113467096476e-12
alpha O 0 1.0782069681525286e-09
carbonic O 0 2.483279182285969e-08
anhydrase O 0 6.602439839298313e-08
gene O 0 3.5561884548229727e-09
, O 0 4.628453523225495e-11
termed O 0 2.9103775389671682e-08
CA12 O 0 2.6389636332169175e-05
. O 0 6.136438024384461e-09

The O 0 2.131979037756082e-09
deduced O 0 5.150840465262263e-08
protein O 0 9.096729480795318e-10
sequence O 0 6.696042054166185e-10
was O 0 3.395441150466638e-10
classified O 0 1.388196502194461e-10
as O 0 1.734034682336627e-12
a O 0 4.758129654169885e-11
one O 0 4.238976281101259e-09
- O 0 5.814931682834867e-06
pass O 0 1.0456789567570013e-07
transmembrane O 0 1.0155071322515141e-05
CA O 0 1.1000385029547033e-06
possessing O 0 4.0738223905378845e-10
an O 0 2.469684613065626e-12
apparently O 0 4.213752902160195e-09
intact O 0 1.4105234757977314e-09
catalytic O 0 2.217629413436839e-10
domain O 0 4.704678313594002e-11
in O 0 8.171638712917151e-12
the O 0 3.4205107496410037e-11
extracellular O 0 1.2825618966871843e-07
CA O 0 0.00012741379032377154
module O 0 2.8453621325752465e-06
. O 0 5.296411753619168e-09

Reintroduced O 0 5.703989700123202e-06
wild O 0 6.468578135354619e-07
- O 0 0.0002515220839995891
type O 0 0.00010707557521527633
VHL B-Disease 0 0.00015988494851626456
strongly O 0 1.0651562298846784e-08
inhibited O 0 1.0453570231661047e-09
the O 0 3.547504954723446e-12
overexpression O 0 1.2067900845291746e-10
of O 0 7.419412306752804e-13
the O 0 5.39806437396817e-12
CA12 O 0 2.526999196561519e-07
gene O 0 8.001633799992192e-10
in O 0 5.3812291428423364e-11
the O 0 7.313750716164691e-10
parental O 0 0.0024890429340302944
renal B-Disease 1 0.8360418081283569
cell I-Disease 1 0.9997087121009827
carcinoma I-Disease 1 1.0
cell O 1 0.9815244078636169
lines O 0 0.0014046337455511093
. O 0 1.314630821980245e-07

Similar O 0 5.054394591752498e-08
results O 0 2.043882219027182e-08
were O 0 1.0841082892509846e-10
obtained O 0 3.7925004803263107e-10
with O 0 3.149799865376224e-11
CA9 O 0 1.175087527371943e-05
, O 0 1.908966691319125e-12
encoding O 0 3.479654758775652e-11
another O 0 4.936381858833272e-10
transmembrane O 0 4.637478559743613e-05
CA O 0 1.9137090930598788e-05
with O 0 1.2148356105801117e-11
an O 0 1.4052455379887085e-11
intact O 0 7.136843294119899e-08
catalytic O 0 1.4818357207957433e-08
domain O 0 1.2718864184080303e-08
. O 0 2.1624901869188307e-09

Although O 0 9.394199196322006e-09
both O 0 7.152054642967087e-11
domains O 0 9.745341200684265e-10
of O 0 2.7586186373412813e-12
the O 0 4.900692698872611e-11
VHL B-Disease 0 1.0008050139731495e-06
protein O 0 2.2781786179759678e-10
contribute O 0 9.942507754601149e-12
to O 0 2.086449285912395e-12
regulation O 0 1.1849937697760993e-10
of O 0 2.2239514917143932e-12
CA12 O 0 2.2973756585997762e-06
expression O 0 3.519285751707457e-09
, O 0 7.335226176463649e-13
the O 0 6.050387513049926e-13
elongin O 0 2.4585871116755698e-09
binding O 0 4.948807474924877e-10
domain O 0 7.251106937111729e-10
alone O 0 3.3218525707923163e-09
could O 0 3.920178348604253e-10
effectively O 0 4.396125241612481e-09
regulate O 0 2.7080741915597173e-07
CA9 O 0 0.00014654095866717398
expression O 0 3.629956495387887e-07
. O 0 5.224352950250477e-09

We O 0 2.8726444156745856e-07
mapped O 0 4.1166722439811565e-06
CA12 O 0 5.248288653092459e-05
and O 0 2.7669910807048836e-09
CA9 O 0 1.1041259313060436e-05
loci O 0 2.245035446435395e-08
to O 0 3.3410724187277197e-10
chromosome O 0 1.0346103636038606e-06
bands O 0 4.21713224341147e-08
15q22 O 0 7.052486239444988e-08
and O 0 4.482931525995326e-10
17q21 O 0 1.4118462843271118e-07
. O 0 3.480687071899524e-09

2 O 0 1.9510487447860214e-08
respectively O 0 6.349599068755651e-09
, O 0 2.6302158367963457e-11
regions O 0 8.112432947626758e-10
prone O 0 1.4502508747682441e-05
to O 0 4.3818896428016174e-11
amplification O 0 9.808879930517378e-09
in O 0 1.2636147336819725e-11
some O 0 9.382707284733005e-12
human O 0 1.8011242275406403e-08
cancers B-Disease 0 0.0002649237576406449
. O 0 7.28447657749598e-09

Additional O 0 2.2846156078060176e-09
experiments O 0 5.458290175397451e-08
are O 0 3.784687147012633e-11
needed O 0 3.086998712209521e-11
to O 0 1.8577520164569927e-12
define O 0 6.196548274495228e-10
the O 0 3.95900716723685e-12
role O 0 5.99539029533247e-11
of O 0 5.0515824162600254e-11
CA O 0 4.316654667491093e-06
IX O 0 4.0368928466705256e-07
and O 0 4.137977516194269e-09
CA O 0 8.037018233153503e-07
XII O 0 6.31992458366426e-09
enzymes O 0 1.421321914329976e-11
in O 0 4.1766251373219487e-13
the O 0 3.3616178959396115e-13
regulation O 0 6.048177930706444e-11
of O 0 1.4217983344486096e-12
pH O 0 3.009178897173115e-07
in O 0 5.084872193444889e-12
the O 0 2.4288511740050422e-12
extracellular O 0 2.581913571830796e-10
microenvironment O 0 8.864476264136556e-09
and O 0 8.10243452192827e-12
its O 0 1.5911607968710495e-12
potential O 0 1.9765092340584545e-10
impact O 0 5.1847153237361e-09
on O 0 3.096402778623997e-08
cancer B-Disease 0 1.0875161251533427e-06
cell O 0 9.067425139619445e-07
growth O 0 3.149246197153843e-08
. O 0 8.39673219843462e-10

A O 0 5.770392608184238e-09
gene O 0 3.470696841034737e-09
encoding O 0 7.84098896922103e-10
a O 0 5.04816577429068e-10
transmembrane O 0 5.345051476979279e-07
protein O 0 3.363260336897156e-09
is O 0 3.0821390578639196e-11
mutated O 0 6.063523461108389e-09
in O 0 3.9897277148703836e-10
patients O 0 5.152923421292144e-08
with O 0 8.94655313459225e-05
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9625074863433838
optic B-Disease 1 0.9999995231628418
atrophy I-Disease 1 0.9999943971633911
( O 0 0.006574132014065981
Wolfram B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
) O 0 1.8918473898565935e-08
. O 0 9.819456359139167e-09

Wolfram B-Disease 1 0.9999890327453613
syndrome I-Disease 1 0.9999998807907104
( O 0 9.983750715036876e-07
WFS B-Disease 0 0.01225965190678835
; O 0 2.4298104861486536e-08
OMIM O 0 0.0002262632333440706
222300 O 0 4.542597480394761e-07
) O 0 1.7475958180579454e-11
is O 0 1.982919731191579e-11
an O 0 9.773034465032637e-11
autosomal B-Disease 1 0.9998168349266052
recessive I-Disease 1 0.9999830722808838
neurodegenerative I-Disease 1 0.9998583793640137
disorder I-Disease 1 0.7800393104553223
defined O 0 8.412690277737056e-08
by O 0 1.330069526739308e-10
young O 0 2.887931005446376e-09
- O 0 6.870586162222025e-07
onset O 0 4.913907218906388e-07
non O 0 5.630094790376461e-08
- O 0 0.00011442400136729702
immune O 0 7.087894482538104e-05
insulin B-Disease 0 0.007914634421467781
- I-Disease 0 0.4457678496837616
dependent I-Disease 0 0.1824389547109604
diabetes I-Disease 1 0.9999971389770508
mellitus I-Disease 1 0.9999969005584717
and O 0 3.395080511836568e-06
progressive O 0 0.001929671037942171
optic B-Disease 1 0.9999258518218994
atrophy I-Disease 1 0.9861206412315369
. O 0 3.793944642893621e-07

Linkage O 0 6.160214979900047e-06
to O 0 1.1542281574961066e-09
markers O 0 8.171701182391189e-08
on O 0 8.403609363938358e-09
chromosome O 0 0.0002338315243832767
4p O 0 0.000543149362783879
was O 0 8.028316074160102e-07
confirmed O 0 1.9426048325499323e-08
in O 0 1.9501456005599493e-11
five O 0 5.761401078441253e-11
families O 0 1.2717620290203513e-09
. O 0 1.9371610981977483e-09

On O 0 9.073837792250572e-10
the O 0 2.7310703611810316e-12
basis O 0 6.019219844777268e-12
of O 0 4.858054063194839e-13
meiotic O 0 2.683151194560196e-07
recombinants O 0 0.00025382585590705276
and O 0 7.087709263942088e-08
disease O 0 4.325506779423449e-06
- O 0 2.779550413833931e-06
associated O 0 5.078126719126885e-08
haplotypes O 0 2.6656698537408374e-07
, O 0 2.382628296049294e-11
the O 0 8.421632315125382e-12
WFS B-Disease 0 1.2011130934297398e-07
gene O 0 1.3869110304653987e-09
was O 0 1.4065412723418547e-10
localized O 0 1.4524724756270757e-09
to O 0 9.453218069443992e-11
a O 0 8.212651003702831e-09
BAC O 0 9.844259693636559e-06
/ O 0 2.2859461878965703e-08
P1 O 0 1.7323873180430382e-06
contig O 0 1.5483985649211718e-08
of O 0 1.4523207940084215e-12
less O 0 7.204657703763218e-11
than O 0 4.959444313556993e-11
250 O 0 1.026834034467683e-10
kb O 0 3.232419771848072e-07
. O 0 1.1993841475543832e-08

Mutations O 0 7.218863174784929e-05
in O 0 6.142207853443438e-10
a O 0 1.773171609542601e-10
novel O 0 8.995501565856046e-10
gene O 0 2.131976017949455e-08
( O 0 3.001612847164381e-11
WFS1 O 0 1.2549918437798624e-07
) O 0 2.966747670012787e-13
encoding O 0 6.898779724567872e-12
a O 0 1.1846202838117215e-11
putative O 0 5.681786596767324e-09
transmembrane O 0 1.0824171781109726e-08
protein O 0 2.061404102970954e-10
were O 0 4.3772034608036137e-11
found O 0 9.151439328558553e-11
in O 0 1.0047875725893718e-11
all O 0 5.318877716736781e-12
affected O 0 2.4746416721344033e-11
individuals O 0 2.67847137698507e-12
in O 0 2.2464827307416835e-12
six O 0 2.520842388997746e-11
WFS B-Disease 0 4.9706830651530254e-08
families O 0 2.989671357700452e-11
, O 0 7.295669060200516e-13
and O 0 5.54336784808207e-12
these O 0 8.471025964018608e-12
mutations O 0 2.45851228264371e-09
were O 0 6.757546605618003e-11
associated O 0 4.821607557659036e-10
with O 0 1.0812357953415841e-10
the O 0 2.1390960114331392e-08
disease O 0 7.618600648129359e-06
phenotype O 0 1.643191239963926e-06
. O 0 2.866604953410956e-09

WFS1 O 0 7.464436930604279e-05
appears O 0 2.671930232622799e-08
to O 0 1.5465132646719226e-11
function O 0 2.717956970599289e-10
in O 0 1.500505275586761e-11
survival O 0 6.593728674175736e-09
of O 0 8.741659306144012e-12
islet O 0 7.461265454367094e-07
beta O 0 5.797354152292655e-09
- O 0 5.498435484696529e-07
cells O 0 5.640603539802669e-09
and O 0 9.506340159504134e-11
neurons O 0 4.9319419659354935e-09
. O 0 2.6852454287906724e-11
. O 0 2.1552049034312404e-10

Stable O 0 4.668488145398442e-06
interaction O 0 1.361541768218899e-09
between O 0 3.354710259584337e-11
the O 0 3.198088929096121e-12
products O 0 2.424871414774543e-11
of O 0 6.172710454756258e-13
the O 0 2.210791966161807e-10
BRCA1 O 0 1.1994470696663484e-05
and O 0 3.798484016215298e-08
BRCA2 O 0 1.500750568084186e-05
tumor B-Disease 0 8.485368425681372e-07
suppressor O 0 1.5988828749868844e-07
genes O 0 3.1707252379220563e-09
in O 0 2.0726788341196567e-11
mitotic O 0 6.422194331889841e-08
and O 0 1.2337888488644921e-09
meiotic O 0 3.0878018151270226e-05
cells O 0 2.3383945517707616e-06
. O 0 7.1138726021047205e-09

BRCA1 O 0 0.005551164969801903
and O 0 4.14293914730024e-08
BRCA2 O 0 4.67268864667858e-06
account O 0 5.294310767567367e-09
for O 0 9.762670706570109e-12
most O 0 3.927808599202276e-12
cases O 0 6.4758246508256345e-12
of O 0 9.075537630437447e-13
familial O 0 4.0776362197902927e-07
, O 0 4.052624208439326e-11
early O 0 5.150029291911551e-10
onset O 0 2.5322870556010457e-07
breast B-Disease 0 0.005607217084616423
and I-Disease 0 9.031780905388587e-07
/ I-Disease 0 0.0014139935374259949
or I-Disease 1 0.581229031085968
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
and O 0 7.95710608514355e-09
encode O 0 1.2919223468799146e-09
products O 0 1.0392755545041155e-09
that O 0 5.93682915328575e-12
each O 0 8.604162521352876e-12
interact O 0 1.421734813211728e-10
with O 0 1.641940611252224e-10
hRAD51 O 0 5.235833100414311e-07
. O 0 1.9758656932822305e-09

Results O 0 9.390459609903701e-08
presented O 0 4.9481014841035176e-09
here O 0 1.2480580457996382e-10
show O 0 8.951019370151414e-10
that O 0 6.638001259773318e-11
BRCA1 O 0 8.84287885583035e-07
and O 0 4.521404139978813e-09
BRCA2 O 0 3.440319687797455e-06
coexist O 0 1.5884961612755433e-07
in O 0 1.2726415407615654e-11
a O 0 1.1847314795865316e-10
biochemical O 0 1.0574078856961933e-07
complex O 0 3.5548117782724376e-09
and O 0 7.195141010774009e-11
colocalize O 0 2.2218830508791143e-07
in O 0 8.398810119603084e-11
subnuclear O 0 7.461423479071527e-08
foci O 0 4.50568649057459e-08
in O 0 6.194414772786594e-12
somatic O 0 4.338728820663107e-10
cells O 0 4.3071821109741393e-10
and O 0 5.098235202061208e-12
on O 0 2.2665059065674065e-11
the O 0 1.3074184746983408e-12
axial O 0 2.1767170288455873e-09
elements O 0 2.23939644605764e-10
of O 0 1.0084469717619449e-11
developing O 0 4.907692030542421e-10
synaptonemal O 0 2.3411320171362604e-07
complexes O 0 1.1453517601012209e-07
. O 0 3.970462625346727e-09

Like O 0 6.024354775036045e-07
BRCA1 O 0 0.0002578792627900839
and O 0 1.5009828047141127e-08
RAD51 O 0 0.0005134198581799865
, O 0 3.6557509797141563e-10
BRCA2 O 0 8.156991384566936e-07
relocates O 0 4.102145823026149e-08
to O 0 5.425072058251601e-10
PCNA O 0 1.7391577102898736e-06
+ O 0 2.0681820145362906e-10
replication O 0 9.301973774578087e-11
sites O 0 7.946693303395591e-11
following O 0 2.9725506778266464e-11
exposure O 0 4.2590045268298127e-07
of O 0 9.724479901884742e-12
S O 0 6.471638585026085e-07
phase O 0 1.1424859946984611e-09
cells O 0 2.0715970605600376e-10
to O 0 1.0472058983856947e-11
hydroxyurea O 0 1.269434193318375e-07
or O 0 6.276857256182211e-09
UV O 0 0.0022867030929774046
irradiation O 0 1.6482199498568662e-06
. O 0 2.116118169581682e-09

Thus O 0 1.882051492430037e-07
, O 0 1.9227598679893987e-10
BRCA1 O 0 6.017452847117966e-07
and O 0 1.0814880102572033e-09
BRCA2 O 0 7.575627023470588e-07
participate O 0 5.817455406287309e-10
, O 0 6.49590234033659e-12
together O 0 2.9606397194958944e-11
, O 0 3.3998964667908416e-12
in O 0 1.465191791678866e-12
a O 0 5.085922655245767e-11
pathway O 0 3.082904764806216e-10
( O 0 2.8825282005068287e-12
s O 0 2.6166196320787094e-08
) O 0 8.056138763902487e-13
associated O 0 1.307090026492208e-11
with O 0 4.0289665592489754e-13
the O 0 4.942743263292027e-13
activation O 0 5.183609617931406e-12
of O 0 6.86945671787148e-13
double O 0 2.9484665375889563e-08
- O 0 1.051886187042328e-07
strand O 0 2.111047869846061e-08
break O 0 3.0079334578658745e-08
repair O 0 3.7789445173075364e-07
and O 0 2.3706939189516163e-10
/ O 0 6.083178405447143e-10
or O 0 3.660898320601014e-11
homologous O 0 2.0892678698203326e-09
recombination O 0 9.941123124690421e-08
. O 0 1.1986545978004415e-08

Dysfunction O 0 4.6382836444536224e-05
of O 0 1.3414273858369796e-10
this O 0 1.469586952129731e-11
pathway O 0 8.069253598641524e-10
may O 0 1.9211257029638773e-09
be O 0 3.858485145974422e-12
a O 0 3.6218363377860108e-12
general O 0 4.2012916583178406e-12
phenomenon O 0 4.960714616863982e-10
in O 0 1.002094132500353e-12
the O 0 1.5616971420478326e-13
majority O 0 1.4373953416413343e-12
of O 0 1.127754912567426e-13
cases O 0 8.327741274349876e-12
of O 0 3.3103233695874756e-12
hereditary B-Disease 0 0.0780322477221489
breast I-Disease 1 0.8698824644088745
and I-Disease 0 1.5237354091368616e-05
/ I-Disease 0 0.008432180620729923
or I-Disease 1 0.8045411705970764
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
. O 0 1.4609392806619326e-08
. O 0 5.403986147456408e-09

A O 0 4.3086572532047285e-08
novel O 0 6.389922813099247e-09
Arg362Ser O 0 6.684001618850743e-07
mutation O 0 7.3382665277677e-08
in O 0 2.056180399556684e-11
the O 0 1.3266890190599678e-11
sterol O 0 5.3038925216242205e-06
27 O 0 2.447885893985813e-09
- O 0 2.4366335082959267e-07
hydroxylase O 0 4.061327217641519e-06
gene O 0 1.1686655199127927e-08
( O 0 1.0227600884260557e-11
CYP27 O 0 9.824855595752524e-08
) O 0 7.205296472315159e-13
: O 0 3.14738252821245e-13
its O 0 6.374802487101039e-13
effects O 0 9.568631442746778e-10
on O 0 1.961647788650822e-10
pre O 0 4.129905661898192e-08
- O 0 5.934981839317288e-09
mRNA O 0 4.9546696606617147e-11
splicing O 0 1.0029289204682712e-10
and O 0 7.726400248764254e-12
enzyme O 0 1.3748291394222178e-10
activity O 0 3.3923924780410175e-10
. O 0 2.4280061294845723e-10

A O 0 5.6164303430250584e-08
novel O 0 1.0779134917981992e-08
C O 0 8.848921595472348e-08
to O 0 7.558381004413306e-12
A O 0 1.0306921982561335e-09
mutation O 0 1.701459240166514e-08
in O 0 7.663567697102636e-12
the O 0 1.2346445046884647e-11
sterol O 0 2.536790589147131e-06
27 O 0 2.0537522793517837e-09
- O 0 1.1238929431556244e-07
hydroxylase O 0 1.4132461956251063e-06
gene O 0 4.82129758339056e-09
( O 0 4.517277177318313e-12
CYP27 O 0 9.752024254794378e-08
) O 0 1.261442014212355e-12
was O 0 1.0676998174474761e-10
identified O 0 1.807820004806615e-10
by O 0 6.668107364014852e-13
sequencing O 0 5.087038429385515e-11
amplified O 0 1.0932020622078653e-08
CYP27 O 0 1.4414174742682917e-08
gene O 0 3.597960124279709e-11
products O 0 4.964562181491994e-12
from O 0 4.952330863103316e-13
a O 0 1.823653866805941e-10
patient O 0 9.410701551360035e-08
with O 0 1.327323850830453e-08
cerebrotendinous B-Disease 1 0.9999970197677612
xanthomatosis I-Disease 1 0.9999942779541016
( O 0 4.829995070565474e-09
CTX B-Disease 0 8.119526319205761e-05
) O 0 2.1528631655165498e-10
. O 0 8.274298468613495e-10

The O 0 5.73680036808355e-09
mutation O 0 2.4984899482660694e-07
changed O 0 3.951710514371598e-09
the O 0 1.7147686048879507e-11
adrenodoxin O 0 2.16439364209009e-08
cofactor O 0 1.1776354336134887e-09
binding O 0 2.320035275005239e-09
residue O 0 5.0544908702931934e-08
362Arg O 0 9.927439315049469e-09
to O 0 6.289205961573785e-11
362Ser O 0 1.383145189493007e-07
( O 0 2.949828922793607e-11
CGT O 0 2.548027744353476e-08
362Arg O 0 9.199856876307422e-09
to O 0 3.485127811342359e-11
AGT O 0 3.125030900719139e-07
362Ser O 0 7.83096343326406e-09
) O 0 8.935056470746328e-13
, O 0 4.435432056359989e-13
and O 0 4.337483063693304e-12
was O 0 7.014059888454938e-10
responsible O 0 6.187336198948401e-10
for O 0 1.4362483424790184e-10
deficiency O 0 8.554129635740537e-07
in O 0 1.072881909182366e-12
the O 0 5.673364122243951e-12
sterol O 0 1.279609250559588e-06
27 O 0 2.016711381225278e-10
- O 0 8.744173385366594e-09
hydroxylase O 0 1.1615923511953952e-07
activity O 0 2.3227485212995447e-10
, O 0 1.6675403462576566e-13
as O 0 2.4052415332868893e-13
confirmed O 0 6.97674643751478e-12
by O 0 5.049053081011834e-13
expression O 0 2.993933920225622e-11
of O 0 1.5448841479085568e-13
mutant O 0 2.288154388185859e-11
cDNA O 0 3.648093979680134e-11
into O 0 2.2066076396654033e-11
COS O 0 4.35297408785118e-07
- O 0 2.070121674080383e-08
1 O 0 3.9600839274456234e-10
cells O 0 3.205214094137432e-09
. O 0 6.366343008323838e-10

Quantitative O 0 4.6820193944085986e-08
analysis O 0 1.2327780574139524e-08
showed O 0 3.601411791009923e-08
that O 0 8.220334135611296e-12
the O 0 1.570213360377326e-12
expression O 0 1.7033081889383794e-10
of O 0 5.805619114791771e-13
CYP27 O 0 1.4865718434009523e-08
gene O 0 9.738627959610113e-11
mRNA O 0 3.917859439650506e-11
in O 0 1.9376312620361658e-12
the O 0 2.8753403737841188e-12
patient O 0 5.0960360375995606e-09
represented O 0 1.3175640578566572e-09
52 O 0 9.376133203176096e-10
. O 0 1.2911709479368483e-09

5 O 0 2.521893138762721e-09
% O 0 6.763645893359538e-11
of O 0 4.201163722461487e-12
the O 0 1.0784738380120729e-10
normal O 0 2.2104568841996297e-08
level O 0 3.54486076048488e-08
. O 0 2.2299224688993036e-09

As O 0 8.61188731438034e-10
the O 0 6.293910531640634e-11
mutation O 0 3.656898428516797e-08
occurred O 0 5.628738808383105e-09
at O 0 6.221577506654308e-12
the O 0 3.174204063656483e-13
penultimate O 0 6.109093092510065e-11
nucleotide O 0 1.4545177562386158e-10
of O 0 1.0960915335089805e-12
exon O 0 2.87820323130461e-09
6 O 0 7.971361765113372e-11
( O 0 1.3260963507844004e-12
- O 0 7.367768062316316e-10
2 O 0 1.6505243352615828e-11
position O 0 5.154491278247519e-10
of O 0 9.320790667066703e-13
exon O 0 1.6171339822790287e-08
6 O 0 2.0969119496339061e-10
- O 0 5.936113822713196e-09
intron O 0 7.411481561803157e-08
6 O 0 2.081362686368049e-11
splice O 0 6.823006049039293e-10
site O 0 2.9471872164954505e-10
) O 0 7.577860322745267e-14
of O 0 2.0530970722349232e-14
the O 0 7.526324940880513e-13
gene O 0 1.3228969308887173e-10
, O 0 1.6198040088052923e-12
we O 0 8.00735085876303e-12
hypothesized O 0 5.623217863570673e-11
that O 0 1.756604627381475e-12
the O 0 4.762031047267357e-12
mutation O 0 9.962457880874354e-08
may O 0 4.50580461830441e-09
partially O 0 5.4677076199993735e-09
affect O 0 2.8731339529741717e-10
the O 0 2.670860060893787e-12
normal O 0 1.6319954068699793e-11
splicing O 0 5.344364534254353e-11
efficiency O 0 2.0559187685620373e-10
in O 0 2.1622807711008107e-12
exon O 0 3.019998251474476e-09
6 O 0 2.5131238756692653e-10
and O 0 1.936376059497036e-11
cause O 0 2.612497718157414e-10
alternative O 0 1.1152765343191984e-11
splicing O 0 2.1535202787692498e-10
elsewhere O 0 9.058085392865678e-10
, O 0 3.452005933705926e-13
which O 0 2.065542615420357e-12
resulted O 0 1.020447094879362e-11
in O 0 1.7998267806684787e-11
decreased O 0 2.7432753846312607e-09
transcript O 0 2.5883641896484733e-09
in O 0 2.621951267212097e-11
the O 0 1.3681428212564128e-10
patient O 0 1.1412205225269645e-07
. O 0 2.9229765274862984e-09

Transfection O 0 5.160897853784263e-05
of O 0 1.197047794221362e-09
constructed O 0 9.637711428922557e-08
minigenes O 0 2.7805258469015826e-06
, O 0 7.733078934146764e-12
with O 0 1.6491671309820655e-12
or O 0 9.487537838692717e-11
without O 0 1.760247676785287e-11
the O 0 2.0521516343879886e-12
mutation O 0 4.854458501846182e-10
, O 0 2.2394998182295733e-13
into O 0 1.0921099094507447e-12
COS O 0 2.763859185961337e-08
- O 0 2.0228261288224303e-09
1 O 0 1.9717449895040318e-11
cells O 0 1.0735297373276609e-10
confirmed O 0 4.482980653364166e-11
that O 0 6.086918078948567e-13
the O 0 4.654600815022503e-13
mutant O 0 2.743331395382853e-10
minigene O 0 4.767002437233714e-08
was O 0 4.700186906347881e-10
responsible O 0 7.166297416594247e-11
for O 0 3.014381008258765e-13
a O 0 1.1459722927542604e-11
mRNA O 0 1.2562283158157328e-10
species O 0 1.0206086843711493e-11
alternatively O 0 1.9231924386353683e-10
spliced O 0 2.8383750461102863e-08
at O 0 5.623995491532696e-09
an O 0 2.706569170174422e-11
activated O 0 2.3444766839020303e-07
cryptic O 0 2.6165098532260345e-08
5 O 0 2.5669737602901366e-12
splice O 0 1.5180147139304268e-09
site O 0 1.26878907380501e-09
88 O 0 6.844887850965264e-11
bp O 0 3.502397483146069e-09
upstream O 0 1.9348106450323144e-11
from O 0 1.5070555480639625e-12
the O 0 6.831381163877048e-13
3 O 0 2.4667327642308168e-12
end O 0 8.262808839920588e-12
of O 0 2.872889860033867e-12
exon O 0 2.301191770470723e-08
6 O 0 1.6139037883888818e-09
. O 0 9.248921628568496e-10

Our O 0 1.1117632148227585e-08
data O 0 2.9197599893393544e-10
suggest O 0 1.8564574877366624e-10
that O 0 2.59286689341387e-12
the O 0 1.4731361746775362e-12
C O 0 1.9161707776049752e-09
to O 0 1.2307762231253405e-12
A O 0 4.0165581971507436e-10
mutation O 0 5.297755567568174e-09
at O 0 2.1277722639378993e-11
the O 0 2.9134192888052857e-13
penultimate O 0 4.198922459730525e-11
nucleotide O 0 7.718670841372344e-11
of O 0 7.035993017595957e-14
exon O 0 2.0317883486775656e-10
6 O 0 3.1828875472761364e-12
of O 0 7.621927042419582e-14
the O 0 4.414705146588149e-12
CYP27 O 0 1.6626100318717363e-07
gene O 0 4.5920603430893436e-10
not O 0 9.138200612879288e-11
only O 0 8.608988522063044e-12
causes O 0 8.296643927430125e-10
the O 0 8.831158582189857e-10
deficiency B-Disease 0 1.397862706653541e-05
in I-Disease 0 6.0819539508816245e-12
the I-Disease 0 8.734475816229992e-12
sterol I-Disease 0 6.195738819769758e-07
27 I-Disease 0 8.170661369710785e-11
- I-Disease 0 3.822991256896557e-09
hydroxylase I-Disease 0 9.947724066705632e-08
activity I-Disease 0 1.0075079659443986e-09
, O 0 9.044812967172466e-13
but O 0 4.5348880900464295e-12
also O 0 4.712309535637171e-12
partially O 0 1.0527583249597683e-09
leads O 0 4.236262382550926e-12
to O 0 2.1785196801897555e-13
alternative O 0 5.8265332662787994e-12
pre O 0 1.692702533695467e-09
- O 0 5.667928903996255e-10
mRNA O 0 2.313779896845336e-11
splicing O 0 3.626939720779987e-11
of O 0 5.977549184799091e-13
the O 0 7.710662837390192e-12
gene O 0 3.4935103698785497e-09
. O 0 1.5508480055714813e-09

To O 0 8.298099984926921e-10
our O 0 4.674421405503892e-10
knowledge O 0 9.041544596355422e-11
, O 0 4.714671578490148e-13
this O 0 1.4059731840137396e-13
is O 0 7.199114351527647e-13
the O 0 3.2716491733635056e-13
first O 0 1.0055486825144566e-11
report O 0 1.3664497484910942e-11
regarding O 0 1.455630060931412e-11
effects O 0 3.410447479978984e-10
on O 0 1.9961749267438655e-11
pre O 0 3.6356289090377913e-09
- O 0 3.368118284274857e-10
mRNA O 0 3.564012366480407e-12
splicing O 0 3.546571022972067e-12
of O 0 4.390181591201227e-14
a O 0 3.1905461345821395e-12
mutation O 0 5.978629813441216e-10
at O 0 1.0368826457163305e-11
the O 0 3.6920171780918665e-12
- O 0 2.692532063974795e-08
2 O 0 7.432295057174798e-11
position O 0 1.1214150497096398e-08
of O 0 1.415053837994229e-12
a O 0 1.745527888896703e-10
5 O 0 6.239287558829076e-11
splice O 0 4.547005616473143e-08
site O 0 1.112098715339016e-07
. O 0 5.018464754869001e-09

ATM O 0 0.0002177656424464658
germline O 0 0.002582940272986889
mutations O 0 0.0003192997828591615
in O 0 4.85005813288808e-08
classical O 0 0.0005815407494083047
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999988079071045
telangiectasia I-Disease 1 1.0
patients O 0 0.0006843000883236527
in O 0 6.047811695886196e-10
the O 0 3.0362204417322403e-10
Dutch O 0 1.2607859389390796e-05
population O 0 1.5184954405000894e-09
. O 0 1.7382162376122778e-09

Germline O 0 0.0005129722412675619
mutations O 0 2.7700727514456958e-05
in O 0 1.7687465381222012e-10
the O 0 4.452598879878256e-12
ATM O 0 6.2400935973983e-08
gene O 0 6.604906399587662e-09
are O 0 1.1154381238109856e-11
responsible O 0 1.5668404074187237e-10
for O 0 1.3202954007862644e-10
the O 0 7.329585059778765e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 0.0009732038015499711
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999996423721313
T I-Disease 1 0.9999998807907104
) O 0 1.3707589729961e-08
. O 0 3.2968630048202385e-09

In O 0 5.092295030095784e-09
our O 0 7.674941793212042e-10
study O 0 7.001731833211622e-11
, O 0 1.5929585124932477e-12
we O 0 1.563179967412065e-11
have O 0 3.2610908331370814e-12
determined O 0 7.488930309218489e-11
the O 0 9.75220555352041e-13
ATM O 0 1.1985654246871036e-08
mutation O 0 7.864368600785099e-10
spectrum O 0 5.497381994068462e-10
in O 0 1.0337665619364333e-11
19 O 0 4.752304019056686e-12
classical O 0 8.636944492934617e-09
A B-Disease 1 0.9999909400939941
- I-Disease 1 0.999996542930603
T I-Disease 1 1.0
patients O 0 3.1453922133550805e-08
, O 0 5.297351099442515e-13
including O 0 7.62874870696359e-14
some O 0 2.3597145288115073e-13
immigrant O 0 6.266386853859274e-10
populations O 0 1.339113958609417e-10
, O 0 3.880106414118345e-13
as O 0 4.3708415250857946e-13
well O 0 3.99394146227694e-12
as O 0 3.013732926410162e-12
12 O 0 3.995966426674491e-13
of O 0 4.183202178750789e-13
Dutch O 0 9.651397903098768e-08
ethnic O 0 5.302089323144799e-10
origin O 0 2.5560641603306067e-08
. O 0 1.9331969358660217e-09

Both O 0 4.094100614082663e-09
the O 0 9.406812828682831e-11
protein O 0 3.842493268013669e-10
truncation O 0 6.635729743464935e-09
test O 0 1.556244022538067e-09
( O 0 1.4260142545963195e-11
PTT O 0 5.6776841006467293e-08
) O 0 4.306058547925984e-13
and O 0 3.931006724560565e-13
the O 0 2.298137537475736e-13
restriction O 0 1.4417672784816649e-11
endonuclease O 0 2.138148547103924e-09
fingerprinting O 0 1.707055941047031e-09
( O 0 3.0402041561322646e-12
REF O 0 1.8094052478545564e-08
) O 0 3.489825548225016e-14
method O 0 1.1292320160546931e-12
were O 0 3.139056939729934e-12
used O 0 1.6530644908474557e-10
and O 0 3.534013012784776e-11
compared O 0 8.52217602043126e-11
for O 0 8.924712504394458e-14
their O 0 4.548416764754704e-13
detection O 0 3.4102262680413276e-10
efficiency O 0 2.0917259244135344e-11
, O 0 5.631449421909275e-15
identifying O 0 1.5936878552946787e-12
76 O 0 8.076154762309828e-13
% O 0 6.813680750259593e-14
and O 0 5.073157605811618e-13
60 O 0 4.013695571649517e-13
% O 0 4.2327042749663174e-14
of O 0 1.2454237131604567e-13
the O 0 5.833408062150269e-11
mutations O 0 9.367774822521824e-08
, O 0 3.1864486743637954e-11
respectively O 0 2.1825041773837484e-09
. O 0 1.208142696995651e-09

Most O 0 1.7187661072171068e-08
patients O 0 2.1830466323535802e-08
were O 0 7.095047327432269e-10
found O 0 8.733634926372247e-10
to O 0 8.437248122383778e-11
be O 0 6.782898687163197e-10
compound O 0 5.6130033954104874e-08
heterozygote O 0 2.6984039322996978e-06
. O 0 5.705994343685461e-09

Seventeen O 0 7.058379765112477e-07
mutations O 0 1.9441765743977157e-06
were O 0 1.3224957240431934e-10
distinct O 0 1.0709284153920251e-10
, O 0 1.6780349896064473e-12
of O 0 6.623652906538602e-13
which O 0 3.5087607819228595e-10
10 O 0 2.970312190653246e-11
were O 0 1.7664414375673232e-09
not O 0 6.478984460045467e-09
reported O 0 1.6234755761956876e-08
previously O 0 6.812229447206164e-09
. O 0 1.8047615624183777e-09

Mutations O 0 0.0001880566996987909
are O 0 1.2701542595472404e-10
small O 0 7.119634742869252e-11
deletions O 0 1.8645009447482153e-07
or O 0 2.7520128398350607e-08
point O 0 1.1842610092571704e-07
mutations O 0 2.8186486815684475e-06
frequently O 0 7.376633703870539e-08
affecting O 0 4.573636580573748e-09
splice O 0 4.888825060334057e-07
sites O 0 3.086912556682364e-07
. O 0 2.3251223169040713e-08

Moreover O 0 4.010486918559764e-06
, O 0 3.4619215827369487e-10
a O 0 5.99189531325095e-10
16 O 0 1.1491319007461698e-09
. O 0 2.6125490659723027e-09

7 O 0 7.167072624270077e-08
- O 0 5.3875634620226265e-08
kb O 0 1.0351496371185931e-07
genomic O 0 1.2571547358675161e-08
deletion O 0 3.051673047593795e-08
of O 0 6.416157969507674e-12
the O 0 5.329184576269297e-12
3 O 0 8.500077378070792e-12
end O 0 1.0973304730155231e-11
of O 0 1.1383704038008674e-13
the O 0 1.3882110521876156e-12
gene O 0 8.145577962137551e-11
, O 0 2.9209360624671277e-13
most O 0 1.0890536383941982e-13
likely O 0 6.28728406143475e-12
a O 0 1.254785446554163e-12
result O 0 8.704921332369775e-12
of O 0 1.7939222698472312e-14
recombination O 0 3.626497366293613e-11
between O 0 4.626829822051981e-11
two O 0 4.742689921344301e-11
LINE O 0 3.658897753666679e-07
elements O 0 7.588409012271313e-09
, O 0 1.3588889562210493e-11
was O 0 2.645296870440461e-09
identified O 0 1.899306312225235e-08
. O 0 1.1607363958887618e-09

The O 0 1.0449044962612675e-09
most O 0 3.818206861794238e-11
frequently O 0 6.631310500715415e-10
found O 0 5.660960589182196e-10
mutation O 0 7.362155685086691e-08
, O 0 5.539520231412354e-12
identified O 0 4.726969371482426e-10
in O 0 4.081860283805527e-12
three O 0 4.073305494983748e-12
unrelated O 0 8.676986240629958e-09
Turkish O 0 1.9291885564598488e-06
A B-Disease 1 0.9999740123748779
- I-Disease 1 0.9996846914291382
T I-Disease 1 0.9999995231628418
individuals O 0 4.3349999145902984e-09
, O 0 2.018272701742596e-11
was O 0 1.1921672538051098e-09
previously O 0 3.442037488365912e-10
described O 0 5.024218263649516e-10
to O 0 1.0809630100749867e-11
be O 0 1.3694063938363144e-10
a O 0 1.070761479482485e-09
Turkish O 0 4.240225734974956e-06
A B-Disease 1 0.9999841451644897
- I-Disease 1 0.9999622106552124
T I-Disease 1 0.9999985694885254
founder O 0 4.059035916270659e-07
mutation O 0 1.0226796121060033e-06
. O 0 2.738935966917211e-09

The O 0 7.942636548463611e-10
presence O 0 6.97731261656287e-10
of O 0 2.385437333773943e-12
a O 0 1.7759639592274112e-10
founder O 0 6.007358610560232e-09
mutation O 0 2.8073946722884102e-08
among O 0 7.630051104823288e-12
relatively O 0 8.720343024071209e-12
small O 0 5.8423127446971534e-12
ethnic O 0 2.008269418818376e-11
population O 0 4.2027986993375954e-12
groups O 0 6.785036399913069e-13
in O 0 9.746180642047908e-13
Western O 0 2.111664836046412e-11
Europe O 0 8.33213498196983e-10
could O 0 9.168390491254286e-10
indicate O 0 6.758155701724888e-10
a O 0 7.486402470169295e-11
high O 0 5.003927050495349e-09
carrier O 0 4.266500752692082e-08
frequency O 0 9.21517440133357e-08
in O 0 1.1756188904310516e-11
such O 0 1.6425850263290798e-11
communities O 0 1.3037243506985874e-10
. O 0 1.5318887269799575e-09

In O 0 2.4205085935591342e-08
patients O 0 4.272655118597868e-09
of O 0 1.3109424136514836e-11
Dutch O 0 8.994914537652221e-07
ethnic O 0 3.135703086076802e-10
origin O 0 5.932129898411631e-09
, O 0 8.911591083127224e-12
however O 0 1.0475255211861434e-11
, O 0 2.9334482976386966e-13
no O 0 4.584407072710794e-12
significant O 0 4.304172036145859e-12
founder O 0 5.015486359560839e-10
effect O 0 2.889986472354167e-09
could O 0 6.904688376607737e-09
be O 0 7.017980641066401e-10
identified O 0 2.3601074872203753e-08
. O 0 1.7973038612950631e-09

The O 0 1.5485631665868027e-09
observed O 0 4.939614495214073e-09
genetic O 0 1.5852439361196957e-09
heterogeneity O 0 5.279507497846225e-09
including O 0 8.7345582155951e-12
the O 0 2.7574626609849773e-11
relative O 0 1.483531661961024e-07
high O 0 3.7922855966598945e-09
percentage O 0 4.315127810627928e-09
of O 0 1.4658683338344969e-12
splice O 0 8.70525411755807e-08
- O 0 7.175860332608863e-07
site O 0 8.577846699608926e-08
mutations O 0 1.5160644579736982e-06
had O 0 1.1312347503178444e-08
no O 0 1.8412271707290984e-10
reflection O 0 1.6180524697873011e-09
on O 0 1.5573893563658459e-10
the O 0 2.9692259762015283e-10
phenotype O 0 1.638579760765424e-07
. O 0 6.57072563026162e-10

All O 0 5.274263692456316e-09
patients O 0 1.711020480854586e-08
manifested O 0 8.865223577458892e-08
classical O 0 8.164843734448368e-07
A B-Disease 1 0.9999524354934692
- I-Disease 1 0.9998675584793091
T I-Disease 1 0.9999992847442627
and O 0 2.0297479252917583e-09
increased O 0 1.075559419305705e-09
cellular O 0 1.2353154055233517e-08
radioresistant O 0 3.891374689146687e-08
DNA O 0 6.2022977864728546e-09
synthesis O 0 2.079925209841349e-08
. O 0 1.6071888264690415e-09

Determination O 0 3.780638735406683e-07
of O 0 1.8349611760615225e-11
the O 0 3.257491498764864e-12
genomic O 0 5.325745400241999e-10
structure O 0 2.7041622274737165e-09
of O 0 1.0019565472446645e-12
the O 0 9.136609871451817e-12
COL4A4 O 0 2.495040121175407e-07
gene O 0 3.8618830355829914e-10
and O 0 6.893610248609461e-12
of O 0 1.0605280759481972e-12
novel O 0 1.2974026297740693e-08
mutations O 0 3.9094622479751706e-05
causing O 0 9.424487507203594e-05
autosomal B-Disease 1 0.9999091625213623
recessive I-Disease 1 0.9999814033508301
Alport I-Disease 1 0.999995231628418
syndrome I-Disease 1 0.999990701675415
. O 0 1.8667407175598782e-06

Autosomal B-Disease 1 0.9999594688415527
recessive I-Disease 1 0.9999868869781494
Alport I-Disease 1 0.9999983310699463
syndrome I-Disease 1 0.9999983310699463
is O 0 1.687649273662828e-07
a O 0 1.4038331386245773e-08
progressive O 0 8.82215317687951e-05
hematuric B-Disease 1 0.9990538954734802
glomerulonephritis I-Disease 1 0.9999985694885254
characterized O 0 0.0012554300483316183
by O 0 2.7905615596068856e-08
glomerular B-Disease 1 0.9993139505386353
basement I-Disease 1 0.9999388456344604
membrane I-Disease 1 0.9950206279754639
abnormalities I-Disease 1 0.9977300763130188
and O 0 4.980377221741605e-10
associated O 0 1.6358833176965959e-09
with O 0 2.489677908279475e-11
mutations O 0 5.983860518199435e-08
in O 0 1.590324053002412e-11
either O 0 9.99422836156505e-11
the O 0 1.0654228367601437e-11
COL4A3 O 0 2.8494361004050006e-07
or O 0 3.8676530728087855e-11
the O 0 2.3493327509088724e-12
COL4A4 O 0 6.611185909832784e-08
gene O 0 2.8281477160163604e-10
, O 0 1.8824625560610875e-13
which O 0 1.8767264489422814e-13
encode O 0 2.0800123776143487e-12
the O 0 1.728005759316087e-12
alpha3 O 0 3.213074961649909e-08
and O 0 1.2941289706525083e-10
alpha4 O 0 4.1417942497901095e-07
type O 0 4.329806870373432e-06
IV O 0 1.2539487215690315e-05
collagen O 0 2.760893494269112e-06
chains O 0 1.3047879292571452e-05
, O 0 3.8363637266947137e-10
respectively O 0 1.0761468161035737e-08
. O 0 2.1225414759129535e-09

To O 0 3.3451535985662417e-10
date O 0 9.399429012901805e-10
, O 0 9.981187968147176e-13
mutation O 0 5.96386690032702e-11
screening O 0 2.8363303025691344e-11
in O 0 4.213200101299552e-12
the O 0 6.732029213599167e-13
two O 0 2.325704212546853e-11
genes O 0 1.715594666329423e-09
has O 0 2.147978184208199e-10
been O 0 1.1219809109563883e-10
hampered O 0 1.5526446794922322e-09
by O 0 6.3378286993542865e-12
the O 0 1.2248822615912314e-11
lack O 0 9.842679449256764e-11
of O 0 1.2585413397200873e-12
genomic O 0 1.3353855798925451e-09
structure O 0 5.4905520130432706e-09
information O 0 3.5882846693979786e-10
. O 0 3.8799866097782854e-10

We O 0 4.7109622869356826e-08
report O 0 3.0839986120412277e-10
here O 0 3.518119172721268e-12
the O 0 1.2658858607617757e-13
complete O 0 1.6276642577153777e-12
characterization O 0 3.6896555255516716e-10
of O 0 5.609349790214324e-13
the O 0 4.283231321705605e-12
48 O 0 3.966943960820313e-12
exons O 0 5.4105813579452544e-11
of O 0 8.45278382878567e-13
the O 0 7.283840197658265e-12
COL4A4 O 0 1.7237702820693812e-07
gene O 0 2.9492791542296004e-10
, O 0 3.3009272398798473e-13
a O 0 7.699974013432309e-13
comprehensive O 0 2.8739215868212042e-11
gene O 0 3.826855776711824e-10
screen O 0 7.541661375398689e-07
, O 0 1.0386997685574162e-11
and O 0 7.825721949801523e-13
the O 0 1.213204206150162e-13
subsequent O 0 6.770483045731579e-12
detection O 0 3.6738409536773986e-10
of O 0 3.119787685568892e-13
10 O 0 1.8316489817926662e-12
novel O 0 1.3026697776030716e-11
mutations O 0 3.2755707035647674e-09
in O 0 3.417204366695792e-11
eight O 0 2.4773454398996364e-09
patients O 0 6.568538424289727e-07
diagnosed O 0 0.0020299036987125874
with O 0 9.11759684640856e-07
autosomal B-Disease 1 0.9999452829360962
recessive I-Disease 1 0.9999898672103882
Alport I-Disease 1 0.9999951124191284
syndrome I-Disease 1 0.9999873638153076
. O 0 1.3434281527224812e-06

Furthermore O 0 1.7374270555592375e-06
, O 0 2.3014000427590275e-10
we O 0 3.253078362241979e-11
identified O 0 2.6981574960394106e-11
a O 0 3.1008826149175883e-12
glycine O 0 9.088820807079401e-10
to O 0 1.4067465725284278e-12
alanine O 0 9.530558980896942e-11
substitution O 0 1.7966439100347564e-11
in O 0 2.419778787066118e-12
the O 0 2.6163051759786615e-12
collagenous O 0 2.257339701827732e-07
domain O 0 1.9956059027492756e-09
that O 0 9.833672764969492e-11
is O 0 7.818747732590836e-11
apparently O 0 2.6406639097587004e-09
silent O 0 1.3297487555519183e-08
in O 0 7.26045482415949e-12
the O 0 2.3482439950872624e-12
heterozygous O 0 1.8731041162567408e-09
carriers O 0 6.139865282861479e-10
, O 0 3.946138554811185e-12
in O 0 1.8549982730431402e-11
11 O 0 2.7420288262192116e-10
. O 0 7.319695405350046e-10

5 O 0 1.0760744517668286e-09
% O 0 1.2541017703482371e-11
of O 0 4.909650702482338e-13
all O 0 2.284324639167945e-12
control O 0 2.5780864110203083e-09
individuals O 0 5.0597304124266884e-11
, O 0 2.9125540954716422e-12
and O 0 1.1293295291980865e-11
in O 0 6.807893658533626e-12
one O 0 1.7952498862494615e-11
control O 0 6.611457492589068e-10
individual O 0 1.5189806010229567e-11
homozygous O 0 3.6521408119938314e-10
for O 0 5.013231041232913e-13
this O 0 6.206521841606305e-13
glycine O 0 2.382312791482377e-09
substitution O 0 2.0307042714051704e-09
. O 0 3.406501192237954e-10

There O 0 2.7205322439272095e-08
has O 0 6.587390077861244e-10
been O 0 4.52809664763798e-11
no O 0 5.465074226496114e-11
previous O 0 1.6983114567437063e-11
finding O 0 4.405099549020797e-12
of O 0 6.191951790711359e-14
a O 0 9.737466909187642e-13
glycine O 0 6.161506721502619e-11
substitution O 0 4.940486214577433e-11
that O 0 2.017179652480383e-11
is O 0 1.1065487935668639e-11
not O 0 2.8371244156083497e-12
associated O 0 8.181838019594156e-12
with O 0 7.293345614944879e-13
any O 0 6.04250469105061e-11
obvious O 0 1.8223241582404626e-08
phenotype O 0 2.7068212560266147e-08
in O 0 4.991491595052189e-11
homozygous O 0 1.0420274776379301e-07
individuals O 0 1.7734328450202952e-09
. O 0 3.133510340092016e-09

Founder O 0 1.58150760398712e-05
BRCA1 O 0 0.0004804361960850656
and O 0 5.226847221706521e-08
BRCA2 O 0 0.00010803853365359828
mutations O 0 5.367283392843092e-06
in O 0 1.867061838467521e-09
French O 0 1.2171415619377512e-05
Canadian O 0 0.008719413541257381
breast B-Disease 1 0.9999576807022095
and I-Disease 1 0.9942903518676758
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 2.691166855584015e-06
. O 0 2.300208734595799e-08

We O 0 1.0788908610948056e-07
have O 0 2.850622793371116e-10
identified O 0 2.5420399119013837e-10
four O 0 1.5805618532732657e-12
mutations O 0 6.749370506931029e-10
in O 0 2.2543035146926904e-12
each O 0 1.6857373786802188e-12
of O 0 5.768061809435787e-12
the O 0 9.124049960007596e-09
breast B-Disease 1 0.9983885288238525
cancer I-Disease 0 0.02573280781507492
- O 0 4.3884687329409644e-05
susceptibility O 0 0.0005990546196699142
genes O 0 2.389421993598262e-08
, O 0 2.235968181441006e-11
BRCA1 O 0 5.1040540682834035e-08
and O 0 2.723493930378851e-10
BRCA2 O 0 1.1915908260107244e-07
, O 0 8.166636637774172e-12
in O 0 2.436591900467633e-11
French O 0 1.297872472605377e-06
Canadian O 0 0.0017116349190473557
breast B-Disease 1 0.9997451901435852
cancer I-Disease 1 0.7594544291496277
and O 0 0.002151363529264927
breast B-Disease 1 0.9999972581863403
/ I-Disease 1 0.9999977350234985
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 7.450174166478973e-07
from O 0 7.82702169743743e-09
Quebec O 0 2.126184654116514e-06
. O 0 1.2684389538719643e-08

To O 0 1.1813406919358727e-09
identify O 0 3.565182282727619e-08
founder O 0 3.2729992938129726e-08
effects O 0 1.69964016549784e-06
, O 0 9.011930784952327e-11
we O 0 4.48408588038518e-10
examined O 0 1.1212888395562004e-08
independently O 0 2.0202968187277293e-09
ascertained O 0 3.794964698045078e-08
French O 0 2.7568095362084932e-08
Canadian O 0 4.51397852430091e-08
cancer B-Disease 0 1.247150294148014e-08
families O 0 5.439592786621317e-12
for O 0 1.8624874862857577e-13
the O 0 3.1151437766135937e-13
distribution O 0 3.157154442393062e-12
of O 0 1.9215175511930888e-13
these O 0 3.323419013948059e-12
eight O 0 6.745120434414886e-11
mutations O 0 3.717725149954276e-08
. O 0 1.2512765268368753e-09

Mutations O 0 4.891661956207827e-05
were O 0 8.8833101985486e-10
found O 0 2.6636132188784245e-10
in O 0 7.163067881899021e-12
41 O 0 1.5550614615444935e-11
of O 0 4.9866452113411786e-12
97 O 0 8.508667104223377e-10
families O 0 1.6808981984084426e-09
. O 0 4.327400215942134e-09

Six O 0 6.494483839603049e-10
of O 0 5.258696256227324e-12
eight O 0 6.740696195661755e-11
mutations O 0 2.1849377418448057e-08
were O 0 8.347851299106424e-10
observed O 0 1.3037555923745003e-08
at O 0 1.085035505887788e-09
least O 0 1.7098182591990252e-10
twice O 0 3.7222022797323007e-08
. O 0 1.8258997647180308e-09

The O 0 1.1578801917266901e-08
BRCA1 O 0 1.1925898434128612e-05
C4446T O 0 6.128153700046823e-07
mutation O 0 5.18380647918093e-06
was O 0 2.1026802521362242e-09
the O 0 7.319604991562478e-12
most O 0 4.894767750840412e-12
common O 0 2.2379062492028368e-10
mutation O 0 7.697085635527401e-08
found O 0 4.3933318094602214e-10
, O 0 9.534221285731337e-13
followed O 0 5.309329798725004e-12
by O 0 4.726712077296469e-12
the O 0 1.0706914521652067e-10
BRCA2 O 0 4.06741673941724e-06
8765delAG O 0 7.41129781545169e-07
mutation O 0 1.0413555173727218e-06
. O 0 4.0109870980131745e-09

Together O 0 1.0457942956065835e-08
, O 0 1.5089662158684902e-11
these O 0 1.9218851770447243e-12
mutations O 0 1.0673114614334622e-09
were O 0 6.862103246740858e-11
found O 0 5.807962097370556e-11
in O 0 8.747930331509668e-12
28 O 0 2.3234242221142898e-12
of O 0 1.0365731032855804e-13
41 O 0 8.218703495543878e-12
families O 0 4.3363832490095344e-12
identified O 0 1.1262094590236416e-09
to O 0 1.831419217668273e-11
have O 0 2.617525363124429e-10
a O 0 6.141446795560057e-10
mutation O 0 5.879017521692731e-07
. O 0 3.930212599811966e-09

The O 0 3.353856525833976e-09
odds O 0 5.556965447794937e-07
of O 0 7.936329544933063e-12
detection O 0 5.7266338338024525e-09
of O 0 2.7782442145463104e-13
any O 0 1.3461042176754479e-11
of O 0 7.06001934431405e-13
the O 0 1.1200111151021819e-11
four O 0 4.717089496786286e-10
BRCA1 O 0 2.727151468207012e-06
mutations O 0 1.6528304058738286e-07
was O 0 1.0381903337020049e-08
18 O 0 6.724288348358698e-10
. O 0 1.5861241209336185e-09

7x O 0 5.1331462600501254e-05
greater O 0 8.415222296775937e-09
if O 0 1.7216098546768421e-09
one O 0 3.3061587322025243e-12
or O 0 2.3477558872692095e-12
more O 0 4.966349597193553e-13
cases O 0 2.1354944201856796e-10
of O 0 5.119342176840291e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 6.248399131436599e-06
also O 0 1.2633893931024431e-09
present O 0 9.065582312617337e-11
in O 0 1.774141597521428e-11
the O 0 4.552326571261034e-11
family O 0 6.96234714325783e-09
. O 0 1.8603788509707897e-09

The O 0 1.4241482437782338e-09
odds O 0 1.3848135438365716e-07
of O 0 1.0567930211480281e-11
detection O 0 1.319196751836671e-08
of O 0 5.499963548830089e-13
any O 0 9.69488465202284e-12
of O 0 9.87900733440128e-13
the O 0 1.2850374410400267e-11
four O 0 2.8258076434362067e-10
BRCA2 O 0 7.472495440197235e-07
mutations O 0 1.6034547911658592e-07
was O 0 2.2891739615005235e-09
5 O 0 1.3734453851999007e-10
. O 0 9.430224379158858e-10

3x O 0 1.8895318135037087e-05
greater O 0 1.3050593494767782e-08
if O 0 2.9651356925342043e-09
there O 0 4.488935959057194e-11
were O 0 4.7394980301485035e-11
at O 0 2.8885505098941167e-11
least O 0 9.39654604126261e-13
five O 0 7.170501171993582e-13
cases O 0 1.5745448347925795e-11
of O 0 1.1364716112627349e-10
breast B-Disease 1 0.9670546054840088
cancer I-Disease 0 0.00016264812438748777
in O 0 4.6418677235315897e-10
the O 0 4.332749714563988e-10
family O 0 3.249077451528137e-08
. O 0 4.4887689121253516e-09

Interestingly O 0 2.0749305349454517e-06
, O 0 3.440034021529037e-11
the O 0 1.412069246253811e-12
presence O 0 7.323430924188745e-12
of O 0 5.649905998779403e-13
a O 0 3.582385055267423e-09
breast B-Disease 0 0.3334944248199463
cancer I-Disease 0 9.104684068006463e-06
case O 0 3.98191435380113e-09
< O 0 1.5610817527544896e-08
36 O 0 6.941757065004328e-12
years O 0 4.8875469643716585e-12
of O 0 6.463419209568055e-13
age O 0 6.347985470611661e-10
was O 0 1.3719503311193648e-10
strongly O 0 1.2233925678062363e-11
predictive O 0 1.2460949806725186e-11
of O 0 3.754011397528664e-14
the O 0 3.5255668827047226e-13
presence O 0 4.7311408263306376e-12
of O 0 4.626319469115854e-14
any O 0 2.8909082159384036e-12
of O 0 3.517359201208464e-13
the O 0 5.710874047964998e-12
eight O 0 7.293687181997299e-11
mutations O 0 1.967698182170352e-08
screened O 0 2.658809705735621e-07
. O 0 1.039291852578117e-08

Carriers O 0 1.1635831853595846e-08
of O 0 8.66202509025582e-12
the O 0 6.609206237850884e-12
same O 0 4.655333757375146e-11
mutation O 0 2.015055233783869e-09
, O 0 3.341379636086911e-13
from O 0 2.0263166687108092e-13
different O 0 1.782090208908571e-12
families O 0 1.2215086581113255e-11
, O 0 6.681067374683658e-13
shared O 0 1.123235011946111e-11
similar O 0 5.7361601579764e-11
haplotypes O 0 4.540866793689702e-09
, O 0 1.9335334115050395e-12
indicating O 0 9.967614927886004e-11
that O 0 1.6190564514073635e-12
the O 0 1.828161238929052e-13
mutant O 0 3.61449550845272e-11
alleles O 0 3.226445499660002e-11
were O 0 6.18846640598747e-11
likely O 0 1.7121712381218401e-10
to O 0 2.915483176060829e-12
be O 0 5.979196998628922e-11
identical O 0 8.68518235108695e-09
by O 0 9.302678419254029e-12
descent O 0 1.0764131808116417e-09
for O 0 7.638434698122032e-13
a O 0 9.22673396019924e-11
mutation O 0 2.0274661949315487e-08
in O 0 1.0873880788853096e-11
the O 0 9.54432453209586e-12
founder O 0 2.1519077630927086e-09
population O 0 9.816675250462481e-11
. O 0 7.402235491227316e-10

The O 0 7.794302425701005e-10
identification O 0 1.0365079905483299e-09
of O 0 1.604262382659538e-11
common O 0 3.5916625229504007e-09
BRCA1 O 0 1.763518957886845e-05
and O 0 1.7082880887642204e-08
BRCA2 O 0 1.5478366549359635e-05
mutations O 0 5.817960300191771e-07
will O 0 5.4890182676903265e-11
facilitate O 0 1.4287375449395512e-10
carrier O 0 1.622423084768343e-08
detection O 0 2.113610264586896e-08
in O 0 8.159727754586399e-11
French O 0 7.251762212945323e-07
Canadian O 0 0.00017711392138153315
breast B-Disease 1 0.9988328814506531
cancer I-Disease 0 0.14874392747879028
and O 0 2.624467379064299e-05
breast B-Disease 1 0.9999922513961792
/ I-Disease 1 0.9999969005584717
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 6.162624231365044e-06
. O 0 1.6560198545789717e-08

Are O 0 1.3948224797388775e-08
Dp71 O 0 2.794471811284893e-06
and O 0 4.866197222952451e-09
Dp140 O 0 1.438463073100138e-06
brain O 0 1.3966101505502593e-05
dystrophin O 0 3.1553183816868113e-06
isoforms O 0 1.9675553630804643e-08
related O 0 5.659548829584082e-09
to O 0 3.5115327312595923e-10
cognitive B-Disease 0 1.7643263845457113e-06
impairment I-Disease 0 0.00010264811862725765
in O 0 7.329747404583031e-07
Duchenne B-Disease 1 0.9999406337738037
muscular I-Disease 1 0.9999436140060425
dystrophy I-Disease 1 0.9998857975006104
? O 0 0.0024032723158597946

Molecular O 0 2.2659598471364006e-05
study O 0 1.5782365636596296e-08
and O 0 1.6102563726860808e-10
neuropsychological O 0 5.667135027920267e-08
analysis O 0 1.6533554525466343e-09
were O 0 5.365957331249227e-11
performed O 0 5.16868492450584e-11
concurrently O 0 1.2264743040613091e-11
on O 0 9.118995142332054e-11
49 O 0 4.934866404404659e-10
patients O 0 1.0502393399391963e-09
with O 0 3.158221062449229e-08
Duchenne B-Disease 1 0.9999722242355347
muscular I-Disease 1 0.9999569654464722
dystrophy I-Disease 1 0.999909520149231
( O 0 4.159257116498338e-08
DMD B-Disease 1 0.9999977350234985
) O 0 1.4619329358200872e-10
in O 0 6.890021973099403e-12
order O 0 2.352255976806328e-12
to O 0 7.969636235671818e-13
find O 0 1.019900899845716e-10
a O 0 2.5609256035230565e-11
molecular O 0 3.240485879629773e-09
explanation O 0 8.903847797947506e-11
for O 0 3.435552081536286e-13
the O 0 1.952293014750861e-11
cognitive B-Disease 0 3.6641594647335296e-08
impairment I-Disease 0 2.490550876643738e-08
observed O 0 1.863142529145989e-08
in O 0 4.4687939459997494e-10
most O 0 1.6783937795139536e-08
DMD B-Disease 1 0.9999984502792358
patients O 0 2.5217032089130953e-06
. O 0 1.0642262182614104e-08

Complete O 0 1.0129363126054614e-08
analysis O 0 1.8493830911125997e-09
of O 0 4.203936677937836e-12
the O 0 3.0813983309396775e-11
dystrophin O 0 2.6747432002593996e-07
gene O 0 2.2651866160572354e-08
was O 0 2.6894921845155295e-09
performed O 0 4.3412121120134373e-10
to O 0 2.839723031375363e-12
define O 0 9.779714815749685e-10
the O 0 4.9734136080281655e-12
localization O 0 3.679984650339918e-10
of O 0 1.4270903252525113e-13
deletions O 0 1.3343950389099746e-09
and O 0 9.333769174224571e-11
duplications O 0 1.521557813077834e-08
in O 0 4.876617512583614e-11
relation O 0 4.514458584736758e-09
to O 0 5.39382670472488e-11
the O 0 1.6105511368991188e-10
different O 0 1.3675285792658087e-08
DMD B-Disease 1 0.999975323677063
promoters O 0 6.720532383042155e-06
. O 0 9.165352921058911e-09

Qualitative O 0 7.600435480981105e-08
analysis O 0 7.386908418283156e-09
of O 0 1.116323613409298e-11
the O 0 1.776738998982008e-11
Dp71 O 0 7.17801711402899e-08
transcript O 0 3.174181983922608e-08
and O 0 7.245656158394453e-11
testing O 0 1.1901053927065863e-11
for O 0 5.0113925053989206e-14
the O 0 8.05825607522008e-14
specific O 0 2.997164690911325e-13
first O 0 6.291983535751389e-13
exon O 0 1.5701491495878628e-10
of O 0 2.8242204581918617e-12
Dp140 O 0 3.1808775613484386e-09
were O 0 6.249425976712075e-10
also O 0 8.126675721253918e-11
carried O 0 1.3116666641721508e-09
out O 0 4.518401486297563e-10
. O 0 6.864555590624377e-10

Neuropsychological O 0 2.937080353149213e-05
analysis O 0 5.180319462283478e-08
assessed O 0 6.661767315563338e-08
verbal O 0 5.476586579789e-07
and O 0 1.2953619288325058e-09
visuospatial O 0 1.822999183787033e-05
intelligence O 0 1.979441179855712e-07
, O 0 1.7901036555856287e-11
verbal O 0 1.0615623047272038e-08
memory O 0 2.9183406695665326e-06
, O 0 1.0163937053109251e-10
and O 0 1.5447509937871473e-10
reading O 0 1.005799532549645e-08
skills O 0 6.7003123049858004e-09
. O 0 5.498682065230298e-10

Comparison O 0 8.8322281044384e-08
of O 0 1.333750748733209e-10
molecular O 0 2.0485428819938534e-07
and O 0 3.2087968393490485e-10
psychometric O 0 3.4029571907012723e-06
findings O 0 1.513072334091703e-08
demonstrated O 0 2.5422350891091128e-09
that O 0 2.737652118889322e-12
deletions O 0 1.977102259687058e-09
and O 0 2.6767669678018358e-11
duplications O 0 5.025632177080297e-08
that O 0 3.955826222146186e-10
were O 0 7.043495647840459e-11
localized O 0 4.277669773955495e-09
in O 0 2.493070853926138e-11
the O 0 3.4703208189046375e-12
distal O 0 3.333713860520504e-10
part O 0 1.2844394818578575e-11
of O 0 7.519523740652512e-13
the O 0 5.375973537863343e-12
gene O 0 3.329919950889604e-10
seemed O 0 8.844273091668242e-10
to O 0 1.4349517667849865e-12
be O 0 2.3035068644206014e-11
preferentially O 0 3.0545073137489e-09
associated O 0 4.6750119331306905e-09
with O 0 5.113208190188345e-10
cognitive B-Disease 0 4.054331839142833e-07
impairment I-Disease 0 1.2301495644351235e-06
. O 0 3.614250898564819e-09

Two O 0 2.3977755336801465e-09
altered O 0 3.871748077699522e-08
Dp71 O 0 3.310879890250362e-07
transcripts O 0 1.842374253158141e-08
and O 0 1.9943975290703797e-11
two O 0 1.2886398762304574e-12
deleted O 0 1.4765104416891717e-10
Dp140 O 0 2.6161978139427333e-10
DNA O 0 7.61104373969701e-11
sequences O 0 2.2268441257633498e-10
were O 0 1.8368872395368996e-11
found O 0 6.261843821242508e-11
in O 0 8.819871048781902e-12
four O 0 1.7998415258180245e-10
patients O 0 2.7747282249634964e-09
with O 0 1.2173146046734473e-08
severe O 0 0.4219526946544647
cerebral B-Disease 1 0.9989295601844788
dysfunction I-Disease 0 0.026494698598980904
. O 0 4.842533840587748e-08

These O 0 1.5568852873570904e-09
findings O 0 1.5672416697753988e-09
suggest O 0 1.0149238116596848e-09
that O 0 6.307150548362506e-12
some O 0 2.8705331297715353e-13
sequences O 0 8.119688255092683e-11
located O 0 3.952867200229804e-11
in O 0 4.6628582071883695e-12
the O 0 1.2558245459162731e-12
distal O 0 3.77339437473978e-10
part O 0 2.4715427621169184e-11
of O 0 9.16379710828863e-13
the O 0 2.901835455954016e-12
gene O 0 2.3023835615809674e-10
and O 0 6.580178762982669e-11
, O 0 4.2683131334930735e-13
in O 0 4.836152637209545e-13
particular O 0 3.536589077146601e-11
, O 0 1.0258288359391021e-12
some O 0 1.5030193886364507e-12
DMD B-Disease 1 0.9997531771659851
isoforms O 0 1.0694021224111339e-09
expressed O 0 1.4037754292317572e-10
in O 0 2.8108780927849075e-11
the O 0 1.988970099731091e-10
brain O 0 0.00014238500443752855
may O 0 8.266257012223832e-09
be O 0 1.388818227088251e-11
related O 0 2.224321594967993e-11
to O 0 3.5517023350140065e-12
the O 0 1.2325206133478872e-10
cognitive B-Disease 0 2.5276352744185715e-07
impairment I-Disease 0 3.684321825403458e-07
associated O 0 3.388974434415104e-08
with O 0 3.4563697681733174e-08
DMD B-Disease 1 0.9999990463256836
. O 0 1.0339140210646747e-08
. O 0 4.165503497688405e-09

I1307K O 0 6.276019121287391e-06
APC O 0 9.488082355346705e-07
and O 0 7.67375551991023e-10
hMLH1 O 0 6.968780041916034e-08
mutations O 0 1.1390295640012482e-07
in O 0 4.8243280897919405e-11
a O 0 1.310973135604243e-10
non O 0 2.0123935851046326e-09
- O 0 8.919021610154232e-08
Jewish O 0 1.356055157053504e-09
family O 0 7.299452153830543e-10
with O 0 1.683823913634086e-10
hereditary B-Disease 0 0.11900680512189865
non I-Disease 0 0.007461963687092066
- I-Disease 1 0.9999862909317017
polyposis I-Disease 1 0.9999904632568359
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
. O 0 2.970084096887149e-06

We O 0 3.0488685354157496e-08
describe O 0 7.924814582338513e-09
a O 0 5.330196839459234e-10
French O 0 1.943804477377853e-07
Canadian O 0 9.438318784305011e-07
hereditary B-Disease 1 0.8040186762809753
non I-Disease 0 0.12416641414165497
- I-Disease 1 0.9999988079071045
polyposis I-Disease 1 0.9999988079071045
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 5.131356601850712e-07
HNPCC B-Disease 0 0.3983398973941803
) O 0 2.2515556086233346e-10
kindred O 0 2.7809346647700295e-07
which O 0 2.914429808598129e-10
carries O 0 2.619653383106879e-10
a O 0 5.045852624618874e-11
novel O 0 8.019754860200123e-10
truncating O 0 1.9741796108974086e-07
mutation O 0 7.991092729753291e-07
in O 0 7.121172540536236e-10
hMLH1 O 0 3.722294934505044e-07
. O 0 2.791028741455648e-09

Interestingly O 0 8.942457725424902e-07
, O 0 5.0685299707309284e-11
the O 0 9.554579349924097e-12
I1307K O 0 4.244987916734999e-09
APC O 0 2.4860788983005477e-09
polymorphism O 0 7.044446448389863e-08
, O 0 2.6928758702082778e-12
associated O 0 9.210482203314552e-12
with O 0 5.842376821045547e-13
an O 0 1.9750902302551054e-12
increased O 0 2.8689147058003073e-08
risk O 0 9.775890248420183e-06
of O 0 1.008597610052675e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.823418476793904e-08
is O 0 1.612373845549797e-10
also O 0 1.7797067639047093e-11
present O 0 1.981418848440164e-11
in O 0 2.7524758514085867e-11
this O 0 2.0759360896960288e-10
family O 0 1.2731362630802323e-08
. O 0 4.434933309482858e-09

The O 0 2.358612194441889e-09
I1307K O 0 1.2236563406986534e-07
polymorphism O 0 1.5542149185421295e-06
has O 0 1.097028134999789e-09
previously O 0 3.540424342585169e-10
only O 0 6.985294721123525e-12
been O 0 1.0782701814759932e-10
identified O 0 3.316907859485241e-09
in O 0 4.8435673874469565e-12
individuals O 0 4.9084174225111354e-12
of O 0 7.961025935698807e-12
self O 0 5.532745490199886e-05
- O 0 4.223528958391398e-05
reported O 0 3.1072241313268023e-07
Ashkenazi O 0 3.884248300778381e-08
Jewish O 0 4.703059275357191e-09
origins O 0 4.84656226262814e-08
. O 0 3.7793097540372855e-09

In O 0 5.153409921021535e-10
addition O 0 9.169645598383624e-11
, O 0 3.196844698682977e-12
in O 0 8.508280885388686e-13
this O 0 1.6352911863179442e-12
family O 0 1.1715009518020736e-10
, O 0 2.1533536672529996e-12
there O 0 6.217876040437442e-12
appears O 0 2.679373389824491e-10
to O 0 9.393684614888986e-12
be O 0 4.786248619659261e-10
no O 0 9.749482471343995e-11
relationship O 0 3.1093491670297624e-10
between O 0 1.300705311686745e-12
the O 0 1.2999215419362553e-12
I1307K O 0 2.69502142824507e-10
polymorphism O 0 6.586363454630373e-09
and O 0 7.50870719767871e-12
the O 0 4.473153618345105e-13
presence O 0 1.5135292324996996e-11
or O 0 4.7135434444456337e-11
absence O 0 9.0117593942729e-11
of O 0 1.7628013632142725e-11
cancer B-Disease 0 9.137498580003012e-08
. O 0 4.725822511097988e-11
. O 0 6.284784359600337e-10

Identification O 0 5.6122541280956284e-08
of O 0 1.951942947553409e-11
a O 0 1.7786759565208143e-10
novel O 0 2.4975566059737275e-09
mutation O 0 2.9357840602983742e-08
of O 0 4.871705903269907e-12
the O 0 2.1303835431862872e-11
CPO O 0 1.0619434220870971e-07
gene O 0 5.084401788479909e-10
in O 0 1.1787533622797941e-11
a O 0 1.9673282447563167e-10
Japanese O 0 5.147055048837501e-07
hereditary B-Disease 0 0.0009525365894660354
coproporphyria I-Disease 0 0.0002440968673909083
family O 0 1.2238477609116671e-07
. O 0 4.546196752386322e-09

Hereditary B-Disease 1 0.9553141593933105
coproporphyria I-Disease 0 0.020622476935386658
( O 0 8.884229352190687e-09
HCP B-Disease 0 4.6341716370079666e-05
) O 0 7.533600132614282e-11
is O 0 6.073078151480615e-11
an O 0 3.2504934854848955e-10
autosomal B-Disease 1 0.999940037727356
dominant I-Disease 1 0.9999352693557739
disease I-Disease 1 0.7126075625419617
characterized O 0 2.15170121009578e-06
by O 0 2.2766062646173424e-10
a O 0 1.0333269528928213e-07
deficiency B-Disease 0 0.00012916233390569687
of I-Disease 0 1.9393292527425388e-11
coproporphyrinogen I-Disease 0 3.5711620967049384e-06
oxidase I-Disease 0 5.4502176993764806e-08
( O 0 1.961968781882817e-11
CPO O 0 1.785258518793853e-07
) O 0 7.064723805960682e-12
caused O 0 2.3258826808980615e-10
by O 0 7.924983586038437e-12
a O 0 3.6895517752100204e-09
mutation O 0 4.165530071986723e-07
in O 0 6.361715321201444e-11
the O 0 7.937543677893899e-11
CPO O 0 8.368581916329276e-07
gene O 0 1.5938338648879835e-08
. O 0 1.368561264314394e-09

Only O 0 2.4136654896977916e-09
11 O 0 2.0159422742249689e-10
mutations O 0 1.915249958628351e-09
of O 0 1.505056170837682e-12
the O 0 6.755133345054398e-12
gene O 0 3.820468830184609e-09
have O 0 7.340475338679653e-09
been O 0 2.042875646424136e-09
reported O 0 4.316051516184416e-08
in O 0 1.561822560169901e-09
HCP B-Disease 0 0.006121951155364513
patients O 0 1.0192177768431065e-07
. O 0 1.2588247777500783e-08

We O 0 7.826084669204647e-08
report O 0 1.1347827122420995e-09
another O 0 4.357851926539702e-11
mutation O 0 9.736594641651664e-09
in O 0 4.5577302348887017e-11
a O 0 6.023625487294737e-10
Japanese O 0 8.748854725126876e-07
family O 0 2.0601092387551034e-08
. O 0 4.001504017026036e-09

Polymerase O 0 2.536130295993644e-06
chain O 0 2.055707000181428e-06
reaction O 0 9.486881680231818e-08
- O 0 1.406317977625804e-07
single O 0 1.6218931753186894e-09
strand O 0 1.0748729017961978e-08
conformational O 0 3.040145246657744e-09
polymorphism O 0 6.3494326241198e-08
and O 0 3.5729693943081786e-12
direct O 0 7.538051779998334e-12
sequence O 0 1.4986983876141835e-10
analyses O 0 4.491370331205502e-10
demonstrated O 0 6.954350290078182e-11
a O 0 2.0056893645925555e-11
C O 0 1.5311585332966615e-09
to O 0 1.458755967582992e-12
T O 0 8.963935149708391e-10
substitution O 0 7.497797955419161e-13
in O 0 1.5108884466891875e-13
exon O 0 4.270532191763543e-11
1 O 0 1.2415962355460941e-12
of O 0 9.970413980108644e-14
the O 0 2.4792798022921225e-12
CPO O 0 2.489932038329812e-09
gene O 0 1.9539769108289917e-11
at O 0 2.061952605186823e-12
nucleotide O 0 8.15106385165798e-11
position O 0 1.2549684902385394e-10
85 O 0 2.9686114677573983e-12
, O 0 3.2619973345734965e-13
which O 0 1.2011679845214118e-11
lies O 0 1.5418171184222729e-09
in O 0 1.5715446305408776e-11
the O 0 7.870783885755017e-12
putative O 0 1.7941937935361807e-09
presequence O 0 3.899077061220169e-09
for O 0 1.4368962833813392e-12
targeting O 0 6.241183125865746e-10
to O 0 1.1435209029686533e-10
mitochondria O 0 2.1747104028690956e-07
. O 0 6.156144483071557e-09

This O 0 1.9308754595215305e-09
mutation O 0 3.371334855728492e-08
changes O 0 1.5353572579979158e-10
the O 0 1.7031375225060041e-12
codon O 0 4.034815190290253e-11
for O 0 5.759260933825908e-14
glutamine O 0 3.056847136528873e-11
to O 0 4.947647651819265e-13
a O 0 4.692552943441619e-11
termination O 0 9.559770752787244e-09
codon O 0 5.713560180531374e-10
at O 0 7.377073257819333e-11
amino O 0 1.18969750717568e-10
acid O 0 5.193342977882764e-10
position O 0 6.2180518511922855e-09
29 O 0 1.0752825296833635e-09
. O 0 2.6071964032148287e-10

MaeI O 0 6.245980330277234e-06
restriction O 0 1.3937640375161209e-08
analysis O 0 2.7533189062012298e-09
showed O 0 2.114383335083403e-09
two O 0 2.336074909903285e-12
other O 0 4.711123418460472e-12
carriers O 0 7.116935929474266e-10
in O 0 1.8238129756431576e-11
the O 0 5.4226168694215815e-11
family O 0 4.390728669534383e-09
. O 0 1.0077808587638515e-09

The O 0 3.531033598846989e-08
C O 0 3.9744041714584455e-05
- O 0 0.0015021675499156117
T O 0 0.09396186470985413
mutation O 0 2.364519787079189e-06
is O 0 9.870748662876849e-11
located O 0 1.2185377706863676e-10
within O 0 1.3462761287719172e-11
a O 0 8.722958466655939e-11
recently O 0 1.5177540335642448e-09
proposed O 0 6.274504527059577e-11
putative O 0 1.1256638954293408e-09
alternative O 0 3.969095538347567e-11
translation O 0 5.231367769531481e-11
initiation O 0 2.802136994661808e-11
codon O 0 4.271976383751763e-10
( O 0 1.5736163457361063e-12
TIC O 0 2.704803314657056e-08
- O 0 6.3978498054950705e-09
1 O 0 2.214314669124473e-11
) O 0 3.402872330703771e-13
, O 0 4.072975206344427e-14
supporting O 0 5.813700215684392e-12
that O 0 3.388142197358057e-11
TIC O 0 1.4401950920728268e-07
- O 0 6.223011439487891e-09
1 O 0 7.57090484054812e-12
is O 0 1.0557729820601103e-12
the O 0 3.2793087906615725e-13
real O 0 7.221793829614853e-09
TIC O 0 1.0866125421671313e-07
rather O 0 1.579074197788355e-11
than O 0 8.752620156426971e-12
TIC O 0 2.2574143443421235e-08
- O 0 8.353234215441319e-10
2 O 0 1.4507406560781977e-11
. O 0 6.759618472601536e-12
. O 0 1.0081437074038746e-10

Human B-Disease 0 3.2648412684466166e-07
complement I-Disease 0 1.0445880889164982e-06
factor I-Disease 0 0.00017751513223629445
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999169111251831
associated O 0 2.169288563891314e-05
with O 0 3.257263597333804e-05
hemolytic B-Disease 1 0.9999936819076538
uremic I-Disease 1 0.9999990463256836
syndrome I-Disease 1 0.9999951124191284
. O 0 3.141230990877375e-06

This O 0 2.460359138645174e-10
study O 0 4.0822827757081015e-11
reports O 0 2.465520669570065e-11
on O 0 1.924732768998627e-11
six O 0 8.757913665113914e-12
cases O 0 8.521525846072464e-11
of O 0 1.6435573735318343e-10
deficiency B-Disease 0 3.6747740523424e-05
in I-Disease 0 4.723981188864412e-12
the I-Disease 0 1.340068030500352e-12
human I-Disease 0 3.734924695908415e-12
complement I-Disease 0 1.6610535863437192e-11
regulatory I-Disease 0 3.5095957390263166e-11
protein I-Disease 0 1.595681642374558e-10
Factor I-Disease 0 8.130308648546247e-10
H I-Disease 1 0.9999977350234985
( O 0 6.67073479787561e-11
FH O 0 6.896950708323857e-07
) O 0 8.709650296985505e-13
in O 0 3.087984512192832e-13
the O 0 6.063881493288681e-13
context O 0 9.438948234130606e-11
of O 0 1.6104551719964277e-11
an O 0 5.390708324171101e-08
acute B-Disease 1 0.9996769428253174
renal I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999996423721313
. O 0 7.80026675784029e-06

Five O 0 3.827527461641722e-10
of O 0 3.1602814982989447e-12
the O 0 1.1242638764397128e-11
cases O 0 1.1104862168709317e-10
were O 0 1.1085081741413205e-09
observed O 0 1.959742590429414e-08
in O 0 6.919367856461633e-11
children O 0 3.2478475464614576e-10
presenting O 0 1.1887142825628416e-08
with O 0 2.0021011550852563e-06
idiopathic O 1 0.9999655485153198
hemolytic B-Disease 1 0.9999970197677612
uremic I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999995231628418
( O 0 3.1098290946829366e-06
HUS B-Disease 1 0.9994847774505615
) O 0 9.292233471569489e-08
. O 0 5.6487461819187956e-08

Two O 0 6.012066955385365e-10
of O 0 1.0421249800607324e-11
the O 0 3.4427450473772936e-11
children O 0 8.893804026577357e-10
exhibited O 0 2.8796003448405827e-07
a O 0 5.4672305793701526e-08
homozygous O 1 0.8004218935966492
deficiency O 0 0.4464757740497589
characterized O 0 6.615421987987702e-09
by O 0 5.014687016330344e-12
the O 0 3.309300533257953e-12
absence O 0 2.7988731124417576e-11
of O 0 1.3720005220905357e-13
the O 0 3.509813154087965e-13
150 O 0 1.2136978705043489e-12
- O 0 1.638227331568487e-10
kD O 0 2.2566803981050043e-10
form O 0 1.3872634594888633e-12
of O 0 4.686403175246934e-13
Factor O 0 5.904560729241837e-10
H O 1 0.999997615814209
and O 0 9.201597817032336e-12
the O 0 3.16964228301575e-13
presence O 0 1.511028281664384e-11
, O 0 8.198560645482356e-14
upon O 0 3.9507982931182017e-13
immunoblotting O 0 6.851213485425944e-10
, O 0 5.3978224884634884e-14
of O 0 9.235236646330369e-15
the O 0 1.0152688151993106e-12
42 O 0 3.1383623998182397e-12
- O 0 3.201870157898412e-10
kD O 0 1.1621636986092199e-08
Factor O 0 8.679762464325336e-10
H O 1 0.9999823570251465
- O 0 1.002795979587745e-08
like O 0 1.5939995157143727e-10
protein O 0 4.234115835721752e-11
1 O 0 7.693122180962852e-12
( O 0 5.047320525940202e-13
FHL O 0 3.0618918511748916e-09
- O 0 2.6945123909882795e-10
1 O 0 4.370535617442828e-12
) O 0 7.390553555426671e-14
and O 0 6.944560486561724e-13
other O 0 3.4380447707510475e-12
FH O 0 3.8339615571203467e-07
- O 0 1.598885290832186e-08
related O 0 1.7361486692735184e-09
protein O 0 1.715110498068384e-09
( O 0 9.837345348040483e-12
FHR O 0 2.585430820545298e-07
) O 0 1.7871015431381032e-11
bands O 0 4.694007849082027e-09
. O 0 2.0910659870310155e-09

Southern O 0 1.2054138665007486e-07
blot O 0 1.43293027576874e-06
and O 0 4.834552549959348e-11
PCR O 0 3.5233962414338293e-09
analysis O 0 2.813222224617995e-11
of O 0 1.1829415485359318e-13
DNA O 0 1.8704006399250517e-10
of O 0 7.671563037603413e-13
one O 0 1.5524306840042357e-10
patient O 0 2.8033920074221896e-08
with O 0 1.199424670694782e-09
homozygous O 0 0.3892861306667328
deficiency O 0 0.4576739966869354
ruled O 0 4.615173576638654e-09
out O 0 5.044755585492666e-11
the O 0 8.582260878527148e-13
presence O 0 2.455007985097124e-12
of O 0 3.4026824597983146e-14
a O 0 1.3239026845288104e-12
large O 0 3.0279202756222645e-11
deletion O 0 2.8796860451762996e-09
of O 0 2.092299640835127e-12
the O 0 6.246145961563698e-11
FH O 0 7.562143764516804e-07
gene O 0 2.621682593240138e-10
as O 0 1.7430019233488636e-11
the O 0 3.102008233613063e-11
underlying O 0 1.1508124089232297e-06
defect O 0 2.8340454605313425e-07
for O 0 2.8741080695948718e-11
the O 0 7.460352335897369e-09
deficiency O 0 0.00014390239084605128
. O 0 1.986745434834347e-09

The O 0 2.1863529042764895e-10
other O 0 3.8181905553935636e-12
four O 0 5.425863317670698e-12
children O 0 1.9411389162726778e-11
presented O 0 5.315566875552236e-10
with O 0 6.993331247429069e-09
heterozygous O 0 0.04157586023211479
deficiency O 0 0.028350133448839188
and O 0 1.1308453479186298e-10
exhibited O 0 2.83598300399035e-08
a O 0 7.129490331436728e-10
normal O 0 6.060343782365862e-09
immunoblotting O 0 2.530867071470766e-08
pattern O 0 3.4714446872641247e-09
of O 0 4.85396933151e-13
proteins O 0 2.1832210518601958e-12
of O 0 2.123627445768661e-12
the O 0 4.6193454616982876e-10
FH O 0 7.238938269438222e-05
family O 0 2.4566150003124676e-08
. O 0 1.4596543973510734e-09

Factor B-Disease 0 0.005533450748771429
H I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9946728348731995
is O 0 4.15915801799116e-10
the O 0 9.081607688088411e-11
only O 0 4.002047759854577e-08
complement B-Disease 1 0.9999988079071045
deficiency I-Disease 1 0.9999998807907104
associated O 0 5.20068397236173e-07
with O 0 5.6361972866625365e-08
HUS B-Disease 1 0.9984899759292603
. O 0 1.63951455078859e-07

These O 0 7.961124537381181e-10
observations O 0 7.145408265074593e-09
suggest O 0 8.466672918316931e-10
a O 0 1.3327937711804516e-11
role O 0 6.077875702725777e-11
for O 0 2.2247542350029015e-11
FH O 0 4.7867697503534146e-06
and O 0 2.144573185702825e-09
/ O 0 3.221076738668671e-08
or O 0 5.288033566586137e-09
FH O 0 1.145054056905792e-06
receptors O 0 2.311907554286563e-09
in O 0 1.7882540934155422e-11
the O 0 6.918945277822885e-11
pathogenesis O 0 3.0021670482938134e-08
of O 0 4.1057107713626806e-10
idiopathic O 0 0.01752079837024212
HUS B-Disease 1 0.9983060359954834
. O 0 3.964304440273736e-08
. O 0 7.3526940091994675e-09

Further O 0 4.20336376816266e-10
evidence O 0 3.9105446658638243e-10
for O 0 1.456218067137638e-12
a O 0 2.0003216097408405e-11
major O 0 2.0411881906934326e-10
ancient O 0 2.0237223452568287e-08
mutation O 0 0.036771614104509354
underlying O 1 0.9437282681465149
myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999996423721313
from O 0 1.514568026550478e-08
linkage O 0 8.139691999531351e-06
disequilibrium O 0 3.133382779196836e-05
studies O 0 1.31651145540701e-09
in O 0 3.575705009861707e-11
the O 0 1.3674613524861101e-11
Japanese O 0 2.993179393229184e-08
population O 0 2.9104912924182713e-10
. O 0 6.504016214492481e-10

The O 0 1.891403371701017e-05
myotonic B-Disease 1 0.9999959468841553
dystrophy I-Disease 1 0.9999995231628418
( O 0 1.5173392057477031e-05
DM B-Disease 1 0.9999996423721313
) O 0 4.298878586439514e-09
mutation O 0 1.275663862543297e-06
is O 0 5.716819240220161e-10
an O 0 6.941019287109995e-11
unstable O 0 7.82614151830785e-05
( O 0 1.1294312707299525e-10
CTG O 0 7.017384717755704e-08
) O 0 2.1004966429399863e-12
n O 0 1.9053940647495438e-09
repeat O 0 1.8271199664354754e-08
, O 0 4.4829247193740873e-13
present O 0 8.875996725804525e-13
at O 0 5.402844404506224e-12
a O 0 2.3228923125284684e-12
copy O 0 5.206325370821219e-10
number O 0 1.8536463596702246e-12
of O 0 1.8369133254411696e-13
5 O 0 6.78146904950494e-12
- O 0 2.6793238738775926e-09
37 O 0 1.0827397138590822e-11
repeats O 0 1.388763271048532e-10
on O 0 2.875100504895478e-11
normal O 0 1.2501044643897785e-10
chromosomes O 0 2.577603130937689e-10
but O 0 5.487612534521569e-12
amplified O 0 2.8481444980243964e-10
to O 0 1.0867654432616947e-12
50 O 0 1.2155118491591343e-12
- O 0 1.786025771721711e-10
3000 O 0 2.6269281194757355e-10
copies O 0 4.1195166722296506e-10
on O 0 5.92008362332308e-08
DM B-Disease 1 0.9999926090240479
chromosomes O 0 6.514143024105579e-06
. O 0 1.2304195884382807e-08

Previous O 0 3.5876997372952246e-08
findings O 0 4.9124144751999665e-09
in O 0 1.2434460405774672e-10
Caucasian O 0 3.542278648183128e-08
populations O 0 5.304092165481222e-10
of O 0 6.907034839909176e-12
a O 0 1.1602283933598301e-07
DM B-Disease 1 0.9999997615814209
founder O 0 2.235699128050328e-07
chromosome O 0 5.361434318729152e-07
raise O 0 8.635145376523212e-10
a O 0 6.277485475880695e-11
question O 0 5.098619304533258e-10
about O 0 1.8073114619460151e-12
the O 0 2.8097229404222546e-13
molecular O 0 6.174697975147581e-10
events O 0 3.4724809833130976e-11
involved O 0 8.622731001439732e-11
in O 0 1.2873975323290932e-11
the O 0 8.88904661683343e-12
expansion O 0 1.6771513067226351e-09
mutation O 0 5.1693827884946586e-08
. O 0 6.529223828266595e-10

To O 0 1.5378726070380822e-09
investigate O 0 1.8015089864320544e-08
whether O 0 1.979910013716335e-09
a O 0 3.391421865561739e-10
founder O 0 3.6537868286501407e-09
chromosome O 0 6.113263140150593e-08
for O 0 1.952374893698927e-11
the O 0 1.764431045714332e-09
DM B-Disease 1 0.9999997615814209
mutation O 0 2.803753204716486e-06
exists O 0 1.2860636999789676e-09
in O 0 1.4334554593667392e-12
the O 0 8.22039268252861e-13
Japanese O 0 1.5714142209688475e-09
population O 0 1.9716010508236126e-12
, O 0 5.315973898058213e-13
we O 0 9.714579835007342e-12
genotyped O 0 1.4324519348463127e-09
families O 0 3.00277966554241e-12
using O 0 2.694500872424399e-11
polymorphic O 0 4.486072846532352e-09
markers O 0 5.671373770610444e-08
near O 0 2.199173998462811e-08
the O 0 1.2558305784171608e-10
( O 0 4.0068920403868447e-11
CTG O 0 2.604559767860337e-08
) O 0 4.792684044768736e-12
n O 0 8.988644495389053e-09
repeat O 0 2.0790373866930167e-07
region O 0 3.0708462439577033e-09
and O 0 7.610118091250229e-10
constructed O 0 3.954661451643915e-07
haplotypes O 0 7.817601726856083e-06
. O 0 1.5270323672211816e-08

Six O 0 9.13289532888939e-09
different O 0 3.101554013618113e-10
haplotypes O 0 1.4214968757642055e-07
were O 0 2.519200847928005e-09
found O 0 1.0139298289857379e-08
and O 0 1.6062249130754935e-07
DM B-Disease 1 0.999998927116394
alleles O 0 1.0564740478002932e-06
were O 0 6.32847942938497e-08
always O 0 1.1540662825382242e-07
haplotype O 0 2.71350046432417e-07
A O 0 1.8567284598702827e-08
. O 0 3.3332514526307477e-09

To O 0 1.0305232223117855e-09
find O 0 4.960185040481235e-10
an O 0 1.3916149049081339e-12
origin O 0 7.047930988823836e-11
of O 0 9.570534469094394e-13
the O 0 2.3231017803881926e-11
( O 0 3.9539439430913426e-12
CTG O 0 3.73706088296899e-09
) O 0 2.7703701962686345e-13
n O 0 4.2344003303718125e-10
repeat O 0 2.2040103075937623e-09
mutation O 0 2.234443963189392e-09
and O 0 7.753662620811619e-13
to O 0 1.426986783945039e-13
investigate O 0 9.605490708386455e-11
the O 0 2.2418000615587186e-12
mechanism O 0 1.818023336042085e-11
of O 0 8.441661811849771e-14
the O 0 1.9446129548208319e-13
expansion O 0 6.240807783747249e-12
mutation O 0 1.1063699262292559e-10
in O 0 3.040724681595275e-13
the O 0 2.165412218025492e-13
Japanese O 0 7.091002229842047e-10
population O 0 9.918826827590155e-13
we O 0 2.2024113435770154e-11
have O 0 3.484787111651677e-12
studied O 0 3.600554923655075e-11
90 O 0 3.5680659815628957e-12
Japanese O 0 1.126094062442462e-08
DM B-Disease 1 0.9999139308929443
families O 0 3.8553087805537345e-11
comprising O 0 5.370982304742089e-12
190 O 0 4.106045711771422e-11
affected O 0 1.1382635112244799e-10
and O 0 4.381822682475445e-11
130 O 0 1.0469147770919562e-10
unaffected O 0 2.8008905417209462e-08
members O 0 1.3666641429654902e-10
. O 0 1.9823320762668573e-09

The O 0 4.6126920061340115e-09
results O 0 6.940139130051648e-09
suggest O 0 3.997270070499326e-09
that O 0 1.0115196007187688e-11
a O 0 9.604717195188517e-12
few O 0 1.0275897320555227e-11
common O 0 1.4247146865042914e-11
ancestral O 0 9.084851759766366e-10
mutations O 0 2.2400341581629846e-09
in O 0 4.223724668628304e-12
both O 0 2.4388656025275957e-11
Caucasian O 0 2.2268718424811595e-08
and O 0 2.8504054672140455e-10
Japanese O 0 1.1888027451334438e-08
populations O 0 6.503939053992269e-11
have O 0 3.357556854072241e-12
originated O 0 1.9102562413830793e-12
by O 0 3.161568432725158e-14
expansion O 0 1.283415214381467e-12
of O 0 6.911916920976716e-14
an O 0 1.0277730408273303e-13
ancestral O 0 1.9419175989465742e-10
n O 0 2.4816868560151306e-09
= O 0 5.963278204568212e-10
5 O 0 7.159745344341439e-13
repeat O 0 2.6332289126962394e-10
to O 0 9.322146353463179e-12
n O 0 3.78081850271883e-08
= O 0 1.1146188860777784e-08
19 O 0 3.371574547328393e-11
- O 0 8.748807234226774e-10
37 O 0 2.6772572006561468e-11
copies O 0 3.8594752393983356e-10
. O 0 1.3115115660156107e-09

These O 0 5.280894610493192e-10
data O 0 2.3322710429596327e-10
support O 0 7.497729867522729e-12
multistep O 0 9.45030165233618e-10
models O 0 6.518049988635255e-10
of O 0 3.0432850250255994e-12
triplet O 0 1.2188536402391037e-06
repeat O 0 1.1530184806929356e-08
expansion O 0 1.6905042643511337e-10
that O 0 1.1587931135481622e-11
have O 0 3.3389731951549706e-12
been O 0 6.389263575677651e-13
proposed O 0 1.042398697741198e-12
for O 0 1.550177304229794e-12
both O 0 2.4581323643246833e-09
DM B-Disease 1 0.9999996423721313
and O 0 2.3710265750764847e-08
Friedreichs B-Disease 0 3.797600356847397e-06
ataxia I-Disease 0 3.9121328882174566e-05
. O 0 2.9557326031159903e-10
. O 0 9.406979639692281e-10

The O 0 1.0721982190986523e-09
molecular O 0 3.932314029952977e-08
basis O 0 2.6371709260786247e-09
of O 0 1.308093828811252e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.139539240746501e-09
the O 0 9.914902232566192e-11
western O 0 5.533929425816098e-10
Cape O 0 8.133973494750535e-09
, O 0 2.4147591912160316e-11
South O 0 4.943332895801511e-11
Africa O 0 1.4440440510021801e-10
. O 0 2.985945934952383e-10

Deficiency B-Disease 1 0.9725468158721924
of I-Disease 0 8.025504566466779e-11
the I-Disease 0 1.9106580900762893e-11
sixth I-Disease 0 1.468447918817617e-09
component I-Disease 0 7.382566225011544e-10
of I-Disease 0 1.864013067162662e-12
human I-Disease 0 6.20830400976935e-11
complement I-Disease 0 4.22924251175516e-10
( O 0 6.38709831551898e-12
C6 O 0 3.7683710729652375e-07
) O 0 1.2174841213311027e-12
has O 0 1.1252206631728878e-11
been O 0 1.7676707320113394e-10
reported O 0 5.350017651117867e-10
in O 0 7.005639015948695e-13
a O 0 7.470636956274923e-12
number O 0 2.260977863266511e-12
of O 0 2.14596840731468e-13
families O 0 4.302907856412741e-12
from O 0 1.3324575817708073e-12
the O 0 3.4037310730344883e-12
western O 0 9.960164637501379e-11
Cape O 0 1.963359474999038e-09
, O 0 1.1263930760341268e-11
South O 0 2.4853129970692223e-11
Africa O 0 5.32060541458268e-11
. O 0 1.6883036635384485e-10

Meningococcal B-Disease 1 0.9927581548690796
disease I-Disease 0 0.003830159781500697
is O 0 3.5915734830638257e-09
endemic O 0 1.3440231150241289e-08
in O 0 3.532497211411467e-11
the O 0 3.788984750952018e-11
Cape O 0 2.6483559789625133e-09
and O 0 5.317278214955756e-11
almost O 0 6.495666851624726e-12
all O 0 5.478552724327845e-13
pedigrees O 0 2.541265420319405e-09
of O 0 2.663891329746093e-11
total O 0 1.4239529946280527e-06
C6 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
( O 0 1.7173945598969453e-10
C6Q0 O 0 8.246244078691234e-07
) O 0 5.6527009635598535e-12
have O 0 3.1881022127810965e-11
been O 0 3.6996058994098746e-10
ascertained O 0 8.330966494440872e-08
because O 0 2.8836857901559654e-10
of O 0 1.5898275751435875e-10
recurrent O 0 0.007440825458616018
disease O 0 0.0012460330035537481
. O 0 1.7189234924330776e-08

We O 0 8.122116668118906e-08
have O 0 1.2594335296878256e-10
sequenced O 0 3.8332551022257633e-10
the O 0 3.0932682630602226e-12
expressed O 0 1.5129519165268945e-11
exons O 0 1.86967649695724e-10
of O 0 7.662672037687945e-13
the O 0 5.970122833598435e-12
C6 O 0 3.0707365539228704e-08
gene O 0 7.380422661906749e-11
from O 0 1.602527355606953e-12
selected O 0 3.3144301105764162e-12
cases O 0 2.5614579901578338e-11
and O 0 1.0041442677355406e-10
have O 0 1.3185764979883885e-10
found O 0 1.8325697903609495e-10
three O 0 1.1714047787325654e-10
molecular O 0 1.9440989490249194e-05
defects O 0 0.0004299804277252406
leading O 0 4.6145023913091165e-10
to O 0 1.2529403903283054e-10
total O 0 3.799013015282071e-08
deficiency O 0 0.0021514210384339094
879delG O 0 2.1967304064673954e-07
, O 0 2.0735963293661008e-11
which O 0 4.9099554283449365e-11
is O 0 5.970225615964386e-12
the O 0 4.441377387393031e-12
common O 0 5.141922443385738e-10
defect O 0 4.850631540875838e-08
in O 0 2.2162077728538065e-11
the O 0 2.2419722328637093e-11
Cape O 0 5.536188174559697e-10
and O 0 1.7820299055837374e-11
hitherto O 0 1.4656245106436927e-09
unreported O 0 8.342073698486274e-10
, O 0 1.009002451902996e-12
and O 0 9.63653093953576e-13
1195delC O 0 4.4558318146314946e-10
and O 0 4.596840703224858e-12
1936delG O 0 9.533909217651626e-10
, O 0 1.4858317484364725e-12
which O 0 9.414203791524578e-12
have O 0 4.760662003500116e-11
been O 0 1.1700673763215264e-10
previously O 0 1.9562376718518237e-10
reported O 0 5.86501736066225e-10
in O 0 1.4136409057230459e-11
African O 0 1.2933807670700848e-11
- O 0 1.4886521171320055e-07
Americans O 0 3.066848330846028e-09
. O 0 9.667842082450306e-10

We O 0 3.57183189692023e-08
also O 0 2.486716561833635e-11
show O 0 8.196102824209461e-11
that O 0 1.6075479706070817e-12
the O 0 2.1515185466558506e-12
879delG O 0 7.43066124186953e-08
and O 0 2.558628642290728e-09
1195delC O 0 2.0348779798951e-05
defects O 0 0.10003519803285599
are O 0 6.566525795337341e-11
associated O 0 8.633547765590777e-10
with O 0 3.701327855321068e-10
characteristic O 0 0.00017886671412270516
C6 O 0 0.04955364018678665
/ O 0 3.933255356969312e-06
C7 O 0 3.0236104066716507e-05
region O 0 3.2549438699902566e-09
DNA O 0 2.5703938533183646e-08
marker O 0 1.5361268879132695e-07
haplotypes O 0 2.705340591546701e-07
, O 0 1.504749796987781e-11
although O 0 2.0688634833065933e-11
small O 0 2.081835225042905e-11
variations O 0 1.0849636744580948e-08
were O 0 9.895603447773738e-09
observed O 0 9.876148254761574e-08
. O 0 1.7139495378515335e-09

The O 0 3.4612830379643356e-09
1936delG O 0 2.0098300410609227e-06
defect O 0 3.45976441167295e-05
was O 0 7.3968902114529556e-09
observed O 0 5.915328671335374e-09
only O 0 5.236676110104144e-12
once O 0 2.3294435824716686e-10
in O 0 1.990721606656698e-12
the O 0 4.438489072805529e-12
Cape O 0 7.165877335957305e-10
, O 0 1.2130984151231816e-12
but O 0 1.9664109750239245e-12
its O 0 9.810077012881169e-13
associated O 0 8.250324035063983e-11
haplotype O 0 3.119228875192448e-09
could O 0 1.2427543438775501e-09
be O 0 1.466535504146549e-10
deduced O 0 3.4660608605463494e-08
. O 0 4.172673873092947e-10

The O 0 9.227512642873137e-10
data O 0 1.1653106257725199e-09
from O 0 6.264468544597834e-12
the O 0 3.513485726316934e-12
haplotypes O 0 1.167678398417138e-08
indicate O 0 3.05985032866829e-08
that O 0 8.678744355117285e-12
these O 0 1.2328084516774473e-12
three O 0 3.5639375565305054e-12
molecular O 0 1.6711765056243166e-06
defects O 0 0.00011323589569656178
account O 0 1.8395950041050213e-10
for O 0 6.060473303759473e-12
the O 0 7.77985065258946e-10
defects O 0 0.009049591608345509
in O 0 8.224442828164147e-12
all O 0 9.307465822366856e-13
the O 0 1.3235089022997637e-12
38 O 0 3.344843499397676e-12
unrelated O 0 7.350723502108636e-11
C6Q0 O 0 9.242387477570446e-08
individuals O 0 6.305541505602363e-11
we O 0 2.2242420405493846e-10
have O 0 2.3406387938962325e-11
studied O 0 1.2858128450865536e-10
from O 0 1.8495424376069325e-12
the O 0 5.3893948331884545e-11
Cape O 0 1.536609772756492e-08
. O 0 3.2005529337908456e-09

We O 0 2.8720199907183996e-07
have O 0 1.523286913274191e-10
also O 0 7.31114908197883e-12
observed O 0 1.8953236202712276e-10
the O 0 3.938333600211896e-12
879delG O 0 4.6701661204906486e-08
defect O 0 1.2653055136979674e-07
in O 0 2.653419671483359e-11
two O 0 1.434379282017062e-09
Dutch O 1 0.9976014494895935
C6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999518394470215
deficient I-Disease 1 0.9999959468841553
kindreds O 0 1.2249808605702128e-05
, O 0 1.6575216893466305e-11
but O 0 7.214390109616664e-12
the O 0 9.271392247683918e-13
879delG O 0 8.112420957218092e-09
defect O 0 1.5627231064740954e-08
in O 0 4.508617871407106e-12
the O 0 4.122137527151626e-12
Cape O 0 6.777751138109522e-10
probably O 0 2.1121906446097682e-09
did O 0 1.3545008170634532e-10
not O 0 2.2197770965098895e-12
come O 0 1.3072339434885838e-12
from O 0 1.4415787899339783e-13
The O 0 2.730955869431617e-12
Netherlands O 0 1.3255578856785633e-08
. O 0 4.2002762379311775e-11
. O 0 1.933568444245637e-10

Complement B-Disease 1 0.9738966226577759
C7 I-Disease 1 0.9999984502792358
deficiency I-Disease 1 0.9999994039535522
: O 0 1.8951114011400705e-09
seven O 0 7.212894170827155e-11
further O 0 7.9020449905709e-11
molecular O 0 0.11458887159824371
defects O 1 0.9998354911804199
and O 0 1.5591446356211236e-08
their O 0 1.1596211768605258e-09
associated O 0 1.9196981781988143e-08
marker O 0 7.191994768618315e-07
haplotypes O 0 2.148588464478962e-06
. O 0 9.342131512823926e-09

Seven O 0 3.569868844977009e-09
further O 0 4.15413148324717e-10
molecular O 0 2.636989506754617e-07
bases O 0 9.337751549765017e-08
of O 0 9.928784265866852e-07
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.975189847935326e-08
described O 0 6.950069746380905e-07
. O 0 5.2548938533902856e-09

All O 0 2.8114102712528677e-10
these O 0 1.8802110909876824e-11
new O 0 6.092278764802117e-11
molecular O 0 7.018468295427738e-07
defects O 0 7.924693636596203e-05
involve O 0 1.2703195162444558e-09
single O 0 1.4848827945002085e-08
- O 0 9.22762595223503e-08
nucleotide O 0 4.064363512412683e-09
events O 0 4.7488995374989074e-11
, O 0 1.4675854119201165e-13
deletions O 0 1.986554948318897e-10
and O 0 1.5939347064453102e-11
substitutions O 0 4.57678450693777e-10
, O 0 3.541634758900958e-13
some O 0 2.647819063886312e-14
of O 0 2.2565907747008201e-13
which O 0 4.423397759190095e-11
alter O 0 1.989198805674164e-09
splice O 0 3.881624799362271e-09
sites O 0 1.959061357581504e-09
, O 0 2.199279820758182e-11
and O 0 3.640232906776397e-11
others O 0 2.2376502040177826e-10
codons O 0 3.9100025439609e-09
. O 0 4.5845691132306854e-10

They O 0 8.353764791024787e-09
are O 0 2.8694069689749746e-12
distributed O 0 4.249955855989418e-12
along O 0 1.2916377169214233e-11
the O 0 2.5226844918568858e-11
C7 O 0 3.8387176459764305e-07
gene O 0 2.368475859881869e-09
, O 0 3.94285082014334e-12
but O 0 9.579939922940706e-13
predominantly O 0 4.357099533600084e-13
towards O 0 1.6765026866760735e-12
the O 0 2.80964943151496e-12
3 O 0 2.3634375706516053e-11
end O 0 3.7663619445460483e-10
. O 0 6.512060335417402e-10

All O 0 1.9787242955260353e-09
were O 0 4.153030419562498e-10
found O 0 2.0048718241127972e-10
in O 0 8.288699587799542e-11
compound O 0 4.0596855654939645e-08
heterozygous O 0 2.109372019276634e-07
individuals O 0 6.7013221638489995e-09
. O 0 3.807564041835576e-09

The O 0 1.928975279952283e-06
C6 O 0 0.10047125071287155
/ O 0 0.00011744519724743441
C7 O 0 0.00020951559417881072
marker O 0 3.880356416630093e-06
haplotypes O 0 3.321295662317425e-05
associated O 0 2.628515574087942e-07
with O 0 7.854685235564318e-10
most O 0 2.5866432551424623e-08
C7 B-Disease 1 0.9993676543235779
defects I-Disease 1 0.9998821020126343
are O 0 2.363905338143013e-08
tabulated O 0 8.701834303792566e-06
. O 0 1.7771430160795632e-10
. O 0 1.357975731863803e-09

A O 0 8.20293379888426e-08
genome O 0 6.67304718149353e-08
- O 0 8.776660109788281e-08
wide O 0 1.7242058891753231e-09
search O 0 4.4865072768018877e-10
for O 0 3.3389301740127664e-11
chromosomal O 0 1.2627137039089575e-05
loci O 0 1.2551463157706166e-07
linked O 0 3.2993906643241644e-05
to O 0 4.033772871281371e-09
mental O 0 0.00026477905339561403
health O 0 5.665751601213742e-08
wellness O 0 2.8100034299427534e-08
in O 0 1.5954168541831848e-10
relatives O 0 1.925921822021337e-08
at O 0 6.670181740275893e-09
high O 0 7.249440159284859e-08
risk O 0 2.663794305135525e-07
for O 0 1.0577539955036741e-09
bipolar B-Disease 0 0.15819738805294037
affective I-Disease 0 0.03254029527306557
disorder I-Disease 0 0.0034379090648144484
among O 0 5.798354504871206e-11
the O 0 4.795136857027593e-11
Old O 0 1.0819243101423126e-07
Order O 0 1.7307091870755187e-10
Amish O 0 2.6005298536802e-07
. O 0 2.352973149655213e-09

Bipolar B-Disease 1 0.9985519051551819
affective I-Disease 1 0.9973331689834595
disorder I-Disease 1 0.9995926022529602
( O 0 3.156216052957461e-07
BPAD B-Disease 1 0.9999991655349731
; O 0 9.015911928145215e-06
manic B-Disease 1 0.9999498128890991
- I-Disease 1 0.9999854564666748
depressive I-Disease 1 0.9999978542327881
illness I-Disease 1 0.9967412352561951
) O 0 1.9569390552476307e-10
is O 0 1.1278963873984083e-10
characterized O 0 1.9341190871102754e-09
by O 0 9.6012919836852e-12
episodes O 0 4.906943185112311e-10
of O 0 1.727743122181824e-11
mania B-Disease 0 1.920864860949223e-06
and O 0 2.2516983833043014e-09
/ O 0 5.2332314481873254e-08
or O 0 2.8902236159922268e-09
hypomania B-Disease 0 1.0571518942015246e-05
interspersed O 0 5.542089098753422e-08
with O 0 2.8457933232139965e-10
periods O 0 2.3946780558503633e-08
of O 0 3.9342906710260195e-10
depression B-Disease 0 2.3642019186809193e-06
. O 0 6.09977313104082e-09

Compelling O 0 5.2682640472312414e-08
evidence O 0 2.9094435749499326e-09
supports O 0 1.8463767181842172e-09
a O 0 4.147969814849439e-11
significant O 0 3.1918686443921374e-11
genetic O 0 1.5880311510230172e-09
component O 0 1.2589297382348263e-09
in O 0 1.2238314528456584e-11
the O 0 1.5862706981284447e-11
susceptibility O 0 4.821079073735746e-06
to O 0 1.9092538661169556e-09
develop O 0 1.2352468274912098e-06
BPAD B-Disease 1 0.9999926090240479
. O 0 5.779625666946231e-08

To O 0 1.117539061290529e-09
date O 0 7.08600289556216e-09
, O 0 1.021259032202293e-11
however O 0 6.197073236513528e-12
, O 0 3.14786879288681e-13
linkage O 0 1.8459013206850727e-09
studies O 0 3.249171764974079e-11
have O 0 1.94181194561327e-12
attempted O 0 4.90973060818245e-11
only O 0 7.415549836513324e-13
to O 0 9.349206521805375e-13
identify O 0 5.563551841447634e-10
chromosomal O 0 2.9272050028339436e-07
loci O 0 2.0606740758211117e-09
that O 0 1.6918204337468268e-10
cause O 0 2.1459276577928676e-09
or O 0 2.40898245795762e-10
increase O 0 3.2351854528656077e-10
the O 0 6.941257291170899e-11
risk O 0 4.275820231214311e-08
of O 0 4.411155468675432e-11
developing O 0 8.40550526959305e-08
BPAD B-Disease 1 0.9999889135360718
. O 0 2.643673902014143e-08

To O 0 4.426243815913722e-10
determine O 0 9.60219903589632e-10
whether O 0 3.352434996273246e-10
there O 0 7.85572995543049e-11
could O 0 7.924266243186651e-10
be O 0 1.9046217727969328e-11
protective O 0 9.200330275405122e-09
alleles O 0 9.433152869942063e-11
that O 0 3.722933419880725e-12
prevent O 0 8.479177082687528e-11
or O 0 9.912670684286695e-11
reduce O 0 3.4677305471575437e-10
the O 0 1.1938634976449425e-11
risk O 0 2.4343786986236182e-09
of O 0 1.4171416861177843e-12
developing O 0 1.1956513557009885e-09
BPAD B-Disease 1 0.999992847442627
, O 0 4.480482391350238e-12
similar O 0 3.9523831256438324e-12
to O 0 1.1953918757634518e-12
what O 0 4.428792055310993e-11
is O 0 2.4794738744809974e-12
observed O 0 7.008171820643838e-11
in O 0 1.0844028583076315e-12
other O 0 1.3586849700875092e-10
genetic B-Disease 1 0.9999966621398926
disorders I-Disease 1 0.9999995231628418
, O 0 7.624617603951833e-10
we O 0 1.2214912414876267e-09
used O 0 1.3190802405915747e-07
mental O 0 2.69325464614667e-05
health O 0 1.2550033012814765e-08
wellness O 0 1.282629824572723e-08
( O 0 4.326749895866566e-12
absence O 0 1.3356701855649078e-10
of O 0 3.095422355936517e-12
any O 0 5.4132836879716706e-08
psychiatric B-Disease 0 0.007827367633581161
disorder I-Disease 0 7.450470002368093e-05
) O 0 1.1377875204499066e-11
as O 0 1.9840804346693552e-12
the O 0 1.3421073280506235e-11
phenotype O 0 8.136242257705817e-08
in O 0 2.8502896223803198e-11
our O 0 2.6369784134061547e-10
genome O 0 1.7231366333803066e-10
- O 0 2.2300330471125562e-09
wide O 0 1.1375652642087175e-09
linkage O 0 7.290387316061242e-08
scan O 0 1.6066570651673828e-07
of O 0 7.049671718779849e-13
several O 0 1.1376199461621272e-12
large O 0 1.84507659151123e-10
multigeneration O 0 2.037427066170494e-06
Old O 0 2.9282624325333018e-08
Order O 0 7.01341415498824e-11
Amish O 0 2.7466013463595118e-08
pedigrees O 0 1.744365647482482e-07
exhibiting O 0 6.168686006446933e-09
an O 0 1.434602263372664e-11
extremely O 0 1.9938363493565703e-07
high O 0 4.319024924370751e-07
incidence O 0 0.003213918535038829
of O 0 2.8316158307006845e-08
BPAD B-Disease 1 0.9999970197677612
. O 0 1.2544917638024344e-07

We O 0 5.29996157183632e-07
have O 0 1.6864208640665623e-10
found O 0 2.1977617642443548e-11
strong O 0 3.4483176730715215e-11
evidence O 0 1.0041347614508922e-10
for O 0 2.838033627550196e-12
a O 0 2.11838269148501e-10
locus O 0 1.3032314427618985e-07
on O 0 1.6441672912037575e-08
chromosome O 0 8.858310138748493e-06
4p O 0 1.8510763766244054e-06
at O 0 6.604336522109122e-10
D4S2949 O 0 5.622751153566696e-09
( O 0 3.907528814406369e-12
maximum O 0 7.718807260026495e-10
GENEHUNTER O 0 3.5597236092144158e-06
- O 0 4.162312450262107e-08
PLUS O 0 1.336239119353877e-09
nonparametric O 0 2.1983384002055573e-09
linkage O 0 7.309905125651994e-09
score O 0 1.515184921974111e-10
= O 0 9.340589413042721e-11
4 O 0 3.9143593423031364e-13
. O 0 3.131556158050136e-13
05 O 0 8.591801575752456e-11
, O 0 4.383841380184439e-13
P O 0 1.4565653572162773e-08
= O 0 1.2205567112566484e-10
5 O 0 2.2226568730052826e-13
. O 0 1.2157987019489197e-13
22 O 0 1.1777033341597853e-12
x O 0 2.5037476536482473e-09
10 O 0 7.336013740921743e-12
( O 0 1.4423524223941553e-12
- O 0 3.1270144251749343e-09
4 O 0 2.051957041782071e-11
) O 0 2.862506781088625e-13
; O 0 3.7195241461493445e-13
SIBPAL O 0 1.727076037738584e-09
Pempirical O 0 7.14277470503788e-10
value O 0 4.949427326317313e-11
< O 0 9.087325336665231e-11
3 O 0 1.374924696664892e-12
x O 0 2.1907828884337732e-09
10 O 0 3.2867994350510576e-12
( O 0 2.752410116230869e-13
- O 0 3.6435010564161985e-09
5 O 0 1.5439843847886436e-11
) O 0 1.4122004347166817e-13
) O 0 1.0579455063733367e-13
and O 0 2.218100919951227e-12
suggestive O 0 2.0878379025646154e-09
evidence O 0 4.132318445759786e-11
for O 0 7.804942673064752e-13
a O 0 2.6969430161338792e-11
locus O 0 2.995875192368658e-08
on O 0 4.710045686806552e-08
chromosome O 0 5.146723196958192e-05
4q O 0 0.00011355887545505539
at O 0 4.900377326144678e-10
D4S397 O 0 3.3448679381820057e-09
( O 0 2.730997285954606e-12
maximum O 0 1.2994773035401863e-09
GENEHUNTER O 0 4.163316134508932e-06
- O 0 3.687956251496871e-08
PLUS O 0 9.660376942832727e-10
nonparametric O 0 2.828451028946688e-09
linkage O 0 1.2459757670058025e-08
score O 0 4.2344408535122113e-10
= O 0 2.6840435429775766e-10
3 O 0 2.530551723028962e-13
. O 0 2.580516366996327e-13
29 O 0 1.8188895485257706e-12
, O 0 2.2033923622287455e-13
P O 0 1.3296954648467363e-08
= O 0 3.944296972369088e-11
2 O 0 2.1597857508513785e-13
. O 0 1.786472852245355e-13
57 O 0 3.305389599181363e-12
x O 0 6.426554399752149e-09
10 O 0 1.9302472814564098e-11
( O 0 9.058244063685217e-13
- O 0 4.7099621980351e-09
3 O 0 9.89049380589746e-12
) O 0 2.0370197770323145e-13
; O 0 3.234612827151401e-13
SIBPAL O 0 8.655757777198403e-10
Pempirical O 0 3.654468117009202e-10
value O 0 2.443218717618212e-11
< O 0 1.0306249603742046e-10
1 O 0 2.3151296418139067e-12
x O 0 3.063223896759837e-09
10 O 0 4.2304645030133425e-12
( O 0 4.135412715391973e-13
- O 0 2.7312776484933465e-09
3 O 0 1.7959621637086975e-11
) O 0 3.660224521476879e-13
) O 0 1.1937575494086472e-13
that O 0 4.544793794775126e-12
are O 0 8.41573945947749e-12
linked O 0 1.5767356842388836e-07
to O 0 1.1560480350780722e-09
mental O 0 0.0004684234445448965
health O 0 2.2964503898492694e-07
wellness O 0 1.9854495292292995e-07
. O 0 3.2721489962028727e-09

These O 0 1.2309165908774844e-09
findings O 0 3.036430440417348e-09
are O 0 1.6640851890903363e-11
consistent O 0 6.957033837906579e-10
with O 0 2.92039179297654e-12
the O 0 5.684812863504529e-12
hypothesis O 0 3.079549115714286e-10
that O 0 5.39108579826475e-13
certain O 0 2.7057832970717177e-12
alleles O 0 7.850008143517329e-11
could O 0 1.0686961038341991e-10
prevent O 0 4.0379277699287286e-10
or O 0 1.0829034197135101e-10
modify O 0 2.6013499687671526e-10
the O 0 4.9557536893618526e-12
clinical O 0 3.410525473146464e-10
manifestations O 0 2.914942509590901e-09
of O 0 6.026081023069452e-11
BPAD B-Disease 1 0.9999995231628418
and O 0 1.9596706479774184e-09
perhaps O 0 3.0954550034323347e-10
other O 0 1.9268375089920298e-11
related O 0 2.6538337749570928e-08
affective B-Disease 0 0.00011826400441350415
disorders I-Disease 0 0.005720984656363726
. O 0 3.7871263458555404e-08

Segregation O 0 0.0002672623086255044
distortion O 0 0.011687543243169785
in O 0 9.508739822194912e-06
myotonic B-Disease 1 0.9999963045120239
dystrophy I-Disease 1 0.9999979734420776
. O 0 1.1344312952132896e-05

Myotonic B-Disease 1 0.9999947547912598
dystrophy I-Disease 1 0.9999995231628418
( O 0 3.8580405089305714e-05
DM B-Disease 1 0.9999998807907104
) O 0 1.8536101542565575e-09
is O 0 1.4086166955085133e-10
an O 0 7.379521993478022e-11
autosomal B-Disease 1 0.9285532832145691
dominant I-Disease 1 0.9986894726753235
disease I-Disease 1 0.8062294721603394
which O 0 5.869821073645198e-09
, O 0 9.484348202637438e-12
in O 0 2.027562579637321e-12
the O 0 3.1317606927899755e-12
typical O 0 5.4287621509274686e-08
pedigree O 0 1.0501275937713217e-06
, O 0 6.702356226441497e-13
shows O 0 1.724427718674537e-11
a O 0 8.738124807061709e-12
three O 0 1.5709810188835327e-11
generation O 0 7.639990862173818e-10
anticipation O 0 2.3291557571525345e-09
cascade O 0 6.60614389857983e-08
. O 0 2.476476135271355e-09

This O 0 2.510394558896678e-09
results O 0 9.966540481798347e-09
in O 0 1.0020923646436586e-08
infertility B-Disease 1 0.9897692203521729
and O 0 0.08449315279722214
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.9341943868766975e-07
CDM B-Disease 0 1.2131654330005404e-06
) O 0 2.8126572251818693e-12
with O 0 3.2732549309910652e-12
the O 0 3.334042764091549e-11
disappearance O 0 2.3674616045354924e-07
of O 0 2.534154885935891e-09
DM B-Disease 1 0.9999998807907104
in O 0 6.080304704170203e-09
that O 0 2.5655091384635398e-09
pedigree O 0 4.625610927178059e-06
. O 0 3.926938330067742e-09

The O 0 3.2960881246602014e-10
concept O 0 2.534487342220615e-10
of O 0 9.603545389480495e-12
segregation O 0 7.991114436833868e-09
distortion O 0 5.8671325859904755e-06
, O 0 1.0497496101546933e-11
where O 0 1.7367331531237262e-11
there O 0 2.730455835389667e-12
is O 0 9.190542207479502e-13
preferential O 0 5.038793340905734e-11
transmission O 0 8.238172921615217e-10
of O 0 7.030935214461312e-14
the O 0 2.961495252588181e-13
larger O 0 1.9777639595486285e-11
allele O 0 3.114358493316871e-10
at O 0 2.5509854645333618e-11
the O 0 7.554953884714166e-11
DM B-Disease 1 0.9999953508377075
locus O 0 4.36427200156686e-07
, O 0 4.488901264587675e-11
has O 0 1.703918256490411e-11
been O 0 1.2382716380043846e-11
put O 0 6.616272807402623e-11
forward O 0 6.118713868907832e-11
to O 0 5.2584555633450325e-12
explain O 0 1.930912096881343e-09
partially O 0 2.764300788271612e-09
the O 0 7.223794045579934e-12
maintenance O 0 4.914042506243277e-10
of O 0 1.3178920628409418e-11
DM B-Disease 1 0.9999954700469971
in O 0 1.7679269159742717e-10
the O 0 1.0154480728497006e-10
population O 0 1.303336466529359e-10
. O 0 7.355383524476622e-10

In O 0 1.7664717466558955e-09
a O 0 3.400249803942046e-10
survey O 0 1.5615523096812467e-08
of O 0 1.0640810454987104e-10
DM B-Disease 1 0.9999997615814209
in O 0 3.8432648175046324e-09
Northern O 0 1.0539979999890647e-09
Ireland O 0 2.182392933036681e-08
, O 0 1.7102805283109035e-11
59 O 0 4.4548264382937575e-11
pedigrees O 0 1.6450330875272812e-08
were O 0 7.173548977057465e-10
ascertained O 0 3.083564195094368e-07
. O 0 1.5243513118434748e-09

Sibships O 0 3.997328349214513e-06
where O 0 1.548273731444283e-09
the O 0 4.665785119373211e-12
status O 0 7.51310558905205e-12
of O 0 9.272589613458157e-14
all O 0 1.9281039438656666e-13
the O 0 2.258584622496021e-13
members O 0 7.726410657105109e-13
had O 0 6.212156899998433e-10
been O 0 7.456120443283254e-11
identified O 0 3.804512815896999e-10
were O 0 1.1191911113150876e-11
examined O 0 1.774954905275905e-10
to O 0 9.663827897632427e-13
determine O 0 2.920929886851553e-10
the O 0 1.2665434022743338e-12
transmission O 0 5.035097339067818e-10
of O 0 2.0845230110175944e-13
the O 0 6.331814933480118e-11
DM B-Disease 1 0.9999569654464722
expansion O 0 1.973514407449528e-10
from O 0 2.1460727292477166e-11
affected O 0 2.6210425496664413e-10
parents O 0 1.4077490562147688e-10
to O 0 9.95315288521148e-12
their O 0 3.304106988011313e-10
offspring O 0 2.9553635982892956e-08
. O 0 7.435474458361568e-10

Where O 0 2.6547299469825703e-08
the O 0 3.176195695342443e-10
transmitting O 0 3.103030167039833e-06
parent O 0 1.0839381303640039e-07
was O 0 5.134300540277081e-09
male O 0 2.5796520475296347e-08
, O 0 2.179219998899029e-11
58 O 0 1.211097611086842e-10
. O 0 5.243167566781892e-10

3 O 0 1.188498299775631e-09
% O 0 2.709539190237642e-11
of O 0 1.2938513108129435e-12
the O 0 2.590890696430037e-11
offspring O 0 2.6417232845687977e-08
were O 0 1.5043410961368409e-09
affected O 0 1.6819748371865728e-10
, O 0 1.4359538948530148e-12
and O 0 9.918320505175604e-12
in O 0 2.482829046523971e-12
the O 0 1.2403795438681309e-12
case O 0 9.513123622184594e-11
of O 0 4.3964685407862913e-13
a O 0 4.637177586364061e-10
female O 0 9.486118415225064e-07
transmitting O 0 1.4184598512656521e-05
parent O 0 2.2953789979851535e-08
, O 0 1.3445927531108293e-11
68 O 0 3.0733821043682497e-10
. O 0 4.0544276269649515e-10

7 O 0 3.8061354956653304e-08
% O 0 7.421249725858559e-10
were O 0 2.5863606811782347e-09
affected O 0 2.6319963097876098e-08
. O 0 7.891284070637994e-09

Studies O 0 4.2236202091316954e-08
on O 0 5.381457501840714e-10
meiotic O 0 1.0636502167926665e-07
drive O 0 2.6420961418693878e-08
in O 0 5.325037299996893e-09
DM B-Disease 1 0.9999991655349731
have O 0 6.129817098354806e-09
shown O 0 5.242320355591801e-09
increased O 0 5.69209956946537e-10
transmission O 0 1.9671491102712935e-09
of O 0 4.714329512704729e-13
the O 0 4.133055388818446e-13
larger O 0 8.500211645667832e-11
allele O 0 1.5549562748518042e-09
at O 0 7.571168691988817e-11
the O 0 1.4684667370978843e-10
DM B-Disease 1 0.9999942779541016
locus O 0 6.088343980081845e-07
in O 0 1.4314331941989167e-09
non O 0 3.8144641223425424e-08
- O 0 0.0009750753524713218
DM O 1 0.9999914169311523
heterozygotes O 0 4.877676019532373e-06
for O 0 3.261517167452155e-10
CTGn O 0 9.014837587528746e-07
. O 0 4.18838430604751e-09

This O 0 1.2890941647469845e-09
study O 0 9.354157726182422e-11
provides O 0 1.563889642786087e-11
further O 0 1.1242182315282512e-12
evidence O 0 5.5778510282822324e-11
that O 0 5.1762125835574935e-11
the O 0 8.381574601035169e-11
DM B-Disease 1 0.9999855756759644
expansion O 0 5.334295227754637e-10
tends O 0 2.1438821828922983e-09
to O 0 1.1931624091521265e-11
be O 0 1.630720419809606e-10
transmitted O 0 7.568883830799678e-08
preferentially O 0 2.6381986373280597e-08
. O 0 1.4147186755408825e-09

Diagnosis O 0 0.29763808846473694
of O 0 1.087926875698031e-06
hemochromatosis B-Disease 1 0.9999850988388062
. O 0 5.278179287415696e-06

If O 0 2.345430948480498e-05
untreated O 0 0.0016047507524490356
, O 0 4.273202947047139e-08
hemochromatosis B-Disease 1 0.9999994039535522
can O 0 0.00039628511876799166
cause O 0 7.127763092285022e-05
serious O 0 0.002543403534218669
illness O 0 0.05346667394042015
and O 0 6.84724221766686e-10
early B-Disease 0 9.852507698582258e-10
death I-Disease 0 3.606044529647079e-08
, O 0 4.404620765341427e-12
but O 0 1.9307923315725617e-11
the O 0 5.6868332959369994e-11
disease O 0 3.6568561512240194e-08
is O 0 1.7211385094917375e-11
still O 0 3.891348632212299e-10
substantially O 0 3.757337552201534e-09
under O 0 4.934416431012778e-09
- O 0 0.03938761726021767
diagnosed O 0 0.000995695241726935
. O 0 1.4493627631395611e-08

The O 0 1.3541529009231112e-09
cornerstone O 0 1.728862386585206e-09
of O 0 9.500096022352356e-13
screening O 0 2.776600893650283e-10
and O 0 1.6174984962535888e-11
case O 0 1.2430144413766442e-10
detection O 0 3.841190920894633e-09
is O 0 3.6300456997956365e-12
the O 0 6.042498858042922e-13
measurement O 0 4.496343741777764e-09
of O 0 4.079105542925676e-12
serum O 0 1.509544134137286e-08
transferrin O 0 1.4152806926404082e-08
saturation O 0 2.797265707954466e-08
and O 0 5.2234907371717654e-11
the O 0 6.848518280255789e-11
serum O 0 4.118818424103665e-07
ferritin O 0 4.721991444966989e-06
level O 0 2.7113632228292772e-08
. O 0 2.30879204643486e-09

Once O 0 4.4044537617082824e-07
the O 0 1.1480671968655543e-09
diagnosis O 0 6.124699666543165e-06
is O 0 1.7546641917220995e-10
suspected O 0 6.916168082682361e-09
, O 0 1.0846061895830594e-11
physicians O 0 1.1501487956477874e-10
must O 0 1.4082109089930128e-10
use O 0 9.650119592308215e-10
serum O 0 2.5170198568957858e-05
ferritin O 0 0.00409240648150444
levels O 0 9.592686183168553e-07
and O 0 4.707149114935305e-10
hepatic O 0 7.451495207533299e-07
iron O 0 3.782019803111325e-06
stores O 0 3.3007701016884994e-09
on O 0 4.02225630580233e-09
liver O 0 1.218503342670374e-07
biopsy O 0 2.127445441146847e-05
specimens O 0 1.5296944866349804e-07
to O 0 7.498020260232607e-11
assess O 0 5.117369639151548e-08
patients O 0 4.0440242821127015e-10
for O 0 1.1612839596192304e-12
the O 0 4.719874231035037e-12
presence O 0 4.3308412411846575e-10
of O 0 4.051843235930441e-11
iron B-Disease 0 0.000834140635561198
overload I-Disease 0 3.9998485590331256e-05
. O 0 3.6146232673672785e-09

Liver O 0 0.03928278386592865
biopsy O 0 0.4821208417415619
is O 0 7.166345739051394e-09
also O 0 8.590224018223402e-12
used O 0 4.56705923079781e-11
to O 0 2.305501276000932e-12
establish O 0 3.85248638545832e-11
the O 0 5.786485873793268e-12
presence O 0 2.4638530105036693e-10
or O 0 1.1685596934540854e-10
absence O 0 2.515013197701421e-10
of O 0 1.5198529934590255e-11
cirrhosis B-Disease 0 3.2012633255362744e-07
, O 0 1.5794084790021756e-11
which O 0 7.173325822229515e-11
can O 0 1.6354098519855143e-08
affect O 0 4.632585159924929e-08
prognosis O 0 5.777460501121823e-06
and O 0 7.818483083177341e-10
management O 0 9.58231161085621e-10
. O 0 2.1822242624036647e-10

A O 0 5.676435765877841e-09
DNA O 0 4.809543341366407e-08
- O 0 2.874507742944843e-07
based O 0 2.226920731152049e-10
test O 0 1.693162450522312e-11
for O 0 7.002749346108478e-14
the O 0 1.3609503064435091e-12
HFE O 0 7.27046014503685e-08
gene O 0 1.531578336377848e-10
is O 0 1.9790989593676533e-12
commercially O 0 1.1093234837666888e-11
available O 0 9.383996184275656e-12
, O 0 1.1520005869375405e-12
but O 0 1.6365330314863091e-12
its O 0 2.8143570915580007e-13
place O 0 1.5437753506097884e-11
in O 0 3.0586186795106274e-12
the O 0 1.614970830676743e-11
diagnosis O 0 1.1953719081247982e-07
of O 0 2.033404972179298e-10
hemochromatosis B-Disease 1 0.9999998807907104
is O 0 5.406096192928089e-07
still O 0 1.4316904994871038e-08
being O 0 2.966928924763579e-09
evaluated O 0 9.685380497614915e-09
. O 0 8.32084345869788e-10

Currently O 0 7.678667657273763e-08
, O 0 2.328864705247735e-11
the O 0 1.6476108671836798e-12
most O 0 3.6774248468422754e-13
useful O 0 1.2846839477637095e-12
role O 0 1.402278141694746e-12
for O 0 3.331255085149698e-13
this O 0 4.551697018427558e-13
test O 0 8.34626725371157e-12
is O 0 2.961653546105364e-13
in O 0 1.4838937099481003e-13
the O 0 4.0343414915190723e-13
detection O 0 2.55435694818118e-09
of O 0 2.9586416649962644e-11
hemochromatosis B-Disease 1 0.9999994039535522
in O 0 7.553748182509423e-10
the O 0 7.780095144516164e-12
family O 0 9.628438324416067e-11
members O 0 2.813213800367115e-13
of O 0 8.495324127326398e-13
patients O 0 8.452921002044533e-11
with O 0 5.634766958584336e-12
a O 0 1.3182854807780586e-09
proven O 0 6.525332878482004e-07
case O 0 3.8026265469781606e-10
of O 0 7.1065792139890505e-12
the O 0 1.1268712629686206e-09
disease O 0 5.828345592817641e-07
. O 0 3.974326645561632e-09

It O 0 3.2867104593492513e-09
is O 0 7.385548422833565e-11
crucial O 0 9.263133593506723e-10
to O 0 1.0999031907488188e-08
diagnose O 1 0.9996728897094727
hemochromatosis B-Disease 1 0.9999998807907104
before O 0 0.000188312929822132
hepatic B-Disease 1 0.9853111505508423
cirrhosis I-Disease 0 0.2559261620044708
develops O 0 1.8774242107610917e-06
because O 0 7.329353124418958e-09
phlebotomy O 0 4.191045809420757e-05
therapy O 0 3.249931978643872e-06
can O 0 2.2481977168808953e-08
avert O 0 0.000133211535285227
serious O 1 0.8820964694023132
chronic O 1 0.9999680519104004
disease O 0 0.3674006760120392
and O 0 9.051008831306717e-09
can O 0 5.425964566541097e-09
even O 0 5.520635060207724e-10
lead O 0 9.439596326821231e-11
to O 0 2.5332779277076334e-11
normal O 0 7.450015271359689e-09
life O 0 1.0870349953506775e-08
expectancy O 0 2.0446542237095855e-08
. O 0 1.3609407004122609e-11
. O 0 1.1063995553062256e-10

Prevalence O 0 0.00023554421204607934
of O 0 2.3092795731205484e-10
the O 0 1.0520553178627878e-10
I1307K O 0 9.570205961040301e-09
APC B-Disease 0 1.961757423174504e-09
gene O 0 3.1950922463330755e-10
variant O 0 8.08147238018364e-09
in O 0 9.089886829349858e-12
Israeli O 0 1.4403119807937514e-09
Jews O 0 4.9499935400598716e-11
of O 0 3.784127687849609e-13
differing O 0 3.050097327483847e-11
ethnic O 0 9.093701486273531e-12
origin O 0 5.304416350604413e-10
and O 0 4.4813586175251885e-10
risk O 0 8.35435827184483e-08
for O 0 2.0520410259905475e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 1.2043916512993746e-06

BACKGROUND O 0 7.426919182762504e-05
& O 0 9.724015370693451e-08
AIMS O 0 8.159207531832635e-09
Israeli O 0 1.132115468038819e-08
Jews O 0 3.694035355383818e-10
of O 0 4.176412254225381e-12
European O 0 1.0594418675680117e-09
birth O 0 6.841243305188982e-08
, O 0 1.7729371790120574e-11
i O 0 1.867695775814582e-09
. O 0 1.01237554038687e-13
e O 0 5.403122393943249e-12
. O 0 1.7395128035484902e-13
, O 0 1.3286679428122644e-13
Ashkenazim O 0 9.039562154367076e-11
, O 0 2.1753058338999653e-13
have O 0 4.955885962026896e-12
the O 0 3.166873707716178e-10
highest O 1 0.9471153020858765
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9987297654151917
of O 0 6.997594170776722e-11
any O 0 1.6710588468527021e-09
Israeli O 0 1.872109010037093e-07
ethnic O 0 1.1997129956142771e-09
group O 0 1.696365181658166e-08
. O 0 2.0169084180565733e-09

The O 0 3.6250484836131136e-09
I1307K O 0 1.2300094454076316e-07
APC B-Disease 0 3.035355078395696e-08
gene O 0 2.1050569287694998e-08
variant O 0 7.472196443814028e-07
was O 0 3.3599857118815635e-08
found O 0 1.6261958446506242e-09
in O 0 2.7974547678333295e-10
6 O 0 6.4455085713177596e-09
. O 0 3.70994546194936e-09

1 O 0 9.77561143145067e-10
% O 0 5.4740123024699106e-12
of O 0 2.4257294306898047e-13
American O 0 2.3586547645559897e-11
Jews O 0 9.535504330582256e-11
, O 0 2.6167739849980443e-12
28 O 0 1.9140309996668048e-12
% O 0 1.6921276120747397e-13
of O 0 8.90885022003518e-13
their O 0 2.9879774388064106e-07
familial O 1 0.9999936819076538
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.518260773991642e-06
, O 0 3.515263427567028e-11
but O 0 6.558038834203472e-11
not O 0 1.9818952035066673e-11
in O 0 6.3607903666440535e-12
non O 0 1.33705935212447e-10
- O 0 5.288298510208733e-08
Jews O 0 9.443567705602618e-09
. O 0 2.6683384390935316e-09

We O 0 1.1214218886834715e-07
assessed O 0 1.4848205331929876e-08
the O 0 4.468757655584632e-11
I1307K O 0 1.179155439956503e-08
prevalence O 0 1.6290145765651687e-07
in O 0 1.3087265646194446e-11
Israeli O 0 2.3352098033058155e-09
Jews O 0 1.4551559956998972e-10
of O 0 4.113056737645865e-13
differing O 0 6.485283837731615e-11
ethnic O 0 1.005828753619653e-11
origin O 0 4.5483020127967677e-10
and O 0 3.6780758994048313e-10
risk O 0 9.48993985616653e-08
for O 0 3.174085634327639e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
. O 0 6.026572805239994e-07

METHODS O 0 4.361750072234827e-08
DNA O 0 1.6183372864020384e-08
samples O 0 1.8941752610857066e-09
from O 0 3.135717813879113e-12
500 O 0 5.322978169353121e-12
unrelated O 0 1.7422251141763212e-10
Jews O 0 4.2611102146761226e-11
of O 0 7.994726842347477e-13
European O 0 8.629148090522065e-11
or O 0 7.426995130010994e-11
non O 0 6.402690183593407e-11
- O 0 8.382509797399962e-09
European O 0 2.3817117722479964e-10
origin O 0 2.037430918422345e-10
, O 0 4.258765649162166e-13
with O 0 4.764927059690283e-13
or O 0 2.4246309821007728e-11
without O 0 6.199887391672432e-12
a O 0 2.5629815110506105e-12
personal O 0 4.336249137537607e-09
and O 0 4.08293926446035e-10
/ O 0 5.006836611975984e-10
or O 0 1.3349188421329927e-10
family O 0 3.7644445893825207e-10
history O 0 2.777480190285786e-10
of O 0 6.310639944634433e-12
neoplasia B-Disease 0 8.458528100163676e-07
, O 0 1.1507845891489676e-11
were O 0 2.0358100621953312e-11
examined O 0 1.3035484913714868e-09
for O 0 8.259652727396483e-13
the O 0 1.924724702534464e-12
I1307K O 0 2.702062462667243e-10
variant O 0 3.922377422860279e-10
by O 0 3.297920747255545e-12
the O 0 2.693627265681897e-11
allele O 0 6.0050902028763176e-09
- O 0 2.171964386121772e-09
specific O 0 1.3655228336961756e-10
oligonucleotide O 0 4.6726120217499556e-07
( O 0 6.847800104736734e-11
ASO O 0 4.74390958515869e-07
) O 0 3.780536647624011e-12
method O 0 4.191818558929583e-10
. O 0 8.305526266738639e-10

RESULTS O 0 3.164625184126635e-07
In O 0 6.612109471060279e-11
persons O 0 2.9190958678038115e-11
at O 0 2.7313074024704065e-10
average O 0 1.6520047552148753e-07
risk O 0 4.434920356288785e-06
for O 0 4.535988409770653e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.4283437543838318e-08
I1307K O 0 1.1721473924808379e-07
was O 0 1.0295845953578464e-08
found O 0 6.011390274451855e-10
in O 0 6.176698041926443e-11
5 O 0 3.8569514249076065e-10
. O 0 1.0086538271281142e-09

0 O 0 1.1775147967796329e-08
% O 0 4.1389679877879004e-11
of O 0 2.0162515320526486e-12
120 O 0 1.2719159926677381e-11
European O 0 2.9814498092584074e-10
and O 0 5.63312896328938e-10
1 O 0 1.6517889278588882e-09
. O 0 1.7056140944049503e-09

6 O 0 1.0551369555855672e-08
% O 0 6.934111618228656e-11
of O 0 2.5331555429664032e-12
188 O 0 4.003148854070382e-11
non O 0 1.230057028456244e-10
- O 0 9.328954497789255e-09
European O 0 2.44767928148093e-10
Jews O 0 2.532148657419242e-10
( O 0 6.962854338238289e-12
P O 0 1.4920348689884122e-07
= O 0 3.550942428987014e-09
0 O 0 4.798503955294464e-11
. O 0 2.428387785996522e-12
08 O 0 5.598912999893457e-11
) O 0 5.967185946753606e-12
. O 0 2.2013539602294685e-10

It O 0 7.641845378714152e-09
occurred O 0 3.270291060175623e-08
in O 0 4.8511052813671185e-11
15 O 0 2.6599425440032576e-10
. O 0 1.0045144716031018e-09

4 O 0 2.9239355381349696e-09
% O 0 5.432918004366627e-11
of O 0 3.310247692275836e-12
52 O 0 3.71903369211779e-10
Ashkenazi O 0 1.570839636144683e-08
Israelis O 0 4.347412208005608e-09
with O 0 5.677494030464914e-10
familial O 0 0.016518784686923027
cancer B-Disease 0 0.0006018023705109954
( O 0 1.941339866640135e-10
P O 0 1.571866414451506e-05
= O 0 5.829554172720464e-09
0 O 0 1.9266428730180252e-11
. O 0 8.789805363597358e-13
02 O 0 9.869914781301947e-12
) O 0 7.369410935436846e-14
and O 0 4.9599430465563366e-12
was O 0 1.1491100293525847e-09
not O 0 1.8510760979584262e-10
detected O 0 2.8631257364963858e-08
in O 0 3.2492259750827035e-12
51 O 0 9.356883323707876e-12
non O 0 2.1104409886341102e-11
- O 0 1.0501352010194864e-09
European O 0 3.748843943607305e-11
Jews O 0 3.534545919836596e-11
at O 0 2.527950349051622e-10
increased O 0 1.140002847677124e-08
cancer B-Disease 0 1.5841407048355904e-06
risk O 0 2.469409992045257e-07
. O 0 2.299518797599376e-09

Colorectal B-Disease 1 0.9818028807640076
neoplasia I-Disease 0 0.39297962188720703
occurred O 0 2.4759050575084984e-05
personally O 0 8.62952788338589e-07
or O 0 6.67621125050033e-10
in O 0 1.1153446222156305e-11
the O 0 1.6469385534165215e-12
families O 0 6.5185283386337556e-12
of O 0 3.1325956368830066e-13
13 O 0 1.3028704634251986e-12
of O 0 3.909889989897608e-13
20 O 0 5.766291090447684e-12
Ashkenazi O 0 1.6927048651638188e-10
I1307K O 0 2.7483593179056243e-10
carriers O 0 7.094813625485585e-11
, O 0 1.8404485021498301e-13
8 O 0 1.9138804310901009e-13
of O 0 2.0548454160006918e-13
whom O 0 3.6036849060394616e-09
also O 0 1.1156052748262368e-09
had O 0 8.641109494611499e-10
a O 0 5.1066557232859466e-11
personal O 0 1.8458007389199338e-07
or O 0 4.19738910295564e-09
family O 0 6.626860171721205e-10
history O 0 3.9243228111551787e-10
of O 0 7.160803894290524e-11
noncolonic O 0 2.8575545002240688e-05
neoplasia B-Disease 0 0.00039761903462931514
. O 0 8.276654028804842e-09

CONCLUSIONS O 0 1.5289258499251446e-06
The O 0 8.419071551024615e-10
I1307K O 0 4.426062716333945e-08
APC O 0 2.0691190982802254e-08
variant O 0 1.0311179465816167e-07
may O 0 1.1427213619796817e-09
represent O 0 4.01009347256176e-12
a O 0 5.4028261031735525e-11
susceptibility O 0 8.763310688664205e-06
gene O 0 2.6943764552811444e-08
for O 0 4.852794166509966e-09
colorectal B-Disease 1 0.9999997615814209
, I-Disease 0 1.2809153737691759e-09
or I-Disease 0 3.196932996107904e-10
other I-Disease 0 5.525783650095484e-11
, I-Disease 0 2.7396399038259744e-10
cancers I-Disease 0 1.9007045921171084e-05
in O 0 2.437146318090555e-10
Ashkenazi O 0 3.528495540194854e-08
Jews O 0 4.53479964690473e-09
, O 0 1.3964229078622381e-11
and O 0 2.4864983336203572e-11
partially O 0 4.840538991857102e-08
explains O 0 2.9937143875002903e-09
the O 0 5.528226314222007e-12
higher O 0 1.1321889203941282e-08
incidence O 0 0.0008471253095194697
of O 0 4.289750449970597e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.5528875013947072e-08
European O 0 1.0039825859564644e-08
Israelis O 0 7.423861347888305e-08
. O 0 5.078201859021192e-09

Systematic O 0 2.0282210755340202e-07
analysis O 0 2.552381239695478e-08
of O 0 1.8039175708750577e-10
coproporphyrinogen O 0 2.0129366021137685e-05
oxidase O 0 1.014329245663248e-05
gene O 0 3.214815660612658e-05
defects O 0 0.29135358333587646
in O 0 1.0732825739268037e-09
hereditary B-Disease 0 0.007965303026139736
coproporphyria I-Disease 0 0.004390272311866283
and O 0 1.7431109000654033e-08
mutation O 0 3.8016480630176375e-06
update O 0 7.914651689588936e-08
. O 0 3.545501003898721e-09

Hereditary B-Disease 1 0.8483080863952637
coproporphyria I-Disease 0 0.01763741299510002
( O 0 3.86808665098215e-08
HC B-Disease 0 0.0609915591776371
) O 0 8.99994578862362e-10
is O 0 2.293102374650857e-09
an O 0 2.487164918463236e-09
acute O 1 0.7762128114700317
hepatic B-Disease 1 0.9979331493377686
porphyria I-Disease 1 0.9999151229858398
with O 0 1.2520024483819725e-06
autosomal O 1 0.9958038926124573
dominant O 0 0.016336863860487938
inheritance O 0 0.07703837007284164
caused O 0 5.902312841499224e-05
by O 0 2.510954777434904e-09
deficient B-Disease 0 6.121353180787992e-06
activity I-Disease 0 2.815984334603172e-09
of I-Disease 0 1.7538333632605152e-11
coproporphyrinogen I-Disease 0 6.412233688024571e-06
III I-Disease 0 4.833283128391486e-06
oxidase I-Disease 0 1.9867715650434548e-07
( O 0 1.2038772756461924e-10
CPO O 0 2.0342395146144554e-07
) O 0 2.944982799291118e-11
. O 0 2.510623098306297e-10

Clinical O 0 4.226278178975917e-06
manifestations O 0 8.76008357408864e-07
of O 0 2.807080956568342e-10
the O 0 1.0692599694550609e-08
disease O 0 7.115569587767823e-06
are O 0 2.0186625981910566e-10
characterized O 0 5.0166587328703827e-08
by O 0 6.2485590035521454e-09
acute O 0 6.596741877729073e-05
attacks O 0 1.2259016330062877e-05
of O 0 3.802920645057384e-08
neurological B-Disease 1 0.9954008460044861
dysfunction I-Disease 0 0.00010001878399634734
often O 0 6.921856421371331e-09
precipitated O 0 1.8969423365433613e-08
by O 0 1.4733363834507074e-11
drugs O 0 1.2975695518058217e-10
, O 0 2.0255719844486375e-12
fasting O 0 1.6256336554665296e-10
, O 0 7.897641741971828e-12
cyclical O 0 4.133057629474024e-08
hormonal O 0 1.157886686087295e-06
changes O 0 6.844760869206823e-10
, O 0 5.0752433505829586e-11
or O 0 1.608947108877601e-08
infectious B-Disease 0 8.33322701510042e-06
diseases I-Disease 0 4.7288952487178904e-07
. O 0 1.2881183897306414e-09

Skin O 1 0.9994858503341675
photosensitivity O 1 0.9993663430213928
may O 0 0.0001807560765882954
also O 0 2.2349939676757913e-09
be O 0 4.280532317491037e-10
present O 0 6.732604473924653e-10
. O 0 5.383308021578159e-09

The O 0 2.0866435246347237e-09
seven O 0 1.1997307314270955e-10
exons O 0 5.530143454279823e-09
, O 0 5.645761635975077e-12
the O 0 3.6374685815493413e-12
exon O 0 1.3848313606956708e-08
/ O 0 8.165372378243774e-09
intron O 0 6.134860086604021e-08
boundaries O 0 2.0256629706949525e-10
and O 0 4.92706396515441e-12
part O 0 7.74692159380419e-13
of O 0 2.324335927721133e-13
3 O 0 3.01778263836483e-12
noncoding O 0 3.292556505218869e-10
sequence O 0 3.0024201874701006e-11
of O 0 2.2083863329604853e-13
the O 0 7.3866119384286e-13
CPO O 0 2.930361731046105e-09
gene O 0 3.879962670594317e-11
were O 0 1.9448597246563004e-11
systematically O 0 7.940576529641419e-10
analyzed O 0 3.1470573369496435e-10
by O 0 8.599252494974341e-13
an O 0 6.183480377036643e-13
exon O 0 1.9555410624150227e-09
- O 0 7.874069396507366e-09
by O 0 3.952475499668928e-11
- O 0 6.562940768617409e-08
exon O 0 9.973447134825619e-08
denaturing O 0 3.147606321363128e-06
gradient O 0 1.4058221040613716e-06
gel O 0 3.7612869618897093e-06
electrophoresis O 0 1.5967556521445658e-07
( O 0 2.731181079906886e-11
DGGE O 0 4.5893681743791603e-08
) O 0 4.881917353011245e-13
strategy O 0 9.605229805975668e-12
followed O 0 1.1910448755730885e-12
by O 0 6.428610085668779e-14
direct O 0 7.315692648023064e-13
sequencing O 0 7.464540270618603e-12
in O 0 2.622515269182224e-12
seven O 0 4.859372453036581e-12
unrelated O 0 7.294807424784722e-09
heterozygous O 0 6.976639497224824e-07
HC B-Disease 0 0.012793529778718948
patients O 0 3.7625603965807386e-08
from O 0 3.5859315516972856e-10
France O 0 2.5655356239440152e-06
, O 0 1.1642480035600755e-10
Holland O 0 2.0183416893360118e-07
, O 0 3.763710176851731e-11
and O 0 1.1849333736435597e-09
Czech O 0 6.739973468938842e-05
Republic O 0 1.346381424127685e-07
. O 0 7.267878299188624e-09

Seven O 0 4.176792689492004e-09
novel O 0 1.4308381146577176e-09
mutations O 0 1.0729846877666205e-07
and O 0 2.5835281830532963e-11
two O 0 2.294192613661039e-12
new O 0 3.89195516092844e-11
polymorphisms O 0 9.339762527815765e-07
were O 0 6.476256686482884e-08
detected O 0 2.5431649191887118e-05
. O 0 3.7436169719740064e-09

Among O 0 4.099124595313697e-09
these O 0 1.0278529416485327e-10
mutations O 0 1.7400150653656965e-08
two O 0 2.2956032907917034e-11
are O 0 6.087156473322253e-11
missense O 0 2.5072265543713e-06
( O 0 2.9634704412639934e-11
G197W O 0 5.1250443888761765e-09
, O 0 3.8807303724686104e-12
W427R O 0 7.499568188684691e-10
) O 0 1.1391855340991963e-12
, O 0 2.776840443783485e-13
two O 0 8.227608047986501e-13
are O 0 4.3824246315216087e-11
nonsense O 0 2.2593011905769345e-08
( O 0 5.763418171531032e-13
Q306X O 0 1.9535344175647396e-10
, O 0 5.255865729615616e-13
Q385X O 0 1.4275471083013969e-10
) O 0 3.443686850436445e-13
, O 0 8.430897039529706e-14
two O 0 2.932458150004674e-13
are O 0 7.8134916071948e-13
small O 0 7.936631386817883e-12
deletions O 0 2.4744425175526885e-08
( O 0 1.2586932364444525e-11
662de14bp O 0 5.478644760081863e-10
; O 0 2.1115188590659084e-12
1168del3bp O 0 1.1333074478869776e-09
removing O 0 1.3411485810799206e-10
a O 0 2.781263934437117e-11
glycine O 0 3.585536534345124e-09
at O 0 1.734522803165106e-10
position O 0 6.602107194275675e-10
390 O 0 1.0790864729548488e-11
) O 0 1.3874082546889988e-13
, O 0 3.020977023225624e-13
and O 0 4.112101718162231e-12
one O 0 1.0972257824537479e-11
is O 0 3.673774392337625e-12
a O 0 1.2402832233471273e-11
splicing O 0 7.84034970280345e-09
mutation O 0 3.5604184489557156e-08
( O 0 6.532779959350643e-12
IVS1 O 0 1.376460545543523e-07
- O 0 7.405038360275285e-08
15c O 0 6.277913655594602e-08
- O 0 2.2451080994301265e-08
- O 0 5.954158055487824e-08
> O 0 4.499415062753087e-09
g O 0 1.0121888216474417e-08
) O 0 1.9325737028470097e-13
which O 0 7.125346862014992e-13
creates O 0 1.0645027394284856e-11
a O 0 5.118081739668989e-12
new O 0 3.649122237020519e-12
acceptor O 0 7.426017439859933e-11
splice O 0 1.978491326326548e-08
site O 0 3.466960052378454e-08
. O 0 3.173460161320918e-09

The O 0 2.145837729727873e-09
pathological O 0 2.7183640227690375e-08
significance O 0 2.3246953251288005e-09
of O 0 4.682742475031754e-12
the O 0 1.6376299621922996e-11
point O 0 1.081564282578995e-09
mutations O 0 6.178789480060232e-09
G197W O 0 1.0700305086430717e-09
, O 0 8.259290061769786e-13
W427R O 0 8.990778954665046e-11
, O 0 3.76876372991386e-13
and O 0 2.454313878866299e-13
the O 0 5.682859239609928e-13
in O 0 6.433952329243375e-12
- O 0 1.798971638322655e-08
frame O 0 7.878397809690796e-06
deletion O 0 5.084513787778633e-08
390delGly O 0 3.0819201413123665e-08
were O 0 1.050036516070385e-10
assessed O 0 8.107188254058428e-10
by O 0 4.902036242204755e-12
their O 0 2.4398845790973844e-11
respective O 0 1.1086175727426095e-10
expression O 0 3.5749772586690653e-10
in O 0 2.6788905295449528e-12
a O 0 5.737568840175067e-12
prokaryotic O 0 2.1483540640909737e-11
system O 0 2.0366331884846822e-11
using O 0 3.838770273878467e-11
site O 0 4.752075621894392e-09
- O 0 3.648579749437886e-08
directed O 0 6.638008365200676e-09
mutagenesis O 0 1.6388140693379682e-06
. O 0 1.08637596696326e-08

These O 0 1.0397533944939141e-09
mutations O 0 2.44113564917825e-08
resulted O 0 3.5923319874342496e-10
in O 0 8.33799262273116e-12
the O 0 1.0973534581015798e-11
absence O 0 5.710389938684557e-10
or O 0 6.846245792502259e-11
a O 0 2.631661034924182e-11
dramatic O 0 1.8064259421635143e-08
decrease O 0 2.4398461917485292e-08
of O 0 5.0801925166599204e-11
CPO O 0 4.518847163126338e-06
activity O 0 9.66196633811478e-09
. O 0 7.45868422580287e-10

The O 0 1.1759520024412495e-09
two O 0 4.161726865903326e-11
polymorphisms O 0 1.355060987862089e-07
were O 0 1.6083716303239015e-10
localized O 0 8.750713931249265e-09
in O 0 6.771183613807352e-11
noncoding O 0 2.232204465713039e-08
part O 0 3.641093676565177e-11
of O 0 1.1668078612678268e-12
the O 0 1.728035466455613e-12
gene O 0 3.190900668692542e-11
1 O 0 1.832008720073497e-12
) O 0 9.832476358714176e-14
a O 0 4.713597567818084e-11
C O 0 1.7405767493983149e-07
/ O 0 8.327420530918062e-09
G O 0 1.369283069152516e-07
polymorphism O 0 2.6655420981569478e-08
in O 0 2.1903295149838797e-11
the O 0 6.241406003137939e-11
promotor O 0 1.4080479786571232e-06
region O 0 9.300488712504773e-10
, O 0 2.8235634316753355e-12
142 O 0 1.2889600845000793e-11
bp O 0 2.6478812475971836e-09
upstream O 0 1.921453621211988e-11
from O 0 2.942487020100165e-13
the O 0 2.4178215310942386e-13
transcriptional O 0 5.4618021910757264e-11
initiation O 0 8.95251147520204e-12
site O 0 8.311607652133901e-11
( O 0 7.186657410666875e-13
- O 0 5.846298445355558e-10
142C O 0 4.566218958501622e-09
/ O 0 6.820472187030191e-09
G O 0 5.7541402753713555e-08
) O 0 5.578951471803262e-13
, O 0 2.630614638881451e-13
and O 0 2.6283688767114732e-12
2 O 0 3.038279697276103e-12
) O 0 1.32671285524473e-13
a O 0 1.6662513382947886e-11
6 O 0 7.712092076062049e-11
bp O 0 6.737001179146773e-09
deletion O 0 1.1933911636674566e-09
polymorphism O 0 1.3322321024133998e-07
in O 0 2.2987669059948423e-11
the O 0 2.7111869606993855e-12
3 O 0 7.145274389525058e-12
noncoding O 0 1.4256131830592267e-09
part O 0 2.466019055624713e-11
of O 0 1.5996507504029145e-12
the O 0 2.287460672267816e-11
CPO O 0 1.310748700689146e-07
gene O 0 5.534077085478373e-10
, O 0 1.8338650910332266e-12
574 O 0 3.778937926468551e-11
bp O 0 6.762307935836986e-10
downstream O 0 9.71949170452957e-12
of O 0 8.659422462940769e-14
the O 0 1.8753713859620547e-12
last O 0 6.03405173049687e-11
base O 0 2.8651917644006986e-11
of O 0 1.0694673228603402e-13
the O 0 4.383860462142675e-12
normal O 0 2.673283538978666e-10
termination O 0 5.012005810378639e-10
codon O 0 1.2145490169146456e-10
( O 0 8.277694935748814e-13
+ O 0 3.741414816849087e-11
574 O 0 8.265921280781185e-10
delATTCTT O 0 1.617865130754126e-08
) O 0 1.260837267924586e-10
. O 0 4.675339559945257e-10

Five O 0 6.939477437128971e-09
intragenic O 0 9.465712764722412e-07
dimorphisms O 0 2.1379353256634204e-06
are O 0 4.963989219675113e-10
now O 0 1.1985368253419892e-10
well O 0 1.3307337003165554e-11
characterized O 0 3.961332595281419e-09
and O 0 5.016976070693069e-11
the O 0 6.026170448064638e-12
high O 0 2.1117142756654772e-10
degree O 0 7.117068739903587e-11
of O 0 6.25314849813513e-13
allelic O 0 9.773565068371681e-09
heterogeneity O 0 2.45619311556311e-08
in O 0 1.0582624776489524e-09
HC B-Disease 0 0.0002352015144424513
is O 0 1.696163876019341e-09
demonstrated O 0 8.225046754795073e-10
with O 0 4.522441015425427e-12
seven O 0 1.4150133972531953e-12
new O 0 3.1863116203671715e-13
different O 0 4.63391694807691e-13
mutations O 0 3.484091140593115e-11
making O 0 4.1831384818731554e-13
a O 0 2.2512055154050303e-12
total O 0 2.3697151012302964e-12
of O 0 2.894483481022392e-12
nineteen O 0 8.406255247450645e-09
CPO O 0 1.1730396181519609e-05
gene B-Disease 0 1.1723043371603126e-06
defects I-Disease 0 0.0683397427201271
reported O 0 1.711683239591366e-08
so O 0 4.1257128269300836e-10
far O 0 3.5039393608826686e-10
. O 0 9.657388083672558e-11
. O 0 4.290717225963192e-10

Coincidence O 0 1.2662544577324297e-06
of O 0 7.387999240160426e-11
two O 0 8.341603449646406e-12
novel O 0 2.2479769434813335e-10
arylsulfatase O 0 8.197427803224855e-08
A O 0 6.189661561073478e-10
alleles O 0 1.4263965564254022e-09
and O 0 7.683213093523378e-11
mutation O 0 6.3924709969853666e-09
459 O 0 1.1075148576011884e-09
+ O 0 1.0190593924264135e-09
1G O 0 8.75011494372302e-07
> O 0 9.993895488946691e-09
A O 0 3.974036377751844e-10
within O 0 8.687123936867991e-12
a O 0 5.902601185603373e-10
family O 0 1.6550158576933427e-08
with O 0 2.988609537624143e-08
metachromatic B-Disease 1 0.9999980926513672
leukodystrophy I-Disease 1 0.9999880790710449
: O 0 3.757421596084498e-10
molecular O 0 8.645445470634172e-10
basis O 0 1.428586849511193e-11
of O 0 3.042594388241726e-12
phenotypic O 0 1.2633171309062163e-07
heterogeneity O 0 1.512846938567236e-05
. O 0 5.931725155505774e-08

In O 0 2.395745823946527e-09
a O 0 7.770522558736559e-10
family O 0 1.4669725434401926e-09
with O 0 7.176911842599054e-11
three O 0 2.494984496781427e-10
siblings O 0 3.7762353599646303e-07
, O 0 7.412032793085999e-12
one O 0 1.8445127369925984e-11
developed O 0 2.5133636838425844e-10
classical O 0 4.026879452112553e-08
late O 0 2.5791459847823717e-06
infantile O 1 0.9951478838920593
metachromatic B-Disease 1 0.9999942779541016
leukodystrophy I-Disease 1 0.999992847442627
( O 0 7.992123585154332e-08
MLD B-Disease 1 0.9999617338180542
) O 0 3.33576638533728e-11
, O 0 2.8726814763763153e-12
fatal O 0 2.627873811889003e-07
at O 0 5.444334316706545e-09
age O 0 9.257751010238735e-09
5 O 0 7.650675926118566e-11
years O 0 4.6564105349311546e-10
, O 0 3.4467248933439665e-12
with O 0 2.3003951521438637e-10
deficient O 0 1.997432718781056e-06
arylsulfatase O 0 4.126670489768003e-07
A O 0 6.899238069735247e-09
( O 0 2.1586184228983285e-11
ARSA O 0 7.352661555160012e-07
) O 0 1.3050890663307557e-12
activity O 0 5.588873114303894e-11
and O 0 5.225162316713217e-12
increased O 0 4.816974596977275e-10
galactosylsulfatide O 0 2.655902790138498e-06
( O 0 4.501713446458666e-10
GS O 1 0.9999767541885376
) O 0 2.7939499672169354e-11
excretion O 0 1.245661462867531e-09
. O 0 4.0890024699535843e-10

The O 0 8.149576014027105e-10
two O 0 9.937237664681131e-12
other O 0 6.321940367037815e-12
siblings O 0 2.2940223942669036e-08
, O 0 1.2246977737495612e-11
apparently O 0 1.4830203731719394e-08
healthy O 0 8.637254245158488e-10
at O 0 3.288136776746775e-11
12 O 0 1.2828327809744078e-12
( O 0 4.523048534560252e-14
1 O 0 7.686649710833549e-13
/ O 0 2.0980552364879834e-11
2 O 0 1.2720195990273409e-12
) O 0 4.795943576627569e-14
and O 0 1.1125181722040911e-12
15 O 0 8.839941582558519e-13
years O 0 5.714077214863389e-12
, O 0 1.7343778865343273e-13
respectively O 0 3.715479313104453e-11
, O 0 4.653118710652715e-13
and O 0 5.586898131626494e-12
their O 0 2.3182813307931482e-11
father O 0 2.131179321906984e-08
, O 0 1.9744726686976577e-12
apparently O 0 8.641768411976614e-10
healthy O 0 7.166926080381941e-11
as O 0 1.29880383791664e-12
well O 0 5.264115098685407e-12
, O 0 2.7617128419213377e-13
presented O 0 1.379244218835396e-10
ARSA O 0 8.83959103248344e-07
and O 0 2.7246904732436406e-09
GS O 1 0.9999754428863525
values O 0 3.0736708733769547e-09
within O 0 1.163092734103588e-12
the O 0 3.878917586436215e-12
range O 0 9.38883970569293e-10
of O 0 9.670626521796066e-10
MLD B-Disease 1 0.9999912977218628
patients O 0 1.1779061281913528e-07
. O 0 3.4358211831175822e-09

Mutation O 0 5.599686119239777e-06
screening O 0 1.4887936217178321e-08
and O 0 4.3458493748094185e-11
sequence O 0 1.7786284944865116e-10
analysis O 0 3.545585700037712e-11
disclosed O 0 2.7104827271529075e-09
the O 0 4.559517368697696e-13
involvement O 0 2.336304760763852e-10
of O 0 4.935235163247564e-13
three O 0 3.947395795650399e-12
different O 0 3.02523006645572e-11
ARSA O 0 2.974503104269388e-06
mutations O 0 1.1798798382756104e-08
being O 0 4.339264711439306e-11
the O 0 7.226409141219969e-13
molecular O 0 3.086947086838876e-10
basis O 0 4.6627159598633394e-12
of O 0 2.641319888502247e-12
intrafamilial O 0 1.9156533426212263e-07
phenotypic O 0 4.117805190162471e-07
heterogeneity O 0 5.970447546133073e-06
. O 0 3.594055542066599e-08

The O 0 7.79488651403426e-09
late O 0 1.5172460621215578e-07
infantile O 0 0.07377426326274872
patient O 0 0.00020004017278552055
inherited O 0 8.611381781520322e-05
from O 0 2.451220615373728e-10
his O 0 8.178367427724709e-10
mother O 0 1.681703842848492e-08
the O 0 1.6793061082334693e-12
frequent O 0 1.109062286452911e-09
0 O 0 2.7343566300075395e-10
- O 0 3.489948952051236e-08
type O 0 3.0350716428984015e-07
mutation O 0 1.0116180249042372e-07
459 O 0 1.0725909049824622e-09
+ O 0 2.445313396215454e-10
1G O 0 4.061188008108729e-08
> O 0 2.017143119203979e-09
A O 0 1.121591930441923e-09
, O 0 5.91958600193454e-12
and O 0 4.657969322752198e-12
from O 0 2.5641452936625564e-12
his O 0 2.279866517795881e-09
father O 0 4.3192631693500516e-08
a O 0 5.618671847229528e-11
novel O 0 3.723751862416691e-11
, O 0 4.880483495638133e-13
single O 0 2.4922815547445687e-11
basepair O 0 4.046981860739152e-09
microdeletion O 0 1.12454801026729e-09
of O 0 3.905604409760316e-13
guanine O 0 3.037535500904909e-10
at O 0 3.1732134281314828e-12
nucleotide O 0 1.5714314571813048e-10
7 O 0 3.3347467582461876e-12
in O 0 6.963235868982787e-13
exon O 0 5.054767715506614e-09
1 O 0 8.112463478759935e-10
( O 0 1.8787698827238408e-11
7delG O 0 4.484441262775363e-08
) O 0 1.0097274405485024e-10
. O 0 5.847670125902482e-10

The O 0 5.208344422413802e-09
two O 0 7.419254099971795e-10
clinically O 0 2.137213414243888e-06
unaffected O 0 2.4816561108309543e-06
siblings O 0 1.8720929517712648e-07
carried O 0 4.217532101336019e-09
the O 0 5.792142113159038e-11
maternal O 0 1.2530927051557228e-07
mutation O 0 1.4854437679900911e-08
459 O 0 1.0711965758858355e-09
+ O 0 9.113818588701861e-10
1G O 0 1.8343416741117835e-07
> O 0 1.5228120986421345e-08
A O 0 3.558868755249023e-09
and O 0 6.239492811310754e-10
, O 0 4.2134893664391715e-12
on O 0 4.727751870547969e-11
their O 0 6.215009756838086e-11
paternal O 0 1.1931304300105694e-07
allele O 0 5.076226550215779e-09
, O 0 7.46872398996179e-13
a O 0 2.392171530307685e-12
novel O 0 5.5235704898848326e-11
cytosine O 0 1.126529536321641e-09
to O 0 6.473906697182508e-13
thymidine O 0 2.0348336349229612e-09
transition O 0 2.5535082381900054e-10
at O 0 3.3097379004143335e-11
nucleotide O 0 5.629487431768609e-10
2435 O 0 8.710614451956644e-09
in O 0 4.575252503247196e-12
exon O 0 4.267474817964967e-09
8 O 0 4.947822707102034e-11
, O 0 5.452241848107053e-13
resulting O 0 1.7804672666765775e-11
in O 0 6.684942313248121e-13
substitution O 0 1.1628626013504562e-11
of O 0 8.243284527198469e-13
alanine O 0 3.341392496025719e-09
464 O 0 2.6756452609077996e-10
by O 0 1.714978853373239e-10
valine O 0 4.251701739121927e-06
( O 0 5.242535225380429e-11
A464V O 0 1.1343461281398959e-08
) O 0 6.649088918342372e-11
. O 0 1.2310692465433704e-09

The O 0 2.9813506330356176e-08
fathers O 0 1.7641950762481429e-06
genotype O 0 9.39376786845969e-06
thus O 0 5.19294962586514e-09
was O 0 1.809866811974814e-09
7delG O 0 5.777762908110162e-07
/ O 0 2.864453847450932e-07
A464V O 0 4.152306587457133e-07
. O 0 5.680096393234635e-09

Mutation O 0 7.235452358145267e-05
A464V O 0 1.689468604126887e-06
was O 0 1.536879423724713e-08
not O 0 1.039610064701435e-10
found O 0 7.973292859286829e-11
in O 0 2.7635229174483023e-11
18 O 0 2.009442889860935e-10
unrelated O 0 1.396199309056101e-06
MLD B-Disease 1 0.9999986886978149
patients O 0 1.3608810434107e-07
and O 0 4.72959393871264e-10
50 O 0 3.4336969378934157e-10
controls O 0 1.5674942233090405e-07
. O 0 8.641904969408643e-09

A464V O 0 4.8274559958372265e-06
, O 0 5.798766467002281e-10
although O 0 1.4328636888105706e-10
clearly O 0 2.330973414288451e-09
modifying O 0 1.6654976064955918e-08
ARSA O 0 7.000823097769171e-05
and O 0 3.4973533047377714e-07
GS O 1 0.9999994039535522
levels O 0 4.02662908527418e-06
, O 0 7.572641125275226e-11
apparently O 0 1.5049730350824575e-08
bears O 0 7.198333484836894e-09
little O 0 7.1997772327359044e-12
significance O 0 1.3022350558999918e-11
for O 0 4.73997252038727e-13
clinical O 0 2.1922866300094768e-10
manifestation O 0 1.2313446262623984e-08
of O 0 1.8552903657820252e-09
MLD B-Disease 1 0.9999983310699463
, O 0 1.6438990446676627e-10
mimicking O 0 1.2616111177976563e-07
the O 0 1.3248892261064071e-10
frequent O 0 7.737415330666408e-07
ARSA O 0 0.000796499487478286
pseudodeficiency O 0 2.325985587958712e-05
allele O 0 4.242256636644015e-06
. O 0 7.993278927642677e-09

Our O 0 5.867529395686688e-08
results O 0 1.2605179122715526e-09
demonstrate O 0 5.557071469652897e-10
that O 0 3.3152014120019224e-12
in O 0 1.3384741448865811e-12
certain O 0 2.3722440678497492e-11
genetic O 0 7.380673139323335e-08
conditions O 0 1.3420375353234704e-06
MLD B-Disease 1 0.9999847412109375
- O 0 2.47107095674437e-07
like O 0 5.049824114422563e-09
ARSA O 0 1.1120516319351736e-05
and O 0 7.934116474928032e-09
GS O 1 0.9999703168869019
values O 0 9.224807584473638e-09
need O 0 2.0579460011105333e-11
not O 0 2.9230890711412494e-12
be O 0 6.930692998674548e-13
paralleled O 0 2.9309624172135784e-11
by O 0 1.4192090211362363e-11
clinical O 0 1.9437359810581256e-07
disease O 0 3.512012654027785e-07
, O 0 1.1066496026848616e-12
a O 0 1.2697127203809e-11
finding O 0 5.073501341268383e-11
with O 0 6.747848807497903e-11
serious O 0 9.487279584163844e-08
diagnostic O 0 1.611825162228797e-08
and O 0 2.7585531081619763e-10
prognostic O 0 5.349839398149925e-07
implications O 0 1.5822760701666994e-07
. O 0 4.56661064518471e-09

Moreover O 0 2.2183182863955153e-06
, O 0 1.5357203009269682e-10
further O 0 1.0233069253073879e-10
ARSA O 0 1.4429089787881821e-05
alleles O 0 1.0504041192405111e-08
functionally O 0 3.4360241318864837e-09
similar O 0 1.121968004613727e-10
to O 0 7.1325293761470565e-12
A464V O 0 1.5206525816324756e-08
might O 0 2.5937872294434783e-08
exist O 0 2.8825530851150916e-10
which O 0 8.675251489398406e-12
, O 0 5.604032320659369e-14
together O 0 3.342998620980975e-13
with O 0 1.0627655439715555e-12
0 O 0 8.809687007671485e-11
- O 0 8.506079041126213e-08
type O 0 1.846721352194436e-05
mutations O 0 2.396694526396459e-06
, O 0 6.17177489670162e-11
may O 0 1.6144519054961393e-09
cause O 0 2.781425978426455e-09
pathological O 0 4.834145101995091e-07
ARSA O 0 0.000322537001920864
and O 0 2.849531028914498e-07
GS O 1 0.9999991655349731
levels O 0 3.358608751113934e-07
, O 0 1.0066919086532122e-12
but O 0 6.626056908015654e-12
not O 0 1.3736909179606904e-11
clinical O 0 1.170437774478117e-10
outbreak O 0 8.311373256297827e-10
of O 0 1.496805717565719e-12
the O 0 2.4826385391918393e-09
disease O 0 9.714206044009188e-07
. O 0 7.530698287183668e-11
. O 0 1.3053771397153469e-09

Human O 0 0.00038329267408698797
MLH1 O 1 0.9974008798599243
deficiency O 1 0.9953521490097046
predisposes O 0 0.0001430527918273583
to O 0 6.44278230765849e-08
hematological B-Disease 1 0.9682969450950623
malignancy I-Disease 1 0.9978917241096497
and O 0 1.32563957322418e-06
neurofibromatosis B-Disease 1 0.997093915939331
type I-Disease 0 0.0009716273634694517
1 I-Disease 0 6.980739186701612e-08
. O 0 1.7161127630060946e-08

Heterozygous O 0 2.8648835723288357e-05
germ O 0 0.0010280981659889221
- O 0 4.821093534701504e-05
line O 0 4.2996353499802353e-07
mutations O 0 7.890263731269442e-08
in O 0 6.0311720895267484e-12
the O 0 5.518481938776576e-12
DNA O 0 1.2078857025699108e-07
mismatch O 0 0.00023941324616316706
repair O 0 1.5417523400174105e-06
genes O 0 1.522161596767546e-08
lead O 0 3.3308744651350253e-09
to O 0 1.226508850038499e-08
hereditary B-Disease 1 0.9999293088912964
nonpolyposis I-Disease 1 0.9999951124191284
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 4.494748282013461e-06

The O 0 1.3124456188506883e-08
disease O 0 1.3735352695221081e-06
susceptibility O 0 3.536315489327535e-06
of O 0 7.936756807325196e-11
individuals O 0 3.3736877735890403e-09
who O 0 1.81056183379269e-08
constitutionally O 0 1.7775761307348148e-07
lack O 0 5.67511204696558e-10
both O 0 1.502796498353831e-11
wild O 0 1.3009330279700748e-09
- O 0 2.7287464376968273e-07
type O 0 1.0083235792990308e-06
alleles O 0 7.572576343761739e-09
is O 0 7.701997373210645e-10
unknown O 0 1.436455399073111e-08
. O 0 8.649320704101626e-10

We O 0 7.792526446337433e-08
have O 0 5.198189101385253e-10
identified O 0 1.0324355814717023e-09
three O 0 4.626862695061851e-12
offspring O 0 9.109786813787935e-10
in O 0 1.449343943471515e-11
a O 0 3.407817672496094e-08
hereditary B-Disease 1 0.9999592304229736
nonpolyposis I-Disease 1 0.9999984502792358
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0001334703847533092
who O 0 1.0371932290809127e-07
developed O 0 4.824740429398844e-08
hematological B-Disease 0 0.0017925688298419118
malignancy I-Disease 0 0.0034389058127999306
at O 0 4.339821280119338e-10
a O 0 1.3570015944264213e-10
very O 0 1.817448691543433e-10
early O 0 4.384801133294758e-10
age O 0 4.171196277269473e-09
, O 0 1.3460906651482918e-12
and O 0 2.8386182293616002e-12
at O 0 2.309437016623228e-11
least O 0 9.424690845458161e-13
two O 0 2.75502575397199e-13
of O 0 2.4669998574360086e-13
them O 0 6.862348796848883e-12
displayed O 0 1.321226790196306e-07
signs O 0 4.470188130767383e-08
of O 0 1.816717332125961e-10
neurofibromatosis B-Disease 0 0.001099598128348589
type I-Disease 0 3.3491483918624e-05
1 I-Disease 0 9.802110234602424e-09
( O 0 5.827750504394658e-10
NF1 B-Disease 0 3.841981197183486e-06
) O 0 2.889257721960803e-10
. O 0 1.6664659652221303e-09

DNA O 0 8.931772299547447e-08
sequence O 0 2.331662640742138e-09
analysis O 0 1.2066182497605382e-09
and O 0 2.2421817874596073e-11
allele O 0 2.449744851418245e-09
- O 0 1.1906537977779408e-09
specific O 0 9.900615743907437e-11
amplification O 0 3.51296813860813e-09
in O 0 1.0757757532009471e-11
two O 0 1.7824923828624328e-11
siblings O 0 8.150112051907854e-08
revealed O 0 2.990634229149691e-08
a O 0 5.73440184226115e-10
homozygous O 0 3.433708843658678e-05
MLH1 O 0 0.00418680626899004
mutation O 0 9.464792469771055e-07
( O 0 1.0624357296706854e-11
C676T O 0 4.1069978529151285e-09
- O 0 6.392351110662275e-07
- O 0 5.534595857170643e-06
> O 0 6.97868998145168e-08
Arg226Stop O 0 3.851111785024841e-07
) O 0 6.51930245898491e-11
. O 0 3.161146622243649e-10

Thus O 0 1.7908242000430619e-07
, O 0 9.62864024622867e-11
a O 0 2.970347579012156e-10
homozygous O 0 3.1841741474636365e-06
germ O 1 0.7934849858283997
- O 0 0.014189138077199459
line O 0 3.0262439395301044e-05
MLH1 O 0 0.029139069840312004
mutation O 0 3.303863195469603e-06
and O 0 3.2534522298455215e-10
consequent O 0 2.2157707917358493e-06
mismatch O 1 0.9551867842674255
repair O 1 0.9611348509788513
deficiency O 1 0.9985575079917908
results O 0 2.401245779992678e-08
in O 0 1.9801316142320502e-10
a O 0 8.548166618993491e-09
mutator O 0 0.0170341357588768
phenotype O 0 3.6219702451489866e-05
characterized O 0 8.45164294105416e-08
by O 0 2.2647101971529082e-09
leukemia B-Disease 0 0.08701962232589722
and O 0 9.471332163002444e-08
/ O 0 0.0009834995726123452
or O 0 0.09753952920436859
lymphoma B-Disease 1 1.0
associated O 0 9.865368156170007e-06
with O 0 6.1161413711374735e-09
neurofibromatosis B-Disease 0 0.0686558410525322
type I-Disease 0 6.952834610274294e-06
1 I-Disease 0 1.5607802827943829e-09
. O 0 2.9004273982558004e-10
. O 0 1.9830808106746645e-09

Missense O 0 0.004855334293097258
mutations O 0 0.0002724619989749044
in O 0 1.4517967938942888e-09
the O 0 3.409717300173476e-11
most O 0 3.809912021285333e-12
ancient O 0 2.5011867577084956e-11
residues O 0 9.623650765178127e-10
of O 0 2.7853607007660708e-12
the O 0 5.5074542149036176e-11
PAX6 O 0 1.6407875591539778e-06
paired O 0 6.768043192550977e-08
domain O 0 5.02910113553412e-09
underlie O 0 5.1659824862326786e-08
a O 0 1.1335079402874371e-10
spectrum O 0 2.659301046037399e-08
of O 0 2.3390780978793657e-10
human O 0 2.787513949442655e-06
congenital B-Disease 1 0.9999498128890991
eye I-Disease 1 0.9976848363876343
malformations I-Disease 1 0.9992055296897888
. O 0 7.072503080962633e-07

Mutations O 0 9.737211257743184e-06
of O 0 1.3445422553104436e-10
the O 0 1.194750270938627e-10
human O 0 2.43283282408413e-09
PAX6 O 0 0.00048153038369491696
gene O 0 7.875177107052878e-05
underlie O 1 0.9857271313667297
aniridia B-Disease 1 0.9999995231628418
( O 0 6.444920472858939e-07
congenital B-Disease 1 0.999535322189331
absence I-Disease 0 8.319391042732605e-08
of I-Disease 0 4.8316947665050236e-11
the I-Disease 0 1.7464703294667316e-10
iris I-Disease 0 3.0015891752555035e-05
) O 0 5.658517751583325e-11
, O 0 2.9950005149548264e-12
a O 0 3.052886554666401e-10
rare O 0 6.610649165850191e-07
dominant O 0 0.0008209847728721797
malformation B-Disease 1 0.861804187297821
of I-Disease 0 6.240361560827523e-10
the I-Disease 0 4.766381955789711e-09
eye I-Disease 0 0.0020514277275651693
. O 0 2.6552362086817993e-08

The O 0 6.693185117256917e-09
spectrum O 0 6.15340027820821e-08
of O 0 1.3453169134258758e-10
PAX6 O 0 4.502106094150804e-05
mutations O 0 1.608570892130956e-05
in O 0 4.6731933878163545e-09
aniridia B-Disease 1 0.9999982118606567
patients O 0 6.567398145307379e-07
is O 0 1.0707119219022232e-10
highly O 0 1.4180785712358812e-10
biased O 0 4.3560008378129567e-10
, O 0 3.011542295920655e-13
with O 0 1.4680444360148925e-13
92 O 0 2.6145791261200646e-12
% O 0 1.9128622297248654e-13
of O 0 1.1389284968691543e-13
all O 0 1.2067044412311656e-11
reported O 0 7.96842147821053e-09
mutations O 0 4.5648169688661255e-09
leading O 0 1.1662239229881521e-10
to O 0 1.1152488654797565e-11
premature O 0 3.085952327008812e-10
truncation O 0 1.3309831015106965e-10
of O 0 1.5214879052830033e-12
the O 0 1.1350672138310536e-11
protein O 0 7.886720720939877e-10
( O 0 3.834816145187325e-12
nonsense O 0 1.2520338543708931e-08
, O 0 2.587672914486361e-13
splicing O 0 1.3867350844021242e-11
, O 0 1.0627670211970155e-13
insertions O 0 1.2102709112671306e-10
and O 0 2.9017912205053786e-12
deletions O 0 2.342694649382082e-10
) O 0 3.4416515319081464e-13
and O 0 9.723918718840263e-13
just O 0 2.4140119157106676e-12
2 O 0 8.159704465923734e-13
% O 0 1.843329227322124e-13
leading O 0 1.0211027986692378e-12
to O 0 6.786366309402894e-14
substitution O 0 1.0521805865817968e-12
of O 0 2.0154085106534325e-13
one O 0 1.1087333308401615e-11
amino O 0 1.5082957452450252e-11
acid O 0 3.925876117250038e-12
by O 0 7.123226704666696e-13
another O 0 7.573089377821418e-11
( O 0 8.021341924013825e-11
missense O 0 7.754279636174033e-07
) O 0 2.816133159999623e-10
. O 0 7.861160056243932e-10

The O 0 6.454067280614595e-10
extraordinary O 0 6.337146363222246e-10
conservation O 0 2.1162372201843915e-11
of O 0 2.1675237017564075e-13
the O 0 1.9309755617397117e-12
PAX6 O 0 7.548541702817602e-08
protein O 0 3.792037794880798e-10
at O 0 2.1708440600676226e-11
the O 0 2.4729699624886914e-12
amino O 0 3.8394586121537344e-11
acid O 0 4.129773259475833e-11
level O 0 8.070572682372656e-11
amongst O 0 3.603790876827162e-11
vertebrates O 0 1.3026884015943097e-09
predicts O 0 1.0096205649290368e-08
that O 0 2.2892545498143235e-11
pathological O 0 2.0221982310886233e-08
missense O 0 1.276148168471991e-06
mutations O 0 8.64794174049166e-07
should O 0 1.04834008141097e-09
in O 0 2.8985400885028767e-11
fact O 0 2.3888727107568286e-10
be O 0 2.3332988319246795e-10
common O 0 3.390385194812495e-11
even O 0 5.089622057141696e-10
though O 0 1.6444541561799753e-10
they O 0 2.511234796498396e-11
are O 0 5.357548606144125e-12
hardly O 0 1.9752250945970218e-09
ever O 0 3.5085219174391113e-09
seen O 0 8.271492824007964e-09
in O 0 4.898293437527457e-10
aniridia B-Disease 1 0.9999747276306152
patients O 0 8.211934243718133e-08
. O 0 2.851260338943007e-09

This O 0 1.674753780100957e-09
indicates O 0 1.85601329860674e-08
that O 0 1.5507133771519577e-11
there O 0 6.226420854599235e-12
is O 0 1.0934250466859696e-12
a O 0 1.0068230103799092e-11
heavy O 0 8.608940049725788e-08
ascertainment O 0 1.8235899688079371e-06
bias O 0 5.311234829719069e-08
in O 0 5.366957746277823e-12
the O 0 1.833329088584204e-13
selection O 0 7.10690078835341e-13
of O 0 1.0414765837934992e-12
patients O 0 3.0610129014840837e-11
for O 0 1.057687791516937e-12
PAX6 O 0 2.92524617862e-07
mutation O 0 2.5007134141219467e-08
analysis O 0 6.107406802513538e-10
and O 0 1.2325363819842838e-11
that O 0 6.858973024964632e-12
the O 0 1.623256390415051e-11
missing O 0 3.6578331474856896e-08
PAX6 O 0 8.403513493249193e-05
missense O 0 0.00042516557732596993
mutations O 0 0.00016329986101482064
frequently O 0 8.95865866823442e-07
may O 0 9.206196693867241e-08
underlie O 0 7.0264636633510236e-06
phenotypes O 0 1.0548651516728569e-06
distinct O 0 6.18107609540175e-09
from O 0 2.2888813067112324e-09
textbook O 0 0.0001060351132764481
aniridia B-Disease 1 0.9999744892120361
. O 0 6.157814169682752e-08

Here O 0 1.6990570372854563e-07
we O 0 6.796029849986951e-10
present O 0 4.9440493365970895e-11
four O 0 1.2104964600134771e-11
novel O 0 7.705891480469518e-10
PAX6 O 0 1.0841509720194153e-05
missense O 0 7.991125312400982e-05
mutations O 0 2.2312067812890746e-05
, O 0 2.578609895054207e-11
two O 0 7.635700231822806e-12
in O 0 2.2512292030540948e-10
association O 0 1.0946468731454218e-10
with O 0 1.863886961439576e-10
atypical O 0 6.478443310697912e-07
phenotypes O 0 5.869057531526778e-06
ectopia B-Disease 0 5.6479443628632e-06
pupillae I-Disease 0 6.638772447331576e-06
( O 0 1.7374165994787916e-10
displaced B-Disease 0 2.572241308840262e-09
pupils I-Disease 0 1.3300151202599864e-08
) O 0 1.121968004613727e-10
and O 0 1.1313409942204089e-07
congenital B-Disease 1 0.9986779093742371
nystagmus I-Disease 0 1.1238216757192276e-05
( O 0 2.2729170975899216e-11
searching B-Disease 0 1.6445239614526486e-09
gaze I-Disease 0 9.71906501945341e-06
) O 0 5.682081107710735e-12
, O 0 2.7122989184474866e-12
and O 0 1.010977499632526e-11
two O 0 7.1810708421327085e-12
in O 0 4.470659259458998e-11
association O 0 2.311502768706508e-12
with O 0 3.92494804019039e-12
more O 0 4.0804144785244745e-11
recognizable O 0 8.010489182197489e-06
aniridia B-Disease 1 0.9999657869338989
phenotypes O 0 5.060531839262694e-05
. O 0 1.1900731067271408e-08

Strikingly O 0 4.70840313937515e-05
, O 0 1.3445422553104436e-10
all O 0 4.936941914307491e-12
four O 0 1.5787910909170755e-11
mutations O 0 9.842689330241683e-09
are O 0 1.0299268382585325e-11
located O 0 1.3701609291594252e-11
within O 0 2.9900691297934934e-12
the O 0 6.948247532889695e-12
PAX6 O 0 2.59647066513935e-07
paired O 0 7.289424619472129e-09
domain O 0 1.9220933733521406e-09
and O 0 1.1468322819174759e-10
affect O 0 5.371592060043895e-10
amino O 0 1.0483374585090743e-10
acids O 0 2.1523364687747737e-11
which O 0 8.22685506957771e-13
are O 0 3.4600219824681977e-13
highly O 0 2.317184985556331e-11
conserved O 0 5.973569416894975e-10
in O 0 8.786725687326413e-12
all O 0 2.7852440406123113e-12
known O 0 5.0769957682383904e-11
paired O 0 4.082886473355529e-09
domain O 0 7.749623720521015e-10
proteins O 0 4.505355255535193e-10
. O 0 2.5842242235007973e-10

Our O 0 1.0762124524887895e-08
results O 0 4.061478653394346e-10
support O 0 5.970498834911853e-12
the O 0 3.801912343975866e-12
hypothesis O 0 2.2530075027837881e-10
that O 0 7.970016248533274e-13
the O 0 1.0640631171315862e-13
under O 0 6.063375496134782e-12
- O 0 4.221296368012162e-10
representation O 0 4.3410192107629086e-11
of O 0 8.45877101002257e-12
missense O 0 6.375283646775642e-06
mutations O 0 1.3677525885213981e-06
is O 0 7.410298069610022e-11
caused O 0 5.251825085927919e-10
by O 0 1.6102983529941994e-11
ascertainment O 0 2.9028713015577523e-06
bias O 0 9.816236570259207e-07
and O 0 4.777820916679332e-10
suggest O 0 5.981709572111527e-10
that O 0 9.348957155305704e-13
a O 0 2.476850322064017e-12
substantial O 0 1.355356382681805e-10
burden O 0 5.474409547900905e-08
of O 0 1.635320004411689e-11
PAX6 B-Disease 0 6.375893281074241e-05
- I-Disease 0 0.0003003043821081519
related I-Disease 0 2.2366468783729943e-06
disease I-Disease 0 4.661143520934274e-06
remains O 0 3.987759011891967e-09
to O 0 2.81581494232519e-11
be O 0 3.6830041794111423e-10
uncovered O 0 3.5784569263341837e-07
. O 0 3.1390123833574535e-10
. O 0 6.490842863193791e-10

The O 0 9.29687049566752e-10
chromosomal O 0 1.791773797776841e-06
order O 0 2.930013731639036e-10
of O 0 2.8492770209193052e-12
genes O 0 6.798311358302556e-10
controlling O 0 7.030457105372534e-09
the O 0 6.733114760182346e-11
major O 0 6.753002046444578e-10
histocompatibility O 0 1.0811728543558274e-06
complex O 0 5.329477748006184e-09
, O 0 1.1874723209945315e-12
properdin O 0 2.129784126836398e-09
factor O 0 2.128029141790222e-10
B O 0 3.8164631455117615e-09
, O 0 1.6946542910276086e-12
and O 0 2.949869792878701e-10
deficiency B-Disease 0 1.574762649170225e-07
of I-Disease 0 1.6792733111177516e-13
the I-Disease 0 1.9024350237512033e-12
second I-Disease 0 4.2901425467700705e-11
component I-Disease 0 1.06040773384386e-10
of I-Disease 0 3.780298556826933e-12
complement I-Disease 0 4.7749351139714236e-09
. O 0 1.0650622606078741e-09

The O 0 7.001615398571914e-10
relationship O 0 2.533541376692483e-09
of O 0 1.47504794836828e-12
the O 0 1.3391509038826466e-12
genes O 0 3.685293042954285e-11
coding O 0 6.968903232262846e-11
for O 0 2.3934711634518435e-13
HLA O 0 4.766897432340045e-10
to O 0 3.799360565742704e-12
those O 0 5.49962029042228e-12
coding O 0 6.765529803054449e-11
for O 0 4.1730020047120453e-13
properdin O 0 8.948735974456667e-09
Factor O 0 1.7500116633595297e-10
B O 0 7.930375245379651e-10
allotypes O 0 3.2149001238934716e-09
and O 0 7.188525816270719e-12
for O 0 8.263880031667004e-12
deficiency B-Disease 0 1.192693588336624e-07
of I-Disease 0 2.036743847579417e-13
the I-Disease 0 1.50266398716431e-12
second I-Disease 0 7.917142635927021e-12
component I-Disease 0 3.507742013519888e-11
of I-Disease 0 2.18610353886102e-13
complement I-Disease 0 1.3767263717934242e-10
( O 0 5.00143849946344e-12
C2 O 0 5.92774398455731e-08
) O 0 4.712621352181978e-13
was O 0 7.898714321497025e-11
studied O 0 4.748250126418441e-10
in O 0 3.9436253741753635e-12
families O 0 4.02101529156651e-12
of O 0 4.509856463968953e-12
patients O 0 2.7024502635697445e-09
with O 0 9.092085306861009e-09
connective O 1 0.9472757577896118
tissue O 1 0.9998960494995117
disorders O 1 0.9123824238777161
. O 0 2.9807821988470096e-08

Patients O 0 1.8926670009022928e-06
were O 0 7.454176165211379e-10
selected O 0 1.0926089200058442e-10
because O 0 1.341754901629244e-10
they O 0 1.1345932006412429e-11
were O 0 1.456682691136635e-11
heterozygous O 0 1.978520680623319e-09
or O 0 4.531200692436954e-10
homozygous O 0 5.092821083962917e-06
for O 0 7.726023795839865e-06
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999982118606567
. O 0 2.7512101041793358e-08

12 O 0 4.542495712911432e-09
families O 0 1.6109412415143964e-10
with O 0 1.0141081550896214e-11
15 O 0 2.7214517098195223e-11
matings O 0 8.822813697406673e-07
informative O 0 1.393016009387793e-05
for O 0 9.130120452027768e-05
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
were O 0 2.1830513219356362e-07
found O 0 1.2216269773546173e-08
. O 0 2.430801337993671e-09

Of O 0 1.9631349879034588e-09
57 O 0 1.375813574178153e-09
informative O 0 2.4594173364533845e-09
meioses O 0 2.5034080408659065e-07
, O 0 2.4959478928110457e-12
two O 0 2.463858923742318e-13
crossovers O 0 4.612082660226946e-10
were O 0 1.0994574001221835e-10
noted O 0 2.403287013841293e-10
between O 0 3.6441666351194613e-10
the O 0 3.0893413622834487e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999966621398926
gene O 0 2.5749904430938386e-09
and O 0 9.33946236320038e-12
the O 0 2.3913503555822446e-12
HLA O 0 1.7235096905210412e-08
- O 0 2.9893570285821625e-07
B O 0 5.830465887868286e-09
gene O 0 6.133471508462662e-11
, O 0 1.4484664552852355e-13
with O 0 4.728808422854551e-14
a O 0 1.0514123209223736e-12
recombinant O 0 6.6962520597901865e-12
fraction O 0 1.2775866475855935e-10
of O 0 8.301637155483377e-12
0 O 0 2.1266384209184253e-09
. O 0 4.503018791179869e-10

035 O 0 0.00871039554476738
. O 0 1.1281405249974341e-06

A O 0 1.7625995951675577e-07
lod O 0 7.429852121276781e-05
score O 0 5.659182455985956e-09
of O 0 3.755540583377792e-12
13 O 0 5.435185287949729e-12
was O 0 6.050601686347079e-11
calculated O 0 3.756219779660341e-09
for O 0 5.139897188422005e-12
linkage O 0 2.9852151783416048e-05
between O 0 0.00038058048812672496
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999995231628418
and O 0 5.945708370092007e-10
HLA O 0 5.6152629213102045e-08
- O 0 1.9486914482058637e-07
B O 0 6.3137073347263595e-09
at O 0 3.0971054713890833e-12
a O 0 1.3533529765602514e-12
maximum O 0 1.7766475790548242e-11
likelihood O 0 3.091111394626367e-11
value O 0 1.2298990818837563e-11
of O 0 4.49882000413699e-14
the O 0 1.267763292348706e-13
recombinant O 0 1.4662878116550315e-12
fraction O 0 3.552781679960759e-11
of O 0 5.8057330644400995e-12
0 O 0 1.2507729296729053e-09
. O 0 8.014295893588042e-10

04 O 0 0.00036860525142401457
. O 0 4.288340846869687e-07

18 O 0 3.76372319976781e-08
families O 0 5.181894913164342e-10
with O 0 5.873623115659754e-11
21 O 0 2.523858899650122e-11
informative O 0 2.8579993927024816e-10
matings O 0 5.927246604642278e-08
for O 0 3.2661204470152416e-12
both O 0 1.8665151022001503e-11
properdin O 0 1.6008084458007943e-07
Factor O 0 3.603387310757711e-10
B O 0 8.577838439549623e-10
allotype O 0 2.75953837558518e-09
and O 0 4.283396901061387e-11
HLA O 0 4.149566379396674e-08
- O 0 1.5439476328538149e-06
B O 0 1.2573495666856616e-07
were O 0 2.86408396998894e-10
found O 0 2.27726326684774e-09
. O 0 1.5926296947910146e-09

Of O 0 3.3212443906194267e-09
72 O 0 3.0396638539542664e-09
informative O 0 9.05719144128625e-09
meioses O 0 1.1154525054735132e-06
, O 0 1.2564049627072915e-11
three O 0 2.0894121936093635e-12
recombinants O 0 3.535566577284044e-07
were O 0 1.6942303115996538e-09
found O 0 3.056767339248978e-10
, O 0 2.050061509439871e-13
giving O 0 2.0561547256492396e-13
a O 0 4.382068980682968e-13
recombinant O 0 2.781092847334299e-12
fraction O 0 3.1191008109665574e-11
of O 0 8.604047162241724e-12
0 O 0 1.9393349148799643e-09
. O 0 7.719278549700448e-10

042 O 0 0.0002972491201944649
. O 0 4.3892868006878416e-07

A O 0 2.1092976965064736e-07
lod O 0 7.888751133577898e-05
score O 0 3.5440272938558337e-09
of O 0 2.7599762753016677e-12
16 O 0 1.3675500835919063e-11
between O 0 2.389564240923292e-11
HLA O 0 9.535954603734353e-08
- O 0 6.204382430041733e-07
B O 0 1.0416832729731595e-08
and O 0 6.183590531977368e-12
Factor O 0 2.2075506353469443e-11
B O 0 1.0504511843700826e-10
allotypes O 0 8.7410673144106e-10
was O 0 2.8286694167545257e-11
calculated O 0 7.11234959815954e-10
at O 0 1.2763236648116738e-12
a O 0 5.373407881842374e-13
maximum O 0 2.2446893302441318e-11
likelihood O 0 3.369498083327649e-11
value O 0 1.8879803970195397e-11
of O 0 2.459964774470611e-14
the O 0 8.446751463423233e-14
recombinant O 0 1.6303052657873351e-12
fraction O 0 4.7698876098900556e-11
of O 0 1.4687853364114822e-11
0 O 0 3.0914444337781788e-09
. O 0 1.7435688448586006e-09

04 O 0 0.00022206016001291573
. O 0 1.1698769952772636e-07

A O 0 5.658469692804147e-09
crossover O 0 4.1425578523046624e-09
was O 0 1.8084900244019764e-09
shown O 0 9.869924877392577e-10
to O 0 1.5728609387144488e-11
have O 0 7.402514018428619e-11
occurred O 0 3.2693711626841093e-10
between O 0 8.126358201805683e-13
genes O 0 5.201694977530202e-12
for O 0 1.874787353356791e-13
Factor O 0 2.3059115381030004e-11
B O 0 3.6600417141485764e-10
and O 0 8.673961722494017e-12
HLA O 0 1.548626116232299e-08
- O 0 3.894590179243096e-07
D O 0 9.91028173302766e-06
, O 0 2.2236841274586583e-12
in O 0 2.4461366092409786e-12
which O 0 9.624104985173076e-11
HLA O 0 8.629621817135558e-08
- O 0 9.801989335755934e-07
D O 0 3.273591573815793e-06
segregared O 0 2.3206297328215442e-08
with O 0 5.103579017728954e-11
HLA O 0 8.670653528497496e-08
- O 0 7.661551393312038e-08
A O 0 8.819884378397091e-09
and O 0 3.1317177739964563e-09
B O 0 4.365969985542506e-08
. O 0 3.691506822445234e-10

These O 0 4.0497283304574694e-10
studies O 0 1.6612541897664812e-10
suggest O 0 1.7460007051273152e-10
that O 0 1.2384174631965839e-12
the O 0 9.226966386039967e-14
genes O 0 3.4631399310758315e-12
for O 0 2.6939122590649567e-13
Factor O 0 7.483422215237567e-10
B O 0 9.858286830422003e-06
and O 0 0.00013301630679052323
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
are O 0 7.816331609733496e-11
located O 0 2.912649982311777e-11
outside O 0 7.933154133610287e-11
those O 0 5.8182928960870406e-12
for O 0 5.08774120923372e-13
HLA O 0 1.3398324671953787e-09
, O 0 4.0585221815214734e-13
that O 0 2.503121950166165e-13
the O 0 5.969297322064304e-14
order O 0 3.460226354577711e-13
of O 0 5.941808053607292e-14
genese O 0 2.901474616123778e-09
is O 0 1.3726301345551306e-11
HLA O 0 4.867605762903793e-10
- O 0 1.5175398715427946e-09
A O 0 1.586750508764112e-09
, O 0 2.584543343231438e-11
- O 0 3.174999818611468e-08
B O 0 5.3274651357071434e-09
, O 0 1.700060882001142e-12
- O 0 8.210725432888921e-09
D O 0 7.070777030548925e-08
, O 0 5.502209473630393e-13
Factor O 0 4.113602167232777e-11
B O 0 3.2724671861217303e-09
allotype O 0 2.3277905256691156e-06
, O 0 2.894319095503306e-07
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999996423721313
, O 0 6.041096008851943e-12
that O 0 1.1186313377334334e-12
the O 0 1.486370271655546e-12
genes O 0 5.082463339078913e-10
coding O 0 2.0716781179430654e-08
for O 0 2.0099936648421135e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999992847442627
and O 0 8.59255944174464e-10
Factor O 0 1.6553117765383263e-09
B O 0 2.1701052066447346e-09
allotypes O 0 1.7685821696034054e-09
are O 0 9.935508362216017e-13
approximately O 0 3.0634278750871213e-13
3 O 0 2.3313879039116303e-12
- O 0 2.8610500635295466e-09
- O 0 6.229198490359522e-09
5 O 0 2.4416057283621617e-12
centimorgans O 0 3.33027549981324e-10
from O 0 4.785995276306021e-13
the O 0 4.710572752177067e-13
HLA O 0 7.492949039011876e-10
- O 0 6.344390568457925e-10
A O 0 1.2810588700951087e-10
and O 0 4.8885839820655974e-11
HLA O 0 2.9892066599757072e-09
- O 0 8.760566494458999e-09
B O 0 2.3550236760705445e-10
loci O 0 1.6500552660336787e-11
, O 0 1.7690779125899975e-13
and O 0 2.4824822644591016e-13
that O 0 1.5218615213516418e-13
the O 0 1.4691481538264828e-13
apparent O 0 1.431195606471647e-09
lack O 0 3.4398307119376526e-11
of O 0 3.0716130593883006e-13
recombinants O 0 3.1678359935227718e-09
between O 0 2.727499216065299e-12
the O 0 2.397762760911193e-12
Factor O 0 1.1781672859534353e-10
B O 0 5.39719779979464e-09
gene O 0 1.5650618578888498e-08
and O 0 8.79247636476066e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.999997615814209
gene O 0 4.235155515175393e-08
suggests O 0 3.5379825735759596e-09
that O 0 9.770307826673097e-12
these O 0 4.92266600746194e-13
two O 0 2.7793427281874727e-12
genes O 0 2.793162923175885e-10
lie O 0 4.841651843889849e-07
in O 0 1.4172126146239084e-11
close O 0 2.3870236343093154e-10
proximity O 0 4.513302509501216e-10
to O 0 1.235318930481455e-10
one O 0 2.783319130728046e-10
another O 0 1.7876421454232627e-09
. O 0 7.775300403523033e-09

Distribution O 0 4.984903156923792e-09
of O 0 6.095777355108467e-11
emerin O 0 9.886152838589624e-07
and O 0 1.0689698015653448e-09
lamins O 0 1.6576226698816754e-05
in O 0 1.124170131983071e-10
the O 0 6.912138916792543e-11
heart O 0 6.347664083250493e-08
and O 0 5.129821914473531e-11
implications O 0 1.1310270497943975e-09
for O 0 3.411005158882041e-11
Emery B-Disease 0 3.079380257986486e-05
- I-Disease 1 0.9855130314826965
Dreifuss I-Disease 1 0.9996715784072876
muscular I-Disease 1 0.998784601688385
dystrophy I-Disease 1 0.9959670305252075
. O 0 3.6943038139725104e-07

Emerin O 0 4.896487735095434e-05
is O 0 3.962533856594064e-09
a O 0 3.3298627744038356e-10
nuclear O 0 6.969696642045164e-08
membrane O 0 2.967043855051088e-08
protein O 0 1.3016701050361235e-09
which O 0 9.149187657486735e-11
is O 0 5.112347697955322e-11
missing O 0 5.03324626421886e-09
or O 0 1.8820176528322463e-09
defective O 0 8.113435796985868e-06
in O 0 6.686001530198382e-09
Emery B-Disease 0 0.005050930194556713
- I-Disease 1 0.9998786449432373
Dreifuss I-Disease 1 0.9999710321426392
muscular I-Disease 1 0.9999337196350098
dystrophy I-Disease 1 0.9999321699142456
( O 0 3.524379792452237e-07
EDMD B-Disease 1 0.9999940395355225
) O 0 2.652197794716926e-09
. O 0 3.0580633580967742e-09

It O 0 1.4032575101907696e-08
is O 0 1.2874619426117562e-10
one O 0 1.3051692539234327e-11
member O 0 1.5250703261013299e-12
of O 0 1.7154538152399507e-13
a O 0 5.1410761064962784e-11
family O 0 5.57339729923001e-10
of O 0 3.4645421947976374e-11
lamina O 0 0.0005033293855376542
- O 0 5.686934400728205e-06
associated O 0 1.2887457323529361e-08
proteins O 0 3.187603653254101e-11
which O 0 2.209192247540348e-12
includes O 0 6.584318593821914e-12
LAP1 O 0 2.764229236618121e-07
, O 0 1.2132679409748715e-11
LAP2 O 0 3.512568582664244e-07
and O 0 9.190836980366157e-10
lamin O 0 1.8348386220168322e-05
B O 0 3.1259790489457373e-07
receptor O 0 3.1518780474470987e-08
( O 0 6.331045132590418e-10
LBR O 0 0.000990820350125432
) O 0 2.0603270478591895e-10
. O 0 9.848412085844416e-10

A O 0 3.058741526729136e-08
panel O 0 6.375229233412938e-09
of O 0 1.265879935596903e-11
16 O 0 3.505715509555252e-11
monoclonal O 0 3.1999607408295105e-09
antibodies O 0 1.0309051390322566e-08
( O 0 5.210035528002699e-12
mAbs O 0 2.294029854965629e-09
) O 0 2.687729162495489e-12
has O 0 2.4522668617965593e-11
been O 0 2.3724792963530916e-11
mapped O 0 7.943974367208284e-09
to O 0 1.4905323069552834e-12
six O 0 3.408673354427655e-13
specific O 0 9.769147296667668e-13
sites O 0 2.5904148617805767e-12
throughout O 0 8.490092309743069e-13
the O 0 6.424629166341955e-13
emerin O 0 1.2302171503719705e-09
molecule O 0 4.663607694466165e-11
using O 0 3.8068320197537364e-12
phage O 0 7.516122169093364e-10
- O 0 2.0659947086443253e-09
displayed O 0 3.3201168481156174e-09
peptide O 0 1.2449315189844157e-10
libraries O 0 1.6533434777504796e-12
and O 0 9.350477857272832e-12
has O 0 7.32572249390051e-12
been O 0 7.795152869548294e-13
used O 0 1.0199664897403427e-11
to O 0 6.053807195122163e-12
localize O 0 2.8338957847040547e-08
emerin O 0 6.040814923835569e-07
in O 0 1.719695497115481e-10
human O 0 2.403956478325142e-10
and O 0 8.255097161402603e-10
rabbit O 0 4.918417107546702e-05
heart O 0 6.800950814067619e-06
. O 0 5.135358360774944e-09

Several O 0 3.0487565805259464e-09
mAbs O 0 2.6106232553502196e-07
against O 0 5.373467226732487e-10
different O 0 1.1431589008736864e-10
emerin O 0 1.9632824432846974e-07
epitopes O 0 2.0632805899367668e-06
did O 0 4.621480975686154e-09
not O 0 1.0166729264016183e-10
recognize O 0 9.825522617745719e-10
intercalated O 0 1.701182639202159e-09
discs O 0 1.8192920947512903e-08
in O 0 3.287885935732149e-11
the O 0 1.0140565470662111e-10
heart O 0 1.810296339499473e-07
, O 0 6.52959067024006e-12
though O 0 3.873706910795249e-11
they O 0 2.0208303780355763e-11
recognized O 0 2.841989317492466e-11
cardiomyocyte O 0 1.690441564505818e-08
nuclei O 0 2.000145293834521e-08
strongly O 0 8.809826201883197e-10
, O 0 7.945079056465021e-13
both O 0 1.348542263100716e-12
at O 0 2.2248052358730952e-11
the O 0 3.2643143830363153e-12
rim O 0 8.580948174241598e-10
and O 0 7.57570395304441e-11
in O 0 1.8951817545853622e-11
intranuclear O 0 2.0443346571141774e-08
spots O 0 9.644714360490525e-09
or O 0 7.745633578970512e-10
channels O 0 8.865152167913948e-09
. O 0 2.339882287927253e-09

A O 0 1.0704377473302884e-07
polyclonal O 0 6.6496954786998685e-06
rabbit O 0 9.58056261879392e-07
antiserum O 0 1.5058883491292363e-06
against O 0 3.2300324637191125e-09
emerin O 0 6.674103474324511e-07
did O 0 7.121665479559169e-09
recognize O 0 1.7221977177683812e-09
both O 0 4.5812801469091724e-11
nuclear O 0 8.279609886585604e-08
membrane O 0 9.34644450722999e-09
and O 0 7.647363992058231e-11
intercalated O 0 5.697315952346571e-09
discs O 0 4.2909835684667996e-08
but O 0 2.0257389515832003e-11
, O 0 4.357978076172976e-14
after O 0 1.8743655987116942e-13
affinity O 0 6.047263818170778e-12
purification O 0 5.1428193301172875e-12
against O 0 1.1102760204273476e-11
a O 0 3.249122151882666e-11
pure O 0 6.105918881615935e-09
- O 0 7.96393976543186e-07
emerin O 0 1.6270986691324651e-07
band O 0 1.5702210365287073e-10
on O 0 7.465594115130259e-12
a O 0 4.397158418628644e-12
western O 0 1.9910642579112903e-11
blot O 0 5.42769498679263e-07
, O 0 2.0241633022499705e-11
it O 0 2.042561952908528e-11
stained O 0 3.0491298730339622e-06
only O 0 5.889035786799113e-11
the O 0 4.049625912383448e-11
nuclear O 0 2.0490998053901421e-07
membrane O 0 4.0795800515525116e-08
. O 0 8.946000606968596e-10

These O 0 1.7648889016896874e-09
results O 0 1.8002475066225543e-09
would O 0 1.0204417866255255e-10
not O 0 7.538527094230751e-12
be O 0 4.063233256801357e-12
expected O 0 1.07788300854339e-11
if O 0 6.547703351733603e-11
immunostaining O 0 1.451753206538342e-08
at O 0 9.882051427156924e-11
intercalated O 0 1.3588203895409379e-09
discs O 0 6.046582967655922e-08
were O 0 3.07807501709334e-10
due O 0 5.1254497174246794e-11
to O 0 1.0317174631985226e-12
a O 0 8.688598451822571e-12
product O 0 2.7008657463301056e-11
of O 0 6.478029375943384e-14
the O 0 1.0066880055253913e-12
emerin O 0 5.4814592864715905e-09
gene O 0 1.8898116405097198e-10
and O 0 2.9213405999817255e-11
, O 0 1.1439342311944656e-12
therefore O 0 9.306086283522585e-12
, O 0 7.304841275054472e-14
cast O 0 3.675820932358409e-12
some O 0 1.2056840443565309e-13
doubt O 0 4.134028883107099e-11
upon O 0 1.0380812962701436e-12
the O 0 1.3676275823631956e-12
hypothesis O 0 1.9941637230402876e-09
that O 0 2.732542248029546e-10
cardiac B-Disease 0 8.133035407809075e-06
defects I-Disease 0 0.1745801866054535
in O 0 7.50199014021291e-09
EDMD B-Disease 1 0.9999998807907104
are O 0 7.665684975677323e-09
caused O 0 2.416919286929442e-08
by O 0 4.634716915807857e-11
absence O 0 2.065104309778576e-09
of O 0 8.646656307620404e-12
emerin O 0 6.077664238546276e-07
from O 0 1.1512241854250149e-10
intercalated O 0 3.1517404863734555e-07
discs O 0 9.569386065777508e-07
. O 0 3.4443115026761006e-09

Although O 0 1.9002522222422158e-08
emerin O 0 7.359249138971791e-07
was O 0 6.309562872175434e-10
abundant O 0 6.566788085526909e-11
in O 0 4.990584768355122e-12
the O 0 6.291746637576701e-12
membranes O 0 5.756079612950771e-09
of O 0 1.4431147249416298e-12
cardiomyocyte O 0 7.192571160885564e-08
nuclei O 0 6.691183784823806e-08
, O 0 7.335440414812933e-12
it O 0 7.048976419926634e-12
was O 0 1.1821177370308078e-10
absent O 0 1.4376215495826017e-10
from O 0 7.312456304538195e-13
many O 0 9.757192883513843e-13
non O 0 1.4754743260514402e-10
- O 0 2.8597092693871673e-08
myocyte O 0 1.1161829860384387e-07
cells O 0 8.73933425626916e-10
in O 0 1.8131612530836172e-11
the O 0 6.31635091452587e-11
heart O 0 2.3992618025658885e-07
. O 0 2.30531149725266e-09

This O 0 1.0231371305735593e-10
distribution O 0 1.7812248204185366e-11
of O 0 1.5998306195433298e-12
emerin O 0 4.823203880732763e-07
was O 0 3.4545752924941553e-09
similar O 0 9.539888323750745e-11
to O 0 5.3783939107932e-12
that O 0 6.960716725235017e-12
of O 0 1.507320093394049e-12
lamin O 0 6.72010799007694e-07
A O 0 5.084171750269206e-09
, O 0 2.1354554409491744e-12
a O 0 3.641786525121482e-12
candidate O 0 5.237140721092715e-10
gene O 0 2.1530069393982387e-10
for O 0 2.5438707130370775e-12
an O 0 1.8190846398646876e-11
autosomal O 0 6.405706244549947e-06
form O 0 8.279972973923577e-08
of O 0 4.457697500015456e-08
EDMD B-Disease 1 0.9999995231628418
. O 0 1.9051573474371253e-07

In O 0 1.0971081820798645e-08
contrast O 0 2.0166754666206543e-07
, O 0 1.6337068364791207e-09
lamin O 0 0.00045407257857732475
B1 O 1 0.7211818695068359
was O 0 3.800121817221225e-08
absent O 0 2.6037055178562696e-08
from O 0 4.6210001103386134e-11
cardiomyocyte O 0 3.6202106912242016e-07
nuclei O 0 1.8621943809193908e-07
, O 0 6.6235424263372256e-12
showing O 0 5.303022909686206e-09
that O 0 3.3423663836629203e-10
lamin O 0 7.510540308430791e-05
B1 O 0 0.01815100573003292
is O 0 1.4583569074577696e-10
not O 0 8.386400081328294e-12
essential O 0 1.0947773720557108e-12
for O 0 1.4792255419691924e-13
localization O 0 6.9410983905005e-11
of O 0 1.135564149765296e-13
emerin O 0 7.335072993441827e-09
to O 0 1.2689065076454398e-11
the O 0 1.527826198888249e-10
nuclear O 0 5.2011082516401075e-06
lamina O 0 9.267891073250212e-06
. O 0 2.9656390676535693e-09

Lamin O 1 0.7988750338554382
B1 O 1 0.9850668907165527
is O 0 2.0904527886500546e-08
also O 0 5.65955726727907e-10
almost O 0 1.9404995665883717e-10
completely O 0 3.0477639967330106e-08
absent O 0 1.3929248154909146e-07
from O 0 5.606192732265924e-10
skeletal O 0 0.00018575349531602114
muscle O 0 1.3232384844741318e-05
nuclei O 0 0.00017361364734824747
. O 0 1.3888892702595967e-08

In O 0 1.9764439684877289e-07
EDMD B-Disease 1 0.9999529123306274
, O 0 1.3483764105259866e-10
the O 0 2.059908450410819e-12
additional O 0 6.437929616492921e-12
absence O 0 2.3061061393825355e-10
of O 0 2.2839423061138397e-11
lamin O 0 0.00010165279672946781
B1 O 0 0.026440439745783806
from O 0 3.4735576637245913e-09
heart O 0 1.2912518286611885e-05
and O 0 1.5382489948478906e-08
skeletal O 0 0.0006062833708710968
muscle O 0 8.377114681934472e-06
nuclei O 0 1.7498236047686078e-05
which O 0 2.099722617998623e-09
already O 0 5.368908650993376e-10
lack O 0 3.246354851604849e-10
emerin O 0 7.105345503077842e-07
may O 0 2.0592318961121236e-09
offer O 0 3.6297063445156486e-12
an O 0 5.374809280912947e-14
alternative O 0 2.544734605328114e-12
explanation O 0 3.699236750254187e-11
of O 0 6.868630555816047e-13
why O 0 1.2406345950566333e-09
these O 0 5.980802224997417e-12
tissues O 0 2.454641823135262e-09
are O 0 1.8242270541368732e-11
particularly O 0 2.719574843101924e-10
affected O 0 1.5316893586803104e-10
. O 0 1.7586772316224852e-11
. O 0 1.5677371900668646e-10

Genetic O 0 1.3269537930682418e-06
mapping O 0 2.3650198954783264e-07
of O 0 2.352662231697167e-10
the O 0 1.927879855756487e-09
copper B-Disease 0 0.0018736966885626316
toxicosis I-Disease 0 0.04684457927942276
locus O 0 1.7340171325486153e-06
in O 0 4.470618597540721e-10
Bedlington O 0 7.713927061558934e-07
terriers O 0 1.085290705304942e-06
to O 0 9.792066463232274e-11
dog O 0 8.758515832596458e-06
chromosome O 0 1.6499232515343465e-05
10 O 0 7.213829533725402e-11
, O 0 9.6882441305568e-13
in O 0 9.680301265441171e-13
a O 0 2.277070892953148e-10
region O 0 1.643489233593698e-09
syntenic O 0 1.403426836077415e-06
to O 0 1.527389048572303e-10
human O 0 1.6564550842090853e-09
chromosome O 0 5.374824922910193e-07
region O 0 3.785412872048255e-09
2p13 O 0 2.3700820861449756e-07
- O 0 2.442308186800801e-06
p16 O 0 3.1622568030797993e-07
. O 0 8.163394404903102e-09

Abnormal O 0 0.09307414293289185
hepatic B-Disease 1 0.6936821937561035
copper I-Disease 0 0.004114535637199879
accumulation I-Disease 0 6.100088285165839e-06
is O 0 5.403674174786488e-10
recognized O 0 5.829662308443062e-10
as O 0 1.936129589985569e-10
an O 0 1.9659797345639163e-08
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 3.335390204028954e-07
man O 0 5.5958516895771027e-05
, O 0 4.891988897304245e-11
mouse O 0 7.177934691071641e-08
, O 0 7.72915967339749e-11
rat O 0 3.0495543796860147e-06
and O 0 2.5951365500986867e-09
dog O 0 3.249922156101093e-05
. O 0 1.1191095161677822e-08

The O 0 3.4258027525879697e-09
major O 0 9.668358336156757e-10
cause O 0 2.78093388317302e-08
of O 0 1.6674443770181568e-10
hepatic B-Disease 0 0.0006843034061603248
copper I-Disease 0 0.08178550004959106
accumulation I-Disease 0 5.927477559453109e-06
in O 0 9.091907227087859e-10
man O 0 4.732296929432778e-06
is O 0 1.9002140139168233e-10
a O 0 6.196737012409415e-10
dysfunctional O 0 1.1417195082685794e-06
ATP7B O 0 4.555362011160469e-06
gene O 0 6.268579966217658e-08
, O 0 3.119102198745338e-10
causing O 0 7.2316794330618e-07
Wilson B-Disease 0 0.0008919825777411461
disease I-Disease 0 1.125342350860592e-05
( O 0 1.1734694327358852e-09
WD B-Disease 0 0.002063555410131812
) O 0 3.193156628000793e-09
. O 0 4.150704224770152e-09

Mutations O 0 2.23571369133424e-05
in O 0 4.768816452838109e-10
the O 0 8.980906990307957e-11
ATP7B O 0 4.096026714250911e-06
genes O 0 1.5573316858308317e-08
have O 0 3.8441205774120135e-10
also O 0 6.30820048974634e-11
been O 0 1.3591720804395635e-10
demonstrated O 0 9.738615469601086e-10
in O 0 1.5264418201654806e-11
mouse O 0 7.967436488343083e-08
and O 0 3.2299278807101928e-09
rat O 0 6.152375135570765e-05
. O 0 3.6426117677734737e-09

The O 0 4.859555868819143e-09
ATP7B O 0 1.7654911061981693e-06
gene O 0 4.701823996811072e-08
has O 0 6.255114204378742e-10
been O 0 3.441156387617994e-11
excluded O 0 1.4835678519009576e-10
in O 0 1.3857190134941577e-12
the O 0 9.87518226913675e-13
much O 0 8.679625768115429e-11
rarer O 0 1.6704613869933382e-07
human O 0 7.819083158722151e-09
copper B-Disease 0 0.0030470467172563076
overload I-Disease 0 0.00130792788695544
disease O 0 5.945578323007794e-07
non B-Disease 0 2.9466378226317147e-09
- I-Disease 0 1.971132860489888e-06
Indian I-Disease 0 2.0817934043293462e-09
childhood I-Disease 0 1.3918102922616526e-05
cirrhosis I-Disease 0 1.2582122508320026e-06
, O 0 8.803399849377502e-12
indicating O 0 8.318101762938568e-09
genetic O 0 6.168875898993065e-08
heterogeneity O 0 3.050822670047637e-06
. O 0 3.868109033078326e-08

By O 0 6.054448609127405e-10
investigating O 0 1.7798551965597653e-08
the O 0 3.3622515882569814e-10
common O 0 4.998501523800769e-08
autosomal O 0 0.4706638753414154
recessive O 1 0.9961720108985901
copper B-Disease 1 0.9987691044807434
toxicosis I-Disease 1 0.9979111552238464
( O 0 3.0042965892818074e-09
CT B-Disease 0 0.00028200424276292324
) O 0 4.286707100398246e-11
in O 0 8.350490438013836e-11
Bedlington O 0 4.054434612044133e-06
terriers O 0 9.308289008913562e-05
, O 0 8.408575502549809e-10
we O 0 1.1076226602568795e-09
have O 0 3.3198093579711596e-11
identified O 0 7.352307651586898e-11
a O 0 6.314661467332616e-12
new O 0 3.677314529271225e-12
locus O 0 1.966421470100954e-09
involved O 0 5.2672062267333786e-09
in O 0 1.2053927633814965e-08
progressive O 0 0.06511805206537247
liver B-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999982118606567
. O 0 2.3784916436397907e-07

We O 0 3.461482478428479e-08
examined O 0 1.4636278855562068e-08
whether O 0 2.7693972115550025e-10
the O 0 3.749630467231313e-11
WD B-Disease 0 7.028503023320809e-05
gene O 0 6.075496372659472e-08
ATP7B O 0 1.0632567864377052e-05
was O 0 1.206579058887769e-09
also O 0 4.202830358041032e-12
causative O 0 5.63283863996844e-10
for O 0 1.2004940227669514e-12
CT B-Disease 0 2.567481715232134e-06
by O 0 6.08985084582514e-11
investigating O 0 1.2836529172943756e-08
the O 0 3.5262112674239177e-10
chromosomal O 0 0.0001581729738973081
co O 0 2.4812632091197884e-06
- O 0 1.1140539868392807e-07
localization O 0 1.4972341588759264e-08
of O 0 2.0698137214586465e-12
ATP7B O 0 1.3884526595120406e-07
and O 0 1.0286211986343385e-11
C04107 O 0 1.2052650544269738e-10
, O 0 6.192589437114052e-14
using O 0 2.622450217051875e-12
fluorescence O 0 1.9065183209932002e-08
in O 0 1.5449978102433093e-11
situ O 0 2.4179276358893276e-09
hybridization O 0 1.2188334785889765e-09
( O 0 1.8937617099479276e-11
FISH O 0 1.393061666021822e-09
) O 0 5.168172487191036e-11
. O 0 7.939183199745514e-10

C04107 O 0 8.735958545003086e-06
is O 0 9.26203835849293e-10
an O 0 2.96601935720342e-12
anonymous O 0 1.6176637807063798e-09
microsatellite O 0 4.0720969991525635e-06
marker O 0 5.391384092945373e-06
closely O 0 6.14379587204894e-07
linked O 0 1.710291940071329e-06
to O 0 9.642722176295138e-10
CT B-Disease 0 0.15647831559181213
. O 0 3.878621868125265e-08

However O 0 1.1582340420090986e-07
, O 0 2.0143510470749248e-10
BAC O 0 1.2402406923683884e-07
clones O 0 2.125279952025494e-09
containing O 0 4.364793859679139e-09
ATP7B O 0 1.948927092598751e-06
and O 0 3.9048781569350766e-11
C04107 O 0 1.6225275567549602e-09
mapped O 0 2.6044109091571954e-08
to O 0 1.2592814811751563e-11
the O 0 2.0906569878076375e-11
canine O 0 4.133852598897647e-06
chromosome O 0 2.389407427472179e-06
regions O 0 1.2620359202131226e-09
CFA22q11 O 0 3.2638857305755664e-07
and O 0 1.8719424621504999e-10
CFA10q26 O 0 7.414860903054432e-08
, O 0 2.3607060316982453e-12
respectively O 0 2.3569278473356547e-11
, O 0 9.474249862287745e-14
demonstrating O 0 2.2920769449097378e-11
that O 0 4.4948132021938036e-11
WD B-Disease 0 3.192102303728461e-05
cannot O 0 1.8138628377073474e-08
be O 0 7.521506854846205e-12
homologous O 0 2.427056888798518e-10
to O 0 3.6244524048711924e-10
CT B-Disease 0 0.0020533252973109484
. O 0 2.4300561562995426e-08

The O 0 1.0283874196659326e-08
copper O 0 1.2334199936958612e-06
transport O 0 3.607735665767109e-09
genes O 0 2.3363415646571184e-09
CTR1 O 0 6.115467385825468e-07
and O 0 2.4130245024345243e-10
CTR2 O 0 3.158612116749282e-06
were O 0 1.714259428853282e-10
also O 0 1.524535879482425e-11
excluded O 0 1.782091314794787e-11
as O 0 7.441620561952911e-13
candidate O 0 5.0374482363224615e-11
genes O 0 1.091881272896611e-11
for O 0 6.173993608027395e-13
CT B-Disease 0 1.034514389175456e-05
since O 0 4.728784475105385e-09
they O 0 2.7775741776037144e-11
both O 0 9.142885233626163e-12
mapped O 0 1.74621646920059e-07
to O 0 4.68164840228269e-10
canine O 0 6.975333235459402e-05
chromosome O 0 4.7129135055001825e-05
region O 0 1.2706333052392438e-07
CFA11q22 O 0 2.3598235202371143e-05
. O 0 2.459474934823902e-08

2 O 0 5.026936023000417e-08
- O 0 4.839901976083638e-06
22 O 0 5.978986639121331e-09
. O 0 2.7023678850213173e-09

5 O 0 7.033182214399858e-07
. O 0 7.482858421781202e-08

A O 0 3.221580158196957e-08
transcribed O 0 5.0581363097990106e-08
sequence O 0 1.461208820607851e-09
identified O 0 7.820213365761219e-10
from O 0 2.5315953760401966e-12
the O 0 1.5840084235593799e-12
C04107 O 0 6.987064260499665e-09
- O 0 3.64249572726294e-08
containing O 0 1.5857983370892725e-08
BAC O 0 1.7990903415920911e-06
was O 0 1.5596375302351362e-09
found O 0 2.5259632926988296e-11
to O 0 1.0791414420049938e-12
be O 0 3.2480673966411855e-12
homologous O 0 2.169676764640638e-11
to O 0 2.3699815981242933e-12
a O 0 1.8545951233073232e-11
gene O 0 6.470102231759256e-10
expressed O 0 4.581542784043435e-11
from O 0 4.646584332579362e-12
human O 0 8.990024696897692e-11
chromosome O 0 6.354157022769868e-08
2p13 O 0 1.553711825863502e-08
- O 0 9.490754848684446e-08
p16 O 0 8.384876792888463e-09
, O 0 1.2902268663184113e-11
a O 0 4.461195302063459e-11
region O 0 5.746566555941968e-10
devoid O 0 1.0511496562060074e-08
of O 0 5.080613664151801e-13
any O 0 1.707539318274165e-11
positional O 0 1.4643790180457472e-08
candidate O 0 3.5903834572081905e-08
genes O 0 1.8346838714933256e-08
. O 0 4.064394598657373e-09

Molecular O 0 2.6516838715906488e-06
analysis O 0 1.4407193660304074e-08
of O 0 1.0910257072782592e-11
the O 0 8.437485085610597e-12
APC B-Disease 0 1.6027744687008294e-09
gene O 0 8.196701095641856e-10
in O 0 1.1604740605963837e-11
205 O 0 3.6053653118539586e-11
families O 0 4.822469854004474e-11
: O 0 1.3121057192144736e-11
extended O 0 2.886051952977198e-10
genotype O 0 2.8407737772795372e-05
- O 0 3.091955704803695e-06
phenotype O 0 2.483085665971885e-07
correlations O 0 5.586164064652621e-08
in O 0 3.507527948642952e-11
FAP B-Disease 0 2.4667272668921214e-09
and O 0 5.588017461949368e-12
evidence O 0 9.623201541186788e-12
for O 0 3.726483368843986e-13
the O 0 1.0975141151794987e-12
role O 0 1.0747174851444274e-11
of O 0 6.288264180198677e-13
APC B-Disease 0 7.510333466242969e-10
amino O 0 8.737328915930931e-11
acid O 0 1.920714420844405e-10
changes O 0 6.10525185962274e-10
in O 0 8.033416634134483e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
predisposition O 1 0.979072630405426
. O 0 5.585918927408784e-08

BACKGROUND O 0 0.00010126957204192877
/ O 0 5.299001486491761e-07
AIMS O 0 7.823872216761174e-09
The O 0 2.7223967871692345e-11
development O 0 7.724148404220088e-11
of O 0 2.0996961325181474e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.6337244324613494e-08
a O 0 1.0136121941783927e-09
variable O 0 3.392590599560208e-07
range O 0 6.87926104969705e-10
of O 0 2.2912859110046924e-11
extracolonic O 0 2.5754841772140935e-05
manifestations O 0 2.0414281607372686e-05
in O 0 1.3124360975780291e-07
familial B-Disease 1 0.9999991655349731
adenomatous I-Disease 1 0.9999699592590332
polyposis I-Disease 1 0.9999972581863403
( O 0 1.6922191647950058e-08
FAP B-Disease 0 4.944037641507748e-07
) O 0 2.815031020786396e-11
is O 0 1.0227132508922043e-11
the O 0 1.5286174019288334e-12
result O 0 9.8506994228309e-11
of O 0 1.8409163082822033e-12
the O 0 8.61459376055862e-11
dominant O 0 4.6616446525149513e-07
inheritance O 0 7.73261854192242e-05
of O 0 1.7421773463865975e-06
adenomatous B-Disease 1 0.9999966621398926
polyposis I-Disease 1 0.9999339580535889
coli I-Disease 1 0.9999843835830688
( O 0 1.6632657917625693e-08
APC B-Disease 0 1.537610074819895e-07
) O 0 1.0674858913484186e-10
gene O 0 2.1145377004927468e-08
mutations O 0 1.9770329799939645e-06
. O 0 9.271993839377046e-09

In O 0 2.412855470979025e-09
this O 0 1.1840126101780868e-11
study O 0 1.6344346015495503e-11
, O 0 1.2435769102848993e-13
direct O 0 2.688226377611791e-12
mutation O 0 1.8327385165051169e-09
analysis O 0 1.7872925361928083e-11
of O 0 1.1528176687997799e-13
the O 0 1.1362559114089232e-12
APC B-Disease 0 1.58901503066744e-10
gene O 0 6.581961364826583e-11
was O 0 1.226725249159344e-10
performed O 0 1.9527622574511128e-11
to O 0 1.9095348132575074e-12
determine O 0 1.3908695528641601e-08
genotype O 0 2.779556598397903e-05
- O 0 6.350982175717945e-07
phenotype O 0 3.477801868712049e-08
correlations O 0 3.0946951667942812e-09
for O 0 3.264663279295421e-12
nine O 0 2.4905043305434305e-11
extracolonic O 0 3.4433018214485855e-08
manifestations O 0 6.441084110520023e-09
and O 0 1.3861083288102538e-11
to O 0 1.2791239421827694e-12
investigate O 0 7.796844836427397e-10
the O 0 6.570296390284724e-11
incidence O 0 2.1394671421148814e-06
of O 0 5.666820745292567e-12
APC B-Disease 0 1.4084730715069327e-08
mutations O 0 1.6213897779948638e-08
in O 0 5.705740879768939e-10
non O 0 6.257656082198082e-07
- O 1 0.9972125887870789
FAP O 1 0.9996292591094971
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
. O 0 1.656105837355426e-06

METHODS O 0 3.6503934097709134e-07
The O 0 1.6009098213753958e-10
APC B-Disease 0 5.20787768465425e-09
gene O 0 1.3368687268311419e-09
was O 0 1.5138156006511139e-10
analysed O 0 9.250068488952934e-10
in O 0 5.102038583282287e-12
190 O 0 2.0245725235179535e-11
unrelated O 0 1.5917641649210168e-09
FAP B-Disease 0 2.939813015245818e-08
and O 0 1.952059347498647e-10
15 O 0 1.1862012760932572e-10
non O 0 2.6083579740543428e-08
- O 1 0.862298309803009
FAP O 1 0.9990707039833069
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999986886978149
patients O 0 1.9709439413873042e-07
using O 0 3.009320570512841e-09
denaturing O 0 7.823851774446666e-06
gradient O 0 4.97834889756632e-06
gel O 0 4.9041218517231755e-06
electrophoresis O 0 4.634264527680898e-08
, O 0 2.3060555201515065e-12
the O 0 2.5308604495975773e-13
protein O 0 6.529117524411987e-12
truncation O 0 2.7065757968181003e-10
test O 0 6.716674438855819e-10
, O 0 6.004654239111229e-13
and O 0 2.9096153654831203e-13
direct O 0 2.639895767264644e-11
sequencing O 0 9.938498912731575e-10
. O 0 9.251444610391957e-10

RESULTS O 0 3.3423173135815887e-06
Chain O 0 2.632945950153953e-07
terminating O 0 8.131010531542415e-09
signals O 0 1.2888515144027224e-08
were O 0 3.5812269816304365e-11
only O 0 3.617486952350868e-12
identified O 0 2.978336910430812e-09
in O 0 4.3248047504329534e-11
patients O 0 8.208775326146167e-11
belonging O 0 7.128837520298248e-10
to O 0 2.2802511615016563e-11
the O 0 5.35764280162887e-11
FAP B-Disease 0 3.268856829663491e-08
group O 0 2.878487448398914e-10
( O 0 2.116211936589729e-12
105 O 0 4.00300383118779e-11
patients O 0 8.055613398560979e-10
) O 0 5.937387387300319e-11
. O 0 8.973686238533674e-10

Amino O 0 2.2853016901080991e-07
acid O 0 1.3880496751994542e-08
changes O 0 3.758181266189098e-10
were O 0 4.796161384712505e-11
identified O 0 1.5427848998328386e-09
in O 0 2.156100124828253e-11
four O 0 4.034192077617682e-11
patients O 0 2.839747326177644e-10
, O 0 1.0649875079038473e-12
three O 0 3.477548110586426e-13
of O 0 4.3046130353795176e-13
whom O 0 1.967621843235179e-09
belonged O 0 1.6647225820065614e-08
to O 0 1.685268764817227e-11
the O 0 1.742549854411024e-11
non O 0 1.409315997236149e-09
- O 0 1.578866459794881e-07
FAP O 0 6.30598293582807e-08
group O 0 1.417944206494326e-09
of O 0 4.26693169686132e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
patients O 0 1.9674896975629963e-05
. O 0 4.016639110204778e-08

Genotype O 1 0.9657771587371826
- O 0 0.001008266699500382
phenotype O 0 4.5075707021169364e-05
correlations O 0 1.313946768277674e-06
identified O 0 2.8659558282129183e-08
significant O 0 7.90152221430418e-10
differences O 0 1.7612553904200468e-07
in O 0 1.1189889292939625e-10
the O 0 1.531305811319772e-11
nature O 0 7.892755338190227e-10
of O 0 7.160291782236372e-13
certain O 0 4.538238881912626e-11
extracolonic O 0 1.8349714991927613e-07
manifestations O 0 1.3333400161741338e-08
in O 0 7.243666083622813e-11
FAP B-Disease 0 7.278105584873629e-08
patients O 0 3.7007491515694824e-10
belonging O 0 8.417770924751267e-10
to O 0 4.822212421040639e-11
three O 0 2.3129295700918817e-10
mutation O 0 8.643208957437309e-07
subgroups O 0 5.85099485306273e-07
. O 0 1.0525540439232373e-08

CONCLUSIONS O 0 1.8924989717561402e-06
Extended O 0 2.9366633569338774e-08
genotype O 0 4.674254887504503e-05
- O 0 2.816157802953967e-06
phenotype O 0 3.2656666348884755e-07
correlations O 0 1.8782712274401092e-08
made O 0 1.759334865292228e-11
in O 0 3.761863650447728e-12
this O 0 1.839382379048571e-12
study O 0 3.6975509459802325e-11
may O 0 4.912346640573162e-10
have O 0 5.753027720011017e-13
the O 0 3.3558252747825645e-14
potential O 0 4.689552999398439e-12
to O 0 5.857596309041813e-13
determine O 0 9.723537947037286e-11
the O 0 2.2695532248245137e-13
most O 0 8.195027501652768e-14
appropriate O 0 1.225921816318254e-12
surveillance O 0 1.2267135918175853e-10
and O 0 4.589289018253062e-12
prophylactic O 0 4.387513907744278e-09
treatment O 0 2.432636869720284e-10
regimens O 0 2.498541651352326e-10
for O 0 6.730231606397186e-13
those O 0 1.6166935845607355e-11
patients O 0 8.3507457893095e-11
with O 0 2.640449837942871e-11
mutations O 0 1.0273429040807969e-07
associated O 0 2.3851043362554947e-09
with O 0 1.0637461744789078e-10
life O 0 1.0265829075706279e-07
threatening O 0 7.146131338231498e-06
conditions O 0 2.389905944255588e-07
. O 0 1.7753991610192088e-09

This O 0 2.3754431754952066e-09
study O 0 3.4962285844208907e-10
also O 0 6.187141510932692e-12
provided O 0 3.666717970918221e-12
evidence O 0 2.6541132139290546e-11
for O 0 9.153490682436982e-13
the O 0 4.10531547992421e-12
pathological O 0 2.1283680595729493e-08
nature O 0 1.5009818943312325e-09
of O 0 4.187866633337256e-12
amino O 0 1.0467710032102673e-10
acid O 0 1.8351712510744633e-11
changes O 0 2.6437140237395296e-12
in O 0 1.6690304737235206e-12
APC O 0 3.5070149562166364e-10
associated O 0 7.62784349572776e-11
with O 0 3.1471322943510405e-12
both O 0 3.7036707034587835e-11
FAP B-Disease 0 1.70901799378953e-08
and O 0 2.9824850922288704e-10
non O 0 1.6923070234042825e-07
- O 1 0.9830575585365295
FAP O 1 0.9995177984237671
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
patients O 0 5.641038114845287e-06
. O 0 1.4791805558189708e-09
. O 0 2.0678949663732737e-09

Inherited B-Disease 1 0.9997962117195129
colorectal I-Disease 1 0.9999992847442627
polyposis I-Disease 1 0.9997568726539612
and O 0 6.624036905122921e-05
cancer B-Disease 0 0.019376268610358238
risk O 0 8.236268513428513e-06
of O 0 1.0359738067400315e-10
the O 0 3.0681926443953955e-10
APC O 0 3.2587445275567006e-07
I1307K O 0 3.0648300253233174e-07
polymorphism O 0 6.792045041947858e-06
. O 0 2.3345608113345406e-08

Germ O 0 0.004101699683815241
- O 0 0.0001084804825950414
line O 0 1.7718794254051318e-07
and O 0 6.99405672266451e-11
somatic O 0 2.2069508442967845e-09
truncating O 0 3.616266397443724e-08
mutations O 0 2.5349104149086088e-08
of O 0 2.8272603442430766e-12
the O 0 6.286708566921595e-12
APC B-Disease 0 9.169335291048242e-10
gene O 0 3.927782543655667e-10
are O 0 1.3917908492366848e-11
thought O 0 8.215118862953119e-11
to O 0 3.3460834797383043e-11
initiate O 0 1.1051078217860777e-05
colorectal B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9859641790390015
formation O 0 1.633185092941858e-05
in O 0 3.711763838509796e-06
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.9999992847442627
polyposis I-Disease 1 1.0
syndrome I-Disease 1 0.9999991655349731
and O 0 1.3543094610213302e-06
sporadic O 0 0.12035493552684784
colorectal O 1 0.9999998807907104
carcinogenesis O 1 0.9996969699859619
, O 0 9.605284390090674e-08
respectively O 0 2.0776263909283443e-07
. O 0 7.847156702212033e-09

Recently O 0 6.73320073474315e-07
, O 0 5.871315933436705e-11
an O 0 5.6245021660961125e-12
isoleucine O 0 4.691612048191018e-06
- O 0 9.040951226779725e-06
- O 0 3.861544882965973e-06
> O 0 4.3207712963067024e-08
lysine O 0 1.7339852220743524e-08
polymorphism O 0 5.354351628739096e-08
at O 0 6.966022758625456e-10
codon O 0 2.5767197264769948e-09
1307 O 0 1.590429654640957e-08
( O 0 9.490785978297223e-13
I1307K O 0 1.4703727124754096e-10
) O 0 1.5766016693129908e-13
of O 0 7.213323092048612e-14
the O 0 2.3353357008620845e-12
APC B-Disease 0 2.4509494433999635e-10
gene O 0 2.0171191106310715e-10
has O 0 6.329641671909414e-11
been O 0 1.1037284801396208e-11
identified O 0 6.065564717161465e-11
in O 0 7.069721327454537e-13
6 O 0 3.788383235586723e-12
% O 0 4.91194595848149e-13
- O 0 9.057532501799415e-10
7 O 0 3.908842347022379e-11
% O 0 4.104115322329377e-13
of O 0 3.9905280685773037e-13
the O 0 6.04625169375872e-11
Ashkenazi O 0 1.1716048575749483e-08
Jewish O 0 2.7808000346851713e-09
population O 0 5.96762472770962e-10
. O 0 8.185390143466975e-10

To O 0 1.599524956930054e-09
assess O 0 2.993898462477773e-08
the O 0 5.98082833258573e-11
risk O 0 2.4310609081368284e-09
of O 0 3.0528994588406577e-13
this O 0 2.135357645913216e-12
common O 0 1.2813106131659424e-10
APC B-Disease 0 1.921855119491056e-09
allelic O 0 3.25235163245452e-08
variant O 0 8.395544455197523e-07
in O 0 4.7277769255060775e-08
colorectal O 1 0.9999982118606567
carcinogenesis O 0 0.265747606754303
, O 0 3.870475939748985e-09
we O 0 9.488972940729923e-10
have O 0 7.055540179878861e-12
analyzed O 0 1.5365730909877584e-10
a O 0 2.572880276885403e-12
large O 0 1.9641188675478816e-10
cohort O 0 1.5684387122405496e-08
of O 0 1.504591937151467e-11
unselected O 0 1.6762523955549113e-06
Ashkenazi O 0 9.809782142156109e-08
Jewish O 0 2.138344390445468e-09
subjects O 0 4.1259298200202466e-08
with O 0 9.818978269349188e-11
adenomatous B-Disease 0 8.297335625684354e-06
polyps I-Disease 0 1.1641485798463691e-05
and O 0 2.9128137679634847e-09
. O 0 1.6830156157610077e-09
or O 0 0.012027913704514503
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 5.728247876035653e-10
for O 0 6.8566055611007926e-12
the O 0 5.82291437289939e-11
APC O 0 4.912641671239726e-08
I1307K O 0 4.241526241344218e-08
polymorphism O 0 7.922088229861401e-07
. O 0 8.281438645951766e-09

The O 0 5.485151000073074e-09
APC O 0 6.926005369223276e-08
I1307K O 0 6.671405117231188e-08
allele O 0 1.0243355319516922e-07
was O 0 1.6401040525693134e-09
identified O 0 2.500502471747268e-09
in O 0 9.884967844264736e-12
48 O 0 5.693678601509378e-12
( O 0 1.7412190667174393e-13
10 O 0 2.469707110260705e-13
. O 0 1.0486599246297204e-13
1 O 0 1.9647801181160718e-12
% O 0 6.8174535027693e-13
) O 0 1.7172773077687997e-13
of O 0 1.0324929930125015e-12
476 O 0 3.209141175020136e-09
patients O 0 1.471541288822209e-08
. O 0 5.0813606655708554e-09

Compared O 0 1.043628614638692e-07
with O 0 3.888356303605178e-11
the O 0 2.1514828113522455e-11
frequency O 0 1.2060463916441222e-07
in O 0 2.8233910435299103e-12
two O 0 4.881302610379445e-13
separate O 0 3.150274832663946e-11
population O 0 8.093213599291715e-12
control O 0 2.061368714612044e-10
groups O 0 3.927374050971544e-12
, O 0 4.862290583183826e-13
the O 0 7.395295313628036e-13
APC O 0 1.9360926750700003e-10
I1307K O 0 5.820196546935108e-10
allele O 0 1.9839661025145006e-09
is O 0 2.96110163298946e-12
associated O 0 5.148943771349224e-12
with O 0 5.932796029624321e-13
an O 0 2.148746241700805e-12
estimated O 0 2.9004881829663987e-10
relative O 0 2.1819981554926926e-07
risk O 0 2.157214140652286e-08
of O 0 6.647729242081901e-12
1 O 0 9.216607477213756e-10
. O 0 3.1313356352313804e-09

5 O 0 7.176812744091876e-08
- O 0 7.775361154926941e-07
1 O 0 6.177657940753534e-09
. O 0 4.508228901300981e-09

7 O 0 2.5270642822761147e-07
for O 0 1.614212585820951e-08
colorectal B-Disease 1 0.9999966621398926
neoplasia I-Disease 1 0.9818103313446045
( O 0 2.5590678465192696e-09
both O 0 2.0181669668772884e-09
P O 0 0.05990526080131531
= O 0 2.515182359275059e-06
. O 0 1.6957683868223938e-10
01 O 0 1.0793494986671703e-08
) O 0 3.176000087923292e-11
. O 0 5.007208536689234e-10

Furthermore O 0 9.739678716869093e-07
, O 0 1.0039814812845549e-10
compared O 0 2.4630963935123873e-10
with O 0 9.781122960184074e-12
noncarriers O 0 6.306632940322743e-07
, O 0 8.018798298981e-12
APC O 0 4.053282987026563e-10
I1307K O 0 9.219315311170817e-10
carriers O 0 1.7817658459762242e-10
had O 0 5.391142740562849e-11
increased O 0 1.0624215049381824e-11
numbers O 0 1.7700179863466836e-11
of O 0 1.7597869775981545e-12
adenomas B-Disease 0 9.409451990904927e-07
and O 0 9.157071758636448e-07
colorectal B-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9900892972946167
per O 0 5.760652044273229e-08
patient O 0 8.11718905424641e-07
( O 0 6.26566715178356e-11
P O 0 3.146264498354867e-05
= O 0 5.1153300262285484e-08
. O 0 2.3231314875277187e-12
03 O 0 6.70492064647199e-11
) O 0 2.836635819899319e-13
, O 0 1.5108710994544278e-13
as O 0 2.830820159446107e-13
well O 0 1.3791849606814566e-12
as O 0 6.95893429686345e-13
a O 0 4.6537620979059113e-11
younger O 0 1.0129884486786978e-08
age O 0 7.090677489607344e-10
at O 0 3.8611247532571724e-10
diagnosis O 0 1.7761612980393693e-07
. O 0 1.230076374092448e-09

We O 0 1.1227917440237434e-07
conclude O 0 7.594881168415668e-09
that O 0 1.7526364040620912e-11
the O 0 9.344593675242319e-12
APC O 0 2.291974388057838e-09
I1307K O 0 3.02459257639498e-09
variant O 0 9.41628197637101e-09
leads O 0 4.2308076486641255e-10
to O 0 5.707349176597987e-11
increased O 0 5.9041273203774836e-08
adenoma B-Disease 1 0.9999979734420776
formation O 0 3.563190276167916e-08
and O 0 4.3785811781882344e-11
directly O 0 4.494075597771818e-11
contributes O 0 3.489724481609002e-11
to O 0 1.2263029133818826e-12
3 O 0 2.116115008915509e-12
% O 0 6.336809874572802e-13
- O 0 9.729734379293475e-11
4 O 0 3.060894636711109e-12
% O 0 2.530252212178813e-13
of O 0 9.737968894793503e-13
all O 0 1.0332944500035524e-09
Ashkenazi O 0 1.6926933312788606e-05
Jewish O 0 0.011571645736694336
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999986886978149
. O 0 5.316647389008722e-07

The O 0 2.7442277339417842e-09
estimated O 0 1.7683898789755403e-09
relative O 0 2.1549523054886777e-08
risk O 0 8.139807938789545e-09
for O 0 8.025133509115268e-12
carriers O 0 2.838405954719292e-09
may O 0 2.9245589283632967e-10
justify O 0 2.187374864570657e-10
specific O 0 7.748966399101498e-12
clinical O 0 1.0332125779943802e-11
screening O 0 2.449292721765084e-12
for O 0 6.917772967960853e-14
the O 0 1.0528626310634531e-13
360 O 0 1.146056990627975e-12
, O 0 1.2800897223729651e-13
000 O 0 2.1581811858462085e-12
Americans O 0 7.860281869831454e-12
expected O 0 6.345703042892614e-12
to O 0 8.048398102492027e-13
harbor O 0 6.511464145653179e-10
this O 0 5.918434579227361e-12
allele O 0 2.706967983101549e-10
, O 0 1.1264134156668826e-13
and O 0 3.362054016263494e-13
genetic O 0 3.8049174921894746e-11
testing O 0 4.742210790720236e-11
in O 0 1.4090774987790544e-12
the O 0 1.2491427163474622e-12
setting O 0 1.3324588654661795e-10
of O 0 1.8329873209543823e-12
long O 0 8.000840545641097e-10
- O 0 1.9509334592271443e-08
term O 0 1.2193542842098282e-09
- O 0 1.3297278833590553e-09
outcome O 0 2.2120701104189067e-10
studies O 0 1.739056815219797e-11
may O 0 2.14971478118553e-11
impact O 0 1.8138957003088763e-10
significantly O 0 1.337399879730583e-08
on O 0 0.0011271766852587461
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
prevention O 0 5.0907354307128116e-05
in O 0 1.0773369002459177e-10
this O 0 1.916464903439774e-11
population O 0 1.1603020627637406e-10
. O 0 7.167654247908217e-10

Localization O 0 1.076360263141396e-06
of O 0 5.783200654474463e-11
human O 0 7.960107573090625e-10
BRCA1 O 0 6.886421601848269e-07
and O 0 1.345866196267309e-10
its O 0 5.090367363735915e-11
loss O 0 4.8676822572701894e-09
in O 0 7.452537198471276e-11
high O 0 2.0702243475057003e-08
- O 0 1.4683192830489133e-06
grade O 0 3.4363284839855623e-07
, O 0 7.545751523618804e-11
non B-Disease 0 9.582809212815846e-09
- I-Disease 0 0.008989803493022919
inherited I-Disease 1 0.9435914158821106
breast I-Disease 1 0.9996228218078613
carcinomas I-Disease 1 0.9999992847442627
. O 0 1.510608967691951e-06

Although O 0 5.873405317657898e-09
the O 0 1.772491008134036e-11
link O 0 2.316498104448783e-09
between O 0 8.670955620182497e-11
the O 0 6.345406977636969e-10
BRCA1 O 0 0.0024435147643089294
tumour B-Disease 1 0.999982476234436
- O 0 1.1525872878337395e-06
suppressor O 0 1.275221165997209e-06
gene O 0 3.701684647694492e-08
and O 0 9.92047333170376e-09
hereditary B-Disease 1 0.9988037347793579
breast I-Disease 1 0.9999977350234985
and I-Disease 1 0.9999884366989136
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 9.75727090235523e-08
established O 0 6.826764153977649e-11
, O 0 3.170616167617185e-13
the O 0 1.9040205610082461e-13
role O 0 2.9815282187595216e-11
, O 0 8.923628437747244e-13
if O 0 2.65891518871908e-12
any O 0 9.19885586973812e-13
, O 0 4.557097903787159e-14
of O 0 8.327669473061003e-14
BRCA1 O 0 1.6696866111942654e-08
in O 0 1.7822689157842575e-10
non B-Disease 0 1.4895860545038886e-08
- I-Disease 0 0.0004746938357129693
familial I-Disease 1 0.8213521242141724
cancers I-Disease 1 0.9990806579589844
is O 0 1.8121406597515488e-08
unclear O 0 4.7166086147854e-08
. O 0 1.9720329813566195e-09

BRCA1 O 0 0.33176273107528687
mutations O 0 0.0002698689349927008
are O 0 5.289806370711858e-10
rare O 0 1.3122072317628408e-09
in O 0 1.346821404402121e-10
sporadic B-Disease 0 1.151402739196783e-05
cancers I-Disease 1 0.9997491240501404
, O 0 6.887689862900004e-10
but O 0 9.449111493253781e-10
loss O 0 4.1045304932652016e-09
of O 0 4.433894657679405e-12
BRCA1 O 0 8.234235906456888e-07
resulting O 0 4.590285040961817e-09
from O 0 1.0047324777717748e-10
reduced O 0 9.322622673835212e-09
expression O 0 1.3596974213214708e-08
or O 0 5.878983411200522e-10
incorrect O 0 1.3806880083677697e-08
subcellular O 0 7.894222875393098e-08
localization O 0 5.086538301668497e-09
is O 0 1.6883436922826567e-12
postulated O 0 2.2216345429981743e-10
to O 0 1.2306917637761039e-12
be O 0 3.741470241264144e-12
important O 0 1.0016279255661842e-12
in O 0 1.0684285921269687e-11
non B-Disease 0 2.7863851226328507e-09
- I-Disease 0 2.802799099299591e-05
familial I-Disease 1 0.8031907081604004
breast I-Disease 1 0.999985933303833
and I-Disease 1 0.9980325102806091
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
. O 0 1.6589987126280903e-06

Epigenetic O 0 3.055309207411483e-05
loss O 0 1.766654895618558e-05
, O 0 2.5782914692129566e-10
however O 0 1.5249090878910465e-10
, O 0 6.313408996982961e-12
has O 0 2.5581967100229974e-11
not O 0 3.785559105767833e-12
received O 0 3.7010469016753034e-13
general O 0 3.387867243687115e-13
acceptance O 0 1.5341854522898934e-11
due O 0 1.136622740371962e-11
to O 0 6.949662199884354e-13
controversy O 0 3.4118136094107854e-10
regarding O 0 1.0810666944971459e-10
the O 0 3.176858949516248e-12
subcellular O 0 6.2688534363530835e-09
localization O 0 3.8625241893797124e-10
of O 0 6.393152608870356e-13
BRCA1 O 0 1.1888639406265611e-08
proteins O 0 2.2823659628912196e-11
, O 0 3.51833227265827e-13
reports O 0 6.48028505856324e-12
of O 0 4.1958279840999257e-13
which O 0 8.898431991255507e-11
have O 0 3.7165992505805434e-11
ranged O 0 1.5065865222041452e-09
from O 0 1.2292934682342493e-12
exclusively O 0 4.4825788914071296e-11
nuclear O 0 4.46405330478683e-08
, O 0 3.1047573908517256e-13
to O 0 6.299813101739993e-13
conditionally O 0 4.219364302393558e-10
nuclear O 0 2.6337476644044955e-09
, O 0 5.663616683927383e-14
to O 0 6.269470890791357e-14
the O 0 8.007549484601029e-12
ER O 0 1.1723743398306397e-07
/ O 0 1.3136070009522882e-09
golgi O 0 9.385280996809797e-09
, O 0 1.352999418231804e-12
to O 0 1.039424622761853e-12
cytoplasmic O 0 7.89722787164493e-10
invaginations O 0 1.5373514017369416e-08
into O 0 1.1804746416488321e-11
the O 0 5.987162848830607e-11
nucleus O 0 5.784045242762659e-09
. O 0 9.898770692018388e-10

In O 0 9.73308100782333e-10
an O 0 6.757465680767849e-12
attempt O 0 5.534436242626839e-10
to O 0 3.753351102142588e-11
resolve O 0 3.33736238644633e-08
this O 0 4.0387727884283464e-11
issue O 0 2.5517663537755197e-09
, O 0 4.776886351753884e-12
we O 0 5.90696797031498e-11
have O 0 3.2197078336793084e-11
comprehensively O 0 2.031181978168206e-08
characterized O 0 1.7258641182849033e-09
19 O 0 5.791358018147896e-11
anti O 0 2.5310939122391574e-08
- O 0 1.9549101125448942e-05
BRCA1 O 0 5.454061465570703e-06
antibodies O 0 1.0429302221837133e-07
. O 0 3.4121605541059807e-09

These O 0 1.676332517241974e-09
reagents O 0 2.4556499056416214e-08
detect O 0 3.419551148908795e-07
a O 0 1.35459130023996e-10
220 O 0 8.365762943496335e-11
- O 0 3.1942242628701933e-08
kD O 0 1.365569062272698e-07
protein O 0 4.1107101056425677e-10
localized O 0 1.886017120256156e-09
in O 0 1.075946103046288e-11
discrete O 0 3.526515524043816e-09
nuclear O 0 1.8519578759423894e-07
foci O 0 7.732164419849141e-08
in O 0 3.552964519815127e-11
all O 0 5.15767246619947e-12
epithelial O 0 8.238966842100126e-08
cell O 0 6.415586085495306e-06
lines O 0 1.9190618161246675e-07
, O 0 8.669127698687773e-13
including O 0 1.9061133422516863e-13
those O 0 1.9298122128086348e-12
derived O 0 3.0173179926817895e-11
from O 0 1.0812110234903471e-10
breast B-Disease 0 0.00018032915249932557
malignancies I-Disease 0 0.000502606388181448
. O 0 1.4193790143224305e-08

Immunohistochemical O 0 0.0002137534029316157
staining O 0 1.751992567733396e-05
of O 0 1.6398506996750939e-09
human O 0 1.4770337486424978e-07
breast O 0 0.1625189334154129
specimens O 0 6.942961772438139e-05
also O 0 2.3001735627303788e-08
revealed O 0 9.80904314928921e-06
BRCA1 O 0 5.397617496782914e-05
nuclear O 0 4.521743903751485e-06
foci O 0 2.4266453692689538e-05
in O 0 2.9956448432955085e-09
benign O 0 0.00298678083345294
breast O 0 0.4605118930339813
, O 0 3.172275597762564e-08
invasive B-Disease 0 0.0002462713746353984
lobular I-Disease 1 0.9997445940971375
cancers I-Disease 1 0.9999744892120361
and O 0 2.601105279609328e-06
low B-Disease 0 0.05617288127541542
- I-Disease 0 0.47105899453163147
grade I-Disease 0 0.017181474715471268
ductal I-Disease 1 0.9955729246139526
carcinomas I-Disease 1 0.9999991655349731
. O 0 1.5629996141797164e-06

Conversely O 0 6.851905709481798e-06
, O 0 1.8786607824949897e-09
BRCA1 O 0 2.9853622436348815e-06
expression O 0 3.9553404462822073e-07
was O 0 1.555633488692365e-08
reduced O 0 3.207562437879119e-09
or O 0 8.367267434472581e-10
undetectable O 0 8.132750650702292e-08
in O 0 2.305092531781905e-12
the O 0 2.889690006377399e-12
majority O 0 1.8882938615516487e-11
of O 0 1.1000904180658022e-11
high O 0 1.028850817874627e-07
- O 0 4.080533017258858e-06
grade O 0 1.6691555515535583e-07
, O 0 2.5481661225512653e-10
ductal B-Disease 0 1.5941590390866622e-05
carcinomas I-Disease 1 0.9999994039535522
, O 0 7.25927096212331e-10
suggesting O 0 1.7477450597880306e-08
that O 0 2.4533146347760493e-11
absence O 0 6.826399862047694e-11
of O 0 4.382112728240628e-12
BRCA1 O 0 9.720266689328128e-07
may O 0 3.4896345812995833e-09
contribute O 0 1.1147895107033179e-11
to O 0 2.1036759573905828e-12
the O 0 5.9589173873053625e-12
pathogenesis O 0 7.189135953211689e-10
of O 0 1.5327887884723085e-13
a O 0 1.8215001989368984e-12
significant O 0 1.389369262000395e-11
percentage O 0 8.449189792258949e-09
of O 0 1.1646717444635524e-11
sporadic B-Disease 0 3.2224586902884766e-05
breast I-Disease 1 0.9999302625656128
cancers I-Disease 1 0.9995194673538208
. O 0 4.944280540541968e-09
. O 0 4.160357836013873e-09

